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ABSTRACT 
 
Multiple Sclerosis (MS) is a complex neurological disease affecting the central 
nervous system and is driven by a complex autoimmune cascade. The peak age of 
onset is between the ages of 20 and 40 years and shows a female preponderance of 
3:1. The most common form of the disease affecting 85% of people living with the 
illness is called relapsing remitting MS (RRMS), and is characterised by 
unpredictable relapses or exacerbations which usually last a few weeks before 
returning to baseline function. There is the possibility of disease progression and 
non-reversible disability after many years. RRMS is also characterised by a 
complicated array of symptoms which may affect sensory function, motor function, 
vision, gait, cognition, mood, bladder, bowel and sexual function. There is currently 
no curative treatment for RRMS, although recently there have been major advances 
in more efficacious treatments called disease modifying therapies (DMTs) to control 
relapses and possibly future disability. 
 
The aim of this study was to gain insights and understanding into the lived 
experience of RRMS in order to inform patient-centred nursing care. Although there 
is an abundance of literature dealing with various aspects of the MS experience, there 
is a paucity of literature specifically exploring the general life experience of living 
with the disease and considering a broader understanding. Life history methodology, 
a form of focused ethnography, was used to explore the illness experience across the 
lifespan of 13 study participants living with RRMS. Semi-structured interviews were 
used to gather data and later transcribed by the researcher, before undergoing data 
analysis. Braun and Clarke’s (2006) method of thematic data analysis ensured a 
systematic and robust exploration of the lived experience and revealed eight key 
themes, 30 subthemes and 44 sub-subthemes, providing clarity and insight into the 
experience of living with RRMS.   
 
Several novel findings were revealed by the thematic analysis including an 
appreciation of the importance of early life events prior to the onset of RRMS and 
their potential impact on later coping, adjustment and resilience after diagnosis. A 
	 15	
key study finding was of people living with RRMS experiencing “Surplus 
Suffering”, a form of suffering over and above that caused by the disease itself and 
inflicted most often by health care professionals and significant others. Other themes 
explored concepts of “Piecing together the Puzzle” of RRMS at the beginning of the 
journey, “(Re)defining self” in the wake of an RRMS diagnosis, “Battling the 
Demons” that RRMS uncovers, dealing with invisible symptoms of the disease, 
managing the DMTs necessary to control the disease and their side effects, and 
ultimately “Taming the Beast” that is RRMS and “Holding Hands with Hope”.  
 
The life history approach revealed these themes to be reflective of the ebbs and flows 
of life, intertwining with each other and changing positions of importance according 
to life events, whether directly related to RRMS or indirectly related. Numerous 
recommendations for clinical practice in MS care have been developed from the 
study findings which are anticipated to improve clinical care and to enhance the 
quality of life for people living with RRMS, along the life trajectory. 
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CHAPTER 1: INTRODUCTION 
Introduction 
 
Life history, a form of focused ethnography, was employed in this study to explore 
the experiences of people living with a specific type of Multiple Sclerosis (MS) 
called Relapsing Remitting Multiple Sclerosis (RRMS). The study uncovered 
participants’ personal meaning and understanding as they learned to live with a 
chronic neurological illness that followed an unpredictable and uncertain disease 
course. Participants discussed and described the impact of RRMS on themselves, on 
their aspirations, their family, their friends, their work and their social and 
community lives. Interactions with various health care professionals (HCPs) formed 
the basis of many of their experiences related to living with RRMS and were 
highlighted as being both satisfying and challenging. Study participants were frank 
and open about their life experiences, drawing the researcher into their world and 
providing powerful and impactful knowledge to provide a truly meaningful 
understanding of what it feels like to live with RRMS.  
 
This chapter introduces key concepts about RRMS, providing a baseline 
understanding of the condition which will be fully explored throughout chapters 2 
and 3. Thereafter follows a discussion of the research question and specific aims of 
the study and the significance of the research, in the context of nursing research and 
in the context of knowledge about the disease. A short discussion regarding nuances 
of the terminology that will be used throughout the thesis will help provide 
consistency and clarity to the following chapters. Finally, an outline of the structure 
of the entire thesis will be presented. 
 
Background 
 
MS is one of the world’s most common neurologic disorders, with 2.3 million people 
diagnosed with the disease and the rate steadily increasing (Browne et al.,  2014). 
The most common form of MS at diagnosis is RRMS, affecting 85% of people living 
with the disease (Compston & Coles, 2008). The remainder of MS cases are 
characterised as Primary Progressive Multiple Sclerosis (PPMS), which has a 
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different prognosis and different characteristics to RRMS (Compston & Coles, 
2008). RRMS is characterised by unpredictable relapses (also called exacerbations, 
attacks or flare-ups) which usually last several weeks before the individual returns to 
baseline functioning (Lublin et al.,  2014). Although there may appear to be a return 
to function after a relapse, it has been reported that there is a measurable and 
sustained effect on disability (Lublin, Baier, & Cutter, 2003). The degree of disease 
progression and disability is unpredictable at the outset of RRMS and may lead to the 
sequale of Secondary Progressive Multiple Sclerosis (SPMS) in later years where 
people with an initial relapsing course develop irreversible disability without a 
relapse, although relapses are still possible (Lorscheider et al.,  2016). RRMS is also 
characterised by a complicated array of symptoms, which may affect sensory 
function, motor function, vision, gait, cognition, mood, bladder, bowel and sexual 
function amongst other many other signs and symptoms (Ben-Zacharia, 2011). There 
is currently no curative treatment for RRMS, although recently there have been 
major advances in more efficacious treatments called disease modifying therapies 
(DMTs) to minimise relapses and possibly prevent future disability (Stüve & Racke, 
2016). 
 
Although there exists an abundance of literature examining the many different 
aspects of MS and MS symptoms, there is a paucity of literature which explores the 
whole life experience of living with MS and more specifically, RRMS. Several 
seminal studies in the 1990’s and 2000’s started to explore the lived experience of 
people living with MS, but some did not disclose the specific type of MS included in 
the study (Hainsworth, 1994., Clair, 2003; Courts, Buchanan, & Werstlein, 2004) or 
else used groups of mixed MS types with varying levels of disability (Koopman & 
Scheitzer, 1999; Barker-Collo, Cartwright, & Read, 2006) making it challenging to 
be able to assess transferability of findings to the individual’s circumstance. It has 
become more important in the last two decades to differentiate between the types of 
MS, as DMTs are only available to treat RRMS; although there have been some 
advances recently for treating progressive types of MS. Miller (1997) was one of the 
first to explore the lived experience of people living with RRMS as 10 participants 
were interviewed as they attended MS clinics in the United States. Interpretative 
phenomenological analysis was used to present a story of the interplay of social 
networks in RRMS, coping skills, issues with control and conflict, unpredictability 
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and loss, fear and relief, getting to know RRMS and of the relationships of revealing 
and concealing the diagnosis (Miller, 1997). This seminal study is the most closely 
linked to the current study question, aims and goals, however it is important to note 
that this study took place before medications were available to treat relapses, unlike 
the current study. There is an absolute dearth of literature exploring the lived 
experience of people living with RRMS (PwRRMS) since this time and this concept 
will be explored further in the literature review in Chapter 3.  
 
Aims of the study 
 
The purpose of this research study was to gain insights and understanding into the 
lived experience of RRMS. More than just listening, describing and appreciating, this 
study aimed to produce a rich, thick account of how it feels for people to live with 
this disease, what is felt and how it is felt, the entire experience along the life 
trajectory. By gaining such insights, MS Nurses may have a deeper understanding of 
their patients’ experience and be able to plan and adjust their nursing care 
accordingly. The ultimate aim of the study is for the findings to have the capacity 
and diversity to improve nursing care and the quality of life for people living with 
RRMS at all stages of their life path and illness trajectory.  
 
The research question 
 
To address these specific aims, the study seeks to answer the research question: 
 
“What is the experience of living with Relapsing Remitting Multiple Sclerosis?” 
 
Methodology 
 
Qualitative research focuses on the way people make sense of their experiences 
(Holloway & Wheeler, 2013) and attempts to make the world visible (Denzin & 
Lincoln, 2000). The very nature of the research question immediately informed the 
choice of methodology. Using a qualitative approach to understand the lived 
experience would ensure the person living with RRMS is firmly at the centre of the 
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research process and their lived experience the focus of the research. The sampling 
method was purposive. Data was collected by conducting 13 semi-structured 
interviews with adults living with a diagnosis of RRMS. A life history approach 
explored the entire life lived to date; with and without RRMS. Thematic analysis 
using the recommendations of Braun and Clarke (2006, 2013) provided a systematic 
and robust method for data analysis, uncovering eight primary themes and over 70 
subthemes and sub-subthemes to further clarify and explain the data and to offer 
meaning and understanding of the lived experience of RRMS.   
 
Significance of the study  
 
Through sharing stories people come to understand their experiences, legitimise their 
behaviour and share their emotional experience with others in holistic form 
(Holloway & Freshwater, 2007a). Stories of illness and disability are often not heard, 
and as the paucity of lived experience literature in the field of RRMS suggests, it is 
time for that to change. By understanding the patient experience, MS Nurses and 
other HCPs can realise that there are more realities beyond the beliefs and 
perspectives they hold in their practice. The seminal work of Miller (1997) in RRMS 
was performed prior to the introduction of medications and modern treatments for 
RRMS, therefore it is critical that further research into the contemporary experience 
explores if and how things have changed for the patient and if subsequently the role 
of the MS Nurse needs to change. Miller’s (1997) seminal recommendations for MS 
nursing practice may need to be reviewed and updated to reflect modern practice.  
 
As a qualitative nurse researcher, my aim in conducting the research was to follow 
Munhall’s (2012) recommendations to add the following to the knowledge base of 
nursing: description, understanding, discovery, meaning, interpretation and 
explanation; all within and amongst genders, regions and cultures. By approaching 
the research question in a qualitative way, I searched for meaning that was different 
from the statistical, from the survey-reported general information often described in 
the literature. I searched for deeper meaning that could ultimately help with 
improving the quality of life for PwRRMS, and to make MS care more humane, safer 
and equalitarian (Munhall, 2012). A major personal goal was to develop 
recommendations for clinical practice based on patient focused nursing care. I 
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strongly believed this would allow MS Nurses to truly understand what PwRRMS 
experience on their life journey and ultimately allow MS Nurses to be in a position to 
make this journey happier, healthier and more rewarding.  
 
As the reporting of scientific and biomedical knowledge in MS has dramatically 
increased in recent years, there has been a shift in focus away from the patient 
experience and on to the next medication, the next molecule, the next blockbuster 
discovery. Instead, I argue that it is vital to go back to basics (to understand how 
patients feel and what they need) in order for any of these new discoveries to have 
their maximum impact. This then highlights what MS Nurses and HCPs can do in 
order to make each patient’s life journey with RRMS the best it can possibly be.  
 
Nuances of the thesis writing style and terminology  
 
Throughout this thesis, there will be certain instances or situations that are specific to 
the context of living with RRMS. I will discuss these now to ensure clarity and 
consistency throughout the thesis.  
 
Firstly, the term PwMS refers to “a person/people living with MS” and the term 
PwRRMS refers to “a person/people living with “Relapsing Remitting MS”. 
Although this research study is primarily concerned with one type of MS, RRMS, 
often previous literature may just refer to MS in general with no distinction between 
different types of MS studied. This makes it difficult to know the degree of relevance 
to RRMS specifically. Literature in this category was mainly prior to the introduction 
of treatments for RRMS (after which delineation of RRMS became more necessary), 
but has also been seen in some more recent work referred to in the current study. In 
these cases the more generic term “PwMS” will be used, reflecting the author’s 
reporting of the information. At other times, the idea or concept will be specific to 
RRMS or researched only in RRMS, and so the term “PwRRMS” will be used when 
this is certain. Each situation and use of the term will have been carefully assessed to 
ensure the correct terminology appropriate to the case. 
 
The second area requiring clarification pertains to the terms “patient” and  
“participant”, which are both used extensively throughout this thesis. Where the 
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discussion refers to a current study participant taking part in the study, the term 
participant will be used, an accepted term in qualitative research (Holloway & 
Wheeler, 2013; Braun & Clarke, 2013). Where the discussion refers to a patient 
rather than a participant, this will be as a result of the specific term patient being 
used in the literature. In the case of the overview of MS in chapter 2 and the clinical 
recommendations in chapter 9, the term patient has been used. This is because it is 
appropriate to the more general context of patients and medicine/nursing concepts 
under discussion in those chapters. 
 
Thirdly, as this is a nursing thesis being undertaken at the School of Nursing, 
University of Notre Dame, the primary audience of this thesis is likely to be an MS 
Nurse, therefore professional references are made to MS Nurse/s, unless a finding or 
comment relates specifically to another member of the health care team (where the 
role will be specified), or to HCPs in general. However, the study findings from this 
thesis and clinical recommendations are likely to universally apply to all MS HCPs, 
no matter what specialty they practice in.   
 
Importantly, much of the qualitative literature referred to throughout the thesis, and 
particularly in chapter 4, is seminal work and as such, can date back decades. Unlike 
scientific and quantitative work which places great value on the most up to date 
information and references, qualitative research texts and terminology very often 
refers to this seminal work, usually as it is the most outstanding representation of the 
qualitative paradigm available. Where more recent explanations or supporting 
evidence is available, it will be used in this thesis. Traditional reporting of 
quantitative findings provides exact numbers, quantities and percentages (Polit & 
Beck, 2010). However, as recommended by Braun and Clarke (2013), findings of 
this qualitative study will use terms such as “some”, “several”, “many”, “most” and 
“all” to refer themes and subthemes generated by the data.  This is because in 
qualitative research, just counting numbers misses the point (Pyett, 2003), whether 
something is insightful or important for shedding light on the research question is not 
determined by numbers (Buetow, 2010; Braun & Clarke, 2013). The goal of 
qualitative research is not to generalise, but to provide a rich, descriptive, 
contextualised understanding of some aspect of human experience (Polit & Beck, 
2010). 
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The peak organisation in Australia providing assistance, education and support to 
PwMS has had several name changes over the years. In the state of New South 
Wales (NSW) where the current study was performed, the MS Society (MSS) later 
became MS Limited (MSL), and is now named MS Australia (MSA). Direct quotes 
from the participants will be unchanged, however all other references made will be to 
the current organisational name, MSA.  
 
Medications have both generic and trade names. In this thesis, they will be referred 
to by their generic names in the more formal discussions.  However, medication 
trade names will also be referred to where necessary to ensure clarity as, very often, 
the study participants referred to their medications by the trade name.  
 
Overview of the thesis 
 
This first chapter has provided a rudimentary overview of RRMS, providing context 
for the research study. The study aims and research question are stated and a clear 
justification for the study is argued.  
 
Chapter 2 will provide a more comprehensive overview of the disease, outlining 
characteristics and features which have an impact on a life lived with RRMS. This 
chapter contextualises the work as one exploring a complex, dynamic and 
unpredictable disease.  
 
Chapter 3 provides a critical review of the existing literature. It is argued that, 
although there has been much research conducted in specific areas of MS care, 
understanding the broader context of the lived experience is poorly understood. The 
significant gaps in the literature indicate that the lived experience in RRMS is under-
researched. Rather than a traditional thesis layout of the literature review in its 
entirety, chapter 3 provides a basic overview of the important work related to the 
lived experience of MS and, if it is specifically referred to by the authors, RRMS. 
However, the study findings located in chapters 6, 7 and 8 will weave more specific 
areas of MS/RRMS knowledge throughout each of the themes to firmly position the 
study findings within the current understanding of these phenomena.  
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A description and justification of the methodology and method that were employed 
to meet the study aims and answer the research question are detailed in chapter 4, 
along with a discussion regarding data management, ethical considerations, study 
rigour and reflexivity.  
 
The individual narratives for each study participant are presented in chapter 5. A 
short life story is presented to provide context to their unique lives. This introduces 
the reader to each participant and provides context for the study finding chapters that 
follow in chapters 6, 7 and 8.  In these later chapters, direct quotes from the study 
participants will be used to provide evidence to justify the study themes.  
 
The findings for the study are presented and integrated with the relevant literature in 
chapter 6 titled “Walking the Low Road” and Chapter 7 titled “Finding the High 
Road”, where a total of eight primary themes are revealed. The main focus of chapter 
6 is the early journey with RRMS, putting together the little hints that something 
might be wrong, seeking help, being diagnosed with RRMS and living with the 
challenges the early days present, some of them serious and confronting; others a 
chance to (re)define self and make new discoveries. The main focus of Chapter 7 is 
finding a path to a brighter future and discovering the skills to live well with RRMS, 
skills critical to  “Taming the Beast” and looking forward to life with positivity and 
hope. 
 
Chapter 8 is called “The Life Journey - Ebbs and Flows of Living with RRMS” and 
weaves the study themes together with life history methodology, demonstrating the 
effectiveness of using this novel method in qualitative MS nursing research. This 
chapter provides meaning and understanding of the lived experience of RRMS and 
highlights how this methodology works with the long-term trajectory of a chronic 
illness.  
 
Chapter 9 concludes the thesis by presenting a summary of the research process and 
the major study findings. Recommendations for clinical practice in MS nursing care 
are presented and are linked to the key themes identified in the study. Limitations of 
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the research are discussed, as well as suggested directions for future research in 
RRMS.  
Conclusion 
 
This study aimed to uncover deep and rich understanding of the experience of living 
with RRMS. Using a life history approach, semi-structured interviews and thematic 
data analysis, themes were developed which detail the stories of people living with 
RRMS as they go about the challenges and joys of their daily lives. Using the life 
history approach also enabled particular attention to each participant’s life before 
RRMS in order to appreciate what came afterwards, with the diagnosis of RRMS and 
(re)defining of self. Chapter 2 provides an overview of the disease, outlining the 
specific challenges for individuals living with RRMS and the modern day treatment 
paradigm. This provides a context for understanding the complexities and intricacies 
of the disease, allowing an appreciation of what it means to be diagnosed with 
RRMS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 					
	 25	
	
CHAPTER 2: OVERVIEW OF MULTIPLE SCLEROSIS 
 
Following on from the brief introduction of MS in the previous chapter, chapter 2 
will provide a more comprehensive overview of MS. This is primarily to support 
situating the context of the study as people living with an unpredictable and 
potentially serious threat to health and wellbeing but also to give an understanding of 
the many possible symptoms of RRMS and the specific issues that relate to living 
with the disease. RRMS has a great variability of possible presentations and disease 
courses, as well as being a complex disease to clinically diagnose and manage. 
Having an understanding of the overall picture of MS and more specifically RRMS 
will help the reader to appreciate the impact of the themes and sub-themes of the 
study findings and to realise the overall significance of the research in terms of 
potentially improving clinical care for PwRRMS in the future. 
 
What is MS?  
 
MS is a disease of the central nervous system (CNS) affecting the brain, spinal cord 
and optic nerves. MS is a progressive inflammatory disorder in which there is 
damage to key components of the nerve cells, namely myelin and axons (Compston 
& Coles, 2008). The pathological processes involved in MS are immune mediated 
and directed against the myelin sheath, the protective covering of the axons, termed 
demyelination (Calabresi, 2004). More recently it has become apparent that grey 
matter disease occurs early in the disease process, causing additional inflammation 
and neurodegeneration and possibly playing a role in physical and cognitive 
disability (Calabrese et al., 2015). 
 
As a result of demyelination and the subsequent healing process, sclerotic plaques 
(scars) develop in multiple areas of the CNS. This pattern needs to occur more than 
once to fulfil the diagnosis of MS - multiple sclerotic lesions in multiple locations. 
However, over time, the disease becomes one of chronic neurodegeneration rather 
than acute inflammation, with progressive accumulation of disability due to nerve 
loss (Compston & Coles, 2008). The impaired nerve conduction, resulting from 
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demyelination and axonal loss, leads to many of the signs and symptoms of MS. The 
course of MS is highly variable and patients may develop irreversible disability, with 
MS remaining a major cause of disability in young adults (Brownlee et al., 2016). 
MS remains incurable, although recent breakthroughs in understanding MS and more 
targeted treatments are resulting in a brighter future for people recently diagnosed 
with the disease.  
Clinically Isolated Syndrome (CIS) 
 
Most cases of MS present with an acute first episode, known as the clinically isolated 
syndrome (CIS) (Compston & Coles, 2008). Until recently, a diagnosis of MS was 
not able to be made at the time of CIS, even if highly suspected, because there 
needed to be two clinical relapses more than 30 days apart to meet the diagnostic 
guidelines of a multiple relapsing MS course (Poser 1983; McDonald et al., 2001; 
Polman et al., 2005). This situation was often frightening for many patients after 
suffering a first relapse, with no clear answers and just a “wait and see” approach. In 
recent years, it has become possible with the revised diagnostic guidelines to 
diagnose MS after one CIS, if the magnetic resonance imaging (MRI) and other 
testing meets certain criteria to demonstrate multiple relapses (Polman et al.,,2011; 
Thompson, Banwell, & Barkof, 2018).  Internationally, the currently used criteria for 
diagnosing MS are known as the 2017 McDonald criteria (Thompson et al., 2018). 
 
Once the McDonald criteria have been met and the diagnosis of MS has been 
confirmed, there are three clinical course descriptions (phenotypes) of MS that will 
categorise the disease and thereby guide future treatment, prognostication and 
management strategies (Lublin et al., 2014). These are relapsing remitting MS, 
secondary progressive MS and primary progressive MS. Educating patients and 
families about the differences between these phenotypes is essential, as they are very 
different disease courses each with different treatment options. 
Relapsing Remitting MS (RRMS) 
 
The majority of people diagnosed with MS (up to 85%) begin with a diagnosis of 
RRMS (Milo & Miller, 2014; Brownlee et al., 2016). A relapse is defined as “patient 
reported or objectively observed events typical of an acute inflammatory event in the 
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central nervous system (CNS), current or historical, with duration of at least 24 
hours, in the absence of fever or infection” (Polman et al., 2011, p.293). Relapses are 
also referred to as “exacerbations”, “attacks” and “flare-ups” but the term relapse 
will be used throughout this thesis for clarity and consistency. New relapses occur 
erratically but seldom occur more than one to two times per year (Compston & 
Coles, 2008). Typically, people recover from a relapse and return to baseline (before 
the relapse) function over a period of four to eight weeks, but recovery can be 
uncertain, variable and incomplete (Sorensen, 2014). Additionally, although it may 
appear that physical function is returned following a relapse, there is still a 
measurable and sustained effect on disability from relapses (Lublin et al., 2003). 
Relapse symptoms are generally considered to resolve over time, even if not treated 
(Ross, Halper, & Harris, 2012). However, if the relapse symptoms are bothersome or 
affecting function, treatment may be considered to speed up the process of recovery, 
usually involving a short course of high dose corticosteroids to reduce the acute 
inflammation (Bevan & Gefland, 2015; Kalincik, 2015; Yamasaki et al., 2016). 
Relapses can be a significant physical, emotional and economic burden with the 
reduction of relapses by using disease modifying therapy (DMT) an important goal 
of treatment in order to reduce future neurological disability (Kalincik, 2015). The 
forms of DMT available to treat RRMS and their implications will be discussed later 
in this chapter. 
 
At present there is no tool or test that can advise what the future clinical course of 
RRMS will be for an individual, adding to the uncertainty at the time of diagnosis 
(Bergamaschi et al., 2015) where no specific information on prognosis can be given.  
However, there are prognostic risk factors which can provide some guidance, 
including a better prognostic outlook for PwRRMS who are female, experiencing 
sensory rather than motor relapses and showing minimal burden of disease on 
imaging (Weinshenker, 1995). There are groups of people with RRMS who 
experience very few symptoms and little clinical activity and yet others have highly 
active clinical and radiological disease (Hum, Lapierre, Scott, Duquette, & Mayo, 
2017). MS progression can be so variable that there was a time when it was thought 
that no common disease course existed and that each patient followed a unique path 
(Minderhoud, van der Hoeven, & Prange, 1988).  
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Secondary Progressive MS (SPMS)	
 
Over time, recovery from relapses in RRMS is incomplete and accumulation of 
disability begins (Compston & Coles, 2008). SPMS is diagnosed retrospectively by a 
history of gradual worsening, after an initial relapsing course, with or without acute 
relapses during the progressive course (Lublin et al., 2014). There are no clear 
criteria to determine exactly when this transition occurs, it can be an unpredictable 
and uncertain period of time for PwRRMS (Bergamaschi et al., 2015) and also for 
their HCPs. The natural history data on the course of MS suggests that on average, 
SPMS occurs about 19 years after RRMS onset, with PwSPMS taking an average of 
20 years to progress to using a walking stick and 30 years for wheelchair dependance 
(Vukusic & Confaveux, 2006). Reaching SPMS at a younger age and with only a 
short RRMS course has also been asssociated with a more rapid disease progression 
(Tremlett, Zhao & Devonshire, 2008).  
Primary Progressive MS (PPMS)   
 
PPMS is a separate clinical phenotype affecting 10-15% of people diagnosed with 
MS (Milo & Miller, 2014). PPMS is progressive in nature from disease onset with 
gradual worsening of neurological function and no relapses occurring (Compston & 
Coles, 2002). It has been hypothesised that PPMS represents a distinct, non-
inflammatory form of MS (Lassmann, van Horssen, & Mahad, 2012), which may 
explain why the traditional DMTs (which are effective in RRMS) do not alter the 
disease course in PPMS. However, there has also been recent literature to suggest 
that in PPMS there may be some inflammatory activity, but it is different in nature to 
RRMS and SPMS and features axonal destruction and eventually brain atrophy 
(Mahad, Trapp, & Lasmann, 2015). Compared with RRMS, people with PPMS are 
older at onset and a higher proportion are men (Lassmann, van Horssen, & Mahad, 
2012). There has recently been a breakthrough in a new treatment for PPMS with 
Ocrelizumab, a CD-20 monoclonal antibody,leading to depletion of B-cells and  
demonstrating effectiveness in PPMS by slowing disease progression (Hauser, 
2015). Ocrelizumab has very recently been approved for use in Australia and 
internationally. 
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New classifications for MS 
 
There has recently been a suggestion to reclassify the phenotypes of MS, taking into 
account disease activity; reclassifying PwMS as experiencing either a relapsing or 
progressive path and with either active or inactive disease and either progression or 
non-progression (Lublin et al., 2014). However, this has not universally been 
adopted at present, so reference to the original phenotypes outlined above will be 
used throughout this thesis. 
 
Natural History of MS 
  
Much is known about the natural history of MS, mainly because there were no 
treatments or disease modifying drugs until the 1990’s (Jacobs et al.,1996). The 
natural history pattern is highly variable. The seminal natural history data from 
Weinshenker (1994) suggests that at 15 years from disease onset, 50% of patients are 
disabled to the point of needing a walking stick to ambulate. Additionally, an early 
age at onset, female sex, relapsing-remitting course at onset, optic neuritis or sensory 
symptoms and relatively few attacks in the first two years are associated with a more 
favourable course (Weinshenker, 1994). Conversely, patients with the greatest risk of 
disability are those with PPMS or RRMS patients who are older at onset, have 
pyramidal or cerebellar involvement, and who have frequent or prolonged attacks 
with incomplete recovery. The biological basis for the variation in the course of MS 
is poorly understood.  
 
Epidemiology 
 
In many countries MS is the leading cause of non-traumatic neurologic disability in 
young adults (Browne et al., 2014). The Australian Bureau of Statistics (ABS) 
estimate a total of 23,700 people in Australia to be living with MS (ABS, 2009). 
However, more recent data from Multiple Sclerosis Research Australia (MSRA) 
suggests this number may now be as high as 25,600, with an average of more than 10 
people being diagnosed in Australia every week (MSRA, 2018). The increasing 
incidence and prevalence of MS over the last five decades (Pugliatti et al., 2006; 
Koch-Henricksen & Sorensen, 2010) is concerning and requires continued research 
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to better understand the potential environmental factors impacting on the 
development of the disease. 
 
Interestingly, the prevalence of MS has a female preponderance with women almost 
three times more likely than men to develop the disease (Koch-Henriksen & 
Sorensen, 2010). RRMS can occur at any age, but the most common age for 
diagnosis is as a young adult between 18 and 40 years, with a mean age of 30 years 
(Compston & Coles, 2008). However, paediatric MS occurs in about 5% of cases 
with onset before the age of 18 years (Lulu, Graves, & Waubant, 2016) and is more 
prevalent in adolescents than younger children (Waldman et al., 2016). 
 
Causes of MS  
 
The cause of MS is unknown, however there are several clues about how MS begins 
(Spencer & Karceski, 2015). It is thought that MS is caused by a complex interplay 
between the immune system and environmental factors (Compston & Coles, 2008). 
It seems unlikely that MS results from a single causative event, but rather the disease 
develops in a genetically susceptible population as a result of environmental 
exposures (Ramagopalan & Sadovnick, 2011). Exposure to environmental risk 
factors in MS is thought to occur before the age of 15 years (Belbasis, Belbu, 
Evanelou, Ionnidis, & Tzoulaki, 2015). The risk factors thought to be associated with 
an increased risk of MS include Epstein-Barr and other viral and bacterial infections, 
vitamin D levels, geographical location/latitude gradient (the closer to the poles, the 
greater the prevalence of MS), cigarette smoke exposure, and certain human 
genotypes (Banwell, Bar-Or, Giovannoni, Dale, & Tardieu, 2011; Sellner et al., 
2011) as well as obesity, gut microbiota and pregnancy exposures (Belbasis, Belbu, 
Evangelou, Ionnidis, & Tzoulaki, 2015). The infection exposure theory is currently 
thought to originate in childhood, where antibodies are formed against an infectious 
agent (an as yet identified virus or bacteria) and for reasons that are unknown, these 
antibodies attach to a protein in the myelin coating of the axons resulting in the body 
becoming confused and destroying the protective myelin (Spencer & Karceski, 
2015).  
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MS has a familial recurrence rate of about 5% for siblings and about 2% for children 
and parents (Compston & Coles, 2008), suggesting genetic links but not heritability 
of the disease, with most PwMS having no affected relative (Coyle, 2016). Recent 
genetic research has accelerated the understanding of genetic MS theories with the 
identification of non-human leukocyte antigen (HLA) risk genes that are related to 
immune function (Waubant et al., 2016), opening exciting new areas of hope for 
answering questions about the causes of MS in the future. 
 
Diagnosing MS 
 
The diagnosis of MS is based on neurological signs and symptoms and is primarily a 
clinical diagnosis, assisted by specific investigations (Brownlee et al., 2016). Often 
there are significant delays before a person with symptoms suggestive of MS sees a 
neurologist and receives a diagnosis (Giovannoni et al., 2016). There are several 
reasons for this delay including lack of recognition of symptoms by the person, the 
family doctor not referring on, lack of available neurology care and appointments 
and symptoms being both vague and intermittent in nature. 
 
In most PwRRMS, clinical manifestations (the symptoms) reflect the area of 
demyelination in the CNS and indicate the involvement of motor, sensory, visual, 
and autonomic systems, but many other symptoms and signs can occur (Compston & 
Coles, 2008). Adding to the difficulties with diagnosis, very few clinical features are 
disease-specific and there is no pathognomonic test for MS. Specifically, there is not 
one symptom, sign, or paraclinical result that provides an unfailingly accurate 
diagnosis of MS (Giesser, 2011). This can be a time of extreme frustration for 
patients as often the diagnosis involves many tests and investigations and can 
sometimes not be definitive, and in some cases, not definitive for many years.  
  
Over the last four decades, certain criteria have been developed to help guide the 
diagnosis of MS, beginning with Poser et al. (1983) and followed by the “McDonald 
criteria” (McDonald et al., 2001), which incorporated the MRI scan for the first time. 
The McDonald criteria were updated in 2005 (Polman et al., 2005), again in 2010 
(Polman et al., 2011) and more recently in 2017 (Thompson et al., 2018) to reflect 
changes in MS knowledge and practice. The most recent changes have made an 
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important impact, allowing for an earlier diagnosis of MS, leading to more rapid 
treatment initiation and reducing the risk of disease progression (Mantero, Abate, 
Balgera, La Mantia, & Salmaggi, 2018). This has led to an increase in MS cases 
being diagnosed but still requires careful assessment to prevent misdiagnosis and 
mistreatments (Mantero et al., 2018). However, this can also create significant 
emotional and coping issues as people can be diagnosed with RRMS in just one visit 
to the neurologist, and then also face difficult and complex treatment decisions 
simultaneously.  
 
Investigations used to diagnose MS 
 
In addition to neurological and clinical examinations, diagnosing MS often depends 
on excluding other disorders that can mimic MS (Filippi et al., 2016). Some of these 
investigations include the MRI scan, neurophysiological tests such as evoked 
potentials and extensive blood tests. A spinal tap or lumbar puncture (LP) can also be 
performed to obtain cerebrospinal fluid (CSF) for examination to assess for the 
evidence of oligoclonal bands, which can assist in confirming an MS diagnosis. Most 
of the investigations are not painful but can be uncomfortable at times (MRI, LP, 
blood tests), difficult (LP) or induce feelings of claustrophobia (MRI).   
 
The	Expanded	Disability	Status	Scale		
 
The Expanded Disability Status Scale (EDSS) is used to quantify the degree of MS 
related disability in individual patients (Kurtze, 1955; 1983). Many studies show that 
MS relapses can leave permanent neurological deficits and play a role in disability 
accumulation (Goodin et al., 2016). The EDSS aims to measure the neurological 
function and provide a score to reflect neurological deficits. A clinical examination 
of eight functional systems impacted by the CNS (pyramidal, cerebellar, brain stem, 
sensory, bowel/bladder, visual, cerebral and other) results in individual scores which 
are compiled together with ambulatory data to form a total score, the EDSS. The 
final score ranges between 0 and 10, with 0.5 measurements between each level. A 
score of 0 indicates no neurological impairment, a score of 1.0 indicates mild 
disability in a single area, a score of 4.0 indicates that a person is fully ambulatory 
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but accruing significant disability in several functional areas, a score of 6.0 indicates 
assistance required to ambulate with a unilateral walking assistance, 6.5 bilateral 
walking assistance or walker, a score of 7.0 indicates wheelchair dependence and a 
score of 9.0 indicates confinement to bed. An EDSS  score of 10 relates to death 
from MS.  
 
Common symptoms in MS  
 
The initial presentation of MS varies according to both the location and size of 
lesions and the type of onset (relapsing or progressive onset) (Brownlee et al., 2016). 
Common symptoms in MS can greatly affect quality of life (QOL) and rarely occur 
in isolation (Crayton & Rossman, 2006; Newland, Thomas, Riley, Flick, & Fearing, 
2012). These symptoms include fatigue, depression, anxiety, cognition issues, 
bladder and bowel dysfunction, sexual dysfunction, pain, spasticity, motor weakness, 
sensory dysfunction, visual disturbances, ataxia and gait disturbances. Symptoms 
usually result directly from nerve conduction issues secondary to demyelination, 
either in response to an acute relapse, or as long-term consequence of previous 
demyelination and axonal loss. Additionally, many of these symptoms are not 
immediately obvious to others and are described as “hidden” or “invisible” 
symptoms of MS, which can lead to possible stigmatisation or poor understanding by 
others who do not have the disease (Joachim & Acorn, 2000).  
 
Symptom management in MS is an integral part of its care, with accurate assessment 
and management providing increased quality of life (Ben-Zacharia, 2011).  It has 
been suggested that MS-related fatigue is different to normal fatigue due to its 
severity and the ability to significantly impact upon daily activities (Newton, 
Griffiths, & Soundy, 2016), being complex, multidimensional and poorly understood 
(Smith, Hale, Olson, Baxter, & Schneiders, 2013). There are two symptoms, not 
diagnostic of, but often peculiar to, demyelination in MS. These are L’hermittes sign, 
which is an electric shock-like feeling when flexing the neck forward and is caused 
by inflammation in the spinal cord (Al-Araji & Oger, 2005). The second is Uhthoff’s 
phenomena, MS symptoms which can be worsened or triggered by factors such as 
the menstrual period, exercise, infection, fever and stress and refers to symptoms 
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coming on paroxysmally and being reversible (Frohman et al., 2013). “Pseudo-
relapses” can occur in RRMS and describe fatigue occurring in isolation or a 
transient fever-related worsening of MS symptoms (Polman et al., 2011).  
 
Aside from the highly variable disease state and multitude of possible neurological 
symptoms, MS can also cause numerous secondary and tertiary effects. Issues may 
develop in highly personal areas of intimacy and sexuality, relationships and 
employment. MS often causes challenges for people coping with the disease and the 
associated changes in life (Rommer, Koenig, Suhnel, & Zettl, 2015). 
MS and mental health issues 
 
 MS is often diagnosed at an exciting time of life, when young adults are graduating 
from school or university, getting married, starting a family or advancing a career, 
MS therefore has the potential to cause significant emotional stress in the lives of 
people diagnosed with the disease. As a result of the current shortened diagnostic 
workup, people with RRMS can be rapidly confronted with a disease of uncertain 
prognosis that requires complex treatment decisions (Solari et al., 2014). This can 
also be at a time of great vulnerability when PwRRMS could be ill-equipped to make 
these decisions due to recent high dose steroid treatments, feelings of stress and 
worry, other mental health issues, confusion over the meaning of the disease and the 
wealth and complexity of available information and resources. Anxiety and 
depression in particular have both been associated with less adherence to medication, 
increased risk of relapses, cognitive impairment, increased use of health resources, 
mortality, fatigue and pain in PwMS (de Jong & Uitdehaag, 2018). An additional 
area of concern is the rate of suicide in people living with MS, which is up to seven 
times greater than the general population (Pompili,  2012). 
 
Anxiety 
 
It is not surprising that the unpredictable nature of RRMS, specifically with respect 
to relapses and potential for disability, leads to anxiety (Morrow, 2018). Anxiety is a 
diagnosable mental health illness under the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V®) with a variety of criteria and specific anxiety disorders 
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(APA, 2013). Several studies exploring anxiety in MS have shown that anxiety is 
more prevalent in the MS population than in the general population (Feinstein, 
Magalhaes, Richard, Audet, & Moore, 2014) and may be as high as 36% in PwMS 
(Hoang, Laursen, Stenager, & Stenager, 2016). A large cohort study (n=5084) of MS 
patients matched with a control population, has reported that during both the pre and 
post diagnostic period, MS patients had an increased risk of anxiety and medication 
usage when compared to the general population (Hoang et al., 2016). In RRMS, 
anxiety may be severe and prolonged due to the uncertain nature of the disease, in 
terms of relapses, symptoms and disease progression (Janssens et al., 2004). 
Furthermore, anxiety has been strongly associated with lower QOL scores across all 
levels of illness severity, from mild impairment to severe (Ionescu et al.,  2012). 
Anxiety is more prevalent in females than males in PwMS (Theaudin, Romero, & 
Feinstein, 2016) and needs regular assessment and evaluation. There is also a higher 
likelihood of alcohol use, substance abuse and smoking associated with anxiety in 
PwMS (Marrie et al., 2015). 
 
Anxiety has also been identified as being significantly associated with low levels of 
disease acceptance and mindfulness in MS (Pakenham & Samios, 2013), which may 
have direct consequences on adherence to DMTs and to MS wellness prescriptions. 
Anxiety is most highly associated with depression, low self-efficacy, stress, emotion 
focused coping, pain, fatigue and QOL, factors that may be amenable to intervention 
if identified and actioned by MS HCPs (Butler, Matcham, & Chalder, 2016).  
 
Depression 
 
As with anxiety disorders, depressive disorders are a diagnosable mental health 
illness under the DSM-V® with listed criteria including depressed mood, loss of 
interest and enjoyment in usual activities, reduced energy, reduced self esteem and 
confidence, ideas of guilt and unworthiness, pessimistic thoughts, disturbed sleep 
and appetite and ideas of self harm (APA, 2013). For people with MS the lifetime 
prevalence rate of a depressive disorder has been reported as greater than 50% 
(Hoang et al., 2016) and is three times higher than the general population (Kessler et 
al., 2012; Patten, Beck, Williams, Barbui, & Metz, 2003). Depression in MS is still 
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undertreated and under-recognised and most importantly, depression can be fatal 
(Feinstein, 2011; Newsome et al., 2017)  
 
A multitude of aetiologic factors contribute to depression in MS, including biological 
(lesion burden, location of lesions and brain atrophy) as well as the stresses, losses 
and threats that accompany living with an unpredictable and potentially disabling 
disease (Patten et al., 2003). Depression in MS is extremely complex and 
complicated by other factors such as fatigue, cognition and physical impairment, 
which can also mimic depression and prevent accurate diagnosis (Gunzler et al., 
2015). Turner and Alschuler (2018) suggest that depressed mood and MS symptoms 
such as fatigue, cognition and pain have a bidirectional relationship, each causing the 
other to be worse. Depression in MS possibly has a different pathophysiology to the 
general population and has been described as chronic rather than episodic in nature 
(Koch et al., 2015). Additionally, depressive syndromes occur with significant 
frequency across the natural history of MS, including patients with very mild forms 
of MS, and do not correlate well with the severity of neurologic disability (Perez, 
Gonzales, & Lazaro, 2015).  
 
Treatments for RRMS 
 
Disease modifying treatments for MS  
 
There have been many recent developments in treatments for RRMS, however a cure 
for the disease remains elusive. The immune dysregulation in the development of 
MS leads to a cascade of events resulting in inflammation and axonal degeneration in 
the CNS (Grigoriadis & van Pesch, 2015). The DMTs act to interrupt this cascade at 
varying points of the process. The goal of the DMT is to delay the accumulation of 
disability and to delay transition to the more progressive and disabling SPMS (Liu et 
al., 2016). The occurrence of a relapse on a DMT is usually considered an indication 
of breakthrough disease and suboptimal response (Liu et al., 2016) and often results 
in a “switch” of DMT to another therapy, usually to a more efficacious medication 
(Bevan & Gelfand, 2015). However, as no current DMT completely eradicates 
disease activity, there is much debate currently about what constitutes breakthrough 
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disease and what the primary aim of treatment is; as treatment goals move and 
monitoring of outcomes is more active (Giovannoni et al., 2015).  
  
In the past 20 years RRMS has been transformed from a disease of relative 
hopelessness, with few, if any, treatment options to one of optimism and robust 
therapeutic promise (Ross & Thrower, 2010). The approval of immune modifying 
medications for RRMS is often cited as a major advance in our understanding, 
however many questions still remain unanswered (Stüve & Racke, 2016). Whilst the 
number of DMTs are rapidly increasing, there is still need to define which patients 
will respond to which drug and who is at higher risk of side effects (Stuve & Racke, 
2016). The option of individualised optimal treatment is complicated because of the 
unpredictable natural behavior of the disease, the different phenotypes and stages, 
the diversity of different therapies, and the serious and sometimes life-threatening 
side-effects of some of the treatments (Rio, Comabella, & Montalban, 2011). 
 
With advances in DMTs, survival in RRMS has increased and a slower accumulation 
of disability has resulted (Tremlett, Zhao, Rieckmann, & Hutchinson, 2010) with the 
natural history of the disease shown to be altered in randomized clinical trials 
(Wingerchuk & Carter, 2014). Treatment options for the disease are most effective 
during the relapsing remitting phase and are recommended to start early after 
diagnosis for the best clinical outcomes (Broadley et al., 2015; Kavaliunas et al., 
2017). Australia is in a fortunate situation in terms of registered and government 
supported programs for DMTs to treat RRMS. There are set criteria to follow in 
order to gain Pharmaceutical Benefits Scheme (PBS) approval, but once these 
criteria are met, patients can be prescribed a range of DMTs, benefitting from an 
individualised approach to choose the DMT most appropriate for their level of 
disease activity and based on pathpohysiology and illness patterns. The cost of these 
medications is high, but the DMTs are made available to patients in Australia at 
greatly subsidised rates. All available medications have been tested clinically for 
safety and efficacy in large, multicentre clinical trials in people with RRMS. Many 
other countries (currently such as Great Britain) have restrictions on which 
medications may be used at which stage of the disease or have regulations on which 
medications need to be used as first, second or third line therapy (Giovannoni et al., 
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2016) or other countries (such as the United States) need to rely on approval from 
insurance companies to begin a certain DMT (Parise et al., 2013).  
 
There are currently 12 DMTs approved to treat RRMS in Australia; the injectable 
medications which the patient learns to self-inject (four forms of interferon beta, two 
forms of glatiramer acetate) the oral medications (fingolimod, dimethyl fumarate and 
teriflunomide) and the intravenous monoclonal antibody medications (natalizumab, 
alemtuzumab and ocrelizumab). A current list of DMTs approved in Australia is 
listed in Table 1. The many options for treatment can be complex and challenging to 
negotiate, however there are suggested guidelines that can be followed to assist in 
choosing the most appropriate DMT for patients with RRMS (Broadley et al., 2014a; 
Finkelsztejn, 2014).  
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Table 1. Currently approved and marketed DMTs for RRMS in Australia 
 
 
All of the DMTs have side effects associated with their use, some of which (such as 
injection site reactions and intermittent mild diarrhoea) can be easily managed. Some 
of the newer treatments (the monoclonal antibodies) are more efficacious than the 
injectable therapies, reducing relapse rates by 50-70% compared to approximately 
30% for injectables (Kalincik et al., 2017). However, they do possess significant 
Generic name  Trade name  Mode of 
delivery  
Frequency 
of dosing  
Common side effects or 
serious side effects  
Interferon 
beta-1b 
Betaferon® subcutaneous 
injection 
every other 
day 
influenza-like 
symptoms (fever, 
chills), injection site 
reactions, depression 
Interferon  
beta -1a 
Rebif® subcutaneous 
injection 
three times 
a week 
as above 
Interferon 
beta- 1a 
Avonex® Intramuscular 
injection 
weekly as above 
Interferon 
beta- 1a-
pegylated 
Plegridy® subcutaneous 
injection 
fortnightly as above 
glatiramer 
acetate 
Copaxone®  subcutaneous 
injection 
daily or 
three 
times/week 
injection site reactions, 
lipoatrophy 
“immediate post 
injection reaction” 
Teriflunomide Aubagio® Oral  daily liver enzyme elevations, 
hair thinning, 
nausea 
Dimethyl 
fumarate 
Tecfidera® Oral  twice daily gastrointestinal 
disturbances, flushing, 
rare PML 
fingolimod Gilenya® Oral  daily first-dose cardiac 
effects, infections, 
macular oedema, liver 
enzyme elevations, skin 
malignancies, rare PML 
Natalizumab Tysabri® Intravenous 
infusion  
Every 4 
weeks 
infusion related side 
effects, variable risk of 
PML  
Alemtuzumab Lemtrada® Intravenous 
infusion cycle 
Annually x 
2 years   
infusion related side 
effects, autoimmune 
side effects (thyroid, 
blood and renal) 
Ocrelizumab Ocrevus® Intravenous 
infusion  
6 monthly   infusion related side 
effects, ?malignancies 
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additional safety concerns. The newer DMTs require specific monitoring for adverse 
events, some of which can be fatal if not recognised early (Finkelsztejn, 2014). The 
added pressures of greater efficacy balanced with an increased side effect profile can 
cause significant stress and emotional burden for PwRRMS. Additionally, factors 
such as cognition issues, tolerance for side effects, cost and fatigue play havoc with 
adherence to treatments (Kopke, Solari, Khan, Heeson, & Giordano, 2014). 
 
Some of the more serious side effects related to DMTs came up frequently in the 
data collection for the current study. Progressive multifocal leukoencephalopathy 
(PML) is a brain infection caused by the John Cunningham virus (JCV) and has been 
associated with natalizumab treatment, and to a much lesser degree with the oral 
treatments fingolimod and dimethyl fumarate (Broadley et al., 2015; Clifford & 
Nath, 2010). The PML infection has been reported in over 750 cases of RRMS with 
a greater than 20% fatality rate and a substantial morbidity in survivors (Biogen, 
2018). PML is difficult to differentiate in PwRRMS because the symptoms of the 
brain infection can mimic MS symptoms and can be missed. There are algorithms to 
help MS HCPs and PwRRMS determine specific risks dependant on individual 
levels of JCV antibodies (measured on a blood test), on the number of infusions 
administered and on previously prescribed MS treatments. Other serious DMT side 
effects are related to treatment with alemtuzumab, and include serious autoimmune 
thyroid issues, idiopathic thrombocytapaenia purpura (a blood clotting disorder) and 
autoimmune renal disease (Coles et al., 2012). Ocrelizumab was not approved for 
use in Australia at time of data collection and did not feature in discussion in the 
participant interviews.   
 
The current treatment landscape in Australia has a myriad of first line treatment 
choices for people diagnosed with RRMS, all with varying degrees of efficacy, risks 
and side effect profiles. Coupled with a rapidly expanding digital world with 
growing information of unknown quality and accuracy, it is no wonder that people 
diagnosed with MS face considerable stress coping with not just the disease and the 
decision making processes that go along with DMT treatment options, but also the 
uncertainty and unpredictability which are features of the disease. The lack of an 
accurate prognostication tool at the beginning of the disease trajectory can be both 
	 41	
frightening and frustrating for people diagnosed with MS and make it difficult to 
reach a comfortable decision on DMT choice (together with their MS HCP).  
Controversial therapies  
 
Even though there are many rigorously clinically proven DMTs to treat RRMS, 
patients can be so desperate for a cure that they will overlook the lack of carefully 
tested scientific evidence and consider unproven and potentially dangerous 
treatments (Bowman, Racke, Kissel, & Imitola, 2015). This is understandable as 
vulnerable patients search for answers to their illness, not just in the absence of a 
cure, but also in the setting of very serious effects from DMTs and the risk of disease 
progression, even when compliant with DMT. 
 
One form of treatment which has been controversial in the past, but with continued 
research is becoming more accepted as a potential treatment in RRMS, is 
haematopoietic stem cell transplant (HSCT). This emerging therapy is being used for 
aggressive RRMS unresponsive to current DMTs, and is currently the subject of 
several international clinical trials (Dorr, 2016). Early results show great promise in 
improving neurological function and preventing new MS lesions (Atkins et al., 
2016), however there is also a 5% mortality reported with the procedure and a 
general consensus on protocols and safety have not yet been established (Dorr, 
2016). The evidence for using HSCT in certain individuals with RRMS is increasing 
and may be an effective treatment for specific situations, in the setting of careful 
patient selection and experienced staff (Alexander et al., 2018). However, outside of 
the clinical trials, some PwRRMS have resorted to “stem cell tourism” which a rising 
internet based industry that offers unproven procedures to people with incurable 
diseases, and in most cases involving travel overseas (Bowman et al., 2015). Once 
again, an understandable option to consider for people living with an unpredictable 
disease and uncertain future. It has been suggested that instead of seeing people who 
pursue unproven therapies as “desperate individuals duped by medical racketeers”, 
they could be seen as “empowered citizens who have taken an informed decision to 
pursue an experimental therapy”  (Mazanderani, Kelly, & Ducey, 2018, p.232).  
 
A controversial treatment that has been shown to be ineffective in MS, but is still 
sought out occasionally by PwMS, is liberation therapy. This type of angioplasty was 
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postulated to correct a possible cause of MS, chronic cerebrospinal venous 
insufficiency (CCSVI), but has been proven to be ineffective (Zivadinov & 
Weinstock-Guttman, 2018). Combating the spread of viral internet popularity for this 
therapy proved difficult, as the value of the MS neurologist and HCP expertise was 
largely ignored in favour of emotionally resonant blogs, despite reported mortality of 
the procedure (Green, Kamel, & Josephson, 2018). In a recent study of 168 
participants all living with RRMS, Chacinska et al. (2017) found that in their search 
for a cure, PwRRMS were likely to accept very risky treatments, with 81% of 
participants accepting a 1:100 mortality for the chance of a cure. 
New therapies 
 
Besides HSCT clinical studies described above, there are many new therapies for MS 
currently in development, with over 20 phase two and three studies in progress 
(Shirani, Okuda, & Stüve, 2016). Several of the new biological molecules, such as 
amiselimod, have shown promise in efficacy with improved side effect profiles over 
the current DMTs (Kappos et al., 2016), leading to a great deal of hope about future 
treatments and their positive and safer impact on not just RRMS, but all forms of 
MS.  
 
Neurorehabilitation 
 
An important adjunct to DMTs, especially after a relapse, is neurorehabilitation and 
physical therapy (Davies et al., 2016). Various forms of exercise such as weight 
training, Pilates and yoga have also been found to be useful in alleviating symptoms 
of MS and in building strength (Feinstein, Freeman, & Lo; 2015). Rehabilitation in 
both physical and cognitive forms is a key treatment for all phenotypes of MS 
(Haselkorn et al., 2015; Khan et al., 2016; Mitolo, Venneri, Wilkinson, & Sharrack, 
2015).  
 
MS and Pregnancy 
 
As RRMS predominately affects women, is on the rise in young women and has a 
mean onset of 30 years of age, many affected by RRMS will be in the childbearing 
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years of their lives (Coyle, 2016; Miller, 2016). Pregnancy does offer some 
protection against relapses (most effectively in the final trimester) although there is a 
return to baseline risk as soon as the baby is born (Miller, 2016). There has also been 
the suggestion that there are long-term benefits from pregnancy on progression of the 
disease (Masera et al., 2015; Ponsonby et al., 2012) and that there are no negative 
effects from pregnancy on MS prognosis (Coyle, 2016).  
 
Many DMTs are not approved for pregnancy and need to be ceased prior to 
conception, which is often difficult to manage in a person with active disease who 
wishes to conceive and become pregnant (Coyle, 2016). Women with RRMS also 
often face decisional conflict regarding motherhood, although pregnancy has been 
found to be safe for mother and baby (Prunty, Sharpe, Butow, & Fulcher, 2008). 
 
Contemporary Issues in MS  
 
Although many people with RRMS continue to work and be independent, there are 
impacts on self esteem, relationships and friendships, community involvement and 
social activities that can be all-encompassing (Holland & Madonna, 2005). PwMS 
often have concerns that their disease will have negative economic and psychosocial 
effects for them and their family, impacts on childbearing and parenting and also 
burdening their partner with the disease (Alwan et al., 2013). There have been 
reports of an increased rate of broken relationships in PwMS particularly with the 
onset of other co-morbidities after the diagnosis of MS, suggested as relating to 
increased stress and demands placed on the relationship (Thormann et al., 2017). 
Perceptions by the PwMS and their partner of being “less able” can also lead to 
feelings of loss within a marriage and increased frustrations in maintaining 
relationships (Tabuleau-Harrison, Haslan, & Mewse, 2016).   
 
There has been a focus on lifestyle matters for PwMS in the last few years, as 
awareness of the impact of positive lifestyle choices on MS has heightened. These 
include adopting a holistic approach to the management of MS and to the positive 
effects of exercise, smoking cessation, reduction of alcohol consumption, activities 
that improve cognitive reserve and a healthy diet (Giovannoni et al., 2016).  
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 Support and resources for people living with MS in Australia 
 
The number of MS groups and organisations worldwide has increased over recent 
years as demand for services and support has increased along with patient numbers 
diagnosed with MS (Browne et al., 2014). Support services are perhaps more 
important now than ever, as treatments evolve and patient management becomes 
more complex. In Australia, the growth of public and private based MS clinics over 
the last decade have increased dramatically to meet the needs of patients, to enable 
timely and efficacious treatments and to monitor disease activity and patient safety as 
the new DMTs become part of the complicated treatment paradigm.  
 
It has been reported that coordinated, multidisciplinary care is of greater benefit than 
medical care alone in MS (Thompson, 2011). The goal of MS clinics is to offer 
specialized, targeted multidisciplinary care.  Recently, patient engagement in their 
own healthcare has been described as “the blockbuster drug of the century” and vital 
for improving outcomes in people with MS (Rieckmann et al., 2015). Achieving 
patient engagement happens in the setting of education, confidence building, 
encouraging treatment adherence, valuing the importance of quality of life, 
empowering through responsibility and providing credible sources of information 
(Rieckmann et al., 2015) These are all important functions of MS clinics and MS 
organizations in Australia, involving an expansive and multidisciplinary approach. 
The importance of continuity of care and in particular communication between 
hospital and community, has never been more important and MS Neurologists, MS 
Nurses and MS organizations are integral in this regard. 
 
MS Australia (MSA) is the national peak body for people living with MS in 
Australia; active in research, advocacy, disease awareness, communications, 
information and support for people affected by MS, their families and carers (MSA, 
2018). Working alongside MSA is Multiple Sclerosis Research Australia (MSRA), 
dedicated to funding, co-ordinating and accelerating MS research, with the aim of 
ultimately finding a cure for MS (MSRA, 2018). Both organisations are integral for 
patients and MS HCPs alike, by providing considerable support, advocacy and 
information resources.  
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Modern communication technology and MS 
 
Since the advent of the electronic and digital age, information and support is much 
more easily and freely available for people living with MS. The way people retrieve 
health information has changed due to an abundance of new media technologies and 
a remarkable growth in health information being available online (Haase, 
Schultheiss, Kempcke, Thomas, & Ziemssen, 2012). Websites from all of the major 
country MS societies and research groups are frequently accessed across the globe 
for information on all aspects of MS. Blogs and online support groups are also 
popular with patients and their families and also provide a means of communicating 
for people who may otherwise be isolated.  
 
However, there are also negative aspects associated with these forms of electronic 
communication, including information overload, accessing inaccurate and outdated 
information, and misrepresentation of information. The rapidly growing production 
of healthcare information increasingly leads to a situation of information overload 
for all people involved in healthcare, patients, doctors and nurses (Klerings, 
Weinhandl, & Thaler, 2015). Having web-based information is an important and rich 
resource in healthcare to support practice and learning, but can also create conflicting 
evidence and security in the information (Bullock, 2014). The issues of technology 
and the digital age bring their known set of issues to living with MS and may impact 
greatly on patient care, in both a positive and a negative way.  
 
The role of the MS Nurse  
 
MS nursing has developed as a specialty after first being introduced in the United 
Kingdom on the early 1990’s (Quinn, Leary, & Bowen, 2014). Evolution of the role 
has intensified over the last decade as new and more complicated therapies have 
been developed, greatly expanding the skillset and knowledge base of the MS Nurse 
as a specialist (Burke, Dishon, McEwan, & Smrtka, 2011). Most developed countries 
recognise this unique specialty, although some countries report no nurses with this 
specific expertise (Browne et al., 2014). Australia has a strong MS Nurse educational 
and resource organisation supporting MS Nurses in their practice, Multiple Sclerosis 
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Nurses Australasia (MSNA), which is a member of the International Organisation of 
MS Nurses (IOMSN).  
 
The MS Nurse plays a critical role in assisting patients at the time of MS diagnosis 
and understanding options for disease treatment and management (Ross & Thrower, 
2010). MS Nurses also play a central role in assisting patients with finding outside 
support to assist them in coping with their MS and in recognizing conversion to MS 
from CIS at an earlier stage (Kennedy, 2013). Additionally, fostering hope to combat 
feelings of hopelessness in MS is pivotal to the nursing role (Morgante, 2000). 
 
In a survey of patients with MS, it was commonly felt that they had received 
insufficient support and education from healthcare providers in understanding and 
dealing with their diagnosis (Solari et al., 2007). Many people will have difficulty 
coming to terms with the diagnosis of MS and will worry about the possibility of 
becoming disabled and the future impact on employment, income, relationships, and 
activities of daily living (Ross & Thrower, 2010). Nurses, as integral members of the 
multidisciplinary healthcare team, play a major role in the education and support of 
the patient, and often at crucial times in living with MS. 
 
Situating the current study in MS care 
 
This overview of MS in general and the intricacies and complexities of RRMS in 
particular that have been presented in this chapter, have demonstrated that RRMS is 
a difficult and uncertain disease to live with. There are so many facets to MS care, so 
many possible symptomologies and so much unpredictability. Negotiating “normal” 
life alongside RRMS brings many challenges that need to be understood by MS 
Nurses and other HCPs in order to provide optimal clinical care to each individual. 
The following chapter will orientate previous research and knowledge of the lived 
experience of RRMS to the current research study in the form of a literature review. 
The significant gaps in the literature will also be discussed and the strengths of the 
current study in addressing these gaps will be presented. 
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CHAPTER 3: THE LITERATURE REVIEW 
 
Format and scope of the literature review 
 
There is a plethora of articles, studies and descriptive reviews reporting on the lived 
experience of MS. However, the great majority of this literature focuses on a certain 
aspect of living with the disease, whether it is a symptomatic aspect such as fatigue, 
bladder dysfunction or gait disturbance or a psychological aspect such as coping with 
diagnosis or change in symptoms. Others have reported on physical aspects such as 
falls, social aspects such as negotiating a changed world after diagnosis, or an 
adaptive aspect of MS, such as adapting to disability. This expansive array of 
literature also covers all phenotypes of the disease, CIS, RRMS, SPMS and PPMS, 
sometimes together and sometimes separately. Interestingly, however, there is a 
paucity of literature published on the overall, whole life experience of living with the 
phenotype of RRMS. In terms of life history research specifically, there is one article 
reporting on one particular symptom in MS, fatigue, but no in depth life history 
studies reported. The reasons for this could include the fact that the subject is so 
broad and heterogeneous that it is simply too vast a topic and needs to be broken 
down into smaller components; or it could be the time consuming nature of analysing 
qualitative work, especially when using the ethnographic life history approach.  
 
This chapter, the literature review, will concentrate only on literature which 
addresses the experience of living with RRMS or MS in general, not reporting on 
specific characteristics or features of the disease, such as MS symptoms or disability. 
Later in the thesis, the findings and discussion chapters (6, 7 and 8) will integrate 
particular literature relating specifically to the study themes, reflecting on how the 
themes relate to what is already known. This approach has been recommended by 
others (Silverman 2010., Wolcott, 1994) as a process of conducting the bulk of the 
literature review in and around the specific data collection and data analysis rather 
than generally before the study commences. As supported by Silverman (2010), one 
of my study aims was to be innovative and creative in relating the literature to the 
study findings. To develop, rather than just present, ideas and concepts related to the 
themes advanced directly from the data. As Wolcott (1994) suggests, this calls for 
introducing related research towards the end of the study rather than at the beginning, 
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in an attempt to keep the literature more connected with the data analysis. Therefore, 
this traditional literature review in chapter 3 presents a critique and synthesis of the 
most significant research in the last three decades; research that is most akin to the 
current research study. In the subsequent chapters, I will present literature more 
directly connected with the study findings, some of which are presented in this 
chapter, but some literature the result of more specialised research in particular 
domains of MS.  
 
The literature review in this chapter will be approached chronologically to show the 
progression of research and to demonstrate how new findings have built on what was 
already known. This approach also reflects how biomedical knowledge about MS 
developed and strengthened over time, allowing access to new and exciting areas of 
MS, supplementing the extensive quantitative and scientific work with qualitative, 
people-focused research.  
 
Several search databases for academic literature were used in this literature review, 
in addition to medical, nursing and science search databases. These included 
CINAHL (nursing and allied health), PubMed (biomedical and life sciences), Scopus 
(scientific, medical, nursing and social sciences), PsycINFO (psychological), Embase 
(biomedical), Web of Life, Australian Bureau of Statistics, Libraries Australia, 
Joanna Briggs Institute, Cochrane library, Google Scholar, the Notre Dame 
University search engine “Summon” and Trove for dissertations/theses retrieval. 
Keywords used to search for the relevant literature were: life history, life experience, 
life story, lived experience, life journey, living with, battling, feelings in, meaning of, 
needs in, paediatric, aged, elderly, qualitative inquiry, qualitative methods, 
qualitative research, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, 
Progressive Multiple Sclerosis, MS, RRMS, SPMS, PPMS, chronic illness, 
neurological disease, neurodegenerative disease, acquired disability and disability 
were used in a combination of ways to acquire the literature search. 
 
The Literature Review 
 
As already outlined in chapter 2, medications used to effectively treat RRMS did not 
become clinically available until just over twenty years ago, with the first treatment 
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for relapsing MS (Beta interferon-1b) approved by the American Food and Drug 
Administration in 1995 (Jacobs et al., 1996). Until that time, a considerable 
proportion of the qualitative MS literature was centred on coping and adjustment to 
the disease (Miller, 1997) with only a few descriptive reports, mostly centring on 
individual experiences living with MS (Robinson, 1990; Toombs 1988, 1990, 1992), 
but no studies offering explanations or latent meaning to the experiences. 
 
Just under three decades ago, a study investigated the burden of disease and 
adaptation in 211 adults with rheumatoid arthritis (RA), hypertension and MS 
(Pollock, Christian, & Sands, 1990). Findings relevant to MS demonstrated that the 
MS group suffered more psychological stress than the other groups, even though the 
RA group were more physically burdened by disease than the MS participants 
(Pollock et al., 1990).  
 
Moving forward through the early 1990’s, a study by Hainsworth (1994) used a 
mixed methods approach to determine the presence of chronic sorrow in people 
living with MS; unfortunately the MS phenotypes were not disclosed nor levels of 
disability of the participants reported. Ten participants (nine female, one male) were 
interviewed individually and completed the Burke/NCRCS chronic sorrow 
questionnaire. The age of the study participants was 28-55 years and the length of 
time from diagnosis one to 22 years. Data was analysed using content analysis. 
Participants reported feelings of sadness, anger, frustration, fear and helplessness, 
with one participant describing their feelings when diagnosed with MS as “I felt a 
stabbing in my heart” and another as “it was a feeling of helplessness”. The study 
also reported on strategies used by the participants to cope with chronic sorrow, 
including continuing to work, gaining support from family and friends, gathering 
information and thinking positively. Study participants also reported that empathic 
nursing support was helpful to them and an important part of their coping strategy. 
Even though the MS phenotypes were not disclosed, the presence of eight of the ten 
study participants reporting chronic sorrow as part of the MS journey possibly 
indicated the likelihood that many of the participants suffered from progressive 
forms of MS rather than RRMS, as this has not been a feature of the recent RRMS 
literature.  
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The first study using phenomenological methodology to examine the lived 
experience of people with RRMS was performed by Miller (1997) an MS Nurse in 
the United States, as part of her doctoral dissertation. This study is the most alike to 
the current study of all studies published in the literature in terms of the research 
question and the study sample. The significant difference however, is the data 
analysis method, which will be discussed in later chapters. The research question  
“What is it like for you living with MS?” was asked of 10 PwRRMS (seven female, 
three male) with an average age of 49 years and average duration of RRMS diagnosis 
of 20 years. Patients were recruited by convenience sampling to the study as they 
presented for neurological appointments at two MS clinics in New York over a 
period of about six months. To be eligible for the study participants needed to have 
an EDSS score of less than 3.5; indicating that they had mild-moderate physical 
impairment from MS and were able to mobilise independently. Semi-structured 
interviews were conducted on site, audio-taped, transcribed and analysed 
concurrently. Hermeneutic phenomenology was used to analyse the transcripts. 
 
Miller (1997) abstracted a total of 12 themes from the study data. These themes 
covered many domains and included social networks (spouse, family, HCPs, can be 
both positive and negative), coping with the disease (changes to life because of MS, 
independence, resting to avoid fatigue), hope/hopelessness (initially “doom and 
gloom”, later hope after seeing the neurologist, hope for a brighter future), issues 
relating to control (difficulty with unpredictability, maintain independence) and 
conflict (conflict with HCPs, employers, family), uncertainty (unpredictable day-to-
day), issues associated with loss (of independence, employment, relationships, 
abilities), fear (before diagnosis of brain tumour, relapses, losing support networks) 
and reveal/conceal issues (concealing from others who don’t understand, HCPs 
keeping MS suspicions to themselves, concealing from family to avoid too much 
concern). More positive themes centred on a feeling of relief with diagnosis (many 
feared a worse diagnosis) and gaining control getting to know MS (resources, 
observing others with MS). Importantly, the themes identified were supported with 
direct quotes from the participants to strengthen the theme development.  
 
The themes from this study provided the first understanding of what it was like for 
people diagnosed with RRMS navigating the rapidly changing world around them, 
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with the first treatment for the disease on the horizon. The themes captured many 
aspects of life and living with illness, highlighting both the positives and the 
negatives. Miller (1997) did not find that chronic sorrow was a part of the experience 
in patients recruited for this study, as previous work had claimed (Hainsworth, 
1994), this may have been a reflection of Miller’s study focusing only on people with 
RRMS and possibly living with lower levels of disability than participants of 
Hainsworth’s (1994) earlier study where the MS phenotype was not disclosed. 
 
Miller (1997) identified that people with RRMS appeared to thrive on a sense of 
hope for, and control of, their MS and a strong drive to really know their disease. 
This was the first study to document these findings. Incredibly, until this time there 
had been arguments at length on whether clinicians should even inform patients of 
their MS diagnosis, due to the unpredictable course of disease, uncertainty of 
diagnosis, concern for stress triggering symptoms and potential emotional 
devastation (Sencer 1988). Miller (1997) argued the need for health care 
professionals (HCPs) to teach families to be supportive rather than stifling in their 
interactions, the role of independence and normalcy for people with RRMS, the need 
for nurses to explain the difference between relapsing and progressive forms of MS 
and the need for patients to be given information about the disease. To this day, these 
findings form the basis of many nursing interactions with newly diagnosed patients 
with RRMS and have influenced nursing practice in the specialty of MS 
considerably.  
 
A major strength of this study was that Miller (1997) presented the themes back to 
patients in order to verify that the themes were congruent with their own experience. 
Additionally men with RRMS were also recruited and reflected the natural 
preponderance of MS incidence of 3:1/female:male (Compston & Coles, 2008), men 
had not been included in many of the qualitative studies up until this time. 
Limitations of the research primarily relate to the geographically limiting nature of a 
rural region in the USA and the fact that all patients interviewed were under the care 
of an MS clinic (and presumably receiving best practice care), potentially biasing the 
scope of the findings. There was also no reference to whether themes were saturated 
at this point, or if new themes were still emerging with the final participants enrolled 
in the study. However, this seminal study was one of the most important qualitative 
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studies in MS at this time, as the first phenomenological nursing study to examine 
the lived experience of RRMS. It is important to revisit the lived experience of 
RRMS in current times, with a completely different treatment paradigm, different 
management strategies, exciting biomedical and scientific MS discoveries. This will 
be discussed in further detail in chapter 8, after the current study findings have been 
reported. 
 
Another seminal paper from Koopman and Schweitzer (1999) followed shortly after 
Miller’s study (1997), and consisted of a qualitative project exploring the journey to 
MS of five participants, three females and two males with a mixture of disease 
courses of RRMS and PPMS. Participants were all diagnosed with MS within the 
previous 12 months, were aged 29-40 years and had experienced symptom onset 
with MS for between six months and 22 years. Although concentrating on the period 
up to and around diagnosis, the study aimed to discover the “essence of the lived 
experience”.  Individual semi-structured interviews were performed starting with the 
question “What was it like to have symptoms of an illness and then to be told you 
have MS?”. Data analysis was not discussed in depth, but was reported as being 
performed using “common threads and patterns”, one would imagine this being an 
early form of thematic analysis. Four major themes were identified from the data and 
were conceptualised as Whispered Beginnings (onset of symptoms, creating possible 
answers), Echoes of Silence (intermittent symptoms, come and go, worry and wait), 
The Spoken Words (unexpected diagnosis, pain, have to tell others, shock, 
numbness) and Recreating Voice (claiming the diagnosis, losses and gains, 
refocusing and changing life plans) 
 
Koopman and Schweitzer (1999) concluded that the diagnosis of MS led to 
uncertainty and variability and participants needed to develop strategies to cope with 
the challenges of a disease with no cure. Although the themes provided new insights 
into understanding the experience, a deeper discussion about the methods of data 
analysis and separating the results for the different phenotypes of the participants 
would have led to readers being able to make informed decisions about 
generalisability to their particular situations and contexts. Similar to Miller (1997), 
this study identified worry, fear and feelings of loss in the participants as major 
themes living with MS. 
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A growing body of literature began to emerge exploring how people with MS were 
making sense of their world, their lived experience. Differences between MS as a 
“disease” and as an “illness” were seen as important to continuing the dialogue. Clair 
(2003) suggested that disease is seen as an objective measure of pathological change 
within the body and illness as the “human experience” of the disease. An exploratory 
study of 16 women diagnosed with MS (phenotypes not disclosed) initially used 
narrative data collection from focus group interviews with six participants, to 
generate an agenda of topics to explore during the second phase of the study with ten 
semi-structured interviews at a later date (Clair, 2003). Participants were recruited 
through a local New Zealand MS Society and purposive sampling was used to select 
women from a variety of settings and situations for the interviews. Data was 
analysed using a computer based software package to assist coding and analysis and 
symbolic interactionism was used to build a theoretical foundation for interpreting 
the illness. Symbolic interactionism has been described as looking for meaning by 
human beings, with the meaning derived from social interactions they encounter and 
subsequently process (Blumer, 1969). 
 
Findings suggested that to live in a world of MS is to live in a world with uncertainty 
and little to no control. Essentially, two separate datasets were evident: women 
striving to identify the cause of their illness and find meaning, and women who 
transformed themselves and their illness, reclaiming control and finding peace and 
harmony (Clair, 2003). Intuitively, the women in the study engaged in story telling to 
make sense of their illness and regain control over their lives. Employing an in-depth 
interview method enabled the women to tell their stories, often for the first time, to 
convey their lived experience with MS. Clair (2003) surmised that MS can be seen in 
one of four ways, firstly MS as an aggressor (fight it head on, or let it run its course), 
or MS as a saviour (delivered to save the person from the person they were or were 
becoming), MS as a guest (but find ways to minimise the intrusiveness) or MS as an 
adversary (inspiring to overcome obstacles). These findings echoed some of the 
earlier findings from Miller (1997) and Koopman and Schweitzer (1999) in terms of 
seeing MS as an adversary and the feelings of participants losing control living with 
uncertainty. Coping with the disease, previously reported by Miller (1997) is aligned 
somewhat with Clair’s (2003) viewing of MS as an aggressor and fighting the 
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disease, or MS as a guest and finding ways to reduce the disease impact. However, 
the findings of MS as a saviour were novel and interesting to consider for HCPs 
caring for PwMS. 
 
Limitations to the study were due to only women being included and that the 
participants interviewed were located in a regional area of New Zealand (NZ). 
Unfortunately the phenotypes of MS of the study participants were not disclosed, it 
would be interesting to know if the themes predominantly reflected a relapsing form 
of MS or if the participants were living with progressive MS. A major strength of the 
study included a purposive sampling method to obtain maximum variation in order to 
reach participants across a wide range of demographics. This improves 
generalisability of the study findings to others. It is also worth noting that although 
published in 2003, the study took place in 1996, before DMTs were available to 
people with MS living in NZ, rendering a replication of the study worthwhile.  
 
The nature of invisible symptoms in MS and the uncertainty of what lies ahead when 
living with an unpredictable disease provided the inspiration for researchers to 
explore the lived experience of MS using separate focus groups for men (n=4) and 
women (n=6) (Courts et al.,  2004). Again, unfortunately the MS phenotypes were 
not disclosed (Courts et al., 2004). The data was analysed by searching for themes, 
but no supporting information on how this was achieved was outlined in the article. 
Study findings identified four main themes; Nobody Listened (nobody takes 
symptoms seriously, a long time to diagnosis), Symptom Devastation (overwhelming 
symptoms, battle for normalcy, pain and anger), Picking and Choosing (making 
choices to regain control, using denial) and Fight Your Own Fight (self advocacy, 
taking charge). Once again, issues of control and conflict with HCPs, as reported by 
Miller (1997) were also a feature of these study findings. The theme of Fighting 
Your Own Fight by taking charge was somewhat seen previously in Miller’s (1997) 
themes of getting to know MS and control, but the presentation of the other themes 
offered new approaches to understanding MS. 
 
Participants in this study described creative solutions to the continual challenges and 
changes of MS interfering with goals in their lives. At times they described feeling 
depressed, dejected and desperate. Their most poignant need was for someone to 
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listen to them and teach them, as they identified knowledge as power (Courts et al., 
2004). The authors suggested that nurses should utilise interventions to empower 
patients and also to teach self-management strategies.  
 
The concept of the devastation experienced with symptom onset was reported by the 
researchers to be greatly helped by patient knowledge of their disease, which 
subsequently assists nurses in planning education sessions for patients and this 
finding is consistent with previous suggestions for practice (Miller, 1997). These 
themes again build on earlier work, as well as introducing new concepts for further 
research. The most notable being the importance of people with MS making their 
own decisions and practicing self-advocacy, which remain as major teaching 
elements in the MS Nurse repertoire to this day. By examining the lived experience, 
nurses are encouraged by the authors to build partnerships with patients, listen to 
patients, teach patients how to navigate the health care system, provide information 
and to teach self-advocacy and self-management.  
 
Limitations to the study by Courts et al. (2004) included the study being confined to 
one small geographical area. A description of the data analysis phase of the study 
was overlooked in the report, which therefore limits readers being able to replicate 
the study in their own environment. Once again, no MS phenotypes were disclosed, 
it would have been interesting to note whether there were differences between 
relapsing or progressive courses. Strengths of the study centred on recruiting both 
men and women with MS to better represent both genders. Having the three 
investigators attend all focus groups together, and reaching a consensus on theme 
identification also strengthened the study results.   
 
The life-world of one person with early onset RRMS was explored in great depth and 
richness during an unstructured interview at the end of the participant’s first year of 
living with RRMS (Finlay, 2003). This dissertation used a case study method to 
focus on one individual’s MS experience. Phenomenological methodology was used 
to access and describe life-world experience, however no meanings or abstractions 
were explained during the course of the research. The interview began with the 
general question “What is living with multiple sclerosis like for you?” and continued 
for a period of two hours, with prompts and requests for examples from the 
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researcher. Analysis of study results took place in two phases. Firstly, a narrative was 
created using verbatim quotes and secondly analytic methods suggested by Wertz 
(1983) involved repeated, systematic readings of the transcript, dwelling on the 
phenomenon through immersion and reflection, then describing the recurring themes 
that were present (Finlay, 2003).  
 
The rich description of this lived experience illustrates the overwhelming impact of 
illness on the life-world and introduces the concept of embodiment in MS nursing 
research (Finlay, 2003). The lived experience in one persons’ body is their own, 
personal experience. By focusing on the impact of physical illness, we are better able 
to understand that our embodied experiencing cannot be separated from the essence 
of who we are as a person and our place in the world (Finlay, 2003). It is just that – 
simply one person’s lived experience.  
 
The major limitation to this study is the focus on just this one individual. However, 
such a rich narrative may provide nurses with greater understanding, which can then 
be applied to others with MS, in ways deemed appropriate by the nurse to the 
context. The second possible limitation to this study is that the subject and researcher 
had been friends for 15 years prior to the study, possibly introducing some bias and 
assumed knowledge into the interview. However that may also be seen as a particular 
strength of the study; with strong rapport, trust and openness already existing 
between researcher and participant. This may have resulted in less censorship and 
more open responses.  
 
Two years later, the life journey of one study participant with RRMS was also 
explored by Fawcett and Lucas (2006) exploring the journey from the first disease 
symptoms of a fit, active female subject aged in her early thirties who was a friend of 
one researcher. This study revealed the following key points; nurses play a pivotal 
role in MS care, the beginning of the journey is fraught with questions, GPs may not 
recognise symptoms as being MS, the impact of the diagnosis of MS should not be 
underestimated, uncertainty is a challenge, understanding and getting to know MS is 
an important step and that support from family and friends is valued by PwMS.  
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Similarly to Finlay’s (2003) study, limitations to this work takes account that one 
researcher and the participant were friends before the study took place. However, as 
already mentioned, this could have strengthened the study findings based on the trust 
and rapport they already shared. Nevertheless, this in-depth case study adds to our 
insights and understanding of RRMS. Identifying the nurse as being in a pivotal role 
in the MS journey, the challenge of uncertainty, the under-recognition of MS 
symptoms in the community, the value of family and friend support and the need for 
resources to get to know MS further supports the previous research of others (Miller, 
1997; Clair, 2003). 
 
Barker-Collo et al. (2006) performed a qualitative study using semi-structured 
interviews to obtain narratives from 16 people, half living with RRMS and the other 
half with progressive MS.  The age range for the study was 27-72 years with five 
males and 11 females. The primary aim of the study was to expand on the earlier 
work of Koopman and Schweitzer (1999) using a larger sample to explore the 
experience and subsequent journey at the time of MS diagnosis. The research was 
analysed using thematic analysis. The strength of this study was the separation and 
comparison of RRMS and progressive MS in the findings and discussion. A marked 
difference was found between PwRRMS and progressive MS. RRMS narratives 
tended to reflect variability and unpredictability for the patient and for their family 
“it’s the not knowing”. This contrasts with progressive MS where the prevailing 
theme was a sense of hopelessness in relation to the inevitability of disease related 
decline “you have this thing that will eventually make you a burden”.  Other themes 
in general, where RRMS and progressive MS results were reported together, 
included the impact of changes to life roles, the fear of impact from MS on others, 
the possibility of positive effects on relationships and on lifestyle and health, the 
potential for isolation from others, the need for appropriate MS related information 
and the central role of the MS nurse in patient care.  
 
Once again, similar themes to previous work from Miller (1997) and others were 
identified, however the emphasis on the positive effects from living with MS were a 
welcome addition to our knowledge about living with MS. The concept that this 
devastating illness could bring fresh and new insights to PwMS and cause positive 
change to lifestyles and relationships was innovative information.  
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Malcomson, Lowe-Strong and Dunwoody (2008) aimed to explore the personal 
accounts of people living with MS in order to gain insights for HCPs and to identify 
effective self management strategies for patients. This study used focus groups to 
interview 13 individuals, nine females and four males, six participants lived with 
RRMS and the rest of the sample with progressive MS. Five study participants were 
no longer ambulant. The study results were analysed using thematic analysis, but 
again unfortunately, findings were not separated according to MS phenotype.  
 
Themes identified included learning something was wrong (distress, uncertainty, 
fear), getting a name (the diagnosis, unhelpful feelings), getting help (lack of 
psychosocial support), consequences to lifestyle (interpersonal, changing 
employment circumstances, challenges), getting on with day to day life (proactivity, 
perspective and control), providing advice for others (peer support, self management) 
and providing advice for HCPs (personal needs, guidance and information, peer 
groups). The concept of patients providing advice for HCPs is particularly 
enlightening and nowadays is an important part of shared decision making in clinical 
care. One would imagine it was a surprising finding when it was first identified, 
before making its way into recommended MS care in recent times (Giovannoni et al, 
2016).  
 
A possible limitation to generalising the study to others with MS is that the study 
participants were invited into the study because they felt “able to cope” with MS and 
may have thus represented only part of the MS population. The method of focus 
groups rather than individual interviews may have also limited the information 
people were prepared to divulge in a group setting in front of strangers, especially in 
regards to sensitive topics such as sexuality and cognition. The findings however are 
useful as they provide an in-depth exploration of a very important time of the MS 
journey (up to, during and just after MS diagnosis) and also considers the insights of 
both males and females.  
 
A more recent qualitative study used interpretative phenomenological analysis (IPA) 
to understand the experience of young adults living with RRMS, and was undertaken 
as part of a nursing dissertation (Beshears, 2010). The research question was “What 
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is the meaning of the experience of living with RRMS for the young adult?” with the 
purpose of understanding the lived experience in order to propose education and 
support for this specific MS population. The cross sectional study used convenience, 
purposive sampling to recruit six female participants between 20 and 40 years of age. 
Data collection involved three in depth interviews, which were transcribed, and data 
analysed using a Miles and Huberman approach and the Heideggerian method. This 
form of IPA uses the researcher as the data collection instrument, uncovering 
meanings in the narratives of the participants (Miles & Huberman, 1994). 
Specifically the study aimed to discover the meaning of changes occurring in the 
participant since their diagnosis of RRMS, to uncover how the participants made 
meaning of the expectations of others in their lives and how they learnt new ways of 
being during MS relapses.  
 
Beshears (2010) presented many ideas from the data analysis, including the 
participants wishing for opportunities to talk to others about MS, living day by day, 
of MS being “scary”, the importance of planning ahead and the value of listening to 
one’s body. These findings led to the compilation of four broader themes; firstly 
participants realising that MS involves uncertainty, their discovery that RRMS is 
frustrating, concepts of being scared and fearful getting to know MS and that RRMS 
is always in the backdrop of life. 
 
Beshears (2010) hoped to interview both sexes in the study, but no men volunteered, 
so unfortunately only women were included in this study, again potentially limiting 
the generalisability of results to men and extending the significant gap in the 
literature relating to RRMS in males. All participants in the study were married with 
the spouse being the household wage earner, thereby further hindering 
generalisability of the results to other social situations. Recruitment of participants 
was in a rural region of the US, with potential local influences biasing the data in 
unknown ways, for example local health care systems and the availability of 
neurology care in the rural area. A major strength of the study is the rich data in the 
six narratives and a strong focus on intimacy and relationships, which are important 
developmental milestones in adult development (Busch & Hofer, 2012).  
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The most recent study to explore the experience of living with MS comes from 
Jordan in the Middle East (Al-Sharman et al., 2018) and is from the speciality of 
rehabilitation. A total of 16 participants (equal numbers of male and female) with an 
average age of 36 years and average time since diagnosis of seven years, participated 
in a total of four focus groups directed by an interview guide. The study aimed to 
explore and describe the daily living experiences and challenges of PwMS. The 
study sample was a convenience sample representing two geographical areas in 
Jordan and was the first of its kind to be undertaken in the region. Unfortunately, no 
phenotype was disclosed for the study participants, however the average EDSS was 
3.5, indicating mild-moderate disability for most of the participants with one 
participant having an EDSS of 6.0 (needing a unilateral walking stick to mobilise). 
The focus groups were split into one gender only to encourage open discussion, 
which may have been impacted in this region by cultural conditions inhibiting 
females from discussing important insights in front of males (Metcalfe, 2008). 
 
Two major themes were developed by the researchers: firstly, experiences related to 
the disease itself (physical decline, psychosocial withdrawal and fear of the future)  
and secondly, experiences related to the health care system (difficulty of diagnosis, 
poor communication and rapport with HCPs, lack of awareness about MS and MS 
rehabilitation)  
 
The researchers recommended greater attention be given to MS in Jordan, with 
improved awareness of MS for both HCPs and for the general public. In addition, Al-
Sharman et al. (2018) also recommended optimising and enhancing rehabilitation 
services for PwMS. The study is limited by the geographical region and cultural 
differences to the western world, however the study is strengthened considerably by 
the inclusion of eight males in the research, a demographic which until now had been 
greatly under-represented in qualitative MS research.   
 
 
Life history research and RRMS 
 
There is only one brief piece of research exploring the life of a PwMS using a life 
history approach (de Chesnay, Rassilyer-Bomers, Webb, & Peil, 2008). This was a 
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four page narrative presented in a book chapter discussion about performing life 
history studies where the purpose was to present an abbreviated story, told by the 
participant and interpreted by the researcher, to teach others about overcoming 
obstacles in chronic illness (de Chesnay et al., 2008). The author of this particular 
MS life history narrative within the combined chapter story (Webb) presented a 
single life history of a 46 year old female who successfully overcame her debilitating 
MS-related fatigue. The data is limited by the study purpose, dealing with only one 
aspect of her MS experience. The current study aims to explore all facets of living 
with RRMS and in many participants. 
 
The lived experience in progressive forms of MS 
 
As the current study focused solely on RRMS, only a very short literature review 
will be presented on progressive MS to provide some perspective of the overall 
situation. Several qualitative studies have concentrated on the lived experience of 
people living with progressive forms of MS (Edmonds, Vivat, Burman, Silber, & 
Higginson, 2007; Olsson, Skär, & Söderberg, 2010; Strupp et al., 2012). Although 
these phenotypes are distinctly different from the proposed study group, people 
living with SPMS did originally start their journey with RRMS, and may have 
important insights to offer when considering living with RRMS. 
 
The most relevant of these studies to the current study, is a recent dissertation in the 
field of psychology (O’Loughlin, 2015). The investigator aimed to gain rich insight 
into the experiences of people with SPMS during the critical, but poorly understood, 
time of disease transition and change of labelled disease phenotype from RRMS to 
SPMS.  A total of 16 people took part in the research, nine PwSPMS and seven 
HCPs involved in MS care. Thematic analysis was used to explore the experiences, 
coping strategies and needs of people during transition from RRMS to SPMS. Four 
themes were developed by O’Loughlin (2015) in exploring SPMS: is this really 
happening? (noticing decline, feeling “in limbo”), SPMS becoming a reality (shock, 
meaning, turning points), feelings of living a life of struggle (“it’s all downhill now”) 
and the concept of brushing oneself off and moving on (accepting, making the best in 
the circumstances). 
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Recommendations from this study included the need for HCPs to undergo education 
regarding the psychological impact of SPMS during the transition, the provision of 
peer support, and exploration of existing resources and coping strategies that 
PwSPMS may already have. A great strength to the study is the fact that participants 
were recruited within 12 months of their SPMS transition, possibly enhancing the 
accuracy of their recall of events.  
As a university research Professor, Toombs (1988, 1990, 1992, 1995, 2001) began a 
series of phenomenological work exploring her own experience of living with MS, 
whilst navigating the world as a researcher. Toombs (1995, p.12) writes:  
“For MS, like every other illness, is experienced not just as the breakdown of 
the body, but as the disruption of the life that is lived in that body. To live 
with MS is to experience a global sense of disorder; a disorder which 
incorporates a changed relation with one’s body, a transformation in the 
surrounding world, a threat to self, and a change in one’s relation to others”.  
Such intimate and descriptive detail adds to the understanding of the individual’s 
lived experience with MS. Toombs (1988, 1990, 1992, 1995, 2001) provided 
reflections of her personal experience of living with progressive MS over many years 
to provide a phenomenological account of the human experience of disability. 
Particularly moving and striking in its simplicity, Toombs (1995) suggested that the 
loss of upright posture, as disability takes hold in MS, diminishes autonomy for the 
person and affects the way one is treated by others, disrupting social connections and 
leading to a loss of dignity. This insight from Toombs profoundly changed the way I 
viewed patients as I consulted in the MS clinic. In particular, it led to many changes 
in how I considered visits and appointments for patients, paying greater attention to 
positioning and clinic set-up to try and restore as much dignity as possible to the 
lives of PwMS visiting the clinic.  
 
The lived experience of children and adolescents diagnosed with RRMS 
 
Significantly fewer studies have focused on the lived experience of children and 
adolescents with MS, mainly due to the rarity of this condition in children younger 
than 18 years. An explorative qualitative study used a phenomenological approach to 
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explore experiences of children living with MS (Boyd & MacMillan, 2005). Patients 
from a children’s hospital in Canada (n=12) were interviewed using a semi-
structured format. A software package was utilised to sort data and then narrative 
analysis was used to generate themes and subthemes. The investigators found that 
the children described similar themes to their adult counterparts described earlier in 
this chapter; that is, worrying about burdens on families, fear of disclosure, hiding 
symptoms, dealing with uncertainty and fear of rejection from their peers (Boyd & 
MacMillan, 2005). A major difference was that the children and adolescents in this 
study reported conflict with their parents and lack of understanding from teachers, 
rather than the experience reported with adults who described this same conflict, but 
with the medical professionals (Miller, 1997). The great strength of the study is that 
it fills an enormous gap in knowledge regarding paediatric MS lived experiences and 
provides an excellent starting point for further research, possibly involving more 
centres and greater numbers. 
 
A further research study in 2009 employed grounded theory to develop a theoretical 
model to understand psychosocial experiences of paediatrics with MS (Thannhauser, 
2009). The study looked at the interplay between grief and peer relationships, which 
adds to the knowledge about paediatric MS, but not the lived experience. It has been 
suggested by others that there are significant gaps in qualitative literature in 
paediatric neurological conditions (Audulv, Packer, & Versnel, 2014).  
 
Other aspects of MS and the lived experience 
 
At the other end of the life trajectory, there is a paucity of research investigating the 
lived experience of the aged population with MS. Currently a quarter of people living 
with MS are aged over 65 years of age and experiencing a decreased health related 
quality of life (Buhse, 2015). This demographic of MS research demonstrates a 
significant gap in the literature and also needs immediate attention. 
 
There have also been several studies investigating the lived experience of caregivers 
and partners of people with MS, but they have not been individually reviewed here 
as it is not aligned with the research question focused on people living themselves 
with RRMS (Aoun, McConigley, Abernethy, & Currow, 2010; Bjorgvinsdottir & 
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Halldorsdottir, 2014; Buhse, 2008; Buhse, Dela Ratta, Galiczewski, & Eckhardt, 
2015; Cheung & Hocking, 2004; Corry & While, 2009; Pakenham & Samios, 2013; 
Strickland, Worth, & Kennedy, 2015).  
 
The lived experience of other chronic illnesses 
 
There are many illness states which have overlapping symptoms or share certain 
features with MS, which may also provide MS Nurses and HCPs with insights to 
help them understand what it is like to live with chronic illness. These lived 
experience studies include those in motor neuron disease (Brown & Addington-Hall, 
2008; O’Brien, Whitehead, Jack & Mitchell, 2012), in stroke (Burton, 2000), in 
spinal cord injuries (Desanto-Madeya, 2006), in Parkinson’s disease (Soundy, 
Stubbs, & Roskell, 2014), in medically unexplained symptoms (Nettleton, 2006), in 
fibromyaligia (Lempp, Hatch, Carville, & Choy, 2009), in the rare illness 
lymphangioleiomyomatosis (Haylen, 2015) and in lupus (Mendelson, 2006; 
Beckerman, 2011). There are some commonalities in the findings between these 
chronic conditions and RRMS, most notably feelings of being unheard and voiceless 
(Nettleton, 2006) of uncertainty (Haylen, 2015) and of invisible symptoms 
(Beckerman, 2015).   
 
The significant gaps in the literature 
 
A significant amount of literature regarding MS has been published in the last 
decade, as important advances in earlier diagnosis of the disease and the advent of 
more efficacious drug treatments have transformed MS care. A search in Google 
Scholar reveals 210,000 articles in MS since 2011. However, the great majority of 
this research has been biological, scientific and medical in nature. Qualitative 
research in particular has been lacking in this specialty. 
 
This literature review did not reveal any other studies using life history methodology 
to explore the experience of people living with MS (besides a short four page 
narrative). Why is this so? Using life history in researching chronic illness reflects 
the complexity of the human experience it is examining (de Chesnay, 2014), 
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presenting an ideal methodology to gain insights and understanding. However, there 
are many challenges inherent in using this methodology, including deeply personal 
narratives which may affect the researcher emotionally and the fact that the 
interviews and follow-up are time consuming and lengthy. Perhaps it is because life 
history is an under-recognised methodology in nursing. These aspects will be 
discussed further under methodology in the next chapter, together with the reasons 
why life history is an ideal approach to explore the entire life experience of living 
with RRMS.  
 
From this literature review examining the experiences of people living with MS, 
three things are abundantly clear. Firstly, there is an enormous gap in recent 
literature surrounding what it is like to live with and experience RRMS. There were 
several pivotal studies in the early to mid 1990’s, most likely they arose at this point 
because drug treatments were not yet available and major breakthroughs in genetics 
and understanding scientific aspects of the disease were still several years away. In 
this setting most of the nursing research centred on trying to understand the patient 
experience, in order to inform patient education and symptom management 
strategies. A seminal paper by Miller (1997) outlined the lived experience of people 
with RRMS using a phenomenological approach and was the first of its kind to 
examine how it felt to be the person at the centre of the MS experience (Miller, 
1997). This informed health professionals to become aware of the patient experience, 
that patients wanted to learn more about their disease, to take control and to be in 
charge, to teach families to be supportive and not stifling in assisting with their loved 
one’s care and for nurses to be at the forefront of educating patients about the 
different phenotypes of MS. Unbelievably, up until shortly before this time, it was 
still regularly debated in medicine whether patients should actually be told their 
diagnosis, for fear of causing emotional devastation in a disease with no available 
treatments (Elian & Dean, 1985; Sencer, 1988). Miller’s (1997) findings set up 
important conceptual frameworks for MS nursing practice to understand the concerns 
of people living with MS.  
 
Several studies in the last two decades have continued to explore the experiences of 
people living with RRMS, but recent studies are lacking. This gap in qualitative 
literature is of prime importance as the landscape of treatments for MS, the potential 
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side effect profiles of these pharmacological treatments and the emergence of even 
more new therapies continues to grow and become even more complicated for people 
with RRMS. How do patients feel? What is it like to be living with MS today? It is 
imperative that qualitative research answers these questions so that nursing practice 
and intervention reflects the needs of patients and that nursing theory and 
frameworks take these needs into consideration and develop as our understanding of 
the disease matures. Many of the studies presented above either did not discuss the 
phenotype of the participants, or only partly included PwRRMS in the research. 
Many of the themes identified in progressive MS research are vastly different to 
RRMS and therefore cannot be extrapolated. If study findings refer to both groups of 
participants, there should be a discussion (where possible) outlining any differences 
between the two groups. 
 
The second area identified with significant gaps in the literature is research involving 
males living with RRMS. Many of the studies described here selectively, or 
coincidentally, recruited only or mainly women. Although the preponderance 
towards women developing RRMS at a rate of 3:1 is widely known, this still leaves a 
significant portion of men in the community whose experience living with RRMS is 
under-researched and unknown. Recruiting men into the current study is an attempt 
to ensure men are adequately represented and by doing so will enhance our 
understanding of the current experience of both genders living with RRMS. 
 
The third areas of significant literature gap in this field involves research into the 
experience of both ends of the lifespan spectrum; children and adolescents, as well as 
the aged population living with MS. In regards to paediatrics and adolescents living 
with MS, this is an acknowledged area of deficit (Audulv et al., 2014). However, this 
will not be the focus of the research question in this proposal due to the specialty of 
the area and lack of experience and skills of the researcher in paediatrics, experience 
which would be essential to undertake such a study. The current study unfortunately 
did not see any PwRRMS over the age of 65 years volunteer to participate.  
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Summary 
 
The current study aims to fill the significant gaps in the qualitative literature 
exploring the experience of adults living with RRMS. To achieve this goal, the study 
sample has targeted both males and females to add to the body of knowledge in the 
area of RRMS. A body of knowledge which is striking for its burgeoning scientific 
and biomedical research, but scarcity of contemporary lived experience literature. 
The findings and discussion following in chapters five to seven will bring into the 
conversation literature relevant to each theme and subtheme as they are explored, to 
provide further knowledge, background and linkage with previous research and 
theory. 
 
There are no studies reported in the literature that have been performed using the 
same methodology and methods as the current study. In many ways, this was 
daunting at the beginning of the study, but as the study progressed and my faith in 
the methodology and methods strengthened with each interview, there was a quite 
confidence I developed in the operational framework of the study as the life histories 
from the participants were so strong with relevant data. These concepts will be 
discussed in the next chapter and will support how the life history methodology, 
underused in MS research (and illness research in general), provides a dynamic and 
useful tool to learn as much as possible about the experience of living with RRMS. 
The final chapter will connect the studies discussed in this chapter’s literature review 
with the findings from the current study, with additional concentration on the 
research from Miller (1997), Clair (2003) Courts et al. (2004) and Beshears (2010) as 
the most alike to the current study, either in study aims or study sample. However, 
the data analysis for these studies used hermeneutic phenomenology, symbolic 
interactionism, searching for themes and interpretative phenomenological analysis 
respectively in their data analysis to uncover meaning rather than the current study 
method, which used thematic analysis (Braun & Clarke, 2006, 2013).    
 
The following chapter, Methodology and Methods, will outline the ontological and 
epistemological viewpoints of the study, and the study process and procedures. 
Chapter 4 will also explain why the selection of the life history approach is an ideal 
methodology to answer the research question “What is the experience of living with 
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RRMS?” in a novel and insightful way, to add to the body of knowledge on the 
experience of living with RRMS. The current research approach differs from 
previous research in that it is contemporary, takes into consideration recent advances 
in MS care and provides a unique viewpoint looking at the whole life experience and 
incorporating previous life events into how RRMS is experienced.  
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CHAPTER 4: METHODOLOGY AND METHODS 
 
The purpose of this chapter is to discuss and justify the qualitative research paradigm 
chosen for the current study, the ontological and epistemological frameworks 
employed to guide the study and the overall research design. This chapter will also 
present a clear justification of the methodology and methods implemented, including 
a discussion of how they link in with the overall ontology and epistemology of the 
current study. The roles of ethical considerations, study rigour and reflexivity in the 
current study will also be discussed. 
 
The qualitative research paradigm 
 
A paradigm may be viewed as a set of basic beliefs dealing with principles, a 
framework representing a worldview, defining the nature of the world and the 
individual’s place in it (Guba & Lincoln, 1994). Qualitative research as a paradigm is 
a form of social inquiry that focuses on the way people make sense of their 
experiences and the world in which they live, with the goal of understanding, 
describing and interpreting phenomena as perceived by individuals and groups 
(Holloway & Wheeler, 2013). Strong advocates for qualitative research,  
Denzin & Lincoln (2000, p.3) have defined qualitative research as: 
 
“A set of interpretative, material practices that make the world visible – these 
practices transform the world. They turn the world into a series of 
representations…qualitative research studies things in their natural settings, 
attempting to make sense of or interpret phenomena in terms of the meanings 
that people bring to them.”  
 
Several elements make up the qualitative research paradigm, and these elements are 
important points of difference from the number focused, hypothesis based, theory 
testing elements of quantitative research (Braun & Clarke, 2013). Holloway & 
Wheeler (2013) suggest the following characteristics as being integral to qualitative 
research; the data have primacy, the theoretical framework is not predetermined, but 
derives directly from the data, the data is context bound, the immersion of the 
researcher into the natural setting of the study participants, a focus on the “emic” 
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perspective (the views of the people being studied), the use of “thick” descriptions 
(dense and detailed [Denzin, 1989]), the presence of reflexivity, identifying the 
researcher as the main research tool and explicitly stating the position of the 
researcher in the study.  
 
Choosing the qualitative paradigm 
 
Central to the qualitative paradigm is a humanistic commitment to always study the 
world from the perspective of the study participant (Lincoln & Denzin, 1994). In the 
early phases of developing the research question and identifying the study aims, I felt 
that the qualitative paradigm, with its roots in gaining insights and deep 
understanding into the experiences of people, would suit the study aims very well. 
The research question required a methodology that would gain deep, rich insights 
and understanding of the experience of living with RRMS. Qualitative research 
retains complexities and nuances and respects the uniqueness of each individual, 
giving importance to the narratives and context of the participant’s stories (Ormston, 
Spencer, Barnard, & Snape, 2014).  
 
In seeking to understand and interpret meaning within context, qualitative research 
also focuses on being inductive (developed directly from the data) and seeks patterns 
in data, but also has an appreciation for differences in data. I was adamant from the 
start of the study that I did not wish for the individual stories of study participants to 
“get lost”, I wanted to have their voices clearly heard because there is so little 
literature available which explores their world and considers the perspective of the 
PwRRMS. I therefore chose a purely qualitative approach early in the research 
design as the best “fit” to meet the goals of this research study.  
 
Qualitative research involves much more than “simply reporting the facts”, it 
involves a great variety of interpretation (Miller & Dingwall, 1997). In general, 
qualitative research is a group of methods and ways of collecting and analysing data 
that are exploratory, interpretative and have a focus on meaning, with reality 
developed collaboratively by both the researcher and the study participant (Smith & 
Noble, 2014). The qualitative paradigm recognises the strength of bringing my own 
subjectivity as an expert MS nurse as a valuable tool to the research process 
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(Silverman, 2001). Constructing the research together with the study participants also 
greatly appealed to my epistemological outlook, which will be discussed in greater 
detail later in this chapter.  
 
Qualitative research in health and nursing 
 
Qualitative research has been conducted across many areas; education, business, 
sociology, psychology and health in particular. Especially relevant to the research 
question in this study, qualitative health research focuses more specifically on 
exploring health and illness as they are perceived by people themselves, focusing on 
their experiences, how they feel and maintaining patient centrality in the story 
(Morse, 2012). Over the last two decades, there has been an upsurge in collecting 
and valuing stories from patients, as Morse (2012, p. 27) observed,  “illness was 
coming out from the closet, and as the door opened, it revealed all of its emotions 
and sensory secrets”. Finding individual meaning and understanding in stories from 
patients is fundamental to the caring and compassionate culture of nursing, and 
something nurses strive for in daily practice (Munhall, 2012). Nurses base their 
clinical practice on learning as much as possible about the people under their care, 
detecting commonalities and differences in order to ultimately individualise their 
care and management (Thorne, Ternulf Nyhlin, & Paterson, 2000). Traditionally, 
nurses are attracted to qualitative research as they value the richness of deep 
understanding and the perspective of the patient, and in doing so, nurses are able to 
develop culturally appropriate interventions and improve competence of care in 
diverse and vulnerable populations (Desantis & Ugarriza, 2000). PwRRMS are both 
diverse and vulnerable, and this will be explored and argued throughout this thesis, 
particularly in the later chapters discussing the study findings and themes.   
 
Morse (2012) suggests that HCPs working in the clinical arena can be considered as 
“street smart”, that is, already having an understanding of the health system. HCPs 
are ideally positioned to conduct qualitative research, having working knowledge of 
the patient population, the ability to monitor patients during the process (for 
symptoms such as fatigue, distress) and being well placed to make clinical 
recommendations at the completion of the research (Morse, 2012). Munhall (2012) 
has proposed a range of elements that qualitative nurse researchers enrich their 
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practice with as a result of their research. These elements include caring for the 
individual, legitimization, understanding of experience, acceptance, change, 
emancipation, compassion, understanding of meaning, empathy, understanding needs 
of individuals and groups and critical needs for healthcare changes (Munhall, 2012); 
all of which are consistent with the personal aims I hoped would result from the 
current study.  
 
As Munhall (2012) also suggests, nursing is a human science, and human sciences 
depend on a perspective from the inside to the outside. This contrasts with natural 
sciences, which investigate objects from outside to inside (Munhall, 2012). As an 
MS Nurse balancing both a clinical role consulting MS patients and a research role 
(in a mainly scientific and quantitative research environment) I often wondered how 
patients felt coming in for their treatments and appointments. I contemplated what 
was going through their minds, how they told their families about feelings and 
symtpoms, what motivated them and how they coped with various aspects of the 
disease. Of course, I would find out some information as we chatted informally 
between tests, but I wanted to know more. I yearned to sit down for an uninterrupted 
hour and just talk, to know more about their motivation to give up their time for 
others, how they viewed their disease and how their life changed because of the 
disease. In the busy, biomedical focused world I worked in, there was insufficient 
time or opportunity to talk and share this vital, yet often overlooked information. As 
I could see that no change in the work environment was possible, it was time to 
explore how I could satisfy this curiosity through research. 
 
Ontological and Epistemological Perspectives 
 
In qualitative research appropriateness of the choice of methodology and method is 
paramount (Holloway & Todres, 2003) and the research design must clarify the 
contributions of epistemology, methodology and methods (Carter & Little, 2007). 
This required prolonged discussions and considerable thought as to how the research 
design could enable the best “fit” to answering the research question and in a way 
that was sensitive to the overarching ontology and epistemology I selected to provide 
the framework for this study.  
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Our own subjective world evolves from all of our previous experiences, those as a 
child, our relationships, the culture we live in, our age, our gender. Our subjective 
perspective is the result of these experiences, forming the context of where we are in 
the world at present, our “situated context” (Munhall, 2012). In constructing and 
defining the overarching ontology and epistemology for this study, I needed to 
evaluate where I sat presently in terms of “situated context”, how I felt about the 
world, what it was possible to know and how it could be known. Several key 
concepts characterizing qualitative research as suggested by Munhall (2012) drew 
me to the paradigm, and ultimately influenced the stance I took in this regard; these 
concepts included believing in a multiplicity of views in the world, perceptivity of 
phenomena, polyvocality of many voices, and the existence of multiple realities. I 
did not believe there was a singular reality or only one answer to the research 
question I posed.   
 
I believed that my source of knowledge to answer the research question was not 
going to come from books and articles, but from the “knowers” (Munhall, 2012); the 
PwRRMS. I could begin to “know” by having conversations with people whose 
world I wanted to gain insights and understanding into. Talking to these informants 
allowed me to construct knowledge with them and learn about their lived world 
(Kvale & Brinkmann, 2007). I considered the PwRRMS as the experts in this 
situation (Windle, 2011). Thus began my allegiance with the qualitative ontology 
and epistemology, a strong belief in the co-construction of knowledge between the 
PwRRMS and myself. 
 
Ontology 
 
Ontology refers to the nature of reality and what there is to know about the world 
(Ormston et al., 2014). Essentially ontology is about how things really are and how 
they work (Guba & Lincoln, 1994).  There are many variations along the spectrum in 
ontology, depending upon how the researcher views the relationship between the 
world and human interactions and practices within it (Braun & Clarke, 2013). The 
ontological beliefs I used to underpin this study were in line with constructivism, 
centred on the world being context specific, co-creating knowledge between the 
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researcher and study participant, being open to revision and possessing multiple 
realities.  
 
Constructivism’s hermeneutic/dialectic methodology is aimed at the reconstruction 
of previously held constructions, and is open to new interpretations as the 
sophistication of the information improves throughout the research process (Guba & 
Lincoln, 1994). This means that knowledge is ever changing, represents various 
interpretations and is context bound. Under the paradigm of constructivism, the 
concept of relativism also provided an excellent “fit” for the current study. 
Relativism explores the concept that all truth is “constructed” by humans and 
situated within an historical moment and social context and that multiple meanings 
of the same data may exist (Cresswell, 2008) and was particularly applicable to the 
values of the current study. Thus, an ontological foundation of constructivism and 
relativism was applied to the current study. 
 
Epistemology 
 
Epistemology has been defined as the nature of the relationship between the 
“knower” and what can be known (Guba & Lincoln, 1994). The essence of 
epistemology is the question of what is possible to know (Braun & Clarke, 2013) and 
how we come to know it. As with ontology, there are also many variations of 
epistemological stance dependant upon the views of the researcher; what they feel is 
possible to know, and the meaning of this knowledge (Braun & Clarke, 2013). 
Constructivist epistemologies state that there are knowledges existing, rather than 
singular knowledge, that knowledge is a product of how we come to understand it, 
and therefore how we construct it (Braun & Clarke, 2013). Knowledge construction 
involves the input of both the researcher and the study participant.  
 
The epistemological base of life history is grounded in a pragmatic approach to 
knowledge, concerned with depicting the lived experience as actual members of the 
culture (in this study it is the PwRRMS) understand their experiences, but also 
understanding that this truth may not be universal (Faraday & Plummer, 1979). The 
constructivist epistemological stance for this research study involved the assumption 
by myself, as the researcher, that people living with RRMS had information to reveal 
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to me that MS Nurses and HCPs could benefit greatly in knowing. Believing that 
patient views are valuable and by asking questions of past experiences I could gain 
insights into understanding what it feels like to live with this disease. I viewed this as 
vitally important in order to better understand RRMS and its effect on people my 
colleagues and I were caring for. Understanding RRMS from a “lived experience” 
perspective would help MS Nurses and other HCPs make deeper connections with 
patients, enhance their understanding of the disease and promote patient adherence to 
both treatment and management strategies, improve quality of life, and provide truly 
empathetic and compassionate care. This is important to provide greater satisfaction 
and connection in work life for the MS Nurses and HCPs, and to ultimately improve 
quality of life for the patients, the PwRRMS.  
 
Constructivist epistemology formed the basis of what I believed and ultimately 
influenced the selection of methodology and methods I selected in order to answer 
the research question in the best way possible. To guide the appropriate choice of 
methodology and methods for this study, it was necessary to gain this depth of 
understanding about my epistemological position and to keep the three elements of 
epistemology, methodology and methods consistent (Carter & Little, 2007).  
 
The use of the first person in the study 
 
A conscious choice was made to use the first person “I” in writing up and reporting 
this research study. The reason behind this was to use my subjective voice, as the co-
creator of the findings (with the study participants) as recommended by Munhall 
(2012). The methodological and method choices were mine to make and to justify, 
and I needed to personalise those decisions. The use of the first person has 
commonly been recommended in qualitative research, especially in ethnographic 
work (Denzin, 1994; Richardson & Lockridge, 1998; Tierney & Lincoln, 1997; 
Tierney, 2000). Using the first person expresses greater vulnerability, keeps 
emotions in the process of knowledge production and promotes the researcher as 
central to the process, rather than being a disengaged observer (Tierney, 2000). 
These concepts were all central to my ontological and epistemological viewpoints, 
therefore the use of the first person was adopted to write the thesis.  
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Methodology 
 
Methodology refers to the framework within which the research is conducted. It 
provides a theory of how the research should proceed and produce valid knowledge, 
while making sense of the research in terms of design and process (Braun & Clarke, 
2013). Choosing a methodological approach that serves the inquiry under study is 
essential, as it acts as the initial guide to dictate the decisions made in a study to 
answer the research question in the best, and most thorough way possible (Holloway 
& Todres, 2003). Methodology also assumes what counts as research, how it is 
conducted and what methods (sample, data collection, analysis) are appropriate for 
the study (Braun & Clarke, 2013). Various forms of qualitative methodology were 
considered for this study, and a form of focused ethnography, life history, was 
chosen to answer the research question. Other forms of methodology that were 
considered for this study were grounded theory (and its many forms), interpretative 
phenomenological analysis and content analysis. The rationale for choosing the 
ethnographically based life history approach (and for rejecting the other qualitative 
forms of methodology) will be discussed in further detail in the data analysis 
procedures, where the procedural differences will be highlighted. 
 
Ethnography as a research methodology 
 
Ethnography is a research methodology which involves the process of learning about 
people by learning from them (Roper & Shapira, 2000) and has its historical roots 
embedded in social and cultural anthropology (Holloway & Todres 2003). Despite 
being popular at the beginning of last century, a long period of remission followed 
through the mid century, before a significant revival in popularity since the 1990’s 
(Plummer, 2001). Ethnography involves key informants who represent the culture 
under study discussing their lives, so that others can better understand the culture (de 
Chesnay, 2014). Traditional ethnographic techniques involved long-term participant 
observation and interviewing, of researchers deeply engaging the socially organized 
settings they sought to describe and analyse (Miller & Dingwall, 1997). The goals of 
ethnography are to describe, interpret and understand characteristics of a particular 
social setting, taking into consideration the diversity and multiplicity of voices from 
key informants, the experts who have rich knowledge of the subject under research 
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(Holloway & Todres, 2003). Ethnography has a place in health research, particularly 
with its focus on the emic, or the patient perspective (Morse, 2012), being holistic, 
contextual and reflexive (Boyle, 1994). This ensured an excellent fit for the 
epistemological foundations and aligned with the broader goals of this study. 
  
Ethnography takes on many forms and has been adapted for use in different settings, 
depending on the goals of the research.  Early ethnographers spent long amounts of 
time in the field (“fieldwork”) getting to know the study participant/s and 
encouraging them to share their life stories, often forming personal relationships (de 
Chesnay, 2014). More currently, time constraints are considered to inhibit such long 
encounters between researchers and study participant/s, especially in the field of 
nursing. In keeping with the important aspects of traditional ethnography (insights, 
understanding and culture), focused ethnography  developed, where researchers 
attempt to learn about certain conditions by asking about the experiences of those 
living with the condition (Cruz & Higginbottom, 2013; de Chesnay, 2014). Focused 
ethnography has become more popular in health research generally, as it is an 
effective method to gain information from a culture who may not necessarily have 
contact with one another (Morse, 2012). Exploring experiences in smaller sub-
cultural units such as a shared illness, honors the ethnographic assumptions and is 
effective for eliciting information on a specific topic (Richards & Morse, 2007) and 
being less time consuming, is therefore more practical for most researchers. 
 
Central to the way that ethnographers think about human social action is the idea that 
people construct the social world, through both their interpretation of it and through 
actions based on those interpretations (Atkinson, Okada, & Talmy; 2011). This is 
consistent with the epistemological framework for this study of constructivism. The 
version of the culture reported by the researcher is simply one version of the world, 
amongst many possible others.  
 
Life history as a form of Ethnography 
 
The life history is a “retrospective account by the individual of his or her life in 
whole or part, in written or oral form, that has been elicited or prompted by another 
person” (Watson & Watson-Franke, 1985, p.2). Life history is the story that a person 
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chooses to tell about the life he or she has lived, told as completely and honestly as 
possible (Atkinson, 1998). Immersing in accounts of people’s stories about their 
lives, in their own words and in local context, the life history is a way to grasp 
meaning from a culture (Fetterman, 1998). The terms life history and life story are 
sometimes used interchangeably (Plummer, 2001). For the purposes of consistency 
and clarity in this study I defined life history as the story told by a person to me as a 
researcher (de Chesnay, 2014) and life story as the narrative analysis I created of the 
person’s life from the life history they told me (Atkinson, 1998). 
 
The history of life history as a method is interesting, as life history was used in 
psychology with Sigmund Freud’s case studies, which later helped establish life 
history as a social science method (Connell, 2010). The genre of social science 
research was highlighted by important life histories earlier in the 20th century by 
Thomas and Znaniecki (1927), who explored the culture and society of immigrants. 
Connell (2010) suggested that this founding social research inspired new areas of life 
history research in gender exploring masculinity and sport (Messner 1992), life 
history studies in feminist sociology (Laslett & Thorne 1997), and race and racism in 
the context of people’s lives (Blauner, 1989). Of course, important life history 
advances were made with Plummer’s (1983, 2001) “Documents of Life” series 
comprehensively exploring and championing the use of social science life stories and 
providing important background to using the methodology. The value of life history 
is that the value of the participant’s own perspective is highlighted in the research, as 
Connell (2010, p.67) so eloquently describes “the passages in an interview transcript 
that in traditional qualitative research are likely to be cherry-picked…in life history 
research become revealing details in a tapestry”.    
 
Life history in general is an underused methodology in nursing, but is perfectly 
suited to the profession, as nurses have always valued the stories and insights 
patients are able to provide to improve understanding of their world (de Chesnay 
2014). Hagemaster (1992) has advocated the use of life history in nursing research, 
and although still developing, many more nurse researchers have used life history 
over the last two decades. Using life history in nursing research explores a person’s 
microhistorical (personal) experiences within a macrohistorical (over time) 
framework, enabling the researcher to deeply analyse relationships, attitudes and 
	 79	
behaviours in a way that might not be possible using other methodologies 
(Hagemaster, 1992). Nursing studies using focused ethnography have been used to 
explore illness in homeless youth (Ensign & Bell, 2004), investigate health in 
immigrant adolescents (Garcia & Saewyc, 2007), report the experiences of 
community mental health nurses (Spiers & Wood, 2010) and to examine the 
experiences of a rare chronic health condition, lymphangioleiomyomatosis (Haylen 
& Fisher, 2014). 
 
Given its ability to provide a comprehensive holistic examination of the subjective 
life experience, the life history method was chosen as the most appropriate design for 
this study, for the purpose of identifying important themes experienced by individual 
PwRRMS, which may also be experienced by their peers (Field & Morse, 1985). A 
great advantage of life history it that it retains the whole individual story and locates 
it in a wider social, cultural and historical moment (Plummer, 2001). Life history 
allows the exploration of experience over time in the context of the whole life, 
including both the individual social context and the broader historical context. Life 
history examines events and how they impact individuals and their life trajectory, 
revealing turning points, epiphanies and transformations that may occur over the 
course of the life living with disease (Haylen & Fisher, 2014). It also provides a way 
of understanding the meaning of illness and how this meaning might change over 
time.  
 
Conceptualising life history in this study 
 
The life history can be seen as a journey towards an inner quest for self, as part of a 
composed life or creation and allowing voices to be heard (Plummer, 2001). As 
suggested by de Chesnay and Fisher (2014), the purpose of the life history approach 
in the current study was to collect a focused history around a disease (RRMS), to 
document the story of each participant, but being careful not to frame this within a 
broader ethnography of all people living with RRMS. The life history methodology 
reflected the cultural and social contexts of each participant, allowed them to 
approach their life history in any way they chose, not necessarily in chronological 
order or centred only on their RRMS diagnosis. Interestingly, many participants 
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talked of other events in their lives being just as pivotal or more so, than their RRMS 
illness diagnosis.  
 
In life history, the researcher and the participant come together as collaborators, 
composing and constructing a story (Atkinson, 1998), consistent with the ontology 
and epistemology of the study. A good relationship between the researcher and study 
participant is important and life history involves establishing a close relationship 
between the two (Plummer, 2001). Figure 1 is based primarily on the work of 
Plummer (2001, p.44), but also includes influences from Blumer (1969) and Tierney 
(1994). This illustration acts as a conceptual model to explain the relationships 
between the life history construction, the researcher and participant, what is 
unknown, what is knowable and the very important role of context. Contextual 
consideration is essential to enable readers of the research to assess for transparency, 
credibility, trustworthiness and transferability, by providing the detail required to 
ascertain how and why the research may be applicable to their own particular context 
or situation. 
 
.  
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Figure 1. Conceptual model highlighting the relationships between the life history 
construction, the researcher and participant, what is unknown, what is knowable and 
the role of context 
 
Motivations in life history 
 
The purpose of using this methodology was to gain insights into the world of living 
with RRMS that could ultimately enhance knowledge in this area for MS Nurses and 
other HCPs, and thereby to potentially improve consultations, disease management 
and understanding. I was also clear that my motivation was part of the wider picture 
of gaining a higher degree in the process, although I was confident in myself that this 
was a secondary motivation. I ensured the study participants were provided with a 
clear discussion regarding my motivation in seeking out PwRRMS and the life 
history method in particular.  
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What motivated the study participants to be involved in the research? Allport (1942) 
suggests that there are many reasons why people volunteer to be the subject of a life 
history, and these include the factors already discussed, as well as self-justification, a 
desire for order, relief from tension, filling in one’s life and as a form of confession. 
Others have reported the benefits of telling stories as being cathartic (Pennebaker, 
2000) or to attribute praise or place blame (Holloway & Freshwater, 2007b). It has 
also been suggested that there could even be improvements in physical and mental 
health after emotions and experiences are made into stories; a result of helping the 
participant to feel visible (Pennebaker, 2000). I often wondered why the study 
participants agreed to be part of the research, to be interviewed, to think about their 
life and to give up their time to a stranger. Several participants openly disclosed their 
own motivations to volunteer for the research; these included wanting to help others 
(altruism), wanting to further research in MS specifically, as a form of therapeutic 
encounter and some participants simply wanted to talk to someone who was 
interested in their story. All study participants told me after the interviews that they 
had found the experience of telling their life history valuable, helpful and a positive 
experience. 
 
Methods 
 
“Everything has the potential to be data, but nothing becomes data without 
the intervention of a researcher that takes note - and often makes note - of 
some things at the exclusion of others”. Wolcott, 1994, p 3-4. 
 
Methods in qualitative research are techniques and procedures used in collecting and 
interpreting data about social settings (Miller & Dingwall, 1997). Sometimes 
methods are recommended within a qualitative methodology as part as the intrinsic 
framework of that methodology (which is the case for both grounded theory and 
interpretative phenomenological analysis), with guidelines to follow for data 
collection and data analysis (Braun & Clarke, 2013). However, ethnography 
methodology allows for flexibility in method selection and it was up to me as the 
researcher, to design a framework for the methods that would meet the goals of the 
study and adequately answer the research question. To guide this process, I followed 
a conceptual model from Carter and Little (2007), which outlined the relationships 
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between methodology and method and the connection they both had to the 
epistemology of the study. It was a model where I had to consider if the 
epistemology of life history (as the methodology) would meet the study objectives, 
and thereby justify the methods chosen to produce knowledge. Having already 
identified the congruence between the study methodology and epistemology in the 
previous section, the influence of epistemology on the various study methods will 
also be discussed. 
 
The current study utilised several different methods that were employed at separate 
stages of the research process and these are discussed as they occurred 
chronologically in the research design; firstly sampling and recruitment methods, 
followed by data collection methods, data management methods and the methods of 
data analysis. 
Methods: Sampling  
 
The sample  
 
Purposive sampling guided recruitment for the current study, targeting people living 
with RRMS. Participants were deliberately selected to serve the task of a specific 
research intention (Morse, 2012). This approach was congruent with the 
epistemological position of the study, seeking to gain insights directly from people 
living with RRMS and co-construct knowledge.  
 
The purposive sample was supported by inclusion criteria to ensure that potential 
study participants met a pre-defined measure to enable fair recruitment and that they 
were in a position to be able to answer the research question within the Human 
Research Ethics Committee (HREC) approval for the study. 
 
Inclusion criteria: 
 
• Diagnosed by a physician with RRMS 
• Aged 18 years or over 
• Able to speak and understand English 
• Ambulant (be able to walk unassisted) 
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The criteria of being formally diagnosed with RRMS by a physician was to ensure 
authenticity of their life experience in terms of living with RRMS and not from 
another disease. The age of 18 years was in line with the HREC approval for adults 
in this particular study, and not for the paediatric (under 18 years) population. This 
was primarily because I wanted to explore the life history of living with RRMS over 
some years and I felt that the purposive sample inclusion criteria of being over 18 
years would achieve this.  
 
Reluctantly, I was only able to interview in the English language. I have respect for 
all cultures, and including people from a non-English speaking background would 
have added considerable depth to the study. As the interviews were conversation 
based and up to three hours in length, I simply did not have the financial support to 
allow for the considerable expense of interpreters or for translation services. This 
remains a goal for future research. The criterion to be ambulant was to capture the 
essence of RRMS. I felt that if a potential participant was wheelchair bound that 
there may be elements of SPMS from gradual progression of the disease and 
therefore a different diagnosis. Whilst I was mindful of the importance of life 
experiences for all PwMS, I wished to fully capture all of the other experiences of 
RRMS as much as possible and concentrate on one disease classification. Hopefully, 
exploring the life experiences of SPMS/PPMS may also be the subject of post 
graduate work.  
 
Recruitment 
 
People living with RRMS were recruited to take part in the study through the local 
state MS Australia (MSA) office, branch of NSW.  A copy of the HREC approval for 
the study (Appendix 1) and flyers briefly explaining the study (Appendix 2) were 
provided to the State Manager of MSA. They were displayed in the Sydney offices 
where people living with RRMS were attending the gymnasium, and were also sent 
internally to regional staff of MSA by email for distribution locally. 
 
A total of 14 expressions of interest were received over a period of ten months from 
March 2016 until January 2017. After making initial enquiries into exactly what the 
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study entailed, 13 PwRRMS agreed to be interviewed. One person making an 
enquiry about the study declined to take part after a brief telephone call and 
discussion, but did not provide a reason. Enquiries about the study filtered in slowly 
and consistently over this time, and I did not need to re-advertise again for 
volunteers. Most participants became aware of the study through the MSA network, 
but one participant was the result of the snow-balling technique (becoming aware of 
the study through someone else who had already taken part in the study), one 
participant heard of the study through a contact at the university I am studying at and 
four participants were alerted to the study by their MS HCP who directed them to the 
MSA flyer. 
 
I was hopeful to attract participants with diverse characteristics to enhance my depth 
of understanding of the phenomena. I identified these characteristics as including 
both sexes, employed and unemployed, married/unmarried, parents/childless, 
rural/city based, newly diagnosed/long term diagnosed and also varying levels of 
disability. I was fortunate to be able to interview all volunteers and to be able to 
cover all of these characteristics comprehensively. This happened organically. 
 
The study sample size was not initially stipulated in the study design, it was 
estimated that between 10 and 20 participants would be ideal. However, that number 
would depend on the amount and quality of data generated from the interviews, 
which was not known at the commencement of the study (this will be discussed in 
detail later in this chapter under study rigour). In conjunction with my study 
Supervisors, it was decided at each monthly meeting if interviews should continue. 
Once 13 participants had been enrolled, interviews performed and transcriptions 
completed, it was apparent that there was a considerable amount of data and it was 
felt that coding should commence before more participants were recruited and the 
situation reassessed again. However, further recruitment was deemed unnecessary 
after data coding due to the overwhelming amount of information and codes 
developed from the 13 interviews and transcripts. I felt that recruiting more 
participants would have lessened my ability to engage so deeply with the data and to 
understand the complexities of the data within the time frame of the study 
(Onwuegbuzie & Leech, 2005). The data was so detailed and plentiful that complete 
data analysis took just over a year working on the study as a full time student. I also 
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began to notice recurring themes across the study interviews from an early stage, 
increasing my confidence in the sample number being adequate. 
 
Enrolled Sample 
 
The demographics of the study participants (n=13) enrolled in the study are outlined 
in Table 2. The first person enrolled into the study was interviewed on the 14th of 
April 2016 and the last interview took place on the 31st of March 2017.  
 
Table 1: Study demographics for enrolled study participants.    
            
Study 
number 
Pseudonym M/F Age at 
interview 
Marital 
status 
Years 
since 
RRMS 
diagnosis 
Parent Working 
01 Piper F 38 m 2 ✓ p/t 
02 Margot F 57 m 16 ✓ r 
03 Kate F 46 m 24 ✓ u 
04 Rudi F 40 m 4 ✓ p/t 
05 Joy F 57 d 12 ✓ f/t 
06 Jane F 42 s 10 ✗ p/t 
07 Paul M 38 m 2 ✓ f/t 
08 Ruby F 36 m 4 ✓ f/t 
09 Will M 32 m 4 ✓ f/t 
10 Griff M 62 m 10 ✓ u 
11 Susan F 40 m 14 ✓ p/t 
12 Davina F 54 m 32 ✓ f/t 
13 Evie F 39 s 20 ✗ f/t 
 
Note: F = female, M = male, age is in years, m = married, d = divorced, s = single, 
p/t = employed part-time, f/t = employed full time, r = retired, u = unemployed, ✓= 
yes , ✗= no 
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Methods: Data Collection  
 
Semi-structured life history interviews  
 
The qualitative interview is a construction site for knowledge (Kvale & Brinkmann, 
2007) and forms the basis of the constructivist epistemological foundation for this 
study in relation to the chosen method of data collection. Semi-structured interviews 
were the chosen data collection method, performed in person and individually, with 
just the researcher and study participant present. A semi-structured interview has the 
purpose of obtaining descriptions of the life world of the participant with respect to 
interpreting the meaning of the described phenomena (Kvale & Brinkmann, 2007), 
making it especially suited to life history research. Semi-structured interviews have 
some pre-defined questions built-in to the interview, but the researcher is also 
permitted to probe further and ask additional questions as the participant responds, 
often leading to the collection of powerful data in the form of insights, experiences 
and perceptions (Peters & Halcomb, 2015). Semi-structured interviews are also 
unique among interview methods for the relevancy they provide a topic, whilst 
remaining responsive to the participant (Bartholomew, Henderson, & Marcia, 2000).  
 
At the commencement of the interview, participants were provided with a verbal 
overview of the study, outlining my background and the study aims. I then asked 
each participant to tell their life history, in any order they wished, and covering 
anything they wished to, with particular thought to the question “What is the 
experience of living with RRMS?”. This approach ensured the information I gathered 
was consistent, rich and participant centred. 
 
Although predominately unstructured in nature, I categorized the interviews as semi-
structured for two reasons. Firstly, I provided reflection questions to study 
participants which gave some direction to the information I was seeking. Secondly, 
because the RRMS component of the research question gave direction about the 
topic I wished to explore in relation to their life history. The reflection questions 
were based on suggestions from Gubrium (1993) and Atkinson (1998) on key topics 
to guide life history and life stories (see Appendix 3) and were provided to 
participants by email approximately a week prior to the interviews. This process, as 
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suggested by Patching and Lawler (2009), allowed the participants to see the style 
and depth of the information required, as well as providing adequate time for 
consideration. The reflection questions served as a general framework for eliciting 
data about the participants lives, cultural background and the events around their 
diagnosis of, and living with, RRMS. Participants were instructed that they could use 
the reflection questions to think about their life, that they could use some of the 
questions, or they could to elect not to use these reflection questions at all. The 
majority of participants used the reflection questions only as a starting point for 
thoughts and did not refer to them during the interview or bring them to the 
interview. One participant chose not to look at the reflection questions at all, 
preferring to tell his life story with no prompters.  
 
Considering other data collection methods 
 
One on one interviews were deemed to be a better fit to answer the research question 
than surveys, which do not allow for extensive exploration. They were also 
preferable to focus groups where participants may have felt inhibited to talk 
truthfully about their experiences in front of others. Focus groups in a permissive and 
comfortable environment can prove to be greatly beneficial for encouraging data 
generation with support from others in similar situations (Krueger & Casey, 2015). 
As I was clear that I wanted to understand each life history in considerable depth, I 
felt that a one on one interview would support this aim. Telephone or video 
interviews were also considered, but I felt that these might lack personal connection 
and rapport, which may have proven important to uncover sensitive parts of the life 
history. As will be discussed in the study findings, at times it was my observation of 
the study participant which added considerable depth to the story when witnessing 
physical reactions recalling emotions such as distress or joy. I was able to explore 
these emotions further, an opportunity that may have been missed entirely with 
telephone interviews. 
 
Preparing for the interviews 
 
As a registered nurse with over 30 years experience, I had developed a repertoire of 
interviewing skills, particularly as a clinical consultant in the last 20 years 
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performing solo consultations with patients in clinics. However, as part of my 
reflexive position (to be discussed in detail later in this chapter), I was aware that life 
history interviewing was going to be a very different form of interviewing than I was 
used to. In anticipation of this, I practiced conducting life history interviews with 
several work colleagues and friends in the months prior to commencing data 
collection. I refined and improved my technique considerably. This was to be an 
ongoing procedure throughout the study interviews, and I reflected after each 
interview in my field notes, on strategies I could use to improve for the next 
interview. Safety for myself was also a consideration as I entered people’s homes to 
conduct most of the interviews. I had a short checklist to ask each study participant a 
series of questions by telephone prior to the interview date (see Appendix 4). In 
conjunction with my Supervisors, I developed a policy whereby I would notify a 
nominated Supervisor of my planned entry to an interview (in “real” time), and then 
again at the end of the interview when I had left the premises (Appendix 5).   
 
I also consulted texts and methods for interviewing tips, especially in regards to the 
life history technique. Plummer (2001) recommended being aware of potential 
practical difficulties, performing dress rehearsals, considering seating arrangements 
(always on the same level facing each other), arriving early and being well 
organized, practicing relaxation techniques and keeping a list of interesting topics for 
discussion and probes should the interview come to a standstill. 
 
Benefits of the interview techniques 
 
One strength of the study was the lack of a formal structure in the interviews, thereby 
adopting a semi-structured approach. This allowed participants to express themselves 
openly and naturally and talk about their experiences as they wished, rather than 
using pre-determined questions. The personal interaction within the unfolding of 
stories and new insights were rewarding for both myself as the researcher, and the 
participant as the story teller, consistent with the thoughts of others (Atkinson, 1998; 
Plummer, 2001; Kvale & Brinkmann, 2007).  
 
 
 
	 90	
Methods: Data management 
 
Good organisation and a systematic management of the data was key for later 
analytical thoroughness in the study (Tuckett, 2005). There was an overwhelming 
amount of data from the verbatim transcripts and also from the coding process, but 
every step of this lengthy process was viewed as an opportunity to further interpret 
the story on a deeper level. Core files of all data in unedited form were arranged in 
chronological order electronically and several hard copy transcripts were kept for 
different purposes; “noticings”, coding, story excerpts and quotes, as recommended 
by Plummer (2001).  
 
Transcriptions  
 
Interviews were recorded using two audio recorders, a primary recorder was used to 
transcribe the interviews while the second recorder was used as a secondary back up 
in case of battery failure during the interviews (which occurred in one interview, the 
first one performed). Interviews were then transcribed by myself verbatim as part of 
total immersion in and familiarisation with the data, as recommended by Braun & 
Clarke (2006, 2013). All interviews were transcribed completely within a week of 
the interview to retain as much detail as possible. I was able to engage deeply with 
the data and begin initial data analysis at an early stage.  
 
Interviews were transcribed into a Word document in a half page vertical format with 
the writing on the left side so that “noticings” and “coding” could be applied on the 
right side of the page during the data analysis phase (these terms will be discussed in 
the next section). Line numbers were also added on the left side of each page for 
easy identification of quotes and location of important ideas during the findings and 
discussion section of the thesis. All observational data relevant to the interview, such 
as non-verbal behaviour I had noted (crying, tearful, expressions of joy) were 
inserted into the transcript as suggested by Miles and Huberman (1994), and 
pauses/times of silence were also noted. I often found these meaningful in 
interpretation, e.g. long pauses could alert me to intense consideration of the question 
and a particularly intense and meaningful answer. 
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An electronic copy of each interview was stored on a password-protected computer 
under a study number and pseudonym for each study participant, and also stored on a 
secure digital card (SD card) as a separate file. Following the transcriptions, each 
interview was listened to several times whilst reading the transcript to ensure 
accuracy of the transcript and to decipher words that may have been difficult to hear 
or misheard on the earlier transcription.  
 
Field Notes 
 
Field notes are writing up observations and comments on impressions and 
descriptions of participants and the study process after the interviews (Tuckett, 
2005). I looked on these observations as an early method of data analysis. I took field 
notes as soon as possible after the interview (usually immediately) making it part of 
my personal debriefing ritual after I had left the interview. Field notes also helped 
me to remember details later in the analytical process and effectively took me back to 
the scene of the interview, which I often found extremely helpful to remember details 
specific to that particular participant. For example, what they were wearing and the 
setting of the interview that then helped me recall the meaning and emotions related 
to their facial expressions and other non-verbal behaviour. I closely observed the 
participants during the study interviews not just for non-verbal behaviour in general 
(laughing, crying, anger for example), but also specifically for signs of fatigue, and 
we took breaks when necessary. Field notes on each study participant detailed 
objective and subjective features of the interview as discussed, but also my thoughts, 
interpretations and advice to myself for future data collections. An example of the 
information collated in the field notes is shown in Appendix 6.  
 
Data security 
 
Using electronic technology both with data collection methods and in transcription, I 
needed to be mindful to prevent compromising participant confidentiality with lapses 
in data security. As suggested by Barnhill & Barnhill (2014), I maintained computer 
security on all hard drives, I used strong passwords on computers and devices, I used 
firewalls in hard and software, I avoided open networks and I disposed of deleted 
soft copy and hard copy information appropriately. This was in addition to using 
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participant numbers and pseudonyms instead of real names and also carefully 
removing potential identifiers from the transcripts.  
 
Methods: Data Analysis 
  
The life history aims to document a person’s life (or significant part thereof) as a 
narrative, telling a representation of a story (Plummer, 2001). The participant 
constructs the history, but as Denzin (1989) suggests, it is up to the researcher to 
interpret and reconstruct the account into a story, which then provides understanding 
and perspective of the experience (de Chesnay & Fisher, 2014). The analytic process 
in the qualitative paradigm is all about moving from “pieces to patterns” (Thorne, 
2008). It involves assembling or reconstructing the data into a meaningful fashion, in 
a way that is transparent, rigourous and thorough, whilst remaining true to the 
accounts of the participants (Smith & Noble, 2014). Several methodologies (such as 
interpretative phenomenological analysis and grounded theory) dictate specific and 
detailed methods of data analysis as part of their process, however this is not the case 
for focused ethnography and the life history. I found the freedom to choose from a 
variety of methods of data analysis a welcome component of the study design. 
 
Data analysis is an interactive process where data is systematically searched and 
analysed in order to provide a description of phenomena (Smith & Noble, 2014). An 
important factor for any researcher to consider when determining the qualitative 
methodology or method to apply to their research design is what will be the best fit to 
answer the research questions. Having (what I saw as) the great benefit of no 
overarching methodology attached to focused ethnography/life history dictating the 
methods for data analysis in the current study, I was able to consider many possible 
methods of data analysis and apply them directly to the research question and goals. I 
was certain that I wished to use a robust and systematic method for data analysis, the 
idea that themes and patterns would simply “emerge” from the data after reading and 
re-reading transcripts (Morse, 2012) did not sit well with me, I needed guidance and 
a solid framework to ensure the data analysis was the most robust it could be. When 
examining the fundamental aims for answering the research question, “What is the 
experience of living with RRMS?” the analytic framework of thematic analysis, as 
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described by Braun & Clarke (2006, 2013), stood out as an excellent candidate. 
Thematic analysis involves looking for patterns in participant experiences across an 
entire dataset and has the capability I required in terms of being both robust and 
organised. 
 
Considering the best method of data analysis for this study 
 
There are many types of data analysis, and some are directly linked with an 
overarching methodology and are an essential part of that framework, such as those 
used in grounded theory and interpretative phenomenological analysis (Braun & 
Clarke, 2013). Other analytic methods such as content analysis and thematic analysis 
consider themes and patterns in data, and although often used interchangeably, there 
are important differences.  Content analysis and thematic analysis can be more 
suitable for studies employing a lower level of interpretation compared to grounded 
theory and interpretative phenomenological analysis, which require a higher level of 
interpretation (Vaismoradi, Turunen, & Bondas, 2013), however thematic analysis in 
the current study was employed for a high level of interpretation. Alternative forms 
of data analysis such as narrative analysis and discourse analysis concentrate more 
on how things are said in data collection, rather than what is said and therefore were 
not suitable for the purpose of this study. The relative merits and drawbacks of 
employing these methods of analysis in the current research study will be discussed 
in further detail. 
 
Comparing thematic analysis against other methods of data analysis 
 
As briefly discussed, other forms of data analysis were explored before concluding 
that thematic analysis was the “best fit” for this research study. As discourse analysis 
and narrative analysis concentrate more on how things are said and the style and 
linguistics of words rather than what was said, they were eliminated early in the 
exploration of data analysis methods. However, there are shared elements of data 
analysis between the methods of interpretative phenomenological analysis, grounded 
theory, content analysis and thematic analysis that could have made those approaches 
a consideration for the current study. These will be briefly compared and discussed, 
and the use of thematic analysis justified. 
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Interpretive Phenomenological Analysis 
 
There are some important differences between interpretative phenomenological 
analysis and thematic analysis, but the end result can look very similar (Braun & 
Clarke, 2013). Both interpretative phenomenological analysis and thematic analysis 
as qualitative methods of data analysis are particularly useful to answer research 
questions about the lived experience of people and their viewpoints and outlooks on 
life (Smith, Flowers, & Larkin, 2008). Thematic analysis has been referred to as a 
phenomenological method (Guest, MacQueen, & Namey, 2012) however Braun and 
Clarke (2013) identify thematic analysis as just an analytic method rather an overall 
methodology. Identifying interpretative phenomenological analysis as a methodology 
means that the overall study design is already specified as part of the ontological and 
epistemological foundations for interpretative phenomenological analysis, being 
critical realist and contextual in nature and based on the theory of phenomenology 
(Larkin, Watts, & Clifton, 2006).  
 
Interpretative phenomenological analysis also targets a small homogenous sample, 
which would not be appropriate for this particular study exploring a heterogeneous 
disease such as MS, where there can be a wide variance of experience, with no two 
people experiencing the same course of the disease. A key difference is that in using 
interpretative phenomenological analysis the researcher codes the first data item then 
progresses to developing themes for that data item, rather than coding across the 
entire dataset, and then progressing to theme development as occurs in thematic 
analysis (Braun & Clarke, 2013). Overall, interpretative phenomenological analysis 
procedures focus on the unique characteristics of each individual participant, 
specifying coding and theme development along the way for each data item. This 
differs from the procedures of thematic analysis where the researcher identifies 
patterns across the entire dataset. I wanted to understand the meaning of living with 
RRMS across all of the participants, both individually and as a group, and in order to 
do so, thematic analysis provided a better “fit” than interpretative phenomenological 
analysis. 
 
	 95	
Grounded Theory  
 
Grounded theory is a research methodology which discovers patterns and generates 
theory from data using a process of constant comparison (Braun & Clarke, 2013). 
Grounded theory was developed in the 1960s (Glaser, 1965; Glaser & Strauss, 1967) 
and was one of the first endeavours to develop a systematic method for analysing 
qualitative data. Currently there are now many versions of grounded theory, each 
with distinctive theoretical underpinnings and procedures. A key difference between 
grounded theory and thematic analysis is that grounded theory is a whole 
methodology, not just a method. As with interpretative phenomenological analysis, 
grounded theory comes with its own theoretical framework and ontological and 
epistemological position, and advocates the use of particular types of research 
questions with a focus on social processes or the factors that influence a particular 
phenomenon (Braun & Clarke, 2013).  
 
 Grounded theory differs from other manifestations of qualitative research in that the 
emphasis is on the theory as a product of analysis (Charmaz, 2006), unlike thematic 
analysis, which does not attempt to develop a theory (Braun & Clarke, 2013). As 
theory generation was not the aim of the current research study, grounded theory was 
not pursued as a viable option for data analysis. 
 
Another point of difference between grounded theory and thematic analysis involves 
engagement with the literature. A common practice in grounded theory methodology 
is to not engage with the relevant literature prior to beginning data analysis, to avoid 
the analysis being shaped by preconceptions from existing research. As part of the 
preparation for identifying exactly where the significant gaps were in understanding 
the experiences of people living with RRMS, the topic was thoroughly researched 
over many years in advance prior to the final study design. Additionally, as reading 
the relevant clinical and research literature as it is published in MS is part of the 
expected clinical, educational and research role I was working in at the time of the 
study commencing, “not engaging” with the relevant literature was impossible. Due 
to these overwhelming factors, grounded theory was not going to be harmonious 
with this particular data analysis. 
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Content Analysis  
 
The terms content analysis and thematic analysis have often been used 
interchangeably to refer to very similar approaches to qualitative data analysis, 
further confused by the fact that the boundaries between the two methods have not 
been clearly specified (Braun & Clarke, 2013; Vaismoradi et al., 2013). Content 
analysis is a general term used to describe a number of different strategies to analyse 
the subject matter of data (Powers & Knapp, 2006) and uses a systematic coding and 
categorizing approach to determine trends and patterns of words used by the 
participants during during their interview, often in a large volume of text 
(Vaismoradi et al., 2013). This may involve looking at frequency of words, and the 
relationships between words (Grbich, 2007). The purpose of content analysis is to 
summarise quantitative messages (Neuendorf, 2002), whereas thematic analysis aims 
to identify, analyse and report patterns within the data (Braun & Clarke, 2006). The 
purpose of this research is the latter, rendering thematic analysis a stronger and more 
appropriate choice than content analysis for this particular study. 
 
Choosing thematic analysis 
 
After careful consideration of the methodologies/methods for data analysis described 
above, I chose thematic analysis to be the most congruent with my research 
ontology, epistemology, with the overarching methodology of focused 
ethnography/life history and with the other research methods chosen for sampling, 
data collection and data management. The various components of the research design 
fit together well to provide a robust framework for operationalising the study and 
meeting the study goals. Another form of data analysis, poetical analysis, was also 
used in this study, although in a very minor capacity. Poetical analysis was used to 
enhance the study findings from the thematic analysis and will also be discussed at 
the end of this section.  
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Method of Data Analysis 1: Thematic Analysis 
 
The following section will briefly describe the historical development of the thematic 
analysis method, explore thematic analysis in more detail and outline how it differs 
from other methods of qualitative data analysis. An in-depth exploration of thematic 
analysis, as suggested by Braun and Clarke (2006, 2013) will demonstrate why this 
method of data analysis is congruent with the aims and goals of this research study 
and will also provide an overview of the framework used to guide data analysis. 
 
Thematic analysis involves the search for common principles that extend through an 
entire dataset (DeSantis & Ugarriza, 2000). It is a method for identifying, analysing 
and reporting patterns or themes within a dataset, ultimately organising and 
describing the data in rich detail (Boyatzis, 1998; Braun & Clarke, 2006). Searching 
for patterns and themes is a common method in data analysis in general, and several 
methodologies in qualitative research (such as interpretative phenomenological 
analysis and grounded theory) actually use forms of thematic analysis as an 
important and basic part of their framework. However, fundamentally thematic 
analysis differs from other analytic methods seeking to describe patterns in 
qualitative data as it is not bound to any one type of theory or methodology, it is 
simply a method of data analysis (Braun & Clarke, 2013). This leaves the researcher 
free to choose their own ontological and epistemological framework and data 
collection method, improving flexibility in answering research questions in the best 
possible way.  
 
As an adaptable method, thematic analysis can be approached in a number of 
different ways, and several of these are specifically aligned with the aims of this 
research study. Thematic analysis can be inductive, the data are examined from the 
“bottom up” and coding and theme development are directed by the content of the 
data. This approach is integral to answering the research question in the current 
study, exploring and finding meaning in the experiences of people living with RRMS 
from the those considered the experts when performing qualitative research - the 
participants themselves (Windle, 2011). This study is not based on any pre-
determined theories, but will be shaped by the experiences of the individual 
participants and the group as a whole, from the emic perspective, which is also 
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congruent with thematic analysis. Moreover, thematic analysis can be semantic, 
deriving codes and themes from the precise, explicit content of the data, or more 
latent, reporting concepts and assumptions underpinning the data and interpreting the 
data at a deeper level. This is consistent with one of the aims of this research study, 
to provide both semantic and latent analysis of the themes and provide interpretations 
on how these themes may be important. 
 
Congruence between methodology and analytic method  
 
Thematic analysis can be a method to reflect reality and to “unpick” the surface of 
reality (Braun & Clarke, 2006), making it ideal for this research study seeking 
insights into the experience of people living with RRMS in the real world. Thematic 
analysis allows examination of the data within a relativist approach, focusing on 
reporting an assumed reality, but is also able to look at the data in a constructionist 
fashion (Braun & Clarke, 2006). This is congruent with the ontology (constructivist, 
relativist) and epistemology (constructivist) for the current study where the 
researcher and participant will co-create the data and the researcher will provide 
latent and abstract explanations from the data. Additionally, the researcher is able to 
determine the level of analysis and choose how to present the data in a way that is 
accessible to others interested in the field of study (Braun & Clarke, 2013). As an 
important goal of the research is to disseminate the information gained from the 
study across as many health professional domains of MS as possible, thematic 
analysis supports this approach.  
 
The thematic analysis method as presented by Braun and Clarke (2006, 2013) suits 
the research question, fits the exploratory topic, allows choice of ontological and 
epistemological viewpoints, aligns with the data collection method, allows the 
researcher to grow and develop as experience is gained with the method, allows 
focus on the context of the research question, is robust and systematic, and allows 
both latent and semantic interpretation of study data. This is an ideal match for this 
research study and promotes congruence between ontology, epistemology, 
methodology and method, essential components of successful qualitative research 
(Carter & Little, 2007). 
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The history of thematic analysis 
 
Thematic analysis was first named as a method by Gerald Holton in the 1970’s 
(Merton, 1975). Initially thematic analysis was described in very simple terms only 
(Leininger, 1985) with little guidance provided in terms of process to actually 
perform the thematic analysis and no clear agreement about what the method entailed 
(Attride-Stirling, 2001). In particular, researchers often described themes “emerging” 
or being “discovered” from the data (Braun & Clarke, 2013; Ely, Vinz, Downing, & 
Anzul, 1997) providing very little in terms of process, transparency and confidence 
to the reader. This has been described as a passive account of the process when the 
process of analysis is very active and engaging and needs a clear description to 
enable others to evaluate the integrity of the data analysis and to understand the 
process (Braun & Clarke, 2006).  
 
Frustrated by a lack of processes underpinning thematic analysis and poor 
demarcation of the method, Braun and Clarke (2006) outlined the theory, application 
and evaluation of their version of thematic analysis to the psychology community. 
Over the last decade, thematic analysis has grown to encompass many disciplines of 
health research with the “in psychology” reference to the method now largely 
disregarded (Braun & Clarke, 2013). However, some factors in the data analysis 
technique have remained in common with original descriptions (Merton, 1975; 
Aronson, 1995; Boyatzis, 1998) but with differing methodological paradigms and 
subtle analytic departures.  
 
Several other authors have also described and explored thematic analysis as an 
analytical method (Boyatzis, 1998; Joffe & Yardley, 2004; Guest et al., 2012). The 
main difference between these method versions and the Braun and Clarke (2006) 
method of thematic analysis is that the former all promote the development of coding 
frames within the method, to enable multiple researchers with different expertise and 
perspectives, to code the same data in order to improve inter-rater reliability. This 
was identified early as being challenging when applied to this research study, as I 
brought to the study my own assumptions and beliefs about RRMS (based on many 
years of working in the specialty) consistent with the stated epistemology and my 
reflexive stance. Invariably applying this experience to the codes and later themes 
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would differ from those that others might determine from the same data. As coding is 
an active and reflexive process that inevitably and inescapably bears the mark of the 
researcher, with no one ‘accurate’ way to code data, the logic behind inter-rater 
reliability disappears (Braun & Clarke, 2006). Braun and Clarke (2013) further argue 
that inter-rater reliability scores can be viewed as two researchers being trained to 
code data in the same way, rather than that their coding being accurate (Braun & 
Clarke, 2013). As this study was only to be coded and themes developed by myself 
as the principal researcher, the Braun and Clarke method (2006, 2013) of thematic 
analysis was the preferred choice. 
 
In summary, thematic analysis has gained more popularity as a method of data 
analysis in recent years, particularly since Braun and Clarke (2006) have detailed and 
described this qualitative data analysis method and made it more accessible for 
researchers. It is one of a group of methods that focus on identifying patterns across a 
dataset and is now anchored firmly as a flexible, robust, systematic framework 
suitable for many types of qualitative research (Braun, Clarke, & Terry, 2014). The 
specific method of thematic analysis based on Braun and Clarke (2006, 2013) 
teachings will now be discussed and explored in further detail. 
 
An overview of the Braun and Clarke (2006, 2013) method of thematic analysis  
 
The Braun and Clarke (2006, 2013) method of thematic analysis involves key stages, 
following directly on from each other: transcription, reading and familiarisation of 
the data, coding, searching for themes, reviewing themes, producing a ‘thematic 
map’, defining/naming themes and writing up the research. The major elements of 
the Braun and Clarke (2006, 2013) process of thematic analysis are outlined below. 
 
  1: Familiarisation with the data 
 
This phase involves reading and re-reading the transcribed interviews, to become 
immersed and intimately familiar with the content. Transcribing the interviews 
personally can be an excellent way to start familiarising the researcher with the data 
(Riessman, 1990) but is not essential to the method. I elected to transcribe the 
interviews myself to promote deep engagement and connection with the data from 
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the earliest stage. 
 
Familiarising with the data is an active process, pondering repeatedly about what the 
data could mean. In this research study, I would also go back and re-listen to the 
original audiotapes regularly. Hearing participant voices helped formulate a 
recreation of the interview to visualise facial expressions and other non-verbal cues, 
enhancing recall of the emotional aspects of the interview. As the method is 
recursive, the opportunity remains for the researcher to come back to this phase 
repeatedly as needed and perhaps identify new insights further in the process. I found 
this extremely helpful throughout the data analysis. 
 
Immersing in the data and getting to know the words and feelings of the participants 
opens up areas of interest for the researcher, helping to notice things that might be 
important to answering the research question. Braun and Clarke (2006), term these 
thoughts as “noticings” and an important first step in engaging and analysing the 
data. At this early stage it is not a systematic and precise procedure, just more similar 
to first impressions of the data.  
 
  2. Generating initial codes:  
 
The second phase involves generating succinct labels called “codes” which identify 
important features of the data that might be relevant to answering the research 
question. Codes identify a feature of the data at it’s most “basic segment” (Boyatzis, 
1998). Coding may be semantic (explicit) or more latent (hidden and awaiting 
development) in nature. The researcher codes the entire dataset, working 
systematically and giving full and equal attention to each data item identifying 
interesting aspects that may form the basis of later themes. Coding should be 
performed widely and thoroughly and be constantly mindful of context.  
 
  3. Searching for themes:  
 
The focus of the analysis now shifts to examining the codes and collated data to 
identify significant patterns of meaning, the broader level of developing themes. 
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Potential themes, known as “candidate” themes are developed and data related to 
each theme is collated to examine and support the viability of the candidate themes. 
 
  4. Reviewing themes:  
 
This phase involves checking the candidate themes against the dataset, to determine 
if they tell a convincing story of the data, and a story that answers the research 
question. At this stage, themes develop and are refined, which sometimes involves 
themes being split into sub-themes to further clarify meaning, being combined with 
other themes, or being discarded altogether. A key component of the phase is 
developing a detailed analysis of each theme, working out the scope and focus of 
each theme; determining the ‘story’ of each theme individually.  
 
  5. Defining and naming themes:  
 
The key feature of this phase is determining that each theme has a central organizing 
concept to securely and confidently anchor the theme in the dataset. A central 
organizing concept is the essence of a theme and is critical to sound theme 
development. Capturing something important about the data, the central organising 
concept unifies the data extracts and is essential for demonstrating coherence of a 
theme (Braun & Clarke, 2013). Each theme presented in the study findings will be 
introduced with a short discussion of the central organizing concept and how it unites 
the theme and subthemes, and how it is meaningful to answering the research 
question. A name for each theme is developed, ideally being both informative and 
succinct. 
 
A thematic map of the data, capturing the “essence” of what each theme is about and 
demonstrating links between the themes often assists this phase of the analysis. 
Constant reference to data extracts by the researcher helps to organise the data into a 
coherent and internally consistent account. Sub-themes are assigned if they are 
needed to give structure to the dataset and also reveal the hierarchy of meaning 
within the data. A sub theme can be a less prominent theme that exists under an 
umbrella theme, or it may be an important feature of the stand-alone theme. By the 
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end of this stage, themes should be clearly defined and concise, demonstrating that 
the researcher has a clear sense of what the theme is about and have a clear, defined 
central organizing concept. 
 
  6. Producing the report 
 
The final phase of the Braun and Clarke (2006) method of thematic analysis involves 
weaving together the analytic narrative from the participant, and contextualising the 
analysis in relation to existing literature. Data extracts are embedded in the analytic 
narrative to illustrate the story of the data and to go beyond a simple description of 
the setting and instead comprehensively answer the research question. 
 
Although these phases are sequential, and each builds on the previous, Braun and 
Clarke (2006, 2013) emphasise that thematic analysis is typically a recursive process, 
with movement back and forth between different phases. In fact, some of the phases 
can often blur together, rather than having clear lines of separation, as the researcher 
moves around the data and explores different labels and themes. The process of 
thematic analysis can be time consuming, laborious and requires intensive effort 
(Guest et al., 2012). Additionally, the researcher needs to rely on their own opinions 
and develop their own understanding of the values and assumptions of different 
research paradigms and their own subjective positioning within those methods to 
ensure rigour in their findings (Braun & Clarke, 2013).  
 
Intensive review of each component of the Braun & Clarke (2006, 2013) method of 
thematic analysis 
 
The coding process 
 
A code is a textual description of the semantic boundaries of a theme and is a short, 
descriptive mnemonic from the data (Guest et al., 2012). Coding is the process of 
identifying aspects of the data, which directly relate to the research question (Braun 
& Clarke, 2013) and is an important process to start early sense-making of the data 
(Averill, 2014). The coding process involves the researcher seeing important 
characteristics in the data and encoding it before interpretation begins, so that the 
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data is organised and reduced before developing themes (Boyatzis, 1998). Coding 
provides logical data organisation to form the basis for later data analysis (Miles & 
Huberman, 1994).  
 
A fundamental step of all coding is to verify the applicability of the code to the raw 
information (Boyatzis, 1998). A researcher should be able to take away the unedited 
data from the codes and still be able to evoke the feeling of the data (Clarke & 
Braun, 2013). This provides an internal validity check prior to progressing to theme 
development and I performed this often to ensure I could “feel” the data in the code 
and that it was still appropriate when separated from the original participant 
transcript. In the current study, working through the stages of code development 
allowed ideas about candidate themes to slowly develop, sometimes days and weeks 
after the first coding exercise. 
 
Coding is an important and integral step for most forms of qualitative analysis and 
different approaches have different labels inherent in their methodology for these 
codes, often with very similar goals and meanings. Braun and Clarke (2006) consider 
that there are two methods of coding practice - selective coding and complete coding. 
 
Selective coding involves looking for instances of the topic of research interest and 
purposefully selecting only those instances in order to obtain data reduction. This is 
not applicable to this particular research study where there is a high degree of 
inclusion to explore the research question thoroughly. 
 
Complete coding has a much broader focus and aims to identify anything at all 
within the entire dataset which may show potential to answering the research 
question. For this reason complete coding is more closely aligned with this particular 
research study than selective coding. All data potentially relevant to the experience 
of living with RRMS was coded from the transcriptions in this study, only becoming 
more selective later in the analytic process. This helped to ensure no data that may be 
important was missed, especially as themes are developed later in the process. Each 
code is essentially a “pithy” label (a brief, concise but meaningful label), which 
captures the core or essence of the data collected (Braun & Clarke, 2013). In 
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complex and data rich datasets, sometimes a second or third round of coding is 
needed to further reduce the data (Saldana, 2015). In the current study, over 2,000 
initial codes were identified from the transcripts in the first round of coding. A 
second round of coding was required to reduce the data even further for theme 
development and resulted in approximately 300 codes, after codes displaying similar 
characteristics were grouped together. 
 
The Braun and Clarke (2006) method of thematic analysis provides guidance on 
complete coding which was the chosen coding method in this study. The principles 
of the method require eliminating irrelevant data to answering the research question, 
but still coding everything which may potentially be important, coding widely and 
extensively and using data in as many ways as relevant to the research question. 
Examining the collated data for similarities and grouping together like codes 
occurred later in the process.  
 
Semantic and latent codes in thematic analysis 
 
Braun and Clarke (2013) identify semantic codes as reflecting the words and 
concepts of the participants directly, they are entirely overt within the data. When the 
researcher goes beyond this overt content and starts to invoke conceptual and 
theoretical frameworks to identify meanings implicit in the data, latent codes are 
developed (Braun & Clarke, 2013). Latent codes are developed by the researcher 
based on what they “see” within the data, not based on what is “said” by the 
participant directly. In general, a much deeper engagement with the data is needed 
for latent coding (Braun & Clarke, 2013). An example of the development of 
semantic and latent codes in the current study is shown in Appendix 7. This research 
study aimed to use both semantic and latent coding in data analysis. 
 
Developing codes into themes 
 
Processing techniques for collating the codes to develop themes can be performed 
electronically or manually. Cutting and sorting written codes and themes manually is 
a common method employed by researchers and involves identifying text that appear 
to fit together, placing the text into piles and moving them around until they 
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represent a theme where they appear to belong (Ryan and Bernard, 2003). As with all 
facets of thematic analysis this process is recursive, and may involve many steps 
forward and back before an ideal match is reached. I used a manual method to group 
codes together in a pile, using a different colour card for each participant code to 
group like codes together to later develop candidate themes. The more colours in a 
pile, the more heavily patterned the theme was. However, this colouring did not 
dictate the importance of the code, it merely raised the possibility of a beginning 
theme. 
 
Manual and computer coding in thematic analysis  
 
The term “computer-assisted qualitative data analysis software” (CAQDAS) refers to 
a range of computer programs used in data analysis. The value of CAQDAS depends 
on the purpose it is used for and the methodological underpinnings of the research 
study. Although CAQDAS can be very effective and assist in interpretation of data 
and developing theories (Silverman, 2016), it is still only a tool to assist with coding 
and analysis (Braun & Clarke, 2013). No computer programs are capable of the 
intellectual and conceptual processes needed to transform data into meaningful 
findings (Thorne, 2000), rendering the researcher the most important instrument in 
the process of developing latent or hidden, more abstract themes. CAQDAS may 
prevent the researcher “immersing” in the data and may cause some detachment from 
the transcriptions of the participants in this study (Braun & Clarke, 2013). If used 
inappropriately, there is also the risk in coding becoming related to quantity of times 
a concept is mentioned in the data and taking away from the significance of the data. 
 
I briefly considered using a software program to assist with thematic data analysis, 
but I felt that deep engagement with the study data might be compromised if I did not 
manually code the data myself. I wanted to “embed” myself in the data and stay as 
close to the data as possible (Munhall, 2012). I was also concerned that using 
software to analyse the data thematically might remove context from the stories and 
reduce the stories to categories and frequencies.  
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Themes and sub-themes in thematic analysis  
 
One of the earliest concepts of a theme was described by an anthropologist, Morris 
Opler (1945): 
 
“In every culture are found a limited number of dynamic affirmations, 
called “themes” which control behaviour or stimulate activity…the term 
theme… is used to denote a postulate or position, declared or 
implied…which is tacitly approved or openly promoted in a society” (Opler 
1945, p.198) 
 
This work was further built upon by Spradley (1979), who described themes as: 
 
 “larger units of thought…they consist of a number of symbols linked into 
meaningful relationships…Themes are assertions that have a high degree of 
generality…they apply to numerous situations…some themes occur within a 
restricted context” (Spradley, 1979, p.186-187) 
 
Desantis and Ugarriza (2000) have examined many nursing research texts in an effort 
to provide a uniform definition of a “theme” in the context of nursing. The concept 
of “theme” was examined and explored across 27 qualitative nursing research texts 
to ultimately define the concept of a theme as “an abstract entity that brings meaning 
and identity to a recurrent experience and its variant manifestations” (DeSantis & 
Ugarriza, 2000). A theme captures something important about the data in relation to 
the research data set (Braun & Clarke, 2006) and brings together components of 
ideas or experiences, which are often meaningless when viewed alone (Leininger, 
1985).  
 
How many themes compose thematic analysis? 
 
There is no precise formula for determining the number of themes in thematic 
analysis, as it depends on many other factors, including the data itself, the research 
question, the length of the analytic report, and the focus of the analysis (Braun & 
Clarke, 2013). Thematic analysis can range from detailed and intensive reporting of 
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one theme as a focus for a research study, to a complete and wide-ranging overview 
of entire and multiple datasets, with less focus on individual themes. Therefore, 
dictating an ideal number of themes and subthemes to demonstrate rigour within an 
analysis is impossible and is not the aim of thematic analysis.  
 
How does a theme achieve importance in thematic analysis?  
 
Referencing exact numbers of participants in describing theme occurrence is also a 
challenge in thematic analysis, and one which Braun and Clarke (2013) address for 
researchers in their recommendations. Rather than using numerical expressions to 
report occurrence, they instead advocate using phrases such as “a common theme” or 
“many participants commented”, and this is for several reasons. Firstly, counting 
responses misses the point of qualitative research, as frequency does not necessarily 
equate to the value and importance of a theme (Pyett, 2003). Ideally, a theme will 
present itself a number of times across the data, however, the number of times the 
theme presents itself is not indicative of the importance of the theme (Buetow, 2010). 
When using unstructured or semi-structured interview method, the absence of a 
theme in an interview should not be regarded as an assumption that the participant 
does not experience or behold the theme as important or relevant. It may simply be 
that topic did not present itself in that particular interview. As the interviews were all 
flexible and interactive, different issues came up in each conversation, which were 
not necessarily discussed with other participants.  
 
In regards to the importance of a particular theme, more instances of a theme across a 
dataset does not necessarily mean that one theme was more important than another, 
rather researcher judgment is crucial to determine what constitutes theme 
significance (Braun & Clarke, 2006).  Additionally, the importance of a theme is not 
dictated by the prevalence of that theme across an entire or partial dataset. Themes 
will be discussed individually in the study finding chapters 6 and 7, and they will 
also be discussed in terms of how they link together to explore the journey of living 
with RRMS in chapter 8. This approach supports the gestalt of qualitative research 
analysis, ensuring that all data is analysed and presented as completely and 
thoroughly as possible. 
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Developing themes and sub-themes across the dataset 
 
Identifying themes from coded data is entirely an active process with the researcher 
examining the codes to create potential patterns (Taylor & Ussher, 2001) and finding 
hidden treasure within the data (Braun & Clarke, 2013). Clarifying and making 
transparent the techniques used to develop themes is important for several reasons; as 
discovering themes is the basis of much social science research, it allows readers to 
assess methodological choices and also promotes research communication across 
disciplines and epistemological positions (Ryan & Bernard, 2003). Providing a step 
by step process of theme development demonstrates transparency in the analysis and 
promotes rigour in the method, as does using excerpts from the data to ensure that 
data analysis remains directly and firmly linked to the words of the participants 
(Fereday & Muir-Cochrane, 2006).  
 
A sub-theme exists as a sub-category of a theme and shares the same central 
organising concept as the theme, but focuses on one specific element (Braun & 
Clarke, 2013). Sub-themes should generally be used in moderation, and only when 
there is one particular element of a theme that has a specific focal point, or is 
particularly important for the research question (Braun & Clarke, 2013). 
 
Organising themes in thematic analysis 
 
Collating and organising the themes and sub-themes is an integral part of the 
analytical method, and requires a process in order to demonstrate rigour (Fereday & 
Muir-Cochrane, 2006). There are several methods available for researchers to 
organise themes and provide structure to thematic analysis, including diagrams such 
as thematic networks and thematic maps. 
 
Thematic networks are web-like illustrations that summarise the main themes of text 
in thematic analysis and provide a tool to systematically present analyses (Attride-
Stirling, 2001). Thematic networks consist of different levels of themes, a global 
theme overarches an organising theme, which overarches a basic theme to build the 
overall network (Attride-Stirling, 2001). Similar to these networks are thematic 
maps, which are simple drawings to reflect relationships between themes and sub-
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themes (Braun & Clarke, 2013). As a key part of the Braun and Clarke (2006) 
method, thematic maps have been developed as part of the data analysis for the 
current study (Braun & Clarke, 2006) and were used at every step of the analytic 
process. A thematic map is essentially a visual aid, which uses a drawing to 
summarise, define and name themes and sub-themes. It is simply a visual 
representation of how themes and subthemes may fit together to tell the story. As the 
study progressed, thematic maps changed to reflect new ways I was seeing the data 
and how themes and subthemes were linking in with each other and developing a 
story. I referred to the thematic maps regularly to act as a framework for the final 
analysis and to demonstrate theme maturation. An example of a thematic map used 
during the study data analysis is shown in Appendix 8. 
  
Method of data analysis 2: Poetical Analysis 
 
Poetical thinking is felt experience, being in the flow of what is being experienced 
and capturing and understanding the feelings of that experience (Freeman, 2017). It 
is a form of thinking that has roots in phenomenology, dealing with concepts of 
experience, perception and language (Freeman, 2017). It has been suggested that 
through poetry, names are given to ideas which were formerly nameless and 
formless, but already felt (Lorde, 2009). By using poetry as a form of art, we can 
experience moving the mind from routinely taken-for-granted assumptions towards a 
sharper focus on a situation (de la Fuente, 2014).  
 
During the data management phase of the study, I began to write the feelings I was 
experiencing as poetry whilst listening to the recordings and reading the transcripts. I 
began writing without explaining, just feeling the words as they flowed for each 
participant. This continued in the theme maturation process of the data analysis, and 
as each theme developed, I then purposely tried to capture the essence of what I was 
feeling from the experiences of the study participants.  
 
The aim of the current research study was not to pursue a poetic form of inquiry (de 
la Fuente, 2014; Freeman, 2017), it was a traditional and method specific systematic 
thematic analysis, but the opportunity presented itself to consider poetical analysis as 
	 111	
I dealt with my own feelings and emotions of constantly re-living the interviews and 
experiences of the study participants, especially through the theme development 
phase. The great majority of the study findings related to the thematic analysis, but I 
have strategically placed poetry (my own and others) in the thematic findings as an 
important adjunct to the data analysis and as a way of connecting and adding 
meaning to the data. Poetical thinking also honours my epistemological viewpoint of 
the researcher and study participant co-creating the study data and findings, by 
listening to the participant stories and finding methods to experience and feel the 
emotions of the study participants. It was a way to intertwine their experiences, my 
reactions and co-construct a new knowledge.  
 
What differentiates poetical thinking from analytic thinking is the reach beyond 
searching for meaning or knowledge, into the difficult to grasp, experiential world 
(Freeman, 2017). I found the poetical thinking and the words that emerged from this 
provided me with a vehicle to release profound feelings I was experiencing, listening 
repeatedly to stories of suffering, of sadness and of constant battle. It was a catharsis 
of sorts and I positioned the poetry at the appropriate places so that readers might 
also gain an enhanced perspective of the data. In some instances, I found a better 
representation of my thoughts and feelings from other poets in the literature and they 
are included where appropriate. As Freeman (2017) notes, making sense of the 
complex interaction between theory and practice (being there, listening, seeking 
understanding) is difficult and poetry may enhance understanding as lived, 
experienced and yet undefined.  
 
In qualitative analysis there is the opportunity to enhance and enrich ideas with deep 
contemplation, which cannot be expressed in other ways such as scholarly text 
(Averill, 2014). I wished to convey additional meaning to the insights I was 
gathering and beginning to understand during the data collection and data analysis, 
and sought to find ways to complement the study themes as findings. Where I have 
used the poetry written by others, it is appropriately named, otherwise the poetry is 
my own work (marked as TB). 
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Methods: Frameworks for the study  
 
Theoretical framework 
 
A framework is essentially a research map for the study, a guide to how the study 
should proceed. A single theoretical framework did not underpin this study, and the 
study was not linked with any particular theory. Due to the broad and multifaceted 
nature of the research question, a singular theoretical perspective would not have 
been possible. However, Green (2014) argues that the epistemology on which a study 
is based is a theoretical framework of sorts, as it provides an overarching philosophy 
for the study, a belief system and theory to guide process. In this regard I would 
agree with Green (2014) and present the constructivist epistemology described 
earlier in this chapter as an appropriate theoretical framework guiding the study. 
 
Conceptual framework 
 
A conceptual framework draws on concepts from various theories and findings to 
guide the research design, identifying worldview and the ontology and epistemology 
of a study. I developed a conceptual model to illustrate this framework, and how the 
various components of qualitative research work together to create knowledge. This 
conceptual model was mostly based on previous work by Carter and Little (2007) 
linking the importance of epistemology, methodology and methods in research, but 
also influenced by Guba and Lincoln (1994) and Cresswell (2008), and is shown in 
Figure 2. 
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Figure 2. Conceptual model highlighting the relationships between ontology, 
epistemology, methodology and methods and the production of new knowledge. 
 
Operational framework 
 
A strength of this study design lies in the operational framework. This framework 
provides an overview of the entire study, maintaining coherence and focus on the 
goals of the research study, it also demonstrates the important links between the 
qualitative paradigm, ontology, epistemology, methodology and methods involved in 
the research process as recommended by Carter and Little (2007) and shown in 
Figure 3. The operational framework is broader than the conceptual framework and 
considers many other elements influencing the research design, including ethical 
considerations, reflexivity, rigour, transparency, context, sensitivity, coherence of the 
research the quality of the product, and fit to empirical literature. The operational 
framework illustrates the framework I developed to ensure consistency in the study 
process and consideration of all the necessary components of high quality qualitative 
research.  
	 114	
 
 
Figure 3. Operational framework highlighting the interplay between the processes of 
the current research study and the relationships between them to produce new 
understandings that are highly relevant, rigourous, context sensitive and impactful to 
clinical practice. 
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Methods: Ensuring rigour in the study  
 
In social research, validation cannot occur through subsequent replication, since 
identical social situations cannot be recreated (Bloor, 1997). Instead, elements of a 
study are viewed as being possibly generalisable across settings, or not generalisable 
at all due to the research being in a truly particular setting (Bloor, 1997). It is up to 
the reader of the research to determine to what extent the findings of a qualitative 
study might apply to their own situation. The researcher can help the reader to make 
this assessment by being transparent in all aspects of describing the sample, data 
collection, data management and data analysis, as I have done in this chapter.  
 
Qualitative research represents a distinctive paradigm, and as such, should not be 
judged by conventional quantitative measures of validity, generalisability and 
reliability (Mays & Pope, 2000). Instead, terms such as accuracy, confirmability, 
transferability and trustworthiness apply in qualitative research (Lincoln & Guba, 
1985). The aim is to discover patterns that exist. In using the ethnography 
methodology and life history, no two researchers will elicit the same life story, and 
no one researcher will ascertain the same life history on two occasions, the aim in 
life history being to grasp unique experiences for what they tell us (Plummer, 2001).  
 
Maintaining rigour in a study helps to safeguard the participant’s point of view, so 
that researchers don’t construct a fictional, non-existent world (Fereday & Muir-
Cochrane, 2006). There are strategies that can be employed by researchers to 
establish and enhance rigour within a study. As Plummer (2001, p.155) suggests “the 
closer I am to the phenomenon I want to understand, the closer I am to validity”. To 
accomplish this, I transcribed my own interviews verbatim and regularly re-listened 
to the original audiotapes to stay as connected to the original data as possible. By 
doing this I was able to build up layers of understanding, gradually building up ideas 
and concepts that eventually became themes and subthemes. Additionally, 
approaching data analysis in a responsive, inductive, transparent and systematic way 
has been reported to lead to openness and balancing quality, science and rigour 
(Averill, 2014). I felt that selecting such a robust and systematic method in thematic 
analysis, and using the method outlined by Braun and Clarke (2006, 2013) to analyse 
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the study data, was crucial to maintaining rigour in the study. Table 3 demonstrates 
elements of rigour and strategies employed during the study to support and maintain 
each element.  
 
Table 3. Elements of rigour identified and strategies employed during the study to 
maintain rigour. 
Element supporting rigour Strategies employed to uphold rigour 
Transparency  In depth discussion of chosen methodology and methods 
Systematic and robust data analysis method with visible 
and linked stages 
Reflexive diary kept throughout study 
Triangulation  As the primary researcher, I was responsible for the initial 
coding and theme development and thematic framework 
→ this was reviewed regularly by Supervisors for 
congruence and fit  
Credibility 
 
Findings discussed extensively with Supervisors and 
supported by both data and interpretative framework 
Peer debriefing of themes with MS nurse experts for “fit” 
of themes to clinical practice 
Prolonged and deep engagement in the field of MS 
The use of field notes to record impressions and describe 
situations in depth 
Participant quotes (raw data) provided as examples of 
particular themes and relationships between themes 
 
Transferability, 
trustworthiness, authenticity 
“Thick” and “rich” description  
Participant quotes (raw data) provided as examples of 
particular themes and relationships between themes 
Thematic framework of evidence of how the data builds 
the interpretation 
Comparison with research 
literature 
Interpretations and analyses compared with existing 
literature to confirm and expand study findings 
Negative case analysis consideration and discussion 
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Member checking 
 
Member checking/ member validation is a common qualitative research method to 
improve rigour in a study by providing the data transcriptions or findings back to the 
study participant to review and comment on; aiming to validate findings by 
demonstrating coherence between the researcher’s analysis and the feelings of the 
participant (Bloor, 1997; Seale, 1999). However, it was not a viable option in this life 
history study for several reasons. Firstly, in life history, participants can gain “new 
horizons” or new ways of seeing things after the interview and discussion, impacting 
on how they see things afterwards and often with a new perspective, which may then 
change the view of the original life story (Plummer, 2001).  
 
Secondly, Morse (2015) suggests that the findings in qualitative health research are 
deeply analytical and abstract and are therefore not appropriate to give back to 
participants, who may not understand the differences and reasoning between what 
they disclosed in the interview and the researcher’s final analysis. Thirdly, there is 
the question of what the researcher should do if there is a discrepancy with the 
findings and how this would be handled (Braun & Clarke, 2013; Morse, 2015). The 
concept of member checking is more appropriate for other approaches to research, 
such as phenomenology, where the specific aim is to record an individual’s 
perception as closely as possible in data analysis (Braun & Clarke, 2013). 
 
The concept of truth telling in life history 
 
The life story told at the time of the interview is taken to be the truth (Denzin, 1989; 
de Chesnay & Fisher 2014). The guidelines of life history assume that no participants 
are lying as they tell their stories, accepting the word of the individual and also being 
aware that there is no such thing as absolute truth (Wiseman, 1974). Of course, some 
stories are not always factual, but the researcher usually accepts the story of the 
participant as true, even though they know that sometimes memory may be confused 
or the story may be overdramatic for effect (Holloway & Freshwater, 2007b). It has 
been suggested that storytellers in narratives rarely tell lies and even when not telling 
the truth, consciously or not, they demonstrate their intentions and motivations 
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(Holloway & Freshwater, 2007b). I accepted the life stories as presented by the study 
participants as being honest accounts of their experiences. 
 
Data Saturation 
 
Essentially, data saturation is reached when the ability to obtain additional 
information has been exhausted or when further coding is no longer feasible (Guest, 
Bunce, & Johnson, 2006). Data saturation assumes that a circumscribed and total 
amount of facts are available (and necessary) to be able to draw conclusions from 
research (Malterud, Sierma, & Gusassora, 2016). This concept is not in alignment 
with qualitative research and the epistemology of this study, which values the 
individual voice; assuming multiple realities, of which only some can be known.  
 
An exception to this in qualitative research is in grounded theory, which has an 
inbuilt system of data saturation derived from data comparison, where every new 
observation is compared with previous analysis to identify similarities and 
differences (Glaser & Strauss, 2017; Malterud et al., 2016). In qualitative research in 
general, it is better to think of data as being both “rich” (focusing on quality, being 
layered, detailed and nuanced) and “thick” (focusing on quantity, a lot of data and 
codes) rather than “saturated” (Fusch & Ness, 2015). However, there are some 
general principles which indicate that enough data has been collected; these include 
no new data arising, identifying no new coding categories, no new themes emerging 
and collection of enough detail to replicate the study (Guest et al., 2006). 
Additionally, if the interview questions are not structured and consistent for every 
participant (as when using semi-structured or unstructured interviews), it is 
impossible to achieve data saturation against a constantly moving target (Guest et al., 
2006). 
 
Malterud et al. (2016) have proposed an alternative term to data saturation to guide 
sample size in qualitative research called “information power”. The more 
information the sample holds relevant to the study and answering the research 
question, the lower the amount of participants needed. Assessing “information 
power” involves a model considering the focus of the study (broad or narrow), 
sample specificity (dense or sparse), and the quality of the dialogue (strong or weak); 
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the model being particularly appropriate to individual interview studies such as life 
history (Malterud et al., 2016). I felt that the current study consisted of diverse 
informants who provided dense, specific and high quality insights; meeting the goals 
of the study, answering the research question and providing excellent “information 
power”. The quality of the interviews in the current study was excellent with the data 
collected giving rise to over 2,000 individual codes. Although I had no new codes or 
themes emerge after the eleventh interview, the final two interviews added a depth to 
the existing data that was exceptional and both were integral to richness in the final 
thematic analysis. As no new information was subsequently uncovered in the final 
analysis, no new interviews were therefore scheduled and data collection was 
deemed complete (Rubin & Rubin, 2011).  
 
Methods: Ethical considerations  
 
The concept of ethics is intrinsic to the constructivist epistemology because of the 
inclusion of participant values in the research (Guba & Lincoln, 1985). More than a 
checklist to simply tick off boxes, attending to ethical considerations is the moral 
responsibility of all researchers (Ryen, 2016). It has been openly discussed in the 
literature that ethical guidelines in general research are inadequate for qualitative 
research, as they focus more on the needs and nuances of quantitative research and 
clinical trials rather than the unique needs of qualitative study (Denzin & Lincoln 
2000; Ryen, 2016). Denzin and Giardina (2016) explore these concepts further, 
suggesting that the biomedical model of research ethics presumes a static, monolithic 
view of the study participants. In life history research in particular, the subject and 
researcher develop collaborative relationships, which are not captured in ethics 
“rules” (Denzin & Giardina, 2016).  
 
Despite these criticisms, the usual process for the ethical conduct of studies was 
followed in line with Notre Dame University guidelines. However, in agreeing with 
the concepts stated above, I decided to add additional considerations and precautions 
into the research design to provide added support to the study participants. The 
epistemological foundations of this study reflected my belief that the participants 
were key informants and that we constructed the reality together. Successfully 
completing the research study (for the sake of both of us) depended on the study 
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participants feeling comfortable, supported and valued. Their needs and welfare were 
critical to my study design.  
 
Ethical approval 
 
Ethical approval for the study was sought and granted by the Notre Dame University, 
Australia, HREC, approval number: 016002S (see Appendix 1). Following the 
recommendations of the Nuremberg code (1947), National Statement on Ethical 
Conduct in Human Research (National Health & Research Council (NHMRC), 2007 
and updated 2015) and the Australian Code for the Responsible Conduct of Research 
(NHMRC, 2007), the study was subjected to a full ethical review, rather than 
abbreviated low-risk review. This was primarily because I viewed the data collection 
interviews as very likely to be sensitive in nature and potentially inducing 
vulnerability in the participants. In addition to the above ethical considerations, the 
four principles of medical ethics were honoured - autonomy, beneficence, non-
maleficence and justice (Gillon, 2015).  
 
The full ethical review and approval included the approval of the HREC submission 
form outlining the research design and study procedures, the Participant Information 
Sheet and Consent Form (PICF)(Appendix 9), and a flyer for participant recruitment 
(Appendix 2). As per the requirements for study approval, a PICF was provided to 
each participant and signed prior to any study procedures taking place. The 
participant and I signed two original copies and took one each for our files. As an 
added protection for the participants, I ensured that they were able to read the PICF 
at least a week prior to our meeting and interview date. This was to avoid the 
situation where participants may have felt obligated to take part on the day we met 
(if they were reading the PICF for the first time) because of the effort required by 
both of us to attend the scheduled interview. This system also provided participants 
the opportunity to ask questions, consult significant others and think about their 
participation ahead of time. I also reminded the participants that on the day of the 
interview they were free to withdraw from the study at any time, and for any reason.  
 
The two specific areas that I identified at the beginning of the research process as 
being potentially challenging to the ethical conduct of the study involved protecting 
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participant confidentiality throughout all methods (transcriptions, coding, analysis) 
and the possibility of exposing the participants to distress and/or vulnerability 
discussing their experiences living with RRMS.  
  
Confidentiality for the study participants was paramount, particularly as some stories 
were distressing or involved family members, friends or HCPs directly (who did not 
volunteer to be part of the study). Pseudonyms (false names) were assigned to each 
participant to protect their identity and were mostly chosen by the participant 
themselves, continuing the feeling of partnership in constructing the research 
together. Still, two participants were adamant that their real names be retained. 
However, after many discussions with the supervisory team for my study, I allocated 
a pseudonym to protect them and their significant others from identification. In both 
cases I felt their intention to keep their real name was for good reason and they 
wanted the world to know their story, however, I believed there were issues they 
didn’t consider which could be detrimental to them or their family if their identity 
were revealed to the public. I also felt that I may inadvertently “hold back” on some 
of their story to avoid revealing their identity, and their stories and messages were 
too powerful to do this. I did discuss this with both of the participants after the 
interviews were completed and they understood and supported the use of a 
pseudonym with our further discussion.  
 
The names of significant others, HCPs and friends were all deleted from the 
transcripts, as well as potentially identifiable data such as birthplaces and 
cities/towns of residence. Where important to the story, reference is made to living in 
a rural town or community rather than to a specific region. Instead of using a 
potentially identifiable occupation, I changed the position to a broader role to 
continue the protection of the participant story as much as possible, without losing 
the essence of the stories and the meaning that this occupation may have had for the 
PwRRMS. Protecting the privacy of participants is a core tenet of research ethics 
(Morse & Coulehan, 2015). I maintained privacy for the participants during the 
interviews by speaking to them away from distractions in their homes or offices (in a 
room, privately from other house members or colleagues) or in the case of two 
interviews that were performed in public places, we inhabited a corner away from 
noise or public traffic where we could not be overheard. All transcripts (audio and 
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written) were immediately coded with pseudonym/study number with no reference to 
real identity. Audio transcripts were deleted from the computer after written 
transcription and kept on a de-identified SD card locked in a safe.    
          
The possibility of my research causing distress or enhancing vulnerability in the 
study participants was one of the areas I felt most strongly about, where I needed to 
have a clear and workable plan in place in case additional assistance was needed to 
cope by participants, particularly after the interviews were completed. I had no idea 
exactly what the participants would tell me about the experiences, but my years of 
clinical experience working in the field with people living with RRMS had shown 
me that often patients could become emotional and distressed talking about things 
that had happened to them previously in terms of their RRMS. I wanted to be well 
prepared in case of distress during or after the interviews. The study design included 
access to a psychologist experienced in MS care to be available to consult 
participants if needed, as well as a flyer (Appendix 10) for the participant outlining 
the procedure they could follow to contact me to institute this care (this information 
was available in the PICF, but also given as a separate flyer for ease of accessibility). 
 
At the end of every interview, participants were given the opportunity to ask more 
questions. I contacted each participant after the interview to thank them for their 
participation in the study and to ensure they were feeling healthy emotionally. No 
study participant required additional care through the research process, and all 
participants expressed gratitude and thanks for the positive experience the interviews 
had provided them, to be heard, believed and listened to. I was also aware that 
participants may reveal thoughts or feelings they never intended to reveal in an 
interview, potentially making them feel even more vulnerable (Holloway & 
Freshwater, 2007a) after their “confessional mode of discourse” (Atkinson & 
Silverman, 1997). Making contact with participants after the interviews also gave 
them the chance to advise if they wished to withdraw information from the study. No 
study participant wished to take this option.  
 
Annual reports were submitted to the HREC over the course of the study to continue 
ongoing HREC approval. Study participants raised no points of concern during the 
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course of the study and no incidents threatening the integrity of the ethical 
considerations were made to the study Supervisors, the HREC or to myself. 
Methods: Reflexivity 
 
Reflexivity fits into the wider perspective of ontology and epistemology (Berger, 
2015) examining the role of the researcher in the generation and construction of 
knowledge and assisting the researcher to act without bias (Holloway & Galvin, 
2016). Unlike quantitative research where an objective stance is necessary, in 
qualitative research the active role of the researcher is valued and appreciated as an 
important research tool  (Braun & Clarke, 2013). However, it is important that the 
researcher makes visible personal reflexivity as a form of quality control within the 
research (Braun & Clarke, 2013), where the aim is for  “empathic neutrality” 
(Ormston et al, 2014).  
 
Personal reflexivity 
 
In this particular study, it was important for me, as the researcher, to be specific 
about my background and possible subjective viewpoints, and to identify early in the 
research process both the potential strengths and limitations of these subjective 
viewpoints. The key to performing a successful life history is to develop a trusting 
relationship with the participant, developing the relationship through rapport 
(Hagemaster, 1992). I committed to using all of my personal and professional skills 
to develop and maintain trusting relationships with the study participants, and part of 
this was my already existing professional background. The majority of study 
participants had been cared for by an MS Nurse as part of their life journey with 
RRMS, and had all valued the MS Nurse, their skills, knowledge and support. 
Belonging to the “MS Nurse club” most likely held some definite benefits for me in 
terms of rapport and trust and I felt that for many participants, this gained me instant 
entry into their lifeworld. However, I was also aware that I could not automatically 
take this for granted, and have expectations because of this role.  First and foremost I 
was a researcher, and my MS Nurse role was secondary to what we were there to 
construct together. I was open and honest about my professional background, but I 
didn’t dwell on it. 
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My personal reflexive stance is that I am a middle aged, middle class, female, 
Caucasian MS Nurse with 34 years of clinical nursing experience and 23 years of 
(mostly quantitative) research experience, with the last 12 years of practice working 
solely in MS. I am married and the mother of two children who are in the prime age 
target of MS onset, in their mid-twenties. I am a spiritual person of a Roman 
Catholic background. I do not live with RRMS, nor am I disabled, but I do live with 
my own chronic illness of 26 years. I am a caring, empathic person and I 
acknowledge that I tend to want to “fix” everything for others and help as much as 
possible. I am not alone here, as a tendency to make suggestions and problem solve 
is a common HCP limitation in research (Windle, 2011). Assessing this situation and 
evaluating the possible effects of these characteristics on the research study was 
challenging, but necessary. The picture of embodiment I presented to the participants 
as an able bodied person inquiring about their world was also a consideration I had 
going into every interview. I wore plain clothing and tried to physically blend into 
the background as a conscious choice.  
 
The positive impacts that my reflexive stance brought to the study were numerous. 
Due to my clinical knowledge of the disease and experience as a registered nurse, I 
was able to build rapport quickly with the study participants and to develop a trusting 
environment. I felt I was able to make them comfortable, to feel free to discuss any 
issue they wished and in any order they wished. As a consequence, I was able to 
obtain data relating to sensitive issues, such as parenting, sexuality, relationships, 
hopelessness, mental health, compromised care and fear. This enabled me to gain 
new insights into living with RRMS that have been reported infrequently or have not 
been reported at all in the specialty. I could also optimise my clinical experience in 
the data analysis phase to see nuances in the data that may not have been discovered 
by a researcher with no clinical MS experience. I understood the MS terminology 
that participants used in their life history and I was able to situate it appropriately due 
to my clinical knowledge; this was important as ethnography relies strongly on 
naturally occurring language of the participants in the field (Holloway & Todres, 
2003). Additionally, I was able to be mindful of when symptoms (particularly 
participant fatigue) threatened to interrupt the integrity of the interview, and organise 
breaks and rest when necessary.  
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I specifically asked myself a set of questions before and after the life history 
interviews as a way of being mentally and emotionally prepared to set aside my 
personal opinions and put the study participants and their experience at the forefront 
of the study (Appendix 11). Even though at this stage I was collecting data to prepare 
for the later analysis, in qualitative research, analysis starts early and I needed to be 
aware of things that could potentially later affect the findings. 
 
I kept a reflexive journal (Braun & Clarke, 2013; Hinton & Kirk, 2017) throughout 
the study process to capture times of indecision and times where I needed to work 
through possible areas of limitation in the study, prompted by my own personal 
views on data and findings. I also used the journal to chronicle how I was feeling at 
various times during the study, such as if I was particularly emotionally affected by 
the interviews, or aspects of the data analysis and literature review. An example of a 
diary excerpt from the study is presented in Appendix 12. I also wondered at times if 
many years of experience working as an MS Nurse in the field may have constituted 
a form of fieldwork in ethnography, where extended participation and observation in 
a culture occurs, but I decided that my experience did not meet the criteria of 
fieldwork as my previous exposure was always in a structured, non-natural clinical 
environment (a hospital clinic) with a different purpose (seeking healthcare and 
advice). My mindset was that this was all going to be new to me.  
 
Functional reflexivity 
 
Functional reflexivity involves giving critical attention to the way research tools and 
processes may have influenced the research findings (Braun & Clarke, 2013). I 
regularly engaged in asking myself if I was limiting what could be found by having 
such a broad research question (Willig & Stainton, 2008) and if the technique of 
interviews was the best way to answer the research question. Using individual semi-
structured interviews provided a solid base to ask additional questions of interesting 
data, to probe further when it was indicated and to enable the privacy for study 
participants to talk about whatever they viewed as important, rather than being 
overwhelmed by other participants in a focus group. During the study, I constantly 
re-assessed if my methodological and method selection was serving the study well 
and I was confident that no alteration was needed to the data collection methods and 
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analytical methods as the study progressed. The more I practiced thematic analysis 
and the more immersed in the entire process, the more natural the analysis became. 
 
Reflexive Analysis  
 
Reflexive analysis involves consideration of how the patterns and themes arose from 
the data, it is up to the researcher to consider and explain exactly how this process 
occurred (Srivastava & Hopwood, 2009). Thinking about this with a reflexive lens, 
the patterns and themes I saw in the data certainly came about because they were 
linked in some way to my extensive clinical experience working in the field of MS 
and thousands of consultations with PwRRMS over the years, and the things I had 
seen and heard. I was concerned that at times, my clinical mindset might overtake 
my inductive qualitative research sensibility. To combat this, once every candidate 
theme was developed, I went back to the original data - the transcripts and the codes, 
to ensure that the themes were firmly embedded in the study data and not my own 
thoughts and opinions. If a candidate theme could not be supported entirely by 
participant quotes and stories, it was discarded, no matter how important I felt the 
theme was personally. This ensured an inductive, data driven analysis.  
 
Emotional reflexivity 
 
At times, the interviews contained highly emotive content and I had difficulty 
disengaging from the data, feeling emotional and vulnerable myself as I re-listened, 
re-read and re-analysed times of sadness and distress in the lives of the study 
participants. Some of the interviews were intense and the willingness of the 
participants to share their lives with me, a stranger, was overwhelming. Several 
participants had suffered neglected childhoods or had been subjected to horrendous 
events and re-living these discussions invoked sad and heart-rending emotions. I paid 
attention to nutrition and fitness and discussed my emotions with a few trusted 
confidantes; debriefing with peers and having regular breaks from the work. These 
measures improved the situation greatly. I read an article by Tanner (2009) exploring 
her experiences listening to sad situations and the difficulties encountered during her 
PhD work, which proved very helpful to me in facilitating this effective mental 
health plan for myself during the study. 
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There were several times during the interviews where the blurred roles between my 
role as researcher and my clinical role intertwined and left me with a strong 
emotional reaction, usually of anger. This was manageable, but there were several 
times when participants were telling me stories of compromised care from other 
HCPs that I became bothered and struggled to hide my feelings. Instead I opted to let 
the participant see that I was affected by their story and I was interested and 
listening, but not the full extent of my feelings. This situation usually involved other 
HCPs not performing to duty of care or treating the participant badly, in a way that 
was not harmonious with my values of nursing care. I wrote about these experiences 
in my reflexive diary so I could come back afterward and look at my responses with 
a reflexive stance to ensure that I was fulfilling my role as researcher and listener 
first and foremost. 
 
In summary 
 
As the ontology, epistemology, methodology and methods, and the links between 
them have been discussed and justified for the current study, the important 
relationship between the methodology and the data analysis and study findings will 
be presented in the following chapters. To introduce the study participants, the next 
chapter will present a narrative of each individual study participant’s story. 
Essentially chapter 5 will consist of a brief overview of the life story for each study 
participant; their upbringing, families, friends, communities, events in their lives, 
work, play, important life turning points and their story of RRMS. Chapter 5 will 
provide context for each life story and important insights in order to gain deeper 
understanding of, and appreciation for, the study themes presented in the following 
chapters.  
 
 
 
 
 
 
 
	 128	
CHAPTER 5: STUDY FINDINGS - THE LIFE STORIES 
 
As comprehensively discussed in the previous chapter, Methodology and Methods, 
the study participants share their life history, but the life stories are co-constructed by 
the researcher (Plummer, 2001). The life histories told by the study participants 
became the life stories co-constructed by me as the researcher, and formed the initial 
part of the study findings. The life stories provide context and understanding to the 
specific thematic findings in the following three chapters (chapters 6 to 8), as the 
reader is able to gain perspective about the lives of the study participants. This helps 
to appreciate each participant’s challenges, joys and life happenings; with each 
narrative a unique story. 
 
All participants were asked to choose their own pseudonym for the study, this 
process involved much thought and care. It is for this reason that I have kept two 
very similar names, Rudi (participant four) and Ruby (participant eight) in the study 
findings and report. For these two participants, their chosen names meant so much to 
them, having a great deal of personal significance. Two participants asked me to 
choose a pseudonym for them. It is impossible to include all of the information 
related to RRMS and other life happenings for the study participants within the word 
limit confines of this thesis, but these stories have taken the most relevant 
information from the history to represent a brief life story for each participant. I have 
included a short summary of the DMT story, because for all study participants, the 
DMT (or choice not to have a DMT) had some effect on their life journey, as told by 
the participants. The life stories of all 13 study participants are presented below, in 
chronological order of the interviews. I added an overarching phrase to each 
pseudonym, a short title of sorts, to describe their journey and to provide a deeper 
portrayal of their story with each pseudonym. 
 
Participant number 1: Piper’s story 	
Pushed around from pillar to post 
 
Piper was 42 years of age at the time of our interview and has lived her entire life in 
the same rural town where she was born. Piper works casually as a volunteer, 
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enjoying her time with people and a chance to do something with meaning. Part of a 
very close migrant family, her extended family is a very important part of her life. 
Married to her childhood sweetheart, Piper is the very proud mother of two busy and 
spirited boys. Diagnosed with RRMS just over two years ago, Piper’s story is 
interspersed with periods of mysterious illness of over 25 years duration, countless 
visits to doctors and a strong sense of determination to find an explanation for her 
unexplained symptoms.  
 
Despite her bright and bubbly exterior, Piper’s life has been tormented intermittently 
with unexplained physical and psychological symptoms, which at times have been 
completely demoralising for her, leaving her feeling “like a fraud” and “like a 
hypochondriac”. Piper attributes part of the challenge of understanding her various 
symptoms to years of living in a rural community with a constant thoroughfare of  
family doctors called General Practitioners (GPs), “always someone new…starting 
again at the front end” and never getting to the bottom of her symptoms. Piper’s 
earliest recollection of neurological symptoms occurred at the age of 13 when she 
experienced the first of many severe headaches, wrapping around her face and 
causing intense and unbearable pain. These types of pain episodes were to continue 
on and off for many years. 
 
Piper recalls “always being at the doctors” and having “all the tests under the sun” to 
find the cause of her unexplained symptoms. From her mid twenties, she describes a 
regular pattern of “getting checked and never finding anything wrong”. Piper 
suffered a severe episode of depression after her marriage and was also diagnosed 
with anxiety. She worked hard with a psychologist to turn her life around and change 
her thought patterns and was also treated with medication for depression and anxiety. 
Piper has since wondered if this episode might have been due to early RRMS, as 
depression is a common co-morbidity. Despite the emotional pain, Piper describes 
this time in her life as a major turning point for her and regards seeking help as “the 
best thing I ever did...I didn’t realise til I was well that I was living half a life”.  
 
Over the ensuing years, Piper was diagnosed with other illnesses (such as 
underactive thyroid, Raynauds, low vitamin D) and also experienced significant back 
pain from disc issues and also suffered years of infertility. The time leading up to 
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Piper’s diagnosis of RRMS was an especially frustrating time in her journey. 
Approximately 6 months prior to diagnosis, Piper was bedridden; suffering fatigue, 
pins and needles, a loss of bladder control and poor memory. She describes this time 
as feeling like she was “getting old really quickly…all of a sudden”. Piper recalls 
saying to her husband “I think I really am going crazy, like the doctors think I am”. 
After a few weeks these symptoms settled down and Piper decided to go on a holiday 
to another state and saw a GP there whilst she was away. This GP performed a 
neurolological examination, surprisingly, her first one ever. MS was suspected and 
Piper was immediately sent for an MRI scan and then to see a neurologist in the 
closest large city.  
 
In quick succession, Piper was diagnosed with RRMS and commenced on a DMT, 
the interferon beta1-b (Betaferon®) and she learnt to self-inject the medication every 
second day. Piper recalls her overwhelming feeling at diagnosis as being “relieved 
that I wasn’t going mad”. Unfortunately the DMT did not control the disease, and 
she suffered further relapses. Piper has since commenced an oral DMT, dimethyl 
fumarate (Tecfidera®) which has stabilised her relapses, but not her symptoms, 
which continue to be a daily reminder to Piper of RRMS. She suffers greatly from 
fatigue, nerve pain, insomnia and spasms but works through each day as best she 
can; eating nutritiously, working casually, caring for her family, exercising regularly 
and “walking through the pain” to be as healthy as possible. Piper’s extended family 
have also been instrumental in providing support and encouragement, particularly 
when she hasn’t felt well or has been experiencing a relapse. They have told Piper 
that they are amazed at her tenacity and determination. 
 
When recalling her diagnosis, Piper says she was “probably lucky…a lot of people 
have to wait years and get pushed around from pillar to post”.  The interesting thing 
was, whilst listening to Piper’s story all I could think about was how Piper was 
“pushed from pillar to post” around a medical system that wasn’t really listening to 
her. In keeping with the new thought patterns she learnt from her therapy to 
overcome depression, Piper has spent the last two years since diagnosis enjoying life 
as much as possible. Piper is expanding her social circle (previously she kept to 
herself and family a lot), travelling overseas at every opportunity and trying to 
extract as much joy out of life as possible. Piper is making the most out of every day. 
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Participant number 2: Margot’s story  	
Making the most of all I have and getting on with it  
 
Margot, aged 57, at the time of our interview, moved to Australia with her parents 
and sister when she was just a baby. Margot recalls her childhood being dominated 
by multiculturalism, speaking, reading and writing English at school and then being 
required to immerse herself in her original culture once back inside her home. 
Margot went to university, worked in retail and customer service and eventually met 
her husband with whom Margot has two sons. Margot was fortunate to maintain 
good health until 16 years ago at the age of 41, when she suddenly tripped and fell 
heavily, causing injuries to both her knees. She didn’t think much of it at the time, 
but Margot developed numbness up to her hips in the ensuing days, alternating 
constipation and diarrhea, and later numb hands. Totally perplexed, she arranged to 
see her local GP who sent her for some investigations. Margot then saw a neurologist 
and had a spinal MRI which revealed some “faded spots” on her spine. The 
neurologist felt it was probably due to a virus. In retrospect Margot recalls feeling 
like she was “patted on the head” on her way out as the neurologist said “there is 
nothing wrong with you, off you go” and that “that was the end of that”. 
 
As years went by, Margot noticed that she was tripping a bit more and reported to 
her GP that the nagging numbness from years before had never really totally gone 
away. She was referred to another neurologist who ordered both a spinal and brain 
MRI. This led immediately to a diagnosis of RRMS. Margot was convinced until this 
point that she had motor neuron disease (MND) and describes a feeling of “relief” on 
hearing she had RRMS. Margot disclosed her new diagnosis to several family and 
friends who were aware of recent events, however she made a conscious decision not 
to tell her parents her diagnosis. Margot felt that their limited English, poor 
understanding of MS, and her father’s tendency to “worry”, would cause too much 
anguish and apprehension for them. Margot also elected not to disclose her diagnosis 
to her workplace at this time.  
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Margot commenced interferon beta1-b (Betaferon®), a medication she self injected 
every second day until natalizumab (Tysabri®) was made available in Australia. 
Margot then attended a monthly hospital visit for an infusion of natalizumab for 
many years. She tolerated the medications well and was delighted to find when she 
started natalizumab that she was paired up with other people with MS having the 
same monthly infusions. This was the first time Margot came into contact with others 
living with RRMS and found it “fantastic”, sharing tips and stories with others and 
feeling a sense of camaraderie. Margot went on to fingolimod (Gilenya®) tablets 
after a couple of years relapse free, which she remains on to this day. 
 
Margot considers herself lucky in that she has not had many troublesome relapses 
and has generally remained well, despite some accrual of disability in recent years. 
She was working part-time until a few years ago when she decided to retire. Travel 
has been important, Margot belonging to a tight knit group of friends who travel 
together regularly.  
 
Margot also sometimes uses a walking stick to help with stability on stairs and 
uneven ground, mainly to alert others that “there is something wrong with her” and 
to “be more careful around her”. Otherwise Margot is gently ambulant, walking 
steadily, slowly and with a limp, but determinedly walking. She also enjoys looking 
“romantic” when out with her husband as they hold hands to aid her stability. She 
looks forward to more overseas travel with friends, conscious that she wants “to do 
more travelling, before I can’t”. 
 
Participant number 3: Kate’s story 	
I get knocked down but I get up again, you can’t beat me 
 
Kate, a clever and engaging scientist, was aged 42 years at the time of our interview, 
and has lived with RRMS for almost 20 years. She has recently retired from her 
career; initially because her job was made redundant and later because her MS 
symptoms have made returning to the workforce difficult. Kate’s husband of 25 
years is supporting Kate through this momentous change in her life, which she 
admits she has still not yet accepted. 
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At the age of 23, and with a toddler son, Kate suddenly went blind in her left eye, 
paving the way for several years of uncertainty as specialists struggled to work out 
exactly what was happening to her. Kate was in the middle of studying part-time and 
working full time when her episode of sudden blindness occurred. It gradually 
resolved, only to be followed by several more episodes of unexplained blindness in 
the following two years. She feared the worst, especially when the first doctor she 
saw told her it could be a brain tumour. After a year or so, Kate was referred to a 
neurologist who told her abruptly at their first meeting that she “probably had MS”. 
Kate recalls that at the time she had no idea what this meant. He told her that she 
“may end up in a wheelchair and you will probably be blind in five years”. Kate 
recalls that she felt “a mess” and he prescribed her anti-depressants to, in the 
neurologist’s words “get over it”.  
 
During yet another baffling episode of unexplained blindness, Kate was referred to a 
physician who immediately told her to throw out her antidepressants, which she 
gladly did and immediately began to feel “a lot better”. This doctor was to become 
one of Kate’s biggest supporters, treating her RRMS with some unusual but forward-
thinking treatments at the time. He was always available for her to treat the 
numerous relapses and symptoms she would go on to suffer. These years were 
especially challenging as Kate juggled her family life, her full time job and her 
studies toward a higher degree, always under the constant threat of another MS 
relapse. Constant short courses of pulse steroids took their toll on Kate emotionally “ 
boy, I was angry…I would get fired up so quickly”, causing arguments with her 
husband, as she struggled with the side effects from the various medications.  
 
It wasn’t until a year after these episodes of blindness that the first brain lesions 
appeared on an MRI, to confirm a diagnosis of RRMS. In keeping with diagnostic 
guidelines at the time, it was still a “probable” diagnosis, but not a confirmed 
diagnosis of RRMS that Kate had had to contend with. Kate commenced treatment 
with the self injected interferon beta1-b (Betaferon®) every second day, struggling 
with the side effects, feeling “totally miserable and really, really sick”. She 
eventually relented and decided to stop DMTs for the next couple of years, 
continuing to suffer relapses. As new medications became available in Australia, 
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Kate eventually started on DMT again. She was commenced on glatiramer acetate 
(Copaxone®). Kate recalls the struggle to find a suitable injection site, being “black 
and blue around the tummy” from the daily injections. Kate later changed to the 
three times weekly interferon beta1-a (Rebif®). A couple of years later, once again, 
the interferon related side effects took their toll and Kate felt she needed to stop 
treatment.  
 
Up until this time Kate had managed to keep her diagnosis of RRMS secret from her 
son, thinking “he’s a kid, there’s no need for him to know...I suppose it’s my idea of 
keeping him safe”. When he started high school and she could no longer disguise the 
side effects from the interferon, Kate felt ready to disclose her diagnosis of RRMS to 
him. She felt like he took the news well, although “you can tell that he was really 
upset”. About ten years after her RRMS diagnosis, Kate commenced the new 
monthly infusible monoclonal DMT natalizumab, but suffered a serious side effect 
which rendered her unable to have further treatment. Once again, there were no 
options left for Kate, but her tenacious nature saw her enroll in a clinical trial for a 
new medication. Today, Kate is being treated with oral DMT fingolimod (Gilenya®) 
and also takes other medications to help with spasticity, her most painful and 
unrelenting MS symptom.  
 
Kate also weathered many storms through these years of living with RRMS, as her 
extended family struggled with grief and illness in other family members. As part of 
a migrant family, there was a sense of family commitment, with Kate vigilantly 
maintaining all of her family responsibilities, despite her own significant health 
issues. Kate also suffered significant injuries from a fall which has impacted her 
mobility in recent years. Since her employment contract was not renewed and Kate 
was forced to stop working in a job that she loved, she feels the great irony is that 
now she has the time to do things she enjoys, but sadly her body cannot keep up to 
do them. 
 
Although Kate believes she is currently at a crossroads in her life, Kate remains a 
fighter. Kate isn’t after a miracle cure, instead she just wants to stay the same and not 
deteriorate further …“if I can stay like this I’ll be happy”. Kate left a lasting 
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impression on me as an absolute powerhouse, as interested as she is in helping 
herself, it is for the many others also suffering that she goes the extra mile.  
Participant number 4: Rudi’s story 		
I’ve been through so much in my life, why more? 
 
Rudi is married and the mother of four lively children and living in a country town, 
close to the community where she was born. Rudy was aged 42 years at the time of 
our interview and working part time in a local business, in a job that is “not very 
stimulating”, but affords her reasonable hours and is mindful of the fact that she has 
“bad days”.  
 
Rudi recalls her childhood as difficult and sometimes it was very emotionally 
painful. Early in the interview, Rudi commented that she wasn’t “going there”, 
however Rudi opened up as the interview progressed, and this openness helped me 
understand some of the childhood trauma she had been through. Rudi described 
living her childhood with an absent father and a mother suffering from mental 
illness. A self-declared rebellious teenager, Rudi left home at a young age, before 
returning years later. Tragically, in later years Rudi was also to suffer the stillbirth of 
her son, a time that she recalls as immensely painful…“not in my wildest dreams did 
I think that would ever happen”, continuing to experience  much emotional pain. 
 
Rudi was diagnosed with RRMS about 11 years prior to our interview at the age of 
31. Working out with a personal trainer one day, she suddenly experienced a facial 
droop. Rudi immediately saw a doctor who wasn’t concerned about the symptom. 
Nothing more happened until 4 years later when Rudi experienced an episode of 
facial numbness, which quickly developed into slurring of speech and limb 
weakness. She was rushed to hospital as it looked to others as if she had experienced 
a stroke. The symptoms gradually resolved over the next week. A subsequent MRI 
was performed and Rudi attended a visit to the neurologist for the very first time. She 
was diagnosed with focal migraines. Rudi recovered, although never completely, 
with some residual numbness down the left side of her body, she then sought a 
referral to a city neurologist. Rudi was diagnosed with RRMS at this first visit to the 
new neurologist. This diagnosis was based on Rudi’s clinical history, neurological 
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examination and the MRI scans. Rudi commenced interferon beta1-b (Betaferon®) 
injections every second day almost immediately.  
 
Rudi recalls feeling “very angry” after the diagnosis, specifically saying that 
“relief…I didn’t find that”. Rudi started treatment without wanting to learn more 
about the disease. Rudi’s mother went to visit the local MS Society and brought 
home brochures, which Rudi promptly threw in the bin. Within three months, Rudi 
was in the intensive care unit suffering another severe relapse, this time losing her 
speech completely. During this period in her life Rudi recalls “ I was sick for a very 
long time” with numbness, weakness and balance issues. Rudi was immediately 
escalated to the oral RRMS treatment fingolimod (Gilenya®). Rudi describes this 
time as very stressful for her young family. Several severe relapses over the next 
year and side effects from fingolimod saw another change in treatment to an oral 
DMT, dimethyl fumarate (Tecfidera®). Although her neurologist has suggested more 
efficacious DMTs such as natalizumab (Tysabri®) or alemtuzumab (Lemtrada®) 
Rudi says she’s not interested. From Rudi’s perspective, the potential side effects are 
just too dangerous with a young family. 
 
Currently, Rudi looks forward to the future as her four children grow up and opening 
the door for more travel. Living with RRMS has encouraged Rudi to take more trips 
away, weekends with friends, and to start travelling more around the world… “I 
dream of that and I dream of me walking in that”.  
  
Participant number 5: Joy’s story  	
Overcoming adversity beyond comprehension and returning to faith 
 
Joy has suffered through many crises and health issues in her 57 years to the time of 
our interview, yet remains a strong, determined and courageous woman living with 
RRMS, while simultaneously defying and astounding her current health care team. 
Joy’s story invokes many feelings; sadness, shock, admiration and inspiration 
amongst them. 
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Joy was born in a small country town and her childhood story is one of unbearable 
pain and neglect, a time she sees as vital to making her the strong person she is 
today. Joy had limited time playing with other children due to “excruciating” pain,  
“I was so hypersensitive that she (mother) couldn’t even touch me, because with the 
pain it was like razor blades…I would wake up in the morning and I’d feel like 
someone had been beating me all night with a baseball bat”. She vividly recalls 
nights of screaming out from leg pain, which nobody believed, or if they did, could 
not put a name to. Joy recalls that her mother was labeled as having Munchausen’s 
syndrome by the local doctors, eventually nobody believed that Joy was suffering 
real pain, “they believed this is the child of the Munchausen’s mother, well of course 
she’s going to be a hypochondriac”.  
 
Things came to a head when Joy was 16 and she developed a complex form of 
dyslexia overnight, not being about to read text type. Nobody believed Joy, and she 
left school at 16 years of age despite been dux of the school the year before. 
Unexpectedly becoming pregnant at the age of 17, Joy married, before developing 
several complications during the pregnancy including a terrifying loss of vision with 
no diagnosis. Joy suffered many other health care issues over the ensuing years and 
eventually her husband left her as a single mother. Joy then experienced further 
distressing and unexplained symptoms, including irregular periods of vision loss and 
deafness. Joy recalls that when she visited the local doctors, none of them doctors 
were interested in looking for a cause “they just didn’t believe me, I was a fruit-
loop…they thought I was crazy and they weren’t remotely interested”. Joy later 
developed right-sided weakness, and reached a stage of utter despair when the 
doctors still did not send her for any tests or investigations, recalling the feeling that  
“it nearly broke me”. 
 
Ten years after her first son was born, Joy gave birth to second little boy. Joy 
enjoyed a period of good health during this time with no further attacks of blindness, 
deafness or weakness. She continued to feel well until her second child was about 
five years of age, when “the fatigue and the pain…was just indescribable, 
sickening…my whole body screaming in pain, absolutely screaming”. The leg pain 
Joy had experienced as a child returned and was to become an everyday occurrence. 
Joy still had no explanation, diagnosis or a HCP who was interested in finding one.  
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Several years later, Joy remarried and with support from her husband, was referred to 
a neurologist. This neurologist subsequently diagnosed Joy with RRMS, Joy 
recalling, “they were amazed that no-one ever bothered to test me before”. Joy 
started on medication for the severe nerve pain and later glatiramer acetate 
(Copaxone®) daily injections as a DMT to treat RRMS. Joy then recalls feeling 
unwell and experiencing a “huge, huge reaction” where “I blew up to 3 times my 
normal body size, just huge”. Joy suspected her husband was poisoning her “my 
husband kept feeding me the medication (to treat nerve pain) and insisting…he 
would put the tablets in my mouth and I would pretend to swallow them and then I’d 
spit them out”. After about six weeks of pretending to take the medications, Joy 
eventually started to feel better and drove herself to the hospital for assessment by a 
doctor to find out for sure what was happening to her. Joy was diagnosed with 
medication toxicity. Joy believes that “I don’t think he necessarily wanted me to 
die…I will never know”. Joy stopped all medications at this point, including 
injectable glatiramer acetate to treat her RRMS. 
 
 An onslaught of migraines in the year that followed led to a referral to a new 
neurologist and more neurological testing. Joy was then diagnosed with complex 
partial epilepsy. The neurologist told Joy that there was no way of knowing if her 
previous symptoms throughout her life had been caused by RRMS, the epilepsy, or 
both. As Joy recalls “she said…how have you had any sort of normal life…how did 
you ever learn to walk and talk?”. Joy refused the offer of DMT to treat RRMS, 
preferring to take her chances on no treatment at all and avoid any side effects. 
 
In the meantime, Joy’s home life was deteriorating, she was feeling constantly 
stressed, not allowed to take time off work when her MS symptoms were at their 
worst. Then, Joy’s husband died suddenly. Joy recalls that her husband collapsed “on 
top of me and squashed me so I couldn’t breathe”. This led to an intense few minutes 
where Joy experienced a surge of “I must live…that adrenaline surge…that kicked in 
because I was dying…I got myself out from underneath him, something…changed 
something in my chemistry…I started to improve…I made a heartfelt decision that I 
would get better…no matter what”.  
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Gradually, Joy began to gain independence and returned to the faith she had with 
God as a little girl. Joy believes she is currently enjoying life to the full, working full 
time in an advocacy role to help others. Joy is a grandmother and remains very close 
to both of her boys and their families. Looking to the future, Joy is not keen to take 
any medications to treat RRMS, “if they can’t come up with a cure…I’m not going 
to take anything that will make me sicker”. Joy’s message is that it is always possible 
to change, to make an effort to overcome difficulties and that it is definitely worth 
the effort.  
 
Participant number 6 : Jane’s story   
 
Losing what’s important to me, but looking on the brightside 
 
Jane, aged 52 years at the time of our interview, has been living with RRMS for 
about 15 years. She has always worked in the field of education, is single, and has 
enjoyed travelling the world for both pleasure and work for most of her life. Jane 
currently lives with her father and is currently working part-time, still in the field of 
education, having recently attained a higher degree of which she is incredibly proud.  
 
At the age of 37 years, Jane, who rarely saw a doctor, was troubled by a severe 
headache and consulted a local GP. The GP ordered some scans but did not provide 
Jane with a diagnosis. Not long afterwards, Jane suffered sudden vision loss when 
she was cycling and it was recommended that she see a neurologist. After several 
tests, the neurologist diagnosed Jane with RRMS. Jane recalls saying to her parents 
at the time “don’t worry about it…it’s MS” after initially being terrified of having a 
brain tumour. Jane elected not to take medication at this stage and decided to start 
her adventures overseas where she worked for many years. Jane came back to 
Australia regularly to see her family and to stay in touch with her neurologist. 
 
Jane returned to Australia several years later following a severe relapse and began 
self injecting interferon beta1-a (Rebif®) for the next few years, feeling 
“disappointed” in starting therapy and beginning a time in her life which she recalls 
as “really, really, really depressing…I don’t think people realise how bad it makes 
you feel”. For about 4 years Jane didn’t do any exercise and stopped travelling as she 
	 140	
felt “like a drug addict” carrying her supply of interferon beta1-a needles around 
with her. 
 
Finally, Jane was switched to the oral DMT fingolimod (Gilenya®) about two years 
ago and says she now feels “much, much better”. The swap to an oral treatment has 
opened up her travel options again and her horizons on life. Presently she is working 
part-time on the advice of, and with the support of, her manager who is aware of her 
RRMS diagnosis, a diagnosis which has not been disclosed to others in the 
workplace because she is worried about losing her employment due to RRMS. 
Support has been essential for managing her severe fatigue, by taking time off in the 
working week to rest. Currently Jane’s symptoms include visual disturbances, 
incontinence, hand weakness and balance issues.  
 
Currently, Jane is planning for a future where she may need a wheelchair, but is not 
dwelling on it, continuing to travel independently. She still worries about  “not being 
able to speak or read or write”; skills she needs to be able to do her job properly, but 
for now, working part-time in a profession she loves “is phenomenal”.  
 
Participant number 7: Paul’s story  	
I am not going down with RRMS, I’m just not 
 
A 37 year old married father of three young children at the time of our interview, 
Paul currently works in the travel industry. Paul greatly enjoys his working role it 
allows him to work from home, travel often and participate in outdoor and adventure 
sports whenever he can. Initially from a science background, Paul is interested in all 
things to do with RRMS, often reading science and medical articles and taking a very 
active role in his own care and treatment decision-making.  
 
Paul recalls a trip to an ophthalmologist to investigate his initial symptom, blurred 
vision, about eight years prior to our interview and was told that he probably had a 
virus causing some inflammation and that his vision would go back to normal, which 
it did.  A few of years later Paul woke up with trouble breathing and chest pain. 
Exhaustive tests were performed but no explanation was found. A further episode 
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occurred a year afterward when Paul describes feeling “psychologically not right”, a 
period of time where he recalls “literally a cloud…sitting in this cloud…I looked 
around and there was this cloud”. With no medical explanation for this sensation he 
was feeling, Paul was left wondering what was happening to him. Subsequently, his 
GP referred him to a neurologist who spent two hours with Paul, exploring his 
symptoms, conducting further tests and eventually diagnosing him with RRMS in 
2014. 
 
Paul recalls suffering significant anxiety in the immediate time following his 
diagnosis. Before starting on a DMT, Paul was admitted to hospital and seen by a 
second neurologist who unfortunately, negatively affected Paul’s life journey. Paul 
felt pressured into a research study by this new neurologist investigating an MS 
treatment. At that time Paul was feeling particularly vulnerable due to his recent 
diagnosis of RRMS, his anxiety, a recent relapse and a course of intravenous high 
dose steroids (which can affect mood and thinking). Despite his misgivings, Paul 
completed the research study assessments because he wanted his negative 
experiences at the beginning of his RRMS journey to count for something and to 
help others. Shortly after this experience, Paul began care at a new MS Clinic where 
he feels he has found great medical support, together with his local GP.  
 
Paul has been discreet about disclosing his diagnosis, choosing to only tell his 
immediate family, no friends and only one work colleague. Paul feels that he wants 
to manage RRMS on his own terms and that disclosing to only a chosen and trusted 
few, gives him the control of RRMS he craves. 
 
Paul’s main RRMS symptoms currently are leg pain, which he describes as “walking 
on ice in wet socks, crumpled wet socks”, and neuropathic pain that comes and goes. 
Paul manages his symptoms mainly by grinning and bearing it, and generally gets on 
with life each day. Although relatively stable on his current oral DMT fingolimod 
(Gilenya®), Paul has recently acquired a new brain lesion on his last MRI scan. With 
his science background, Paul voraciously reads science papers reporting on MS 
therapies and wonders if now is the time for a DMT change to a higher efficacy 
medication.  
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Paul has tremendous hope for the future with RRMS, reasoning that science has 
come along so far in medicine in recent years and that advances in other disease such 
as cancer will also help in MS. He continues to research new advances in MS and 
advocate for himself to receive the best care and DMT treatment that is possible. It is 
impossible to come away from meeting Paul without feeling the same sense of hope. 
 
Participant number 8: Ruby’s story 		
If I could turn back time, I’d do things differently for my children 
 
At the time of our interview, Ruby was 38 years old, married, the mother of two 
young children and currently the main wage earner in her household. Ruby’s 
husband has taken time off to care for the family whilst Ruby works full-time. 
Working in the field of education, Ruby is a passionate and finds great inspiration 
and delight in her work. Part of a small but involved extended migrant family, Ruby 
lives close-by to her relatives who provide much needed support as she works, 
manages RRMS and looks after her family. 
 
Troubled by some leg cramps on an overseas trip about 14 years prior to our 
interview, Ruby didn’t think much of her early RRMS symptoms, and certainly did 
not think they were significant at the time or the first presentation of RRMS. Further 
neurological symptoms of leg weakness and clumsiness several years later saw Ruby 
consult a neurologist and undergo tests, where she was informed that she had RRMS 
but not offered treatment at the time. Instead, newly married Ruby was advised to 
start her own family now and to come back after her family was complete to discuss 
further management. Two years after her diagnosis when her first child was still a 
baby, Ruby noticed pain and cramping in her arms, but put it down to physical work 
that she was doing at the time. Her symptoms worsened and could no longer be 
ignored. Ruby was subsequently seen by a new neurologist and started the DMT 
Tysabri® shortly afterwards, but her RRMS continued to progress. 
 
Although it was still early in her life journey with RRMS, by this time Ruby had 
already gained significant disability, particularly in regards to mobilising and she 
was only able to walk short distances without help. Adding to Ruby’s burden is that 
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she remains troubled by a decision she made four years ago, when deciding on a 
DMT after the birth of both her children. Due to concerns about safety and the 
potential for significant side effects, Ruby decided to take more conventional DMT 
rather than the more efficacious medication recommended by her Doctor. 
Unfortunately Ruby has gained considerable disability over the last few years and 
she feels as if the decision she made at that time, understandably based on fear, has 
negatively influenced the progression of her RRMS. The drug is now registered in 
Australia and Ruby has recently commenced the medication, alemtuzumab 
(Lemtrada®). Ruby has great hope that she will improve and return to living the life 
she wants, to be a more active mother to her little children. 
 
Being diagnosed with RRMS has caused considerable heartache for Ruby. She 
misses simple things like walking to the local shops with her children for icecream 
without any planning or running around with them in the local park. Perhaps one of 
her greatest disappointments with RRMS is the pressure she feels it places on her 
husband, her children and on her extended family, “I just wish it wasn’t all about 
me”. Ruby would much rather be in the shadows and not the focus of family life. She 
still hopes that one day this may become a reality. 
 
Participant number 9: Griff’s story 		
I’m a pretender to the throne 
 
Griff was 62 years old at the time of our interview, and the married father of two 
teenage boys. Griff describes himself as a “house husband” caring for the family and 
home whilst his wife works full time in a demanding job. Initially trained in the 
public service, Griff worked for many years in a government job and believes he did 
very well in this position. Years later in his forties, he retrained and ran his own 
business, only to suffer a serious relapse of MS which led to his eventual diagnosis. 
This diagnosis and significant symptoms of fatigue, ultimately led to unemployment, 
and loss of the business. Griff has not worked outside the home since that time.  
 
After a childhood fraught with unrelated lung illnesses, Griff experienced what he 
feels were the first symptoms of RRMS in his early twenties. He was hiking in the 
	 144	
snow and noticed that he had no sense of where his feet were in relation to his body 
and experienced weakness in his hands. He decided not to disclose this to his partner 
at the time and recovered over a few weeks.  In retrospect, Griff feels he experienced 
many more short relapses of MS over subsequent years but was not seen by a 
neurologist or diagnosed with RRMS and until he was in his late forties. This was 
mainly because Griff did not report his symptoms or seek help for them from his 
family doctor.  
 
A tumultuous few years followed Griff’s RRMS diagnosis. He was commenced on 
the injectable therapy glatiramer acetate (Copaxone®) which he needed to administer 
to himself every day. Griff recalls that this became more and more difficult, he 
detested the injections and missed many doses. He later started on natalizumab 
(Tysabri®) necessitating a half day stay in the hospital clinic. These were the most 
stable years of Griff’s journey with RRMS, he suffered no relapses, felt well on the 
medication and greatly enjoyed the clinic visits at the hospital. These hospital visits 
were his major social outings and finally gave him the social contact that he was 
craving. After several years Griff returned a positive JCV test which indicated that he 
was at a higher risk of the serious side effect of PML if he continued taking 
Tysabri®. Griff then transitioned to fingolimod (Gilenya®) and has remained on this 
DMT ever since. Although he has remained relapse free, he is still hopeful of a better 
and more effective treatment in the future. 
 
Griff feels that RRMS has impacted greatly on his socialisation, largely due to not 
working but also from the severe fatigue he suffers. As his two children have become 
teenagers and require less help, Griff feels his days are “spent wastefully” and that he 
has been a less than optimal role model to his children who see him resting and tired 
most of the time. The second negative effect of RRMS on Griff’s life has been in the 
area of sexual health. Griff discussed several times in the interview his 
disappointment that there doesn’t appear to be the help available that he needs to deal 
with sexual health issues related to his RRMS, despite several attempts to do so. 
 
A key event occurred shortly after Griff’s diagnosis with RRMS, when he attended 
an event at the MSL to learn more about his new diagnosis. At that stage Griff 
showed no signs of physical disability and his major MS symptoms were all invisible 
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to others. Griff recalls that the mother of a severely disabled young girl in the same 
meeting “attacked” him, coming over to his group and yelling “What are you? You 
haven’t got MS!” This confrontation left Griff shaken and upset, although he did feel 
sorry for the mother in her situation. However, this experience has stayed with Griff 
over the years and has led to him sometimes feeling like an imposter to the MS world 
and a “pretender to the throne”. 
 
Participant number 10: Will’s story  	
Fitting everything into life I possibly can…and then some 
 
Will was born overseas and migrated to Australia in his late teens, before his 
diagnosis of RRMS in his mid twenties. He was aged 35 years at the time of our 
interview, and is the married father of two children, enjoying an active life with 
plenty of team sports and individual exercise.  
 
Will experienced a traumatic childhood, after his single mother died when Will was 
in his teens, he was raised by his grandmother. After experiencing an episode of 
optic neuritis at 17 years of age, Will had some tests but never attended follow-up 
visits to find out results. Will travelled to Australia, where he started a new career. A 
few years later, Will was hospitalised for a number of weeks as doctors battled to 
diagnose his unusual neurological presentation. Will recalls feeling depressed during 
this time. Eventually, after several months, Will was diagnosed with RRMS by a 
neurologist who was consulted on his case. This neurologist continues to look after 
Will and provide significant support. 
 
Following his diagnosis, Will began treatment with interferon 1-a (Rebif®) and 
things went along well for a short period of time, but not long afterwards, Will 
recalls becoming depressed again. He recalls how he lost his focus, quit his job and 
stopped attending his MS Clinic for follow-up. Very quickly things spiraled out of 
control and Will had worries for his own mental health and for his future. He called 
on his resilience from childhood and managed to stop the negative cycle he was in 
without any medical intervention. He reconnected with his MS care team, started on 
the monthly infusion natalizumab (Tysabri®) and began to enjoy good health, the 
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relapses stopped and “I just felt great”. Will started going out socially after months 
of staying at home, and started making a conscious effort to talk to others, he joined 
various sporting teams, made new friends and reconnected with old friends. Will 
then met his future wife and felt like he had true support, embracing positivity and a 
healthy future. 
 
Will’s continued on this journey to wellness, he was thriving on the new treatment, 
enjoying his new level of fitness and remaining relapse free for several years. The 
only thing Will did not enjoy about the hospital visits for his monthly infusions was 
meeting with other RRMS patients having treatment at the same time. Rather than 
bonding with them, Will kept a deliberate distance because he did not want to be 
around those with RRMS who wished to talk about their disease. Unfortunately after 
several years of disease stability, Will returned a positive JCV blood test which 
indicated that the natalizumab treatment was no longer safe for him due to a higher 
risk of PML, and so he stopped the treatment. Shortly afterwards Will commenced a 
new medication alemtuzumab (Lemtrada®), given in two annual cycles as an 
intravenous medication, also in a hospital setting. At the time of the interview Will 
was about three months post his first treatment cycle and still not feeling “back to 
normal”. However, Will is hopeful this new treatment will keep him healthy, active 
and able to play sport with his two children. Appearing fit, healthy and strong to 
others is very important to Will. In his words “I want to be able to tell my son (about 
RRMS), I don’t want him to notice it first”.  
 
Will’s main symptoms currently include headaches, fatigue and numbness in his 
hands. He manages his symptoms and prefers not to discuss RRMS daily in his life. 
He has worked out a system with his wife, as he doesn’t want to complain of his 
symptoms all the time, he will only tell her sometimes. For Will, this works and helps 
to keep RRMS in the background and happiness and positivity in the foreground. 
This is how Will wants to live with RRMS. 
 
Participant number 11: Susan’s story   	
Dreams really do come true, you just have to get through a lot first 
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Susan, 40 years old at the time of our interview, is married and a busy mother of one 
toddler. Susan works part-time in health care, a job she enjoys. Susan spends the rest 
of her time nurturing her family. After many years of being single and worrying 
about her future, Susan met her partner and married at the age of 37 years, she 
describes her dreams coming true when she later gave birth to her cherished little 
girl. 
 
Susan began her journey with RRMS in her twenties when she suddenly experienced 
sensory lower limb symptoms whilst at work. She initially blamed sleep deprivation 
for her leg numbness, but soon realised that something more serious was happening. 
Susan sought help from her GP who refused to refer her for assessment and testing, 
even though Susan was a HCP herself and had specifically requested a referral to a 
neurologist. Susan realised her symptoms were serious and neurological in nature. 
Finding help elsewhere, after many tests, and several months of waiting, Susan was 
eventually diagnosed with RRMS. Susan was living at home at the time and her 
parents were devastated at her diagnosis, her father in particular blamed himself for 
her illness with Susan suffering substantial grief watching him try to make sense of 
what was happening. This led to several years of struggle where she sometimes felt 
that she would never find a partner to share her life with. She believed it would take 
a special type of person to accept her diagnosis of RRMS and the uncertainty that 
goes along with it.  
 
Starting with an injectable interferon 1a treatment soon after her diagnosis and later 
glatirimer acetate (Copaxone®) daily injections, Susan managed her early DMT 
years well. She suffered three relapses over the next ten years but recovered well 
physically from each relapse. She gradually progressed to an oral DMT, dimethyl 
fumarate (Tecfidera®) in later years and has been relapse free now for some time. 
Susan had some issues with becoming pregnant and sought the help of a fertility 
specialist, which resulted in the birth of her only child. She had to remain off DMT 
for a period of time during the preparation for and during pregnancy, but remained 
free of relapses.  
 
After struggling emotionally for many years living with RRMS, Susan embarked on 
a counseling course, which changed her life for the better. She learnt skills with a 
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group of other people, not with MS but other mental health issues and illnesses, 
which has transformed her approach to her own illness. Susan applied her new 
learning and thought processes to her life with RRMS. This changed her mindset 
from “struggling” to a “can-do” attitude and more confidence. Susan feels this 
attitude helped bring her future partner into her life and saw the start of her dream to 
be a wife and mother become a reality.  
 
Currently Susan feels well, remains positive and is excited about her future. Susan 
continues to work as a HCP and has embraced the learning she has from living with 
RRMS to apply to her HCP practice, teaching people how to live better with chronic 
illness. Susan also encourages and helps those newly diagnosed with RRMS by 
speaking with PwRRMS experiencing difficulty. Susan advocates living healthily, 
maintaining a nutritional diet, continuing exercise and paying attention to mental 
health, Susan lives this by example.  
 
Participant number 12: Davina’s story  	
A second chance at love, support and happiness 
 
Davina was aged 55 years at the time of our interview and has worked as a HCP for 
most of her life, a role she greatly enjoys. Davina was due to be married a few weeks 
after our interview and she was very excited at the prospect of her future. Several 
years prior, Davina had divorced the father of her four adult children, after a 
tumultuous marriage that was marked by many years of little support, accentuated by 
her husband’s lack of insight and understanding into RRMS. 
 
Davina was diagnosed with RRMS shortly after her first marriage, when she was in 
her very early twenties. Davina had just received news that she was accepted into a 
course and was to embark on a new career. A few days later she developed her first 
MS symptoms, sensory symptoms along her spine and leg weakness, and was taken 
to the emergency room and admitted to hospital. After several days she was given 
the news that she had RRMS and was devastated at the way she was told, by a 
specialist at the end of the bed who told her that she “likely had MS” and “if children 
were something you were thinking about, it’s better to be a disabled younger mother 
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than an older one”. Davina was devastated, she withdrew from the course she had 
dearly wanted to complete and sadly received little support from her husband 
throughout the early years after diagnosis. Following the specialist’s comments about 
starting a family, within a year, Davina had her first baby, then three more children. 
Although these years living with RRMS and with four children were very 
demanding, Davina recalled that being a mother gave her the wonderful feeling “that 
I was finally good at something”.  
 
Davina suffered occasional relapses during this time, but always recovered back to 
her usual function. There were no DMTs available when Davina was first diagnosed, 
but in later years she commenced an injectable interferon, interferon-1a (Avonex®) 
as soon as it was registered in Australia, which she remained on for over a decade. 
Only recently has Davina switched to her first oral DMT, fingolimod (Gilenya®). 
This was a difficult decision for Davina, although she had felt miserable from side 
effects self-injecting, she persisted for many years because she felt “safe” taking the 
medication. The thought of new, oral tablets was attractive, but she was fearful of the 
unknown side effects on her body and resisted changing therapies for a long time. 
Although happy with her decision, she still is mindful that things could change at any 
time. Davina has been relapse free now for several years but still suffers significant 
fatigue and Uhthoff’s phenomenon (a temporary recurrence of earlier relapse 
symptoms due to heat, infection or stress) from time to time.  
 
Davina’s early years living with RRMS were also marred by her extended family 
arguing over whose fault it was that Davina had developed RRMS. They searched 
for a genetic link because Davina had a close relative with MS who had been 
wheelchair bound and eventually was placed in a nursing home, the family refusing 
to acknowledge that he had MS to others outside the family. This refusal to 
acknowledge the disease left Davina feeling unsure and vulnerable within her own 
family unit. Although Davina’s mother was very supportive, Davina’s husband and 
father  regularly contributed to her sense of low self esteem and loss of confidence, 
often  refusing to believe her invisible symptoms, such as severe fatigue. On one 
occasion her husband ridiculed her in front of the children when she was extremely 
tired, telling her “don’t play that MS card again”. Her husband never attended 
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medical appointments with Davina and did not want to know anything about the 
disease. Davina’s mother was her primary, and often sole, support and cheerleader. 
 
After many years of struggling, meeting her new partner has instilled a great sense of 
hope for Davina in her future. Davina was formally diagnosed with depression a 
decade ago, but had resisted counselling and medication for her mood disturbances. 
However, recently Davina has sought psychological counselling and feels she is 
more positive in terms of both mood and attitude to life. Davina looks forward to the 
future, has supportive, loving relationships with her adult children and believes that 
she has a life partner who understands and supports RRMS. Davina is keen to do as 
much as she can living with RRMS, whilst she can.  
 
Participant number 13: Evie’s story  	
RRMS, you can run but you can’t hide, I’m coming to get you 
 
Evie is a vibrant, strong and fit campaigner, acting as an advocate to others about her 
life living with RRMS. At the time of our interview, Evie was 38 years old and living 
with her partner, had never married nor had any children. Evie’s career has always 
been very important to her. She works for a government agency and because of her 
covert occupation, I have to be very careful about personal life details in this 
narrative, and unfortunately have to leave out some relevant details because of this 
situation.  
 
Evie experienced a turbulent childhood, suffering various respiratory and allergic 
conditions and she recalls being bullied at both school by classmates, and at home by 
her father. Evie’s first MS symptoms started in her late teens just after she finished 
school. Troubled by sensory symptoms in her hands, she then experienced changes to 
her gait, which were noticeable to others and she was referred to a neurologist. Over 
the next two years Evie had extensive testing, without a conclusion, but after another 
relapse was subsequently diagnosed with RRMS. Despite her young age, Evie took 
the diagnosis in her stride, understanding fully that she could do well with RRMS, or 
“she could bomb”. Evie has had an extremely challenging journey with the disease, 
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suffering well over a dozen relapses since her diagnosis, several of the relapses being 
very serious and requiring hospitalization. 
 
Eventually when it became available, Evie commenced on her first DMT, an 
injectable interferon beta 1-b (Betaferon®). She describes it as a time which made 
her unhappy due to this “God awful drug”. Evie stopped taking the medication, 
preferring to be on no DMT for several years than to experience side effects, but 
after several serious relapses she felt compelled to restart treatment. Evie was happy 
when natizumab (Tysabri®) was introduced, attending a hospital infusion clinic 
monthly for the treatment and being relapse free, and almost completely symptom 
free, for many years. During this time, she was in the best physical condition she had 
been in many years. However, after several years, natalizumab needed to be stopped 
after a positive, high titre blood test for JCV revealed that Evie was at considerably 
high risk for the side effect PML. Evie then progressed onto an oral therapy dimethy 
fumarate (Tecfidera®), but she suffered a significant increase in disease burden in a 
very short period of time. Subsequently Evie commenced the new monoclonal 
antibody infusion alemtuzumab (Lemtrada®). Having recently completed the second 
of the two annual cycles of alemtuzumab Evie is still waiting to see if the treatment 
has been effective but is extremely positive about her condition and hopeful for the 
future. Evie strongly believes a cure will happen. 
 
Currently, Evie’s main symptoms are fatigue, Uhthoff’s phenomena, gait instability 
and occasional episodes of motor weakness. Despite her many serious relapses, Evie 
is grateful that her vision has remained relatively unaffected and so she has been able 
to continue in her working role. To Evie, this is a saving grace of RRMS. 
 
Despite her advocacy for MS, Evie still has times when she would prefer to be 
known for other things she does than being someone who lives with RRMS. Evie is 
passionate about showing the bright side of MS and regularly participates in sports 
and riskier pursuits such as skydiving and rock climbing in order to prove that you 
can do anything with RRMS. She wishes that these moments were the ones captured 
and advertised for people living with MS rather than showing people in wheelchairs 
or with significant disability. Evie is a strong believer in doing everything you can, 
whilst you can, and has refused to be labeled as only a person with MS. Despite her 
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significant disease burden, Evie participates in life to the full and is committed to 
showing MS in the best light possible.  Meeting Evie made me, and I am sure others, 
feel the same.  
Narratives and further findings	
 
The life stories presented in this chapter highlight the diversity of the study 
participants, and contextualise their individual suffering, their joys, their strength and 
their resilience living with RRMS. Each story offers so much to MS Nurses to gain 
insights into living with RRMS. Each story has a unique perspective about things 
that have happened along the life journey, independent of RRMS, which may affect 
the life lived with RRMS. Ultimately, the narratives display a sense of hope, despite 
the many life challenges the participants have experienced. 
 
The next two chapters will present and discuss the study findings as themes and 
related subthemes. Each theme will be introduced individually and then be supported 
with direct quotes and stories from the participants to support the analysis. This is 
where the participant life stories presented in this chapter will support the more 
formal study findings, allowing the reader to have some appreciation of the lives of 
the participants and their journey, in order to better understand the themes abstracted 
from the study data. Understanding the journey of the study participants also makes 
the experience more personal and allows a more intimate connection with each story, 
a concept very much in alignment with qualitative research methodology and with 
the ontology and epistemology of the current study.  
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CHAPTER 6 – STUDY FINDINGS: “WALKING THE LOW 
ROAD” 
 
Following on from the narratives in the previous chapter introducing the study 
participants with their life stories, this chapter presents the first five of a total of eight 
themes developed from the study data analysis and findings. The five themes 
comprising this chapter titled “Walking the Low Road”, reflect the difficulty, 
struggle, hardship and a redefinition of self following a diagnosis of RRMS. 
Although this chapter is mostly a story of challenge, there are some key moments of 
positivity, of finding hope and of moving forward with optimism and with 
anticipation. Hints of what is yet to come. In the early years after diagnosis these 
times of positivity seem to be frequently interwoven with times of struggle, 
especially in the very early days after a diagnosis of RRMS. However, as the story 
progresses, PwRRMS develop their own set of expert skills in managing RRMS and 
work towards a better future living with RRMS. There are suggestions of this in 
Chapter 6, but these skills really came to the fore in the following chapter “Finding 
the High Road”, as study participants identified key ways in “Taming the Beast”, as 
they shared their experiences living with RRMS. 
 
This chapter Walking the Low Road, consists of five themes, each possessing its own 
central organising concept, as suggested by Braun and Clarke (2006, 2013) to 
succinctly outline the inclusions and boundaries of each theme. Themes have been 
categorised into subthemes and sub-subthemes to further clarify and highlight 
specific areas and concepts related to the overarching theme. A discussion of each 
theme will follow, interwoven with what is known from the MS body of knowledge 
to further introduce, explain or justify the concepts. Quotes from the participant 
transcripts will demonstrate the grounding of the themes in the study data and 
provide support to the theme development. The participant quotes are italicised and 
will be documented by the line number the quote commenced in the transcript. If 
data unrelated to the theme was then discussed within the quote, it will be left out 
and be represented within the quote by three ellipses (…) in the transcript text. Often 
participants would discuss a concept, go on to something else and then come back to 
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the original thought. As the quotes are taken out of context, if any clarifications on 
exactly what the participant is referring to are needed, they will be placed within 
brackets in the quote. As per APA guidelines, each developed theme will only be in 
“quotation marks” until explained. Table 4 demonstrates a summary of the themes, 
subthemes and sub-subthemes comprising Walking the Low Road.  
 
Table 4. Summary of themes one to five of the study findings; demonstrating central organising 
concepts, subthemes and sub-subthemes developed from the study data. 
 
Theme Central organising 
concept summary 
Subthemes Sub-subthemes 
1. Piecing 
Together the 
Puzzle 
Experiencing or dealing 
with the initial 
neurological symptoms, 
seeking help for them, 
undergoing tests and being 
told the diagnosis of 
RRMS 
What’s happening? Pieces 
start to form 
 
 
 
Tests, tests, tests (the puzzle 
starts to come together) 
 
The puzzle is complete (the 
day my life changed forever) 
• Seeking help 
• “Brushed off” 
• Exposure to vulnerability –as 
the pieces form 
 
 
 
 
• Vivid recall of the diagnosis 
• Relief at the diagnosis 
• Disclosing to others 
• With-holding disclosure 
2. (Re) 
defining Me 
Now That I 
Have RRMS 
Making sense of the world 
with a diagnosis of RRMS, 
working out how to 
manage life, family and 
community, balancing the 
losses and the gains 
Getting acquainted with 
RRMS 
Dare to compare 
Negotiating normalcy, 
disability and independence 
 
Working out work 
 
Parenting with RRMS 
 
 
 
 
 
 
 
 
 
• I think I’m normal, aren’t I? 
• How others see me 
• Maintaining independence 
 
 
• To be or not to be (a parent) 
• Breaking the news to 
children 
• Impact of RRMS on 
parenting 
• Parental losses 
• Joys of parenthood 
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Balancing losses and gains 
(my life plan (re)defined) 
 
• Battling losses 
• Accepting gains 
3. Battling 
the Demons 
The battle of negative or 
difficult emotions that can 
get in the way of life 
enjoyment, threaten 
vulnerability and steal 
away joy 
Facing fears 
 
 
 
 
 
Weary with worry and anxiety 
 
 
Depression and despair 
 
 
Struggling with the saboteurs 
• Fear of symptoms/relapses 
• Fear of DMTs & side effects 
• Fear of progression/disability 
• Fear of the wheelchair 
 
• Worry about being a burden 
to family 
• Existing with Anxiety 
• Dealing with depression 
• Face to face with despair and 
hopelessness 
• Coping with uncertainty 
• I’m never free from RRMS 
• Social isolation 
4. Surplus 
Suffering 
Suffering over and above 
that imposed by the 
diagnosis and disease state 
of RRMS and often 
inflicted by others 
Surplus Suffering inflicted by 
HCPs in clinical care 
 
Surplus Suffering inflicted by 
“brush-off”  
 
Surplus suffering inflicted by 
HCPs in research care 
 
Surplus Suffering inflicted by 
family, friends and 
community 
 
5. High 
(In)Visibility 
The presence of invisible 
symptoms which cannot be 
seen by others and cause 
chaos and 
misunderstandings, but 
may also provide a refuge 
from chronic illness  
Striving to make the invisible 
visible 
 
 
When my RRMS isn’t 
enough- reverse stigma of 
RRMS  
 
Invisibility as a welcome 
cloak- the downside has an 
upside 
• Please see me 
• Exposing the “secret one” 
 
 
• I’m not enough MS for you, 
devaluing the impact 
• A “pretender to the throne”  
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Theme 1- “Piecing Together the Puzzle”  
 
It’s silent, it’s dark 
I try to sleep but the burning pain stops me 
Where is this coming from? 
This pain stopping me being able to see  
Do I get some help or see what happens? 
Risk sounding silly and complaining 
Or hope it goes away 
It goes away, there it goes, it settles again 
I no longer have to worry 
Hold on... back it comes 
I’ll need a day off work again 
They will wonder what’s wrong with me 
The problem is…I don’t know 
  
What you say, what is this? 
It is MS, of that they now are sure 
What does that mean, how will things be? 
Regarding that, no-one can tell me 
I don’t know what to expect 
How to act, what to do 
What’s going to happen, what’s true 
But I’ll keep going, keep getting up 
And hopefully I’ll get through 
TB 
 
The central organising concept for the theme “Piecing Together the Puzzle” is the 
participant’s recall of experiencing initial neurological symptoms, seeking 
professional help, undergoing multiple tests and finally being told that RRMS is the 
most likely diagnosis. The theme is anchored by the notion that diagnosing RRMS is 
essentially about putting together a puzzle piece by piece, as symptoms are initially 
often vague and remitting in nature. After confirmation of the diagnosis, the theme 
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then explores dealing with the immediate aftermath and impact of the disease. Often 
the journey to diagnosis involves exposure to intense vulnerability, and for some, 
involved long periods of waiting time before an answer was given. Most study 
participants vividly recalled the day they were diagnosed formally with RRMS, 
dealing with their own feelings and emotions and also negotiating disclosure of the 
diagnosis to others. The theme of Piecing Together the Puzzle involves three distinct 
subthemes as the puzzle starts to materialise and progress: “What’s happening?” 
(pieces of the puzzle start to form), “Tests, tests, tests” (the puzzle comes together) 
and “the puzzle is complete” (the day my life changed forever) the first and third 
subthemes having several sub-subthemes to provide further clarity. 
 
The time prior to a diagnosis of RRMS is often burdened with challenges, with 
research suggesting that the period from the onset of symptoms, to when diagnosis is 
delivered is a time where communication challenges between PwMS and HCPs are 
particularly heightened (Thorne et al., 2004). This was certainly the case in the 
current study, where almost all participants faced challenges communicating with 
various HCPs, including family doctors [known in Australia as General Practitioners 
(GPs)], along their journey to the diagnosis of RRMS. Participants were desperately 
trying to make sense of strange and frightening symptoms, and often went on to seek 
the help of a GP, who may or may not have been actively thinking about or aware of 
the symptoms of, a diagnosis of MS. The diagnosis of MS is always challenging and 
generally there may be poor awareness of MS by GPs (Hinton & Kirk, 2015). 
 
The vagueness and intermittent nature of symptoms also plays havoc with the 
diagnostic process, patients seeking help to legitimise their symptoms and the HCP 
trying to piece together the puzzle, sometimes on very limited evidence. For several 
of the participants in the current study, the process of being investigated for, and 
diagnosed with RRMS, was viewed as traumatic and left a lasting impression. 
During our interview, several participants cried or became distressed as they recalled 
the time of diagnosis, and some participants were visibly distraught. For some of 
these participants, the diagnosis was decades prior to the study interview, but they 
recalled the event in fine detail and with much emotion. 
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What’s happening? Pieces of the puzzle start to form 
 
Recent research from Hinton and Kirk (2017) in the field of paediatric MS found the 
process of diagnosing MS to be lengthy and frightening, with the involvement of 
multiple HCPs, each giving conflicting opinions, different labels and expressing 
professional uncertainty, further intensifying parental anxiety in the possibility of the 
diagnosis. Uncertainty was a recurring theme, and similar to many participants in the 
current study, making sense of being ill and experiencing symptoms without a 
definitive diagnosis was difficult. Interestingly, previous work has also reported that 
PwMS had trouble differentiating MS symptoms from routine ailments and found it 
difficult to know exactly when to go to the GP for advice, regardless of the severity 
of their disease (Moriya & Suzuki, 2011).  
 
Pieces of the puzzle were the little clues that something was amiss, but usually in the 
beginning never progressing to the thought that this could be a sign of a chronic 
neurological disease. Usually, but not always, the initial symptoms (the first pieces 
of the puzzle) were sudden in onset, were vague in nature, stayed around a little 
while and then disappeared. They were not severe enough to prompt a visit to the 
doctor or to seek help at that point, but nonetheless they caused some worry for many 
participants as they described feeling “different”. At times, participants wondered if 
they were imagining symptoms, self-diagnosing that they were sleep deprived, too 
busy or too stressed at work. Sometimes symptoms were forgotten about, only to 
resurface as memories at a later date when HCPs questioned directly about vague 
and unexplained symptoms in the past. Participants such as Ruby suffered vague 
symptoms at first, Ruby’s symptoms coming on after a plane trip which led to her 
reasoning that the sensory leg symptoms she was experiencing were related to flying. 
Ruby did not to seek medical help for some time after this first event. 
 
One of my first symptoms…the calves got very tight and tingly and numb…that lasted 
a couple of years…I thought it was just the flight…because it happened on the 
flight…then when I got home I could walk fine, it was just uncomfortable…it must 
have been a year…two years…the first sign that things aren’t going quite so well. 
Ruby line 288 
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Others experienced long periods of remission after the first symptoms disappeared, 
times of silence and seemingly, no connection between the various symptoms. Paul 
did not link any symptoms of the “funny” episodes he was experiencing, mainly 
because they occurred several years apart. The medical staff Paul had consulted 
along the way did not link the episodes together either. 
 
I had L’hermitte’s (an electric shock-like sensation along the spine when moving the 
neck forward)…it only lasted a couple of days…but it was a really funny feeling…a 
bit odd…it lasted a couple of days and disappeared…a couple of years later I had 
optic neuritis and it (my vision) just went completely white…I went to the 
ophthalmologist and he gave me some prednisone…he said it was probably a virus. 
Paul line 15 
 
Susan described initially being a bit concerned with the sudden onset of her first 
neurological symptoms, but made a self-diagnosis of sleep deprivation as she had 
been working on night shifts. 
 
I was at work one night and I thought my legs feel funny, it’s a bit numb at the 
calf…maybe I just need to sleep…it went on for a few days. Susan line 151 
 
For some, the background pieces of the puzzle, the symptoms, became harder to 
disregard. For others, new symptoms, new puzzle pieces, appeared and could not be 
ignored due to their intensity and severity. For many participants in the study, this 
was the time that they decided they had to tell others about the symptoms they were 
experiencing and to seek help. For many, the GP was the first port of call, and then 
participants described the response as being “brushed off” by being ignored or the 
symptoms minimalised, left in a holding pattern with recognition but no plan to 
investigate further, or referred on to a neurologist. 
 
Seeking help 
 
Most participants were stalled at the start of their MS journey for varying periods of 
time, but eventually found a HCP who recognised that RRMS might be a possibility 
and referred them on appropriately. Very few study participants were fortunate to be 
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referred on early to the appropriate professional and begin the journey to a RRMS 
diagnosis promptly. After initially seeing her own GP who trivialised her symptoms, 
Susan sought alternative help for her vague sensory symptoms from an 
acupuncturist, who gave the help she needed. The acupuncturist (also a GP) realised 
there something serious was happening, refused to treat her with acupuncture, but 
referred her on to a neurologist. Piper had been unsuccessfully trying to have her 
vague symptoms diagnosed for many years with local GPs in her country town, but 
exasperated after yet another neurological event, sought advice from a HCP 
girlfriend who immediately recognised what this could be. 
 
(for help with sensory symptoms) I went to this acupuncturist, an old Chinese 
man…he said I’m not going to touch you, I want you to go and see a specialist…a 
neurologist…and I said “I’ve been going to my GP and he’s not listening to me, he 
thinks nothing’s wrong with me”…the acupuncturist was also a doctor and referred 
me on. Susan line 176 
 
I called my girlfriend, she was a doctor…she straight away said…”it sounds like MS 
to me…I can’t believe nobody has sent you for an MRI”…(she referred me to a 
neurologist) and she (neurologist) diagnosed me straight away…I was probably 
lucky…a lot of people have to wait years and get pushed around from pillar to post. 
Piper line 556 
 
“Brushed off” 
 
“I was becoming more and more anxious, knowing there was something wrong but 
people were just brushing me away”. Piper line 506 
 
Almost half of the participants in the current study described being “brushed off” in 
their initial encounters with HCPs, meaning that they presented and described their 
symptoms, but weren’t taken seriously or investigated any further. The term “brush-
off” is more formally defined as rejection or dismissal in which someone is treated as 
unimportant (Oxford dictionary, 2017). For several participants, this was their first 
encounter with the hospital/medical system and they simply did not have the health 
literacy or the awareness to request and insist on investigative tests or a second 
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opinion. Health literacy is a multidimensional concept referring to a person’s ability 
to acquire, understand and use information about health and health services 
(Batterham et al., 2016). Health literacy is important as people possessing health 
literacy often have better health outcomes than people with low health literacy 
(Berkman, Sheridan, Donahue, Halpern, & Crotty, 2011), a skill which could effect 
the entire life journey living with a chronic illness such as RRMS. Participants in the 
current study already possessing greater health literacy moved on quickly to other 
HCPs after initially being brushed off, and were subsequently diagnosed with RRMS 
not long afterwards. Other participants tried to help themselves when told nothing 
was wrong by their HCP, by increasing or decreasing exercise, changing work hours, 
reducing stress, anything to help the strange and unexplained symptoms they were 
feeling.  
 
Recent studies in adults exploring the diagnostic period and diagnosis delivery in 
RRMS are lacking, although some recent paediatric studies exploring these themes 
have shone much needed light on this topic. Hinton & Kirk (2015) explored the life 
experience of children with MS and found that many early symptoms of MS are 
misinterpreted, because they are vague and non-specific in nature. Parents began to 
feel unease as symptoms returned and the realisation struck that something might be 
wrong with their child. Communicating these concerns to HCPs was met with a 
variety of responses, some meeting expectations to investigate symptoms further and 
others not. Parents also expressed difficulty in communicating symptoms that were 
intangible and without physical evidence (headache, sensory symptoms) and many 
felt as if they were dismissed by the HCP. These findings present a very similar 
pattern to some of the adult participants of the current study.  
 
Piper suffered for many years struggling with her unexplained and undiagnosed 
symptoms, her situation exacerbated by living in a small rural town where there was 
a constant stream of GPs coming in and out for short periods of time, offering little 
continuity of care. Piper describes being regularly brushed off by the GPs when she 
presented with her symptoms and how it made her feel. At times she felt like she was 
“going crazy” and spent many sleepless nights during a severe relapse just prior to 
her RRMS diagnosis, worrying about what might be happening to her.  
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You feel like a hypochondriac because you are always at the doctors and nothing 
ever found. Piper line 251 
 
The doctor said “there’s nothing wrong…you know, go away”…I went to a few 
doctors actually…I feel like a fraud because I can feel these things…I’m not 
dreaming it…I was really struggling to grip and turn…no strength and I was told it’s 
cold, because this is winter go home and put some gloves on…it actually makes me 
cranky because I’m not making it up…I know what’s normal. I said” I think there’s 
something neurologically wrong with me” and she said “no there’s not, there’s 
nothing wrong with you”...new doctors would come and do a 12 month stint and 
move on…I feel like a fraud because I can feel these things…I’m not dreaming it.  
Piper line 407 
 
Susan, a HCP herself, consulted her long time family GP and requested a referral to a 
neurologist on numerous occasions, but her GP ignored her symptoms and did not 
provide the referral.  
 
(My GP) he’s not listening to me, he thinks nothing’s wrong with me and I’ve asked 
him “could you send me to a specialist because I think something’s wrong” but he 
kept pushing it aside saying “no, you’re fine, you’re fine”. Susan line 184 
 
Margot also felt like she was not listened to when seeking help for continuing vague 
sensory symptoms in her legs. She had waited a long  period of time, firstly for an 
appointment with the neurologist, and then for an MRI scan. Margot was keen for 
some answers to explain what was happening.  
 
I saw him (neurologist) and he said “there are a couple of spots on the spine…so I 
think it’s a virus”…in hindsight, as if he patted me on the head, well off you go, 
nothing wrong with you, it’s only a virus. Margot line 309 
 
Joy had experienced a childhood where her mother had taken her to the doctors 
repeatedly for her many symptoms, but her mother was known in their small town as 
a “Munchausen’s mother”, so Joy felt the backlash of that label as she tried to piece 
together the puzzle of the mysterious symptoms plaguing her. She feared nobody 
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would ever take her seriously and investigate what was happening; in the end she 
gave up and lived in silent agony for many years.  
 
I was sick…and they just treated Mum like she was a Munchausen’s mother…they 
thought she was crazy, so when I went to the doctor’s and said “I’m sick” they just 
believed that this is the child of the Munchausen’s mother, well of course she’s going 
to be a hypochondriac. Joy line 375 
 
The form of brush-off discussed in Piecing Together the Puzzle relates only to the 
time in the lead up to the RRMS diagnosis. The concept of feeling brushed off will 
be explored again in a later theme “Surplus Suffering”. 
 
Exposure to vulnerability as the pieces form 
 
Previous studies in the adult population of PwMS have supported the theme of 
vulnerability when dealing with MS, which was also experienced by many of the 
participants in the current study. Isakkson et al. (2006) used content analysis to 
investigate the illness experience of PwMS from onset of symptoms to diagnosis, 
interviewing 61 PwMS (type not specified). Findings from the study revealed that 
when initially diagnosed, most PwMS perceived disablement and death to be their 
future with MS. The lack of efficacious MS DMTs available over a decade ago may 
have strongly influenced this perception. Participants in that particular study also 
reported that MS was a disease that no-one talked about after the diagnosis. It is 
possible that the changed perception nowadays to openly discussing the disease is 
because of current levels of patient education, internet availability of accurate and 
up-to-date information and social media support. However, participants in Isakkson 
et al.’s (2006) study did report that the period from symptom onset to diagnosis was 
stressful, exposing them to immense vulnerability, as most of the participants in the 
current study also experienced. It appears the concepts of a decreased time between 
symptom recognition and the introduction of DMTs have not changed these feelings 
in this population.  
 
For several participants in the current study, the onset of symptoms provided the 
PwRRMS their first experience in hospital or with specialists, and many were 
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overwhelmed by this experience and felt intensely vulnerable. Participants felt anger 
and mistrust when they felt they had not been taken seriously or brushed off with a 
dismissal or a psychosocial explanation. However, other participants felt confidence 
in the HCP when they were treated kindly and offered support through the process.  
An earlier study found that many PwMS were treated for depression and emotional 
issues prior to their diagnosis, and it was common for PwMS to feel like they were 
“going crazy”, were hypochondriacs or that they were imagining the symptoms 
(Russell, White, White, & Parker, 2006). For some participants, just the validation 
that they weren’t “going crazy” and that something was physiologically wrong, was 
all the support they needed.  
 
The early days of unexplained and strange symptoms led to intense vulnerability as 
several study participants struggled with whether to let anyone else into their world 
and share the load of worry, or whether to just keep pressing on and hope things 
would settle down. Periods of symptom remission often confused them and made it 
hard to work out what to do, if anything. Alternatively, for participants such as Piper, 
earlier visits to the doctor without any resolution had led them to feel that they 
weren’t coping with life and the fault lay firmly within them.   
 
I got to a point that I remember laying in bed one night…I was becoming more and 
more anxious with it, knowing there was something wrong…and I said “I really think 
I’m going crazy…I must be going crazy like the doctor’s think I am”…in the end I 
gave up almost…they can’t find anything wrong. Piper line 506 
 
Even with intense and dramatic symptoms, some participants reported that they kept 
things to themselves, worried they would expose their vulnerability, not be believed 
or not be able to explain their symptoms well enough to be understood. Participants 
described how the symptoms could be frightening and scary, occur without warning 
and leave most of them clueless as to what could be causing the symptoms. Trying to 
pretend nothing was wrong and keep the symptoms secret from her work colleagues 
failed for Davina, exposing her to intense vulnerability when the symptoms suddenly 
took hold. 
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So, a year to the day (after the first relapse) I was at work again and every time I 
bent my head…I got this strange sensation down my back and in my feet…and I 
ignored it…and I felt like I had a really tight belt on...it just got…worse…and they 
had to put me in a wheelchair and take me to emergency. Davina line 410 
 
After initially seeking help, the investigative phase also led to feelings of 
vulnerability for participants, wondering what it could be, what was happening or 
what they possibly did to cause the symptoms. Many participants recalled this period 
in their lives, expressing emotional pain and distress, at being given no immediate 
answers to quieten their minds. Susan, working as an HCP, intrinsically knew 
something was wrong whilst she was undergoing nerve tests and feared the 
symptoms were a result of something she had done, she wasn’t told the diagnosis for 
several weeks after testing. 
 
I got in and they said…well, something’s not right here…and they got a doctor to 
come in…but they would not say anything to me, everything was hush hush and I 
could tell something wasn’t right…and I thought…did I do something when I bunjee 
jumped?...I was so scared. Susan line 219 
 
Other participants put the symptoms aside as they remitted and forgot about them 
and moved on with life, not sharing their experience with anyone else. At the age of 
18, Will had some initial tests after some neurological symptoms but never went 
back for follow-up after his first episode resolved and never told anyone else about 
them. As a teenager with no parents and little close family around him, he felt 
vulnerable and uncertain without close support of others. 
 
I never went back for results…I forgot all about it…had I followed up back then 
probably I would have been diagnosed much earlier…but just…young…naïve…there 
was always something in the back of my mind that something was wrong…in my 
early teens I could always run but if I stopped, I couldn’t run again…I am telling my 
foot to do one thing but it’s not doing what I’m telling it to do…I never told anyone 
about it. Will line 506 
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For those lucky few participants (such as Jane) who were sent to an MS Specialist 
neurologist early on in the journey through the medical system, there was mostly a 
rapid diagnosis of RRMS made and a treatment plan commenced. For several 
participants, specifically Rudi and Davina, being transferred to a specialist caused 
further frustration as they were brushed off yet again, or sent on their way with no 
real answers or guidance. 
 
(the neurologist told me) “your symptoms sound like it might be MS…but it isn’t 
conclusive…before we go any further, you’ve just married, have your family and 
once you have children, come back and we will do the next phase”. Ruby, line 49 
 
He (the neurologist) told me I was a textbook case of optic neuritis and a severe 
one…he said he knew I would go home and look it up, and that it was a symptom of 
MS…but I wasn’t to panic because I had no other indications of it. Davina, line 389 
 
Tests, Test, Tests…the puzzle comes together 
 
Although diagnosing MS earlier is advantageous (with efficacious DMT choices to 
alter the course of the disease), it is more important to be correct in the diagnosis 
(Giovannoni et al.,  2016). Meticulous care should be taken to exclude the many 
conditions that mimic MS, and this can take time and patience (Aliaga & Barkhof, 
2014), which is hard to explain to a patient experiencing symptoms. What is now 
emerging is that MS has a variable and sometimes long pre-symptomatic phase of 
years, potentially decades, and this may include a significant amount of cognitive 
deficit (such as issues with information processing and memory) (Giovannoni, 2016). 
Possessing cognitive deficits could also hinder PwRRMS in coping emotionally with 
the long and arduous diagnostic process because of these issues with information 
processing. However, a frank discussion from the HCP and MS Nurse about the 
reasons for the careful and thorough testing at the beginning of the journey could 
potentially change the goals of the journey for PwRRMS and significantly lighten 
their emotional load. 
 
For some participants, the constant stream of tests and more tests was a trial in itself, 
trying to find the elusive answer to what was happening. Many participants recalled 
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this time as challenging and difficult as they played a game of test, wait, doctor, 
another test, more waiting, another test, doctor again and hopefully, but not always, 
an answer. Evie, Paul and Will describe the ongoing barrage of tests over extended 
periods of time, which still did not always conclude in a definitive diagnosis. 
 
My GP said…straight to a neurologist…go…then that led to two years worth of tests, 
which are just the worst…lumbar punctures and electrode tests. Evie line 525 
 
(I took myself off to the hospital to have it checked out) I ended up having an 
angiogram, I had a colonoscopy, an endoscopy they did everything to find out what’s 
going on…(with no answer), but I went back to the doctor and said “something’s not 
right”…Paul line 63 
 
I was in hospital for 4 weeks, I wasn’t recovering…I was having MRIs, tests…I was 
diagnosed with sarcoidosis…nothing was happening…then I had test after 
test…biopsies behind the eye…it was just so hard…I had a breakdown…I hid it from 
everybody…I was released from hospital without a diagnosis. Will line 683 
 
Piper describes having numerous tests done but they were not appropriate tests to 
determine a diagnosis of MS. She had test upon test, but never once a simple 
neurological examination, even though the majority of her symptoms were sensory in 
nature.  
 
I had all the tests under the sun. Piper 131 
 
I’ve had everything and they can’t find anything wrong. Piper line 259 
 
Because she (diagnosing GP) did a lot of the neurological things that the neurologist 
would do…nobody had done any of that to me, nobody had checked for sensitivity. 
Piper line 573 
 
Other study participants suffered the opposite experience, with no investigations 
what-so-ever. Joy pleaded for most of her life to be investigated, when she developed 
new symptoms and when she experienced blindness and deafness, but to no avail. 
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Finally, there was one participant, Rudi who had testing completed but the results 
were either ignored or misunderstood by her HCP. Rudi recalls reading her MRI 
report herself and noting the comment that it was likely demyelination given her age 
and sex, and yet was diagnosed with migraines and sent away, only to be diagnosed 
with RRMS years later after a relapse so severe she was admitted to intensive care. 
 
They couldn’t work out what caused it (blindness) they didn’t really do a barrage of 
tests, they couldn’t understand, again, they didn’t believe me. (and later on) they 
weren’t really interested, they didn’t believe me...I was a fruit loop, they thought I 
was crazy. Joy line 130 
 
Even though the MRI report indicated that I had lesions, demyelination, consistent 
with my age and female…the report was saying…he (neurologist) treated me for 
focal migraines and I slowly got new symptoms. Rudi line 92 
 
The puzzle is complete- the day my life changed forever 
 
It was only about 30 years ago that it was discussed in the medical literature the 
merits of even telling a patient that they had MS. In some cases it was advised that 
this was not always a good idea, potentially causing unnecessary upset and stress in a 
disease with no cure (Sencer, 1988). Two decades later, research into receiving a 
diagnosis of MS reported that PwMS often felt intense feelings of abandonment and 
isolation from their neurologist following their diagnosis of MS. Most often this was 
likely because they were sent away with no plans for follow-up or treatment 
(Johnson, 2003). This was not replicated in the current study, possibly because there 
were no, or limited, treatments for RRMS in the years prior to the earlier study 
reports and no need to be reviewed again by the neurologist, with family doctors and 
community care taking over care in many cases. However, this has changed greatly 
in recent years and now close follow-up care after diagnosis and commencement of a 
DMT is expected by the Neurologist and MS Nurse, and crucial to ongoing 
management (Giovannoni et al., 2016). Imparting a diagnosis of MS is the start of a 
transition between HCP/MS team and the PwMS, which needs to provide 
information, offer advice and continue support in an ongoing manner (Johnson, 
2003). 
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Vivid recall of the diagnosis  
 
For several participants in the current study, recalling the day they formally received 
their diagnosis of RRMS was fraught with emotional distress; for some it was the 
method in which the diagnosis was delivered and for others it was recalling the lack 
of support or information received afterwards. It has been reported that the day of 
MS diagnosis can be recalled by PwMS vividly and with a great deal of emotion and 
detail (Isaksson et al., 2006; Solari et al.,  2007; Malcomson et al., 2008; Solari et al.,  
2014). This highlights the importance of the conversation and the amount of effort 
the HCP needs to invest in the consultation. As highlighted in previous sections of 
this theme, sometimes PwMS have been waiting years (and occasionally decades) for 
a diagnosis and most often the diagnosis will come from a Neurologist. The power of 
this interaction and the potential impact on the future life of the PwMS cannot be 
underestimated. PwMS have reported frustration with the vagueness of the diagnosis, 
lack of commitment, and lasting negative impressions of the HCP (Malcomson et al.,  
2008), themes strongly supported by several  participants in the current study. An 
honest, frank discussion from the Neurologist/HCP explaining the reasons for the 
delays of making the diagnosis, the need to be certain of the diagnosis, the 
difficulties in prognostication, together with the potential for hope and the power of 
current research, could counteract much of this negativity and set the PwRRMS on a 
more hopeful and positive path for the future.  
  
All study participants recalled in detail the day (and the way) they were diagnosed 
and given the news that the symptom cluster and diagnosis of RRMS was confirmed. 
Participants recalled how they felt as the words “MS” were verbalised, sometimes 
for the very first time. Some participants were alone when they received the news, 
others had the support of others, but no matter the circumstance, the day is firmly 
etched in their memory. Even though it was over 20 years ago, Evie recalled what 
she believed were the exact words from her neurologist. 
 
I remember the day I was diagnosed (20 years prior)…I remember the exact 
wording…he said to me “ I think you have a mild case of MS”…and I went “Oh 
OK”…I knew it wasn’t good, it could have been bad…”there is potential for it to be 
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very bad”…I wasn’t scared, I wasn’t upset, I wasn’t angry…so OK…what do we do 
about this? Evie line 567 
 
Rudi recalls how she felt as the diagnosis was being delivered, as sensory symptoms 
started to ascend in reaction to the stress she was feeling as the words she had feared 
became reality.  
 
 And she (the neurologist) was starting…I knew where she was going and I could feel 
the numbness coming in my face, I remember that vividly…and then…I had the 
wheelchair in mind. Rudi line 1616 
 
After months of waiting for a diagnosis, Will begged his neurologist to tell him the 
diagnosis over the phone, and so he was in his car in a garage on the side of a major 
freeway when he heard the news that he had RRMS.  
 
(the neurologist rang and he wanted me to come in) I said “can you tell me now 
because…it’s killing me…I’m waiting for your call”…so I pulled over to a garage 
and he said “this is most likely what we’re going to have to…the route that we’ll 
take”…I wanted him to tell me…he said “I can’t tell you over the phone…I cannot 
have that conversation with you”…but I said” if you don’t…I’m not coming 
in…what are you going to do?”. Will line 755 
 
For many, having solved the puzzle and leading to a diagnosis of RRMS left them 
deeply wounded by the revelation. They felt the covert message from the HCP was 
this is your new life, accept it, move on, I’ve done my job now. This was 
heartbreaking for some, and was the start of a difficult relationship with RRMS and 
with their HCPs. The manner in which the diagnosis itself was delivered caused utter 
devastation for both Kate and Davina, who can both clearly recall the encounters 
over 20 years later. 
 
The first thing he said to me was “you know what, I think you have MS”… I 
said…”oh what does that mean”? Because I had no idea what MS was … and he 
turns around “and you may end up in a wheelchair and you will probably be blind in 
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five years time”… I said “I’m only going to be 27 and I’m going to be blind?”…and 
I was a mess. Kate line 234 
 
The consultant I wanted to see was away so the one I had (in hospital) stood at the 
end of my bed and said “it’s 99% definitively MS because you fit the sex, the age, 
your symptoms are very textbook…so I suggest to you that you think about your 
future and perhaps if children were something you were looking forward to, it might 
be something to think about now, because better to be a disabled young mother than 
a disabled older mother” (starts to cry)…I was distraught. Davina line 467 
 
Other participants felt resentment at the diagnosis and a sense of unfairness, 
particularly Rudi who felt a sense of anger upon hearing the news.  
 
Even though I read the report…after I was diagnosed I became very angry… 
(another friend with MS) say’s it’s relief…but I didn’t find that, I wasn’t researching 
anything…it didn’t come as a complete surprise...later Mum went down and got 
some pamphlets…”Mum” I said “you can stick these up your arse, I don’t want to 
know anything about it”, I was at that angry stage…I don’t want to know. Rudi line 
777 
 
Griff was grateful to have a diagnosis after many years of trying to find the cause of 
his symptoms, but didn’t feel as happy as he thought he might in finding an answer. 
Solving the puzzle was “cold comfort” for what lay ahead.  
 
 I feel like death warmed up…then I have a name to it…but it’s a cold comfort… 
because the name comes along and all of a sudden, now I have “it”. Griff line 1312 
 
Relief at the diagnosis 
 
Although some participants felt devastated at their diagnosis of RRMS, and others 
felt anger, some participants felt a sense of relief. Making downward comparisons is 
very common, both in the lead up to diagnosis, and in the immediate period 
afterwards (Taylor, 1983). Downward comparisons happen when patients compare 
themselves favourably with the lives of others whom they believe to be worse off 
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them themselves (Taylor, 1983). This was echoed on multiple occasions in the 
current study as participants pieced together the puzzle themselves; fear of having a 
brain tumour, cancer, motor neuron disease (MND) or permanent blindness were 
common, and felt to be a far worse outcome than MS. Perhaps this was a coping 
mechanism which assisted participants survive the period from symptom onset to 
diagnosis, and beyond. For several participants, the day they were diagnosed with 
RRMS was a day of relief and the puzzle was solved, and in their minds, solved in 
their favour. The fact it was RRMS brought a lightening of their burden and 
possibilities for the future. Piper, Margot and especially Joy had all imagined 
illnesses they considered worse than RRMS and were grateful to have an answer 
they considered to be less of a burden. 
 
I said (to the neurologist) thank you…I was relieved…I was relieved that I wasn’t 
going mad. Piper line 614 
 
You go through every scenario…what could it be…could it be cancer…and I don’t 
think MS came to mind really…I was thinking motor neuron disease…so I was really 
quite worried…two to five years of expectancy…it was a relief…thank goodness it 
wasn’t MND. Margot line 385 
 
I said what have I got again?…and he said “MS”...and I said “is it going to kill 
me?”…and he said “no”…and then I said “you’ve just given me my life back 
again…I’m laughing yes, I’m not going to die from this”…I don’t have to line up 
foster care for my son, I can finish raising him myself…I don’t have to live in fear 
anymore. Joy line 1879 
 
Disclosing to others 
 
Piecing together the puzzle and confirming the diagnosis of RRMS was one thing, 
however telling this story to loved ones was another, and often induced feelings of 
dread and uncertainty.  The journey wasn’t over with confirmation of the diagnosis, 
in many ways it had really only just begun. Many participants struggled with sharing 
their news, even though they may have been relieved themselves, they were still 
mindful that they were about to change the lives of their loved ones forever. Telling 
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someone they loved that they had an incurable neurological disease, of which no-one 
could tell them where or when the next relapse would strike, how severe it would be, 
if they would recover and that they would need to take a medication which could 
make them feel worse, or do serious harm, was a mammoth task. They would often 
have to put their own feelings aside so they could comfort others, and sometimes this 
came at a high price for their own mental health. 
 
Most participants were diagnosed between the age of 20 and 40 years and were 
reluctant to tell their parents of their diagnosis for fear of worrying and upsetting 
them, particularly if parents were elderly and would base their understanding of MS 
on that of years ago, when wheelchair scenarios were common. This was especially 
difficult for Susan, who had to halt her own intense feelings, to deal with the hurt and 
responsibility her parents felt upon learning her diagnosis.  
 
I think they (Mum and Dad) didn’t understand it…they were very emotional and 
blaming themselves…how could this happen? It was very emotional (and Dad) 
sobbed like a little boy…I didn’t show any emotion, I held it all in because I had to 
be strong for them…that didn’t help me because it delayed my grieving and delayed 
me dealing with it because I was trying to be strong for Mum and Dad. Susan line 
374 
 
This time was also difficult for Davina, whose diagnosis of RRMS caused a family 
rift. Davina’s uncle, who was diagnosed with MS decades prior, had been hidden 
away at home and denied the diagnosis of MS by his family, associating the disease 
with shame. 
 
I also had my two families…my father’s family and my mother’s bickering about 
whose fault it was genetically…so that was a bit hard to deal with and I was in the 
middle...and my mother was frightened…because on top of all of this I had an uncle 
who had MS and was wheelchair bound…so that was a lot for my family…because 
my grandmother used to tell everybody he had a head injury when he fell off a ladder 
and he didn’t have MS. Davina line 568 
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With-holding disclosure 
 
Other participants held the diagnosis close and from diagnosis to retelling their story 
to me, told only the bare minimum number of people they needed to. Paul had still 
only told his wife, his parents, his brother and his work boss of his diagnosis, not one 
other friend. Paul says he doesn’t need other people worrying about him, he does 
enough of that himself.  
 
Not many people know…I told my CEO…nobody else knows…I much prefer it that 
way…no friends know…I just get enough canoodling from Mum, I don’t need any 
more, that’s enough you know…I’m reminded enough of it as it is. Paul line 994 
 
What next? 
 
Now that the pieces of the puzzle have completed a picture of RRMS, it was time for 
the study participants to work out the next step on the journey of living with RRMS. 
However, just because the puzzle was solved for now didn’t mean that it was solved 
forever. The unpredictable nature of living with RRMS ensured that new pieces of 
the puzzle were very likely to form, at any given time in the future, and often 
suddenly. The next theme, (Re)defining me now that I have RRMS, begins the story 
of how PwRRMS make sense of their new diagnosis and how they move forward in 
their lives. 
 
Theme 2 :” (Re)defining Me now that I have RRMS” 
 
Who is this new me I find in my old body? 
How do I belong? Where do I belong? 
Do I belong? Will I belong? 
I didn’t choose to change, it choose me 
Finding my way without warning is difficult 
I struggle to be 
The road isn’t sign posted and I cannot see the lights  
Does the old me even exist anymore? 
What fate awaits me? 
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I need to be, I need to see 
Let me try and find how to be me 
TB 
 
The first weeks, months and years after being diagnosed are critical for the PwRRMS 
to define, or (re)define their identity now that they are living with RRMS. For some, 
the confusion and devastation of the diagnosis of RRMS played heavily on their 
minds and bodies and they struggled greatly, as discussed in the previous theme. 
Others seemed to take the diagnosis in their stride and march on, eager to find out 
more about the disease they had acquired and boldly declare that they are ruling it, 
it’s not ruling them. How do PwRRMS make sense of the time after diagnosis and 
move along on their life path, still the same person, but now different?  
 
After the diagnosis of a chronic illness such as RRMS, people are confronted with 
new situations that challenge their habitual coping strategies, strategies they may 
have used in past illnesses or times of hardship, and now they must find new ways of 
coping (Taylor & Aspinwall, 1996). It has been said that a diagnosis of RRMS opens 
the door to uncertainty and variability and has specific challenges (Koopman & 
Schweitzer, 1999) as well as extremely complex ones (Dennison et al., 2010).  
Additionally, as RRMS occurs in the prime of life, it is likely to leave a strong 
psychological imprint, with very real changes in values and beliefs in how the 
PwRRMS views him or herself (Irvine, Davidson, Hoy, & Lowe-Strong, 2009). 
Defining oneself, or (re)defining oneself, in the face of a newly diagnosed chronic 
illness is always difficult, but the challenge is amplified in RRMS where the long 
term prognosis of the illness is not known and the future is highly unpredictable.  
 
The central organising concept of the theme “(Re)defining Me Now That I Have 
RRMS” is about how the PwRRMS makes sense of the world with their new 
diagnosis. This involves discovering more about the disease, working out how to 
manage feelings relating to work and finances, relationships, parenting and finally 
balancing the losses and gains of now living with RRMS. It is a mammoth task. Six 
subthemes presented during the current study, each distinct but sharing the central 
organising concept of defining a part of self or finding a part of self in their context 
as a PwRRMS. The subthemes that are grouped under the theme (Re)defining Me 
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Now That I Have RRMS are: getting acquainted with RRMS, dare share compare, 
navigating normalcy, disability and independence, working out work, parenting with 
MS and balancing losses and gains, each with further sub-subthemes to provide more 
detail and clarity. 
 
Getting acquainted with RRMS 
 
“Diagnoses, especially those that relate to serious illness, mean much more to 
patients than simply the identification of a particular disease state. Diagnoses are 
permeated with cultural and personal meaning” 
(Toombs 1995, p7) 
 
In the time immediately following a RRMS diagnosis, the majority of study 
participants were determined to find out as much as possible about their new 
companion in life, RRMS. Of course, the uncertainty and unpredictability of RRMS 
in general ensured that many questions remained unanswered. For several 
participants, this was extremely difficult, as they were provided with minimal 
information at diagnosis and received little follow-up care.  
 
Prior to the 1990’s, the MS neurology consult was sometimes referred to as 
“diagnose and adios” or “MRI and goodbye”, first coined by Neurologist Labe 
Scheinberg at an MS meeting in 1986 (Pearce, 2004). Thankfully MS practice has 
moved on since this time, mostly due to the introduction of DMTs. Now the primary 
role of the neurologist and MS team is not just to diagnose an untreatable condition 
and then say farewell, but to continually assess and monitor after the diagnosis for 
the entire life journey with RRMS; to ensure DMT safety, to detect relapses and to  
observe for signs of disease progression. 
 
In order to (re)define self, many study participants set out to acquire knowledge of 
what RRMS was and what was most likely to happen to them in the future. Most 
PwMS find information on MS empowering (Malcomson et al., 2008), but 
unfortunately for many, there is a lack of information given at the beginning of the 
journey (Rintell & Melito, 2013). This reality applied to several participants in this 
study. Kate, Ruby and Davina recall that they were provided with little information 
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after diagnosis, no chance to ask questions and no health management plan. A 
systematic review addressing the information provided to PwMS following diagnosis 
reported that there is growing evidence that information provision can increase 
disease related knowledge and may have a positive effect on decision making and 
quality of life, with no negative effects noted (Kopke et al., 2014). Information for 
PwMS needs to be given in a way that allows appropriate time, repetition, flexibility 
and must be individualised according to needs (Krahn, 2014). HCPs also need to be 
mindful that the information and resources are appropriate for the individual and take 
into account factors such as education, occupation, financial status and social level. 
If these factors are not considered, PwMS can be left feeling vulnerable and the 
information rejected as useless (Sharifi et al., 2016). This was the case for Jane, who 
literally threw the initial information booklet and resources straight into the rubbish 
bin. Jane felt that the information provided and the method of delivery did not meet 
her individual needs at the time.  
 
Lode et al. (2007) revealed that almost half of their study participants (n=86) were 
dissatisfied or very dissatisfied with the information provided to them at the time of 
MS diagnosis. As optimising information delivery early in the disease course induces 
coping styles that provide a better adaption to living with MS (Lode et al., 2009), MS 
HCPs and MS Nurses need to manage this important process in a method which is 
supportive of individual needs. A later study interviewed 61 PwMS at their first MS 
clinic appointment regarding their on line MS research activity, and discovered that 
82% of people in the study gathered medical information on line before their first 
appointment, yet only 36% discussed what they found with the physician (Hay, 
Strathmann, Lieber, Wick, & Giesser, 2008). This area needs further investigation so 
HCPs can stay engaged and aware of information seeking habits of PwMS, to 
provide guidance on appropriate, relevant and reputable websites and to truly partake 
in shared decision making, based on the same shared information. Careful and 
individualised education planning (incorporating written, verbal and electronic 
methods) is needed in newly diagnosed PwRRMS, and with reassessment as 
necessary along the disease trajectory. 
 
Nowadays typing the words “Multiple Sclerosis” into a Google search results in 
almost 29 million “hits” at your fingertips in less than a second. However, there are 
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unfortunately no systems in place to advise what is factual and trustworthy 
information, and what is not. For someone newly diagnosed with RRMS, possibly 
medicated with high dose steroids and dealing with the suddenness and havoc of the 
new diagnosis, trying to negotiate 29 million websites and work out what is helpful 
must be almost impossible. Many study participants in the current study commented 
that there was “a lot of junk” out there and that the sheer volume of information was 
overwhelming. Other participants tended to wade though the minefield of 
information and narrow down the websites that seemed to make sense to them. A 
recent Australian study explored online information seeking in PwMS (n=51, type 
not specified) using focus groups (Synnot et al., 2014). The study revealed that all 
participants had used the internet for information at some stage of living with MS 
and mostly indiscriminately soon after diagnosis. Many participants in this study also 
described the dichotomy that exists for MS information; in that they felt there was 
too much information in general, but too little information on what they really 
needed (Synnot et al., 2014). Worry about parents or children obtaining information 
on the internet about a family member with RRMS, particularly if there was a focus 
on wheelchairs in MS, also concerned several study participants. This phenomenon 
has not been supported by recent literature, however is worthy of further exploration. 
 
There was a great deal of difference between participants in the current study 
regarding how they acquired knowledge, depending on the decade they were 
diagnosed. Participants such as Davina and Evie, who were diagnosed over 20 years 
ago, had to rely on books, pamphlets and phone calls to receive information, others 
diagnosed more recently such as Piper and Paul, were able to embrace the internet 
immediately. Most participants were somewhere in between, relying on help from 
the MSA for initial information, finding others with MS in their local community to 
ask questions of, or receiving information from their MS Neurologist, MS Nurse and 
local MS clinic, where these were functioning. However, information gathering is 
not static, initial information at the start of the journey was sought, but in MS, 
information needs are continual and all participants relied on the internet and 
websites for their current updates and new information. Some participants such as 
Kate, Paul and Will preferred highly scientific websites for their knowledge, but 
others such as Ruby and Piper favoured more low-key blogs and real-life stories. 
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I just have this…overwhelming…overwhelming thirst for trying to understand reality 
I think…I mean there’s a lot of trash out there, but there’s a lot of good stuff as 
well…I register with on line scientific journals…at night I don’t have very good 
sleep…I get on my phone or my ipad and just read about all this stuff…for hours at 
night, every night. Paul line 647 
 
Absolutely yes (I go to the internet)…some of the stuff, I take with a grain of 
salt…I’m registered with a couple of scientific journals, I get a bit from there as 
well. I hate the MS Australia stuff because it’s all wheelchair shit you know…it’s all 
worst case stuff. Paul line 693 
 
Margot also realised that not everything on the internet was factual and helpful; and 
was grateful because her elderly parents didn’t have a computer and wouldn’t be 
exposed to that information to cause them further worry.  
 
The good thing with elderly parents was that they didn’t have a computer and they 
couldn’t look things up on the internet…but everything on the internet, just because 
it’s on the internet doesn’t mean that its true…so I’ve kept that in my head… so you 
don’t trail for all sorts of quick fixes and horrible stories. Margot line 532 
 
Seminars and webinars seemed to be an effective way for PwRRMS to gain the 
information they needed and also garner support to educate their family and friends. 
Positives for some participants included the fact that the information was freely 
available at a time when it was convenient for them, and in the case of webinars, that 
they could do this in the privacy of their own home or office.  Susan found MSA 
helpful in her quest to learn more about many aspects of her new illness. 
 
I always thought knowledge is power. I joined MS Society because I asked them what 
to do, what do I need to do, where do I get my information…I used to go to a few 
talks…whatever drug I was on at the time…how to live with MS…anything to help 
me. Susan line 448 
 
However, not all participants valued the sources of information in the same way. 
Rather than turning towards the information available to them, some participants 
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turned away. Not all study participants were ready to take on the wealth of 
information in RRMS at the beginning of the journey. Rudi had definite views that 
they would acquire information in their own time, when they were ready to do so. 
This highlights the importance of gathering and providing information appropriate to 
the individual at suitable times in their RRMS journey.  
 
My Mum went down to the MS Society here and got pamphlets…I was sitting there 
rolling my eyes and I said “Mum, you can shove these…I don’t want to know 
anything about it…I’ve got MS, don’t talk to me about it, I don’t want to know. Rudi 
line 797 
 
Jane wished to keep a positive mindset from the beginning and didn’t want 
information focusing on negative aspects of RRMS around her.  
 
(after diagnosis) Mum gave me the book about MS…and you end up in a wheelchair 
and incontinent…all the horrible things with this…it was a really old book…and I 
just binned it. Jane line 105 
 
Following diagnosis, many participants had some sort of contact with the MSA, 
whether in person, by phone or internet. However, no participants mentioned any 
contact during the diagnostic process. Ruby, Piper and Susan all gained value from 
the help of MSA as a professional organisation in the early days of acquiring 
knowledge, and Susan also took family and friends along to educate them directly. 
 
The MS Society is brilliant…I used to love the blogs but I can’t handle 
negative…(there is also) a facebook page that was a really good site to be on (for a 
particular DMT)…I think on line there’s a fair bit but I use it quite discerningly and 
I try not to look at too many blogs…there’s a few on there that whinge too much and 
I can’t stand that, I know there’s a lot to whinge about, but when you’re feeling low 
anyway, it doesn’t really help. Ruby line 995 
 
I went and saw (our local MS Society representative) when I was first diagnosed to 
find out whatever information she had. Piper 1793 
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I’ve done a few webinars, I love those…just to be updated with anything that’s 
new…there’s that much junk out there. Piper 1921 
 
I took a couple of girlfriends and my Mum with me (to the MSA) just so they could 
understand what was going on because…they see me as…as I’m OK, they don’t 
know what’s going on inside…I wanted them to understand what MS is about. Susan 
line 498 
 
Dare to Compare 
 
Another source of information to acquire knowledge to help (re)define self involved 
daring to compare oneself to others also living with MS. For some study participants, 
there was struggle in deciding whether to engage with the world of MS, or whether 
to avoid the world of MS. This was reported by participants in Dennison et al.’s 
(2010) study as whether to engage or avoid “the cripple club”. Engaging with other 
PwMS and witnessing disability can potentially have three effects: helpful 
interactions (support and advice, sharing tips), to be shown the spectre of what may 
happen (dare to see) or to not relate at all (compare and not fit in) (Dennison et al.,  
2010). Moreover, being with other PwMS can lead to empowerment in the peer 
community and to shared resources, a mutual recognition of ability, social relations 
and an environment that displays no “stereotyping shame” (Skar, Folkestad, Smedal, 
& Grytten, 2014).  
 
Following diagnosis, many study participants described how they needed to see what 
RRMS looked like in others, but the participants differed greatly in their reasons for 
doing so. Most initially knew very little about what RRMS meant, the little they did 
know was through MS read-a-thons conducted in primary schools in Australia many 
years previously. If they dared to compare they sought out MSA meetings where 
they could meet others dealing with the same disease, or what they thought was the 
same disease. Other participants tread more carefully and sought out individuals they 
knew through others to gain access to the MS world. This subtheme is concerned 
with several aspects: daring to see what was out there in the MS world and seeing 
what they may become as a PwMS, comparing themselves on the MS severity scale 
and also hopefully learning more about RRMS in the process. 
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Whatever their motivation, attending MSA meetings was a common event for 
participants to dare to compare in their journey. Some participants went to MSA 
meetings solely to make downward comparisons, to prove to themselves that their 
MS was less severe and that they compared more favourably than others. For Paul, 
this marked an important line in the sand to make sure that he could cope with the 
diagnosis. Paul harboured guilt, daring to compare himself against others with MS, 
but mostly in the progressive state and not the RRMS type he was diagnosed with. 
Paul did this early in his RRMS journey when he was relatively unaffected by 
disability. He attended a meeting, knowing the meeting would attract people living 
with progressive MS, and in a worse situation than himself. He felt as if he needed to 
see the worst the disease could do, and found comfort in doing so. It was part of 
daring to see what could happen and comparing himself more favourably against that 
outcome. He utilised the information to actively do every thing he could possibly do 
to stave off the same future, he (re)defined himself as someone with MS but not that 
type of MS.  
 
I don’t know if this is a little bit morbid…(MSA were running seminars)…and this is 
the morbid bit…I wanted to see what other people with the condition were like…I 
think people that have been more severely affected were probably more interested in 
being there…I hope that was the case because it was pretty depressing actually…and 
I don’t know if I was going there to be depressed…I was thinking…with everything 
I’m reading, maybe this isn’t a very big deal…so I wanted to go and see… this 
sounds really terrible, but it was a comfort thing…well, I’m alright. Paul line 1310 
 
Jane also went to a meeting with people with progressive MS, but her experience 
was very different, suffering reverse stigma about her own RRMS. Jane’s “dare to 
compare” didn’t go as planned. 
 
I did go to a few MS meetings…the first meeting I went to was really depressing and 
these young kids who have the other type of MS…we were all just sitting there crying 
and I thought…I don’t want to go back to this because this is just too 
depressing…and it was like I was the lucky one in the room…it’s almost as 
though…well, you’re lucky, it makes them feel even worse. Jane line 202 
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Susan also went along to a group meeting, but what started out as an uneducated 
glance at her possible future, ended with Susan acquiring new knowledge about 
RRMS, which she used to empower herself and move forward. Margot sat back and 
watched the reactions of others in her physiotherapy group, as a severely disabled 
PwMS began therapy, and felt that everyone in the room was glad it wasn’t them. 
The comparisons for them were favourable. 
 
There were a few people in wheelchairs…really bad ones…that scared 
me…confronting…I thought…that’s going to be me…that’s how I felt…but then, 
doing more reading and research…that’s the worst of the worst…it doesn’t always 
have to be like that…everyone’s different. Susan line 506 
 
(on seeing patients in a wheelchair today) I feel OK because I know that I’m not 
going to be like that…I’m better…I’m different because there’s all different MS’s. 
Susan line 1239 
 
(in my physio group) there’s people there a lot more disabled…they get driven by 
community transport and they’re in wheelchairs…there’s a woman…and she has to 
be wheeled in…I don’t think she can do much herself at all…there were a few people 
with MS around…I just glanced at them…everybody was looking…I could imagine 
in their mind, thinking “oh gosh, she’s worse than me, it could be worse”…they’re 
probably all thinking “at least that’s not me, I’m better than her at this stage”. 
Margot line 2204 
 
Signing up for the nearest MSA meeting straight away was not for everyone and 
some participants chose a more measured approach to joining the MS world. Will 
avoided others with MS as much as possible, not wanting to compare with them. 
When Will attended the day admission centre at the hospital for his monthly DMT 
treatment, he carefully avoided PwRRMS, preferring the company of “cancer 
patients” also attending the same centre for treatment, who he felt had a better and 
happier disposition.  
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I stay away from other people with MS …because I don’t want to hear bad stories 
and I don’t want to know how other people cope with it, because I believe the way I 
cope with it…works for me…I would purposively sit with the cancer patients because 
you could have fun with them. Will line 289 
 
Other participants such as Margot and Griff enjoyed their time receiving their 
medication in the infusion centre at the hospital surrounded by others with RRMS. 
They both expressed their sadness at the loss of their readymade social RRMS 
network when their DMT infusions were stopped and they were switched to different 
DMTs, demonstrating the experience as a helpful interaction. 
 
Although the majority of study participants sought to dare and compare against 
others with RRMS, several participants sought comparing with others who had 
difficult life circumstances but were non-RRMS, in an effort to (re)define 
themselves. Susan enrolled in a course to help with making positive life plans, 
attended by people with mental health issues, loss of family members and other sad 
events. Davina was directed to a church group by her Church Minister to help her 
come to terms with her own diagnosis by appreciating and sharing the hardships of 
others who had been in war zones and lost children. Both Susan and Davina were 
able to spend time with people they considered to be worse off than themselves, 
helping them to build positivity and to have hope in their own futures. 
 
In that group course, I met lots of beautiful people who had lots of sad stories who 
came there to learn, also how to be strong and cope with difficulties in life…people 
had lost children or partners or also dealt with illnesses…it gave me a lot of 
strength…also people didn’t understand what they were going through, weren’t 
listening to them…it’s similar, it’s similar. Susan line 731 
 
(as I struggled after my diagnosis, a Minister) got me in contact with women in the 
church where they had been in some really bad situations overseas, where they had 
lost children to diseases…older women… it made me stronger. Davina line 1178 
 
Daring to compare for the PwRRMS is an important part of (re)defining self after 
their diagnosis. PwMS organising their own network can function as a coping 
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system, assisting with stigma and introducing role models who have accepted MS 
into their lives and adjusted (Grytten & Maeside, 2006). However, as demonstrated 
by participants in the current study, this needs to be the right group for the right 
person, there is definitely no “one size fits all” approach. Mixing PwMS of different 
types and stages can be disastrous to self-identity and image, as Jane discovered at 
her first MSA meeting with progressive PwMS and no people living with RRMS. 
Jane recalled how many in the group cried as they heard sad and demoralising stories 
and how it left her feeling depressed afterwards. However, when Jane connected with 
a group of people living only with RRMS, the situation was vastly different and she 
gained much more out of the meeting and left feeling positive. It is important that 
MS Nurses are able to assist, advise and educate PwRRMS on how to engage in 
meaningful and appropriate social relationships with others living with MS, and how 
to negotiate social contexts and comparisons of MS in a fair and realistic way. 
Referrals to appropriate sources of support in this regard have the potential to be life 
changing.  
 
Negotiating Normalcy, Disability and Independence: what’s what and who’s who 
 
Trying to (re)define self as a PwRRMS led to numerous participants struggling with 
the idea of what being “normal” actually meant, against their existing perceptions of 
disability. I feel normal, am I normal? What is normal? Am I disabled if I just have 
numbness in my little finger? Do I need to be immobile to be disabled? Do you have 
to see disability for it to be real? 
 
One way to manage chronic illness is to construct and live a story of “life as 
normal”, for people to think of themselves as living a normal life, just with a few 
problems (Robinson, 1993). At the beginning of the RRMS journey this can be 
particularly difficult, but is possible once the disease is under control, less active and 
the PwRRMS has had time to process the changes and acquire knowledge about 
living with the disease. Normalisation is a chiefly positive response to illness 
acquisition and involves actively adapting to changes wrought by the illness, 
allowing resumption of previous roles and responsibilities (Joachim & Acorn, 2000). 
Returning to work, or usual daily activities, and minimising disruptions as soon as 
possible after a relapse also provided opportunity to assume to live “a normal life” 
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(Dennison et al., 2010). Kate demonstrated this repeatedly, suffering a relapse, going 
to hospital for treatment, straight to work and home again without telling her family, 
much preferring to keep things as normal as possible. 
 
I think I’m normal, aren’t I? 
 
The body of work by Charmaz (1983, 1987, 1990, 1999, 2006) in chronic illness 
explains how living with a chronic illness implies feelings of living a restricted life 
with loss of the former self image (Charmaz, 1983), sufferers striving to include the 
illness in their daily lives and their identity (Charmaz, 2006). Several of the study 
participants either still viewed themselves as normal, or tried to give the illusion of 
being normal, either to themselves, or to others (or in most cases, both). Some 
participants queried what normal was, particularly in terms of vague symptoms such 
as fatigue and tiredness. To most study participants, looking and behaving normally 
meant not looking disabled to others. Susan took a pragmatic view to negotiate her 
symptoms and for Ruby and Kate, the appearance of normal was very important. 
 
I get tired… but I work four days…they’re tough days…and I look after a house, my 
husband, a little one who is full of beans…that’s normal…I’m just like a normal 
everyday mother doing all the normal things a mother does…and she gets tired. 
Susan line 1144 
 
Just normal, I want a normal lifestyle, I want to be able to teach my kids to give…I 
want them to be happy…I just don’t want to be in bed…or on the sofa…I want to be 
moving. Ruby line 1575 
 
I do make an effort every morning to have my shower, get dressed, put some make up 
on…to get my nails done…so I can be a normal person. Kate line 1930 
 
For Davina, the quest for normalcy was so central to her sense of self that it led her 
to overachieve, to work harder to be accepted as normal. In contrast, just maintaining 
the function of mobility constituted normal for Piper, and is her goal living with 
RRMS. 
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I would say that since I was diagnosed I have tried harder in everything to be 
normal…I have not worked on a normal level, I’ve worked above target…now I am 
exhausted because I’ve tried so hard to do that to make myself look normal. Davina 
line 978 
 
Being diagnosed has…now I can hopefully control it…I feel more confident…I do 
envisage myself…hopefully…never being with a walking aid…so that’s what I’m 
hoping for…I think you can live a normal life. Piper line 2017 
 
How others see me - not being defined by my diagnosis 
 
Even if the PwRRMS view themselves as normal and not disabled, ill or sick; if 
others look at them differently or treat them as different, frustration and anger can 
develop as PwRRMS are judged against their disease instead of themselves. In 
essences, others judge them as a person with MS based on what they know about the 
disease. Both Rudi and Ruby felt that RRMS had hindered them from appearing 
normal to others. 
 
I notice still to this day, that people treat me differently since my diagnosis…I’m fine, 
just treat me like I’m normal! So I found that a bit condescending…they look at me 
as a person with a disease now, which is a bit frustrating. Rudi line 1435 
 
The hard thing is…when people look at you like a basket case and you lose your 
identity…Oh…that’s MS. Ruby line 707 
 
Not wanting to be seen as disabled, Will did not disclose his diagnosis to his 
extended family for some time and only wanted to see them in person when he was 
at his best and not as someone who appeared disabled. 
 
 I only went to see them (extended family) for the first time, two years ago…and I 
think I know what it is…being seen, I don’t want to be seen as having a disability…I 
think that’s the first time I’ve used that word today…I think that’s the first time I 
have used it, ever. I want to be seen as Will, everyone knows Will as the big, strong 
guy. Will line 1235 
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Dealing with episodic disability presents further challenges for PwRRMS in 
negotiating normalcy, possibly being disabled one week with a relapse and not the 
next, and can prove a difficult concept to deal with. Most people with episodic 
disability inhabit the space between illness and wellness, a space that is fluid, 
dynamic and open to change at any time between sick and well, normal and disabled 
(Vick, 2013). Thus, they can be living under the appearance of, and genuinely 
feeling, normalcy for long periods of time. Additionally, invisibility of symptoms 
encourages the belief that the PwRRMS is normal, especially if they look normal to 
others and function well most for the time, challenging the notion of what it is to be 
disabled (Vick, 2013). For those with episodic disability holding onto the appearance 
of normalcy and being reluctant to disclose their diagnosis, stress and worry about 
others uncovering their secret was ever-present. Several participants were determined 
to present the persona of normalcy and not disclose their diagnosis (to be discussed 
further in the next section), hiding their episodic disability and thereby proving to 
themselves and to others, that they were functioning as normal. Success in this was 
essentially proven if others around them did not notice any issues.  
 
Maintaining independence  
 
Maintaining some degree of independence was extremely important to many study 
participants. If they could possibly manage to do a task, they certainly wanted to try. 
Asking for help was simply not something that came easily to them. This may be a 
reflection of wanting to appear normal to others or reinforcing normalcy to 
themselves. 
 
I have plenty of family, everybody’s here…so I’m lucky in that regard I don’t like to 
ask people to do anything…I do it myself thanks if I can…I’ll do it myself…it’s only 
when I’m really down and out with fatigue and I can’t do much…then I’ll ask for 
help…but I will push on if I can. Piper line 1300 
 
It’s hard to ask for assistance…it was hard to ask for help…I didn’t want to seem 
needy, I guess. Margot line 1188 
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(when I needed steroids) I would do things myself, I don’t really depend on 
anybody…you can’t be seen as you’re moaning and groaning all the time…and half 
the time (my husband) didn’t even know I’d just had steroids…I did things myself. 
Kate line 946 
 
It’s really tough when you go through a relapse and you’ve got to give up your 
independence…the simplest thing…that was a big struggle…having to ask for help 
for simple things like giving kids lifts and things…I know it’s no hassle because I do 
it all the time for people…to do that and ask yourself was a big hill to climb. Rudy 
line 1743 
 
Working out Work 
 
Part of (re)defining self for many participants involved negotiating employment and 
what their work fututre might look like with their new diagnosis of RRMS. For some 
study participants this was a positive experience, and for others a more negative 
experience. This proved to be an issue at many times during the life trajectory (not 
just in the post diagnostic period) and could be an issue for a different reason at a 
different time. For example, a relapse could suddenly bring a new symptom (such as 
loss of sensation in the hands) which impacted on work performance. Making the 
decision to disclose a diagnosis of RRMS at work was a significant decision for 
many participants. For a few participants, secrecy and non-disclosure ensured that 
they could maintain control over who knew the diagnosis and allow them to try and 
maintain normalcy at work. For others, disclosure meant they were able to secure the 
help they needed at work to allow them to keep working and performing in their 
position, albeit with some adjustments. 
 
Most participants in the study were still working, part time or full time, only Kate 
and Griff (not by choice) and Margot (by choice) were not currently employed. The 
situation in regards to MS and employment in Australia appears to be improving, 
with a recent longitudinal study of 1260 participants suggesting that employment 
rates for PwMS (type of MS not specified) increased over the study time period 2010 
- 2013 compared to the general population and was thought to be related to positive 
organisational responses to work adjustments and work roles for PwMS (van Dijk, 
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Kirk-Brown, Taylor, & van der Mei, 2016). However, the news was not as good for 
men living with MS, as the data showed that male unemployment rates in MS remain 
significantly lower than the general population (van Dijk et al., 2016).  
 
Rudi needed over 2 years off work to recover from a severe MS relapse and recalls 
her feelings from this time and how she turned it around into a positive (re)definition 
of self. 
 
When I lost my job I thought…I can be down and think that I’m unemployable, I 
can’t work…or the path I chose to take was well, work’s always going to be forever, 
the kids are going to grow up and I need to look at this as I’m lucky because I get to 
spend this time with my children…whilst it was tough financially, we adapted. Rudi 
line 944 
 
It has been reported that fatigue, cognitive difficulties and mood disorders may have 
an enormous impact on work ability for PwMS (Sterz et al., 2016). A recent study 
exploring the meaning of work in the lives of PwRRMS found that becoming 
familiar with the disease, adjusting expectations, having a supportive, realistic 
manager and seeing work as meaningful, were all helpful in facilitating employment 
(van Gorp et al., 2017). For several participants, they took the opportunity to 
(re)define themselves in terms of work. Ruby enjoys her job, it gives her purpose, 
and although ambulation is difficult, she can perform her role in education with 
adaptations and has excellent support from work colleagues. Davina worked harder 
to prove herself at work, and Susan was given an opportunity to change her work 
environment to suit her new needs living with MS. For Rudi, whilst the work itself is 
not interesting, she values that she can choose her days and hours to suit her lifestyle 
and this is currently more important to her.  
 
I’m really supported, I’ve got lots of friends there who check on me and I feel very 
supported. I’m working full time but have asked next year to have part-time so 
hopefully I will get a day off a week…to do a little gym…and I want a day with (my 
daughter) at home. Ruby line 790 
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Workplace was good…I was very close to my boss and on a level of that first line 
management…the rest of management didn’t know, where I worked was such a big 
organisation that I was protected…I think I showed them that it didn’t worry my 
ability to work. Davina line 946 
 
(after my diagnosis, a manager I knew offered me a role)…so you don’t get as tired 
and without shiftwork so you can stay healthy…I liked where I (already) worked, so I 
decided to do half in both, two days and two days…they looked after me and they 
understood, so I was very grateful and very blessed. Susan line 579 
 
I’m now back working 12 hours a week I chose the hours and the days…this just 
landed in my lap so I was lucky…whilst it’s not the most stimulating job, it’s a job, 
this is good for now. Rudi line 955 
 
The decision to disclose or to not disclose an MS diagnosis at work was one of the 
most important and personal decisions for study participants. Protective disclosing is 
a tactic used by many PwMS to successfully inform others the diagnosis of MS, in 
their own words and in a way that is acceptable to them, as a form of information 
control (Grytten & Maeside, 2006). This enables PwMS to protect themselves and 
exert some control over who knows the diagnosis and exactly what they know, a 
concept important in the workplace. Individuals with MS develop strategies and 
utilise resources, identifying priorities, and planning, part of (re)defining themselves 
not just as a PwRRMS, but also as an employee/ worker after diagnosis. Some 
participants in the current study chose to fully disclose their diagnosis at work with 
good outcomes (Piper, Evie, Ruby, Susan), others partially disclosed (Davina, Paul) 
practicing information control, and others have never disclosed (Jane, Joy, Will) 
because they don’t feel it is necessary. No study participants in the current study 
expressed regret at their decision.  
 
Several participants had chosen not to disclose their RRMS diagnosis in their 
workplace and were committed to keeping the secret, for reasons of privacy, fear of 
losing employment and/or fear of being stigmatised.  Employment discrimination has 
been reported in MS, primarily through not providing needed accommodations at 
work, unfair working conditions, denial or delay of promotion and different 
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standards of performance (Roessler et al., 2011). However, it has also been suggested 
that early disclosure at work may help maintain employment, if disclosure is 
followed by appropriate work adjustments (Frndak et al.,  2015).  
 
I still haven’t told my current workplace that I have MS…I don’t want to tell 
them…I’m only on a year’s contract and they might not employ me full-time…better 
if I don’t. Jane line 504  
 
Not many people know…I told my CEO, he’s provided support in knowing…I got a 
major promotion a few months ago…and he knew at that point…very supportive, but 
nobody else knows, I much prefer to keep it that way. Paul line 994 
 
(when I was being diagnosed) my workplace were being very difficult at the time 
about the amount of time I took off and they actually put me on performance 
management…it was really hard to hit my (work) target…and my manager was not 
supportive, or the company…they didn’t give me any help at all. Will line 740 
 
For Joy, who did not disclose her diagnosis at work, in hindsight losing her job gave 
her the chance to recover fully from a previous relapse and allowed her the time to 
rest and later to (re)define who she wanted to be and what she wanted to do. Joy 
changing her area of employment to one which she enjoyed more and gained 
fulfilment in. 
 
I pushed and pushed and I just deteriorated, it was really hard and I was just trying 
to hold down a job…I’m so sick and I can’t work (and my husband wouldn’t let me 
leave my job)…I was just heartbroken…I lost my job…I wasn’t doing my job…but 
not working gave me the reprieve…I could just sleep and heal. Joy line 853 
 
(and now) I really do love my job, my job is to give other families’ hope…I teach 
what I’ve learnt. Joy line 1851 
 
Evie experienced an interesting situation at work, where a work colleague newly 
diagnosed with RRMS became aware that Evie also had RRMS and started asking 
her questions during work time. Eager to help in the beginning, Evie was soon 
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overrun with questions and conversations from this person, which started to impact 
her own work role in both time spent talking about RRMS (and therefore not 
working) and in how others viewed her (always talking about RRMS). She had 
previously disclosed discreetly at work to a selected few but Evie had not openly told 
all of her colleagues, who were now aware of her diagnosis. Evie had preferred to 
have a division in her life between RRMS and work, but that was now dissolved.  
 
(the colleague with MS would constantly ask questions and advice at work) so, my 
MS had now infiltrated my personal life and my work space…so I was forced to think 
about that whilst I was at work too…I couldn’t get away from it. Evie line 1089 
 
Re-establishing a new identity after the loss of the role as a worker has been 
identified as often leaving a void in the life of the PwMS (Hunt, Nikopoulou-Smyrni, 
& Reynolds, 2014). Griff has felt this most keenly as he has struggled with financial 
dependence on his wife and maintaining any sort of social circle since leaving 
employment due to his MS. For years he was reliant on attending his monthly 
treatment infusions to provide social stimulation, and with a change in therapy and 
no longer a need to attend the centre, he has struggled to maintain any social 
interaction. Leaving the workforce has been reported as shrinking the social and 
geographical worlds of PwMS, as lives are now hidden from view, particularly as 
disease progression occurs (Dyck, 1995). For Griff, losing social contact was a major 
casualty of not working. 
 
No income, that’s a bit hard…all of a sudden I’m a dependent, financially dependent 
and that’s never sat comfortable with me. Griff line 837 
 
After working for 22 years…reality slaps me in the face…social contact is what 
you’re trying to establish so people have a community to operate in…all those links 
have gone…I don’t have those links anymore. Griff line 504 
 
It has been reported that mourning the loss of a meaningful occupation is a real threat 
for PwMS (Matuska & Erikson, 2008). In the current study, this was experienced 
profoundly by Kate, who suffered greatly with the loss of her identity along with her 
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employment, a world where she felt accepted and valued, moving to her new reality 
of unemployment and struggling to make a meaningful contribution.  
 
(losing my job last year) it was a bit of a nightmare at work…they wanted to shut 
down my department…it didn’t make sense…I fought really hard, to the point where 
I got sick…and I thought…I can’t do this…I‘ve done everything for them, and this is 
the way they treat me…there was a lot of anger as well…I can’t cope with it, I’m a 
real mess…there are times when…I’m lost…I’d rather work…I loved my job. Kate 
line 1899 
 
If new roles, identities and interests could be established, participants spoke of how 
losses could be turned into gains with new hobbies and new opportunities. For both 
Griff and Kate, they have still not recovered from the loss of the work role in their 
lives, whilst others such as Piper, Margot and Rudi, have made the most of their 
enforced time off work and have found new ways to enjoy their time, travelling, 
exercising, maintaining wellness and expanding social circles.  
 
The MS Nurse has an important role to play with support, education and guidance on 
aspects of work and employment in living with RRMS. Early referrals for advice 
from MS organisations to assist with work disclosure decisions and allied health 
professionals such as occupational therapists for practical work management 
solutions (Yu & Mathiowetz, 2014) can significantly impact the journey. 
(Re)defining self in regards to employment is an important part of the life journey 
with RRMS.  
 
 Parenting with RRMS  
 
One of the most surprising revelations when analysing the current study findings was 
realising what an enormous impact the role of parenting had on PwRRMS. As a 
parent myself, I was always cognisant of the fact that the parental role was important 
in chronic illness, yet I was completely unprepared for just how important this role is 
to PwRRMS. It may be due to the unpredictability, which threatens to change the 
parental role, or being at the mercy of a disease which could render disability at any 
given time. It may be the heightened sense of value placed on parenthood living with 
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a chronic illness. All but two of the participants in the current study were parents and 
they all became visibly physically changed during the interviews when talking about 
their children, their faces and voices softening, becoming animated and happily 
discussing the positive aspects, and becoming sad and upset when discussing the 
challenges of parenting as a PwRRMS.  
 
To be or not to be (a parent) 
 
Historically, women with MS were advised not to have children, and if pregnant, to 
terminate the pregnancy (Smeltzer, 2002). This is currently not the case with 
pregnancy reported to have some protective effects on the course of RRMS and on 
disability progression (Pozzilli & Pugliatti,  2015). The impact of MS on family 
planning was an issue for several participants in the study. Plans for more children in 
families were curtailed as a direct result of the impact of RRMS, and also as a result 
of unknown effects of some of the RRMS treatments. Ruby wanted a third child, but 
understood that the bulk of the childcare would probably fall to her husband as she 
was gaining disability and so elected not to contemplate further pregnancies. For 
Kate, there were simply too many unknowns to consider a second pregnancy, and 
coming from a science and medical background, she felt very strongly that this was 
the right parenting decision for her and how she wanted to (re)define herself with 
RRMS. 
 
(with two kids) we were blessed…and now that my body is so worn…there is no way 
that I can put that pressure (another baby) on him (my husband)…I would if I was 
physically able to take care of the child…I think we’re very blessed to have the two 
that we have, I can’t be too greedy. Ruby line 1320 
 
And the decision not to have any more children…it was related to MS…I was scared, 
thinking, what if I have another child, I get sicker, how am I going to bring up two 
children? And I’ve got no idea what these drugs are doing to me and what they’re 
going to do to a baby…I did make the right choice, I know that. Kate line 1377 
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Breaking the news to children 
 
Breaking the news of an MS diagnosis to children could be a daunting process. The 
impact of MS on children has been shown to be a concern for parents with MS, 
supported by research reporting that MS can have a negative effect on children 
(Bogosian, Moss-Morris, & Hadwin, 2010) with most children having a poor 
understanding of MS (Bostrom & Nilsagard,  2016). A recent studied identified that 
children may also worry that their parent with MS would die, highlighting the 
importance of support and communication to strengthen the child’s ability to cope 
(Bostrom & Nilsagard, 2016). Rudi needed professional help for her daughter, who 
experienced emotional trauma after witnessing Rudi suffering a severe relapse. 
 
I had to get my 12 year old into therapy because she didn’t cope, she became quite 
anxious and she thought I was going to die every time I got carted away by the 
ambulance. Rudi line 600 
 
At the time of diagnosis, more than half of the participants were already parents. 
Rudi (four children under 12) and Paul (three children under the age of eight) 
described how they set out to explain RRMS to their children. 
 
You know what it’s like as a mother…you just get on with it, as hard as it is…I got 
them (four kids) all together and explained as best I could to a child…they knew I 
was sick, no hiding that…the youngest took off halfway through the conversation to 
go play on the swing…it was hard…it was hard work. It’s been distressing, 
especially my two young girls…I find that tougher than the physical side of things 
sometimes.  Rudi line 568 
 
I really haven’t gone into too much…I have explained with…Dr Seuss’s book “Inside 
Outside” and he (son aged seven) always goes “they’re yucky white blood 
cells…you’ve got yucky ones”...and sometimes he asks me “how’s your brain today, 
Dad?”. Paul line 980 
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The impact of MS on parenting 
 
Recent studies have shed light on the impact of MS on parenting, although most of 
this literature has concentrated on mothers and MS; with a paucity of literature 
exploring the experience of fathers and MS. An Italian study interviewed 16 female 
PwMS, of varying types and stages, aiming to uncover the value of motherhood in 
PwMS (Willson, Tetley, Lloyd, Messmer-Uccelli, & MacKian, 2017). The 
researchers described how the participants strove to maintain control of their MS, 
how they compared themselves to other mothers and how they frequently felt 
different to other mothers (Willson et al., 2017). Several participants in the current 
study echoed these concepts. Rudi, a mother of four, reported that she felt different 
to other mothers because of what she could not do related to her RRMS. 
 
My girls look at that (what I can’t do) and see that I’m not like other Mums and 
that’s hard for them when I say “I just can’t go because I’m too sick”…and that, 
that’s hard on them. Rudi 685 
 
A study exploring the lived experience of mothers with MS (type not specified) has 
reported that PwMS who are mothers of young children describe the experience as 
physically challenging, yet highly rewarding (Plumb-Parlevliet, 2015). Mothers with 
MS recognised that energy is limited, and this is often challenged by children, 
causing the mother to regulate and limit activity (Payne & McPherson, 2010). Many 
mothers have support networks in place to help them cope with MS and this includes 
partners, family and friends (Payne & McPherson, 2010; Pakenham, Tilling, & 
Cretchley, 2012). In the current study, Piper, Margot, Kate, Rudi, Davina and Ruby 
all reported the importance and value of a close network to assist them in their 
motherhood challenges with partners and family being particularly supportive.  
 
My mother-in-law…if I tell her I’m crook she’ll be around in a heartbeat, so that’s 
good. Piper line 1329 
 
When we moved here, Mum and Dad bought around the corner, they knew that that 
there was a potential diagnosis…I’m pretty close to my family, and my sister lives 
close by…this has brought us closer together for sure. Ruby line 1122 
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Parental losses  
 
It has been reported that mothers also experience loss related to their ability to fully 
engage/participate in their children’s lives due to MS (Willson et al., 2017). In the 
current study this was expressed by a father, Griff, who struggles greatly with the 
impact MS has made on him as a parent, his sons observing their father exhausted 
with fatigue instead of playing with them and taking them to the park.  
 
My kids have grown up with someone who struggles…when I should have been going 
to the park, when I could have been kicking a ball… their primary role model was 
probably somebody who fell asleep at 3 o’clock in the afternoon. Griff  line 1323 
 
As Ruby experienced a severe relapse shortly after delivery, she missed out on 
crucial time with her first baby,  those memories still haunting Ruby seven years 
later.  
 
(my new baby) it was hard not being able to take care of my baby…I  couldn’t pick 
him up, I just had no strength, I couldn’t get up to him, I couldn’t change 
him…(cries)…it was so...hard…the kids have seen a lot…it’s hard on them as well 
because it limits us from what we can do. Ruby line 430 
 
The joys of parenthood 
 
In the current study, all mothers and fathers valued their parenting role and several 
participants felt that parenting with RRMS left them feeling empowered and bringing 
out their best qualities. Being a mother may bring some beneficial psychosocial 
effects to the life journey with MS, enriching lives and providing purpose (Plumb-
Parlevliet, 2015) which may be important given the high rates of depression reported 
in MS (Feinstein, 2011). Possible rewards from parenthood cannot be 
underestimated, it has been reported that PwMS who are mothers have higher quality 
of life and more social activities compared to childless women with MS (Twork et 
al., 2007). Davina gained a sense of empowerment from motherhood and Will uses 
his love of fatherhood to give himself hope for a future where he is active with his 
children. 
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I was desperate to have a third child…I was good…at least I was really good at 
something…I really enjoyed being a mother and I felt I was quite successful at it…it 
gave me a sense of empowerment. Davina line 675 
 
I want to be able to play sport with my son and daughter…we are the best of 
friends…we play netball and we play golf…I want to play football with my son and I 
want to take him on the golf course! Will line 1488 
 
The immense value of the role of a mother remains evident, regardless of the degree 
of disability or whether the MS diagnosis or motherhood came first in the equation 
(Willson et al., 2017). The fathers in the current study also expressed happiness and 
delight in fatherhood, although it wasn’t always easy to keep up with the children. 
Balancing both the challenges and the joys of parenthood takes skill, patience and 
time. The MS Nurse has a vital role to provide guidance, education and support on 
parenting issues at all stages of the life journey with RRMS. 
 
Balancing losses and gains – my life plan (re)defined   
 
Chronic illness has been described as a disorder that persists for an extended period, 
affecting a person’s ability to function normally (de Ridder, Geenan, Kuijer, & van 
Middendorp, 2008) and profoundly impacting day to day lives (Moss-Morris, 2013). 
The presence of chronic illness has the potential to induce intense changes in a 
person’s life and can result in negative effects on both their wellbeing and quality of 
life (Sprangers, Hanneke, & Haes, 2000). However, chronic illness can also provide 
the potential for individuals to find advantage in the situation and a positive effect on 
lives, known as benefit finding (Pakenham 2005a, 2005b). Findings from the current 
study to be discussed in this section demonstrated examples of both scenarios, and 
sometimes both scenarios in the same person, at different times. Balancing these 
losses and gains was an important part of (re)defining self and setting a new life plan 
with RRMS.  
 
It should also be noted that the onset of MS doesn’t necessarily bring into question a 
person’s sense of self, rather it is the degrees to which symptoms impact on a 
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person’s ability to fulfil roles important to their pre-MS self, that appear to have the 
greatest re-defining impact (Mozo-Dutton, Simpson, & Boot, 2012). MS symptoms, 
which have the power to threaten the PwMS’s perception of self, may also contribute 
to emotional issues such as depression and anxiety (Mozo-Dutton et al., 2012). For 
several participants in the current study, this was certainly the case. Kate’s 
burgeoning career in academic study was grossly threatened by sudden blindness, 
rendering her unable to read intermittently and leading to failure to complete a 
course for the first time in her life. On treatment, Kate’s relapses lessened and she 
gradually regained some control and resolution of her symptoms. Accepting this 
particular symptom into her life story was not easy for Kate and involved years of 
anguish. MS HCPs can apply this knowledge to their dealings with PwRRMS by 
assessing patients and clients for symptoms which impact the most upon their life; 
and not just the symptoms that HCP working within the medical model, believe to be 
the most important.  
 
Battling losses 
 
Feelings of loss dominated the immediate post diagnostic period for several 
participants and for some, this was repeated again at various times later on in the life 
journey. The fact that RRMS could occur randomly and cause relapses at almost any 
time could potentially lead to the loss of important life milestones. Piper believes she 
lost the opportunity for a memorable wedding and honeymoon due to RRMS 
symptoms, suffering continuously from severe headaches and facial nerve pain in the 
weeks prior to and involving her wedding. 
 
I’d be in tears with those headaches…I had this new bout just before I was 
married…they don’t go away and they just wrap around my face…it’s just horrible. 
Piper line 384 
 
(my honeymoon) was a disaster actually…(and the) wedding day was a disaster…I 
again had really severe, severe headaches…my wedding day was a blur…(and the 
honeymoon) we actually came home early…and called the doctor. Piper line 361 
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The onset of a new relapse and/or significant physical disability could induce 
feelings of loss for the normal body, and loss of independence without warning. Rudi 
keenly felt the loss of her normal life during a severe relapse and the degradation of 
not being able to perform activities of daily living. Jane was an avid athlete who was 
not able to go back to her usual level of competition after her diagnosis and 
continues to feel this loss of physicality. 
 
(with a severe relapse) it was degrading…have to be wheeled to the toilet...the 
basics…and that was hard to cope with…things are just taken from you…that’s what 
I find hard with MS, giving up simple things like not being able to go for a 
walk…because that’s my time out and I enjoy doing it…and you don’t think it’s much 
to ask. Rudi line 276 
 
My balance and the way I hold a pen isn’t good…my balance isn’t good…I don’t 
ride a bicycle any more…(MS) has curbed my lifestyle…not that I was ever a risk 
taker, but I used to do a lot more…things like that are disappointing. Jane line 552 
 
Margot had a difficult time dealing with her gradual loss of mobility. Her husband 
began looking at wheelchairs as they enjoyed travelling and he felt it would be a 
safer option, but he was met with stiff opposition from Margot who didn’t give in 
easily. 
 
It’s a real mental block…(crying)…it’s really hard to do that…it’s the elephant in 
the room…it was a real mental block to sit in that (a wheelchair)…in public. Margot 
line 1533 
 
Accepting gains 
 
Appreciating the gains that may occur in RRMS will be discussed more deeply in the 
theme of positivity and hope, but for many participants, finding some benefit in their 
new life with RRMS was crucial to them finding peace and courage to move on and 
integrate RRMS into their life. Benefit finding is a specific type of coping strategy 
whereby, despite adversity, individuals positively evaluate their circumstances and 
report gains such as personal growth, improved relationships and changes in 
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priorities and goals (Pakenham 2005a, 2005b). Research has shown that benefit 
finding has been strongly and directly correlated with positive outcomes in MS 
(Pakenham 2005a) and practicing benefit finding by valuing life and acknowledging 
simple pleasures could be beneficial in MS (Irvine et al., 2009).  
 
Benefit finding was a positive and active process for Rudi, who appreciated the 
personal, family gains she found directly as a result of living with RRMS.  
 
I got really angry (after my MS diagnosis), but by the end of it I actually think of it as 
a gift because it’s made me live my life differently…it’s made me start to travel 
whereas I would have put that off…I was heavily involved with my kids anyway…but 
I just have a different outlook on life now, I tend to care less about things I don’t 
have time for gossip, I’ve let all that go…so I view MS as a gift. Rudi line 835 
 
Margot overcame her fear of the wheelchair to gain new awareness and opportunities 
and find benefit in the things she had learnt. 
 
I think I accept things a lot more…I think you become more patient, you tolerate a 
lot more and you become…more accepting of people and maybe you develop a 
thicker hide…overseas people are so good to people in wheelchairs…they were just 
fantastic…and straight to the front of the queue…it was great…I thought, I can’t 
believe I haven’t done this sooner, it was the best thing. Margot line 964 
 
Enrolling in a course to help her cope with her new diagnosis, Susan gained so much 
more and greatly valued the insights she learnt which improved other areas of her life 
as well.  
 
I had lots of fun and went on more holidays…I hadn’t had any relapses and I felt 
better about myself and I was doing a course…in that group I met lots of beautiful 
people…what I’ve learnt through this has made me a better person. Susan line 731 
 
Balancing the losses and gains after a diagnosis of RRMS often led to constructing a 
new life plan. Gathering new information, working out what is important to the self, 
what doesn’t matter and what might matter in the future takes time and effort.  How 
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participants managed this, and how long this took, was highly individual, but always 
involved a personal decision to move on and to embrace a new life, with changed 
attitude and values. The majority of study participants had moments where they 
made a decision to embrace the new self and move forward with purpose. It was as if 
they reached a cross-road and actively chose to embrace their life living with RRMS. 
 
I said, from that point, nothing’s going to stop me I’m sick of being…that guy that 
just goes home…I never used to go out (following diagnosis)...I used to go home 
from work, go to sleep…I just said I’m not going to go home and sulk on my 
own…go to work and live in circles…so I joined a basketball team, I joined a 
football team…I’d go and play poker with my friends…I just lived this active life. 
Will line 1151 
 
I thought well, I’ve got to try harder…to try and meet someone or do other 
things…so I started up doing other hobbies and taking up different interests to try 
and meet people…and also to learn other things to make myself feel better. Susan 
line 697 
 
So I got really angry and obviously went through the stages of grief, but by the end of 
it I actually think of it as a gift because it’s made me live my life differently…it’s 
made me start to travel whereas I would have put that off. Rudi line 835 
 
I take each day as it happens, one day at a time. I don’t plan for the future, if things 
happen, they happen...you’ve got to put things in little pigeon holes…with my studies 
and my work I did not put too much emphasis (on relapses)…it was an 
inconvenience…but it was not my biggest problem…you’re (RRMS) not going to beat 
me. Kate line 2419 
 
(I had an experience) where I said “fuck you body, you will do what I tell you to 
do”…so I got my two walking sticks out and went for a six kilometre walk…and I 
pushed hard and the more it hurt…you are not doing this anymore and I took 
back…took back control of my own life…yes, the disease doesn’t control me, I 
control my own body. Joy line 1090 
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It is true that although MS does present complex challenges and signals a difficult 
period of adjustment, the majority of PwMS do adjust successfully (Eeltink & Duffy, 
2004), and we as HCPs can openly discuss this with PwRRMS early in the journey. 
Pakenham (1999) has also shown that adjustment to MS improves as the time since 
the onset of symptoms lengthens, meaning that for many PwRRMS, that time will 
often be their friend. Time will heal emotional pain and time will help (re)define who 
they are and where they fit in, not just within the MS world, but within their own 
world and what is important to them as an individual. Adjusting to RRMS, like many 
chronic illnesses, is a process that continues throughout the course of the life lived 
with MS, and responds to changes in the illness status over that time (Sharpe & 
Curran, 2006). In RRMS, these changes are likely to present many times and 
particularly around times of relapse, new symptom onset, pregnancy, medication 
change, and disease progression. A PwRRMS is likely to require many redefinitions 
of self throughout their lifetime. 
 
Participants described their losses, different for everyone depending on their 
individual beliefs and values. As previously discussed, loss of employment was a 
major concern for several participants, and for Griff and Kate, this continues to be a 
major issue in their lives. Other losses, affecting the participants in the current study, 
such as loss of independence, physicality and mental health have also been discussed 
in this chapter (Clair, 2003; Courts et al., 2004). The sense of loss and regret for 
PwMS who are parents knowing that children are observing the journey and possibly 
missing out on life (Willson et al., 2017) was replicated in this study (by study 
participants Rudi, Ruby, Griff and Davina). There is a paucity of recent literature on 
the experience of being a PwMS and feelings of loss. 
 
There have been several research studies identifying benefit finding in MS 
acceptance and adjustment (Pakenham, 2005a, 2005b, 2009) and thereby impacting 
positively on (re)defining self. A study exploring story making and living with MS 
uncovered that for some, being diagnosed with MS was akin to MS being a saviour, 
delivered to save them from the person they were becoming (Clair 2003). No study 
participants in the current study expressed their feelings in this regard, although Rudi 
discussed how she changed her “attitude to gratitude” after living with MS for a 
while and recovering from her initial relapse. Most participants in the current study 
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viewed MS as a partner, finding new ways of working with the disease rather than 
against it.  
 
Many PwMS change negative reactions (denial, concealment, loss of confidence) 
into positive changes and outlooks, including an increased appreciation for life and 
spirituality (Irvine et al., 2009). Most PwMS modified their lifestyle to do the things 
they wanted to do and needed to do (Matuska & Erikson, 2011). This was also 
demonstrated by several study participants, most notably Rudi, who described how if 
she wants to “play hard” and enjoy activities and sports, then she also needs to “rest 
hard” and nap regularly, even if it means missing out on other things. 
 
 Coming to terms with a new life plan may mean consequences to current lifestyle 
for PwMS. These concepts will be discussed further in the following chapter but it is 
important to recognise what these changes might be in terms of (re)defining the self 
with MS.  The amended life plan for many study participants meant changes to 
family life, to relationships, to social lives, a new strategy of planning, changes to 
workplace and employment, to new methods of stress management and to seeking 
joy and happiness in their lives. Some looked at the balance scales of life and chose 
to openly accept the gains (Joy, Evie), some chose to focus on the losses (Paul, Griff, 
Kate), some participants accepted both (Piper, Rudi, Susan, Will). But, for all study 
participants, the process was fluid and dynamic, it could change regularly and 
swiftly, and signalled a new life trajectory. It became the nature of living with the 
disease for many, part of who they were now, an identity that was constantly open to 
change and (re)defining. It prepared participants for one of the next important steps 
in their lives living with RRMS, to Taming the Beast and set up their life in a way 
that they felt they were in control of RRMS. This will be discussed further in the 
next chapter. Before this time however, many participants needed to embark on 
“Battling the Demons” before they could regain some of this much needed control.  
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Theme 3: “ Battling the Demons” 
 
My Demons 
Though quiet 
Are never quite silenced 
Calm as they may be 
They wait patiently 
For a reason to wake 
Take an overdue breath 
And crawl back to my ear 
Sarah Boswell 
 
For the purposes of this study, “demons” were conceptualised as negative emotions, 
sometimes very strong emotions, which can threaten the livelihood of PwRRMS. 
Demons can be subtle, creeping in every so often on a bad day and upsetting routine 
and peace of mind, or they can be like a runaway freight train completely 
annihilating all in its path. The end result is that PwRRMS are mostly never free, 
even when clinically or physically things are in quiescence, there’s potentially 
always something beneath the surface, where demons lay. For all participants in the 
current study, a variety of demons threatened them at different times, and for 
different reasons.  
 
The central organising concept for Battling the Demons in this study encompasses 
the experiences of confronting and living with the negative emotions that PwRRMS 
may feel throughout the life course, the things that steal away joy from life. There 
are many potential trigger points in an RRMS life journey to disrupt emotional 
equilibrium and quality of life (Dennison et al., 2009), including the time of 
diagnosis, the presence of new or chronic symptoms, with a relapse, change of DMT, 
when meeting other PwMS, or with disease progression. MS has been described not 
just as a journey of feelings, but a journey of feelings that change over time 
(Lysandropoulos et al., 2015). Adding to the burden is that people with neurological 
disability may be more likely to resort to ineffective ways of coping with emotions, 
which adds additional strain (Gedik et al., 2017). 
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Psychological problems in MS have been recognised for many years. A seminal 
paper on common psychological problems in MS from Burnfield and Burnfield 
(1978), described emotional reactions to MS as being inevitable, having serious 
effects on both the patient and their family, and also recognising at this early stage 
that they may be responsible for more disability in terms of suffering, than physical 
effects of MS. 
 
Too often in our busy clinics today, a patient’s emotional well being generally takes 
a back seat to discussions about DMTs, medication side effects and physical 
symptoms (Minden, Turner, Kalb, & Burke, 2014). Unfortunately, necessitated by 
the highly efficacious, but also potentially dangerous medication armamentarium of 
the modern day. The presence of these new, and longed for DMTs and earlier and 
more rapid diagnosis clearly does not remove the emotional burden in PwRRMS. At 
times it can be just the opposite, they can be the cause.  
 
The theme of Battling the Demons comprises four intricate sub themes, which all fall 
under the umbrella of demons, stealing away happiness and causing angst to the 
PwRRMS. These subthemes are facing fears, weary with worry and anxiety, 
depression and despair, and struggling with the saboteurs. Each of these subthemes 
also contains additional sub-subthemes to provide deeper exploration.  
 
Facing Fears  
 
Fear can be best described as an unpleasant emotion caused by the threat of danger, 
pain or harm (Oxford dictionary, 2017). This threat can be real or perceived, which is 
an important point in RRMS as so much is unknown, and nothing can be guaranteed. 
This means that some threats are connected to reality, but some may not be. For the 
purposes of coding and analysis in this study, and to separate fear from some similar 
emotions such as worry, stress and anxiety; fear was conceptualised as being 
frightened to the point of terror, invoking physiological body changes such as body 
heat, shaking, sweating and crying (Scheff, 2015). Some of these body changes I 
witnessed when the participants talked about fear and what they were fearful of. This 
reference to fear being a distressing emotion was essential in the initial coding for 
this category. For example, during Paul’s interview, he started to turn red in the face 
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and loosen his collar when talking about his fear of wheelchairs, he started to 
perspire and needed to have a short break, his fear was intense and physiological.  
 
It has been reported that for PwMS, the first two to three years after diagnosis can be 
marred by distress and worry about the future, from being seen as healthy, normal 
and able-bodied to sick, abnormal and disabled (Mortensen & Rasmussen, 2017). A 
mixed methods study using both questionnaires and semi-structured interviews of 85 
PwMS explored the theme of uncertainty in MS (Boeije & Janssens, 2004). The type 
of MS was not specified, but many were on DMTs and had a low-moderate disability 
score, suggesting a high proportion of RRMS participants. Uncertainty about future 
disease progression was a predominant factor, for those with both low and high 
perceptions of risk. Wheelchair dependence was perceived as a serious outcome, 
primarily because of lack of independence and a shrinking social world (Boeije & 
Janssens, 2004) and provides some understanding for the current study where so 
many participants were fearful of the possibility of needing a wheelchair and disease 
progression in the life journey, feeling like a burden to their family and worrying 
constantly about the future and what might happen. One would have thought the 
advent of higher efficacy medications to treat RRMS may have had some effect on 
these emotions, but for many that is not the case, fear continues to be a constant 
battle. It is a hard task for MS HCPs and MS Nurses today to change the 
stereotypical representation of PwMS being wheelchair bound and 
misunderstandings surrounding what RRMS actually is and how the disease course 
can be significantly altered with modern treatments abound.  
 
Elements of facing fear expressed by the current study participants included the sub-
subthemes of fear of medication side effects, fear of symptoms/relapses, fear of 
disease progression/disability and fear of the wheelchair.  
 
Fear of symptoms/relapses 
 
For PwMS, symptom changes can be overwhelming and almost feel akin to 
receiving a diagnosis of MS all over again, facing an acutely uncertain future much 
like an “emotional yo-yo” (Blundell-Jones, Walsh, & Isaac, 2014). Several study 
participants voiced a fear of symptoms striking at any time and relapses occurring 
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suddenly, blindness in particular. Rudi had a tendency to relapse rapidly and 
severely, and as the mother of 4 young children, this induced fear of relapses, and 
what her children may witness. 
 
I can relapse very quickly…when the paralysis comes…it happens very 
quickly…they’ve seen that happen and it’s been quite distressing, especially for my 
two young girls…the other week I fell and lost my balance, I lost my speech. Rudi 
line 582 
 
For Joy, sudden blindness from optic neuritis (a common presentation of MS 
involving demyelination of the optic nerve) induced deep fear and a second relapse 
causing dyslexia left her terrified, again. For Susan, a hospital admission with a 
severe relapse left her fearful of what may happen in the future and if she would 
recover. 
  
I was completely blind…for periods of time…terrifying, really terrifying and they 
couldn’t work out what caused it…and it happened again and terrified…absolutely 
terrified. Joy line 123 
 
So I came into hospital and I stayed the night…I was very scared and I was crying…I 
couldn’t sleep…I said to the nurse “I’m very, very scared, I don’t know what’s going 
on”. Susan line 280 
 
Fear of DMTs and side effects 
 
The physiological look of fear on some of the faces of PwRRMS during the 
interviews in relation to some DMT side effects has never left me. Once again, there 
were strong physiological reactions talking about how dangerous they felt some of 
the DMTs are, as well as possible unknown effects in the future. This concept will be 
discussed in greater depth in theme 7, “The DMT Dance”, but also belongs as part of 
the story of fear in this particular theme as well. The most dramatic of these fear 
reactions were Piper and Joy, who had very strong feelings. After a relapse, Piper’s 
neurologist wished to increase her treatment to a new DMT known to cause PML, 
but she was adamant she was not having it, nor the new and experimental HSCT 
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because of perceived high mortality. Joy was also equally adamant she wasn’t taking 
a DMT which had recently been associated with deaths in others living with RRMS.  
 
That PML thing keeps popping up …what does scare me with that is how do you 
know it’s that or an MS symptom causing it?…I’d rather be in a wheelchair than 
dead…Piper line 1362 
 
(later when talking about HSCT) I think the risk is too great…I get that these people 
are in a real state of bother…they’re struggling…but I just think I’d rather be, like I 
said, I’d rather be in a wheelchair than dead, I just think the risk is too great. Piper 
line 1960 
 
(my neurologist) wanted me to go onto a drug that was about at the time…which had 
only killed about three people…it had only killed three people! So I said “you’ve got 
to be kidding”. Joy line 820 
 
Ruby had been offered a stronger DMT after her disease had progressed rapidly, but 
Ruby declined due to fear about the significant side effects. A couple of years later 
during our interview, Ruby wished she had taken the opportunity earlier, crying as 
she recalled her lost opportunity, lost to fear. 
 
I really wish I’d listened to him (neurologist), I was just so scared, he said it could 
lead to other autoimmune things…and I think it was just pure fear, pure 
fear…going…I’ve got two young kids and the risk of cancers…I just didn’t know if it 
was worth the risk…my fear of the PM…? What was it called, PML? That was 
massive…like every time you have that injection, you just go…(sobbing). Ruby line 
511 
 
Fear of progressing/disability 
 
Although this subtheme has similarities with fear of the wheelchair, it is more 
general and involves disability in all forms, rather than the specific fear of a 
wheelchair itself. Some study participants met others with more severe disability at 
clinic visits or at MSA, and many became fearful that this might also be their future. 
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Being lonely and isolated as a result of disability weighed heavily on their minds and 
the possibility of a bleak future was ever strong, especially when confronted with the 
reality of other PwMS. 
 
Margot attended exercise sessions at the local MSA and observed people living with 
progressive and more serious forms of MS on many occasions. She talked to them 
and realised many were socially isolated, raising with her a fear deep inside that this 
may one day happen to her as well.  
 
A lot of them (people with progressive MS) I think are isolated and a lot of them are 
lonely…it’s very isolating…people become very isolated which is a real shame 
because then it’s hard to…how would you make friends if you’re isolated at home 
with disability? who are you going to meet?...I think that would be very hard. Margot 
line 2517 
 
Griff was a family friend of a celebrity with progressive MS who featured in many 
MSA fundraising campaigns for MS. As one of only a few people Griff knew with 
MS at the time, he was fearful for his own future with disability. 
 
(I knew) the picture boy for the MSS for years so I’d been exposed to MS for at least 
15-20 years with him…so it was a pretty scary image to measure myself against 
him…so I did have an understanding at least of how much damage it could do. Griff 
line 511 
 
Will had personal experience of what severe disability in MS looked like, and he 
became immediately fearful at diagnosis that this could be his future with disability 
as well. 
 
A friend of mine’s stepfather has MS…he’s in a wheelchair and he’s flat ninety five 
per cent of the day…the first thought in my mind when I was diagnosed was what 
happened to him. Will line 16 
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Fear of “the wheelchair” 
 
When confronted with a diagnosis of RRMS, many study participants jumped 
straight to imaging life in a wheelchair, an expectation which is common in the 
community and based on the natural historical progress of the disease. Before 
modern day DMTs and treatments, the risk of requiring a walking aid to walk half a 
block was quoted as 50% at 15 years from MS onset (Weinshenker, 1994). 
Nowadays the risk of needing assistance to ambulate in the future has not been 
quantified, the common switching between medications and the heterogeneity of 
RRMS making predicting future scenarios difficult. This fear of the wheelchair 
commonly settles with education and guidance from MS trained neurologists and MS 
Nurses, but for some participants in the current study, abject fear was the resulting 
emotion, terrifying and paralysing in intensity. Fear of the wheelchair could strike at 
any time, during relapses or with new symptoms, at the sight of another PwMS, or 
sometimes, with no specific trigger at all.  
 
Rudi considered her future and the possibility of being in a wheelchair during a 
severe relapse, where she lost all motor function in her legs as well as the power of 
speech. The episodic disability of this relapse induced fear that one day the 
symptoms may be permanent.  
 
The worst case scenario is I will be in a wheelchair…and that will be a very, very 
black day for me, or a black time if it does happen…afterwards I thought how’s this 
going to affect my life…I might be in a wheelchair next year…and those sorts of 
thoughts…and that’s why I used to get down quite quickly with my relapses because 
it’s almost like a little bit of a taste of what may be reality. Rudi line 856 
 
Paul disliked the MSA education material and resources because he felt that there 
was an undue focus on wheelchairs in MS, unnecessarily inducing fear in PwRRMS. 
Paul became emotional as he recalled how he felt reading this information. 
 
I hate the MSL stuff because it’s all wheelchair shit you know…it’s all worse case 
stuff…I don’t want to be in a wheelchair. Paul line 880 
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Susan’s fear of the wheelchair was directly related to the fact that she felt that level 
of disability would take away any chance of her finding a partner to share her life 
with. Susan was tearful as she recalled her feelings at that time. 
 
I’m very, very scared…well if it’s MS am I going to be in a wheelchair, or what’s 
going to happen…will I meet someone…who’s going to look after me…you know, 
will I be a burden? Susan line 335 
 
I always thought it (MS) was bad…that people would look…Oh no…I don’t want 
to…to be with her cause she might end up in a wheelchair…I might have to look 
after her or they’ll leave…that’s what I thought. Susan line 855 
 
Davina was terrified at her diagnosis, because her uncle’s MS had rendered him 
wheelchair dependant at a young age and was looked upon by the family with shame. 
The family used to tell people he had a head injury from falling of a ladder, denying 
MS. The fear of the reality of a wheelchair in MS was personal for Davina. 
 
I felt terrified, absolutely terrified because I had no idea what was happening to 
me…and my mother was frightened…because on top of all of this, I had an uncle 
who had MS and who was wheelchair bound . Davina line 360 
 
Post traumatic stress disorder (PTSD) is a disabling condition typically characterised 
by the re-experiencing of a traumatic event and experiencing intense fear, 
helplessness or horror (APA 2013, p. 467). The prevalence of PTSD in MS was first 
postulated as being approximately 15% in a study sample of 58 participants 
(Chalfant, Bryant, & Fulcher, 2004). However, this finding was not replicated in a 
larger study of 232 participants where PTSD prevalence was reported as 
approximately 5% (Ostacoli et al., 2013). Interestingly, there was no relationship 
found between the presence of this mental health disorder and the severity of the 
disease. There are some peculiarities in PTSD in MS, as it is not related to a single 
event in the past but rather to the course of the degenerative condition, and the 
intrusive PTSD symptoms are typically orientated to the future, such as fear of the 
wheelchair, relapses and progression (Ostacoli et al., 2013). In the current study, no 
participants were formally diagnosed with PTSD, however intense physiological 
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reactions to talking about fear of future disability and wheelchairs figured strongly 
for Paul, Davina, Will and Susan.  
 
The mere thought of MS can strike fear in people, even without any knowledge of 
the disease (Lysandropolous et al., 2015). Previous studies have demonstrated fear as 
an emotion central to the MS journey, but more recent studies on these specific 
phenomena in RRMS are lacking. A qualitative study, which interviewed ten women 
with SPMS, described how the women felt fear due to uncertainty about the future, 
fear intruding as the participants felt they did not know what was happening to their 
physical bodies (Olsson et al., 2008). A larger study interviewed 27 PwMS and used 
IPA methodology to reveal that fear of the future was prominent for PwMS, and in 
particular, fear of mobility loss, becoming a burden to family members and 
placement in a nursing home (Finlayson, van Denend, & DalMonte, 2005). Although 
the authors did not specify the type of MS in their inclusion criteria, participants 
needed to have MS for more than 15 years and be aged over 55 years, suggesting 
some elements of progressive MS and possibly influencing the fact that nursing 
home placement figured in fear. This nursing home fear was not evident in the 
present study, perhaps due to earlier disease stage of the participants or the presence 
of more effective patient education and DMTs in the modern era.  
 
Fear is often induced by the vagueness of symptoms pre-diagnosis, and the 
uncertainty of the cause of MS post-diagnosis and the possible disease trajectory 
(Thorne et al., 2004). A study from Thorne and colleagues (2004) used focus 
groups/individual interviews and phenomenological methodology with a group of 12 
PwMS and introduced the concept of “fear points” in the MS journey. “Fear points” 
are modifiable moments where patients receive either support or obstruction to their 
fear (Thorne et al., 2004). If timely, relevant and accurate information and validation 
of their experience is provided at these vulnerable times, the MS HCP/MS Nurse can 
modify these experiences significantly for PwMS (Thorne et al., 2004). “Fear points” 
will be different for each individual, but if carefully looked for and assessed by MS 
HCPs and MS Nurses, appropriate referrals may prevent future escalation of 
emotions and improve QOL. For some participants in the current study, fear resolved 
over time, but for others it never completely resolved. Fear sometimes turned to 
more chronic worrying, or expressed itself in other ways such as anxiety and 
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depression. Sometimes it was addressed with counselling and psychological 
interventions and sometimes it was shelved temporarily only to resurface at a later 
time. But fear in some form, at some time, featured in almost every participant’s life 
story. 
 
Theoretical foundations from fear studies can also help MS HCPs understand that 
perhaps some degree of fear may be helpful in clinical care. Looking at a positive 
aspect to the fear story, the seminal work of the “fear drive model” assumes that the 
emotional response of fear can function as a drive to mediate belief change and 
behaviour change (Leventhal, Meyer, & Nerenz, 1980). At times during the RRMS 
journey, our patients need to change beliefs and to change behaviour in order to 
adhere to evidence-based MS wellness prescriptions such as smoking cessation, 
adherence to DMT regimes, adherence to safety monitoring programs and follow-up 
appointments. A careful assessment by the MS HCP/MS Nurse is crucial in 
determining the impact of fear on an individual patient and whether referral to 
appropriate resources is required.  
 
Weary from worry and anxiety 
 
Worry is carrying tomorrow’s load with today’s strength 
Carrying two days at once and moving tomorrow ahead of time 
Worry does not empty tomorrow of its sorry 
It empties today of its strength 
 
Corrie ten Boom 
 
Worry is negative thinking arising from anxiety; it is a longer-term feeling than fear 
and has been described as an active anticipation of possible negative outcomes 
(Vasey, Crnic, & Carter, 1994). For the purposes of coding clearly and consistently 
for data analysis in this study, worry was conceptualised as different to fear and was 
defined as both a noun and a verb  “being troubled or feeling troubled over actual or 
potential problems” (Oxford dictionary, 2017). Anxiety disorders are listed in the 
Diagnostic and Statistical Manual of Mental Health disorders, fifth edition (DSM-V), 
(APA, 2013) as a diagnosable mental health illness, of which I am not authorised to 
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diagnose as an registered nurse. However, I do have the skills to assess for the 
presence of anxiety and to refer to appropriate HCPs for further assessment and 
advice. For the purposes of this study, anxiety was based on DSM-V descriptions; 
challenging a person’s control, consisting of a mix of symptoms such as fatigue, 
impaired concentration, irritability, difficulty sleeping and impacting on day to day 
activities for a prolonged period of time, and conceptualised as excessive worry. 
 
Previous studies have demonstrated high levels of worry in PwMS, and a link 
between worry and anxiety, separate but unique related psychological constructs 
(Bruce & Arnett, 2009). A quantitative survey based study of 50 patients (of mixed 
RRMS and SPMS) demonstrated that 36% of participants experienced worry in the 
elevated range and also that worry was associated with depression and anxiety 
(Bruce & Arnett, 2009). The authors report that indeed, the very nature of MS 
(uncertainty, symptoms, threat of relapse) may create an optimal environment for 
excessive worry, supporting the findings in the present study where some degree of 
worry interjected the lives of all participants at some time. The concept of worry in 
MS as an independent construct certainly requires further exploration and research, 
particularly as excessive uncontrollable worry can also progress to a more serious 
generalised anxiety disorders (Bruce & Arnett, 2009) or other anxiety and depressive 
disorders (Thornton, Tedman, Rigby, Bashorth, & Young, 2006). 
 
In the current study worry took on several forms, and sometimes the participants 
worried about themselves, but just as often they worried about their loved ones and 
how RRMS was affecting the family unit as a whole. Almost all participants worried 
about something directly related to MS at one time or another, with worry about 
becoming a burden in the future a common worry. The chronic worriers could then 
go on to feel anxiety, either acutely or more long term, and for this reason (as a 
linked concept) anxiety has also been included in this sub theme. 
 
In the midst of a severe motor function relapse, Rudi felt at her most vulnerable, 
feeling anxiety herself, but also feeling that she was the cause of anxiety for her 
young daughter. Rudi was worried about hurting her children if a relapse came on 
suddenly whilst she was driving and caused an accident. 
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I went through a really bad period with anxiety, to the point where I nearly gave up 
driving…because it happens so quickly (relapse)…so I thought…I’m going to hurt 
my children or I’m going to hurt someone else…I suppose it’s going to be always in 
the back of your mind…I mean I was to the point where I used to drive with no-one 
in the car and see how long it would take me to stop by pulling the handbrake 
on…working on things to keep my children in the safest place possible. Rudi line 702 
 
In the first year after his diagnosis, Paul spent hours at night researching on the 
internet everything he could about MS, his GP suggesting that he might need some 
professional help and counselling because the worrying and need for information 
became excessive. 
 
And you know at night …and this is why the GP sent me off to the psychologist, I 
don’t have very good sleep at all, I sort of just lay there and I sort of get on the 
phone or ipad and read all this stuff (on MS) for hours at night, every night…the first 
year after diagnosis was very hard…I was…you know…anxiety…and you know, no 
matter how you try, and rationalise it, you can’t, you just can’t beat the fact that 
you’re a human being and that emotions are part of…you know, being alive. Paul 
line 477 
 
Davina was learning to cope with her new diagnosis of RRMS and became pregnant 
shortly afterwards, causing her worry and anxiety over how she was going to balance 
both the new disease and motherhood. 
 
It was a huge shock and I was such an anxious person to start with, so dealing with a 
diagnosis and then being a very young mother…I also had a very anxious pregnancy 
because I didn’t know how. Davina line 539 
 
Worry about being a burden to the family  
 
Worry about being a burden, either in the present or in the future, and worrying 
about what MS was threatening to do to their family unit and loved ones was 
common to almost all participants at some point of their RRMS journey. This sub-
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subtheme also focuses on the participants worrying about family members being 
worried about their RRMS.  
 
It has been suggested that one of the greatest challenges for children whose parents 
have MS is balancing caring for the parent with restraint in expressing their own 
feelings to protect their parent and avoiding burdening them with their own sadness 
of MS (Moberg, Larsen, & Brodsgaard, 2016). For Rudi, her children witnessing her 
last severe relapse has been a constant cause of worry for her, sometimes much more 
than the worry she has for herself physically. Rudi sought psychological counselling 
for her daughter to help manage the anxiety her daughter feels.  
 
(When my last relapse happened) the children were hysterical…the kids, so they 
were in tears and so…so…that’s really tough…I find that tougher than the physical 
side of things sometimes...they shouldn’t have to go through that at such a young 
age…(my daughter) she takes too much of it on board. Rudi line 625 
 
After a serious fall and fractures a few years before, Kate’s mother worried 
constantly about Kate falling again and being on her own, sometimes frustrating 
Kate as she struggled to get to one phone with limited mobility. 
 
If I don’t answer the phone then she’ll ring the mobile and if I don’t get to that in 
time, she’ll ring again and it’s whole panic stations, she thinks something’s 
happened to me…I know she worries but it doesn’t help. Kate line 2398 
 
Ruby worries for her sister, that her sister feels left out of the family unit as there is 
so much fussing over Ruby. The situation of Ruby requiring frequent assistance with 
home and childcare because of her significant MS symptoms also causes stress for 
her retired parents as well.  
 
MS has changed our family dynamics…I mean Mum and Dad were stressed about 
me…I think my sister feels a bit left out (Ruby cries)…it would be nice if it wasn’t all 
about me. Ruby line 1147 
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Worry for PwMS regarding affording MS healthcare and medications has figured 
prominently in an overseas study (Jones & Amtmann, 2014), however this theme did 
not present in the current study. This could be due to the fact that the Australian 
government has subsidised access for residents prescribed DMTs to treat RRMS, 
providing them at a greatly reduced cost. 
 
Existing with anxiety 
 
As previously discussed in chapter 2, anxiety is more prevalent in the MS population 
than in the general population (Wood et al., 2013; Feinstein et al., 2014) and has 
been strongly associated with lower QOL scores across all levels of illness severity, 
from mild impairment to severe (Ionescu et al.,  2012). Anxiety is also more 
prevalent in females than males in PwMS (Theaudin et al., 2016). Several 
participants in the current study reported feeling anxious at many stages of their 
RRMS journey and often felt that they were left to cope with anxiety on their own. 
 
High levels of anxiety have been associated with an emotional preoccupation of MS, 
and focusing on the emotional consequences of the disease (Roy-Bellina et al.,  
2010; Tan-Kristanto & Kiropoulos, 2015) rather than physical symptoms. Susan 
demonstrated this in the present study when she described a time in her life when she 
felt being completely mentally overtaken by MS, to the point where she couldn’t 
concentrate anything else in her life, not her family, not her work and not her usual 
sources of happiness. Paul described spending many nights lying awake, feeling 
anxious and researching MS on the internet, despite having very little physical 
disability at the time. 
 
Interestingly, negative life events, problems in family life and social functioning can 
also be significantly associated with anxiety (Liu et al., 2009). Stress in childhood 
has been explored as potentially being a risk factor to developing MS in later life 
(Nielson et al., 2014). Childhood stress was present in the life stories of Joy, Will, 
Margot, Rudi, Davina, Evie, and Griff, for varying reasons including loss of parents, 
divorce, alcoholism, moving to foreign countries and childhood illness. A nationwide 
cohort study from Denmark found that there was an increased risk of MS amongst 
persons exposed to stressful life events before the age of 18, especially long term 
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stress (such as parental divorce) rather than acute events of significance (such as the 
death of a parent or sibling) (Nielsen et al., 2014). Others have also found that 
exposure to abuse and neglect in childhood increased MS risk (Spitzer et al., 2012). 
In regards to stress influencing MS activity, there is substantial evidence that disease 
activity is increased under stress (Saul et al., 2016), but this particular study looked 
at stressful life events in the 12 months preceding diagnosis, not in earlier childhood.  
 
A systematic review exploring predictors of anxiety found that positive 
reinterpretation, social emotional support and humour predicted an improvement in 
anxiety symptoms (Butler et al., 2016). In the current study this was demonstrated 
repeatedly as study participants recounted stories of anxiety followed by seeking 
assistance and at times, psychological help. Anxiety is most highly associated with 
depression, low self efficacy, stress, emotion focused coping, pain, fatigue and QOL, 
factors that may be amenable to intervention if identified and actioned by MS HCPs 
(Butler et al., 2016). Furthermore, a prospective study has shown that depression can 
strongly predict anxiety and anxiety can predict later depression (Brown et al., 2009), 
continued revisiting of both of these issues by MS HCPs longitudinally could have 
an immense impact in preventing future problems.   
 
Depression and Despair 
 
Depression…I knew what that felt like…there was nothing…it’s nothingness…a 
feeling of nothingness…I know this sounds strange but it’s the only way I can 
describe the feeling. Evie line 270 
 
Dealing with depression 
 
As already discussed in chapter 2, for people living with MS the lifetime prevalence 
rate of a depressive disorder has been reported as greater than 50% (Hoang et al., 
2016). As with anxiety disorders, depressive disorders are a diagnosable mental 
health illness under the DSM-V (APA, 2013), following listed criteria including 
depressed mood, loss of interest and enjoyment in usual activities, reduced energy, 
reduced self esteem and confidence, ideas of guilt and unworthiness, pessimistic 
thoughts, disturbed sleep and appetite and ideas of self harm (APA, 2013). For the 
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purposes of this study, depression was coded if it seemed reasonable in the 
descriptors the participants used to express their feelings, or if the participants used 
the term themselves (which occurred in the great majority of cases). “Feeling 
depressed” is a common phrase people use to describe many emotions, but I only 
included it in the coding if there was supporting evidence from the study participant 
that it was more serious than a fleeting emotion (such as a formal diagnosis or a story 
of prolonged depression with symptoms such as those described above). Despair was 
defined as a noun, the complete loss or absence of hope; and as a verb, to be without 
hope (Oxford dictionary, 2017). Both depression and despair have been 
conceptualised under the same subtheme, as they often paired together in the 
participant’s narratives. However, the accounts of the participant’s stories for 
depression and despair will be kept separate. 
 
A British study exploring patient’s feelings when transitioning from RRMS to 
SPMS, used thematic analysis to interview nine PwMS and seven HCPs. The 
researcher found that shock and devastation is common in response to being 
reclassified as SPMS, and is a significant psychological blow (O’Loughlin, 2015). 
Participants in the study emphasised the importance of being able to debrief with an 
MS Nurse after discussions on this topic so that they have ample opportunity to ask 
questions and reconfigure the news in a hopeful manner (O’Loughlin, 2015). In the 
current study, this experience was shared by Davina who pinpoints the day she was 
told that she would one day transition to SPMS, as the day her battle with depression 
began.  Davina was reviewed by a psychologist and diagnosed as being moderately 
depressed, but failed to follow-up or seek further care, she had a fear that she would 
be medicated and didn’t want that for herself following years of working in the 
health system herself.  
 
When something does happen it hits me like a steam train and I go down to the 
depths of depression…like I won’t get back up again…I think I’m consistently just a 
little bit depressed…I think it after I was told that it could convert to 
progressive…and then the interferons would make that feeling of 
desperateness…hopelessness…it would make it a hundred times worse. Davina line 
1068 
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Piper was formally diagnosed with depression at different stages of her life journey, 
both before and after her RRMS diagnosis. Despite the negative impact depression 
was having on her life, she was not keen to seek help until her husband demanded it.  
 
I sort of probably had a bit…a bout of depression…I was treated with a 
counsellor…in hindsight you could see a pattern from younger and it was only that 
my husband said to me if you don’t do something about it…this marriage is 
over…that it sort of pushed me. Piper line 279 
 
Susan was single for many years, deeply concerned that she would not find a life 
partner who would accept her RRMS. Living alone with RRMS at times of major life 
events often triggered symptoms of what Susan termed as depression.  
 
(Buying a house) was another turning point for me because I was 
again…depressed…thinking I’m doing it on my own and what if something happens 
again? Susan line 633 
 
After her first MSA meeting, where she met several young people living with 
significant disability and progressive MS, Jane refused to go to any more meetings 
and to avoid the feelings of sadness she was experiencing, which Jane referred to in 
her life history as depression. 
 
We were just sitting there crying and I thought I don’t want to go back to this 
because it’s just too depressing…because they don’t work, they don’t study, they’re 
at home in a wheelchair and they’re not going anywhere…and it’s just too 
depressing. Jane line 211 
 
The interferon injections were also a constant source of what Jane refers to as 
depression, not just the fact she was self injecting, but that she always felt so much 
worse after the injections. Jane ceased treatment after a couple of years, finding it 
preferable to be on no treatment and risk relapses rather than feel depressed.  
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(being on Rebif®) you just had to inject all the time and it’s just depressing…I used 
to hate it…and I thought I might as well just give up and do nothing…and it was just 
really depressing. Jane line 372 
 
After his neurologist sought special permission for compassionate use of an 
expensive DMT so he could have it at no cost, Will was tormented about doing the 
right thing and battling his feelings of depression. His life went into a downward 
spiral for several months. 
 
It’s probably the greatest thing anyone has ever done for me…but then I threw it all 
back in his face…depression set in pretty bad…I just wasn’t feeling any better…I 
didn’t contact them (MS team) so I went unmedicated…I quit my job…I hadn’t told 
my family at this point about my diagnosis. Will line 880 
 
Rudi felt that because she has been through so much in her life, from a troubled 
childhood living with a single mother diagnosed with bipolar disorder to the stillbirth 
of her third son, that it was time for life to be fair to her. Rudi often felt the demons 
of depression and worked hard to fight them. 
 
I do tend to crash and burn emotionally because things are just taken from you…I 
suppose that’s when I get down cause I think it’s not fair…I think because I’ve been 
through so much in the past that you know how hard I have to fight and you look at it 
and you feel tired just thinking about it…when you’ve had to fight all of your life. 
Rudi line 1690 
 
Face to face with despair and hopelessness 
 
It has been suggested in chronic illness literature that despair and hopelessness 
actually help move towards hope for patients, as awareness of the future and 
consequences become clearer (Morse & Penrod, 1999). It has also been suggested 
that maintaining hope is a balancing act between hope, hopelessness and despair, 
with patients often passing through despair when moving toward hope or 
hopelessness in a study of living with another chronic illness, acquired immune 
deficiency /human immunodeficiency syndrome (Kylma, 2005). Moore (2005) has 
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placed hopelessness at the centre of despair, with despair occupying the bigger 
picture and hopelessness one component of it. Threats to hope (and thereby openers 
to hopelessness and despair) include pain and other uncontrolled symptoms, spiritual 
distress, fatigue, anxiety, social isolation and loneliness (Fitzgerald Miller, 2007), all 
potential threats when living with RRMS. Interestingly, perceptions of hopelessness 
from those seen by the patient as “powerful”, such as HCPs and family, may also 
threaten hope (Fitzgerald Miller, 2007). 
 
Davina described times of feeling hopelessness and the angst she felt at never ending 
darkness. For several years after her diagnosis, Susan  struggled with managing her 
feelings around RRMS, often taking two steps forward and one step back and never 
feeling emotionally in control as life when on around her. 
 
I’ve had times of hopelessness, people say to me you’re not your disease and I’m 
not…but…sometimes it becomes my focus and I can’t think past it because hope to 
me is looking to my future, that’s hope. Davina line 1523. 
 
Hopelessness is dark and it’s lonely…and it’s never ending darkness and 
misery…hopelessness feels like it’s never going to end, that nothing’s ever going to 
fix it. Davina line 1539 
 
I felt like I’m here but I’m not here…I felt numb…I thought I can’t feel like this…I 
can’t think like this. Susan line 481 
 
Joy suffered debilitating bouts of deafness and blindness, the aftermath of coping 
with sensory loss took her to the depths of despair. 
 
It was horrific…it nearly broke me (tearing up)…and I went into a downhill spiral 
emotionally…(and later)…I deteriorated from there…so the visual thing would come 
and go it was just really, really hard and I’m trying to hold down a job and I’m 
saying to my husband I’m so sick I have to, I have to give up work I’m so sick, I can’t 
work and he was just like ‘absolutely not”…I was heartbroken. Joy line 855 
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Choosing to keep thoughts of despair and hopelessness to themselves was sometimes 
the chosen path, no matter how much support was around them at the time. Will 
discussed his feelings, keeping his friends away from what was happening after the 
diagnosis of RRMS was made. He made this conscious decision to distance his 
friends from his diagnosis of MS because of a family friend who was wheelchair 
bound and severely disabled. 
 
I had a breakdown to be honest…and no-one saw it, not even my best friends, I hid it 
from everybody…it was just the worst and again, looked back at my friends 
stepfather…and that’s all I could think of. Will line 700  
 
Depression, despair and loss of hope in MS can be serious and life threatening issues. 
Loss in MS goes beyond loss of ambulation and function and also incorporates the 
loss of future plans and dreams, pre-morbid roles and significant relationships (Gedik 
et al., 2017). Thoughts of death and self-harm are prevalent in MS, with data 
suggesting that over a quarter of PwMS (type not specified) contemplate suicide 
(Feinstein et al., 2012) and that young males in the first five years of diagnosis are 
the most at risk (Feinstein, 2011). A recent study of 3,823 MS patients used a 
systematically collected questionnaire during routine clinic visits to capture the 
frequency of thoughts of death in patients with epilepsy and MS (Dickstein et al., 
2015). A prevalence rate of 15% in the MS cohort was reported (slightly higher than 
epilepsy), associated factors being depression, male and unmarried, medical co-
morbidities and poor QOL (Dickstein et al., 2015).  
 
Exploring suicidal thinking in MS, researchers used questionnaires and semi 
structured interviews to talk to 16 PwMS (type not specified) who all expressed 
suicide ideation, but not suicidal intent (Gaskill, Foley, Kolzet, & Picone, 2011). 
Fear of burdening their family was one of the most common reasons participants 
gave for thinking about suicide as a way of reducing family tension. They also 
identified issues of feeling a loss of control, loss of femininity/masculinity, 
hopelessness, feeling lonely and symptoms of MS; all amplified if they were in 
distress (acute symptoms, pain) exacerbating the feeling of being a burden (Gaskill et 
al., 2011). Despite most participants in the current study expressing concerns about 
burdening their families, no participants in the current study spoke directly about 
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suicidal thoughts. Will discussed having several emotional “breakdowns” during the 
course of his life journey living with RRMS, during his long diagnostic process and 
hospitalisation and then again a few months following his diagnosis of RRMS. 
 
Struggling with the saboteurs 
 
A saboteur destroys, damages or obstructs (Oxford dictionary, 2017).  Saboteurs are 
the unwelcome demons that threaten happiness and downplay moments of joy for 
PwRRMS. These saboteurs were different for each individual, but could have a 
significant negative impact on living with RRMS. The saboteurs I identified as 
subthemes were “Coping with uncertainty”, “I’m never free of MS” and “Social 
isolation”. 
 
Coping with uncertainty 
 
When a person’s actual present and future is characterised by uncertainty, a person’s 
sense of feeling whole is threatened (Olsson et al., 2008). Uncertainty in chronic 
illness has been well recognised (Mishel & Braden, 1988; Mishel, 1990) and it is not 
surprising that the uncertain and ambiguous nature of MS creates the “perfect setting 
for uncertainty to thrive” (Tams, Prangnell, & Daisley, 2016).  Uncertainty can take 
several forms in MS, including symptom uncertainty, medical uncertainty and daily 
living uncertainty (Gray & Arnett, 2014). This is further hampered by a lack of 
pattern manifestation in terms of remission and relapses (McReynolds, Koch, & 
Rumrill, 1999), so it becomes difficult to control and predict. Eventually being 
diagnosed with MS and piecing together the puzzle doesn’t do away with the concept 
of uncertainty, in many ways the uncertainty has only just begun. 
 
Mishel (1990), a nurse researcher and theorist, spent many years studying 
uncertainty in illness theory. Mishel (1990) defines illness uncertainty as being 
multifactorial and encompassing doubts and unpredictability’s relating to symptoms, 
diagnosis, treatments, relationships, prognosis and future planning. All of these 
components are features in the RRMS journey and impact directly on PwRRMS, 
sometimes on a daily basis and in multiple ways. Every participant in the current 
study felt the wrath of unpredictability at some time in their life, with the inability to 
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plan for a “normal” future, presenting as a constant stumbling block. Coming to 
terms with uncertainty in MS and the inability for long term planning is problematic 
for many PwMS (Finlayson et al., 2005) and, as previously explored, can lead to 
other demons, such as anxiety, fear, despair and depression breaking through the 
barriers to take control.  
 
Of all the saboteurs, coping and living with the uncertainty of such an unpredictable 
and incurable disease caused challenges for most of the study participants. They told 
of stories about the uncertainty of where MS will target next, how bad a relapse 
might be and how their individual disease may ultimately progress. Many found the 
concept of being diagnosed with a disease with no definite prognosis difficult to live 
with and coming to terms with uncertainty was a daily battle for them. Kate was the 
mother of a two year old child when she was diagnosed and uncertainty caused some 
challenges in planning life. 
 
RRMS…is unpredictable…and scary…extremely scary because you don’t know 
what’s going to happen…Kate line 24 
 
I had a two and a half year old son at the time (of diagnosis)...it was scary…You 
couldn’t plan your life because you were always worried about a relapse…going on 
a holiday…I was scared and always at the back of my mind was what would 
happen…what am I going to do? Kate line 1248 
 
Knowing the DMTS could reduce relapses, but not stop them altogether impacted 
both Jane and Piper, the uncertainty always a factor.  
 
You just think it’s a very difficult disease because you never know what’s going to 
happen…you can’t judge anything. Jane line 745 
 
I’m still going to relapse at some point really…aren’t I…I could relapse more often 
on one of them (medications)…you don’t know. Piper line 1393 
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I’m never free of RRMS 
 
Caring for chronic illness takes planning, time and motivation by the patient (Katon 
et al., 2010) and can be hampered by constant intrusion to everyday lives (Larsen, 
2016). Integrating illness into daily life includes skills of modifying lifestyle and 
seeking normalcy through balancing activities and illness needs (Schulman-Green et 
al., 2012). Some participants discussed how RRMS is always with them, which is 
one of the realities of living with a chronic illness. This seemed to be most prevalent 
in the time after diagnosis when thinking about MS took up so much time and 
energy. Life enjoyment was sabotaged by the continuous preoccupation with RRMS, 
and this could happen at any stage. For Paul, it was constantly on his mind, and he 
felt that he didn’t need to share that burden with others. 
 
There wasn’t a moment that would go by where I wasn’t thinking about MS…I’ve 
always got it in the back of my mind…don’t get too comfortable and think that 
everything’s going to be OK…be prepared. Paul line 852 
 
(on non-disclosure to his close friends) I’m reminded enough of it as it is…I don’t 
need to…other people to…I don’t need any more, that’s enough, you 
know…everyday you don’t go without thinking about it…it’s impacted my life in that 
way, in a big way. Paul line 1024 
 
Between relapses, Rudi kept a lot of her symptoms to herself and frequently hid how 
she was feeling, reluctant to let others know that RRMS is always with her, even 
when she appears well and back to “normal”. Similarly, Will refused to be a burden 
to his wife, he worried that he wouldn’t be seen as the strong man he wanted to be 
seen as and often hid symptoms from his wife so that she won’t have cause for 
worry. However, sensory loss in his hands and the loss of the feeling of intimacy 
when holding hands with his wife, are reminders that he is never free of RRMS. 
 
I don’t think (my husband) realises that I have something every day…because I don’t 
tell people…oh I had pins and needles today…or I’m a bit tired today…I get sick of 
talking about MS. Rudi line 1413 
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I hid it from my family and I do it for the simple fact that…my wife’s pretty 
fragile…we’ve got responsibilities…I need to be that strong person…I wouldn’t want 
anybody to have to go through how I feel on a daily basis. Will line 64 
 
I hide the aspirin packet so my wife doesn’t see it because I don’t want her worrying 
about it…she’s got a baby to look after…I know how hard it is to deal with all of this 
and all of that…My hands are very numb you know, things like having my wedding 
ring on, I don’t know if I’ve got it on or not, I can’t feel it, which is sad…I’ve never 
said this to my wife because my wife always wants to hold my hand and I don’t know 
if I’m holding it or not. Will line 100 
 
Social Isolation 
 
Social isolation refers to the absence of social relationships and social networks 
(Umberson & Montez, 2010) and has been reported to be a risk factor for suicide in 
MS (Feinstein, 2002; Pompili, 2012). Seminal work in chronic illness suggests there 
are health risks of social isolation and loneliness (Charmaz, 1983). There is a paucity 
of literature exploring social isolation and MS, but there have been reports in health 
policy literature, which suggest that both the quality and quantity of social 
relationships affect mental health, health behaviours, physical health and mortality 
risk (Umberson & Montez, 2010). Prospective studies of mortality have shown that 
individuals with low levels of social relationships were more likely to die than those 
with greater social relationships (House, Umberson, & Landis, 1988). In adults with 
medical conditions, social relationships also reduce mortality risk, confirmed in a 
study of coronary artery disease (Brummett et al., 2001). 
 
The daily grind of social isolation could be a constant saboteur to mental health and 
how the participants saw themselves. Griff became a stay at home father after losing 
his job because of his MS symptoms and has never returned to the workforce. Now 
that his children are older, he finds himself frequently alone and struggling with 
social isolation.  
 
The social consequences of social isolation…I was never allowed to be completely 
“in” with the mothers groups, with the playgroups…the kids start high school and 
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the first thing they tell you is we don’t want to see you…my days are spent 
wastefully…social contact is what you’re trying to establish so people have…you 
know, community to operate in…well I don’t have those links anymore...it’s not 
going to be easy for me to return to the workforce…who’d want me anyway? Griff 
line 707  
 
Recognising the demons to battle 
 
What we know about some of these demons (fear, anxiety, depression, PTSD) and 
MS is that they can be fatal. Of course, MS and MS treatments can also be fatal, but 
that situation is far less prevalent than demons such as depression, which can induce 
suicide (Feinstein et al., 2014). The demons of fear, worry, anxiety, depression, 
despair and social isolation can be interlinked in many ways, for example depression 
and anxiety often go hand in hand to sabotage mental health, predictive of each other 
in MS (Brown et al., 2009). Worry can lead to anxiety, anxiety can lead to panic and 
depression can lead to despair and hopelessness. These negative emotions can then 
also interfere with RRMS treatment, with people suffering mood and anxiety 
disorders in RRMS being five times more likely to non-adhere to their DMT (Bruce 
et al., 2010). MS Nurses have an important role to play in assessing and monitoring 
for signs of these demons, as trusted confidantes by PwRRMS, they often can 
discuss these issues and advocate for PwRRMS to ensure early referral to appropriate 
services (Porten & Carrucan-Wood, 2017).  
 
The following theme of “Surplus Suffering” explores a novel concept in MS care, 
which may inadvertently contribute to some of the demons experienced by people 
living with RRMS. The concept of Surplus Suffering is suffering over and above that 
experienced by the disease of RRMS itself and represents an area of MS care with no 
existing specific literature.  
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Theme 4: “ Surplus Suffering” 
 
Only through the experience of trial and suffering can the soul be strengthened, 
vision cleared, ambition inspired and success achieved. 
The world is full of suffering; it is also full of overcoming it. 
 
Helen Keller (1880-1968) 
 
The central organising concept for the theme of “Surplus Suffering” is suffering 
inflicted by others onto the PwRRMS over and above that imposed by the condition 
itself. 
 
Eric Cassell, a physician who has explored the concept of patient suffering in 
medicine for decades, has defined suffering as “the distress that is brought about by 
the actual or perceived impending threat to the integrity or continued existence of the 
whole person” (Cassell, 1991, p. 4). Suffering affects the entire person, extending 
past the physical to emotional, social, spiritual, existential and financial domains and 
often not fitting neatly into current biomedical paradigms (Epstein & Back, 2015). 
Many people living with chronic illness suffer as they experience their illness, but it 
is the broader significance of the suffering beyond physical discomfort which can 
cause the loss of self for many people with chronic illness (Charmaz, 1983). Indeed, 
consequences of suffering spread and accumulate through one’s life and can prevent 
patients moving forward into the present, stealing joy and limiting social worlds 
(Charmaz, 1999). Suffering is important for MS HCPs to consider because it can 
lead to some of the demons discussed in the previous chapter, especially isolation, 
hopelessness and vulnerability (Reed, 2003) and involve a loss of dignity and 
alienation (Coulehan, 2011).  
 
It has been argued by Cassell and others that little attention or discussion has been 
given to the problem of suffering and patient emotions in medical education, 
research or practice despite the relief of suffering being considered one of the 
primary ends of medicine by both patients and the general public (Cassell, 2004; 
Kenny et al., 1997; Shapiro, 2011). Furthermore, suffering is ultimately highly 
personal, the presence and degree of the suffering can only by known to the sufferer 
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(Cassell, 2004). If suffering is not relieved, there is a threat to the person’s integrity 
and a loss of part of that person as their suffering continues (Cassell, 2004). This 
degree of suffering and loss to self was evident during the current study. Several 
participants whose physical, mental and emotional suffering continued with them for 
many years after the precipitating event, felt an intense impact on their present sense 
of self and their life living with RRMS. This will be highlighted throughout the 
remainder of this theme with the use of participant comments, crystallising their 
experience of Surplus Suffering. 
 
Medical models of suffering tend to concentrate on fixing, curing and eliminating 
illness compared to the nursing perspective which tends to look at the broader 
paradigm of the quality of a life lived (Ferrell & Coyle, 2008). As nurses play a 
fundamental role in the caring of those who suffer, and are present for people as they 
struggle through illness, the relief of suffering is at the core of nurse’s work (Ferrell 
& Coyle, 2008). Suffering is a universal human experience and nurses commonly 
encounter pain and suffering at all levels when caring for their patients (Davitz & 
Pendleton, 1969; Reed et al., 2003). Nurse researcher Morse (2001) has identified 
two stages of suffering: enduring suffering which occurs when the sufferer brackets 
their emotions so that they continue on in everyday life, not expressing the negative 
emotions and emotional suffering which is a distressing state where emotions are 
unconstrained. Individuals can move between the two types of suffering depending 
on their circumstances and context (Deal, 2011). Participants of the current study 
reported experiences of both enduring and emotional suffering. 
 
Surplus Suffering as a concept was first described by James and Clarke (2001) as 
they explored the experience of Portuguese immigrant women adjusting to life in a 
new country and the extra suffering inflicted on them as a result of seeking healing in 
a western health care system where disagreement arose between their old culture and 
the new health care system (James & Clarke, 2001). In that particular study, Surplus 
Suffering was conceptualised as the women suffering over and above the signs and 
symptoms that brought them to medical care in the first place (James & Clarke, 
2001). Further work in Surplus Suffering by Clarke and Fletcher (2005) explored 
experiences of parents when their child was living with cancer, interviewing 29 
parents and discovering that “problems in the system” and carelessness, unkindness 
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and mistakes led to increased suffering for children and their families. In this work, 
the authors conceptualised Surplus Suffering as the extra, unnecessary suffering that 
can result from the HCPs and the health care system, in addition to the inherent 
physical suffering already resulting from cancer and its treatment (Clarke & Fletcher, 
2005). Clarke went on to explore further themes of “Surplus Suffering” as a key 
component in studies of people living with Asperger’s syndrome (Clarke & van 
Amerom, 2007), parenting a child with mental health issues (Clarke, 2012) and 
childhood mental health issues (Clarke, 2013).   
 
Whilst listening to the stories of many of the participants I interviewed in the current 
study, at times I was struck by the realisation that the medical/health system had let 
these PwRRMS down in some way and induced additional distress on top of the 
burden of living with RRMS. By this I mean suffering in addition to that caused by 
disease onset, disease symptoms and disease related disability and in addition to the 
considerable mental health and emotional burdens discussed in the previous theme, 
Battling the Demons. Very sadly, the stories of additional distress experienced by the 
participants in the current study sometimes involved compromised care from their 
HCPs, neurologists and nurses, exacerbating the disease-related suffering these 
PwRRMS were already experiencing. For other study participants, it was the 
additional emotional pain inflicted by those they loved or trusted, such as family or 
friends or sometimes by strangers. During the study interviews I was struggling to 
find a way to describe some of the similar feelings and experiences I was hearing 
from the participants (and later coding and analysing) that effectively described the 
concept of what I initially termed “added distress” or “compromised care”. When I 
unexpectedly came across the work of Clarke at a qualitative research conference in 
May 2017, the concept of Surplus Suffering fit the data exceptionally well and truly 
captured the essence of the stories I had been told. Unfortunately, I realised at that 
moment that Surplus Suffering was alive and happening in the field of RRMS.  
 
Surplus Suffering reminded me of the seminal work by Charmaz (1999, P.365) of 
suffering and chronic illness: 
 
“When in agony suffering is immediate and relentless. Suffering can also be 
insidious. It steals in and it spreads out. It is of the self and it is social. As suffering 
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spreads out it shapes social relations and limits social worlds. Such suffering means 
work - for chronically ill people, caregivers and co-workers.”  
 
 The notion that suffering is dangerous, stealing in and spreading out and affecting 
many others in its path was highlighted in the stories of study participants. Surplus 
Suffering presented a risk to the health and livelihood of the affected study 
participants until it was discussed, assessed and positively managed. The significance 
of suffering in chronic illness has been well documented by nurse researchers (Morse 
& Carter, 1996; Charmaz, 1999); suffering shapes stories and meaning and poses 
existential problems of identity and self as one lives with chronic illness (Charmaz, 
1999). Often MS Nurses will hear stories from patients of positive and negative 
experiences they have had with other HCPs leading up to, and after, their diagnosis 
of RRMS. Even if Surplus Suffering was not inflicted under their care, the MS Nurse 
could possibly be dealing with the impact of previous Surplus Suffering on the 
PwRRMS in current consultations. This could in turn influence learning and 
education, adherence to medication/lifestyle recommendations, trust, loyalty and 
likeliness to partner with us as HCPs in future care. It is something MS Nurses need 
to explore and assess at the beginning of their professional healthcare journey with a 
PwRRMS. Everyone’s journey is unique, not all PwRRMS will have stories of 
Surplus Suffering to tell, but many may well.  
 
Towards understanding and a definition of Surplus Suffering in RRMS 
 
From the study participants’ interviews and stories, and from the literature on the 
phenomena of suffering, I have adapted a definition of Surplus Suffering from the 
work of James and Clarke (2001), Clarke and Fletcher (2005), Clarke & Amerom 
(2007) and Clarke (2012, 2013) to fit a conceptual model of living with RRMS: 
 
Surplus Suffering is suffering caused to PwRRMS over and above suffering from 
the existing physical, emotional and mental burdens of the disease. Surplus 
Suffering in RRMS is caused by the actions of others; including HCPs, the 
healthcare system, family, friends or community. 
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Surplus Suffering inflicted by HCPs in clinical care 
 
The most moving story I listened to during the interviews was the multifaceted story 
of Surplus Suffering incurred by Joy for most of her childhood and then continuing 
into her adult life. As a small child Joy endured mysterious burning sensations which 
interrupted her sleeping patterns and stopped from her enjoying play with other 
children in her small country town. Joy’s Surplus Suffering began when her parents 
never believed Joy’s pain and neither did doctors when her mother eventually took 
her to be assessed. The Surplus Suffering lay in the emotional pain in this case of 
being ignored, rather than the physical pain. Additionally, Joy’s mother had been 
labelled as having Munchausen syndrome, a form of factitious disorder listed in the 
DSM-V (APA, 2013) where people exaggerate or create symptoms to seek medical 
attention and assume the patient role. Growing up in a small rural community this 
was a difficult label for Joy to avoid. Her pleas for help were not taken seriously and 
intense pain and sensory symptoms were not investigated further. Even when Joy 
suffered a form of sudden dyslexia at age 16 and in just a few months plummeted 
from an A level student to failing school, she was still not believed; not by parents, 
not by teachers nor by HCPs. This pattern stayed with Joy into her adult life as she 
suffered various neurological complaints over the years (such as blindness, deafness, 
stroke-like symptoms) but was never investigated properly by her HCPs, often 
refusing her requests for further specialist referrals or investigative testing. 
 
The doctors really weren’t interested, they just didn’t believe me…they thought I was 
a fruit loop, they thought I was crazy. Joy line 360 
 
They just thought I was crazy and they weren’t remotely interested and it didn’t help 
that my mother…they treated her like she was a Munchausen’s mother…they thought 
she was crazy, so I went to the doctor and said “I’m sick”…they thought…they 
believed this is the child of the Munchausen’s mother, well of course she’s going to 
be a hypochondriac…I didn’t even get any tests or anything. Joy line 369  
 
I went deaf and my right leg dropped and right arm…but again he wouldn’t send me 
for tests to see if I’d had a stroke…and I thought you’re frigging joking! My right 
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side had dropped and you’re not willing to do any tests on me? I just…despair…it 
nearly broke me. Joy line 403  
 
Kate, highly educated and with experience in the medical and scientific field, sought 
neurological medical attention after sudden episodes of blindness could not be 
explained. Over 25 years prior to our study interview, Kate recalled her first visit 
with the neurologist when she was told her likely diagnosis was MS. Kate had no 
knowledge of the disease at that point in time and struggled greatly with the abrupt 
delivery of the diagnosis, leading to extreme Surplus Suffering in the many years 
since. There was no follow-up education and no chance to ask more questions at that 
consultation. 
 
He says “you probably have MS”…he turns around and goes to me “and you may 
end up in a wheelchair and you will probably be blind in five years time”…I looked 
at him and thought, five years…I said I’m only going to be twenty seven and I’m 
going to be blind? And I was a mess…he gave me antidepressants to get over it and I 
thought…Oh, this can’t be happening to me. Kate, line 243 
 
Davina’s experience of Surplus Suffering was also the result of the news of her 
diagnosis when it was revealed to Davina at the foot of her bed in a full hospital 
room shared by others. The doctor was presumably unaware of her family history. 
Davina had an uncle who had been hidden away from family and society with his 
MS, his physical disability instead explained to others as being the result of an 
accident and head injury. Davina was left devastated with no offer of follow-up care 
at that point and cried during the interview as she recalled this experience. 
 
He stood at the end of the bed and said it’s probably 99 percent definitively MS 
because you fit the age, your sex and your symptoms are very textbook…so I suggest 
to you that you think of your future and perhaps if children was something you were 
looking forward to, it might be something you think about now, because better to be 
a disabled younger mother than a disabled older mother…I was distraught…there 
was no-one to go to really. Davina line 471 
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In the area of power, dominance and medical interaction, the doctor-patient 
relationship has traditionally been viewed as an area where doctors exercise power 
over patients (Pilnick & Dingwall, 2011). In recent years this has been addressed in 
medical training programs, but research on whether there is a positive impact on a 
more patient centred approach having a positive impact on health outcomes has not 
been established (Jaen et al., 2010; Lee & Lin, 2010). One extreme model of the 
doctor-patient relationship is paternalism, where the doctor makes all the decisions 
without patient input (Goodyear-Smith & Buetow, 2001). In some ways, recent 
advances in medicine (such as the introduction of the more efficacious RRMS DMTs 
in the last decade) discards the whole person and concentrates on a list of scan results 
and blood tests (Aitini et al., 2014). This feels especially true of RRMS where the 
new DMTs dictate careful and prolonged scan and results monitoring, perhaps at the 
expense of a closer doctor-patient relationship. MS HCPs must be mindful to 
maintain a balanced, individualised and holistic approach. Relationships between 
doctors and patients with MS are particularly complex (Burnfield, 1984).  
 
However, more recently it has been suggested that proper disclosure with effective 
communication requires discernment, tact, timing, flexibility, responsibility and 
sustained attention to the particular needs of the patient as a person in their own, 
unique context (Krahn, 2014). Studies have also shown that getting clear information 
can help reduce patient anxiety and distress with suspected MS, at all stages of the 
process (Heesen et al., 2004; Kopke et al., 2012). This means that the consultation 
where a diagnosis of MS is revealed should be planned thoughtfully with adequate 
time for preparation, a discussion of the likely diagnosis and planned treatment 
options, sources of support for afterwards, time for questions from the patient and a 
planned date for a follow-up appointment. 
 
The paternalistic delivery of diagnosis and prognosis experienced by both Kate and 
Davina affected them negatively for many years. Kate immediately decided not to 
consult further with that particular neurologist and was fortunate to find a new 
specialist she was able to talk to about her concerns, listen to her questions and 
consider her feelings. However, she still felt anger and resentment for many years 
after her encounter. A gentler approach with Kate that took into consideration her 
specific context of being a 22 year old balancing terrifying symptoms, full time 
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work, mothering and part time university study may have ameliorated many years of 
Surplus Suffering and given Kate opportunities to manage her feelings. Davina still 
retains the emotional scars of the day her diagnosis was revealed to her, crying and 
emotional as she recalled the story from almost three decades ago. Similarly for 
Davina, realisation from the doctor of her previous life experience with MS in a 
close family member may have resulted in a gentler, more compassionate delivery of 
her RRMS diagnosis. 
 
Studies have shown the importance of the physician-patient relationship to patients 
and the effect this relationship has on long-term adherence to therapies and lifestyle 
prescriptions (Koudriavtseva et al., 2012). In a disease such as RRMS, regular and 
consistent adherence to DMTs are essential to gain disease control and prevent future 
disability (Bruce & Lynch, 2011). A recent study of 97 people with “mild” MS using 
mixed methods of interviews and questionnaires, explored the physician-patient 
relationship and determined that patients with MS sought a close relationship with 
their doctor and more disease related information. On the other hand, sources of 
dissatisfaction included poor management of diagnosis, unavailability and poor 
accessibility, low levels of psychosocial support and a lack of information 
(Koudriavtseva et al., 2012). Furthermore, Mead and Bower (2002) identified five 
dimensions essential in a patient centred approach; a biopsychological perspective, 
viewing the patient as a person, sharing power and responsibility, practicing 
therapeutic alliance and also viewing the doctor as a person. Unfortunately, in the 
stories of Joy, Kate, Davina and Paul, they all believed that their biopsychological 
position was ignored, they were not viewed as individuals, they were given no power 
or access to shared decision making and no exposure to therapeutic partnership. 
Their care (in the stories discussed in this theme) was not patient centred and lacked 
information and support. 
 
Surplus Suffering inflicted by brush-off 
 
The concept of brush-off was explored in the first theme Piecing Together the Puzzle 
as study participants reported feeling ignored or dismissed by HCPs in the early days 
of their quest to identify the cause of their symptoms, in the lead up to a diagnosis of 
RRMS. As part of piecing together the puzzle, the concept of brush off was anchored 
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strongly in that theme. However, it is definitely also a form of Surplus Suffering and 
also belongs in this theme to tell a story of the emotional pain induced by the refusal 
of HCPs to take symptoms seriously, to investigate symptoms further or to trivialise 
symptoms. All of the participant stories and quotes from feeling brushed off as a part 
of Piecing Together the Puzzle also belong here in Surplus Suffering. Rather than 
repeat them, I will acknowledge their strong links as a form of Surplus Suffering, and 
also add some other instances where brush off figured strongly in participant stories.  
 
Participants Davina and Susan have both served long careers as HCPs, and were 
impacted by Surplus Suffering directly from the nurses looking after them during 
inpatient hospital stays during severe relapses of MS. Both of these cases happened 
many years prior to the study interviews, but were still as real and distressing to 
Davina and Susan when I interviewed them. They have never forgotten what they 
felt as being abandoned by fellow health professionals when they needed them the 
most, the Surplus Suffering exacerbated by the fact this was from a profession they 
valued as caring and kind. 
 
Davina worked at the same hospital where she was admitted as an inpatient and tells 
how the nurses secluded her in the furthest room from the nurse’s station, causing 
her to feel isolated and alone at a time of intense vulnerability. Recalling her 
memories of what happened induced distress and she cried as she remembered how 
she felt. 
 
They put me in the end room and the nursing staff on the neurology ward avoided me 
because I don’t think they wanted to face me, that was very, very obvious…how do 
you treat someone who has just been given the worst news of their life...of which they 
didn’t understand either. Davina line 511 
 
When Susan was an inpatient following a severe relapse, she recalls feeling 
desperate for support in the middle of the night but received no compassion or 
guidance from the nurses looking after her.  
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I was scared and I was crying…and the nurses kept coming in and doing obs…I 
couldn’t sleep and I said to the nurse, I’m very, very scared…I don’t know what’s 
going on”…there was no support. Susan, crying, line 280 
 
As explored in Piecing Together the Puzzle, Susan’s GP would not refer her on for 
tests or to see a specialist despite her neurological symptoms and requests. Although 
the GP has since apologised to Susan, the impact of the Surplus Suffering from his 
disbelief of her symptoms remained with her and were expressed during the study 
interview. 
 
To acknowledge what I was feeling that’s all I wanted…and I was angry when it all 
started with my GP not listening to me…I accept his apology but he needs to listen to 
his patients, people know their own body. Susan line 1008 
 
Surplus suffering inflicted by HCPs in research care 
 
Paul’s story has significant implications for poor clinical research conduct but also 
for compromised care and Surplus Suffering. Paul had been carrying around the 
emotional scars from a consultation encounter with a neurologist, not telling anyone 
else about it until our interview, and carrying the burden of Surplus Suffering for 
several years. At the time of the Surplus Suffering encounter, Paul was already under 
the care of a neurologist he trusted and who had recently diagnosed him with RRMS 
(after several years of Piecing Together the Puzzle) and was about to start his first 
DMT in a few weeks. In the wait time before his next follow-up appointment he 
suffered a further relapse and was admitted to the emergency room of a local 
hospital. He then saw a different neurologist who provided emergency treatment and 
advised a follow-up appointment to check Paul’s progress a week later. As Paul had 
very little experience with the medical and hospital system, he was unsure of the 
correct etiquette in this situation and agreed to attend the appointment. Upon arrival 
to his consult with the emergency room neurologist, Paul was ushered through to 
another room, unfortunately apart from his wife who had accompanied him. The 
neurologist asked if he would like to begin a DMT soon, Paul answered that he 
would, and within minutes Paul recalls that he was signed up to a new clinical drug 
trial without explanation and without the chance for him to ask why. The neurologist 
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told him that the nurse would explain it all to him later. Unfamiliar with MS clinical 
care and procedures, Paul felt bullied into signing the papers and assumed that he 
would be given better explanations later. However, this did not happen, leaving Paul 
feeling angry and taken advantage of.  
 
I said “what’s going to, what’s this all about? and he says “Oh well, we can go over 
all of this later on but what I want to know is to see if you would like to start 
treatment today or in the near future?”…and I said “well, you know, obviously I 
want to get onto something, but what does that mean? ” And he says “Oh well, OK, 
I’ll take you out to the nurse out the back and we’ll get you enrolled in this 
trial”…and I’m thinking…what is this? what is this?...And so, ten minute consult 
without anything…what the hell is going on?”…he stood up…he went and stood at 
the door, just under ten minutes to usher me in and out…it was quite horrific in 
hindsight. Paul line 250 
 
Not once through that whole episode did he do any neurological test, you know, 
tapping a knee and all that sort of stuff…and that would at least be baseline stuff that 
you would be doing? …I was worried about what sort of results were coming out of 
this thing…you’ve got to treat these things very seriously. Paul line 371 
 
Despite his misgivings, Paul completed the twelve-month trial commitment as he 
didn’t want his efforts and time already spent to be in vain. I asked Paul why he 
continued in the trial and returned for follow-up visits when he felt so violated. Paul 
recalled how his background in science encouraged him to complete the research 
trial for altruistic reasons (for others rather than himself) and he was pleased that he 
did so, despite the personal cost to his piece of mind continuing to be regularly 
exposed to the neurologist who he believed was the cause of his Surplus Suffering. 
This was made easier by the fact that Paul rarely ever came across him at research 
visits; ancillary research staff seeing Paul for most of the trial assessments.  
 
I wouldn’t have gone through it other than thinking you know…if I can help in some 
way because bloody hell, I don’t want anyone else to…or I would want other people 
to be helped as well. Paul line 408  
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As a researcher in clinical trials for many years I was horrified by Paul’s story, but 
more than that, I was affected by the degree of Surplus Suffering this act of disregard 
for clinical guidelines had on Paul. He tensed up when discussing it, his fists became 
small balls, he became red in the face and the anger surfaced as he became emotional 
recalling the day the Surplus Suffering began. Paul’s basic right to autonomy was 
violated, he was not provided with the appropriate information to make an informed 
choice. In fact, all four of the general principles of international research ethics were 
violated in some way: beneficence (the welfare of the patient comes first), non-
maleficence (do no harm), autonomy (independence, in charge of self) and justice 
(fairness to patients).  
 
What’s happening?  Unravelling the cause of Surplus Suffering inflicted by 
healthcare and preventing Surplus Suffering 
 
All of these encounters have shown areas where HCPs have let their patients down in 
some way and even though most likely (and hopefully) this has not been intentional, 
the Surplus Suffering has been felt for years and sometimes decades afterwards. A 
research study looked at the evidence for quality care encounters alleviating patient 
suffering (Arman & Rehnsfeldt, 2007). The authors found, that similar to other 
research, healthcare encounters may actually increase suffering rather than alleviate 
it (Arman & Rehnsfeldt 2007; Clarke & Fletcher, 2005; Wiman & Wikblad, 2004). 
Findings also showed that the basis for this suffering was essentially neglect; patients 
were not seen as whole human beings and their suffering was not noticed by the 
HCPs. The stories described above certainly fit this category and highlight situations 
where kindness and compassion from medical and nursing staff could have 
potentially changed the journey for these PwRRMS. 
 
Compassion has been defined as understanding or being aware of another person’s 
suffering and acting to end this suffering (Crawford et al., 2013) and has been 
described as an important part of the ethos of nursing (Bradshaw, 2011). 
Papadopoulos and Ali (2016) explored compassion in nurses and other HCPs in an 
integrative review and found several overarching themes as the main components of 
compassion These included being empathetic, recognising and ending suffering, 
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being caring, communicating with patients, being competent, connecting to and 
relating to patients, and involving the patient in their care.   
 
Similarly, “turning toward” is a concept in medicine which involves recognising 
suffering, becoming curious about the patient’s experience and intentionally 
becoming more present and engaged (Epstein & Back, 2015). Turning toward is 
about being authentic, emotionally available and engaged, intentionally tending to 
the immediacy of the patients experience even when the suffering is horrific and 
troubling.  Expressing loyalty, honesty, shared humanness and non-abandonment to 
patients can be shown through caring actions, taking an extra minute or two, calling a 
worried relative, choosing words carefully and caring gestures (Epstein & Back, 
2015) and can be long remembered by the patient after the visit.  
 
Suffering occurs when an individual feels voiceless, when their suffering is unheard 
or when they cannot give the words around an experience (Ferrell & Coyle, 2008). 
When nurses ask questions and act as confidants for patients, they can aid relief from 
suffering and reduce physical, emotional, social and spiritual distress (Ferrell & 
Coyle, 2008). Several participants who recalled experiences of Surplus Suffering in 
the study interviews contacted me afterwards to say that they felt better for having 
told “secrets” about their previous care and that they now felt more optimistic about 
the future. Paul told me that he could now “let go” and move on from his previous 
bad experience of research in MS care (which he felt was now due to his “good” 
research experience in the current study) and Joy was equally as happy to have been 
able to tell her complete story to someone who listened and engaged. I feel humbled 
that this research study was able to be a catalyst for such positive change. The degree 
of (often silent) Surplus Suffering experienced by these individuals was distressing at 
times to listen to, but helping participants to regain some optimism and trust in MS 
HCPs is extremely fulfilling.  I felt that the simple act of telling me their life history 
and exploring their feelings helped each participant to move forward with positivity 
and hope, despite this not being a specified aim of the study.  
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Surplus Suffering inflicted by family, friends and community 
 
In a seminal paper on the lived experience of RRMS, Miller (1997) reported a theme 
of conflict arising as a result of RRMS in two ways; the first was conflict with HCPs, 
particularly physicians regarding the diagnosis of RRMS or explaining the disease, 
as described in the three subthemes discussed above. The second area of conflict 
involved study participants reporting considerable conflict within their own family 
(Miller, 1997), a concept that was also experienced by some of the participants in the 
current study. 
 
Joy continued to suffer greatly, not just from the Surplus Suffering from HCPs 
already discussed, but also from people she loved. When she was 16 years old and 
suddenly became blind to typed text (a form of dyslexia) she was not believed by her 
family or teachers.  
 
No-one believed me, my teachers didn’t believe me, my parents didn’t believe me, I 
wasn’t taken to the doctor, no-one believed me, no-one cared, no-one did anything 
about it, nothing…you are lazy, stupid, ridiculous. Joy line 57 
 
Joy’s second husband worked in the healthcare sector, his championing her search 
for a diagnosis and health care connections had been integral to Joy finally being 
diagnosed with RRMS after decades of undiagnosed symptoms. However, he 
showed no compassion in relation to Joy’s RRMS symptoms and disability. Joy 
recalls him forcing her to take more medication when she was already showing signs 
of drug toxicity, something she feels that he would have identified as a HCP. It took 
Joy some time to realise what was making her feel so sick, finally getting herself to 
hospital and being diagnosed with valproate toxicity (a drug used to treat epilepsy as 
well as nerve pain) from overdosage.  
 
Over a number of years I ended up going on Copaxone® injections as well as 
Epilum…I ended up having this huge, huge reaction, I blew up to three times my 
normal size…Epilum toxic and the Copaxone®. Joy line 694 
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He did this twice during our marriage…but I figured out it had to be medication 
induced…He would put the tablets in my mouth and I would pretend to swallow them 
and then I’d spit them out…that’s what got me better and then I would drive myself 
to the hospital…I don’t think he necessarily wanted me to die…I don’t know…I will 
never know. Joy line 743 
 
On a separate occasion Joy’s husband forced her to continue to work as she battled a 
severe relapse, not allowing her to take sick leave (which would have been unpaid) 
and pushing her to breaking point.  
 
I’m so sick and I can’t work and he was…”absolutely not, you have to go to 
work”…I was just heartbroken, I kept going but my legs went on me and I started 
walking with a cane because I was really struggling to walk…and then I lost my job 
because I wasn’t doing my job, so while my husband was screaming at me “you have 
to go to work”, I lost my job, so I couldn’t go to work. Joy line 859 
 
The impact of Surplus Suffering from Davina’s immediate and extended family 
brought tears to her eyes as she recalled the unkindness inflicted by her family over 
many years. This happened initially at diagnosis when her mother and father’s 
families argued openly over whose fault it was genetically that she had developed 
RRMS. This caused extra angst at a time when Davina desperately needed support. 
Later, her (now ex) husband did not engage with Davina and she felt at the time that 
there really wasn’t anyone else to go to or confide in. He treated Davina and her 
RRMS symptoms with contempt and also encouraged their children to do the same. 
Additionally, Davina’s sister-in-law accused her of taking away attention from other 
family members because of her RRMS. 
 
The problem is… because my husband didn’t want to know, he never shared it with 
them (our children)…he never was supportive of me…so then it became them against 
me…so if I lost it or I got really tired, I’ve got MS or whatever, don’t stress me so 
much, they’d turn around and say “Oh, don’t pull that MS card again”…he would 
never defend me, he’d never say “don’t you speak like that to your mother, she’s got 
a condition”…and that went on for years. Davina line 1264 
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She (my sister-in-law) said to me that you use your MS as a crutch and said your 
parents give you so much more attention and provide far more to you then they do to 
your brother…and out of that came the greatest reign of jealousy…how could 
someone say that to me? Davina line 1778  
 
MS Nurses managing Surplus Suffering 
 
The three important questions that arise from this data and discussion are firstly, how 
can MS Nurses ensure that they aren’t the perpetrator of Surplus Suffering? 
Secondly, how can Surplus Suffering in the PwRRMS be managed in a way that may 
lead to healing and enhanced nursing and medical care for the future? And thirdly, 
how can MS Nurses educate others (HCPs and family/friends/community) on how to 
avoid inflicting Surplus Suffering on PwRRMS? 
 
Empathic nursing and “going the extra mile” may be the key to setting up better 
outcomes for the PwMS in the future (Davies, 2014).  The word empathy comes 
from the Greek empatheia meaning physical affection or passion, but shares its roots 
with pathos, which means suffering (Stueber, 2011). Unlike sympathy, empathy goes 
beyond merely acknowledging suffering. When a nurse truly practices empathy with 
a patient, they share the patient’s struggle and feel their pain (Davies, 2014), 
allowing the nurse to interact on the same emotional level as the patient and helping 
to establish trust (Ward, Cody, Schaal, & Hojat, 2012). Four components of empathy 
have been conceptualised by Morse’s group in a model to provide insight into 
developing and expressing empathy (Morse, Bottorff, Anderson, O’Brien, & 
Solberg, 1992). This includes consideration of moral empathy (unconditional 
acceptance of another human being when encountering their suffering), cognitive 
empathy (sensing what another human is thinking), behavioural empathy (nonverbal 
communication to convey understanding such as a smile or head nod) and emotive 
empathy (perceiving and sharing the patient’s feelings) (Morse et al., 1992). These 
empathic qualities should be mindfully considered by MS Nurses at every step of the 
life journey for PwRRMS.  
 
By embracing holistic care and practicing empathy with PwRRMS, the MS Nurse is 
in the ideal position to establish a relationship of trust, taking into consideration the 
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vulnerable state of the person who may have experienced Surplus Suffering in the 
past and may continue to live with it. Discussing past hurts, past compromised care, 
past disappointments and perceived let-downs can help build a bridge to the future 
based on common goals and realistic expectations, improving care effectiveness. 
This does not mean that the MS Nurse ridicules or supports past care or injustices, 
but that they listen closely to the patient stories, reflect and validate the patient’s 
feelings to enhance mutual respect and understanding. Patients can also find meaning 
in suffering through personal growth (Pollack & Sands, 1997), if we, as engaged MS 
Nurses are courageous enough to guide them. 
 
The challenge for MS Nurses is to foster an atmosphere where patients realise that 
finding meaning in their suffering is a possibility and they may gain skills to help 
them in current and future situations (Pollack & Sands, 1997). MS Nurses cannot 
always alleviate suffering, but can listen, support, show kindness and compassion 
(Deal, 2011) and create a safe, empathetic environment in which patients can heal 
and gain strength. As Helen Keller reminded us in the opening quote to this theme, 
suffering can strengthen the soul, and as MS Nurses, part of our mission is to find 
strength and lend strength until the patient finds their own. To help patients 
understand the place of Surplus Suffering and to help them to heal. 
 
The following theme of “High (In)Visibility” explores some of the reasons why 
Surplus Suffering may have occurred in the first place; the occurrence of many 
invisible symptoms in RRMS, symptoms which cannot be easily seen or understood.		
	 248	
Theme 5:” High (In)Visibility” 
 
But you look so well, are you sure that’s what you have? 
Of course I’m sure, I didn’t make this up for attention 
Attention I don’t want and don’t need 
Maybe if I just hide in the corner and work hard you won’t notice 
You’ll forget  
And then I’ll never have to try and explain 
I’ll never have to tell you I’m not the same 
That I’m different to you 
That I’m different to me 
So I hide, I keep secrets 
I hide symptoms I can’t really make clear 
I pretend, I pretend I am the normal person you think I am 
I am normal 
But if I am normal, why do I feel so wretched 
So strange, so unknown to me 
 
I wish I could take you on a journey 
A journey through my body 
Through the sensations, the weird noises 
The sharpness of pain and the prickles 
The feeling of not being able to move even though I do move 
Of looking normal to you but feeling like a log to me 
Of fogginess and clouds 
Of tiredness and misunderstandings 
Not quite here, not quiet there 
Not quite anywhere 
TB 
 
For the purposes of this study, I conceptualised invisible symptoms as symptoms 
which cannot be seen by others. Invisible symptoms are very commonly experienced 
by PwMS (Ben-Zacharia, 2011) and were experienced by all participants in the 
current study at some time in their life journey with RRMS. Invisible symptoms in 
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RRMS are numerous and include fatigue, mental health issues (including mild 
depression and anxiety), sensory symptoms and pain (pins and needles, tingling, 
burning), mild cognitive dysfunction (thinking and memory issues), mild sexual 
dysfunction, mild bladder and bowel issues (urge incontinence, constipation) and 
visual disturbances (blurred vision, colour loss).  I have used the descriptor of “mild” 
in some of these invisible symptoms, because there are more noticeable features by 
others in the case of moderate to severe classifications. Additionally, invisible 
symptoms represent an extra layer of invisibility and complexity because PwMS 
reluctantly discuss them and MS HCPs may not enquire about them (Lysandropoulos 
et al., 2015). This may be related to lack of time in a consultation, inability by the 
patient to express the symptom or to understand its connection with RRMS, or 
perceived inability to treat the invisible symptoms by the HCP.  
 
The central organising concept of this theme is the presence of invisible symptoms 
and their impact upon life with RRMS. Invisible symptoms may cause chaos with 
activities of daily living and may also cause misunderstandings with others, but on 
the other hand they can also provide a refuge from chronic illness and the struggles 
that MS brings. The fact that invisible symptoms are invisible can have both 
undesired and desired effects, sometimes leading to conflicting feelings in the same 
person about the same or other invisible symptoms. Some study participants suffered 
greatly from the effects of invisible symptoms in their lives, but other participants 
held on to the welcome cloak of invisibility protecting them.  
 
There are three subthemes to High (In)Visibility; striving to make the invisible 
visible (please see me), reverse stigma (when my MS isn’t enough for you) and 
invisibility as a welcome cloak (the downside has an upside). The subthemes are all 
linked by concepts of invisibility but all had different effects on the lives of the study 
participants, clarified further by sub-subthemes.  
 
Understanding the impact of invisible symptoms 
 
Invisible symptoms are not peculiar to RRMS, it is well documented that invisible 
symptoms exist in many other chronic diseases, such as mental illness (Jackson, 
2015), systemic lupus erythematous (Brennan, 2016), fibromyalgia (Cunningham & 
	 250	
Jillings, 2006; Parsa et al.,  2015), Parkinson’s disease (Hermanns et al., 2013) and 
heart failure (Whitehead et al., 2017) to name but a few. It has been suggested that in 
living with invisible symptoms, PwMS may feel that they are not being seen heard or 
met properly in the social environment (Lohne et al., 2010). Most people would 
identify a PwRRMS as someone who has significant overt disability and possibly 
using a wheelchair to ambulate. The idea of a PwRRMS functioning at a high level 
with no outward signs of disability at all, but claiming to have significant unseen 
symptoms, may cause issues for the understanding of MS in the wider community.  
 
In a German MS registry study report (involving over 18,000 PwMS of all MS types) 
20% of PwMS lost work capacity due to invisible symptoms despite being able to 
mobilise independently (Stuke et al., 2009). The impact of MS on quality of life is 
also emphasised by the high number of persons in the registry who suffered from 
invisible symptoms (notably fatigue, cognition difficulties and mood disorders), both 
in the early and the late stages of MS (Stuke et al., 2009). The invisible symptoms of 
MS, often combined with the difficulty in communicating these invisible symptoms 
to others, can often cause inattention towards the disease and ignorance (Grytten & 
Maeside, 2006). It must also be remembered by HCPs that invisible symptoms can 
often be more distressing to PwMS than visible symptoms (White, White, & Russell, 
2008), even if they are not brought up and discussed.  
 
Study participants discussed both positive and negative qualities about living with 
invisible symptoms, some aspects were complicated for them to understand and often 
involved more than just the symptoms. For example, Kate was appreciative that she 
could keep her symptoms of RRMS invisible at work where she had not widely 
disclosed her diagnosis, but what she wasn’t counting on was the fact that her DMT 
side effects were threatening to give the secret away. The side effects from her 
interferon treatment, including flu like side effects, temperatures and fatigue led to 
people at work wondering “why is she so sick all of the time?”. Kate couldn’t 
explain to them the reasons why as she did not wish to disclose her diagnosis.  Rudi 
lamented that her husband didn’t realise that she suffered invisible symptoms 
everyday and preferred to keep it to herself; she didn’t wish to talk about invisible 
symptoms as she felt this gave them and her RRMS some sense of control. Paul gave 
an example of an invisible symptom he found it difficult to explain to others, he 
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didn’t really understand it himself, but he felt it everyday for months before the 
symptom remitted.  
 
It’s like a cloud…I was sitting on a cloud…I don’t understand…it’s really hard to 
describe…a very, very weird feeling and I could sense there is something not right. 
Paul line 78 
 
Balancing whether to tell or not to tell others about invisible symptoms was 
individual for each participant and each decision had consequences, either for telling, 
or against telling. On the one hand, participants wished to have invisible symptoms 
understood, but on the other hand, to disclose the invisible symptoms might mean 
disclosing the diagnosis of RRMS as well, which was a big step for some. Others 
disclosed the invisible symptoms but had their experiences devalued as their RRMS 
was deemed to be not severe enough. Some participants were glad their RRMS 
symptoms were (mostly) invisible as they could continue hiding their diagnosis 
whilst getting on with life. The subthemes of High (In)Visibility will explore these 
concepts in more detail. 
 
Striving to make the invisible visible 
 
Research into another autoimmune illness with predominantly invisible symptoms, 
systemic lupus erythematosus (SLE or lupus), revealed that others were disbelieving 
of the diagnosis because the participants looked so well and normal, leading to 
feelings of psychological invalidation and loneliness for the person living with the 
disease (Brennan & Creaven, 2016). The researchers also discovered that this lack of 
meaningful sympathy extended past family and friends to include HCPs and GPs and 
these experiences may then have deterred participants from disclosing their diagnosis 
to others or from seeking support afterwards (Brennan and Creaven, 2016). As 
discussed in the preceding two themes Battling the Demons and Surplus Suffering, 
similar situations also applied to PwRRMS, with several participants in the current 
study experiencing invalidation from HCPs and GPs, and for some participants such 
as Piper and Joy, this was a repeated occurrence. Several participants in the current 
study also experienced similar feelings of disbelief, invalidation and loneliness from 
family, friends, work colleagues and the community. 
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Please see me 
 
Living with an invisible chronic illness raises questions of illness validity where no 
evidence can be seen by others (Moore, 2013) and is challenged significantly if the 
disclosure of the illness produces no visible support (Moss & Dyck, 2002). Doubts 
regarding symptom severity can be raised by family, friends, work colleagues and 
also by doctors and other HCPs, significantly impacting on identity and self for the 
PwMS (Skar et al., 2014). In addition, the lack of proof for such invisible symptoms 
as fatigue and sensory dysfunction can lead to others punishing the PwRRMS for 
being lazy, malingering and lacking credibility (MacAllister et al., 2009). Many 
participants in the current study were the recipient of doubts by others on the severity 
of their invisible symptoms, were not believed or brushed off and felt unsupported in 
their claims.   
 
Struggling to come to terms with the diagnosis of RRMS diagnosis herself, Susan 
wished her friends and family could better understand her invisible symptoms, so 
that they could truly understand her difficulty. Susan took them along to her initial 
education meetings at MSA, believing that if they attended and learnt about the 
disease that they might be able to relate to her invisible symptoms such as severe 
fatigue and sensory loss. 
 
I took a couple of girlfriends and Mum…just so they could understand what was 
going on because…they see me as I’m OK they don’t know what’s going on 
inside…so I wanted them to understand. Susan line 498 
 
Evie disclosed her diagnosis of RRMS in the workplace early on in her journey and 
had worked with the same group of work colleagues in a senior role for many years. 
She organised for someone else with RRMS to come into her workplace to talk about 
what it was like to live with invisible symptoms in an attempt for her work 
colleagues to appreciate the daily struggles she encountered. Evie felt it helped to 
provide greater understanding of her situation in her workplace, and it was beneficial 
that a stranger (rather than herself) did this introduction.  
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I wanted them to see somebody else other than me. They see me, they see me well, 
but they don’t see me, they’ve never seen me bad. I wanted them to see something 
different to me…and they were absolutely floored…most of that I have suffered at 
some point and some I go through on a daily basis. Evie line 26 
 
Margot cleverly devised a way of protecting herself in crowds when she was affected 
by invisible symptoms such as dizziness, finding a way to alert others to stay clear 
and keep herself safe from being knocked over or falling. 
 
People (in crowds) don’t know you might be a bit rocky, so you have to be very 
careful…I take that (a walking stick) with me and it made such a difference, even 
though I wasn’t using it to help me…people thought straight away, oh there’s 
something wrong with her…I’ll be careful around her, which is great…that was a 
very good tool…so even though it wasn’t assisting me walking, it let other people 
know. Margot line 1969 
 
For Davina, a constant struggle was having her invisible symptoms seen and 
appreciated by others, she wished there was some outward physical sign to alert them 
of her severe fatigue.   
 
The hardest part for me is when I don’t feel a hundred percent…I wished I suddenly 
developed little green spots or something would happen to me where people would 
say “Oh, she’s not great”. Davina line 786 
 
Exposing the “secret one”  
 
Sexuality, in particular, is an invisible symptom which has been significantly 
neglected in literature and is often neglected in MS consultations (Esmail, Munro & 
Gibson, 2007). Griff openly discussed what he referred to as “the secret one”, the 
invisible symptom “nobody wants to really talk about”, sexual dysfunction in MS. 
Griff discussed how the concept of sexual dysfunction is hard for HCPs to hear, hard 
to talk about by patients, hard to treat by doctors and leads to “hushed tones” in MS 
circles and in Griff’s case, led to more questions than answers. Over the years Griff 
had unsuccessfully sought out treatment and assessment for sexual dysfunction. Griff 
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felt that but has been left to deal with it on his own, and felt that his neurologist was 
not skilled in assisting with this symptom or referring him to the appropriate 
resources and personnel to help.  
 
Nobody ever wants to really deal with that (sexual dysfunction), not even me...I don’t 
want to deal with it either, (doctors) don’t want to talk about it…a young fellow me 
(a fellow person living with RRMS) at a meet and greet came up to  and said “what 
about sex?”…it’s all in hushed tones and it’s industry wide I think, nobody wants to 
deal with this…how you express it to your partner, how you even tell yourself that 
you’re not a bad person? Griff line 575 
 
Sadly, Griff is not alone, prevalence reports indicate that 40-80% of PwMS report 
changes in sexuality (Foley, 2010; McCabe, 2004; Redelman, 2009). Sexual 
dysfunction has been found to be associated with depression and reduced QOL and 
to have implications related to relationships, fertility, pregnancy and parenting 
(Delaney & Donovan, 2017). Additionally, it has been suggested that MS HCPs 
often wait for patients to initiate discussions about sexual dysfunction rather than 
bringing up the issue themselves (Gromisch et al., 2016), perhaps restricted by time 
in a consultation or by inability to actually help with the issue. This is an area that 
needs immediate action by MS HCPs to improve assessment, reporting and treatment 
of sexual dysfunction in MS. Interestingly, despite the reported high prevalence of 
sexual dysfunction in males and females with MS, no other study participants 
discussed sexual dysfunction in the study interviews. This may have been for several 
reasons, such as time constraints, embarrassment at discussing sexual health with a 
stranger, importance placed on other issues they wished to discuss first or the fact 
that it was not a concern for them personally, or the fact that it is the “secret one”, 
even in the arena of research. 
 
When my MS isn’t enough: reverse stigma of RRMS 
 
MS has been described as an “invisible employer who hides their needs as a patient” 
and can lead to feelings of silence, belittling and ignorance (Lohne et al., 2010). 
Many participants in the current study with predominantly invisible symptoms of MS 
felt that their disabilities were less important than others with more obvious and 
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disabling MS symptoms such as people using a wheelchair or with poor speech. And 
yet they struggled each day, trying to lead a normal life whilst managing debilitating 
invisible symptoms. The dichotomy about how the PwRRMS feels on the inside with 
invisible symptoms, against how the PwRRMS appears on the outside as physically 
normal, can be difficult to cope with.  
 
One of the surprises to me investigating invisible symptoms with the study 
participants, revolved around the concept of reverse stigma, the idea that as someone 
with RRMS, their MS wasn’t severe enough to be considered legitimate or to secure 
empathy and understanding from others. So, rather than suffering from the stigma of 
a disabling disease, this was just the opposite, it was stigma in reverse. This could 
happen for two reasons, being compared to progressive forms of MS and RRMS 
being viewed as insignificant against it, or being “fobbed off” as unimportant when 
trying to give insight into invisible symptoms to others, because they looked well and 
healthy and not unwell and sick. Both reasons had the same effect, loss of confidence 
and self esteem for the PwRRMS.  
 
Seminal work from Goffman (1963) exploring stigma in illness, reports that 
ignorance from others is an assimilative technique to establish sameness and 
common identity amongst a group. In the case of participants in the current study, it 
had the opposite effect and left them feeling vulnerable and isolated. Experiencing 
others refusing to acknowledge MS is a violation of self and imposes alienation 
(Grytten & Maeside, 2006). A previous study in RRMS has also reported that PwMS 
have been discriminated against for being “too healthy” and have taken advantage of 
the sick role to secure benefit for themselves (Miller, 1997).  
 
I’m not enough of MS for you, devaluing the impact 
 
There appeared to be two distinct sides to stigma in MS described by study 
participants; one of being ignored, or the MS symptoms being devalued or 
undervalued (“reverse stigma”) and the other of having MS over-emphasised and 
over-acknowledged (Grytten & Maeside, 2006). Findings from the current study 
support reverse stigma as being particularly applicable to RRMS, whereas the latter 
possibly applies to more progressive forms of the disease displaying more overt 
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disability, and was not reported by any participants in the current study. Grytten and 
Maeside (2006) also reported that PwMS experienced minimalisation of their illness 
by others, even amongst friends. 
 
Margot struggled with the “filthy looks” people gave her as she parked in the 
disabled car spot close to the local shopping centre and then proceeded to walk once 
she disembarked from the car. For months Margot carefully avoided parking in the 
disabled parking bay, she struggled with her invisible symptoms of fatigue and pain, 
sometimes overwhelming her on shopping trips and making it difficult to walk long 
distances, but she did persevere. One day Margot gave up the fight, put her disabled 
parking sticker on the dashboard and parked in the disabled bay, only to be 
confronted with looks from strangers that she felt conveyed a message to her of         
“ fancy parking there, you’re not even disabled”. Margot went back to struggling 
after that for some time, parking long distances away from the shops rather than risk 
perceived judgement from strangers again. In recent times though, Margot has come 
to terms with the situation and puts herself first. 
 
Davina struggled with acceptance of her invisible symptoms from others, particularly 
hurtful was that her husband and children often did not believe the severity of her 
invisible MS symptoms and openly made fun of her. Davina just wanted to be seen, 
believed and understood. 
 
(I didn’t tell my four kids much) I didn’t want to burden them I suppose…but because 
my husband didn’t want to know, he never shared it with them…never was 
supportive of me…so then it became them against me… if I was…really tired…he 
would never defend me and that went on for years…and then they’d make a joke of 
me…he (ex husband) would undermine me. Davina line 1263 
 
Recently one of Davina’s now adult children recently contacted her after watching a 
documentary about MS on television. As Davina recalled the conversation, tears fell 
down her cheeks as it meant such much to her that finally, her RRMS was visible to 
at least one member of her immediate family. 
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She (daughter) said…”I just watched this documentary on someone who’d just been 
diagnosed with MS and I was unaware of what you must have gone through”…so it’s 
been really hard…it meant that maybe she’d started thinking a little bit about it. 
Davina line 1298 
 
Interestingly, two participants, Susan and Davina, who reported lack of 
understanding of invisible symptoms from close friends, both worked in the 
healthcare profession, as did their friends who failed to understand the difficulties 
they were under fighting invisible symptoms. Perhaps their exposure to more serious 
conditions in healthcare desensitised them to the suffering of their friend, the 
PwRRMS. Davina was particularly surprised that her HCP friends would question 
her invisible symptoms and devalue her severe fatigue levels. 
 
My (HCP) friends would turn around and say “Oh, what’s wrong with you, you can’t 
keep up anymore, you’re getting old?”…and they do it til this day…how dare 
they…and then they’ll try and make me feel better by saying “oh, everybody gets 
tired”…but I said, I don’t get tired, it’s more than that and it can hit me really 
suddenly and I go down like a pack of cards. Davina line 794 
 
For Susan, although she felt that she has already educated her friends about the 
invisible symptoms of RRMS, she felt they still didn’t fully understand the impact 
that invisible symptoms of RRMS could have. 
 
People, they don’t understand…they see you as you’re OK because mine’s only mild, 
but inside…in here, it’s hard to accept and hard to make other people understand 
how you’re feeling…it was hard to talk to friends about and if I did say anything, 
they’d say “Susan, you’re OK, look at other people, you’re very lucky”…so I went 
OK…but I was really sad and thought…well, what about me? Susan line 670 
 
Jane was fundraising for MS awareness and research in an endurance bicycle event. 
The riders were to cycle a long distance in extreme heat and the day prior to the 
event Jane expressed her concern to the organisers that fatigue and Uhthoff’s 
phenomenon (when the body overheats and old MS symptoms reappear from 
previous nerve damage) would be a problem for those with MS in completing the 
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course. Jane requested an earlier start time to avoid the midday heat for herself and 
the fellow MS riders taking part, but this request was refused. Jane was then forced 
to leave the ride without even starting it, causing her to lose the significant amount of 
fundraising money she had been promised to take part in the event. Jane felt that she 
had been shamed for speaking up and verbalising her issues, her invisible RRMS 
symptoms. The irony of the situation is overwhelming, raising awareness of MS and 
MS symptoms in a fundraising event, only to have her own invisible MS symptoms 
overlooked and devalued by the very group that should have the greatest 
understanding.  
 
They thought I was being demanding…it was so disappointing…I said…I have 
MS…I know what it’s like. I had to leave the trip early, it wasn’t possible to do…very 
disappointing, people had sponsored me and I had to tell them I couldn’t do the ride 
for these reasons…I raised a lot of money but I didn’t do the ride like I said I was 
going to…it was so disappointing. Jane line 798 
 
A “pretender to the throne”  
 
Griff’s tale of reverse stigma is as poignant as it is astonishing. As a newly 
diagnosed, vulnerable man diagnosed in his forties with RRMS, he was navigating 
his first MSA meeting and getting to know more about MS and the invisible 
symptoms he had been battling silently for many years. After the seminar there was a 
chance to meet other PwMS. Griff was surprised when the mother of a severely 
disabled and wheelchair bound young lady came over to Griff and verbally 
“attacked” him, accusing him of not having MS and not being serious. This public 
humiliation threatened his newfound confidence, and although he understood the 
reasons behind the reverse stigma, the emotional scars are still borne by Griff today. 
He felt like, and still feels like, a “pretender to the throne” of MS.  
 
Compared to so many other people, I am light years ahead…which brings its own 
problems in fact…I coin the phrase “pretender to the throne”…when I was at a 
welcome to your disease meeting, there was a girl…probably early twenties…and in 
one of those wheelchairs you never really get out of…her Mum’s with her and 
absolutely distraught, saw me and maybe 3 other people chatting…we have much 
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lower damage…and she came over and attacked us…I was upset at the time but I 
wasn’t cranky at her…I’d hate to think what she was going through…(she) had a go 
at me because “what are you? You haven’t got MS!”…that’s always been at the back 
of my mind, that I’m a bit of a “pretender to the throne”. Griff line 532 
 
Invisibility as a welcome cloak: the downside has an upside  
 
Many people living with chronic illness don’t look so different from those healthy 
people around them, and it can be a huge burden to make the invisible visible (Siouta 
et al., 2016). Some PwRRMS decide to keep the diagnosis private and the invisibility 
of many MS symptoms suits them very well.  Previous studies regarding living with 
MS have noted that PwMS often wish to deal with their disease privately (Clair, 
2003) and this may be due to several reasons including stigma, embarrassment and 
(perceived) career advancement. Several participants in the current study were able 
to continue working and functioning at a pre-RRMS symptoms level and were able 
to keep their diagnosis of RRMS hidden from those they did not wish to disclose to. 
However, not disclosing their illness could also expose the PwRRMS to real threats 
of physical and emotional well being rendering PwMS “damned if they do, damned 
if they don’t” in regards to disease disclosure (Vickers, 1997). If they were not sure 
what to do, participants in the current study tended to err on the side of caution by 
withholding the diagnosis and practicing information control. For some participants 
such as Kate, Paul and Jane, this was the great benefit of invisibility; there was 
definitely an upside to the downside. Keeping a diagnosis of RRMS concealed from 
a public that knows little about the disease of RRMS has been previously reported 
(Miller, 1997) and this may help the PwRRMS retain the identity they wish others to 
see and avoid being labelled.  
 
The presence of invisible symptoms could also be seen as a blessing to some 
participants. At times the invisibility of MS symptoms was an added bonus and seen 
in a more positive light, especially when there was reluctance to disclose the MS 
diagnosis to others, such as in the workplace or to extended family or friends. This is 
a form of information control, not just in deciding disclosure just after diagnosis, but 
continually along the life journey living with RRMS. The presence of invisible 
symptoms allowed decision making by the PwRRMS, who received what 
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information, how and when was then up to each individual. Will wished to control 
what his family sees of the disease, especially his wife as she is caring for a new 
baby. Piper also keeps her symptoms from her children, acting as she always has and 
pushing herself to live and look as normally as possible. 
 
The invisible stuff…I hide it from my family…my wife’s pretty fragile, we’ve got two 
children, we’ve got responsibilities…I need to be that strong person. I don’t want her 
worrying about it…she’ll see what’s going on…she just leaves it alone because she 
knows that’s how I deal with it…I keep it to myself. Will line 64 
 
My kids don’t see the impact of MS, I guess they don’t see it because I just…if 
I…stopped every time there was something wrong I would do nothing basically and 
I’m not like that…I’m a do-er…the kids I guess don’t see, a lot of people don’t see 
it…all the symptoms anyway because of my way of day to day living…I will do it…I 
will push myself and I will do it. Piper line 838 
 
Not disclosing the diagnosis and not being “called out” on it led to feelings of 
success in keeping MS hidden, success mainly due to the predominantly invisible 
symptoms. Paul and Kate were both successful in controlling who knew about their 
diagnosis of RRMS in the workplace; Paul also kept the diagnosis secret from his 
many friends and extended family. 
 
Nobody else knows, I much prefer to keep it that way…my wife’s parents don’t know, 
only my Mum and Dad and my brother know…(I haven’t disclosed to any friends) I 
doubt they would think they could catch it…but I don’t know. Paul line 1004 
 
(I was offered a new job and the Boss knew I wasn’t well) but due to invisible 
symptoms he said “no-one needs to know, you can do the job”…and I thought, why 
not? I’d hide my relapses and treatment and it worked quite well. Kate line 590 
 
MS Nurses can educate PwRRMS that it is helpful to have a few close confidants 
they can talk to about their symptoms (invisible and visible) and how they are 
feeling, openly and honestly. The confidant can also help advise on sensitive issues 
such as disclosure and can provide a “sounding board” for feelings. Having a 
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sounding board to practice with can also help improve communication skills and 
provide systems to make it easier to explain invisible symptoms to others. This is 
especially important at the beginning of the journey and many MS clinics will advise 
new patients to bring someone trusted with them to the first few appointments for 
this reason. Becoming skilled at explaining invisible symptoms will take time and 
practice, but is possible with the right guidance. 
 
MS Nurses also need to become skilled at assessing for invisible symptoms in 
PwRRMS and providing opportunities for open discussion and education. Setting 
time aside to discuss fatigue, cognition, pain and sensory symptoms, mental health 
issues, sexual dysfunction, bladder and bowel issues are just as important to the 
PwRRMS as scan results, DMT prescriptions and laboratory tests. Discussing 
invisible symptoms provides the words, phrases and framework to talk to others 
about the symptoms and the difficulties they face. PwRRMS then learn the 
terminology and they discover that the symptoms are understood by others, there are 
reasons for the symptoms and that they are considered genuine. This instils 
confidence in managing the life journey with RRMS.  
 
This final theme of High (In)Visibility concludes chapter 6 of the thesis, Walking the 
Low Road. The skills that have been learnt and practiced by the study participants 
and the things they have learnt about themselves and others along the life journey so 
far has prepared them well as they embark on “Taming the Beast”, the next and 
opening theme to the following chapter , “Finding the High Road”. This really marks 
the start of a brighter future and a time of much personal growth and development. 
This is the time when PwRRMS begin feel a sense of taking control of their lives, 
living with RRMS, not living against RRMS.  
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CHAPTER 7- “FINDING THE HIGH ROAD” 
 
The following chapter “Finding the High Road” outlines the final three themes from 
the data analysis and explores a distinctly different overall feeling from the previous 
chapter Walking the Low Road, where despite some occasional glimpses of 
brightness, there was more a sense of confusion, of negativity, of unanswered 
questions and of battle. Finding the High Road feels exactly like the metaphor it is 
taken from, taking a turn in the road for a higher path, to be able to reach higher 
ground and look down on the muddy waters below. A journey of self-discovery, of 
finding previously unknown talents and gifts, of packing a personal “toolkit” to live 
the best life possible with RRMS. A time of immense personal growth and 
achievement, sometimes noticed by others and sometimes not. But always active, 
always engaging, are the choices in Finding the High Road.  
 
The three themes making up Finding the High Road and their related subthemes and 
sub-subthemes are listed below in Table 5. The only subtheme in this chapter 
requiring elucidation is the sub-subtheme “decisions driven by fear” which is placed 
under the main theme of “The DMT Dance”. This sub-subtheme also relates to the 
concept of fear, which was introduced in the third theme Battling the Demons in the 
previous chapter. However, I have included decisions driven by fear in this chapter 
and theme because it is part of the negotiation of successfully completing The DMT 
Dance and an important element of perhaps later reaching “decisions driven by 
hope”. This sub-subtheme also forms an opposing force to decisions driven by hope 
and for this reason I felt DMT decisions driven by fear and decisions driven by hope 
belonged together for clarity and understanding, both being key components of The 
DMT Dance.  
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Table 7. Summary of themes six to eight of the study findings; demonstrating central 
organising concepts, subthemes and sub-subthemes developed from the study data. 
Theme Central organising 
concept summary 
Subtheme Sub-subtheme 
6. Taming the 
Beast 
Finding tools and 
packing a toolkit to live 
with and manage 
RRMS, the different 
ways that PwRRMS 
regain control of their 
life 
Finding my North Star 
Getting a handle on 
RRMS symptoms and 
relapses 
Maintaining physical and 
mental health and 
wellness 
Choosing my medical A-
Team 
Harnessing support from 
family, friends, 
organisations and 
workplaces 
Riding high on resilience  
 
7. The DMT 
Dance 
Negotiating and coping 
with the medication 
therapies to treat RRMS 
The hardyards: making 
decisions about DMTs 
and adherence 
 
 
 
 
Switching to a better life 
• decisions driven by 
fear (“I’d rather be in 
a wheelchair than 
dead”) 
• decisions driven by 
hope 
8. Holding 
Hands with 
Hope 
Hope and positivity 
about reaching happier 
times and the beginnings 
(or totality) of 
acceptance of RRMS 
into life and how 
looking to the future 
with hope brings its own 
peace and rewards 
Hope in its many forms  
 
 
 
Purposeful positivity  
• functional hope 
• restorative hope 
• curative hope 
• defiant hope 
• optimism and a 
positive outlook  
• searching for meaning 
• harnessing a sense of 
humour 
• faith, religion and 
spirituality 
• giving back and being 
involved 
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Theme 6: “Taming the Beast” 
 
Now I have arrived 
Armed in my combat gear 
I’m taking you on 
Gone is my negativity, my fear 
This time I’m ready 
I’ve read the rules of the fight 
This time I’ll take you 
I’ll show you my might 
I’ve gained so much 
I’ve lived and I’ve learned 
I’m a new person now 
Full of  positivity I’ve yearned 
TB 
 
The theme of “Taming the Beast” represents a turning point for PwRRMS, a time 
where they start to conquer the demons they have battled since suffering their first 
RRMS symptoms, a time where they have gained some experience living with the 
disease and now have some knowledge about what RRMS actually is, and is not. It is 
a time for positive change, for the beginnings of acceptance, sourcing the best 
support, sharing tips, gaining confidence and for recognising the incredible things 
they have achieved since Piecing Together the Puzzle, working on (Re)defining Me 
now that I have RRMS, Battling the Demons, managing Surplus Suffering and 
learning how to live with High (In)Visibility. Taming the Beast brings life firmly 
into the foreground, working to be a person living with RRMS, not an RRMS person. 
Evolution is key to this theme, as the nature of RRMS means that change is always 
potentially around the corner and nothing is static. Adapting to change and living 
with uncertainty has become a major life achievement. 
 
The central organising concept for this theme is packing a metaphorical “toolkit” to 
live with and manage RRMS, the different ways the study participants found to 
regain control of their life. Taming the Beast comprises six subthemes: finding my 
North Star, getting a handle on MS symptoms and relapses, maintaining physical and 
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mental health and wellness, choosing my medical A-Team, harnessing support from 
family, friends, organisations and workplaces, and riding high on resilience. Several 
sub-subthemes will add further clarity and explanation to these subthemes. 
 
Finding My North Star  
 
This subtheme goes beyond the “getting acquainted with MS” subtheme of 
(Re)defining Me now that I have MS discussed, in the second theme of the previous 
chapter. Finding my North Star is after the settling in period, where the initial shock 
or devastation of the diagnosis and the thirst for knowledge or running away from 
knowledge has advanced into more of an acceptance of RRMS. This subtheme has a 
positive feel, in recognition of the qualities this stage has invoked in the participants, 
finding new meaning in life and finding a place where both the person and RRMS 
can cohabit the same body. For some participants, these feelings of regaining control 
were still very new and developing, and for others the sense of control had been well 
established for years prior to the interviews, yet was always constantly evolving.  
 
The North Star, or Polaris, is the brightest star in Ursula Minor. The North Star does 
not appear to move in the sky to the naked eye, remaining fixed above the North Pole 
to mark the way due North (Hirsch, Kett, & Trefil, 2002). The North Star in the sky 
guiding and lighting the path due North captures the sense of PwRRMS finding their 
inner light and a way to move forward in life living with RRMS. Even though RRMS 
was ever changing, the study participants could find their way to their fixed point of 
control, their North Star, to keep travelling in a positive direction. 
 
The turmoil and upset explored and discussed in the earlier themes started to settle as 
education and learning brought confidence, as symptom mysteries unravelled, DMTs 
were commenced and disease control started to become a reality. Although a difficult 
concept for MS Nurses to explain to patients, the simple notion of time assisting 
assimilation with the disease is real. Study participants Paul and Davina describe 
how time can be the friend PwRRMS need, how time helps PwRRMS to understand 
that life can be about more than RRMS, especially with some tools. 
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As time rolls on and nothing happens, you tend to become a little more complacent I 
guess...I’m always a bit cautious, so just a little more planning involved with things. 
Paul line 937 
 
I’m comfortable in my own skin now, I think I’ve accepted wisdom that comes with 
age rather than worrying…I have got a wonderful partner, best friend…we have our 
own quietness. Davina line 1746 
 
Research has identified that several key skills are beneficial to successfully adjusting 
to life living with RRMS. These include positivity, perceived control over life 
situations, self-efficacy in disease management, optimism, hope, benefit finding and 
spirituality (Dennison et al., 2009). Additionally, patterns such as developing 
strategies to combat difficulties, making extra time to manage daily needs and 
avoiding making MS the life focus, begin to develop as confidence and experience 
living with MS grows (Dennison et al., 2010). Several study participants 
incorporated some of these skills into their new existence living with RRMS and 
chose to change their feelings and attitudes about RRMS as a conscious and 
deliberate choice. I conceptualised this as slowly progressing in Taming the Beast. 
Joy contemplates how she chose to look at RRMS in a new light rather than being 
bitter and angry about feeling different to others.   
 
That was my gift…it actually was my gift at birth to be given this brain that didn’t 
function the same as other people’s, so I just didn’t see the world the way other 
people saw it…and it gave me something more to work with…I am blessed. Joy line 
2009 
 
Similarly, Rudi describes how she purposefully changed her attitude to see RRMS as 
a gift in her life and a facilitator for positive change, the chance to finally travel and 
see the world. 
 
As a mother you just get on with it…as hard as it is. I got really angry and obviously 
went through the stages of grief…but by the end of it I actually think of it as a gift 
because it’s made me live my life differently…it’s made me start to travel whereas I 
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would have put that off…I just have a different outlook on life…I tend to care less 
about things now so I view it as a gift…MS is not such a bad thing. Rudi line 835 
 
After initially struggling with what he termed depression for many months, and not 
adhering to his DMT or treatment plan, Will realised he needed to actively make 
some changes to his life to successfully live with RRMS. His life turned around as a 
result and he learnt what he needed to do for himself to secure happiness, finding his 
North Star. 
 
From that point I just said nothing’s going to stop me, I’m sick of being that guy that 
just goes home…I never used to go out I used to go home from work and go to 
sleep…I just said I’m not going to go home and sulk on my own, get up and live in 
circles…so I joined a sporting team, I’d go and play poker with my friends…I just 
lived this active life. Will line 1151  
 
A recent study explored the experiences of 10 PwMS after being diagnosed with MS 
(unfortunately the MS subtype was not defined) and reappraising their lives 
(Flensener & Rudolfsson, 2016). The authors explored feelings about changing from 
a healthy, strong body before MS, to experiencing altered bodily functions and the 
possibility of changes to life activity. Much like the concept of Finding my North 
Star in the current study, Flesner and Rudofsson’s (2016) work revealed that PwMS 
“learn to fly with broken wings” by getting to know their new foreign body and 
“building a new living space” for the body to function. Building a new living space 
took time, requiring adjustment, reappraising and creating new meaning in life, and 
was sometimes uncomfortable. Many participants in the current study displayed 
features of these themes as they partnered with RRMS in a new life, learning to fly 
with broken wings over time. 
 
Susan suffered greatly in the early years of her RRMS diagnosis, and being a HCP 
herself, she was frustrated that she couldn’t seem to make sense of her new MS 
world and make positive progress. For many years she was sad, lonely and deeply 
fearful of what her future life was going to be. Being single, she felt intensely alone 
and that nobody would want to partner her in life with RRMS. One day after a 
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relapse that all changed, Susan decided enough was enough. It was time to find her 
North Star. 
 
What I was looking for was to help myself to be able to understand these little 
demons…to then thinking you are good enough…don’t listen to them...to be strong 
and I could also help others…to just accept it, to embrace it because it doesn’t mean 
the end…that was a new beginning for me. Susan line 773  
 
MS doesn’t make you the person…that’s not you, there were other things before that 
and there’s going to be more things, that’s just there and you deal with it. Susan line 
1299 
 
Coming to terms with the occasional need for wheelchair assistance if her mobility 
was impaired by a relapse or severe fatigue was a huge stumbling block for Margot, 
steadfastly refusing her husband’s attempts to try a wheelchair so that she could still 
enjoy outings and travel. But, once she tried it, she was amazed at the difference it 
made to both their lives and how easy things became now that the stress and worry 
about possible falls was taken out of the picture. Finding her North Star to include 
the occasional use of the wheelchair or walking stick with relapses or severe fatigue 
brought new perspectives for Margot.  
 
It was a real mental block (tearing up)…it’s really hard to do…it’s the elephant in 
the room. The thing is it was so stupid…you do become more accepting…but it was 
fantastic. Margot line 1533 
 
I thought I can’t believe I didn’t do this sooner, it was the best thing…it was the 
initial embarrassment but once I sat the first time…this is fantastic…now I’ll take my 
wheelchair and the girls will wheel me around shopping. Margot line 1701 
 
Starting to see unexpected benefits from situations that previously caused angst can 
be a positive catalyst for change as well. Rudi turned the dismay she felt at not being 
able to work due to her severe MS relapses into a positive as she was able to spend 
more time with her four young children.  
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Whilst it (our lifestyle) may not be extravagant, I’m just doing a lot more and loving 
it…loving it…I look at this as I’m lucky because I get to spend this time with my 
children…whilst it was tough financially, we adapted, as you do. Rudi line 950 
 
Evie took a different approach, yet one that firmly changed her future path to one of 
positivity for not just herself, but for others with RRMS. She began talking to others 
as an MS advocate and sharing her story to change public perceptions about RRMS, 
improving her own outlook on MS along the way. Evie’s North Star was all about 
others and less about herself. 
 
If I’m going to have it I may as well do something with it…that was the way I saw 
it…I want to help others and make a difference, I want people to see people who 
aren’t disabled by MS…it’s not all doom and gloom. You shouldn’t focus on what 
you can’t do, it’s what you can do, what you want to do…yeah it’s going to feel like 
shit sometimes and you’re going to get angry and upset, but you need to pare that 
back and take a different perspective. Evie line 1210 
 
As study participants were able to look back on their journey with RRMS, their MS 
experience generally gave them confidence about how they viewed the disease in the 
future. As discussed in the literature, over time, PwMS tend to develop expectations 
about their disease path, and often with minimal input from MS HCPs in regards to 
prognosis (Dennison, McCloy-Smith, Bradbury, & Galea, 2016). As confidence 
grows, PwMS begin to make more decisions, to make plans and to become more 
actively engaged as their knowledge increases and they regain a sense of control over 
what is happening (Clair, 2003). Taking on a more active role in treatment decisions 
is something that PwMS tend to opt for as they become more educated and engaged 
as the life journey with MS continues (Heesen et al., 2004). This prepares them for 
new challenges on the life journey, guides them in finding their new North Star and 
allows them to start building positivity and hope, which will be discussed in greater 
depth in Theme 8,  “Holding Hands with Hope”. 
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Getting a handle on MS symptoms and relapses 
 
The course of RRMS is characterised by unpredictable relapses interspersed with 
periods of remission from disease activity (Halper, 2007a). Relapses can either be 
mild and barely noticed by the PwRRMS, cause a myriad of sensory and motor 
symptoms, or be catastrophic in their effect causing paralysis, blindness and gait 
disturbances. Although most people living with RRMS usually recover from early 
relapses, some residual effects can remain and over time, relapse recovery tends to 
lessen (Mills, Mirza, & Mao-Drayer, 2017). To add to the mix of confusion and 
unpredictability for people learning to live with RRMS, “pseudo” relapses which feel 
like a new relapse coming on but are not inflammatory in nature, can occur in the 
setting of infection or changes in body temperature (such as with exercise or 
overheating) and can be very frightening to the PwRRMS (Mills et al., 2017). 
Working out the difference between true relapses and “pseudo” relapses takes time 
and experience, none of which are accessible to the patient in the early stages of 
living with RRMS. For most participants in the current study, coming to terms with 
various RRMS symptoms and managing relapses was initially difficult for them, but 
as time passed and with education and experience, their confidence in managing MS 
symptoms and relapses grew as they began Taming the Beast. 
 
After initially being worried about new onset symptoms and not understanding the 
meaning of them, Piper gradually set up a system of communication between her 
local GP and her MS clinic, which was located several hours drive away from her 
rural town. Relapses became a nuisance rather than the cause for deep concern, 
which she had felt in the early days. 
 
They’re just a nuisance…I get a build up of things…you go to the doctors…I do 
converse with my neurologist which is really good and so between here and there, 
they get this agreement…you just hope they are not as bad or severe as before. Piper 
line 1240 
 
Piper’s husband set up an excel spreadsheet for her, with separate columns to score 
her symptoms daily in an attempt to help Piper try and work out what triggers her 
symptoms, her bad days or high fatigue days and hopefully avoid those triggers in 
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the future to improve her quality of life. It is his way of providing support and has 
been key for Piper to uncover ways of managing her own MS symptoms and Taming 
the Beast. 
 
Everyday I fill out a spreadsheet with all my meds, and symptoms, give myself a pain 
score, how many hours I’ve slept, exercise, diet…we’ve even got the weather…so the 
idea is we’ll see a graph and there might be some pattern. Piper line 1522 
 
Becoming experienced and educated in RRMS provided Kate with the plan she 
needed to instil confidence that she could manage her relapses, whenever and 
wherever they occurred, which was important as she planned to travel overseas. Kate 
felt as if she had regained some control over RRMS. 
 
Being relapse free for four years was fantastic because you could plan your life…I 
felt a lot better and my doctor gave me his mobile number, steroids to take and told 
me what to do…so I thought I felt a lot better knowing that I had a backup plan. Kate 
line 1247 
 
For study participants Rudi, Margot, and Joy, the initial (undiagnosed) relapses 
became less of a worry for them once they knew that it was MS and not something 
they viewed as more sinister such as a stroke or brain tumour. This was particularly 
so for Rudi, who suffered rapid onset and serious relapses which often resulted in 
admissions to hospital. 
 
Everyone else got panicky around me but I know it’s the MS so I don’t…I don’t feel 
highly stressed…I know I’m not dying, I’m not having a stroke…I tend to cope better 
than everyone else around me. Rudi line 252 
 
For Margot, letting go of household chores that worsened her MS symptoms has 
made a positive impact on her general health and fatigue levels. This has been an 
effective tactic in Taming the Beast. 
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I’ve pulled back on domestic duties, I don’t do cleaning anymore…I think you just let 
things go really, but it’s not that important…I accept things a lot more…I’ll walk 
past dust in the hallway…it’s not important…I’ve become more patient with MS. 
Margot line 952 
 
Kate suffers terribly with pain from spasticity, a condition caused by nerve damage 
from MS where her leg muscles become tight and painful. A new drug has recently 
become available internationally, which has had good results reported in reducing 
spasticity symptoms. Although she is yet to try the medication, Kate is on a crusade 
to bring the new drug to Australia because no treatments she has tried so far have 
given any relief. Kate is determined to bring this quality of life-sapping MS symptom 
under control, even if it means organising her own treatment to engage in Taming the 
Beast. 
 
I need it, I desperately need it…I don’t need it in three years time I need it now…I’ve 
called the PBS…this is the problem and I need to do something about it…you have to 
be on everyone’s back…I put that on the backburner until next week when I get 
another burst of energy. I really do feel like I have to be my own advocate. Kate line 
2158 
 
Rudi suffered from severe bouts of fatigue, particularly after relapses. Rudi had to 
find a way to deal with this debilitating symptom so that she could reclaim her life as 
a busy and engaged mother of four children. Balancing rest and life enabled Rudi to 
get a handle on her MS symptoms and to take on Taming the Beast.  
 
I do recover…when the symptoms disperse, it’s very draining…it’s like I’ve been hit 
with a truck…very tired...I go straight to bed basically cause there’s nothing else I 
can do, and I will sleep…usually I recover pretty well. Rudi line 1087 
 
There’s periods where I would have to go to bed…because I feel like I’ve been hit 
with a truck…I’ve learnt…I can play hard but I also have to rest hard…because I’ve 
done it before where I just keep going and pushing and pushing and I crash and 
burn…so I’ve found I just have to balance. Rudi line 1769 
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Maintaining physical and mental health and wellness  
 
MS poses challenges to both physical and mental health and wellbeing, and 
increasing disability over the course of the disease is associated with increasing 
burden and transformation of life plans (Rommer, Suhnel, Konig, & Zettl, 2017). 
Indeed, the adjustment process in RRMS does not conclude when early stage 
PwRRMS get used to their MS symptoms, it continues as future disease status 
changes occur, as their life journey goes on (Dennison et al., 2010). Learning to 
manage health and wellbeing is therefore an important part of the life journey with 
RRMS and one which is in a constant state of flux depending on symptoms, relapses, 
medication side effects, as well as general life, work and family commitments and 
responsibilities. It has been reported that after diagnosis, PwMS often say they won’t 
be able to cope in certain situations or with certain symptoms, but longitudinally as 
life progresses and the changes happen, they do learn to cope and often very well 
(Dennison et al., 2010). This pattern was displayed by most participants in the 
current study, capturing the concepts of Taming the Beast, so vital not just to coping 
with the disease, but for thriving with RRMS. Maintaining physical and mental 
health and wellness is an important step in this process. 
 
The “Shifting Models Perspective” (Paterson, 2001) believes that people choose to 
have a predominant focus of either wellness or illness in the foreground of their lives 
and that encounters and experiences are selected which will support their preferred 
perspective. During the time of Piecing Together the Puzzle discussed in theme 1, 
study participants demonstrated that a perspective of illness lay in the foreground 
leading up to RRMS diagnosis, with the tests, many consultations, hospital visits and 
uncertainty. As time progresses after diagnosis, symptoms dissipate, relapses come 
under control and PwRRMS generally become more settled, their focus often starts 
to shift from the initial illness in the foreground to one of wellness in the foreground. 
Holding the burden of illness in the background sustains a sense of well being, and 
many study participants concentrated on a wellness plan for physical and mental 
health.  
 
As mentioned in theme 2, (Re)defining Me Now That I Have RRMS in the subtheme 
dare to compare, Will took the view that he wished to stay away from others with 
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RRMS during his DMT treatment in the day admission ward of the hospital where he 
underwent his monthly infusions. Will chose to look after his mental health and 
commit to mental wellness, deliberately sitting with patients being treated for cancer, 
rather than his fellow MS colleagues. Staying away from others with MS and out of 
the so-called “cripple club” (Dennison et al., 2010) distanced Will from MS 
stereotypes and helped him place his RRMS in the background. Will also chose not 
to read up on RRMS or engage with education programs for the same reason. 
 
I don’t want to read the bad sides of MS because I can’t influence them and I can’t 
change the way they feel…I don’t need to hear it…I know some people are geared to 
go out there and really advocate, be positive and speak about their problems…that 
doesn’t work for me. Will line 301  
 
Will’s attitude to others with MS was in the minority for the study participants, most 
of whom embraced being with others with RRMS, talking with them, sharing tips in 
Taming the Beast and looking forward to their treatment infusions for this reason. 
Margot looked forward to the monthly infusions of her DMT in the hospital day 
admission ward and was disappointed when her DMT changed to an oral medication 
and she no longer spent time with people living with RRMS. It had become an 
important part of her mental health wellness strategy. 
 
In the hospital you met other people with MS, which was fantastic…because people 
had little tips, they had stories…you’d exchange how long you’d been diagnosed, 
what your reactions were…and there were people from all walks of life. Margot line 
503 
 
An important facilitator for resilience in MS is physical wellness including exercise, 
stress reduction and energy management (Silverman, Molton, Alschuler, Ehde, & 
Jensen, 2015). Studies have shown that continuing physical exercise behaviour over 
time predicts a continuation of enhanced QOL for PwMS (Dennison et al., 2009). 
The most dramatic turnaround from illness to health and wellness in the current 
study was from Joy, who described how she felt in the aftermath of her husband’s 
death when her RRMS symptoms were at their worst and she attended his funeral 
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aided by two walking sticks, making a decision that day to reclaim wellness to the 
forefront of her life and take back control. 
 
At my husband’s funeral I made an absolute heartfelt decision that I would get better 
no matter what…something switched on…when my husband died…I had to choose 
life…this resurgence wants to do what I wanted it to do, there must be another 
pathway…I started fighting for my own health…I felt like I had the power to control 
my health…I made it true…I was suddenly aggressively and passionately seeking 
wellness and I have done ever since…I took back control of my life…the disease 
doesn’t control me, I control my body. Joy line 983 
 
Making the active decision in Taming the Beast by becoming healthier physically 
was more than just a decision to move forward for many of the study participants, it 
was also an act of defiance, challenging the very essence of what RRMS takes away 
in physicality and mental health to do the physical activity which is threatened by the 
disease. Many study participants described how maintaining or commencing acts of 
physical health, exercise and sports helped them to feel better, stronger and more 
connected in both physical and mental wellbeing. Piper was proud that she pushed 
through her symptoms to maintain her physical health. 
 
Just get out there and do stuff while you can and I do that everyday, I like going for 
walks or runs…I do it because I can…I’ve got my own gym…even when I am 
fatigued with MS I still do it, I will still do my walk, it actually makes me feel 
better…if you move you’ll be amazed at the difference. Piper line 990 
 
Margot has recently started gym work and has already felt the benefit, feeling 
stronger physically. Rudi and Evie have also found that physical activity has helped 
regain control with specific symptoms, as well as being a mental health boost of 
positivity for Evie. 
 
Since I’ve finished work I haven’t had many falls at all because I’ve started going to 
the gym. I had an assessment and program done and now I go twice a week which 
has been the best thing…my legs are stronger. Margot line 1341 
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I do regular yoga…I started playing team sports…I’m absolutely loving it, whilst I 
could be more active, I have consistency…and I paddleboard to help with the 
balance. Rudi line 993 
 
I’ve gone back to gym now, my muscles needed it…keeping fit and healthy…just to 
remind myself that I was being more defiant…you can knock me down but I’m going 
to get up. Evie line 1358 
 
Susan embraces the holistic view of improving both her physical and mental health 
and also in educating others living with MS and sharing her tips to living life better 
with RRMS. 
 
I always tell others with MS just try and do all the good things like eating good food 
and exercising…the whole wellness thing is what you need, MS medications are part 
of that but exercising, eating well, rest, seeing friends…that’s what makes you 
healthier in mind and body…you have to be healthier up here too. Susan line 1305 
 
Choosing my medical A-Team  
 
The subtheme of “Choosing my Medical A-Team” is all about the PwRRMS gaining 
some control in Taming the Beast by selecting members of the health care team to be 
on their side, to take charge of their own care, to engage with self-management 
strategies and to make decisions about who makes them comfortable and who they 
trust to manage living with RRMS. Often when symptoms first strike, patients are 
referred for consults and tests to people they have never met before and they don’t 
have choice in who they see, especially so if they are referred by GPs or present 
through emergency rooms. After diagnosis and the settling in period however, it 
appears important for PwMS to choose their A-Team for the long life journey ahead 
with a chronic neurological condition. It has been reported that PwMS choosing their 
own doctors and health care teams helps the PwMS to take charge, a concept which 
is extremely important to moving forward and gaining some control (Clair, 2003).  
 
Several participants described scenarios where their MS HCP, in particular the 
neurologist or MS Nurse, went “over and above” what was required to advocate for 
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them, securing trust and instilling confidence in the care they were receiving. Will 
was unable to gain financial assistance from the government for the expensive DMT 
he needed due to residency issues. The medication cost was almost the same amount 
as his earnings at the time. Will became very emotional as he recalled the day his 
neurologist advocated for him and sought compassionate use for the medication, 
meaning it would be provided at no cost to him. 
 
He said don’t worry about it, you focus on what you have to do and we’ll work out 
the rest…since that day I still make sure I come to him because he’s just the best. 
Will line 672 
 
I broke down in front of him…I don’t know what to say…it’s probably the greatest 
thing anyone has ever done for me. Will line 877 
 
After many years and failed attempts to secure a diagnosis for his intermittent 
symptoms while Piecing Together the Puzzle, Paul was referred to a neurologist who 
gave him plenty of time, spending two hours with him on the first consult and finally 
providing a diagnosis and treatment plan. 
 
My neurologist was brilliant…he had a number of MS patients…he had a massive 
checklist he was going through, the first consultation I had with him would have 
been over two hours and he was wanting to solve this…he later retired but not before 
sending me to the best MS Neurologist…he’s the one in Australia that you want to be 
with and he organised all that for me…he was wonderful. Paul line 112 
 
The family doctor or general practitioner (GP) can often be the first consult when 
PwMS develop their first symptoms (Giovannoni et al., 2016) and an important part 
of the health care team during the lifetime living with a chronic illness. A systematic 
review has shown that being under the care of an empathic family doctor improves 
patient adherence to medical advice, decreases anxiety and distress, improves clinical 
outcomes and improves patient enablement (Derksen, Bensing, & Lagro-Janssen, 
2013). Paul was also fortunate to secure a GP who supported him at every 
opportunity, becoming an important member of his Medical A-Team.  
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My GP, she’s another one who spends hours with you, she’s learning from me about 
MS, so whenever she’s at conferences she tries to go up and find out a little bit more 
with neurologists, she’s told me she’s loving having me because I’m the only one that 
she’s got. Paul line 481 
 
MS Nurses have been perceived by patients as being ideally situated to discuss 
practical and emotional issues relating to MS (Dennison et al., 2016). MS Nurses 
play an integral role in helping patients and families come to terms with diagnosis 
(White, 2012) and across the entire disease trajectory providing expert information, 
relapse intervention and decision support (Mynors, Bowen, & Doncaster, 2016). MS 
Nurses cover many domains, including advocacy, empowerment, disease expertise 
and education (Halper & Harris, 2016) and have an important role in preventing 
unnecessary emergency and hospital admissions (Quinn et al., 2014). Rudi and Ruby 
both valued the support of MS Nurses who advocated regularly for them and were 
both interested and available as members of their A-Team.  
 
I’ve got a great GP, she’s advocated on my behalf, I’ve had her great support and 
the whole MS clinic has been great…if I ring and say I need to see someone, they 
know I’m sick and they will get me in…the MS Nurse, the fact that I can ring her, 
that’s awesome because you probably have more contact with them than you do with 
the doctor and she can answer your questions. Rudi line 1871 
 
My neurologist, he’s just beautiful, he loves what he does and the MS Nurse…she 
takes the edge off going, I’ve never met a more efficient woman in my life…the 
nurses are divine and it’s a comfortable environment. Ruby line 494 
 
Harnessing support from family, friends, organisations and workplaces 
 
Social support systems can vary greatly between countries and cultures but mostly 
comprise of family, friends and HCPs (Rosland et al., 2013), as well as 
organisations, societies and work places. Immediate family, significant others and 
close friends also play an important role as the first line of support, especially true 
for spouses of PwMS who are often sharing the burden of MS on a daily basis 
(Aymerich, Guillamon, & Jovell, 2009). When appropriate support is provided it can 
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be positive and affirmative for the PwMS, however, sometimes social isolation can 
occur as family and friends may withdraw from the ill person, especially if they feel 
there is nothing they can offer in terms of help (Reade, White, White, & Russell, 
2012). As discussed in earlier themes, for Davina and Joy sadly this was the case 
many times during their lives with RRMS as those dearest to them withdrew their 
love and support, refusing to acknowledge the impact of RRMS in their lives. 
However, for the majority of the participants in the current study, family and friend 
support was present in abundance and became a welcome refuge from RRMS and an 
important factor in Taming the Beast. 
 
Ruby and Paul described how their immediate families rallied around and provided 
support when they needed it the most. 
 
My husband’s become a pro at managing it now, I’m very blessed…Mum and Dad 
bought a house around the corner and my sister wants to move closer…Mum and 
Dad are just there which is a godsend with the children and this has brought us 
closer together for sure. Ruby line 1122 
 
My family first and foremost got me through that first year…my parents are just out 
of this world, but my wife is just the best. Paul line 861 
 
I try and give my wife time off MS, let me look after the kids for a while, but she’s 
like no, we’ll do everything as a family…I’m very, very lucky. Paul line 947 
 
For Susan, after many years of worrying and searching for a partner who would 
accept both her and RRMS into their life, she was fortunate to find someone who 
was willing to partner wholly with her in living with RRMS.  
 
He was beautiful…such a gentle soul and I told him about my MS and he was so 
accepting of it and he said that doesn’t worry me, he was so loving, he was very 
supportive…I’ll do it with you…and then I forgot about my MS, it wasn’t the focus 
any more when I had been focusing on that for the last whatever many years before I 
met him…I was more. Susan line 884 
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Simply holding the belief that others will provide appropriate support has been 
shown to increase patients perceived ability to cope with chronic illness and to lower 
their stress levels (Uchino, Cacioppo, & Kiecolt-Glaser, 1996) and actually receiving 
support from loved ones can be an integral part of the illness journey (Kiecolt-Glaser 
& Newton, 2001). MS focused research has repeatedly demonstrated that greater 
social support is associated with better mental health outcomes (Koelmel et al., 2016) 
and that the presence of social support can protect against stress and improve the 
sense of purpose for PwMS (Bambara, Turner, Williams, & Haselkorn, 2011; 
Kirchner & Lara, 2011; Krokavcova et al., 2008). Additionally, social relationships 
are known to play an important role in stress and coping (Wirth & Bussing, 2016), 
factors that are absolutely vital for PwMS in the unpredictable RRMS journey ahead. 
 
High quality social interactions have been shown to lead to higher levels of life 
satisfaction and also lower levels of depression and anxiety in a study using a mixed 
methods questionnaire in 103 PwMS, most of whom were living with RRMS (Reade 
et al., 2012). Supporting these findings is a recent Iranian study which demonstrated 
that increased social support for PwMS was also positively associated with more 
effective coping strategies and also enhanced psychological well being, both so 
important for quality of life living with MS (Farran, Anmar, & Darwish, 2016). In 
order to be effective, it appears that social support needs to be of high quality, 
worthwhile and appropriately applied to times of need for the PwMS. Examples of 
social support that did not fit these categories in the current study included Jane’s 
mother providing her with MS information at diagnosis which was well meaning, but 
outdated and wheelchair-focused, and Paul’s mother “canoodling” him with worry 
and over emphasising MS. However, the great majority of participants in the current 
study described situations where family and friends provided much needed support 
and encouragement at just the right time, were consistent in their support and greatly 
assisted them in Taming the Beast. In Piper’s case, her social world widened 
significantly after her diagnosis and she took every opportunity to participate in life, 
laughing as she recalled the toll her new social life took on her. 
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I’ve met another girl and she’s become a good friend of mine…she was the one who 
recommended the neurologist…we sort of catch up nearly every other week and have 
coffee…her experience with MS has been different but it’s actually nice to have 
someone who understands. Piper line 695 
 
I’m probably doing more than ever…my social life is more than I can take…I’ve had 
that many weekends away…I’m actually a little tired of it! Piper line 683 
 
A study exploring stigma in MS found that PwMS were sometimes ignored in social 
situations and interpersonal relationships, described as “polite inattention” towards 
the illness (Grytten & Maseide, 2006). Kate felt a sense of losing friendships when 
her friends learned of her diagnosis with RRMS. However, Kate also felt that the 
worthwhile friendships were able to withstand her life with RRMS and she takes 
comfort in the strength of these current friendships.  
 
Your real friends stick by you…friends that I’ve come to learn were more like 
acquaintances…the minute you get sick and you can’t do things that you used to 
do…they are no longer your friends…you’re in the too-hard basket…good friends 
make the effort, they make the effort to come and we have developed strong 
friendships. Kate line 1994 
 
Rudi felt the support from her country town environment, where everybody pitches 
in to help those who need it.  
 
I’m very lucky, I couldn’t have had more support and friends…in small towns people 
are so willing to help…people that you’re friends with, but you don’t really associate 
with…give me a call…I’ll pick kids up, can I cook you something? So, I’m very 
fortunate. Rudi line 1721 
 
MS Societies and organisations can be an important source of social and emotional 
support and can be vital in strengthening morale for PwMS as they adapt to their 
disease (Ebrahimi et al., 2017). Additionally, connecting with social support from 
other PwMS is an important positive coping behaviour (Rommer et al., 2016). 
Several participants in the current study reinforced the importance of sharing stories 
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and being supported by others with RRMS, people who truly understood how they 
were feeling and the battles they were facing. This could happen in organisations 
such as MS Australia, or more informally at MS clinics and infusion centres where 
PwRRMS tend to gather together at common times for consultations and treatments.  
 
The MS Society is brilliant, I love them…I used to love the blogs but I can’t handle 
the negative…I’m quite a positive person. Ruby line 995 
 
Natalizumab (Tysabri®) is a DMT infusion that needs to be given regularly every 
four weeks in a hospital clinic, usually for a period of several years if all progresses 
well. Patients would often be scheduled to receive their next infusion on the same 
day four weeks later, leading to meeting up with the same fellow patients regularly. 
For some study participants such as Margot and Griff, this led to strong friendships 
being forged and a sense of support from others living with RRMS and having the 
same treatment. Griff also valued the chance to see other diseases he viewed as 
worse off than his own, appreciating the perspective this brought to his life. 
 
You had a common thing, MS…I made friends there and it was nice… different 
experiences rather than just yourself, the Tysabri® days were fun and I still keep in 
contact. Margot line 506 
 
Tysabri®  became my social world…it was a big part of my social life…one of the 
great pleasures was actually keeping the disease in perspective, I’m sitting there 
with people having their cancer drugs as well…you’ve got to just do it…it was such 
a good social environment. Griff line 958  
 
Work places and work colleagues can also provide support at difficult times, 
providing understanding during sudden relapses or on “bad days” when MS 
symptoms were overwhelming. Having the ability to choose to work days and hours 
to assist with fatigue management was seen by several participants as being a great 
advantage in Taming the Beast. Rudi was able to chose hours that suited her RRMS 
symptoms best and allowed her a rest time in the afternoon prior to collecting 
children from school.  
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Now I’m back working twelve hours a week I chose the hours and the days…this just 
landed in my lap so I was lucky and it was the right time… and while it’s not the 
most stimulating job, it’s a job and this is good for now. Rudi line 955 
 
For both Ruby and Susan, having their immediate work manager understand their 
unique needs has led to them feeling supported at work and able to continue 
balancing work and life with RRMS.  
 
I’ve just asked next year to have part time reduced hours to have a day off in the 
week…my body’s really craving to move…my boss has been really good so 
far…work’s been really supportive, so I feel blessed to be in that work environment. 
Ruby line 657 
 
They looked after me and understood…I was very grateful, very blessed…two days 
on, one day off, two days on…and I rested and felt healthy. Susan line 591 
 
Riding High on Resilience  
 
Resilience can be defined as the human capacity to persist, to bounce back and to 
flourish when faced with stressors (Bonnano, 2004). More formally, resilience is the 
capacity of an individual to successfully maintain or regain their mental health in the 
face of significant adversity or risk (Stewart & Yuen, 2011). In disability and illness, 
resilience has been identified as an important contributor to QOL (Terrill et al., 2014; 
Silverman et al., 2015). Moreover, in the case of RRMS, the very nature of the 
unpredictability of the disease can present unique challenges in resilience right 
through the life trajectory (Silverman et al., 2017). For all of these reasons it is 
imperative that MS HCPs are aware of the benefits of resilience for PwRRMS and 
that they themselves acquire skills to enhance and develop resilience for patients 
under their care. 
 
After only the first few interviews in this life history series, I was humbled by the 
stories of resilience I was hearing from the study participants. This pattern continued 
throughout all of the interviews and was one of the study highlights for me 
personally. I have consulted thousands of patients over the years of my nursing 
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career, and even more intensely since working in the field of MS, but, I questioned 
myself, have I ever asked a patient to talk to me about previous life difficulties and 
how they overcame them? Had I ever asked a patient with MS to relate stories from 
their life that told me about some of their life challenges and how they managed 
them? To my great embarrassment I could not recall ever asking that particular 
question. But very quickly during this research study I became acutely aware of how 
important resilience was for PwRRMS to Tame the Beast and what an essential part 
of the life journey with RRMS that resilience occupied.  
 
The stories of past resilience in the lives of the study participants differed of course, 
but the common thread they all had was overcoming difficulty and moving forward 
in life, sometimes even managing to thrive along the way. Some stories were 
incredibly sad, comprising of very harsh and neglected childhoods and family 
situations. Will had endured a home situation of an absent father and a mother who 
died from alcoholism when he was thirteen, Joy had overcome a lifetime of 
abandonment and neglect to be thriving, and Davina and Evie had both survived 
bullying during school years and traumatic home situations from their fathers. 
Margot and Kate were the children of ethnic parents who moved to Australia,  
without speaking English, and later becoming translators for their parents and taking 
on family responsibility beyond their years. Ruby, Piper and Susan also suffered 
issues with infertility, and Rudi was to suffer incredible grief as her full term son was 
stillborn. Surviving these traumas provided a strong base and an individually 
acquired skill set for their later battles with RRMS. 
 
During a particularly dark time in her RRMS life journey, Joy was desperate to 
reconnect with her old, happier self and spent time trying to recall a time when she 
felt carefree and happy. She wanted to use these memories to conjure up a new 
direction for herself and in the process, Joy provided an excellent example of 
harnessing resilience and moving forward to conquer demons. 
 
I thought about when I felt most alive and full of joy and it was when I was in my 
twenties, I used to wear stilettos and I really enjoyed it…the joy part is around the 
high heels I hadn’t worn them for years, I had to wear flat shoes (because of  
instability walking from MS)…so I thought, well, let’s give this a try. So I bought 
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four inch high heels…I felt amazing, I felt amazing…I was walking better and I was 
much more conscious of the way I walked and carried myself…I adjusted my gait for 
wearing the high heels and then I walked towards the mirror with confidence, I was 
so empowered and I felt so strong, so joyful. I felt like I got my whole life back…I 
would walk downtown, dance all night long…that was a special time. Joy line 1151 
 
Although most of the study participants did not outwardly recognise their great 
achievements in resilience, several participants did recognise that previous 
challenges had helped them gain valuable life skills to help navigate life with RRMS. 
Piper and Margot both did realise that their special challenges had given them 
resilience to shape their lives today. 
 
People don’t see all the symptoms because of my day to day living…even if I’m 
having a bad day with MS I know now that I am in control of my thoughts and I can 
change that thought process…I think I’ve become more resilient along the way. 
Piper line 1772 
 
I think having MS was the big thing that impacted on my life…I think growing up in 
an ethnic background with parents who didn’t speak English for a long time…you 
are growing up in two different cultures…I think it gave me resilience…and a bit 
more empathy for people. Margot line 1424 
 
Rudi also recognised that the hardships she has endured throughout her life have also 
helped her to deal with life so far and this resilience will help with whatever the life 
journey is going to bring for her. 
 
We’ve been through a fair bit...I think so very much...and I look at that as a gift as 
well…and you know people had it worse than me, but people had it better…it does 
give you resilience, not that it’s any easier, but it gives you something to be able to 
get through it and get back on track. Rudi line 1275 
 
I had Max, not in my wildest dreams did I think that would ever happen (his 
stillbirth)…so yeah, it’s been tough but…you obviously carry some sort of 
strength…the death of my son changed everything. Rudi line 1320 
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Resilience is a learnable behaviour (Manning, 2015) and interventions can be created 
for patients to provide training in resilience enhancement, important for the entire 
life trajectory with MS (Mealer et al., 2012). A recent study explored the impact of 
resilience in chronic illness and on later life disability (Manning, 2015). This 
research supported the observation that high levels of resilience can protect against 
the negative impact of disability in later life and that teaching resilience from the 
beginning of the journey can have a profound effect in protecting against chronic 
illness and disability in a normal aging population (Manning, 2015). The message for 
MS Nurses is to take every opportunity to develop resilience in PwRRMS, as the 
benefits may be life long and may even lessen later disability.  
 
It is also important for MS Nurses to be aware that resilience is dynamic, it is under 
constant negotiation and is often contextual (Ferguson & Walker, 2014). A recent 
three year longitudinal study of 31 adolescents with chronic illness found that a key 
component of living with chronic illness was the desire to live life as “normally” as 
possible, as highlighted in the second study theme (Re)defining Me Now That I Have 
RRMS; even in the face of challenges, and to focus on opportunities and optimism 
(Ferguson & Walker, 2014). Similarly, participants in the current study were keen to 
focus on the positive aspects of the situations they found themselves in instead of 
focusing on the negative, although this was sometimes a struggle for the participants 
to remain positive as some hardships were particularly difficult to deal with (death of 
a child, childhood parental neglect). Participants were able to describe how they 
faced challenges, developed new ways of looking at the problems and continually 
moved forward with the help of family, friends and community. 
 
MS Nurses have an important role in helping families through both the diagnosis of 
RRMS and living life with RRMS, being in a unique position to facilitate 
normalising the response to extreme events (such as diagnosis and relapses or 
medication changes), ideally by providing narratives of families in similar situations 
(Chesla and Leonard, 2017). Talking about stories of how other families successfully 
overcame difficult or challenging periods instils confidence and practical information 
to consider for the PwMS and is an important educational role for MS HCPs. Of 
course, no two families are exactly the same, but knowing others have survived such 
challenges can be immensely helpful for those navigating difficult times and can also 
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be helpful for novice clinicians and HCPs to enhance their own learning and 
development (Chesla & Leonard, 2017).  
 
Sharing experiences and narratives through reflection also helps to strengthen 
resilience in people living with chronic illness, showing the possibility of mastery in 
a situation and fostering connectedness between the HCP and the patient (Kralik, 
Van Loon, & Visentin, 2006). However, it is important to remember that this is 
contextual for the PwRRMS and is not a one-off discussion, and PwRRMS may need 
additional resilience assessments and education at each clinic visit. It is important to 
reassess scenarios with patients and not assume they are at the same level of 
resilience as the last clinic visit. They may have shown high levels of resilience at the 
last appointment, but the nature of living with a chronic and evolving illness such as 
RRMS means that they may also have lost some momentum along the way with life 
and may need a reminder of the importance of fostering and developing resilience.  
             
Approaches MS Nurses can use to nurture and build resilience in their patients 
include discussing the importance of maintaining social connections both within and 
outside the MS community, using strategies such as using humour, discussing ways 
to creating a normalcy in their life, the benefits of maintaining a positive outlook, 
methods of practicing self compassion, and the importance of planning ahead and 
managing commitments (Silverman et al., 2017). Almost all of the participants in the 
current study reported using at least one of these techniques to help when Taming the 
Beast and many participants used several techniques. Harnessing resilience is an 
important and valuable skill in the life story of PwRRMS, and a skill that can be 
developed with the help of the MS Nurse. 
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Theme 7- “The DMT Dance” 
 
Shall we dance? 
The first dance of the night is with me 
Alone and fragile 
Scared about the first steps and where my feet shall go 
Some lessons, some guidance, a show 
I start to feel a little more confident 
But still not ready 
The waltz commences, regardless of me 
Stepping on toes 
Feeling clumsy I suppose 
I start to learn the steps 
I sail through the air 
I continue my lessons, I practice, I step this way and that 
Life has more in store than I imagine 
I change my dancing partners 
This one feels more comfortable 
These steps I know 
My confidence starts to show 
I can salsa, I can two-step, I can sway 
I am now a dancing master, but in my own way 
TB 
 
The central organising concept of “The DMT Dance” consists of negotiating and 
coping with medication therapies to treat RRMS, the DMTs. There are two distinct 
subthemes within this concept, the first subtheme “The hard yards: making decisions 
about DMTs and adherence”, further subdivided into DMT decisions driven by fear 
and DMT decisions driven by hope, and the second subtheme switching to a better 
life. 
 
Although the past 25 years has seen the development of the first effective treatments 
for RRMS with DMTs, there is still no curative treatment for RRMS (Torkildsen, 
Myhr, & Bo, 2016), meaning that relapses on therapy are still possible (Anderson & 
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Philbrick, 2014). Nowadays it is widely accepted that early treatment with a DMT 
will reduce both MS relapses and MRI activity, which will ultimately delay disease 
progression (Smith, Cohen, & Hua, 2017; Comi et al., 2017). Whilst DMTs have 
improved the disease course of RRMS dramatically, they have also added a layer of 
complexity to RRMS care (Comi et al., 2017). Managing DMTs provides challenges 
for both patients and MS HCPs and requires close communication to improve 
clinical outcomes and QOL for PwRRMS (Tintore et al., 2017).  
 
The current focus in RRMS care is on both early diagnosis and prompt 
commencement of a DMT in order to modify the disease course and result in better 
outcomes for PwRRMS (Kobelt, Eriksson, Phillips, & Berg, 2017). That seems 
straightforward, but PwRRMS and their HCPs are faced with complex decisions 
regarding which treatments will be most effective and appropriate for them 
(Bottomley, Lloyd, Bennett, & Adlard, 2017). As discussed in previous themes, this 
is often at a time when Piecing Together the Puzzle, (Re)Defining MS now that I 
have RRMS and Battling the Demons have led to increased vulnerability and distress 
for the PwRRMS, further impacting on DMT decision making. Assessing the relative 
benefits and risks for individuals of each DMT can be confusing and complicated for 
the PwRRMS. Additionally, potential side effects (risks) of some DMTs can be very 
serious, adding further worry, stress and uncertainty about treatment decisions. These 
serious side effects include progressive multifocal leukoencephalopathy (PML), an 
incurable brain infection which has contributed to many deaths in PwRRMS 
(Chataway & Miller, 2013) and also autoimmune blood and kidney conditions which 
have also led to fatality in PwRRMS (Coles et al., 2012). There is also preparation 
needed at the start of the DMT journey regarding family planning and pregnancy, as 
most DMTs have pregnancy related risks and considerations (Wingerchuk & Carter, 
2014). With many PwRRMS diagnosed and commencing treatment during their 
child-bearing years, this is an important factor in The DMT Dance. 
 
Evidence from clinical trials and from daily clinical practice has demonstrated that 
not all patients respond satisfactorily to a given DMT, the response to medications 
and their effects are highly individual  (Comi et al., 2017). Switching between DMTs 
is common in RRMS, particularly if the patient does not respond well to the 
medication (e.g. experiences a relapse or has new lesions on the MRI) or experiences 
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significant side effects (Costello, Thrower, & Giesser, 2015; Giovannoni et al., 
2016). This often leads to a PwRRMS experiencing several different DMTs during 
their lifetime, all with their own particular set of risks and benefits. This scenario was 
referred to by Ruby in the current study as starting “the wave of medicines ” (Ruby, 
line 110). 
 
In Australia, the first DMT to treat RRMS was Betaferon® and was registered in 
1995 (Broadley et al., 2014b). This injectable interferon was followed in 1998 by 
two more interferons (Avonex® and Rebif®) and in 1999 by another class of drug, 
glatiramer acetate (Copaxone®) (Broadley et al., 2014b). All of these DMTs 
required PwRRMS to learn how to self inject the medication at various intervals 
ranging from daily to weekly administration. The first infusible (by intravenous 
infusion or “drip”) medication was natalizumab (Tysabri®), being registered in 2006 
and the first long awaited oral medication to treat the disease, fingolimod  
(Gilenya®), was registered in Australia in 2011 (Broadley et al., 2014c). Fast 
forward to 2018 and there are currently 12 DMT choices for PwRRMS registered 
with the Therapeutic Goods Administration (TGA) in Australia. Currently, all of 
these DMTs are available at a heavily government subsidised cost on the 
Pharmaceutical Benefits Scheme (PBS). 
 
There are variable modes of administration between the DMTs ranging from 
subcutaneous injections just beneath the skin, to oral tablets to intravenous infusions 
that need to be administered in a hospital or clinic setting. This results in truly 
individualised MS care where the best drug can be selected for the right patient at the 
right time, without having to consider step-wise approaches, insurance company 
preferences or other ‘red-tape’ which may govern DMT prescribing in many other 
countries. Australia is one of only a few of countries in the world with so many 
effective treatments available first line and at a low cost to the patient (Broadley et 
al., 2014c). Many other regions, such as some areas in Europe and the USA, can 
have restricted access to DMTs or restricted government or company reimbursement 
(Wilsdon, Barron, Mitchell-Heggs, & Ginoza, 2014; Comi et al., 2017), causing 
DMTs to be out of reach financially for some PwRRMS. For example, some 
insurance companies in the USA require a PwRRMS to experience treatment failure 
on a DMT before being permitted to start a more highly efficacious drug (Owens, 
	 291	
2013), thereby missing the early time in RRMS when the anti-inflammatory effects 
of the drug may be the greatest (Hauser, Chan, & Oksenberg, 2013). In an ideal 
world where the evidence points to the need for early and effective treatments in 
RRMS, there would be DMT treatment access for all PwRRMS and the full range of 
DMTs available to PwRRMS and supported by national bodies, regulatory 
authorities and reimbursement agencies (Giovannoni et al., 2016). 
 
The hard yards: making decisions about DMTS and understanding adherence 
 
As the course of RRMS is heterogeneous, a confident prediction of long term 
individual prognosis of RRMS on a particular DMT is not yet possible (Wingerchuk 
& Carter, 2014). This can be frustrating and confusing for patients as they are faced 
with making DMT decisions when the long term benefits are unclear and the degree 
of side effects and risks they may experience are also uncertain. A recent UK study 
found that most patients with RRMS wished to be part of the decision making 
process regarding their DMT and that shared decision making underpinned effective 
disease management, especially when supplemented by MS Nurse support (Colhoun, 
Wilkinson, Izat, White, Pull, & Roberts, 2015). However, there is very little 
literature available exploring how PwRRMS make decisions about the best DMT to 
suit their situation, their beliefs, their values, their disease state and their lifestyle or 
how they balance treatment risks and benefits. By taking into account factors such as 
patient preferences, lifestyle, how patients view risks and benefits, personal 
tolerance, acceptance of side effects and the time commitment required for treatment 
and safety monitoring, shared decision making between the MS HCP team and the 
PwRRMS can be made. 
 
People living with a chronic medical illness must balance the probability of current 
side effects with treatment with the probability of long-term benefits (Bruce et al., 
2016). For a disease such as RRMS where disease remission and return to baseline or 
‘normal’ functioning occurs between relapses, it can be very difficult to reconcile the 
side effects from DMTs that make patients feel unwell with the fact that they often 
feel better without any treatment. Jarmolowicz et al. (2016) reports that side effects 
can often make patients feel much worse in the present moment, causing the patient 
to consider balancing their current QOL (reduced by the taking DMT now) with the 
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potential of reduced QOL in the future (reduced by not taking DMT now). Unlike 
drugs such as analgesics where an immediate benefit may be felt, DMTs in chronic 
disease are preventative medications to reduce the probability of negative future 
effects with no immediate observable benefits (Jarmolowicz et al., 2016).  
Additionally, DMTs do not typically improve acute symptoms in RRMS and so 
PwRRMS do not usually experience observable improvement while taking the 
medication (Bruce et al., 2016).  
 
Adherence has been defined by the World Health Organisation (WHO) as “the extent 
to which a person’s behaviour - taking medication, following a diet and/or executing 
lifestyle changes - corresponds with agreed recommendations from the HCP” (WHO, 
2003). Studies have shown that DMT adherence in RRMS is particularly 
problematic, with up to 25% of PwRRMS non-adherent to their DMT (Devonshire et 
al., 2011). No medication is going to be effective in controlling a disease if the 
patient is non-adherent, as former US Surgeon General C.Evert Koop stated, “drugs 
don’t work in people who don’t take them” (Osterberg & Blaschke, 2005). 
Maintaining DMT adherence in MS has been described as comprising of three 
actions: those of acceptance (the patient accepting that therapy is needed), 
persistence (continuing to take the treatment over time) and compliance (taking the 
treatment as prescribed at the right time and right dose) (Remington et al., 2013). 
This subtheme will define adherence as taking the prescribed DMT as directed by the 
MS HCP. 
 
Recognising adherence and non-adherence to DMTs is a crucial part of the MS HCP 
role (Costello et al., 2008). The Global Adherence Project (GAP) was a worldwide 
study of 2,648 participants, the goal of which was to evaluate the degree to which 
patients with RRMS adhered to dosing schedules for DMTs as outlined by their 
neurologist (Devonshire et al., 2011). Several factors were found to relate to greater 
DMT adherence: being female, the ease of administration, satisfaction with therapy, 
treatment at a designated MS centre and the presence of family support. Of further 
importance in the GAP study was that adherent patients reported higher QOL scores 
than non-adherent patients. This finding is significant for MS HCPs, as it suggests 
that by targeting strategies to improve DMT adherence, there may also be indirect 
improvement in patient QOL.  
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Adherence to DMTs in RRMS can be difficult to quantify and the specific 
combination of factors influencing an individual patient’s likelihood to adhere to a 
DMT can be difficult to determine (Remington et al., 2013). Patients who are non-
adherent to DMTs usually follow one of two patterns; either missing doses and 
taking the DMT less frequently than prescribed (Wicks et al., 2015) or by 
abandoning therapy completely, usually within the first six months (Rio et al., 2005). 
Adding to the complexity of adherence or non-adherence on DMTs, there may also 
be a wide range of emotional and cognitive factors present which are specific to 
RRMS (Wicks et al., 2010), with mood and anxiety disorders prevalent in the disease 
(Feinstein, 2011; Feinstein et al., 2014).  
 
Increasing the complexity of DMT decisions further for PwRRMS, is the fact that the 
more highly efficacious (more effective) therapies have rare, but potentially serious 
side effects and unfortunately, the safest therapies have much lower rates of efficacy 
(are less effective) in controlling RRMS (Smith et al., 2017). Very little is known 
about how patients decide between oral (tablet) therapies and parental (injection or 
infusion) therapies, or how patients ‘trade off’ the convenience of oral therapies 
against treatment frequencies or side effects of the other medications (Lynd et al., 
2016; Utz et al., 2014; Wilson et al.,  2015). Additionally, not all patients respond 
satisfactorily to DMTs and a ‘one-size fits all’ approach is not attainable in RRMS 
(Comi et al., 2017). Ideally, the best treatment option would be the safest treatment 
that eliminates disease activity (Hauser, 2013), but the identity of this DMT is not 
known at the beginning of the RRMS journey. This is currently an area of intense 
research interest and hopefully biomarkers (measures such as blood tests or scans 
which can determine responses to a medication) will be able to shed light on this in 
the future (Hegen, Auer, & Deisenhammer, 2016).  
 
Understanding how the PwRRMS makes decisions about which DMT will suit them 
best is vital for MS HCPs to understand, but there is limited literature to provide 
guidance and support for MS HCPs in this regard.  A recent study of 189 PwRRMS 
in Canada used focus groups and individual interviews to determine attributes of 
DMTs that were most important to patients. The researchers concluded that overall, 
the most important attributes were the avoidance of side effects and the improvement 
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of symptoms (Lynd et al., 2016). Unfortunately, both of these attributes cannot be 
guaranteed for patients with the current DMTs. As the adherence data discussed 
above has suggested, actually taking the DMT as prescribed is a particular problem 
area in RRMS, and an area where the MS Nurse and other MS HCPs can target 
understanding to enhance adherence in the future. Unravelling how these decisions 
are affected by other factors is poorly understood, however participants in the current 
study shed some light on how these decisions were driven, some decisions appeared 
to be driven by fear and some decisions driven by hope.  
 
DMT decisions driven by fear: “I’d rather be in a wheelchair than dead” 
 
As discussed briefly in theme 3 Battling the Demons under the subthemes of facing 
fear and weary with worry; fear and worry can be major barriers contributing to 
adherence issues in RRMS, especially fear of medication administration and 
worrying about potential side effects (Anderson & Philbrick, 2014). This fear and 
worry can be further impacted by mental health issues in RRMS (for example 
depression and anxiety) leading to negative cycles that threaten DMT adherence 
(Anderson & Philbrick, 2014). Indeed, fear and worry can sometimes influence a 
patient’s decision to take any form of DMT, with some PwRRMS preferring to stay 
unmedicated and take the risk of further relapses and possible disease progression 
over what they perceive as unacceptable potential side effects. A one percent risk of 
a serious side effect can reduce patient preference for a particular DMT fivefold 
(Wilson et al., 2015). 
 
A recent study using focus groups in PwRRMS found that patients who opted out of 
DMT entirely felt that this was mainly due to side effects they experienced, feeling 
that their present QOL was more important to them than future disease progression 
(Mortensen & Rasmussen, 2017). In the current study, this was the case for Joy, who 
adamantly refused to take the advice of her neurologist and commence a DMT. Joy 
suffered greatly from side effects on earlier DMTs, at one stage needing 
hospitalisation from medication toxicity. This experience made Joy reluctant to try a 
new DMT, preferring to feel well in the present moment and take a risk with possible 
disease progression in the future.  
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I don’t see any point on going on a drug that could potentially kill me…I don’t see 
any point on going on a drug that’s not going to cure me and when it doesn’t really 
alleviate the symptoms. Joy line 1651 
 
I don’t believe that medication is the answer for me…if they can’t come up with a 
cure then, really…I’m not going to take something that may make me sicker. Joy line 
1687 
 
The Health Belief Model (HBM) looks at anticipated gains and losses balancing 
present and future QOL (Rosenstock, Strecher, & Becker, 1988). Using the HBM, 
health behaviour can be determined by personal perceptions about the perceived 
susceptibility and seriousness of a disease together with the perceived threat and 
benefits from a given behaviour, that is, in order for an individual to take a certain 
medicine, potential gains must be considered greater than losses (Mortensen & 
Rasmussen, 2017). Adding complexity to this theory in RRMS is the uncertainty of 
the disease and the lack of prognosticative ability in the future (Wilson et al., 2015) 
and if the chosen DMT will have the desired effect at all. On a background of fear 
and worry, there is no definitive answer that can be given to a patient on what their 
individual risk might be for a given DMT, and for some, the fear is too great. Piper 
had researched the newer DMTs in preparation for a change to a DMT with 
improved effectiveness, but was unconvinced this was the right move for her. She 
preferred to take her chances with the disease than mindfully expose her body to 
potential fatal side effects. 
 
With the newer, unproven medications, I just think the risk is too great…I get that 
these people are in a real state of bother, they’re probably prepared to give anything 
a go...but I just think I’d rather be in a wheelchair than dead…I just think the risk is 
too great. Piper line 1960 
 
The list of reasons to be fearful about starting a DMT, often outlined in great detail 
by MS neurologists and MS Nurses when considering DMTs (and supported by 
product brochures and internet research) can sometimes be more frightening for the 
PwRRMS than the disease itself. This is particularly so in recent years with the 
advent of more efficacious (effective) therapies with more potent side effect profiles 
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and where deaths have been reported in PwRRMS receiving the various DMTs. The 
introduction in Australia in 2006 of the monthly intravenous infusion natalizumab 
(referred to in the interviews by patients as the trade named Tysabri®) was exciting 
because at that time it was the most highly effective treatment for RRMS and showed 
long term benefit (Smith, Cohen, & Hua, 2017). However the occurrence of a 
potentially life threatening brain infection called PML (Chataway & Miller, 2013) 
forced the drug off the market shortly afterward. Natalizumab was reintroduced to 
the market a year later, with a safety warning about PML which necessitated special 
safety monitoring when using the drug. As of December 2017, there had been 756 
reports worldwide of PML associated with natalizumab therapy, with 25% of the 
cases being fatal (Biogen, 2018).  
 
In more recent years, PML has also been associated with some of the other DMTs 
(fingolimod and dimethyl fumarate), although not in numbers as high and as 
predictable as with natalizumab (Faulkner, 2015). Several participants in the current 
study openly discussed PML as a great fear for their current and future treatment. 
Piper was adamant in choosing possible disease worsening from RRMS over 
potential death from PML. 
 
And that PML keeps popping up and I don’t like the sound of that…and what does 
scare me about it is how do you know it’s PML or an MS symptom? And it’s not 
curable. Piper line 1362  
 
A blood test called the JCV test can measure for a specific antibody and give an 
indication of whether a PwRRMS has a higher risk of contracting PML on 
natalizumab treatment (Torkildsen et al., 2016). For Rudi, knowing that she was JCV 
positive influenced her decision to refuse treatment with natalizumab (referred to by 
Rudi as Tysabri®) and to risk further disease progression on her current oral DMT, 
which had so far been not been able to control her relapses. 
 
One medication they’re considering is Tysabri and I refuse to go on because I carry 
the JC virus, they tested me for that and I’m just not willing to (take that risk). Rudi 
line 501 
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Participants also experienced fear when changing treatments after many years on the 
same DMT, even if it was perceived by the MS HCP as a change for “good”; such as 
changing from an injectable therapy to an oral therapy. This was the case for Davina, 
after many years of struggling with the side effects of a weekly self-administered 
intramuscular injection, to contemplating a daily oral medication. The fact that it was 
a change at all was frightening for Davina, even if there were benefits expected from 
the treatment switch by her MS HCP. 
 
Changing treatments…that was really hard, I’m not good with change…so to change 
a medical treatment was really scary because I’m going on the hearsay of someone 
who knows more about it…but hasn’t actually received it…so I had to think a lot 
about that…it’s a bit of an unknown, I don’t know if I’m going to have problems in 
the future. Davina line 1423 
 
Having a son before her diagnosis of RRMS, Kate made the decision not to expand 
her family and have another child after her diagnosis, even though she did once wish 
to have more children. From a science background, Kate was deeply concerned about 
the possible effects of the DMTs she had previously taken on a foetus, especially as 
Kate had needed less conventional and more toxic treatment options in the time 
before many of the modern DMTs had become available. 
 
Being on all of these drugs, I thought…I’m not going to have a child that’s going to 
turn out to be sick. I’ve got no idea what these drugs are doing to me…and what 
they’re going to do to a baby. Kate line 1393 
 
There are very few qualitative studies addressing patient perspectives in regards to 
preferences in selecting a DMT in RRMS. However, a recent study explored patient 
perspectives on DMT choice by interviewing ten PwRRMS and using hermeneutical 
phenomenological methodology to analyse the findings (van Capelle et al., 2017). 
Researchers found themes of “constant confrontation with the disease” voiced by 
study participants who felt frightened at the prospect of having to use medication 
with possible side effects for the rest of their lives, reflecting similar themes of 
participants in the current study. Emotional fear as a theme was also described by 
van Capelle (2017), including a fear of injections and the act of injecting oneself 
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making the patients feel ‘different’ to others. These themes were also supported by 
current study participants, most notably Jane, who felt that her need to self inject her 
interferon DMT curtailed her ability to travel freely with the medications to remote 
countries (as she loved to do) and left her feeling disappointed and ‘different’ to 
others.  
 
I can’t do this now…you have to inject three times a week and it’s just a pain, you’re 
travelling with syringes and everyone thinks you’re a drug addict, and I absolutely 
hated it…it was really, really depressing…I thought I may as well just give up and do 
nothing. Jane line 338 
 
DMT decisions driven by hope  
 
For other study participants, their choice of DMT, and indeed their choice to remain 
adherent to the medication, was driven more by a positive sense of hope for future 
good health rather than by fear of DMTs or potential side effects. Adhering to one’s 
DMT is also an important way that PwRRMS can take control of their disease (Settle 
et al., 2016). This appeared to be a conscious choice for Paul in the current study, 
who performed considerable scientific research to decide on the DMT he thought 
would give him the best result in the long term. 
 
I was happy to go on Gilenya because at the time there was going to be some 
neuroprotective effect and it looked like a better option than 2 pills and possibly 
being sick all day…I was happy going on Gilenya at that point. Paul line 635 
 
A little later on in his life story, Paul suffered a further MRI relapse with a new 
lesion in a delicate area of the brain, of which he was considerably fearful. With a 
science and physics background, Paul introduced the concept of “front end loading” 
which I had never heard applied to DMT decision making before our study 
interview. “Front end loading” is an industry or economic term involving developing 
strategic information to address risk and to make decisions to commit resources early 
in a project in order to maximise the potential for success (Merrow, 2012). In Paul’s 
case, he was using the term to describe how he preferred to use one of the newer high 
efficacy DMTs now before he deteriorated, rather than continuing the moderate 
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efficacy DMT he was currently prescribed and risking further disease progress. His 
neurologist did not agree to change treatments at this time and preferred that he stay 
on his current therapy with close supervision. Paul argued that with an unpredictable 
disease such as RRMS it was better to “front load” and possibly stop the disease and 
he was willing to risk the potential serious side effects, which he felt were 
manageable with his level of education and understanding of what they meant. With 
a young family, an exciting new job and a love of the outdoors, Paul argued that he 
had a lot to lose not escalating his DMT to a higher level and would continue to seek 
out support to change therapies with another neurologist. 
 
I’ve developed a new MS brain lesion and I’m not real happy about that. My 
thoughts on how I want to proceed with all this are…front load risk, I would much 
prefer to have it out and discuss with my neurologist again. I don’t want to be at a 
stage where it is something they think about, you know, around the world at the 
moment they’re using it as a front line…I’m aware that there’s lots of therapies. 
Paul line 522 
 
The best drug on the market is alemtuzumab, I mean, it does come with a lot of risks, 
but they’re even more manageable than MS is…so if I take a thyroid medication for 
the rest of my life, that’s great…a better outcome. Paul line 600 
 
After experiencing significant deterioration in her physical condition over a short 
period of time, Ruby placed hope in her new DMT (alemtuzumab, also known as 
Lemtrada®) to be able to improve her mobility and prevent further decline so that 
she could enjoy her two small children and participate more actively in family life. 
 
I hope from the alemtuzumab (the DMT) to be able to walk…I don’t feel so weak…I 
hope so…this time last week I couldn’t even strengthen my own body to come up so 
this week I woke up and I can actually get up by myself…it’s no marathon, but for me 
it’s pretty good, so fingers crossed. Ruby line 598 
 
I was really excited about Lemtrada®…so hopefully it will start working and I’ll be 
really happy. Ruby line 868 
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Several participants in the current study described nursing support as an integral part 
of successfully managing their DMT and a reason for their DMT adherence at 
various stages of undergoing DMT therapy (such as complying with blood tests and 
other safety monitoring). This was particularly so for those study participants 
diagnosed for longer than ten years, who only had access to the self-injectable 
medications in the beginning of their treatment journey and relied on nursing support 
to teach them the injection techniques and injection site management. Margot had an 
MS Nurse visit her to introduce her to the injectable DMT in the comfort of her own 
home and surroundings. 
 
A nurse actually came out and showed me how to do the injections which was 
fantastic, she showed me how to do it and she made it so easy. Margot line 475 
 
Hope in a DMT refers to more than just statistics of how well a DMT works to 
control RRMS, hope also refers to feeling positive and confident about adhering to 
treatment, with family and nursing support being an important factor in commencing, 
continuing or changing DMT (van Capelle 2017). In the current climate of so much 
choice, complicated therapies, monitoring programs, and evidence for using early, 
effective DMTs, MS Nurses are more integral than ever to managing RRMS by 
implementing patient-centric programmes and supporting PwRRMS (Giovannoni et 
al., 2016). 
 
Switching to a better life 
 
Almost all of the study participants had stories to tell about past unhappiness on 
earlier DMTs, particularly as two thirds of the participants had previously been 
taking interferons or glatirimer acetate injections before the newer oral and infusible 
medications were introduced. For these study participants, they were switched to 
newer therapies as soon as they became available. Difficulties for patients with the 
early injectable medications are well documented, particularly in terms of PwRRMS 
suffering from skin reactions, injection site reactions, flu like symptoms and feelings 
of depression as side effects (Costello et al., 2008). As these side effects and patient 
experiences are already well documented (Miller & Jezewski 2001; Miller & 
Jezewski 2006), only a selection of participant comments will be presented here. 
	 301	
These participant stories also have a role to play for the MS HCP to consider the 
resilience shown by PwRRMS in overcoming challenges, as discussed in the 
previous theme of Taming the Beast. These insights from Davina, Will, Evie, Griff 
and Kate also give some background for the MS Nurse to understand why adhering 
to DMTs can be difficult, and how the effects can infiltrate all areas of life. 
 
When I started on the interferon…that feeling of desperateness, hopelessness…so if I 
felt like that on the day I had the injection, it would make it a hundred times worse. 
Davina line 1083 
 
My symptoms were getting worse, depression set in pretty bad and I became non-
compliant…I went unmedicated and I quit my job. Will line 884 
 
I went onto the interferon Rebif®, God awful drug…I don’t have a problem with 
needles, it was the reactions…site reactions made me look like a red and white 
checkerboard and the cold and flu symptoms, the headaches, the pains, the 
fevers…you just wanted to curl up basically…I didn’t take the treatment properly…I 
wanted to do it…but…I feel fine, so I stopped it. Evie line 835 
 
(Injecting glatirimer acetate) I hit a vein once, or a capillary and straight into my 
bloodstream and I thought I was going to die…it scared the shit out of me, it knocked 
me flat…and I had limited sites it was getting to the stage where I was hitting scar 
lines…(as a consequence) my compliance was getting sloppier…because it was 
fucked, I hated it and the thought of having to wake up everyday and do it again. 
Griff line 892 
 
I was on the Betaferon® which I really couldn’t tolerate, it was just like getting the 
worst flu…I just couldn’t function…I’d have my injection and the next day I’d be 
totally miserable and really sick…and going to work people would just be thinking 
…well, why is she sick all of the time? And you just couldn’t explain it to them. I’ve 
always been quite vocal about how I feel and I said to the Neurologist “I don’t like 
this, it’s making me sick, it’s not making me better and I don’t want it. Kate line 743 
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Several of the non-adherence scenarios described above were first reported to the MS 
Nurse rather than to the neurologist. Physicians have been found to miss indicators of 
poor adherence in patients (Osterberg & Blaschke, 2005), possibly due to the subject 
not being brought up in clinic encounters and MS patients not being keen to report 
non adherence to their physician themselves (Schwartz et al., 2017). Implications for 
HCP practice include the need to check at every clinic visit and care encounter 
(email, text, phone) on the status of adherence for DMTs. Often adherence is difficult 
when patients are faced with intolerable side effects, especially when mental health 
is also affected (Costello et al., 2008). The value of the MS Nurse as someone the 
patient can confide in about true DMT adherence and also to discuss issues they are 
having to maintain adherence are important aspects of the MS Nurse role (Burke et 
al., 2011).  
 
It is rare that the more serious side effects reported with the use of RRMS DMTs 
actually do happen in clinical practice but when they do, the consequences can be 
horrific. Kate suffered one of the first reported anaphylactic (allergic) reactions to 
natalizumab (referred to by Kate as Tysabri®) and recalls the horror of that day 
when hope in her new DMT suddenly was taken away. After this event, Kate was 
switched to one of the new oral treatments and has thankfully remained well since 
that time. 
 
This Tysabri® was a nightmare, after three months it was stopped, it was working 
really well and I was quite excited about the whole thing…I went back on it and I 
had an anaphylactic reaction…that was horrible…I think I was the only case at the 
time…that was absolutely horrific…I felt my back was itchy but before I could even 
finish saying anything my face swelled up and the doctor’s trying to get a thing down 
my throat…I was just terrified. Kate line 1076  
 
For some study participants, specifically Griff, Margot and Susan, moving on to a 
new DMT after suffering at the hands of their first treatments led to improvements in 
their quality of life. Additionally, for both Griff and Margot, starting natalizumab 
(referred to by the participants as Tysabri®) widened their social circles as an 
unexpected benefit of a DMT change as they spent a half-day at their local hospital 
day admission unit for the DMT infusion with other PwRRMS. These feelings about 
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natalizumab were in stark contrast to those study participants who had earlier refused 
to consider natalizumab because of the potential side effect of PML in the first 
subtheme decisions driven by fear. Life just felt better on this DMT for these 
participants, despite the reported risks. 
 
On Tysabri®, I just felt flat afterward and then 36 hours later it was gone and I had 
the rest of the month to myself, it was a joy and it was a big part of my social scene. 
Griff line 954  
 
I had Tysabri® for four years, that was actually really good. When I went to have the 
Tysabri®, you met other people with MS which was fantastic…it was sort of like a 
day out really. Margot line 494 
 
For the first time in years Susan felt “normal” taking tablets rather than self injecting 
her DMT.  
 
I feel more relaxed…it’s just a little tablet, I take it, I don’t have to get up, it doesn’t 
hurt…the injections were hurting. It’s improved, I don’t have to take injections with 
me, to find a freezer or to have a letter on the plane about why I have syringes, so 
now I feel normal taking tablets, I feel better and I feel positive. Susan line 1179 
 
Oral treatments, especially when taken once daily, have been widely reported as 
being preferred by the majority of patients with RRMS over injections and 
intravenous infusions (Utz et al., 2014; Thach et al., 2016; Mortensen & Rasmussen, 
2017). A recent study in adolescents with RRMS found higher levels of DMT 
adherence since the introduction of oral therapies in this population than in past 
studies (Schwartz et al., 2017). Over half of the participants in the current study were 
now taking an oral DMT and were happy with the change in terms of lifestyle and 
ease of administration. 
 
To enable a DMT to have the maximum impact on the course of RRMS, adherence 
to the prescribed regime is essential. Maintaining adherence involves developing 
strategies to manage side effects, successful and safe DMT commencement and 
monitoring safety and drug tolerance as vital aspects of the role of the MS Nurse. 
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When The DMT Dance moves elegantly, controlling the disease with minimal side 
effects, with the engagement of an educated empowered patient, a reliable support 
network and an approachable invested HCP team, the results can be outstanding. 
Switching to a better life is achievable. The treatment goal with RRMS is clear, early 
and effective DMTs in a shared decision making environment (Giovannoni et al., 
2016), performing The DMT Dance. Although some decisions are initially decisions 
based on fear, that doesn’t mean they will always remain so. At times, another 
relapse, a severe relapse or progression of disease (either by EDSS disability 
assessment, by reduced mobility or by MRI progression) may prompt a PwRRMS to 
reconsider their past DMT decisions, and the basis for these, and change their 
thought process and direction. As demonstrated within this theme, a major part of 
this revolves around decisions based on hope and switching to a better life, and 
merges well into the final theme from the study findings, theme 8, which is all about 
Holding Hands with Hope and developing purposeful positivity.  
 
Theme 8: “ Holding Hands with Hope” 
 
Hope summons, hope heals 
Hope can see me, hope can share 
Hope understands, hope feels 
Hope teaches, it helps me to bear 
Hope wakes with me each bright new day 
Hope teaches me to think in brand new way 
Hope, stay with me 
Hope, help me to be 
TB 
 
Linda Morgante passed away in 2007. Linda was based in New York and was an 
exceptional MS Nurse researcher, author, clinician, teacher and leader (Halper, 
2007b) who became well known for her belief in the concept of hope being an 
essential component of living well with MS. As a noted speaker and writer in MS 
nursing, Linda inspired and encouraged nurses from all over the world to instil hope 
in MS care, both in their patients and in themselves. Linda Morgante wrote, spoke, 
taught, lived and breathed hope. 
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“Hope is an essential element of life - it embodies our vision of the future, our 
opinion of ourselves and others, and our sense of control over the events and 
direction of our lives. The presence of hope for someone experiencing an illness can 
provide the energy necessary to promote health and well-being.” (Morgante, 2000, 
p.9) 
 
Looking back over the transcripts again in preparation to explore themes of hope and 
positivity revealed a startling, yet irrefutable, pattern. Almost every interview with 
participants in this research study commenced with stories of worry, of uncertainty, 
of the uninvited guest of RRMS invading lives and causing havoc in many forms, 
and almost all interviews ended with stories of hope, of some form of acceptance, of 
resolve and a will to do well in the future. This should not have been wholly 
unexpected by me, as the participants all volunteered to be part of the study and to 
share their stories (suggesting a purpose to help others and an essence of positivity). 
Nonetheless, it was a striking feature of the study and I was left astounded. 
 
This theme of “Holding Hands with Hope” encompasses ideas of hope, positivity, 
defiance, and spirituality, giving back to others and sharing stories. I also felt a sense 
of determination, where PwRRMS held on tightly to their newfound peace and 
positivity, often borne after many years of struggle. Holding Hands with Hope also 
reflects the way fingers intertwine to provide support, not by a single finger, but by 
many fingers and a thumb working together to link perfectly inside one another. It 
reflects touch and sensitivity and it reflects hard work to get there. These hands are 
not soft and protected; they are often calloused and tough. PwRRMS hold many 
hopes and dreams in them, for themselves, but also for others living with RRMS and 
progressive forms of MS, and also for the people working in the field of MS as well. 
 
The central organising concept of this theme is hope and positivity, it is all about 
reaching happier times, of the beginnings (or totality) of acceptance of RRMS into 
life and how looking to the future with hope brings its own peace and rewards. 
Expressions of hope differed greatly between participants of course, but the essence 
of hope remained remarkably similar. It was palpable and it was present in every 
study participant I interviewed. It often left me leaving the interviews smiling and 
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happy, reflecting on the remarkable achievements of my informants, even if there 
were tears and sadness interspersed regularly during the interviews. This theme is 
divided into two subthemes and several sub-subthemes to provide additional clarity. 
The two subthemes, “hope in its many forms” (including the sub-subthemes of 
functional, restorative, curative and defiant hope) and “purposeful positivity” 
(including the sub-subthemes of optimism and a positive outlook, searching for 
meaning, harnessing a sense of humour, faith, religion and spirituality and giving 
back and being involved) provide exploration of the role of hope in the lives of 
PwRRMS and the various ways PwRRMS express this hope and positivity. 
 
Despite the anguish, ambiguity and suffering that appears to be part of the life 
journey with RRMS discussed in the earlier themes, participants often lingered after 
the end of the interview to ensure I understood the entire story. The fact that 
happiness and hope were a very important part of that story, even if it took years for 
some participants to feel hope, or even if it was more of a temporary or fleeting 
feeling. It was still present and it was overwhelming in intensity. As the MS Nurse is 
a pivotal part of the team in ensuring the PwRRMS maintains a sense of hope 
throughout the lifetime living with the disease, understanding the role of hope in the 
disease is critical for MS Nurses (Morgante, 2000). I have never felt, or believed this 
more, than after hearing the stories of these study participants. 
 
What is hope? Why hope?  
 
Defining hope for this particular theme was difficult, primarily because there are so 
many different variations of the concept of hope, with literature spanning many, 
many decades. Haase and colleagues (1992, p.143) sought to clarify the concept of 
hope for nurses, reviewing the available hope literature at the time and defining hope 
as: 
 
“Hope is an energised mental state involving feelings of uneasiness or uncertainty 
and characterised by a cognitive action-orientated expectation that a positive future 
goal or outcome is possible”.  
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Noted hope researcher and writer, Snyder (2002) also embraced the concept of goals 
as an important component of hope and emphasised the active role needed to achieve 
these goals. Snyder (2002, p.249) defined hope as: 
 
“Hope is defined as the perceived capability to derive pathways to desired goals, 
and motivate oneself via agency thinking to use those pathways”.  
 
As a complex concept to describe, Clarke (2003, p.164) resonated strongly with my 
own feelings, noting that: 
  
“We know hope when we see it, feel it intensely when it is gone. But it is hard to 
describe”. 
 
The literature surrounding hope in both chronic illness and nursing care in general is 
substantial and stretches back for decades. Less common is literature specifically 
exploring hope and MS, although recent years have seen studies emerging, 
particularly in areas of allied health and MS (Soundy et al., 2012; Soundy et al., 
2013; Soundy et al., 2016). Herrestad and colleagues (2014) have suggested that 
instead of generalist work in hope, what is needed to understand hope more deeply, 
are in-depth and context specific hope studies. As this theme developed and the data 
evidence to support hope as a theme was extensive, I was keen to explore and define 
hope in a way that captured the very essence of hope in this specific population. 
Even in the absence of supporting literature, the data from the participants 
demonstrated that hope is important to PwRRMS, and as MS Nurses, we have an 
obligation to at least try and form some sort of understanding of what hope might 
mean for patients under our care. If we make this effort, then we can recognise hope, 
we can facilitate hope and also introduce strategies to inspire and coach hope in 
others. We can take the beginnings of hope and help mould them into achievable 
goals and aims and strategise pathways to reach these goals. We can partner with our 
patients to make hope an important, active and achievable part of their health care 
plan. 
 
Dialectic relations between hope and despair have been referred to as the existential 
paradox of chronic illness (Barnard, 1995). The line between hope and hopelessness 
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can often be very fine and sometimes blurred. Several study participants spoke about 
hope and hopelessness in the same sentence, feeling that talking about one 
necessitated mentioning the other. Living the paradox means those suffering chronic 
illness simultaneously confront their limitations and losses at the same time as 
leaning towards hope and possibility. The concept of therapeutic hope in MS was 
explored by Slater and Yearwood (1980). The need for a positive, affirmative mental 
attitude in MS management by HCPs was proposed to counteract the natural 
tendency toward negativity in PwMS (Slater & Yearwood, 1980). We, as nurses in 
general, have a responsibility to notice, acknowledge, understand and verbalise the 
possibilities, the abilities and the skills to live with chronic illness and to develop 
strategies with patients to do this successfully (Chesla, 2005).  
 
In healthcare, hope is of special interest because of the disruptive nature of illness 
that requires considerable healing resources for recovery to occur (Tutton, Seers, & 
Langstaff, 2009). For MS Nurses, understanding hope may also help to understand 
the individual’s experience of the recovery process and identify effective support 
strategies. In the field of MS, hope has been described as an essential element of the 
life journey, and the very presence of hope may help a patient to continue 
functioning more successfully or to remain independent for longer, bolstering self 
esteem and well-being (Morgante, 2000). Every person has a perceived future and in 
this dimension of existence, hope lives (Cassell, 2004). 
 
Hope research and hope theory 
 
“In studying hope I observed the spectre of human strength. This reminds me of the 
rainbow that is frequently used as a symbol of hope. A rainbow is a prism that sends 
shards of multicoloured light in various directions. It lifts our spirits and makes us 
think of what is possible. Hope is the same – a personal rainbow of the mind.” 
(Snyder 2002, p.269) 
 
Stepping back from the enormity of the hope literature in academia, exploring hope 
theory and its origins is necessary to give insight into how our thinking about hope 
has evolved over the years and how hope fits into life with RRMS. Early general 
hope literature recognised the desire to seek goals as part of hope (Cantril, 1964; 
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Frank, 1975) and the concept of hope as a way of thinking, as a cognitive process, 
was beginning to be recognised (Snyder, Irving, & Anderson, 1991). This led to hope 
being defined as “a positive motivational state based on an interactively derived 
sense of successful agency (goal directed energy) and pathways (planning to meet 
goals) ” (Snyder et al., 1991, p.287). 
 
In the following years, Snyder became a leading theorist on hope, believing that 
having a goal is the cognitive component anchoring hope theory (Snyder, 1994), the 
goal providing the targets of mental action sequences (Snyder, 2002). The means to 
achieve goals Snyder refers to as “pathways” (Snyder, 2002); what we would 
recognise as actions, the plan of what we would do to achieve a goal. An important 
part of hope theory also rests with the motivation to reach these goals, the “agency 
thinking” to achieve them. Hopeful thinking necessitates both “pathways” and 
“agency thought”, and they often feed off each other (Snyder, 2002). Thus, for 
PwRRMS, hope can be inspired and sustained by developing goals, making plans on 
how to achieve these goals, discussing contingency plans in case of obstacles, and 
maintaining the motivation to see the goals through to achievement.  
 
Snyder’s theory of hope conceptualises hope as a cognitive-motivational 
construction, which relies on the perception that goals can indeed be met (Snyder, 
1989) and therefore, realistic. Further research by Snyder and colleagues (2006, 
2014) suggests that people with high-hope (thinking characterised by specific and 
clear goals) are more successful at harnessing the resources needed to achieve their 
goals and at negotiating alternatives when obstacles appear. In contrast, people with 
low-hope (characterised by vague goals) tend to ruminate and rely on avoidance, and 
repeat cycles of goal blockage, escape and failure (Snyder, 2002).  
 
The MS Nurse is in an ideal position to assess the hope status of the PwRRMS. 
Identifying exactly where the PwRRMS is positioned in terms of low and high hope 
potential could prove helpful to the life journey as early intervention and guidance 
can provide the PwRRMS with both tools and resources to successfully self-manage 
the condition. When considering an unpredictable disease such as RRMS, with many 
losses along the way, with relapses, with an uncertain prognosis and with no cure, it 
is easy to see how easily a lack of hope can penetrate the thinking processes for 
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PwRRMS, block goals and impact on goal attainment. Indeed, RRMS can erode 
well-being and interfere with goal pursuits on many levels (Madan & Pakenham, 
2014) for example, interfering with cognition, mood and energy levels. However, if 
hope related pathways and agency thinking can be engaged and supported by MS 
HCPs, adjustment to RRMS may be improved, despite the losses (Madan & 
Pakenham, 2014). If MS Nurses have a basic understanding of hope theory and the 
importance of goals, they can help PwRRMS develop goals, articulate aspirations 
and strategise pathways to goal achievement and also discuss alternative routes 
(pathways) in the event of upheaval along the way. Additionally, as hope theory 
suggests that hope is a cognitive process, the high rates of cognitive deficits seen in 
RRMS (Chiaravolloti & DeLuca, 2008) may also have an impact on the ability of the 
PwRRMS to set up goals, and the agency thinking and pathways skills needed to 
achieve their goals. The MS Nurse can assess, intervene and help the PwRRMS in 
the case of issues with cognition with both goal setting and strategies to achieve 
goals, promoting both agency thinking and pathways. 
 
There are very few studies investigating hope specifically in MS, however a recent 
Australian study surveyed 296 PwMS (two thirds with RRMS) using various hope 
scales in an attempt to explore concepts of MS disease adjustment and hope (Madan 
& Pakenham, 2014). Findings from the study suggested that greater hope was 
associated with better adjustment to MS. Greater hope scores also predicted better 
life satisfaction, positive states of mind and lower depression, consistent with the 
earlier work of others (Foote et al., 1990; Lynch, Kroencke, & Denney, 2001). It is 
interesting that even though there were several decades between the studies, they 
showed similar results, despite the introduction of DMTs in the interim. This 
suggests that concepts of hope are just as important in the present time, even though 
treatments and prognosis have greatly improved, essentially leading to greater levels 
of hope. Hope has also been identified as a potent protective resource for coping with 
MS (Madan & Pakenham, 2014), and a resource that the MS Nurse is perfectly 
positioned in the health care team to recognise and assist with (Morgante, 2000). 
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Hope in the nursing literature 
 
“Hope is central to life and specifically is an essential dimension for successfully 
dealing with illness”(Fitzgerald Miller, 2007, p.12) 
 
Various conceptualisations of hope have also been posed in the nursing literature. As 
difficult as it is to conceptualise hope into a simple and neat definition, it is an 
important model for nurses to understand as it underpins our views about strategies 
to use with patients, especially during different stages of health and illness 
(Fitzgerald Miller, 2007). Hope has been described in theoretical terms for decades, 
but recognition of hope as a concept in nursing is a more recent development (Herth, 
1990), which continues to grow (Cutcliffe & Herth, 2002). Before any inductive 
nursing studies were undertaken, Miller (1985) explored the empirical literature on 
hope and identified elements of hope that can be demonstrated and taught to patients 
and families by nurses. These elements included radiating hope, expanding the 
patient’s coping skills, teaching reality surveillance, helping with setting and 
obtaining goals and helping to renew spirituality (Miller, 1985). 
 
In the 1980’s, the first inductive nursing studies of hope were performed, looking at 
the role of hope in specific groups such as adolescents and those suffering cancer 
(Hinds, 1984; Owen, 1989). Hind’s study used grounded theory methodology to 
define hope as the degree to which an adolescent believes that tomorrow exists 
(Hinds, 1984). The research in cancer also used grounded theory methodology to 
develop a conceptual model of hope, resulting in six themes: goal setting, positive 
personal attributes, future redirection, meaning in life, peace and energy (Owen, 
1989). Indeed many of the key elements and themes of hope as expressed by Miller, 
and later by Owen, were also important for participants in the current study and will 
be discussed at length in the two subthemes to follow.  
 
Further work in the following two decades built upon these theories and concepts of 
hope with Stephenson (1991) reviewing over 50 papers to develop conceptual 
attributes of hope. These attributes included viewing hope as a basic human 
experience, providing meaning in life, being fluid in nature and not static, being 
multidimensional and being associated with nursing (Stephenson, 1991). All of these 
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attributes could be applied to the current study participants and particularly the 
concept of hope being fluid and not static. This has deep connections to the variable 
disease course of RRMS, with unpredictability and periods of remission. Several 
years later Morse & Doberneck (1995) reported the concept of hope as being poorly 
understood, despite the growing nursing research, and proceeded to interview 
patients themselves to gain a deeper understanding of hope. This resulted in seven 
universal components of hope being identified: a realistic initial assessment of the 
threat, envisioning alternatives and the setting of goals, bracing for negative 
outcomes, a realistic assessment of personal and external resources, socially mutually 
supportive relationships, continuous evaluation for signs to reinforce goals and a 
determination to endure. Whilst all of these hope components were seen in most of 
the current study participants, a determination to endure was also present in all of 
them.  
 
There is a paucity of hope related nursing research specifically in MS. However 
nurse researchers in other areas of chronic illness have found that patients showing 
signs of higher hope (characterised by specific and clear goals) have been associated 
with better adjustment in spinal cord injuries (Elliott et al., 1991; Lohne, 2001) and 
breast cancer (Stanton, Danoffburg, & Huggins, 2002). A nursing study of hope 
which fits well with the life story of MS is from a study exploring hope and its 
meaning in patients with spinal cord injuries (Lohne, 2001). In this study of 10 
people one year after their initial injury, Lohne (2001) found that every participant in 
the study had hope, although for some it was sometimes silent hope, which was left 
unexpressed.  Hope was described as intensely personal, as giving inner strength and 
as being a motivational spark (Lohne, 2001). Lohne developed this concept of hope 
in later years, describing hope further as a universal and dynamic concept, which is 
personally significant (Lohne & Severinsson, 2006). Similarly to how Lohne 
described hope in spinal cord injuries, hope appears to be universal, dynamic, 
motivational and personally significant in RRMS as well.  
 
Morgante (1996) provided the first insights into hope, PwMS and the role of the MS 
Nurse. MS Nurses can be a healing presence in the lives of their patients due to their 
nurturing care, empathy and support of PwRRMS (Morgante, 1996). Additionally, 
nurses who care for PwRRMS and their families can provide resources to inspire 
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hope and prevent hopelessness (Morgante, 2000), often maintaining hope whilst 
untangling a web of false hope (Morgante, 1996). MS Nurses are in an ideal position 
to develop strategies with their patients to explore personal goals, to utilise support 
and resources and to formulate care plans to enhance the likelihood of goal 
achievement, which has been demonstrated to be a vital component of hope. Hope 
may also help a patient with MS to continue functioning more successfully, remain 
independent for longer and may also have a synergistic effect on medical therapies 
(Morgante, 2000). 
 
The overarching theme of Holding Hands with Hope can be further developed into 
two subthemes to explore these concepts in greater depth - hope in its many forms 
(how hope is expressed by PwRRMS and different types of hope) and purposeful 
positivity (actively seeking out positivity to express hope).  
 
Hope in its many forms  
 
Our personal ideas of hope will be shaped considerably by our own personal 
experiences, and no two life experiences will be exactly the same. During the 
interviews with participants for the current research study, I was struck at times by 
the different types of hope people fostered, although during the interviewing phase I 
had difficulty in defining exactly what these types of hope were, and how hope fit 
into the wider model of MS care. A recent study from the 
physiotherapy/rehabilitation specialty in neurological diseases and injuries has shed 
some light on several different types of hope that PwMS may possess and use in their 
MS journey, including concrete hope, hope in possibility, active hope and 
transcendent hope (Soundy et al., 2013). Further work by Soundy and colleagues 
(2016) used thematic synthesis to examine 47 studies of MS to identify expressions 
of hope in MS patients as hope for a cure, hope for improvement, hope for normality 
and hope to cope. I did not recognise all of these elements of hope in the current 
study participants, possibly because Soundy et.al’s. 2013 study primarily focused on 
spinal cord injuries and stroke, and to a lesser extent on MS. However, all of these 
concepts of hope helped me build a clearer picture of the types of hope I was being 
informed about by the participants. I was guided in some of my hope descriptors on 
concepts from Soundy and colleagues (2012, 2013, 2016) research work in hope, but 
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also extended them to be more inclusive of the personal stories I was hearing and 
types of hope that have not previously been reported in this population.  
 
Previous qualitative nursing research on the experience of living with RRMS 
reported that PwRRMS hoped to manage and maintain function as part of their future 
(Miller, 1997). As Miller’s study (1997) was conducted prior to the introduction of 
DMTs to control RRMS, it was interesting to explore if hope to maintain function 
would still be as important to PwRRMS today now that disability outcomes have 
greatly improved. The answer was a resounding yes, it was extremely important for 
many of the current study participants, and in several different ways, which will be 
discussed in further detail below.  
 
The specific types of hope I developed from the study participants during the 
interviews included the following: functional hope (wanting to retain functional 
ability, especially the ability to walk unaided), restorative hope (to be returned to 
their previous state of health), curative hope (hope for a cure) and defiant hope 
(challenging and resisting RRMS). To a smaller degree, realistic hope (acceptance at 
the current situation and a good understanding of the possibilities ahead) also had a 
place in almost every story, but was more inferred in their storytelling and overview 
of their condition rather than discussed openly as a form of hope. In addition, I 
believe that every participant harboured personal/secret hopes which live inside of 
them, mostly unsaid and perhaps never truly examined, shared and explored. I felt 
this because I witnessed the looks of longing, the pensiveness in conversation, the 
struggling to grasp something when discussing hope and put it into words. I am 
unsure of why this may be. Perhaps the participants were frightened to share their 
feelings of hope in case they are not shared by others and therefore may be 
extinguished, resulting in devastation. Or perhaps, speaking them out loud takes 
away some of the mystery and reveals too much of their soul. Or perhaps, these 
secret hopes are simply too complicated to summarise into words and feelings. In a 
study of hope in spinal cord injuries, the researcher felt that every participant in the 
study had hope, although for some it was “silent hope”, remaining unexpressed when 
physical progress stagnated, but requiring courage and endurance (Lohne, 2001). 
Perhaps a similar concept could also apply to PwRRMS, hope remaining even in 
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times of distress or crisis, just remaining unexpressed at that particular time. But not 
far from the surface. 
 
Hope has also been identified as both an active process and as a more passive one 
(Soundy et al., 2013). Active hope can be seen in patients who can identify and act 
on a goal, possessing connectedness and demonstrating optimism (I see this as being 
aligned with Snyder’s version of high-hope) as opposed to those patients 
demonstrating more passive hope where they may have a vision of hope but cannot 
use that vision to move forward, often kept back by fears  (I see this as being aligned 
with Snyder’s (2002) version of low-hope) (Soundy et al., 2013). Most of the types 
of hope uncovered in the current research study are quite active in their character, 
perhaps participants did not express more passive hope in keeping with the nature of 
the concept. Being able to identify different types of hope in patients enables MS 
Nurses to be able to engage more deeply, to gain more from interactions with 
patients and perhaps most importantly, to be able to help patients in adjusting to 
RRMS and to ensure the best possible outcomes, assisting with realistic goal setting, 
pathways management and goal achievement.  
 
Functional hope 
 
Functional hope captures the hope of retaining functional capacity, the ability to 
perform activities of daily living such as walking, showering and getting dressed. 
Functional hope aligns somewhat with Soundy et al.’s (2013) description of adaptive 
hope, which centres on the hope to manage and retain functional ability in 
neurological conditions. However, functional hope in the current study appeared 
more urgent, more determined and more centred on keeping function rather than 
adapting (as shown in the quote from Paul below). Expressions of functional hope 
were very common in the interviews and pertained mainly to ambulation and the 
ability to walk. Functional hope was expressed by the study participants in one of 
either two ways; to stay out of a wheelchair/walking aids or to be actively walking 
and ambulant. Two sides of essentially the same hope, to retain walking function. 
Optimistic, goal directed cognitions are aimed at distancing a person from negative 
outcomes (Gillham et al., 1995), which is slightly different to hope theory where the 
person aims for future positive goals and the methods to achieve them (Snyder, 
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2002). In the current research study, the participants most often expressed this as an 
overt wish to stay away from anything to do with wheelchairs and ambulation aids 
such as walking sticks and canes. Thinking optimistically to distance from negative 
outcomes, this would be a desire to not be wheelchair bound or requiring a walking 
stick. Thinking in terms of hope theory, it would be a desire to stay fully ambulant, 
to be walking “as normal” and the methods to achieve this state, such as participating 
in yoga classes, taking DMTs as directed or seeing a physiotherapist for an exercise 
prescription. 
 
As discussed in an earlier theme, (Re)defining Me now that I have RRMS, under the 
subtheme dare to compare, Paul expressed determination to stay out of a wheelchair 
in the future, having glimpsed a little of what that type of life could entail during his 
unhappy, early visits to MSA meetings not long after his diagnosis (he refused to 
attend these meeting again). What he witnessed there made him determined to avoid 
the “wheelchair scenario”, demonstrating optimistic goal directed cognition. This 
was also Paul’s reasoning in the theme The DMT Dance with his wanting to front 
end load and have a higher efficacy DMT despite the side effect risks. Paul did not 
want to end up in a wheelchair as a result of RRMS, his functional hope active and 
determined. Paul’s quote is breathtaking, almost childlike in its simplicity about 
camping being the other option to a wheelchair. 
 
I don’t want to be in a wheelchair, I want to be able to go camping. Paul line 727 
 
For Rudi, Margot, Ruby and Piper, the physical act of walking holds personal 
importance for them, and their hope for the future involves being ambulant and 
functional, and the reason they pay such close attention to their own health, fitness 
and well-being. 
 
I see life being good and I hope to continue to travel and do the things I want…I see 
my future as I am today…I dream of me walking in that. Rudi line 1707 
 
So the future I see…I hope that I don’t get to the stage where I need a wheelchair all 
the time…but hopefully…I think, use it or lose it…I make myself do things. Margot 
line 2459 
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I’m going to walk…to do things with my husband…let’s go do this, let’s go do 
that…my son really wants to go to Hawaii, so I hope my legs can work enough to 
take him. Ruby line 1560  
 
If I wasn’t being treated it might be a slippery slope downwards…I feel more 
confident knowing that a lot of these drugs are showing positive results…I do 
envisage myself hopefully never being with a walking aid, purely because of the 
medications…that’s what I’m hoping for. Piper line 2021 
 
Restorative hope 
 
Similar to functional hope, restorative hope is mainly about retaining function, but 
differs from functional hope in that it is more of a hope to be returned to previous 
levels of function, before the onset of RRMS. This would have been considered 
impossible even a decade ago, but some of the newer DMTs have been reported to 
improve function and reduce disability, for the first time in MS care (Coles et al., 
2012).  
 
For study participant Ruby, recently completing a course of the DMT alemtuzumab 
encouraged her to be hopeful for a complete recovery and return to earlier function, 
of restorative hope. Rudi had experienced bouts of hopelessness after several severe, 
debilitating attacks, but also gained confidence from her neurologist that the newer 
DMTs may restore her to better health.  
 
I don’t feel so weak…I was walking yesterday, it’s no marathon but for me it was 
pretty good…so fingers crossed I really hope so, I want the function back…I used to 
be able to walk with the kids everyday when we first moved here…so I want that sort 
of function back. Ruby line 629 
 
Normal, I just want a very normal lifestyle…I just don’t want to be in bed or on the 
sofa…I want to be moving…just a very simple life…and not all about me, it would be 
nice if it wasn’t all about me. Ruby line 1575 
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(The neurologist said) with treatment we don’t hope to keep you where you are at, 
we hope to keep you better…so I think…I had a bit of confidence in her…great. Rudi 
line 1635 
 
Curative hope 
 
Of course, hope for a cure in the future was also very common in this group, fuelled 
by recent advances in DMT development and in new therapies. For many 
participants, they felt lucky to be diagnosed in a time where a cure could be possible, 
and this was expressed as a form of hope.  Will and Susan feel certain that a cure for 
MS is imminent. Evie was also hopeful of a cure, but not in her lifetime, perhaps also 
exercising a form of realistic hope. 
 
In this small amount of time we’re only getting better, we’re getting more efficient at 
what we do…it’s only a matter of time…a cure is going to happen so I know for me 
it’s not going to be an issue, but now I need to make sure I keep on top of myself. 
Will line 374 
 
I believe that some type of drug…will be a permanent solution. I believe there will be 
something. Will line 1507 
 
I feel very positive about the future and with all the new medications, all the support 
out there…a cure…and with all the research and new medications, there’s a lot there 
to help people to lead a normal life. Susan line 1047 
 
All of this research happening, one day they’ll find a cure and I might be dead by 
that point, but it’s going to happen…you need to be optimistic about it, the future 
and what you can do…there’s a lot of good people doing good work. Evie line 1458 
 
Defiant hope 
 
I really don’t do things by halves…getting back to gym so soon after treatment was 
very important to me…I was being more defiant…it helps…you know what, MS? You 
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can knock me down, but I’m going to get up, and then you bounce back, kinda 
defiant. Evie line 1299 
 
Defiance has also been referred to as a “fighting spirit” as the PwMS shows 
determination to battle MS (Reynolds & Prior, 2003), demonstrated succinctly by 
Evie in the quote above. One of the hardest aspects to accept for patients can be the 
drastic change to their identity brought about by MS, often hoping to return to their 
pre-diagnosis identity (Soundy et al., 2012). A recent study of 11 PwMS, five of 
whom had RRMS, used content analysis and thematic analysis to explore patients 
expressions of hope in a rehabilitation setting (Soundy et al., 2012). Some study 
participants set themselves a challenge to overcome, to defy MS and the expectations 
and passiveness that other patients or clinicians had towards MS, by taking action 
they were doing something to progress hope (Soundy et al., 2012). After several 
interviews in the current study, I identified this type of defiant attitude as a direct 
expression of hope, almost at its most bold and daring and key to the participants in 
their hope journey. Defiant hope provided a way to challenge the expected prognosis 
and progression of MS. Defiance didn’t come easily for most study participants and 
involved more than positive thoughts and an optimistic outlook; defiance needed 
deliberate action, clear goals, and to be supported with plans, resources and active 
engagement. The majority of the participants in the current study openly challenged 
their RRMS, issuing a resistance that at times captured the very essence of defiance.  
 
After twenty years of living with RRMS, Evie still offers resistance to RRMS and 
remains positive about the future, regularly challenging her physicality and 
expressing defiance as a means to show others that RRMS doesn’t stop her doing 
anything. 
 
I did go bungee jumping six months later (after MS diagnosis) just because I 
could…trying to prove a point and now I’m almost 40 and I still do those things just 
to prove a point…I went indoor rock climbing a few weeks ago…you’re not going to 
get me, it’s not going to happen…sky diving, same thing. Evie line 657 
 
Piper tries to live each day issuing resistance to MS, becoming even more defiant 
when she is troubled by debilitating symptoms of MS such as fatigue and nerve pain. 
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OK…just get out there and do stuff while you can…and I do that everyday. I like 
going for my walks and runs…people say to me “why do you do that to yourself?” 
and I say “well, I do it because I can…because I know what it’s like to not be able to 
walk”…Even when I’m feeling lousy and I’m feeling fatigued with the MS in 
particular, I will do it, I will push myself and I will do it. Piper line 990 
 
Kate was working full time, mothering, looking after sick parents and studying for a 
higher degree when she experienced many debilitating relapses. Although many 
would have reduced their workload at such a busy time, for Kate, studying was her 
lifeline, her turning point against the disease. Kate describes achieving her higher 
degree as her greatest life accomplishment and representing active defiant hope 
against RRMS.  
 
MS would just pop up it’s ugly head but I didn’t make it important…I tried not to. I 
did not place too much emphasis, it was an inconvenience yeah, but it was not my 
biggest problem…I thought…you’re not going to beat me, I’m going to do what I 
want. Kate line 1777 
 
Joy was confined to wearing sensible, flat shoes due to her significant gait issues and 
depended on a local shoe shop in her small rural town to order her supplies. Trying 
to recapture positive and happier times, Joy decided she wanted to try high heels. Of 
course, the shop assistant used to Joy’s usual symptoms didn’t think this was a good 
idea and questioned her choice, but Joy was determined. This simple act of defiance 
led to a simple, yet remarkable turnaround. 
 
So I took a deep breath and I stood up in these high heels…so I stood up, adjusted 
my gait and then I walked towards the mirror…I walked with my head held high, 
with confidence…I was so empowered, I felt so strong…I felt like I got my whole life 
back…it was really special. Joy line 1291 
 
The study participants seemed to garner more hope with their defiance, perhaps 
because this meant that they were actively taking a stand and actively taking control, 
rather than MS taking control. Defiance gave a certain sense of purpose, a reason to 
get up in the morning, a reason to exercise, a reason to take DMTs even when the 
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going gets tough. Defiance is a form of hope and an expression of being hopeful, of 
belief in oneself. MS Nurses can foster defiance in patients by helping them to 
understand their current capabilities (not just their disabilities), to resist comparisons 
with others and to concentrate on the resources and value that they already have and 
which can be developed even further. 
 
Nurses have been identified as having a crucial role in facilitating hope in patients 
and their families (Tutton, Seers, & Langstaff, 2009). It has been suggested that 
nurses are an important source of hope for people that are vulnerable and ill (Herth, 
1990; Herth, 1996; Cutcliffe & Gant, 2001) due to their constant and prolonged 
contact with those who are suffering, forming close connections and being in an ideal 
position to influence feelings of hope (Travelbee, 1971). Nursing strategies to inspire 
hope involve the presence of another human who demonstrates unconditional 
acceptance, tolerance and understanding (Cutcliffe & Herth, 2002). Other hope 
promoting strategies include fostering interpersonal connectedness with others, 
assisting with attainable aims and goals, encouraging spiritual practice in those who 
value spirituality, encouraging personal attributes such as a sense of humour and 
affirming the worth of a person (Herth, 1990), benefit finding, expanding coping 
skills and sustaining caring, therapeutic relationships (Miller, 1991), functions all at 
the heart of the MS Nurse’s role. Communicating one’s own sense of hope is also an 
important strategy for inspiring hope in others (Fitzgerald Miller, 2007), and for the 
modern day MS Nurse, this is a somewhat easier task than in years gone by, with so 
many new, proven, efficacious DMTs and many promising treatments on the 
horizon. As demonstrated by the forms of hope discussed above, for PwRRMS 
today, hope burns brightly as the possibilities for the future, for treatments and for 
the Holy Grail, a cure, are for the first time very real.  
 
Purposeful positivity 
 
I think there’s a measure of optimism, I think it’s not even control, I think you can 
decide what path you’re going to take…if you’re being negative all the time it’s 
going to be bad for your MS, if it’s negative, it’s down, it’s feeling awful, woe is 
me…it’s getting out of that perpetual cycle of negativity, it’s being optimistic about 
the future, about looking forward to something going well. Evie line 1435 
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Throughout the interviews I detected a sense of purpose for many participants when 
they were discussing hope and remaining positive through their journey, a process 
where they actively engaged with being positive, which I later termed “purposeful 
positivity” to capture this intention. It didn’t seem to just happen randomly, as 
highlighted by Evie in the quote above, purposeful positivity was a very active 
process which was more conducive to living well and happily with RRMS for the 
study participants. Examples of purposeful positivity included choosing and 
sustaining optimism, benefit finding, searching for meaning, harnessing a sense of 
humour, expressing spirituality, and giving back to the MS community. 
 
Perhaps one of the most poignant examples of purposeful positivity came from Joy, 
whose obese husband suffered a sudden fatal heart attack, falling on top on her and 
crushing her beneath him. She managed to crawl out from underneath him and 
survive, the incident starting a new path for Joy where positivity became key to 
regaining control. 
 
That instant (my husband died unexpectedly) was beyond devastating…but that surge 
of whatever it was when he fell on top of me…that choosing life…whatever it was 
that surged through me at that point did something in my chemistry…at his funeral I 
was battling into the church to walk…but I started to improve, in fact I made an 
absolute heart felt decision that I would get better no matter what…something 
switched on, I chose life…if my body won’t do what I want it to do…there’s got to be 
another road…I started fighting for it…I felt like I had the power to control my 
health…it may or may not have been true, but I made it true. Joy line 969 
 
Optimism and a positive outlook 
 
Being diagnosed with RRMS in the current climate of breakthroughs in scientific 
research and newer, more efficacious DMTs gives rise to the possibility of greater 
positivity and optimism. Additionally, the huge variability in possible RRMS 
symptoms and disease severity can also inspire confidence. A recent study exploring 
parents’ experiences of their child living with RRMS, interviewed 31 parents in 
semi-structured interviews and used grounded theory to analyse the results (Hinton 
& Kirk, 2017). One of the important findings identified in managing the uncertainty 
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of MS was “optimistic thinking”, hoping for a future where their child would be 
minimally affected and lead a “normal life”, the huge variability of RRMS by its 
very nature aiding optimism in this regard (Hinton & Kirk, 2017). Although this was 
the viewpoint of the parents and not the PwRRMS, the concept of the latitude for 
hope and positivity in an uncertain disease is an important one, and also has 
applicability to adults living with RRMS. As MS Nurses, the unknown disease 
variability forms the basis of many consultations with our patients and allows 
positivity and hope to always have a place in our care.  
 
Often the diagnosis of RRMS can cause negative reactions in the PwRRMS, as 
explored by the earlier themes of this study in chapter 6. Over time however, many 
PwMS report positive changes in terms of values and outlooks, as well as an 
increased appreciation for life (Irvine et al., 2009). It has been reported that thoughts 
are effective tools in garnering the motivation necessary to commit to behavioural 
change and that positive thinking may benefit motivation in MS (Hall-McMaster, 
Treharne, & Smith, 2016). Positive thinking is an active behaviour and entails having 
a goal in mind, being self sufficient, letting go of the past and reinforcing positive 
actions by doing something good (Hall-McMaster et al., 2016). Once again, as with 
hope theory, it is postulated that positivity takes deliberate cognitive action and 
working out what is necessary to reach goals, of possessing determination (Hall-
McMaster et al., 2016). Traumatic events challenge beliefs, with the result that 
humans make active efforts to restore, or to enhance their beliefs and exercising 
positivity is a way to cope with adversity (Taylor & Armor, 1996). Dennison’s 
model of adjustment to MS suggests that those who adjust more successfully to the 
diagnosis use the following resources: positive reappraisal, optimism, hope, benefit 
finding and spirituality (Dennison et al., 2009). 
 
Strategies to sustain optimism include avoiding being around those with negative 
views who challenge (sometimes fragile) hope (Hinton & Kirk, 2017). Staying away 
from negativity in others could involve distancing from family members, friends, 
work colleagues and sometimes MS organisations in some cases. In the current 
study, participants Will, Paul and Jane elected not to become involved with the local 
MSA meeting groups to avoid being reminded of the negative aspects that MS could 
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bring and to maintain and instead to nurture optimism and positivity from their own 
family and friends. 
 
Patient attitude has been identified as a major influence on overall disability burden 
in MS in a large, cross sectional Belgian study of 1372 participants living with 
RRMS (D’Hooghe et al., 2013). This study reported that those patients who scored 
higher on health promoting behaviour (such as physical activity, spiritual growth) 
were significantly less likely to reach a level of disability where they needed 
assistance to ambulate (a single walking stick) (D’Hooghe et al., 2013). As patient 
attitude is an area of possible control for the PwMS, educating patients about the 
importance of a positive attitude could significantly contribute to better and more 
positive outcomes (Lysandropoulos et al., 2015). 
 
Both Piper and Griff exercise the power of positivity, of being in control of the 
disease and verbalising a better future. A sense of control appears to resonate heavily 
with a sense of hope and positivity. Piper has had extensive counselling so that she 
can feel in control of MS and enjoys the challenge of keeping the disease in check. 
This leads to hopeful feelings for her future health. Griff, ever the optimist, simply 
regards himself as lucky and is pragmatic about what may happen in the future. 
 
Even if I’m having a bad day with MS I know that I’m in control of my thoughts and I 
can think whatever I want…I can change that thought process. Piper line 1772 
 
I think I live almost day by day…I can’t picture what it’s going to be like…if I look to 
a future with MS I do believe that I’ll be dead and buried before my MS puts me in a 
wheelchair…I just don’t think it’s going to happen. I’m lucky. Griff line 1367 
 
Susan, unhappy with the way RRMS was controlling her emotions and keeping her 
from her dreams, embarked on a counselling course so she could learn to take back 
control of her life, and understand herself better in the process. Susan regards this 
course as a life-changing event for her, finally enabling her to enjoy life, help others 
in her role as a HCP, exude positivity and put years of despair firmly behind her. 
Susan uses the skills she learnt during the course now as a new mother with RRMS 
and fatigue, to see things differently and remain optimistic and positive.  
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Accept it, embrace it, because it doesn’t mean the end…and then I looked at it…that 
it was a new beginning for me…I did look after myself more with what I ate and I 
exercised. Susan line 806  
 
You always have to hold on to your dreams because that’s what keeps you 
going…what you are striving for…you have that to help you get up each day and get 
on with life and make yourself a better person and stronger to help others around 
you. Susan line 1128 
 
I feel positive about the future and people being diagnosed with MS now…this 
medication will be able to help them…there’s a lot that’s happened. Susan line 1202 
 
MS Nurses can foster positive thinking in patients by encouraging a focus on 
positive aspects of their life and by using positive self talk (Roger et al., 2014).  MS 
Nurses can also remind patients that cultivating optimism and hope will assist with 
self confidence and regaining control of their lives, and taking part in programs such 
as intensive wellness programs can also improve self efficacy and positivity (Ng et 
al., 2013). As a positive attitude helps with regaining control over MS and more 
positive outcomes overall (Lysandropoulous et al., 2015), providing education on the 
importance of positivity and methods of achieving a positive state of mind can 
potentially have a significant impact on the future for the PwRRMS.  
 
Searching for meaning 
 
Searching for meaning is another expression of positivity and has been described as a 
cognitive process to find order and purpose in illness (Sharpe & Curran, 2006). 
Creating meaning in life for PwMS can involve participating in meaningful 
activities, developing new interests, and engaging in life with more purpose. This 
concept was captured in a recent study where participants learning to live with MS 
were likened to “learning to fly with broken wings” (Flesner & Rudolfsson, 2016). 
Several of the participants in the current study expressed feelings of gladness that 
things changed in their life, sometimes for the better, as a result of MS. Rudi 
described the time where she couldn’t work due to recurrent severe relapses leaving 
her with residual neurological dysfunction for several years. At the time she was 
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raising four young children and really needed the money to support the family. 
However, she chose to look at the situation differently and saw meaning in the illness 
as giving her time to spend with her family during some very important years. 
 
When I lost my job, I thought I can be down and think I’m unemployable…I can’t 
work…the path I chose to take was that work’s always going to be there forever, the 
kids are going to grow up and I need to look at this as I’m lucky because I get to 
spend this time with my children…whilst it was tough financially, we adapted. Rudi 
line 944 
 
Choosing to rise above the possibilities of the diagnosis and concentrate on a life 
well lived with MS is a conscious, positive choice. Kate looked inward to find her 
life meaning and Rudi changed her perspective on money to live life to the full and 
uncover new meaning. By seeing RRMS as something she lives with, but not the 
entire story, Evie makes a choice to find meaning in all she can do rather than what 
she cannot do. 
 
It gave me strength to think, whatever this is, I want to get over it…I’ve got things to 
do…more important things…and that’s the way I was driven. Kate line 388 
 
Finances play a big role with anyone and I had lost my full time job (because of 
RRMS) but you know, stuff it, it’s just money, so we went to Fiji last year…I’m just 
doing a lot more and loving it…you change perspective. Rudi line 910  
 
MS is not the main life…it doesn’t define who I am, yes I have it, but it isn’t who I 
am…I do not let it define me, I have it, it bothers me, it drives me insane and it makes 
me angry, but it is not the core of who I am as a person. Evie line 1184 
 
It’s not all doom and gloom like people might think…if I ever go rock climbing again 
I want some photos because I want to upload to MS Society so people can see that 
you can do these things…you shouldn’t focus on what you can’t do, it’s what you can 
do, it’s what you want to do. Evie line 1232  
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Harnessing a Sense of Humour 
 
Another strategy to maintain a positive sense of self whilst living with a neurological 
condition is to use humour (Roger et al., 2014). A qualitative study interviewed 27 
women with MS and used interpretative phenomenological analysis to investigate the 
results, finding that positive thinking and finding “jewels” in their situation were 
important themes when living with MS (Reynolds & Prior, 2003). Participants were 
found to consciously value special and positive moments, actively looking for 
benefits, maintaining social relationships and enjoying fun and humour (Reynolds & 
Prior, 2003). Similarly, an earlier study reported exercising a sense of humour, along 
with maintaining a positive attitude, as important tools to living a life well with MS 
(Gulick, 2001). Several study participants demonstrated a healthy sense of humour 
during our interviews, at times telling me poignant or distressing stories but laced 
with laughter, giggles and the ability to have a laugh at their own expense. It has 
been reported that humour is a way to maintain a positive sense of oneself and play 
down the challenges in life, playing an important role in encouraging positivity in 
neurological diseases (Roger et al., 2014). Kate and Margot in particular, perhaps the 
two most physically disabled participants in the study, recalled sad stories at times, 
but quickly focused on humour to see the funny and bright side.  
 
Kate was describing to me a time when she had to do a presentation but was crippled 
by severe spasticity which affected her gait. Recalling the situation, which could 
have also been portrayed with torment, Kate laughed and re-enacted the walking 
motion in front of me. 
 
I can’t bend my knees…and when I walk, I walk like, you know, the Tinman! 
(laughing) in the midst of all this I had to give this lovely presentation (giggles). Kate 
line 1343 
 
Margot, who initially experienced so much angst thinking about the possibility of a 
wheelchair as her mobility gradually and intermittently deteriorated, saw the funny 
side of a wheelchair mishap on holidays with her husband overseas. 
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We unwrapped the wheelchair…it was all bubble wrapped that’s got fragile all over 
it…everything was chucked on top…and one of the struts on the side was bent, so 
(husband) is manoeuvring it (laughs boisterously) and he ended up breaking it (more 
laughing)…and broke the strut…so off we go…(bouncing on) cobblestones all 
through (the town) (giggles). Margot line 1633 
 
Margot also told a story of rising from her wheelchair in a shop to shock the shop 
assistant, walking slowly away from the wheelchair and proclaiming at the 
assistant’s puzzled look “I know, it’s a miracle!”. For some, a touch of humour (at 
the appropriate time) can be a more comfortable way to address some of the more 
uncomfortable aspects of living with RRMS. MS Nurses can also support and 
encourage PwRRMS in the value of humour in their life journey. 
 
I did wonder if Kate and Margot laughed at the time of the incidents, or if time 
allowed them the luxury of being able to look back on an initially emotionally 
painful event with a new sense of humour. But, getting to know Kate and Margot 
through the life history interviews, I suspect they both did feel the brighter side of the 
situation at the time.  
 
Faith, religion and spirituality 
 
Improving the health and well-being of the whole person, mentally, physically and 
spirituality has been at the forefront of nursing since inception (Nightingale & 
Skretkowicz, 1992; Reinert & Koenig, 2013), therefore considering the impact of 
spirituality in the life journey of RMMS is essential. For the purpose of this study, 
concepts of faith, religion and spirituality will be viewed as not just as traditional 
religious faith, but as belief or belonging to any sort of higher being or spirit and will 
collectively be referred to as “spirituality”.  
 
It has been suggested that spirituality is related to better adjustment to illness, 
providing a sense of coherence and meaning, purpose and the courage to endure 
suffering (George, Larsen, Koening, & McCullough, 2000). However, there are very 
few studies exploring spirituality in MS and those that have been published have 
somewhat contradictory messages regarding the importance of spirituality in MS. An 
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early study in Australia surveyed a group of 101 participants with MS (phenotype 
not specified) and reported that those PwMS who derived high levels of meaning 
from personal belief systems also experienced high levels of quality of life and 
psychological well-being, as well as lower levels of depression and anxiety (Makros 
& McCabe, 2003). A small study of seven PwMS (type not specified) found that 
PwMS did have an increased appreciation for spirituality in their lives (Irvine et al., 
2009), which has also been supported by others suggesting that spirituality may be a 
helpful resource to cope with chronic disease in general (Bussing et al., 2009; 
Bussing et al., 2013; Levine, Aviv, Yoo, Ewing, & Au, 2009).  
 
However, contrasting with this work are early empirical findings in larger studies 
which have suggested that PwMS may be less engaged in spirituality when compared 
to patients living with other chronic diseases (Bussing et al., 2005). A more recent 
study of 213 participants, half of whom identified as RRMS, found relatively low 
levels of faith importance in the study sample, with only 10% of participants 
reporting reliance on faith to carry them whilst living with MS, most participants 
citing family or themselves as their source of support in the MS journey (Wirth & 
Bussing, 2016). It is worth noting however, that this particular study enrolled 
younger participants between the ages of 25 and 40 years, possibly influencing the 
results as it has been suggested that age is also positively related to higher measures 
of spirituality (Bussing et al., 2005).  
 
In the current study, Joy expressed positivity from actively practicing spirituality, 
when she recalled stories about the disciples of Jesus healing a cripple, which is how 
she used to see herself.  She used this story to inspire positivity in herself and a belief 
that miracles could happen. 
 
I was reading my bible one day and I read this passage that talked about the 
disciples and there was a beggar there crippled from birth…they said “in the name 
of Jesus Christ rise up and walk” and then the cripple stood up...walking and 
leaping and praising God…and this really impacted me…suddenly I could relate to 
it…if that kind of miracle is possible, what does walking, leaping and praising God 
look like in my life? And I pushed my body to walk. Joy line 1120 
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In western religious thought, individuals strive to maintain an idea of self that is in 
harmony with the universe and God and suffering has a purpose and provides a way 
for humankind to enter a divine relationship with God (Goodrick-Clarke, 2008). It is 
important for the MS Nurse to have an awareness of the cultural/spiritual beliefs of 
the patient, as it is helpful to form the basis of individualised and patient-centred 
care, and can be incorporated into the nursing care plan.  
 
When things aren’t going so well in life, spirituality can provide an avenue of 
support that adds another element to purposeful positivity. For Evie, this was an 
important support in her hour of need, for Joy as a child it was the only real support 
she had, and for Davina, re-engaging with spirituality during a dark time gave her 
new insights, although she started off angry and disbelieving. 
 
It doesn’t scare me because I think there’s more…there’s more…I have always 
believed there’s more…call it God, or whatever religious faith, I don’t particularly 
hold any, I consider myself very spiritual…you have to turn to your faith when life 
isn’t so great. Evie line 683 
 
Faith was really the only thing I had growing up as support. I took myself to church 
from age six…faith is a huge part for me…in spite of everything around me…I 
couldn’t explain that to people…it was my faith that kept me going especially when I 
lost my ability to comprehend (when Joy became dyslexic). Joy line 1819 
 
The other thing I got back that’s really helped me…I got my faith back…after I was 
diagnosed with MS I went back to church…but I went back really angry. Davina line 
1152 
 
The minister helped me I was this screaming possessed woman and he turned my life 
around, got me in contact with women in the church who had been in really bad 
situations overseas, older women...having my faith back actually made me a bit 
stronger, it has helped me tremendously…I feel a bit more supported. Davina line 
1176  
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Expressions of spirituality were not confined to participants in the current study. At 
times, spirituality was an important coping mechanism for their loved ones as well. 
Susan’s family engaged in regular prayer groups after her diagnosis, drawing 
strength from others in the group, whilst Susan elected not to become involved. 
Kate’s mother was deeply religious and although Kate herself was absolutely 
terrified of her symptoms, her mother was convinced from her spiritual beliefs that 
RRMS was going to go away. Because of the natural relapsing and remitting 
evolution of the disease, this may have enhanced this aspect of hope for families as 
symptoms disappeared and their loved one regained usual function, possibly as a 
result of their faith. 
 
Giving back and being involved 
 
Another strategy to inspire hope and positivity demonstrated by the participants was 
a willingness to become involved in the fight against MS and to give back to the MS 
community in some way. Kate expressed one of the most incredible stories of 
selflessly giving back to the MS community. Kate had experienced a miserable time 
on an interferon DMT and eventually ceased it due to intolerable side effects, despite 
persevering for some time. Kate was keen to help medical science and “give back” 
and sought information on a new clinical drug trial. Kate made enquiries and was 
disappointed to find that the trial involved being randomised (randomly allocated) to 
one of two medications - a new oral medication that she was keen on trying and the 
older DMT she had suffered greatly with. Kate elected to participate in the trial and 
was randomised to the old interferon DMT. Not only did Kate administer the DMT 
again for another year, suffering significant side effects, Kate also completed all of 
the trial requirements, demonstrating both persistence and altruism. 
 
Evie acts as a mentor for newly diagnosed PwRRMS and also as a speaker and 
advocate in the MS community, regularly participating in MS events and raising 
awareness of the disease and the impact of RRMS. Evie is adamant that she wants to 
show the world the positive side of RRMS and what can be achieved, to be more 
positive in the message. 
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I want to believe in other people, that’s why (I advocate for MS), so I want to make a 
difference and I figured that I can talk to people, I can write really well…if I’m going 
to have it, I may as well do something with it…I want people to see people who 
aren’t disabled by MS. Evie line 1205 
  
Other participants such as Griff helped out by educating newly diagnosed PwRRMS 
or those that are new to infusion treatments by performing a meet and greet role at 
the local MS infusion centre, especially being available to help young men during 
this challenging time. It was an important way of displaying positivity to others by 
demonstrating living positively with the disease by example.  
 
Raising money for MS research was an important display of positivity for Susan 
after her diagnosis, becoming involved in fundraising bike rides even though she had 
never ridden a bike before. Susan also made herself readily available to help others 
newly diagnosed if they needed someone experienced to talk to, enhancing positivity 
for others as well.  
 
I thought well, OK, I can do something for myself…so I started entering the 
charities…the MS bike rides…and I raised money. Susan line 538  
 
My friends would ask me…can you talk to so and so…people who have been newly 
diagnosed…and encourage them and give them ways that they can help 
themselves…so they feel more positive and not to think that you’ll end up in a 
wheelchair. Susan line 1225 
 
Of course, by way of volunteering in the current research study, being willing to tell 
their stories and give up time for others in the hope of contributing to MS research, 
demonstrates being involved and giving back to the MS community for every 
participant involved in the current research study. 
 
Towards a definition of hope in RRMS 
 
After researching the hope stories of the study participants, the evolution of hope 
theory, hope nursing literature, MS specific hope literature and considering the 
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thousands of MS patient consultations I have performed over the last 15 years, I have 
come to my own beginnings of a definition of hope in the context of RRMS for MS 
Nurses. I say beginnings, because the hope story has such a long way to go in 
RRMS, and is likely to change as our understanding of hope deepens and as new 
research adds certainty to current uncertainty in RRMS. In addition, further disease-
specific hope research is greatly needed in all aspects of MS, in both RRMS and in 
progressive forms of the disease, before we can truly understand its significance.  
 
My current definition: The experience of hope is a future inspired phenomenon, 
remarkable for its elements of promise, possibility and positivity. Hope is essential 
to human life, can be inspired, sustained and coached in others and is contagious 
in nature. Hope is tangible and a very important aspect of living well with RRMS.  
The MS Nurse can be, and often is, a beacon of positivity and potential for 
PwRRMS, providing inspiration and hope in words and in actions.  
 
A final word on hope  
 
In order to assess, recognise and to inspire hope in others, MS Nurses need to feel 
hopeful themselves. This has been aided tremendously in recent years as the first 
DMTs have been developed to halt progression of the disease and prevent future 
disability, with MS Nurses often administering the medications and monitoring 
progress and therefore at the forefront of positive change in RRMS. However, in 
order to inspire and sustain hope, it has been well reported that MS Nurses need to 
strategise self-care within themselves (Morgante, 2000). As workload increases 
dramatically, patient numbers grow and as DMT monitoring becomes more time 
consuming and critical due to potential life threatening side effects, self-care 
becomes even more important than ever before. Networking with peers, exercising 
regularly and eating nutritiously, using confidantes, nurturing supportive 
relationships, expanding knowledge bases, sharing expertise, taking holidays and 
stress reduction are all methods the MS Nurse can use to nurture self care (Morgante, 
2000). Feeling hopeful themselves is also a way that MS Nurses inspire hope in 
others (Morgante, 1996). This should be a priority for MS Nurses, not just for 
themselves and their own health, but because it will shine through and inspire in all 
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interactions with PwRRMS, their loved ones and other HCPs working in the 
speciality.  
 
Take one's adversity 
Learn from their misfortune  
Learn from their pain  
Believe in something  
Believe in yourself  
Turn adversity into ambition  
Now blossom into wealth 
 
Emily Dickinson  
 
This theme concludes Chapter 7, Finding the High Road, and the thematic and 
poetical findings of the current study. Following along the lines of hope and 
positivity which completed the formal study findings, the next chapter will discuss 
the study themes in relation to the life journey of RRMS. How the ebbs and flows of 
life and the life history methodology fits together with the study findings to further 
enhance the participant stories and bring the key concepts of the lived experience of 
RRMS alive. 
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CHAPTER 8: THE LIFE JOURNEY – EBBS AND FLOWS OF 
LIVING WITH RRMS 
 
I have many faces, I am never still 
Today I am here, tomorrow I am gone 
I haunt you for days and then I leave 
You can never work out what to believe 
Darting in and darting out 
I cause havoc and play games with your mind 
I cause you to second guess yourself, to self-doubt 
And before you know it I’m in and I’m out 
My face tomorrow looks completely new 
I can still creep up, I can still surprise you 
But then you change, you get better at this 
You learn, you discover, you realise what I am 
You start to beat me down and tell me I’m a sham 
I’ve now met a considerable foe, you’re ready for a fight 
We’ll face up against each other and you’ll show me your might 
TB 
 
The life journey of RRMS takes many twists and turns; it is never a linear journey, 
but rather one of continual flux, which is mainly due to the innate unpredictability 
and uncertainty that comes with the diagnosis of RRMS. I have been surprised many 
times in my clinical work by the stability of a patient’s condition at a routine 
appointment, only to see things change dramatically and seriously, within a matter of 
days. Nothing is set in concrete in this disease. The great advantage of the life history 
approach is that it reflects the entire life journey; with and without RRMS. By using 
this process I was able to uncover many aspects of each participant’s life, which had 
an impact on their later journey with RRMS. In particular, many participants 
described events in childhood, which gave rise to the development of resilience, such 
as childhood neglect, illness and migration from non-English speaking countries. 
This resilience was then to serve the study participants well in later life, drawing on 
coping skills to help them through the difficult and challenging times of RRMS. In 
their narratives, I was able to uncover details about the participants which profoundly 
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affected their RRMS story, even if they were unaware of it or of any connection 
between other life events and their personal development and understanding of 
RRMS. Even the process of telling the life history helped the participants to 
understand where they came from and where they were situated now. They 
recognised their achievements, revelled in their joys and respected their lows.  
 
Although presented theme by theme in a logical succession, the eight themes 
presented in these study findings do not always follow in sequence and definitely do 
not always “end” with hope and positivity. Instead, the themes intermingle with each 
other to reflect the ebb and flow of life. They tell the story of possible stops along the 
life journey with RRMS and the constant moving backwards and forwards. For 
example, a newly diagnosed PwRRMS might go through various aspects of the first 
three themes in fairly quick succession, Piecing Together the Puzzle, (Re)defining 
Me Now That I have RRMS and Battling the Demons, then encounter theme seven, 
The DMT Dance with an attitude of theme eight’s Holding Hands with Hope. Then 
an unexpected pregnancy throws everything into chaos. The PwRRMS is right back 
to Piecing Together the Puzzle, (Re)defining Me, Battling Demons and having to 
face difficult decisions about whether to proceed with the pregnancy considering 
their exposure to medications known to cause foetal harm. Putting together a medical 
team to help support and solve this problem will form part of Taming the Beast and 
then (hopefully) using skills from Holding Hands with Hope to move forward.  
 
Thereafter may be a year of stability and quiescence living with RRMS, with perhaps 
the occasional Battling the Demons making an appearance on days of significant 
fatigue or with the occurrence of a bladder infection. Then the uncertainty presents 
again with the development of a severe motor relapse just days before a big work 
event. A hospital admission and many tests follow, unleashing Piecing Together the 
Puzzle and Battling the Demons (worry, anxiety, despair) as their perceived world 
falls apart. The DMT Dance is set to start again as the specialist highly recommends 
changing to a new, higher efficacy DMT, with several potentially life threatening 
side effects. Whilst trying to use the skills learnt in Taming the Beast, the PwRRMS 
is unable to see past the side effect profile and Battling the Demons threatens to take 
over all they have learnt so far. Will I walk again? Will my Boss want to sack me? 
What about the mortgage? Maybe this is my life now? Will my husband want to 
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leave me now he can see what is possible with RRMS? I’ve always been unlucky, 
surely I will get that side effect that kills…and there starts the long road back to 
Taming the Beast, The DMT Dance and Holding Hands with Hope to reign in 
positivity and belief about the future. As symptoms subside, the new DMT starts to 
take effect, work allows time off to recover and life starts to settle again, Holding 
Hands with Hope moves back into the foreground of life. Until a year later when a 
work opportunity means a move to another town without an MS Specialist…and the 
possibility of either Battling the Demons, or Taming the Beast arises. It could go 
either way. 
 
Using ethnography methodology, and the life history method in particular, to 
uncover the study themes works in skilfully with the life trajectory of RRMS. The 
most effective way to demonstrate the linking of the life trajectory, life history 
methodology and the themes uncovered by this research study, is to illustrate the life 
course of several study participants and the interlinking of the study theme findings 
with their individual stories. The true value of the life history methodology can then 
be clearly seen as the themes overlay their life lived with RRMS. The ebbs and flows 
are shown below in four examples of life stories and recurring themes of Susan 
(Table 6), Will (Table 7), Griff (Table 8) and Piper (Table 9). These participants 
have been selected to represent a cross section of male and female experiences, short 
and long term diagnoses, a range of other health issues and a range of disease 
severity living with RRMS. Similar tables for the remaining nine study participants 
have also been completed and can be located in Appendix 13.  
 
Susan’s life story instilled in me a sense of resilience acquired by many years of 
suffering, mostly in silence. Susan absorbed much of her parents’ grief and blame 
when she was diagnosed with RRMS and remained strong as those around her 
crumbled. It wasn’t until many years later that Susan realised she was dormant in her 
journey; she wasn’t able to move forward. Working as a HCP, Susan was well aware 
of the journeys of others with chronic illness, further complicating her view of self 
and how she was progressing compared to others. Determined to change, Susan 
began a counselling course, which set her on a new path (finding her North Star) and 
life gradually began to change for the better. Today Susan is thrilled with her family 
and totally in love with life, despite continued hardships along the way.  
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Table 6: Susan’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life 
events and clues to resilience 
• Child of a migrant family 
• Severe illness of glandular fever as a child 
• Physically and emotionally demanding 
employment 
• Working in healthcare 
• Living and working overseas 
Onset of first symptoms Piecing Together the Puzzle 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
Symptoms worsen Piecing Together the Puzzle (what’s happening?) 
 Surplus Suffering (brushed off) 
 Piecing Together the Puzzle (tests, tests, tests) 
 Battling the Demons (fear, worry & anxiety) 
Hospitalised, it could be MS Surplus Suffering (inflicted by clinical care) 
 Battling the Demons (fear, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity) 
Confirmed diagnosis of 
RRMS 
Piecing Together the Puzzle (the day my life 
changed forever) 
 Re(defining) Me now that I have RRMS (getting 
acquainted) 
 Battling the Demons (fear of burden) 
 Holding Hands with Hope (faith) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare) 
 Battling the Demons (fear, worry & anxiety, 
despair) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on 
hope) 
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 Battling the Demons (fear of the wheelchair) 
Sharing journey with family 
and friends  
Re(defining) Me now that I have RRMS (getting 
acquainted, reverse stigma, normalcy) 
 Taming the Beast (support from family, friends and 
community) 
Relapse Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (fear, worry & anxiety) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on 
fear and hope) 
Completes life counselling 
course to better understand 
self and illness 
Taming the Beast (support from family, friends and 
community) 
 Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare) 
Relapse Piecing Together the Puzzle (what’s happening?) 
 The DMT Dance (decisions based on fear and 
hope) 
 Re(defining) Me now that I have RRMS (working 
out work, normalcy) 
Living with RRMS alone Battling the Demons (fear, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity, 
defiant hope, functional hope, search for meaning) 
New beginnings Re(defining) Me now that I have RRMS (normalcy) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, finding 
my A-Team) 
 Holding Hands with Hope (purposeful positivity, 
defiant hope) 
Searching for a life partner Battling the Demons (fear of being a burden) 
 Holding Hands with Hope (purposeful positivity, 
defiant hope) 
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Relapse Battling the Demons (all fears, worry & anxiety) 
 The DMT Dance (hardyards: decisions based on 
fear and hope) 
Meeting husband and 
beginning relationship 
Taming the Beast (support from family, friends and 
community) 
 Holding Hands with Hope (purposeful positivity) 
Infertility issues The DMT Dance (hardyards: decisions based on 
fear) 
 Taming the Beast (resilience) 
 Re(defining) Me now that I have RRMS (balancing 
losses & gains, parenting with RRMS) 
Pregnancy achieved Holding Hands with Hope (purposeful positivity, 
optimism) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, finding 
my A-Team) 
 Battling the Demons (fear of being a burden) 
Life parenting with RRMS Taming the Beast (support from family, friends and 
community) 
 Holding Hands with Hope (purposeful positivity, 
optimism) 
 Battling the Demons (fear of being a burden) 
 Re(defining) Me now that I have RRMS (balancing 
losses & gains, parenting with RRMS) 
Change of DMT The DMT Dance (decisions based on fear & hope) 
 Holding Hands with Hope (purposeful positivity, 
optimism) 
 Re(defining) Me now that I have RRMS (getting 
acquainted) 
Serious illness for husband Battling the Demons (fear, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity, 
optimism, defiant hope) 
	 341	
 Taming the Beast (support from family, friends and 
community, resilience) 
Life settles with RRMS- 
current status quo 
Holding Hands with Hope (giving back and getting 
involved) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness) 
 
Will’s life story also reflected several years of hardship as he battled depression after 
his diagnosis and fought his way back to a happier life, determined to live life to the 
full. One of his most difficult challenges came about when the DMT that was 
successful in controlling his relapses, natalizumab, needed to cease due to an 
unexpected high-level JCV result, which put him at higher risk for the serious and 
potentially fatal side effect, PML. Will had experienced many years of disease 
stability up until this time and this came as a shock. However, as his life journey 
reflected, this time when challenge presented itself, his life circumstances were 
different to earlier in his journey, and he now had the close support and love of his 
wife helping him in Taming the Beast.  
 
Table 7: Will’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life 
events and clues to resilience 
• Fractured family life, childhood neglect 
• Death of mother when he was 13 years old 
• Experience of MS from a close friend who 
suffered progressive MS and was severely 
disabled and blind 
Onset of first symptoms at 17 Piecing Together the Puzzle (what’s happening?) 
(with no follow-up) Battling the Demons (fear) 
 High (In)visibility (welcome cloak, hide) 
Living well, no symptoms  Battling the Demons (fear, worry & anxiety) 
 Taming the Beast (maintaining health & wellness) 
 Piecing Together the Puzzle (tests, tests, tests) 
Travelling overseas, working Taming the Beast (maintaining health & wellness) 
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hard 
 High (In)visibility (welcome cloak, hide) 
Onset blindness and 
unexplained neurological 
symptoms, hospitalised with 
no diagnosis for weeks 
Battling the Demons (fear, worry & anxiety) 
 Piecing Together the Puzzle (what’s happening?, 
tests,tests,tests) 
 Surplus Suffering (misdiagnosis) 
 High (In)visibility (welcome cloak, hide) 
Diagnosis of RRMS Piecing Together the Puzzle (the day my life 
changed forever) 
 Re(defining) Me now that I have RRMS (getting 
acquainted, working out work, non-disclosure) 
 Battling the Demons (fear of burden, worry & 
anxiety, saboteurs, uncertainty) 
 Holding Hands with Hope (purposeful positivity, 
optimism) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare) 
 Battling the Demons (fear, worry & anxiety, 
depression & despair, uncertainty) 
 High (In)visibility (welcome cloak, hide) 
 The DMT Dance (decisions based on hope) 
 Holding Hands with Hope (defiant hope) 
 Taming the Beast (Finding my North Star, choosing 
my A-Team) 
Battling depression  Piecing Together the Puzzle (what’s happening?) 
 Taming the Beast (support from family, friends and 
community) 
 The DMT Dance (hardyards: decisions based on 
fear) 
 Battling the Demons (depression & despair, I’m 
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never free, social isolation) 
 High (In)visibility (welcome cloak, hide) 
 The DMT Dance (hardyards: decisions based on 
fear and hope) 
 Taming the Beast (Finding my North Star, choosing 
my A-Team) 
Recovering from depression 
and living well with RRMS 
Holding Hands with Hope (purposeful positivity, 
defiant hope, functional hope, searching for 
meaning, harnessing a sense of humour) 
 The DMT Dance (hardyards: decisions based on 
hope, switching to a better life) 
 Re(defining) Me now that I have RRMS (working 
out work, balancing losses & gains) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, 
choosing my A-Team) 
 High (In)visibility (welcome cloak, hide) 
Well and relapse free on 
natalizumab 
The DMT Dance (hardyards: decisions based on 
hope, switching to a better life) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, resilience) 
 Holding Hands with Hope (purposeful positivity, 
optimism) 
 Re(defining) Me now that I have RRMS (balancing 
losses & gains, dare to compare, normalcy, working 
out work) 
Meeting life partner and 
starting a family 
Taming the Beast (support from family, friends and 
community, finding my North Star) 
 Re(defining) Me now that I have RRMS  
(normalcy, parenting with RRMS) 
 Holding Hands with Hope (purposeful positivity, 
optimism, searching for meaning) 
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Missed JCV blood test and 
then a positive high titre 
result- immediately cease 
natalizumab 
The DMT Dance (decisions based on fear) 
 Battling the Demons (fear, worry & anxiety) 
 Taming the Beast (support from family, friends and 
community, resilience) 
 Re(defining) Me now that I have RRMS (balancing 
losses & gains) 
Decision to start alemtuzumab Taming the Beast (support from family, friends and 
community) 
 The DMT Dance (the hardyards: decisions based on 
hope) 
 Holding Hands with Hope (purposeful positivity, 
optimism, restorative hope) 
Living with RRMS, finding 
life balance  
Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, 
choosing my A-Team) 
 Holding Hands with Hope (purposeful positivity, 
optimism, curative hope) 
 Re(defining) Me now that I have RRMS (normalcy, 
working out work, balancing losses and gains, 
parenting with RRMS, disclosure) 
 High (In)visibility (welcome cloak, hide) 
 
 
Griff feels that he has lived for many decades with RRMS, despite not being 
diagnosed until his late forties. He recalls symptoms he covered up in his twenties 
and thirties that indicate he may have been living with RRMS for much longer than 
15 years. This situation gives Griff confidence to view the future as bright, knowing 
he is (relatively) mildly physically disabled by RRMS after so many years of living 
with the disease. However, there is a flip side to this scenario, one where this 
confidence was severely impacted. This was discussed in Chapter 6, when Griff 
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attended an MSA meeting and was confronted by the mother of a severely disabled 
young lady with MS. To this day Griff often feels he isn’t as worthy as others to have 
the diagnosis of RRMS. This is because he feels he doesn’t have the added suffering 
and disability that more severe MS entails.  
 
Table 8: Griff’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life 
events and clues to resilience 
• Severe illness as a child and young adult- 
multiple respiratory conditions, 
hospitalisations 
• Working in government agency 
• Death of parents 
• Several long term relationships 
• Marriage separation 
Onset of first symptoms in 
early twenties 
Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (welcome cloak) 
 Battling the Demons (fear, worry) 
Intermittent symptoms 
continue for next 20 years on 
and off 
Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (fear, worry) 
Diagnosed with Guillian Barre  
12 years prior to RRMS 
diagnosis 
Piecing Together the Puzzle (what’s happening, 
tests, tests, tests) 
 Battling the Demons (fear, worry) 
 Surplus Suffering (misdiagnosis) 
Personal relationship issues 
with partner, separation 
Battling the Demons (fear, worry) 
 Holding Hands with Hope (purposeful positivity) 
Relationship strengthens 
through separation, back 
Taming the Beast (support from family, friends and 
community) 
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together, children  
 Holding Hands with Hope (purposeful positivity) 
Severe relapse at work  Piecing Together the Puzzle (what’s happening, 
tests, tests, tests) 
 Battling the Demons (fear, worry) 
Confirmed diagnosis of 
RRMS 
Piecing Together the Puzzle (the day my life 
changed forever) 
 Re(defining) Me now that I have RRMS (getting 
acquainted, disclosure, working out work) 
 Battling the Demons (fear of burden) 
 Holding Hands with Hope (purposeful positivity, 
optimism) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare) 
 Battling the Demons (all fears, worry & anxiety, 
saboteurs, social isolation) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on 
hope) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, 
choosing my A-Team) 
Comparing self with friend 
with progressive MS 
Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare) 
 Battling the Demons (fear, worry & anxiety) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS) 
Unemployment and role as 
“house husband”  
High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, 
saboteurs, uncertainty, social isolation) 
 Re(defining) Me now that I have RRMS (working 
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out work, dare to compare, parenting with RRMS, 
losses & gains) 
 Holding Hands with Hope (purposeful positivity, 
optimism, searching for meaning) 
Confrontation at MSL meeting 
with mother of a severely 
disabled girl 
Re(defining) Me now that I have RRMS (getting 
acquainted, dare to compare, parenting with RRMS, 
normalcy) 
 Battling the Demons (fear, saboteurs, uncertainty, 
social isolation) 
 Surplus Suffering (inflicted by community) 
 High (In)visibility (strive to be visible) 
Sexual health dysfunction Piecing Together the Puzzle (what’s happening?, 
tests, tests, tests) 
 Re(defining) Me now that I have RRMS (losses & 
gains, normalcy) 
 Battling the Demons (fear, worry & anxiety) 
Struggling with DMT 
glatiramer acetate 
The DMT Dance (hardyards: decisions based on 
hope) 
 Battling the Demons (fear, worry & anxiety) 
 Re(defining) Me now that I have RRMS (losses & 
gains) 
 Taming the Beast (getting a handle on RRMS, 
finding my North Star, maintaining health & 
wellness, choosing my A-Team) 
Treatment change to 
natalizumab 
Holding Hands with Hope (purposeful positivity, 
defiant hope, restorative hope, functional hope) 
 The DMT Dance (switching to a better life) 
 Battling the Demons (worry) 
 Taming the Beast (support from family, friends and 
community) 
Struggling with severe fatigue 
/feeling a poor role model to 
his children  
Battling the Demons (fear of burden, worry, 
despair, saboteurs, social isolation) 
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 Re(defining) Me now that I have RRMS (losses & 
gains, parenting with RRMS, normalcy, dare to 
compare) 
 Holding Hands with Hope (purposeful positivity) 
 Taming the Beast (resilience, North Star, 
maintaining health & wellness) 
 High (In)visibility (strive to be visible) 
Thriving on natalizumab with 
social interactions at the 
hospital, mentoring others 
with RRMS 
Taming the Beast (support from family, friends and 
community) 
 Holding Hands with Hope (purposeful positivity, 
optimism, giving back and being involved) 
 Re(defining) Me now that I have RRMS (balancing 
losses & gains, negotiating normalcy) 
 The DMT Dance (hardyards: decisions based on 
hope, switching to a better life) 
Missed blood test for JCV, 
then high titre JCV blood test 
positive - ceased natalizumab 
immediately  
Battling the Demons (fear of burden, worry, 
despair, saboteurs, uncertainty, social isolation) 
 The DMT Dance (hardyards: decisions based on 
fear) 
 Re(defining) Me now that I have RRMS (dare to 
compare, normalcy, losses & gains) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness, 
resileince) 
Commencing new treatment 
fingolimod and refusing 
alemtuzumab 
Holding Hands with Hope (optimism, restorative 
hope) 
 Taming the Beast (maintaining health & wellness, 
North Star) 
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 The DMT Dance (hardyards: decisions based on 
fear, switching to a better life) 
 Battling the Demons  (uncertainty, social isolation) 
Moving forward, living well 
with RRMS 
Taming the Beast (maintaining health & wellness, 
North Star, support from family, friends and 
community, resilience) 
 Holding Hands with Hope (optimism, restorative 
hope, searching for meaning, giving back & getting 
involved) 
 Re(defining) Me now that I have RRMS (normalcy, 
losses & gains) 
 
The final life story presented in this section is Piper’s story, reflecting a shorter life 
span living with RRMS than the previous three participants presented, but still an 
abundance of applied themes and subthemes to her story. Piper’s life journey has 
been marred by many years of Surplus Suffering due to constant brush-offs of her 
symptoms by HCPs in her small rural community. However, her fierce determination 
to not be defined by the disease and to live her best life possible is completely 
overwhelming in intensity. Piper starts every day believing she is capable of  Taming 
the Beast and is constantly on the lookout to do so. Although disappointed by her 
many years of struggle, she is in no way bitter about it, she still views many other 
PwRRMS as going through worse scenarios and is grateful that she was eventually 
diagnosed correctly.  
 
Table 9: Piper’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life 
events and clues to resilience 
• Child of a migrant family 
• Debilitating headaches and nerve pain as 
an early teen through to adulthood 
• Small rural community upbringing 
Onset of first symptoms Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
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 Surplus Suffering (brushed off)- repeated 
Symptoms worsen- come and 
go over many years 
Piecing Together the Puzzle (what’s happening?)-
repeated 
 Surplus Suffering (brushed off)- repeated 
 Piecing Together the Puzzle (tests, tests, tests)- 
repeated 
 Battling the Demons (fear, worry & anxiety, 
depression & despair) 
 High (In)visibility (strive to be visible) 
Depression Battling the Demons (depression) 
 Taming the Beast (support from family, friends and 
community) 
 Surplus Suffering (brushed off)- repeated 
Recovery from depression Holding Hands with Hope (purposeful positivity) 
 Taming the Beast (support from family, friends and 
community) 
Infertility Piecing Together the Puzzle (tests, tests, tests) 
 Taming the Beast (resilience) 
 Battling the Demons (fear, worry & anxiety) 
Significant relapse with new 
symptoms 
Piecing Together the Puzzle (what’s happening, 
tests, tests, tests) 
 Taming the Beast (choosing my A-Team) 
 Battling the Demons (fear, worry & anxiety) 
 High (In)visibility (strive to be visible) 
Confirmed diagnosis of 
RRMS 
Piecing Together the Puzzle (the day my life 
changed forever) 
 Re(defining) Me now that I have RRMS (getting 
acquainted, normalcy) 
 Battling the Demons (fear of burden, worry & 
anxiety, fear of the wheelchair) 
 Holding Hands with Hope (restorative hope, 
purposeful positivity- searching for meaning) 
 The DMT Dance (hardyards: decisions based on 
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hope) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (dare to 
compare, parenting with RRMS, normalcy) 
 Battling the Demons (fear, worry & anxiety, 
despair, uncertainty) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on 
hope) 
 Battling the Demons (fear of the wheelchair) 
 Taming the Beast (finding my North Star, 
maintaining health & wellness, getting a handle, 
resilience) 
Sharing journey with family 
and friends  
Re(defining) Me now that I have RRMS (getting 
acquainted, normalcy, dare to compare) 
 Taming the Beast (support from family, friends and 
community, getting a handle) 
 Battling the Demons (fear) 
Side effects from DMT 
interferon 
Piecing Together the Puzzle (what’s happening?) 
 Holding Hands with Hope (defiant hope, functional 
hope, search for meaning) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on 
fear and hope) 
Commence new DMT 
dimethyl fumarate 
The DMT Dance (switching to a better life) 
 Re(defining) Me now that I have RRMS (getting 
acquainted) 
 Battling the Demons (all fears, worry & anxiety, 
saboteurs) 
First travel overseas Holding Hands with Hope (purposeful positivity, 
defiant hope, search for meaning) 
 Taming the Beast (support from family, friends and 
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community, finding my North Star) 
 High (In)visibility (a welcome cloak) 
New relapse Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (fear, worry & anxiety, 
saboteurs) 
 Re(defining) Me now that I have RRMS (normalcy) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, 
choosing my A-Team) 
Living with RRMS  High (In)visibility (strive to be visible) 
 Holding Hands with Hope (purposeful positivity, 
defiant hope, search for meaning, sense of humour) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness ) 
 Re(defining) Me now that I have RRMS (dare to 
compare, normalcy, parenting with RRMS, losses 
& gains) 
Sister has a neurological 
episode  
Battling the Demons (fear, worry & anxiety, 
saboteurs) 
 Taming the Beast (support from family, friends and 
community) 
 Holding Hands with Hope (purposeful positivity) 
Relapse at Christmas Re(defining) Me now that I have RRMS (balancing 
losses & gains, parenting with RRMS) 
 The DMT Dance (hardyards: decisions based on 
fear) 
 Taming the Beast (getting a handle, support from 
family, friends & community, resilience) 
 Battling the Demons (fear of being a burden) 
 Holding Hands with Hope (purposeful positivity, 
functional hope, restorative hope) 
Moving forward with RRMS  Taming the Beast (support from family, friends and 
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community, maintaining health & wellness, 
resilience) 
 Holding Hands with Hope (purposeful positivity, 
optimism, giving back and getting involved) 
 Re(defining) Me now that I have RRMS (getting 
acquainted, parenting with RRMS, normalcy) 
 
As noted life history author Plummer (2001, p.7) reflects “life is in fluctual praxis, 
always in flow and ever messy.” As I began the task of linking each individual’s life 
events with the themes and subthemes, the process, although “messy”, felt incredibly 
straightforward despite being very time consuming. This process flowed organically 
and seemed to fit together very neatly, participant after participant as I worked 
manually through each transcript. I was surprised at first at the ease in which the 
themes and life events all fit together so well. I then realised that this organic flow 
was demonstrating to me that the themes fit back with the data well, and that this was 
a reflection of good coding and theme development. As Braun and Clarke (2013) 
suggest, to be able to invoke the original data just by reading the code or theme is the 
result of capturing the both latent and salient features well, and is a fundamental aim 
of the coding process. The further inclusion of specific subthemes within each theme 
category in the life trajectory tables gave the added ability to “drill down” even 
further into each theme, to identify a feature of the theme that was more descriptive 
of the life event, but still fell under the same central organising concept of the 
overarching theme. 
 
Life history gives voice to the ordinary members of a culture as they cope on a daily 
basis with the joys and challenges of life (de Chesnay & Fisher, 2014), and was 
embraced and welcomed by every participant in the current study. The use of 
focused ethnographic life history methodology worked cleverly with the ebbs and 
flows of living with a chronic illness such as RRMS to reveal themes and subthemes 
exploring the lived experience of RRMS. As RRMS is most commonly diagnosed in 
young adults and is usually not life threatening (Compston & Coles, 2008), it 
represents a long period of time to live with a chronic illness. Hopes, dreams, school, 
study, sport, work, relationships, marriages, pregnancies, children, friends, 
relationship breakdowns, grieving, set-backs, loss, pride, happiness, contentment; 
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these are some of life’s typical challenges and joys, occurring with or without the 
presence of RRMS. Using the life history approach generated rich and detailed data 
about the experiences of living with RRMS and unearthed some extraordinary 
insights, which have been outlined throughout the study findings chapters and will be 
given deep clinical relevance in the following, concluding chapter.  
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CHAPTER 9 - CONCLUSIONS AND RECOMMENDATIONS 
FOR PRACTICE 
 
 
The final chapter of this thesis will re-examine the aims and findings of the research 
study and discuss how the research question is answered by attributing meaning and 
understanding to the lived experience of RRMS. This chapter will also link the study 
findings to recommendations for MS clinical practice. These clinical 
recommendations will concentrate particularly on MS nursing care, however, they 
will also be applicable in varying ways for all HCPs involved in the management of 
MS.  
 
Introduction 
 
This research study posed the question “What is the experience of living with 
RRMS?”. The aim of this research study was to explore the experiences of people 
living with RRMS, in order to gain insights and understanding of the lived 
experience. It is anticipated greater understanding will positively impact on the care 
provided by MS Nurses in particular, but also for all MS HCPs in general. The 
purpose of these insights and understandings is to be able to provide improved 
clinical care, to offer patient-centred support in patient-focused areas, and to 
ultimately improve the quality of life and nursing care for PwRRMS. This life 
history study revealed the meaning of the lived experience of 13 people as they met 
the daily challenges and joys of life, living with RRMS. This understanding of their 
lived experience was accomplished initially by co-creating a life history, through the 
telling and ordering of the life history by the participant to me as the researcher, and 
further co-created by my questions and reactions as this interview took place. 
Mishler (1995, p.90) suggests this model of narrative analysis is “reconstructing the 
told from the telling” and highlights the active role of the researcher in this process. 
Importantly, the co-construction of the data also supported the epistemological basis 
of the study, a constructivist approach, where the participant and research co-create 
knowledge together.  
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The second part of the research process centred on revealing meaning in my 
interpretation and ordering of the life history into a life story, and the subsequent 
development of themes and subthemes to reflect this meaning. A third step in the 
process will occur, and is indeed occurring now, as readers of this thesis and future 
journal articles, and the listeners of future presentations and workshops, will develop 
further meaning from the stories and themes as they are presented.  
 
Alongside these meanings, the study participants also reported a deeper 
understanding of themselves throughout the process. The act of reflecting on their 
lives allowed both introspection and benefit finding. Throughout all phases of the 
research, I too, deepened my understanding of not just PwRRMS, but also of myself 
as an MS Nurse, a mother, a wife, a friend, a patient and a carer. 
 
Throughout the research process, new meaning constantly evolved as the participants 
merged their experiences of RRMS between the past and the present, often moving 
backwards and forwards through the life history. Although at times recalling their 
life history could be uncomfortable or distressing, all study participants concluded 
their life history interview interpreting their experiences with RRMS in a mostly 
positive light. This constantly amazed me; mainly because many of the participants 
had suffered significant hardship during their life with RRMS, however they 
constantly moved adversity aside to bring in positivity and end on an optimistic note. 
There was a real sense of moving RRMS into the background of life and keeping 
positivity, hope, family, friends, health and wellness in the foreground. This was 
mostly achieved by employing the elements of one of the major study themes, 
Taming the Beast. The elements identified in the study findings included finding my 
North Star, getting a handle on RRMS symptoms and relapses, maintaining physical 
and mental health and wellness, choosing my medical A-Team, harnessing support 
from family, friends, organisations and workplaces and riding high on resilience. For 
the study participants, these components all added up to one overwhelming factor- 
regaining as much control as possible over a disease with no cure, no predictability 
and no certainty. It was all about finding ways to once again be in charge of their 
life after their diagnosis of RRMS. 
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However, as Chapter 8 explored, this is not always a “done deal” or something that 
automatically happens once a checklist is completed or a DMT is commenced. Any 
number of negative experiences could threaten to take away the gains made by the 
PwRRMS, at any stage and at any time in the life journey. These were the forces 
explored in Battling the Demons; dealing with fear of disability and fear of losing 
mobility and becoming dependant on a wheelchair, fear of DMTs and potentially life 
threatening side effects, and living with the constant fear of relapse. Living with this 
fear presented, in some participants, as sheer terror, especially when thinking about 
the possibility of using a wheelchair in the future. However, although initially fearful 
of the consequences of RRMS, others who previously thought they would be unable 
to cope with physical disability adapted over time and came to respect and appreciate 
the advantages that a walking stick or wheelchair gave them, especially during a 
severe relapse. But the road to this point could be frequently fraught with high 
emotion. 
 
Participants in the study also highlighted a “push/pull” relationship with their RRMS, 
part of them did not want to see what RRMS could develop into (as SPMS) in years 
to come and deliberately avoided gatherings such as MSA meetings and education 
seminars where it was expected to meet others living with MS. However, they would 
find themselves engaging in internet searches and reading to find out more 
information about what progression might look like. The main difference was they 
could do this in the privacy and safety of their own home. A slightly different 
variation on this push/pull relationship was the scenario of a PwRRMS attending an 
MSA meeting (often with people living with progressive MS) in order to prove to 
themselves that their RRMS was “better”, or that their MS was going to be different 
to that lived by others with the disease. These examples of the push/pull relationship 
reveal the PwRRMS once again trying to regain some control over the disease, of 
being “in charge” and wanting to look at the future, but in small doses that they 
could attempt to control. Being aware of the intracies of this “push-pull” relationship 
could help MS Nurses and other HCPs in assisting adjustment to the diagnosis of 
RRMS and in times of relapse, disease progression, symptom change or other life 
events impacting on RRMS. 
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I believe that one of the most shocking revelations of the current study findings was 
the abundance of Surplus Suffering for many PwRRMS. This suffering over and 
above that caused by living with RRMS, was frequently caused by HCPs, and mostly 
(and hopefully) unknowingly. Unequal power relationships between doctors and 
patients led to many of the scenarios described by study participants, scenarios which 
could have been easily diffused if the doctor had taken the time to explain things 
more carefully and to realise the impact of a diagnosis of RRMS on a person. It has 
been suggested from previous research that the day of diagnosis for a PwMS is a day 
they remember clearly with very strong memories (Solari et al., 2007), for many 
study participants these memories and feelings came flooding back in great detail 
during our interview. Surplus Suffering was often caused by HCPs brushing off 
PwRRMS. This sense of being brushed off stemmed from not understanding the 
symptoms, not believing the symptoms existed, relying too heavily on previous 
patient assessments or simply not being aware of RRMS and the need to quickly 
refer on for treatment early in the disease process because this leads to the best 
clinical outcomes (Giovannoni et al., 2016).  
 
Understanding what has led to Surplus Suffering is key to unravelling the causes. 
Other specialities have reported difficulties and stress in nurses looking after diseases 
which are incurable or unpredictable, such as in cancer (Corner, 2002; Lange, Thom, 
& Kline, 2008) and myeloma (Cormican & Dowling, 2016), an area which is inder-
researched in MS care. The area of Surplus Suffering in MS deserves further 
exploration to try and understand why it is occurring in the first place; understanding 
the underlying causes of Surplus Suffering is the only way it can be prevented in the 
future, rather than simply managed by nurses and other HCPs.  
 
The invisibility of many common symptoms of RRMS had some interesting flow-on 
effects for those living with the disease. For some, invisibility was seen as a welcome 
component of the diagnosis, the fact that others could not always see the symptoms 
and know the diagnosis gave a positive slant to the disease. These participants felt 
this invisibility allowed them to avoid the stigma of a chronic and poorly understood 
illness. For others, they desperately wanted their condition to be seen, they wanted to 
“out” the invisible symptoms and earn understanding from others as to how difficult 
and challenging it is to live with debilitating symptoms which were difficult to 
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explain to others. These symptoms in particular were fatigue, cognition issues and 
the “hushed one”, sexual dysfunction. Interestingly, these invisible symptoms are 
also amongst the most difficult to effectively treat, further compounding their 
invisibility. For MS Nurses and other HCPs, being aware of the challenges of 
verbalising and discussing these symptoms in an important step forward to guiding 
patients to negotiate MS jargon and language in a way that helps them explain the 
complexities and difficulties of these invisible and difficult to describe symptoms. 
 
Although the role of Piecing Together the Puzzle began the sequence of themes in 
the findings, this concept actually lasts a lifetime of living with RRMS. Due to the 
unpredictability of the next relapse (in terms of the exact area of demyelination in the 
CNS), RRMS can be a constantly surprising disease to live with. Often each new 
relapse brings a host of new symptoms. Building experience to learn exactly what a 
new relapse is often proves difficult, as one relapse may involve visual symptoms 
and the next motor weakness and the next a bout of severe fatigue or cognitive 
difficulty. It is all unpredictable. Thus, life is a constant act of defining and 
(re)defining self as RRMS changes and morphs. Comparing oneself against others 
can also be difficult as every case of RRMS is different, however this also gives the 
PwRRMS an advantage, a chance to define, or (re)define themselves. 
 
On the other hand, completing the study themes with Holding Hands with Hope, 
exploring the different types of hope and purposeful positivity, doesn’t mean that the 
life journey ends neatly there either. Life with RRMS is constantly in flux and 
although the role of hope will always weave into the RRMS life in some way, it will 
be more present at certain times and it will be harder to find at others. As a disease 
with no current cure, hope represents an integral part of the “toolkit of living well 
with RRMS” of both the MS Nurse and the PwRRMS. 
 
Summary of the key findings and recommendations for clinical practice 
 
This study set out to explore and capture a rich, thick and comprehensive 
examination of diverse experiences of living with RRMS. Using focused 
ethnography and a life history approach, the study gained insight into many key areas 
of living with this unpredictable autoimmune, neurological disease over the life 
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trajectory. This knowledge, partly supporting previous research further and partly 
innovative, develops the body of literature that is available to enhance nursing 
practice in MS care. 
 
Several previous studies (Beshears, 2010; Clair, 2003; Courts et al., 2006; Miller, 
1997) were identified in Chapter 3 as being the most similar in terms of study aims to 
the current study, exploring the lived experience of MS. However, only Miller 
(1997) and Beshears (2010) specifically stated that their research involved only 
PwRRMS, not PwMS in general. Examples of themes, subthemes and sub-
subthemes from the current study supporting the previous literature identified in 
chapter 3 include: harnessing social support, concepts of hope and hopelessness, 
getting acquainted with RRMS, conflict with HCPs, facing fears, coping with 
uncertainty and disclosure (Miller, 1997; Beshears, 2010); concepts of MS as an 
adversary and of a saviour (Clair, 2003); concepts of brush-off, symptom 
devastation, regaining control and self advocacy (Courts et la; 2004) and feelings of 
living with uncertainty and RRMS always being in the backdrop of life (Beshears, 
2010).  
 
There are subtle elements of previous qualitative studies in all of the current study 
themes, some stronger than others. For example, themes such as MS as an adversary 
(inspiring to overcome obstacles) (Clair, 2003) are not semantically linked to the 
current study, but may integrate more latently with the themes of purposeful 
positivity and searching for meaning. Other themes such as getting acquainted with 
MS in the current study explore the difficulties in navigating communication and 
information resources, representative of changing times and new outlooks, as we 
learn more about the disease process, symptom management and treatments. 
Information access has become easier for patients in recent times with the internet, 
but more challenging in terms of understanding the content and which information is 
accurate and secure. Although a different process nowadays, these current themes 
integrate back to Miller’s (1997) earlier themes of getting to know MS and the 
importance of correct information, locating appropriate resources and observing 
others with MS.  
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There are many novel findings from the current study findings. The most significant 
of these include Surplus Suffering (novel to reporting in RRMS), the push/pull 
relationship with comparing to others with RRMS, finding my North Star, choosing 
my medical A-Team, feeling a pretender to the throne (involving elements of reverse 
stigma), the welcome cloak of invisibility, giving back and getting involved and The 
DMT Dance - the hardyards: decisions based on fear and decisions based on hope. 
The new study findings provide the opportunity for review of current MS nursing 
practices and also the opportunity to make changes based on the new knowledge. 
These new findings will be woven throughout the clinical recommendations to 
follow. 
 
 In addition to the thematic findings outlined in Chapters 6, 7 and 8, there are 
numerous clinical practice recommendations that have been developed from the 
study findings. I have kept these clinical practice recommendations linked to the 
theme they pertain to, for consistency in the story and for clarity of the context of the 
recommendation. Although applicable and practical for all HCPs involved in MS or 
chronic illness care, these recommendations particularly honour the unique role of 
nursing and support patient focused nursing care of the PwRRMS. 
 
Piecing Together the Puzzle 
 
• During the investigative phase for a diagnosis of RRMS, there may be 
important points at which HCP intervention can assist each patient 
considerably. Consideration should be made to providing information for the 
patient detailing the multiple diagnostic tests, the reasons why they are 
necessary and a discussion about the difficulties and intricacies in an MS 
diagnosis. Consider support from MSA during the pre-diagnostic period if 
MS is strongly suspected and it is appropriate and sought by the patient. 
 
• MS Nurses should take particular note of the past experiences and HCP 
encounters that PwRRMS bring to their initial appointments and be mindful 
that the path to the MS Clinic/Neurologist may not have been an easy one. 
There may have been much suffering in the years prior, undiagnosed or 
diagnosed as RRMS; being ignored by HCPs, having symptoms dismissed or 
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trivialised and some made to feel like they “are going mad”. The MS Nurse 
can discuss with PwRRMS how they came to be diagnosed and goals for the 
path forward to build their confidence and trust. Asking about prior 
experiences in healthcare and what their expectations are of RRMS care can 
enable effective communication and goal setting for the future, and a 
mutually acceptable, and achievable, nursing care plan. 
 
• The day of diagnosis is vividly remembered by many PwRRMS. Often HCPs 
can be distracted, tired and busy managing multiple patients and situations at 
the one time in a clinical setting. It is vital to be aware of just how influential 
the day of diagnosis is for the PwRRMS and the considerable impact 
kindness and compassion at this time can have on the life journey ahead. The 
involvement of an MS Nurse at the time of diagnosis delivery would be an 
optimal situation.  
 
• MS Nurses are in an ideal position to implement the need for flexibility, 
repetition, time and understanding when delivering a diagnosis of RRMS. 
The approach should be tailored to individual patients in a format that is 
straightforward for them to understand. The involvement of families and 
significant others can also assist engagement with information and improve 
communication within the family and significant other networks.  
(Re)Defining Me Now That I have RRMS 
 
• Individual education and information needs at the time of diagnosis for 
PwRRMS differ greatly. MS Nurses should personalise disease education and 
information at a time when the PwRRMS is ready to accept the information, 
taking into account their preferred method of learning and also including 
family members or friends (where this is desired by the PwRRMS). 
 
• Early referrals should be made for psychological assistance when the 
PwRRMS seems to be struggling with adjusting to the diagnosis and 
maintaining a positive sense of self. This should also be revisited regularly at 
routine clinic visits, even when things appear to be going well from a clinical 
point of view.  
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• MS Nurses can share with the PwRRMS the perspective that “time can be 
their friend”, and that many people dealing with similar issues after an RRMS 
diagnosis, do adjust successfully in time. Discuss openly with PwRRMS the 
particular challenges of dealing with the unpredictability and uncertainty of 
the disease and how challenging this can be. Discuss the value of maintaining 
a positive attitude and investing in skills which promote personal coping. 
These include resources such as managing stress, faith and spirituality, and 
cultivating optimism. 
 
• MS Nurses are ideally positioned to enquire as to which MS symptoms are 
affecting a PwRRMS’s life to the greatest extent, and thereby potentially 
threatening identity, at any given time. These symptoms may be different to 
the symptoms HCPs pay the most attention to, but may be impacting the 
patient’s QOL significantly. Care should be taken to provide advice for these 
symptoms in order to safeguard mental health and wellbeing. 
 
• MS Nurses can skilfully provide information on the benefits and the 
disadvantages regarding disease disclosure in the workplace. Employment, 
and maintaining employment, provides a sense of personal fulfilment, 
socialisation and empowerment to many PwRRMS. Such discussions should 
be highly individualised and take into account personal needs as well as the 
workplace environment. Referral to an Occupational Therapist skilled in 
workplace adjustments may be helpful. Adjustments can enable work to 
continue to be an important part of life and socialisation for the PwRRMS.  
 
• MS Nurses can enhance awareness of the significant impact of RRMS on 
parenting; the joys and the challenges, and offer support and guidance to the 
PwRRMS. This concept should be revisited regularly over the course of the 
disease, and particularly with events such as relapse or disease progression, 
which could present new challenges to parenting with RRMS at different 
stages of the family life trajectory.  
 
•  
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Battling the Demons 
 
• MS Nurses are ideally positioned to ask about childhood illnesses and life 
challenges at the beginning of the RRMS journey. Look for clues about prior 
displays of resilience, which may be helpful the PwRRMS in their current 
battle. This will also provide information for the MS Nurse to assess coping 
styles and the need for psychological referrals. It is also beneficial to build 
confidence for the PwRRMS on their journey, reminding them of their 
strengths and what they are capable of overcoming.  
 
• Signs of depression and anxiety need to be assessed for and addressed early, 
and often. As depression and anxiety both strongly correlate with a lower 
quality of life, it is important for MS Nurses to recognise anxiety and make 
appropriate referrals early on. Similarly, accessing social support can reduce 
anxiety and the need for this should be regularly assessed. Anxious patients 
may also have distorted perceptions of the availability of support, so gentle 
guidance from the MS Nurse may also be required. Social support systems 
also assist with managing depression. 
 
• It is important for MS Nurses to understand that the uncertainty of RRMS can 
be a source of concern, regardless of the individual’s degree of symptoms or 
stage of RRMS. During clinical appointments, emotional well-being can 
often be overlooked by more pressing physical symptoms, discussions on 
DMTs, MRI results and medication side effects. MS Nurses and HCPs need 
to ensure emotional well-being is assessed thoroughly at every routine clinic 
visit. Emotional illness can be just as fatal as physical/DMT issues, just 
sometimes much quieter. 
 
• It is vital for MS Nurses to be aware of “fear points” on the RRMS life 
journey where even the most seemingly well-adjusted PwRRMS may 
experience upheaval and require assistance to navigate the life journey. These 
fear points include times of relapse, reports of MRI progression, new 
symptom onset, pregnancy, change to personal circumstances, loss or change 
in employment, DMT medication change or DMT risk factor change.  
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• MS Nurses are ideally positioned to assess for the possibility of PTSD in all 
PwRRMS, and be familiar with possible signs of PTSD such as nightmares, 
flashbacks, emotional detachment and avoidance of social situations. If signs 
of PTSD are identified, urgent referral to a psychologist/psychiatrist is 
indicated. 
Surplus Suffering 
 
• The MS Nurse is perfectly positioned to lead the MS health care team by 
example, practicing holistic care, empathetic nursing, “turning toward” and 
demonstrating compassion. MS Nurses can also support and educate the 
loved ones, work colleagues and friends of PwRRMS regarding appropriate 
resources to help them partner with the PwRRMS on their life journey.  
 
• Patients undergoing testing or assessment for RRMS should be treated with 
dignity, respect and recognised as a holistic human being in a unique and 
challenging context, rather than a diagnosis or potential diagnosis. An extra 
minute or two, an opportunity for questions, a gesture, eye contact and nods 
of understanding can significantly influence a health care encounter and can 
go a long way to providing a positive experience, despite what the eventual 
diagnosis and prognosis might be.  
 
• A new patient under care, no matter what stage of the RRMS journey they are 
at or how many years they have been diagnosed with RRMS, may benefit 
from a frank discussion on their previous healthcare and any issues that may 
have come up in the past. This can provide opportunities for discussion about 
past encounters with HCPs but also provides an opportunity to discuss 
current expectations. Goals for future RRMS care to improve care 
effectiveness and HCP relationships can also be discussed. 
 
• Every patient is an expert in his/her own body and feelings. Acknowledging 
this and using the patient’s knowledge is an important part of individualised 
and holistic care. Connecting with, engaging with, and preserving the dignity 
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of patients as human beings are fundamental not just to MS nursing care, but 
and to all HCPs caring for PwMS.  
 
• A critical function of the MS Nurse is to lend strength, until the PwRRMS 
recovers their own. Not taking over, not racing ahead, not leaving behind. 
Lending strength can be conceptualised as nurses providing 
information/education, guidance, emotional support and advice. This is also a 
key function of all MS HCPs in the healthcare team and MS support 
organisations in the community. 
High (In)Visibility 
 
• MS Nurses provide education and guidance for PwRRMS suffering invisible 
symptoms about specific symptom management. Open discussion from an 
early stage of the MS life journey on the high probability of invisible 
symptoms (at least at some stage of the disease) can facilitate honest and 
frank conversations in the future and possibly earlier detection and treatment 
if and when they do arise. This will also assist PwRRMS to understand the 
reasons and challenges behind invisible symptoms and how symptoms can be 
treated and managed, thereby aiding confidence and self-efficacy. 
 
• Discussion of invisible symptoms should be a regular part of MS 
consultations from the outset of the MS life journey so that the PwRRMS will 
feel more comfortable discussing the more socially taboo subjects, such as 
sexual health issues, cognition and bowel and bladder issues, if and when 
they do arise. Early detection and treatment is key.  
 
• MS Nurses can provide guidance on managing invisible symptoms with 
family, friends and work colleagues, and advise the PwRRMS how to explain 
invisible symptoms to others and how to ask for support. Educational 
materials can also be supplied to assist in discussions and adaptations that 
may be needed. If the PwRRMS feels secure in understanding their own 
invisible symptoms, they will be more confident explaining to others.   
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Taming the Beast 
 
• To feel comfortable with an MS Nurse or other HCP, to be provided with 
individualised information/education, to have confidence in their RRMS 
management and to understand treatment plans and goals are all important 
factors to consider for PwRRMS. MS Nurses in particular can encourage 
PwRRMS to develop a supportive MS care team around them which meets 
their individual needs – choosing my A-Team. MS Nurses should be 
particularly mindful of PwRRMS living in isolated situations or rural 
communities, facilitating effective communication with local health care 
teams and to have plans in place in the event of relapse or other crisis. 
 
• Asking for help from others can be difficult for many PwRRMS. MS Nurses 
are in an excellent position to provide guidance and advice for PwRRMS on 
how to ask families, friends and organisations for assistance and to pinpoint 
times when they may need special help, such as during a relapse, for the 
duration of post partum care and during times of co-morbid illness. 
 
• MS Nurses can help build and enhance resilience in PwRRMS by providing 
reflections and narratives on how other PwRRMS have managed similar 
problems and moved forward. By being aware of strategies to enhance 
resilience and encouraging these strategies in PwRRMS, MS Nurses and 
HCPs can assist in confidence building and later overcoming difficulties 
during the life trajectory with RRMS. The issue of resilience should be 
assessed and discussed regularly and skills continually enhanced.  
 
• MS Nurses can assist families and friends of the PwRRMS to understand the 
challenging nature of the disease, the invisible symptoms and the difficulties 
that the PwRRMS may experience. MS Nurses in particular can provide 
guidance and support as the loved ones of PwRRMS also come to terms with 
what RRMS means and the many ways that they can help on the life journey. 
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The DMT Dance 
 
• MS Nurses need to develop effective tools to improve communication and 
support for PwRRMS in learning more about the disease and the specific role 
of DMTs within their disease management. Being educated and engaged will 
encourage active participation in DMT decision-making and help PwRRMS 
to become more effective self-advocates.  
 
• There is no cure or one size fits all approach for treatment in RRMS. 
Sometimes DMTs need to be trialled to assess their effectiveness and 
compatibility on a PwRRMS. As perceived lack of efficacy can be an 
important barrier against medication adherence, MS Nurses are ideally suited 
to ensure PwRRMS have realistic expectations from their prescribed DMT 
and also provide written information, which can be referred to at anytime. 
 
• Adherence to treatment regimes is essential to ensure PwRRMS receive the 
maximum benefit from their treatment and also to ensure that the treatment is 
cost-effective. Adherence to the DMT plan should be assessed at every MS 
Nurse encounter, whether in the clinic or by text, internet based consultation, 
phone or email. 
 
• PwRRMS should be informed of DMT options, the potential benefits and 
risks of each treatment and the importance of adherence, using an approach 
which suits their style of learning and their level of health literacy. Allowing 
an active role for PwRRMS in treatment decisions may also give a sense of 
empowerment and provide motivation to continue DMT when things don’t go 
according to plan. 
 
• MS Nurses can provide guidance and support for PwRRMS to build their 
own support network to assist with adherence. This can take the form of 
education regarding the possible avenues of company support with the chosen 
DMT, the importance of the support of family and friends, or by providing 
information on how to access clinic, local medical and community support. 
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Holding Hands with Hope 
 
• Hope is never static; it is always dynamic and changing form, requiring 
constant supervision by the MS Nurse during the entire life journey with 
RRMS. 
 
• Being at the forefront of care in RRMS, the MS Nurse is in a unique position 
of trust to be able to observe and assess all aspects of emotional and spiritual 
health. The MS Nurse can inspire, demonstrate, nurture, coach, educate about 
and sustain of forms of hope for the PwRRMS. 
 
• Tools for the MS Nurse to inspire and sustain hope include regular hope 
assessments, education, storytelling, advocacy, counselling and referrals 
where necessary. Educating the PwRRMS about the importance of 
maintaining optimism, a positive outlook, searching for constructive 
meaning, maintaining a sense of humour, considering faith and spirituality, 
where appropriate, and possible avenues to “give back” and be involved in 
the MS community. These are examples of purposeful positivity, an 
important component of the MS Nurse role. 
 
• MS Nurses build particularly strong therapeutic relationships with their 
patients, often built on respect, caring, empathy, invested time and their 
strong knowledge base. Being a symbol of hope is also an important part of 
this relationship, leading by example and inspiring hope by living with hope 
and positivity themselves. This requires self awareness, insight and self-care 
by the MS Nurse. Living hope teaches hope.  
 
Limitations of the study 
 
There are some limitations to this research study. As a qualitative study this data 
draws on a relatively small number of participants, however the information rich 
informants gave the study powerful information. Additionally, the study was 
confined to participants living in the state of NSW, Australia and the themes may not 
be transferable to other geographic regions and countries. 
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My role as an MS Nurse in clinical practice invariably influenced the data 
interpretations in the study. I did my best to disclose and to be acutely aware of these 
possible influences, not just during the interviews but also at all stages of the data 
analysis process. However, despite these safeguards, it is likely that my MS Nurse 
role has influenced the research findings in some way and may in fact have brought 
greater depth to the study. 
 
Directions for future research 
 
This life history study has explored the lived experience of RRMS in the state of 
NSW, Australia. Further research is required to explore the experiences of PwRRMS 
in other contexts, in other regions, in other countries. Many previous studies have 
purposively or inadvertently enrolled mainly women in their research, and the lived 
experience of men with RRMS is also grossly under-researched and requires further 
attention. Additionally, similar research to the current study needs to be performed in 
currently overlooked areas of living with RRMS - in both children/adolescents and in 
the aged population living with RRMS, interestingly both ends of the life trajectory. 
There also exists little research on the lived experiences of carers of PwRRMS and 
also on the lived experience of MS Nurses other MS HCPs.  
 
Surplus Suffering in RRMS care emerged as a key, novel finding for this particular 
population and would be the ideal concept to form the basis of further research work 
in RRMS. Not just in recognising and managing Surplus Suffering, but in truly 
understanding the underlying causes of the phenomena. Additionally, the concepts of 
parenting with RRMS, comparisons with others with MS, invisibility as a welcome 
cloak, harnessing resilience, the experiences of reverse stigma, worry and fear in 
RRMS all warrant further exploration to better understand their basis and their 
direction. Moreover, all aspects of hope and purposeful positivity could be examined 
in further detail for further support and evidence on how the MS Nurse can best 
assist and promote this important function.  
 
This thesis explores and discusses how PwRRMS are active in Taming the Beast, but 
just as importantly, the study highlights the importance of Holding Hands with Hope. 
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In a time of great scientific and biomedical progress into RRMS, this situation 
requires careful observation and monitoring so that knowledge of the patient 
experience does not get left behind the rapidly changing and expanding medical 
knowledge. 
 
The life history method, the study findings and me 
 
As a researcher, choosing the life history method proved to be an absolute privilege 
for me, gaining so much more from the data than I had ever dared imagine. The 
depth of emotions and information the participants shared with me still profoundly 
affects me. I feel eternally grateful to the study participants for sharing their deepest 
despair and their most rising joy, and amongst it all telling me about all of the other 
facets of life that we so rarely have time to ask about in the roles of MS Nurse and 
patient. It was these facets of life that ultimately helped me build up a picture of 
hope, resilience and overcoming adversity that I had never really thought too much 
about. My previous understanding was generated by the perspective of a perpetually 
exhausted, task-orientated, problem solving MS Nurse. Perhaps I was a little 
frightened to ask more questions because it might just open a “Pandora’s box” that 
we didn’t have time to explore in a time-limited and already rushed clinical 
appointment. 
 
The life history methodology gave the study much more emotion and insight than 
would have been achieved by simply asking pre-determined interview questions in a 
structured format, or by presenting the participants with a survey or questionnaire of 
things that I felt were important. Instead, life histories flowed naturally for the study 
participants, forming stories and presenting a wide range of themes. These were 
stories that sometimes broke my heart, and sometimes healed it, but always affected 
my heart and understanding in some way.  
 
Within a life trajectory it is possible to identify critical life events working through 
central life themes such as love, work and play (Plummer, 2001). For PwRRMS, 
these components make up their daily life living with the disease and how they get 
through them, survive and thrive is what we, as MS Nurses and MS HCPs need to 
understand more about in order to provide optimal care and education. It is not just 
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about the exact moment of the person living with RRMS sitting in a consultation. 
Patients cope and live with a lifetime of experiences which could ultimately be 
affecting the present. Whilst it is impossible to assemble a life history for every 
patient, it is possible to ask the right questions to bring together important details 
which may affect current and future consultations, and have a significant impact on 
their life journey with RRMS.  
 
This thesis explored the experiences of 13 people living with RRMS, and has 
outlined important areas of reflection for MS Nurses and provided recommendations 
for clinical MS nursing care. The reason for this is to generate insights of the lived 
experience of PwRRMS so that nurses have a deeper understanding of the RRMS 
experience in order to plan nursing care accordingly. A critical role of the MS Nurse 
is to lend strength whilst we repair and support Piecing Together the Puzzle, we 
guide (Re)defining self, we assess, act and refer on when Battling the Demons, we 
repair and prevent Surplus Suffering, we advocate for High (In)Visibility, we teach 
skills in Taming the Beast, we educate and monitor The DMT Dance, we 
acknowledge and inspire Holding Hands with Hope. In short, we, as MS Nurses, act 
in the capacity of strength for our patients through the life journey of RRMS. From 
Eric Cassell (2004, p.43): 
 
“Recovery from suffering often involves borrowing the strength of others as though 
persons who have lost parts of themselves can be sustained by the personhood of 
others until their own recovers”. 
 
As MS Nurses, we lend strength so very well. My hope is that through the new 
knowledge gained into the life journey of RRMS in the current study, and by 
generating future research, we can enhance and build upon this even further.  
 
 
 
 
 
 
 
	 373	
REFERENCES 
 
Aitini, E., Martignoni, G., Labianca, R., Italian Group for the study of Digestive 
Tract Cancer (GISCAD), & On behalf of the Italian Group for the study of 
Digestive Tract Cancer (GISCAD). (2014). Communication models for doctor-
patient relationships. Journal of Cancer Education, 29(2), 211-212. 
doi:10.1007/s13187-014-0616-z 
 
Al-Araji, A. H., & Oger, J. (2005). Reappraisal of L’hermitte's sign in multiple 
sclerosis. Multiple Sclerosis, 11(4), 398. doi:10.1191/1352458505ms1177oa 
 
Al‐Sharman, A., Khalil, H., Nazzal, M., Al‐Sheyab, N., Alghwiri, A., El‐Salem, K., 
& Al-Dughmi, M. (2018). Living with multiple sclerosis: A Jordanian 
perspective. Physiotherapy Research International, 23(2), n/a. 
doi:10.1002/pri.1709 
 
Alexander, T., Farge, D., Badoglio, M., Lindsay, J. O., Muraro, P. A., & Snowden, 
J. A. (2018). Hematopoietic stem cell therapy for autoimmune diseases – Clinical 
experience and mechanisms. Journal of autoimmunity, 92,35-
46.doi:10.1016/j.jaut.2018.06.002   
 
Aliaga, E. S., & Barkhof, F. (2014). MRI mimics of multiple sclerosis. In Handbook 
of Clinical Neurology , Vol 122, p. 291-316. Elsevier Health Sciences. 
doi:10.1016/B978-0-444-52001-2.00012-1 
 
Allport, G. W. (1942). The use of personal documents in psychological science: 
Prepared for the Committee on Appraisal of Research. New York NY. Social 
Science Research Council. 
 
Alwan, S., Yee, I., Dybalski, M., Guimond, C., Dwosh, E., Greenwood, T., . . . 
Sadovnick, A. (2013). Reproductive decision making after the diagnosis of 
multiple sclerosis (MS). Multiple Sclerosis Journal, 19(3), 351-358. 
doi:10.1177/1352458512452920 
 
	 374	
American Psychiatric Association. (2013). Diagnostic and statistical manual of 
mental disorders (5th ed.). Washington, DC: Author, APA. 
 
Anderson, S. S., & Philbrick, A. M. (2014). Improving multiple sclerosis care: An 
analysis of the necessity for medication therapy management services among the 
patient population. Journal of Managed Care & Specialty Pharmacy, 20(3), 254. 
 
Aoun, S., McConigley, R., Abernethy, A., & Currow, D. C. (2010). Caregivers of 
people with neurodegenerative diseases: Profile and unmet needs from a 
population-based survey in South Australia. Journal of Palliative Medicine, 13(6), 
653-661. doi:10.1089/jpm.2009.0318 
 
Arman, M., & Rehnsfeldt, A. (2007). The `little extra' that alleviates 
suffering. Nursing Ethics, 14(3), 372-386. doi:10.1177/0969733007075877 
 
Aronson, J. (1995). A pragmatic view of thematic analysis. The qualitative 
report, 2(1), 1-3. 
 
Atkins, H. L., Bowman, M., Allan, D., Anstee, G., Arnold, D. L., Bar-Or, A., . . . 
Freedman, M. S. (2016). Immunoablation and autologous haemopoietic stem-cell 
transplantation for aggressive multiple sclerosis: A multicentre single-group phase 
2 trial. The Lancet, 388(10044), 576-585. doi:10.1016/S0140-6736(16)30169-6 
 
Atkinson, D., Okada, H., & Talmy, S. (2011). Ethnography and discourse 
analysis. Continuum companion to discourse analysis, 85-100. 
 
Atkinson, P., & Silverman, D. (1997). Kundera's Immortality: The interview society 
and the invention of the self. Qualitative inquiry, 3(3), 304-325. 
 
Atkinson, R. (1998). The life story interview. Thousand Oaks, CA: Sage 
Publications. 
 
Attride-Stirling, J. (2001). Thematic networks: an analytic tool for qualitative 
research. Qualitative Research, 1(3), 385-405. 
	 375	
 
Audulv, A., Packer, T., Versnel, J., (2014). Identifying gaps in knowledge: A map of 
the qualitative literature concerning life with a neurological condition.Chronic 
Illness, 10(3), 192-243. doi:10.1177/1742395313516133 
 
Australian Bureau of Statistics (ABS). (2009). Profiles of disability, Australia: 
Multiple Sclerosis. Retrieved from 
www.abs.gov.au/ausstats/abs@.nsf/Lookup/4429.0main+features100182009 
    Viewed 16 June 2018. 
 
Averill, J.B. (2014) .Qualitative data analysis In: De Chesnay, M. Nursing research 
using data analysis: Qualitative designs and methods in nursing. New York: 
Springer Publishing Company. 
 
Aymerich, M., Guillamón, I., & Jovell, A. J. (2009). Health-related quality of life 
assessment in people with multiple sclerosis and their family caregivers. A 
multicenter study in Catalonia (Southern Europe). Patient Preference and 
Adherence, 3, 311-321. doi:10.2147/PPA.S6217 
 
Bambara, J. K., Turner, A. P., Williams, R. M., & Haselkorn, J. K. (2011). Perceived 
social support and depression among veterans with multiple sclerosis. Disability 
& Rehabilitation, 33(1), 1-8. doi:10.3109/09638288.2010.481026 
 
Banwell, B., Bar-Or, A., Giovannoni, G., Dale, R. C., & Tardieu, M. (2011). 
Therapies for multiple sclerosis: considerations in the pediatric patient. Nature 
Reviews Neurology, 7(2), 109. 
 
Barker-Collo, S., Cartwright, C., & Read, J. (2006). Into the unknown: The 
experiences of individuals living with multiple sclerosis. The Journal of 
Neuroscience Nursing: Journal of the American Association of Neuroscience 
Nurses, 38(6), 435. 
 
Barnard, D. (1995). Chronic illness and the dynamics of hoping. Chronic illness: 
From experience to policy, 38-57. 
	 376	
 
Barnhill, G.D; & Barnhill E.A. (2014). Data security in qualitative research. In De 
Chesnay, M. Nursing research using data analysis: Qualitative designs and 
methods in nursing. New York: Springer Publishing Company. 
  
Bartholomew, K., Henderson, A. J., & Marcia, J. E. (2000). Coded semi-structured 
interviews in social psychological research. Handbook of research methods in 
social and personality psychology, 286-312. 
 
Batterham, R. W., Hawkins, M., Collins, P. A., Buchbinder, R., & Osborne, R. H. 
(2016). Health literacy: Applying current concepts to improve health services and 
reduce health inequalities. Public Health, 132, 3-12. 
doi:10.1016/j.puhe.2016.01.001 
 
Beckerman, N. L. (2011). Living with lupus: A qualitative report. Social Work in 
Health Care, 50(4), 330-343. doi:10.1080/00981389.2011.554302 
 
Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J; & Tzoulaki, I. (2015). 
Environmental risk factors and multiple sclerosis: An umbrella review of 
systematic reviews and meta-analyses. Lancet Neurology, 14(3), 263-273. 
doi:10.1016/S1474-4422(14)70267-4 
 
Ben‐Zacharia, A. B. (2011). Therapeutics for multiple sclerosis symptoms. Mount 
Sinai Journal of Medicine: A Journal of Translational and Personalized 
Medicine, 78(2), 176-191. doi:10.1002/msj.20245 
 
Bergamaschi, R., Montomoli, C., Mallucci, G., Lugaresi, A., Izquierdo, G., 
Grand'Maison, F., . . . Trojano, M. (2015). BREMSO: A simple score to predict 
early the natural course of multiple sclerosis. European Journal of 
Neurology, 22(6), 981-989. doi:10.1111/ene.12696 
 
Berger, R. (2015). Now I see it, now I don’t: Researcher’s position and reflexivity in 
qualitative research. Qualitative Research, 15(2), 219-234. 
doi:10.1177/1468794112468475 
	 377	
 
Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J., & Crotty, K. 
(2011). Low health literacy and health outcomes: An updated systematic 
review. Annals of Internal Medicine, 155(2), 97. 
 
Beshears, B. K. (2010). The experience of young adults living with relapsing-
remitting multiple sclerosis. (Doctoral dissertation). University of Missouri-
Columbia. 
 
Bevan, C., & Gelfand, J. M. (2015). Therapeutic management of severe relapses in 
multiple sclerosis. Current Treatment Options in Neurology, 17(4), 1-14. 
doi:10.1007/s11940-015-0345-6 
 
Biogen (2018). Tysabri HCP website. Retrieved from 
https://www.tysabrihcp.com/en_us/home/safety/risk-pml-jcv.html. Viewed 15th 
May 2018. 
 
Bjorgvinsdottir, K., & Halldorsdottir, S. (2014). Silent, invisible and 
unacknowledged: Experiences of young caregivers of single parents diagnosed 
with multiple sclerosis. Scandinavian Journal of Caring Sciences, 28(1), 38-48. 
doi:10.1111/scs.12030 
 
Blauner, B. (1989). Black lives, White lives: Three decades of race relations in 
America. University of California Press. 
 
Bloor, M. (1997). Techniques of validation in qualitative research: a critical 
commentary. In Dingwall,G (Ed.).Context and method in qualitative 
research.London UK: Sage Publications.  
 
Blumer, H. (1969). Fashion: From class differentiation to collective selection. The 
Sociological Quarterly, 10(3), 275-291. 
 
 
 
	 378	
Blundell Jones, J., Walsh, S., & Isaac, C. (2014). “Putting one foot in front of the 
other”: A qualitative study of emotional experiences and help-seeking in women 
with multiple sclerosis. Journal of Clinical Psychology in Medical Settings, 21(4), 
356-373. doi:10.1007/s10880-014-9408-1 
 
Boeije, H. R., & Janssens, A. C. J. W. (2004). ‘It might happen or it might not’: How 
patients with multiple sclerosis explain their perception of prognostic risk. Social 
Science & Medicine, 59(4), 861-868. doi:10.1016/j.socscimed.2003.11.040 
 
Bogosian, A., Moss-Morris, R., & Hadwin, J. (2010). Psychosocial adjustment in 
children and adolescents with a parent with multiple sclerosis: a systematic 
review. Clinical Rehabilitation, 24(9), 789-801. 
 
Bombeke, K., Symons, L., Debaene, L., De Winter, B., Schol, S., & Van Royen, P. 
(2010). Help, I'm losing patient-centredness! experiences of medical students and 
their teachers. Medical Education, 44(7), 662. doi:10.1111/j.1365-
2923.2010.03627.x 
 
Bonanno, G. A. (2004). Loss, trauma, and human resilience: have we underestimated 
the human capacity to thrive after extremely aversive events?. American 
Psychologist, 59(1), 20. 
 
Boström, K., Nilsagård, Y. (2016). A family matter – when a parent is diagnosed 
with multiple sclerosis. A qualitative study. Journal of Clinical Nursing, 25(7-8), 
1053-1061. doi:10.1111/jocn.13156 
 
Bottomley, C., Lloyd, A., Bennett, G., & Adlard, N. (2017). A discrete choice 
experiment to determine UK patient preference for attributes of disease modifying 
treatments in multiple sclerosis. Journal of Medical Economics, 20(8), 863-870. 
 
Bowman, M., Racke, M., Kissel, J., & Imitola, J. (2015). Responsibilities of health 
care professionals in counseling and educating patients with incurable 
neurological diseases regarding “stem cell tourism”: caveat emptor. JAMA 
Neurology, 72(11), 1342-1345. 
	 379	
 
Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and 
code development. Thousand Oaks CA: Sage Publications. 
 
Boyd, J. R., & MacMillan, L. J. (2005). Experiences of children and adolescents 
living with multiple sclerosis. The Journal of Neuroscience Nursing: Journal of 
the American Association of Neuroscience Nurses, 37(6), 334. 
 
Boyle, J. S. (1994). Styles of ethnography. Critical issues in qualitative research 
methods, 2, 159-85. 
 
Bradshaw, A. (2011). Compassion: what history teaches us. Nursing Times, 107(19-
20), 12-14. 
 
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative 
research in psychology, 3(2), 77-101. 
 
Braun, V., & Clarke, V. (2013). Successful qualitative research: A practical guide 
for beginners. London, England: Sage Publications. 
 
Braun, V., Clarke, V., Terry, G. (2014). Thematic analysis In  Rohleder, P., & 
Lyons, A. (Eds.). Qualitative research in clinical and health psychology. 
Basingstoke: Palgrave Macmillan  
 
Brennan, K. A. M., & Creaven, A. (2016). Living with invisible illness: Social 
support experiences of individuals with systemic lupus erythematosus. Quality of 
Life Research, 25(5), 1227-1235. doi:10.1007/s11136-015-1151-z 
 
Broadley, S. A., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R., 
... & Marriott, M. (2014a). Therapeutic approaches to disease modifying therapy 
for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 
Treatment practicalities and recommendations. Journal of Clinical 
Neuroscience, 21(11), 1857-1865. 
 
	 380	
Broadley, S. A., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R., 
... & Marriott, M. (2014b). Therapeutic approaches to disease modifying therapy 
for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 
Historical and established therapies. Journal of Clinical Neuroscience, 21(11), 
1835-1846. 
 
Broadley, S. A., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R., 
... & Marriott, M. (2014c). Therapeutic approaches to disease modifying therapy 
for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 
New and emerging therapies and their efficacy. Journal of Clinical 
Neuroscience, 21(11), 1847-1856. 
 
Broadley, S. A., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R., 
. . . Willoughby, E. (2015). A new era in the treatment of multiple sclerosis. The 
Medical Journal of Australia, 203(3), 139-141. doi:10.5694/mja14.01218 
 
Brown, J., & Addington-Hall, J. (2008). How people with motor neurone disease talk 
about living with their illness: A narrative study. Journal of Advanced 
Nursing, 62(2), 200-208. doi:10.1111/j.1365-2648.2007.04588.x 
 
Brown, R. F., Valpiani, E. M., Tennant, C. C., Dunn, S. M., Sharrock, M., 
Hodgkinson, S., & Pollard, J. D. (2009). Longitudinal assessment of anxiety, 
depression, and fatigue in people with multiple sclerosis. Psychology and 
Psychotherapy, 82(Pt 1), 41-56. doi:10.1348/147608308X345614 
 
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & 
Thompson, A. J. (2014). Atlas of multiple sclerosis 2013: A growing global 
problem with widespread inequity. Neurology, 83(11), 1022. 
 
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2016). Diagnosis of 
multiple sclerosis: Progress and challenges. The Lancet, 389(10076), 1336-1346. 
doi:10.1016/S0140-6736(16)30959-X 
 
	 381	
Bruce, J. M., & Arnett, P. (2009). Clinical correlates of generalized worry in multiple 
sclerosis. Journal of Clinical and Experimental Neuropsychology, 31(6), 698-705. 
doi:10.1080/13803390802484789 
 
Bruce, J. M., Bruce, A. S., Catley, D., Lynch, S., Goggin, K., Reed, D., . . . 
Jarmolowicz, D. P. (2016). Being kind to your future self: Probability discounting 
of health decision-making. Annals of Behavioral Medicine, 50(2), 297-309. 
doi:10.1007/s12160-015-9754-8 
 
Bruce, J. M., Hancock, L. M., Arnett, P., & Lynch, S. (2010). Treatment adherence 
in multiple sclerosis: Association with emotional status, personality, and 
cognition. Journal of Behavioral Medicine, 33(3), 219-227. doi:10.1007/s10865-
010-9247-y 
 
Bruce, J. M., & Lynch, S. G. (2010;2011;). Personality traits in multiple sclerosis: 
Association with mood and anxiety disorders. Journal of Psychosomatic 
Research, 70(5), 479-485. doi:10.1016/j.jpsychores.2010.12.010 
 
Brummett, B. H., Barefoot, J. C., Siegler, I. C., Clapp-Channing, N. E., Lytle, B. L., 
Bosworth, H. B., . . . Mark, D. B. (2001). Characteristics of socially isolated 
patients with coronary artery disease who are at elevated risk for 
mortality. Psychosomatic Medicine, 63(2), 267. 
 
Brush off/ brushed off. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/brush off. 
https://en.oxforddictionaries.com/definition/brushed off 
 
Buetow, S. (2010). Thematic analysis and its reconceptualization as 'saliency 
analysis'. Journal of Health Services Research & Policy, 15(2), 123. 
 
Buhse, M. (2008). Assessment of caregiver burden in families of persons with 
multiple sclerosis. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 40(1), 25. 
 
	 382	
Buhse, M. (2015). The elderly person with multiple sclerosis: Clinical implications 
for the increasing life-span. The Journal of Neuroscience Nursing : Journal of the 
American Association of Neuroscience Nurses, 47(6), 333. 
doi:10.1097/JNN.0000000000000172 
 
Buhse, M., Della Ratta, C., Galiczewski, J., & Eckardt, P. (2015). Caregivers of 
older persons with multiple sclerosis: Determinants of health-related quality of 
life. The Journal of Neuroscience Nursing: Journal of the American Association 
of Neuroscience Nurses, 47(2), E2-E12. doi:10.1097/JNN.0000000000000117 
 
Bullock, A. (2014). Does technology help doctors to access, use and share 
knowledge?. Medical education, 48(1), 28-33. 
 
Burke, T., Dishon, S., McEwan, L., & Smrtka, J. (2011). The evolving role of the 
multiple sclerosis nurse: An international perspective. International Journal of 
MS Care, 13(3), 105-112. doi:10.7224/1537-2073-13.3.105 
 
Burnfield, A. (1984). Doctor-patient dilemmas in multiple sclerosis. Journal of 
Medical Ethics, 10(1), 21-26. doi:10.1136/jme.10.1.21 
 
Burnfield, A., & Burnfield, P. (1978). Common psychological problems in multiple 
sclerosis. The British Medical Journal, 1(6121), 1193-1194. 
doi:10.1136/bmj.1.6121.1193 
 
Burton, C. R. (2000). Living with stroke: A phenomenological study. Journal of 
Advanced Nursing, 32(2), 301-309. doi:10.1046/j.1365-2648.2000.01477.x 
 
Busch, H., & Hofer, J. (2012). Self-regulation and milestones of adult development: 
Intimacy and generativity. Developmental Psychology, 48(1), 282-293. 
doi:10.1037/a0025521 
 
 
 
	 383	
Büssing, A., Matthiessen, P. F., & Ostermann, T. (2005). Engagement of patients in 
religious and spiritual practices: Confirmatory results with the SpREUK-P 1.1 
questionnaire as a tool of quality of life research. Health and Quality of Life 
Outcomes, 3(1), 53-53. doi:10.1186/1477-7525-3-53 
 
Büssing, A., Fischer, J., Haller, A., Heusser, P., Ostermann, T., & Matthiessen, P. F. 
(2009). Validation of the brief multidimensional life satisfaction scale in patients 
with chronic diseases. European Journal of Medical Research, 14(4), 171. 
 
Büssing, A., Janko, A., Baumann, K., Hvidt, N. C., & Kopf, A. (2013). Spiritual 
needs among patients with chronic pain diseases and cancer living in a secular 
society. Pain Medicine, 14(9), 1362-1373. 
 
Butler, E., Matcham, F., & Chalder, T. (2016). A systematic review of anxiety 
amongst people with multiple sclerosis. Multiple Sclerosis and Related 
Disorders, 10, 145-168. doi:10.1016/j.msard.2016.10.003 
 
Calabresi, P. A. (2004). Diagnosis and management of multiple sclerosis. American 
family physician, 70(10), 1935-1944. 
 
Calabrese, M., Magliozzi, R., Ciccarelli, O., Geurts, J. J., Reynolds, R., & Martin, R. 
(2015). Exploring the origins of grey matter damage in multiple sclerosis. Nature 
Reviews Neuroscience, 16(3), 147. 
 
Cantril, H. (1964). The human design. Journal of Individual Psychology, 20(2), 129. 
 
Carter, S. M., & Little, M. (2007). Justifying knowledge, justifying method, taking 
action: Epistemologies, methodologies, and methods in qualitative 
research. Qualitative Health Research, 17(10), 1316-1328. 
doi:10.1177/1049732307306927 
 
Cassell, E. J. (1991). The nature of suffering: And the goals of medicine. New York, 
NY: Oxford University Press. 
 
	 384	
Cassell, E. J. (2004). The nature of suffering and the goals of medicine (2nd ed.). 
New York: Oxford University Press. 
doi:10.1093/acprof:oso/9780195156164.001.0001 
 
Chacinska, W., Brzostowska, M., Nojszewska, M., Podlecka-Pitowska, A., 
Jdrzejczak, W. W., & Snarski, E. (2017). "Cure" for multiple sclerosis (MS)--
evolving views of therapy goals in patients on different stages of the disease: A 
pilot study in a cohort of polish MS patients. Brain and Behavior, 7(6) 
doi:10.1002/brb3.701 
 
Chalfant, A. M., Bryant, R. A., & Fulcher, G. (2004). Posttraumatic stress disorder 
following diagnosis of multiple sclerosis. Journal of Traumatic Stress, 17(5), 423-
428. doi:10.1023/B:JOTS.0000048955.65891.4c 
 
Charmaz, K. (1983). Loss of self: A fundamental form of suffering in the chronically 
ill. Sociology of Health & Illness, 5(2), 168-195. doi:10.1111/1467-
9566.ep10491512 
 
Charmaz, K. (1987). Struggling for a self: Identity levels of the chronically 
ill. Research in the sociology of health care, 6(283-321). 
 
Charmaz, K. (1990). 'discovering' chronic illness: Using grounded theory. Social 
Science & Medicine (1982), 30(11), 1161. 
 
Charmaz, K. (1999). Stories of suffering: Subjective tales and research 
narratives. Qualitative Health Research, 9(3), 362-382. 
doi:10.1177/104973239900900306 
 
Charmaz, K. (2006). Constructing grounded theory: A practical guide through 
qualitative research. London, UK: Sage Publications.  
 
Chataway, J., & Miller, D. H. (2013). Natalizumab therapy for multiple sclerosis. 
Neurotherapeutics, 10(1), 19-28. doi:10.1007/s13311-012-0171-4 
 
	 385	
Chesla, C. A. (2005). Nursing science and chronic illness: Articulating suffering and 
possibility in family life. Journal of Family Nursing, 11(4), 371-387. 
doi:10.1177/1074840705281781 
 
Chesla, C. A., & Leonard, V. (2017). Using a Life-World Approach to Understand 
Family Resilience. In Family Resilience and Chronic Illness (pp. 1-17). Springer, 
Cham. 
 
Cheung, J., & Hocking, P. (2004). Caring as worrying: The experience of spousal 
carers. Journal of Advanced Nursing, 47(5), 475-482. doi:10.1111/j.1365-
2648.2004.03126.x 
 
Chiaravalloti, N. D.,& DeLuca, J . (2008). Cognitive impairment in multiple 
sclerosis. Lancet Neurology, 7(12), 1139-1151. doi:10.1016/S1474-
4422(08)70259-X 
 
Clair, V. W. (2003). Storymaking and storytelling: Making sense of living with 
multiple sclerosis. Journal of Occupational Science, 10(1), 46-51. 
doi:10.1080/14427591.2003.9686510 
 
Clarke, D. (2003). Faith and hope. Australasian Psychiatry, 11(2), 164-168. 
doi:10.1046/j.1039-8562.2003.00550.x 
 
Clarke, J. N. (2012). Surplus suffering, mothers don’t know best: Denial of mothers’ 
reality when parenting a child with mental health issues. Journal of Child Health 
Care, 16(4), 355-366. doi:10.1177/1367493512443904 
 
Clarke, J. N. (2013). Surplus suffering: The search for help when a child has 
mental‐health issues. Child & Family Social Work, 18(2), 217-225. 
doi:10.1111/j.1365-2206.2011.00824.x 
 
Clarke, J. N., & Fletcher, P. (2005). Parents as advocates: Stories of surplus suffering 
when a child is diagnosed and treated for cancer. Social Work in Health 
Care, 39(1-2), 107-127. doi:10.1300/J010v39n01_08 
	 386	
 
Clarke, J., & van Amerom, G. (2007). 'surplus suffering': Differences between 
organizational understandings of asperger's syndrome and those people who claim 
the 'disorder'. Disability & Society, 22(7), 761. doi:10.1080/09687590701659618 
 
Clarke, V., & Braun, V. (2013). Teaching thematic analysis: Overcoming challenges 
and developing strategies for effective learning. The Psychologist, 26(2), 120-123. 
 
Clifford, D. B., & Nath, A. (2010). PML: Underdiagnosed in MS patients on 
natalizumab – authors' reply. Lancet Neurology, 9(6), 564-565. 
doi:10.1016/S1474-4422(10)70123-X 
 
Coles, A. J.,Twyman, C. L.,Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J. . . 
. CARE-MS II investigators. (2012). Alemtuzumab for patients with relapsing 
multiple sclerosis after disease-modifying therapy: A randomised controlled phase 
3 trial. The Lancet, 380(9856), 1829-1839. doi:10.1016/S0140-6736(12)61768-1 
 
Colhoun, S., Wilkinson, C., Izat, A., White, S., Pull, E., & Roberts, M. (2015). 
Multiple sclerosis and disease modifying therapies: Results of two UK surveys on 
factors influencing choice. British Journal of Neuroscience Nursing, 11(1), 7-13. 
doi:10.12968/bjnn.2015.11.1.7 
 
Comi, G., Radaelli, M., & Sørensen, P. S. (2017). Evolving concepts in the treatment 
of relapsing multiple sclerosis. The Lancet,  389(10076), 1347-1356. 
doi:10.1016/S0140-6736(16)32388-1 
 
Compston, A., & Coles, A. (2002). Multiple sclerosis. The Lancet ,359(9313), 1221-
1231. doi:10.1016/S0140-6736(02)08220-X 
 
Compston, A., & Coles, A. (2008). Multiple sclerosis. The Lancet, 372(9648), 1502-
1517. doi:10.1016/S0140-6736(08)61620-7 
 
	 387	
Connell, R. (2010). Lives of the businessmen. Reflections on life-history method and 
contemporary hegemonic masculinity. Österreichische Zeitschrift für 
Soziologie, 35(2), 54-71. 
 
Corner, J. (2002). Nurses’ experiences of cancer. European Journal of cancer 
care, 11(3), 193-199. 
 
Corry, M., & While, A. (2009). The needs of carers of people with multiple sclerosis: 
a literature review. Scandinavian Journal of Caring Sciences, 23(3), 569-588. 
 
Costello, K., Kennedy, P., & Scanzillo, J. (2008). Recognizing nonadherence in 
patients with multiple sclerosis and maintaining treatment adherence in the long 
term. Medscape Journal of Medicine, 10(9), 225. 
 
Costello, K., Thrower, B. W., & Giesser, B. S. (2015). Navigating life with multiple 
sclerosis. US: Oxford University Press. 
 
Coulehan, J. (2011). On hope in palliative medicine. Perspectives on suffering. New 
York  NY: Springer. 
 
Courts, N. F., Buchanan, E. M., & Werstlein, P. O. (2004). Focus groups: The lived 
experience of participants with multiple sclerosis. The Journal of Neuroscience 
Nursing : Journal of the American Association of Neuroscience Nurses, 36(1), 42. 
 
Coyle, P. K. (2016). Management of women with multiple sclerosis through 
pregnancy and after childbirth. Therapeutic Advances in Neurological 
Disorders, 9(3), 198-210. 
 
Crawford, P., Gilbert, P., Gilbert, J., Gale, C., & Harvey, K. (2013). The language of 
compassion in acute mental health care. Qualitative Health Research, 23(6), 719-
727. 
 
	 388	
Crayton, H. J., & Rossman, H. S. (2006). Managing the symptoms of multiple 
sclerosis: A multimodal approach. Clinical Therapeutics, 28(4), 445-460. 
doi:10.1016/j.clinthera.2006.04.005 
 
Creswell, J. W. (2008). Educational research: Planning, conducting, and evaluating 
quantitative and qualitative research. (3rd Ed). Upper Saddle River, NJ : Pearson. 
 
Cruz, E. V., & Higginbottom, G. (2013). The use of focused ethnography in nursing 
research. Nurse Researcher, 20(4), 36. 
 
Cunningham, M. M., & Jillings, C. (2006). Individuals’ descriptions of living with 
fibromyalgia. Clinical Nursing Research, 15(4), 258-273. 
doi:10.1177/1054773806291853 
 
Cutcliffe, J., & Herth, K. (2002). The concept of hope in nursing 2: Hope and mental 
health nursing. British Journal of Nursing, 11(13), 885-893. 
doi:10.12968/bjon.2002.11.13.10447 
 
Cutcliffe, J and Gant, G. (2011) What are the principles and process of inspiring 
hope in cognitively impaired older adults within a continuing care environment?  
Journal of Psychiatric and Mental Health Nursing, 8(5), 427-431. 
 
Davies, B. L., Arpin, D. J., Liu, M., Reelfs, H.,Volkman, G., Healey, K.,  . . . Kurz, 
M. J., (2016). Two different types of high-frequency physical therapy promote 
improvements in the balance and mobility of persons with multiple 
sclerosis. Archives of Physical Medicine and Rehabilitation, 97(12), 2095-
2101.e3. doi:10.1016/j.apmr.2016.05.024 
 
Davies, N. (2014). Empathic nursing: Going the extra mile. Practice Nursing, 25(4), 
198-202. doi:10.12968/pnur.2014.25.4.198 
 
Davitz, L. J., & Pendleton, S. H. (1969). Nurses' inferences of suffering. Nursing 
Research, 18(2), 100. 
 
	 389	
Deal, B. (2011). Finding meaning in suffering. Holistic Nursing Practice, 25(4), 205-
210. doi:10.1097/HNP.0b013e31822271db 
 
De Chesnay, M. (2014). Nursing research using life history: Qualitative designs and 
methods in nursing. New York: Springer Publishing Company, LLC. 
 
De Chesnay, M; Rassilyer-Bomers,R; Webb, J; & Peil,R.(2008). Life historirs of 
successful survivors of colostomy surgery, multiple sclerosis, and bereavement. 
In:De Chesnay, M., & Anderson, B. A. (Eds.). Caring for the vulnerable: 
Perspectives in nursing theory, practice, and research (2nd ed.). Sudbury, MA: 
Jones And Bartlett Publishers. 
 
D'hooghe, M. B., Nagels, G., De Keyser, J., & Haentjens, P. (2013;). Self-reported 
health promotion and disability progression in multiple sclerosis. Journal of the 
Neurological Sciences, 325(1-2), 120-126. doi:10.1016/j.jns.2012.12.018 
 
de Jong, B. A., & Uitdehaag, B. M. (2018). Anxiety is more important than 
depression in MS – commentary. Multiple Sclerosis Journal, 24(4), 444-445. 
doi:10.1177/1352458518756516 
 
de la Fuente, E. (2014). Why aesthetic patterns matter: Art and a “qualitative” social 
theory. Journal for the Theory of Social Behaviour, 44(2), 168-185. 
 
 
Delaney, K. E., & Donovan, J. (2017). Multiple sclerosis and sexual dysfunction: A 
need for further education and interdisciplinary care. NeuroRehabilitation, 41(2), 
317-329. 
 
Dennison, L., Moss-Morris, R., & Chalder, T. (2009). A review of psychological 
correlates of adjustment in patients with multiple sclerosis. Clinical Psychology 
Review, 29(2), 141-153. doi:10.1016/j.cpr.2008.12.001 
 
 
 
	 390	
Dennison, L., Moss-Morris, R., Silber, E., Galea, I., & Chalder, T. (2010). Cognitive 
and behavioural correlates of different domains of psychological adjustment in 
early-stage multiple sclerosis. Journal of Psychosomatic Research, 69(4), 353-
361. doi:10.1016/j.jpsychores.2010.04.009 
 
Dennison, L., McCloy Smith, E., Bradbury, K., & Galea, I. (2016). How do people 
with multiple sclerosis experience prognostic uncertainty and prognosis 
communication? A qualitative study. PloS One, 11(7), e0158982. 
doi:10.1371/journal.pone.0158982 
 
Denzin, N. K. (1989). Interpretive biography. Newbury Park: Sage Publications. 
 
Denzin, N. K. (1994). The art and politics of interpretation. Handbook of qualitative 
research 1. Thousand Oaks, CA: Sage Publications. 
 
Denzin, N. K., & Giardina, M. D. (Eds.). (2016). Ethical futures in qualitative 
research: Decolonizing the politics of knowledge. New York NY: Routledge. 
 
Denzin, N. K., & Lincoln, Y. S. (2000). Handbook of qualitative research (2nd ed.). 
Thousand Oaks, CA: Sage Publications. 
 
Derksen, F., Bensing, J., & Lagro-Janssen, A. (2013). Effectiveness of empathy in 
general practice: A systematic review. British Journal of General 
Practice, 63(606), 76-84. doi:10.3399/bjgp13X660814 
 
de Ridder, D; Geenen, R., Kuijer, R., & van Middendorp, H. (2008). Psychological 
adjustment to chronic disease. The Lancet, 372(9634), 246-255. 
doi:10.1016/S0140-6736(08)61078-8 
 
DeSantis, L., & Ugarriza, D. N. (2000). The concept of theme as used in qualitative 
nursing research. Western Journal of Nursing Research, 22(3), 351-372. 
doi:10.1177/019394590002200308 
 
	 391	
DeSanto-Madeya, S. (2006). The meaning of living with spinal cord injury 5 to 10 
years after the injury. Western Journal of Nursing Research, 28(3), 265-289. 
doi:10.1177/0193945905283178 
 
Despair. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/despair 
 
Devonshire, V., Lapierre, Y., Macdonell, R., Ramo‐Tello, C., Patti, F., Fontoura, P., 
. . . GAP Study Group. (2011). The global adherence project (GAP): A 
multicenter observational study on adherence to disease‐modifying therapies in 
patients with relapsing‐remitting multiple sclerosis. European Journal of 
Neurology, 18(1), 69-77. doi:10.1111/j.1468-1331.2010.03110.x 
 
Dickstein, L. P., Viguera, Adele C., Nowacki, A. S., Thompson, N. R., Griffith, S. 
D., Baldessarini, R. J., & Katzan, Irene L. (2015). Thoughts of death and self-
harm in patients with epilepsy or multiple sclerosis in a tertiary care 
center. Psychosomatics, 56(1), 44-51. doi:10.1016/j.psym.2014.05.008 
 
Dörr, J. (2016). Haemopoietic stem-cell transplantation for multiple sclerosis: What 
next?Lancet, the, 388(10044), 536-538. doi:10.1016/S0140-6736(16)30377-4 
 
Dyck, I. (1995). Hidden geographies: The changing lifeworlds of women with 
multiple sclerosis. Social Science & Medicine, 40(3), 307-320. doi:10.1016/0277-
9536(94)E0091-6 
 
Ebrahimi, H., Hasankhani, H., Namdar, H., Khodadadi, E., & Fooladi, M. (2017). 
Dealing with chronic illness: Experiences of Iranian families of persons with 
Multiple Sclerosis: A qualitative study. Multiple Sclerosis International. 
    doi:10.1155/2017/9243161 
 
Edmonds, P., Vivat, B., Burman, R., Silber, E., & Higginson, I. J. (2007). Fighting 
for everything': Service experiences of people severely affected by multiple 
sclerosis. Multiple Sclerosis, 13(5), 660-667. doi:10.1177/1352458506071789 
	 392	
 
Eeltink, C., & Duffy, M. (2004). Restorying the illness experience in multiple 
sclerosis. The Family Journal, 12(3), 282-286. doi:10.1177/1066480704264567 
 
Elian, M., & Dean, G. (1985). To tell or not to tell the diagnosis of multiple 
sclerosis. The Lancet, 326(8445), 27-28. 
 
Elliott, T. R., Witty, T. E., Herrick, S. M., & Hoffman, J. T. (1991). Negotiating 
reality after physical loss: Hope, depression, and disability. Journal of Personality 
and Social Psychology, 61(4), 608-613. doi:10.1037//0022-3514.61.4.608 
 
Ely, M., Vinz, R., Downing, M., & Anzul, M. (1997). On writing qualitative 
research: Living by words. London: Taylor and Francis. 
doi:10.4324/9780203451427 
 
Ensign, J., & Bell, M. (2004). Illness experiences of homeless youth. Qualitative 
Health Research, 14(9), 1239-1254. doi:10.1177/1049732304268795 
 
Epstein, R. M., & Back, A. L. (2015). Responding to suffering. JAMA, 314 (24), 
2623-2624. doi:10.1001/jama.2015.13004 
 
Eriksson, K. (2008). The Suffering Human Being. Chicago, IL: Nordic Studies Press. 
 
Esmail, S., Munro, B., & Gibson, N. (2007). Couple's experience with multiple 
sclerosis in the context of their sexual relationship. Sexuality and 
Disability, 25(4), 163. doi:10.1007/s11195-007-9054-8 
 
Faraday, A., & Plummer, K. (1979). Doing life histories. The Sociological 
Review, 27(4), 773-798. 
 
Farran, N., Ammar, D., & Darwish, H. (2016). Quality of life and coping strategies 
in Lebanese multiple sclerosis patients: A pilot study. Multiple Sclerosis and 
Related Disorders, 6, 21-27. doi:10.1016/j.msard.2015.12.003 
 
	 393	
Faulkner, M. (2015). Risk of progressive multifocal leukoencephalopathy in patients 
with multiple sclerosis. Expert Opinion on Drug Safety, 14(11), 1737-1748. 
doi:10.1517/14740338.2015.1093620 
 
Fawcett, T. N., & Lucas, M. (2006). Multiple sclerosis: Living the reality. British 
Journal of Nursing, 15(1), 46-51. doi:10.12968/bjon.2006.15.1.20310 
 
Fear. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/fear 
 
Feinstein, A. (2002). An examination of suicidal intent in patients with multiple 
sclerosis. Neurology, 59(5), 674. 
 
Feinstein, A. (2011). Multiple sclerosis and depression. Multiple Sclerosis 
Journal, 17(11), 1276-1281. doi:10.1177/1352458511417835 
 
Feinstein, A., DeLuca, J., Baune, B. T., Filippi, M., & Lassman, H. (2012). 
Cognitive and neuropsychiatric disease manifestations in MS. Multiple Sclerosis 
and Related Disorders, 2(1), 4-12. doi:10.1016/j.msard.2012.08.001 
 
Feinstein, A., Magalhaes, S., Richard, J., Audet, B., & Moore, C. (2014). The link 
between multiple sclerosis and depression. Nature Reviews Neurology, 10(9), 507. 
 
Feinstein, A., Freeman, J., & Lo, A. C., (2015). Treatment of progressive multiple 
sclerosis: What works, what does not, and what is needed. Lancet Neurology, 
14(2), 194-207. doi:10.1016/S1474-4422(14)70231-5 
 
Fereday, J., & Muir-Cochrane, E. (2006). Demonstrating rigor using thematic 
analysis: A hybrid approach of inductive and deductive coding and theme 
development. International Journal of Qualitative Methods, 5(1), 80-92. 
 
Ferguson, P., & Walker, H. (2014). ‘Getting on with life’: Resilience and normalcy 
in adolescents living with chronic illness. International Journal of Inclusive 
Education, 18(3), 227-240. doi:10.1080/13603116.2012.676082 
	 394	
 
Ferrell, B., & Coyle, N. (2008). The nature of suffering and the goals of 
nursing (illustrat ed.). New York;Oxford;: Oxford University Press. 
doi:10.1093/acprof:oso/9780195333121.001.0001 
 
Fetterman, D. M. (1998). Ethnography: Step by step (2nd ed.). Thousand Oaks, CA: 
Sage Publications. 
 
Field, P., & Morse, J. M. (1985). Nursing research: The application of qualitative 
approaches. Rockville, MD: Aspen Systems Corp. 
 
Filippi, M., Rocca, M. A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L.,, 
. . . MAGNIMS Study Group. (2016). MRI criteria for the diagnosis of multiple 
sclerosis: MAGNIMS consensus guidelines. Lancet Neurology, 15(3), 292-303. 
doi:10.1016/S1474-4422(15)00393-2 
 
Finkelsztejn, A. (2014). Multiple sclerosis: overview of disease-modifying 
agents. Perspectives in Medicinal Chemistry, 6, PMC-S13213. 
 
Finlay, L. (2003). The intertwining of body, self and world: A phenomenological 
study of living with recently-diagnosed multiple sclerosis. Journal of 
Phenomenological Psychology, 34(2), 157-178. 
doi:10.1163/156916203322847128 
 
Finlayson M.F., Van Denend  D. T., &  DalMonte J.D. (2005). Older adults' 
perspectives on the positive and negative aspects of living with multiple 
sclerosis. The British Journal of Occupational Therapy, 68(3), 117-124. 
doi:10.1177/030802260506800304 
 
Fitzgerald Miller, J. (2007). Hope: A construct central to nursing. Nursing 
Forum, 42(1), 12-19. doi:10.1111/j.1744-6198.2007.00061.x 
 
	 395	
Flensner, G., & Rudolfsson, G. (2016). Learning to fly with broken wings–forcing a 
reappraisal of time and space. Scandinavian journal of caring sciences, 30(2), 
403-410. 
 
Foley, F. (2010) Sexual dysfunction in multiple sclerosis. In Giesser, B. S.(Ed.). 
Primer on multiple sclerosis. New York, NY. Oxford University Press. 
 
Foote, A. W., Piazza, D., Holcombe, J., Paul, P., & Daffin, P. (1990). Hope, self-
esteem and social support in persons with multiple sclerosis. The Journal of 
Neuroscience Nursing : Journal of the American Association of Neuroscience 
Nurses, 22(3), 155-159. doi:10.1097/01376517-199006000-00004 
 
Frank, J. D. (1975). The faith that heals. The Johns Hopkins Medical 
Journal, 137(3), 127. 
 
Freeman, M. (2017). Modes of thinking for qualitative analysis. New York NY: 
Routledge. 
 
Frndak, S. E., Irwin, L. N., Kordovski, V. M., Milleville, K., Fisher, C., Drake, A. S., 
& Benedict, R. H. B. (2015). Negative work events reported online precede job 
loss in multiple sclerosis.Journal of the Neurological Sciences, 357(1), 209-214. 
doi:10.1016/j.jns.2015.07.032 
 
Frohman, T. C., Davis, S. L., Beh, S., Greenberg, B. M., Remington, G., & Frohman, 
E. M. (2013). Uhthoff's phenomena in MS--clinical features and 
pathophysiology. Nature Reviews. Neurology, 9(9), 535. 
 
Fusch, P. I., & Ness, L. R. (2015). Are we there yet? Data saturation in qualitative 
research. The qualitative report, 20(9), 1408. 
 
Garcia, C. M., & Saewyc, E. M. (2007). perceptions of mental health among recently 
immigrated mexican adolescents. Issues in Mental Health Nursing, 28(1), 37-54. 
doi:10.1080/01612840600996257 
 
	 396	
Gaskill, A., Foley, F. W., Kolzet, J., & Picone, M. A. (2011). Suicidal thinking in 
multiple sclerosis. Disability and Rehabilitation, 33(17-18), 1528-1536. 
doi:10.3109/09638288.2010.533813 
 
Gedik, Z., Sorias, O., & Idiman, E. (2017). Do coping styles mediate the relationship 
between disability status and psychosocial loss in people with relapsing remitting 
multiple sclerosis? Journal of Health Psychology, 22(6), 707-721. 
doi:10.1177/1359105315611958 
 
Gelfand, J. M., Cree, B. A. C., & Hauser, S. L. (2017). Ocrelizumab and other 
CD20+ B-cell-depleting therapies in multiple sclerosis. Neurotherapeutics, 14(4), 
835-841. doi:10.1007/s13311-017-0557-4 
 
George, L. K., Larson, D. B., Koenig, H. G., & McCullough, M. E. (2000). 
Spirituality and health: What we know, what we need to know. Journal of Social 
and Clinical Psychology, 19(1), 102-116. doi:10.1521/jscp.2000.19.1.102 
 
Giesser, B. S. (2011). Diagnosis of multiple sclerosis. Neurologic clinics, 29(2), 381-
388. 
 
Gillham, J. E., Reivich, K. J., Jaycox, L. H., & Martin E. P. Seligman. (1995). 
Prevention of depressive symptoms in schoolchildren: Two-year follow-
up. Psychological Science, 6(6), 343-351. doi:10.1111/j.1467-
9280.1995.tb00524.x 
 
Gillon, R. (2015). Defending the four principles approach as a good basis for good 
medical practice and therefore for good medical ethics. Journal of Medical 
Ethics, 41(1), 111-116. 
 
Giovannoni, G., Turner, B., Gnanapavan, S., Offiah, C., Schmierer, K., & Marta, M. 
(2015). Is it time to target no evident disease activity (NEDA) in multiple 
sclerosis?. Multiple sclerosis and related disorders, 4(4), 329-333. 
 
	 397	
Giovannoni, G. (2016). How long is the presymptomatic phase of multiple 
sclerosis? Multiple Sclerosis and Related Disorders, 7, 12-13. 
doi:10.1016/j.msard.2016.02.010 
 
Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., . 
. . Vollmer, T. (2016). Brain health: Time matters in multiple sclerosis. Multiple 
Sclerosis and Related Disorders, 9, S5-S48. doi:10.1016/j.msard.2016.07.003 
 
Glaser, B. G. (1965). The constant comparative method of qualitative 
analysis. Social Problems, 12(4), 436-445. 
 
Glaser, B. G & Strauss. A.L .(1967). The discovery of grounded theory: Strategies 
for qualitative research. Mill Valley,CA: Sociology Press. 
 
Glaser, B. G., & Strauss, A. L. (2017). Discovery of grounded theory: Strategies for 
qualitative research. New York NY: Routledge. 
 
Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. 
Harmondsworth, England: Penguin. 
 
Goodin, D.S., Reder A.T; Bermel R.A., Cutter G.R;.,Fox R.J;.,John G.R….Waubant 
E. (2016). Relapses in multiple sclerosis: Relationship to disability. Multiple 
Sclerosis and Related Disorders, 6(10 – 20). 
 
Goodrick-Clarke, N. (2008). The western esoteric traditions: A historical 
introduction. New York;Oxford: Oxford University Press. 
doi:10.1093/acprof:oso/9780195320992.001.0001 
 
Goodyear-Smith, F., & Buetow, S. (2001). Power issues in the doctor-patient 
relationship. Health Care Analysis, 9(4), 449-462. doi:10.1023/A:1013812802937 
 
Gray, V., & Arnett, P. (2014). Aging with multiple sclerosis: Cognitive, emotional 
and neuropathological considerations. Neurodegenerative Disease 
Management, 4(2), 187. 
	 398	
 
Grbich, C. (2007). Qualitative data analysis: An introduction . London UK: Sage 
Publications. 
 
Green AJ.,Kamel H., & Josephson SA. Combating the Spread of Ineffective Medical 
Procedures : A Lesson Learned From Multiple Sclerosis. JAMA 
Neurol. 2018;75(1):15–17. doi:10.1001/jamaneurol.2017.3066 
 
Green, H. E. (2014). Use of theoretical and conceptual frameworks in qualitative 
research. Nurse Researcher. 21(6), 34. 
 
Grigoriadis, N., & Pesch, V. (2015). A basic overview of multiple sclerosis 
immunopathology. European Journal of Neurology, 22(S2), 3-13. 
 
Gromisch, E. S., Schairer, L. C., Pasternak, E., Kim, S. H., & Foley, F. W. (2016). 
Assessment and treatment of psychiatric distress, sexual dysfunction, sleep 
disturbances, and pain in multiple sclerosis: a survey of members of the 
Consortium of Multiple Sclerosis Centers. International Journal of MS 
Care, 18(6), 291-297. 
 
Groopman, J. (2004). The anatomy of hope. The Permanente Journal, 8(2), 43. 
 
Grytten, N., & Måseide, P. (2006). 'when I am together with them I feel more ill.' the 
stigma of multiple sclerosis experienced in social relationships. Chronic 
Illness, 2(3), 195-208. doi:10.1179/174592006X129482 
 
Guba, E. G., & Lincoln, Y. S. (1994). Competing paradigms in qualitative 
research. Handbook of Qualitative Research, 2(163-194), 105. 
 
Gubrium, J. F. (1993). Speaking of life: Horizons of meaning for nursing home 
residents. Transaction Publishers. 
 
 
 
	 399	
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An 
experiment with data saturation and variability. Field Methods, 18(1), 59-82. 
 
Guest, G., MacQueen, K. M., & Namey, E. E. (2012). Applied thematic analysis. Los 
Angeles: Sage Publications. 
 
Gulick, E. E. (2001). Emotional distress and activities of daily living functioning in 
persons with multiple sclerosis. Nursing Research, 50(3), 147-154. 
doi:10.1097/00006199-200105000-00004 
 
Gunzler, D. D., Perzynski, A., Morris, N., Bermel, R., Lewis, S., & Miller, D. 
(2015). Disentangling Multiple Sclerosis and depression: an adjusted depression 
screening score for patient-centered care. Journal of Behavioral Medicine, 38(2), 
237-250. 
 
Haase, J. E., Britt, T., Coward, D. D., Leidy, N. K., & Penn, P. E. (1992). 
Simultaneous concept analysis of spiritual perspective, hope, acceptance and self-
transcendence. Image--the Journal of Nursing Scholarship, 24(2), 141. 
 
Haase, R., Schultheiss, T., Kempcke, R., Thomas, K., & Ziemssen, T. (2012). Use 
and acceptance of electronic communication by patients with multiple sclerosis: A 
multicenter questionnaire study. Journal of Medical Internet Research, 14(5), 
e135. 
 
Hagemaster, J. N. (1992). Life history: a qualitative method of research. Journal of 
Advanced Nursing, 17(9), 1122-1128. 
 
Hainsworth, M. A. (1994). Living with multiple sclerosis: The experience of chronic 
sorrow.The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 26(4), 237-240. doi:10.1097/01376517-
199408000-00008 
 
 
 
	 400	
Hall-McMaster, S. M., Treharne, G. J., & Smith, C. M. (2016). ‘The positive feel’: 
Unpacking the role of positive thinking in people with multiple sclerosis’s 
thinking aloud about staying physically active. Journal of Health 
Psychology, 21(12), 3026-3036. 
 
Halper, J. (2007). The psychosocial effect of multiple sclerosis: the impact of 
relapses. Journal of the Neurological Sciences, 256, S34-S38. 
 
Halper, J. (2007). In Memoriam Linda Morgante, RN, MSN, MSCN Defining an MS 
Nurse. International Journal of MS Care, 9(1), vii-vii. 
 
Halper, J; & Harris, C. (2016). Nursing practice in multiple sclerosis, fourth 
edition Springer Publishing Company. 
 
Haselkorn, J. K., Hughes, C., Rae-Grant, A., Henson, L. J., Bever, C. T., Lo, A. C., 
... & Armstrong, M. J. (2015). Summary of comprehensive systematic review: 
Rehabilitation in multiple sclerosis Report of the Guideline Development, 
Dissemination, and Implementation Subcommittee of the American Academy of 
Neurology. Neurology, 85(21), 1896-1903. 
 
Hauser, S. L. (2015). The Charcot Lecture: beating MS: a story of B cells, with 
twists and turns. Multiple Sclerosis Journal, 21(1), 8-21. 
 
Hauser, S. L., Chan, J. R., & Oksenberg, J. R. (2013). Multiple sclerosis: Prospects 
and promise. Annals of Neurology, 74(3), 317-327. doi:10.1002/ana.24009 
 
Hay, C; Strathmann, C; Lieber, E; Wick, K & Giesser, B. (2008). Why patients go 
on-line: Multiple Sclerosis, the internet, and physician-patient communication. 
The Neurologist, 14(6),374-381. 
 
Haylen, D. C. (2015). Women's experiences of living with a rare disease, 
lymphangioleiomyomatosis (LAM): A life history study. (Doctoral dissertation). 
University of Sydney. 
 
	 401	
Haylen, D; & Fisher, M. (2014). Using life history to explore the experience of 
women living with a rare chronic illness: Lymphangioleiomyomatosis in De 
Chesnay, M. Nursing research using life history: Qualitative designs and methods 
in nursing. New York: Springer Publishing Company, LLC. 
 
Heesen, C., Kasper, J., Segal, J., Köpke, S., & Mühlhauser, I. (2004). Decisional role 
preferences, risk knowledge and information interests in patients with multiple 
sclerosis. Multiple Sclerosis Journal, 10(6), 643-650. 
 
Hegen, H., Auer, M., & Deisenhammer, F. (2016). Predictors of response to multiple 
sclerosis therapeutics in individual patients. Drugs, 76(15), 1421-1445. 
doi:10.1007/s40265-016-0639-3 
 
Hermanns, M. (2013). The invisible and visible stigmatization of Parkinson's 
disease. Journal of the American Association of Nurse Practitioners, 25(10), 563-
566. doi:10.1111/1745-7599.12008 
 
Herrestad, H., Biong, S., McCormack, B., Borg, M., & Karlsson, B. (2014). A 
pragmatist approach to the hope discourse in health care research. Nursing 
Philosophy, 15(3), 211-220. doi:10.1111/nup.12053 
 
Herth, K. (1990). Fostering hope in terminally-ill people. Journal of Advanced 
Nursing, 15(11), 1250. 
 
Herth, K. (1996). Hope from the perspective of homeless families. Journal of 
Advanced Nursing, 24(4), 743. 
 
Hinds, P. S. (1984). Inducing a definition of ‘hope’through the use of grounded 
theory methodology. Journal of Advanced Nursing, 9(4), 357-362. 
 
Hinton, D., & Kirk, S. (2015). Paediatric multiple sclerosis: a qualitative study of 
families’ diagnosis experiences. Archives of Disease in Childhood, 100(7), 623-
629. 
 
	 402	
Hinton, D., & Kirk, S. (2017). Living with uncertainty and hope: A qualitative study 
exploring parents’ experiences of living with childhood multiple 
sclerosis. Chronic Illness, 13(2), 88-99. 
 
Hirsch, E. D., Kett, J. F., & Trefil, J. (2002). The new dictionary of cultural literacy. 
Boston MA: Houghton Mifflin. 
 
Hoang, H., Laursen, B., Stenager, E. N., & Stenager, E. (2016). Psychiatric co-
morbidity in multiple sclerosis: The risk of depression and anxiety before and 
after MS diagnosis. Multiple Sclerosis Journal, 22(3), 347-353. 
doi:10.1177/1352458515588973 
 
Holland, N. J., & Madonna, M. (2005). Nursing grand rounds: Multiple 
sclerosis. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 37(1), 15. 
 
Holloway, I., & Todres, L. (2003). The status of method: flexibility, consistency and 
coherence. Qualitative Research, 3(3), 345-357. 
 
Holloway, I., & Freshwater, D. (2007a). Vulnerable story telling: Narrative research 
in nursing. Journal of Research in Nursing, 12(6), 703-711. 
 
Holloway, I., & Freshwater, D. (2007b). Narrative research in nursing. Ames, Iowa 
USA: Wiley-Blackwell. 
 
Holloway, I., & Wheeler, S. (2013). Qualitative research in nursing and healthcare. 
West Sussex, U.K;: Wiley-Blackwell. 
 
Holloway, I., & Galvin, K. (2016). Qualitative research in nursing and healthcare 
(4th ed.). Chichester, West Sussex, UK; Ames, Iowa;: John Wiley & Sons Inc. 
 
Hopelessness. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/hopelessness 
 
	 403	
House, J. S., Umberson, D., & Landis, K. R. (1988). Structures and processes of 
social support. Annual Review of Sociology, 14(1), 293-318. 
doi:10.1146/annurev.so.14.080188.001453 
 
Hum, S., Lapierre, Y., Scott, S. C., Duquette, P., & Mayo, N. E. (2017). Trajectory 
of MS disease course for men and women over three eras. Multiple Sclerosis 
Journal, 23(4), 534-545. 
 
Hunt, L., Nikopoulou-Smyrni, P., & Reynolds, F. (2014). "It gave me something big 
in my life to wonder and think about which took over the space  and not MS": 
Managing well-being in multiple sclerosis through art-making. Disability & 
Rehabilitation, 36(14), 1139-1147. doi:10.3109/09638288.2013.833303 
 
Ionescu, P., Petrescu, S., Munjev, N., Gheorghe, R. O., Stoean, M. R., & Boanta-
Serban, O. (2012). The importance of depression and anxiety level for the 
functioning and life quality of multiple sclerosis patients. European 
Neuropsychopharmacology, 22, S385. 
 
Irvine, H., Davidson, C., Hoy, K., & Lowe-Strong, A. (2009). Psychosocial 
adjustment to multiple sclerosis: Exploration of identity redefinition. Disability & 
Rehabilitation, 31(8), 599-606. doi:10.1080/09638280802243286 
 
Isaksson, A., Ahlström, G., Högskolan i Jönköping, A; Hälsohögskolan, & H. 
Kvalitetsförbättringar H. (2006). From symptom to diagnosis: Illness experiences 
of multiple sclerosis patients. The Journal of Neuroscience Nursing: Journal of 
the American Association of Neuroscience Nurses, 38(4), 229. 
 
Jackson, N. A. (2015). Music therapy and chronic mental illness: Overcoming the 
silent symptoms. Music Therapy Perspectives, 33(2), 90-96. 
doi:10.1093/mtp/miv017 
 
 
 
 
	 404	
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, 
A. M., . . . Whitham, R. H. (1996). Intramuscular interferon beta-1a for disease 
progression in relapsing multiple sclerosis. the multiple sclerosis collaborative 
research group (MSCRG). Annals of Neurology, 39(3), 285. 
 
Jaén, C; Ferrer, R; Miller, W; Palmer, R; Wood, R., Davila, M., , . . . Stange, K. 
(2010). Patient outcomes at 26 months in the patient-centered medical home 
national demonstration project. Annals of Family Medicine, 8(Suppl_1), S57-S67. 
doi:10.1370/afm.1121 
 
James, S., & Clarke, J. (2001). Surplus suffering: The case of Portuguese immigrant 
women. Feminist Review, (68), 167-170. 
 
Janssens, A. C. J. W., van Doorn, P. A., de Boer, J. B., van der Meché, Frans G.A, 
Passchier, J., & Hintzen, R. Q. (2004). Perception of prognostic risk in patients 
with multiple sclerosis: The relationship with anxiety, depression, and disease-
related distress. Journal of Clinical Epidemiology, 57(2), 180-186. 
doi:10.1016/S0895-4356(03)00260-9 
 
Jarmolowicz, D. P., Reed, D. D., Bruce, J. M., Bruce, A. S., Catley, D., Lynch, S., . . 
. Norouzinia, A. N. (2016). Using EP50 to forecast treatment adherence in 
individuals with multiple sclerosis. Behavioural Processes, 132, 94-99. 
doi:10.1016/j.beproc.2016.09.003 
 
Joachim, G., & Acorn, S. (2000). Stigma of visible and invisible chronic 
conditions. Journal of Advanced Nursing, 32(1), 243-248. doi:10.1046/j.1365-
2648.2000.01466.x 
 
Joffe, H., & Yardley, L. (2004). Content and thematic analysis. Research methods 
for clinical and health psychology, 56, 68. 
 
Johnson, J. (2003). On receiving the diagnosis of multiple sclerosis: Managing the 
transition. Multiple Sclerosis, 9(1), 82-88. doi:10.1191/1352458503ms856oa 
 
	 405	
Jones, S. M., & Amtmann, D. (2014). Health care worry is associated with worse 
outcomes in multiple sclerosis. Rehabilitation Psychology, 59(3), 354-359. 
doi:10.1037/a0037074 
 
Kalincik, T. (2015). Multiple sclerosis relapses: Epidemiology, outcomes and 
management. A systematic review. Neuroepidemiology, 44(4), 199. 
 
Kalincik, T., Brown, J. W. L., Robertson, N., Willis, M., Scolding, N., Rice, C. M., 
... & McGuigan, C. (2017). Treatment effectiveness of alemtuzumab compared 
with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple 
sclerosis: a cohort study. Lancet Neurology, 16(4), 271-281. 
 
Kappos, L., Arnold, D. L., Bar-Or, A., Camm, J., Derfuss, T., Kieseier, B. C., ... & 
Harada, T. (2016). Safety and efficacy of amiselimod in relapsing multiple 
sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 
2 trial. Lancet Neurology, 15(11), 1148-1159. 
 
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, 
B., . . . McCulloch, D. (2010). Collaborative care for patients with depression and 
chronic illnesses.The New England Journal of Medicine, 363(27), 2611-2620. 
doi:10.1056/NEJMoa1003955 
 
Kavaliunas, A., Manouchehrinia, A., Stawiarz, L., Ramanujam, R., Agholme, J., 
Hedström, A. K., ... & Hillert, J. (2017). Importance of early treatment initiation 
in the clinical course of multiple sclerosis. Multiple Sclerosis Journal, 23(9), 
1233-1240. 
 
Kennedy, P. (2013). Impact of delayed diagnosis and treatment in clinically isolated 
syndrome and multiple sclerosis. The Journal of Neuroscience Nursing: Journal 
of the American Association of Neuroscience Nurses, 45(6 Suppl 1), S3. 
doi:10.1097/JNN.0000000000000021 
 
Kenny, N. P. (1997). Ethical implications of human suffering. Humane Health Care 
International, 13(2), 27. 
	 406	
 
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. 
(2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety 
and mood disorders in the United States. International Journal of Methods in 
Psychiatric Research, 21(3), 169-184. doi:10.1002/mpr.1359 
 
Khan, F., Amatya, B., Elmalik, A., Lowe, M., Ng, L., Reid, I., & Galea, M. P. 
(2016). An enriched environmental programme during inpatient neuro-
rehabilitation: A randomized controlled trial. Journal of Rehabilitation 
Medicine, 48(5), 417-425. 
 
Kiecolt-Glaser, J. K., & Newton, T. L. (2001). Marriage and health: His and hers. 
Psychological Bulletin, 127(4), 472-503. doi:10.1037//0033-2909.127.4.472 
 
Kirchner, T., & Lara, S. (2011). Stress and depression symptoms in patients with 
multiple sclerosis: The mediating role of the loss of social functioning. Acta 
Neurologica Scandinavica, 123(6), 407-413. doi:10.1111/j.1600-
0404.2010.01422.x 
 
Klerings, I., Weinhandl, A. S., & Thaler, K. J. (2015). Information overload in 
healthcare: Too much of a good thing? Zeitschrift für Evidenz, Fortbildung Und 
Qualität Im Gesundheitswesen, 109(4-5), 285. 
 
Kobelt, G., Eriksson, J., Phillips, G., & Berg, J. (2017). The burden of multiple 
sclerosis 2015: Methods of data collection, assessment and analysis of costs, 
quality of life and symptoms. Multiple Sclerosis Journal, 23(2_suppl), 4-16. 
 
Koch, M. W., Patten, S., Berzins, S., Zhornitsky, S., Greenfield, J., Wall, W., & 
Metz, L. M. (2015). Depression in multiple sclerosis: a long-term longitudinal 
study. Multiple Sclerosis Journal, 21(1), 76-82. 
 
Koch-Henriksen, N., & Sørensen, P. S. (2010). The changing demographic pattern of 
multiple sclerosis epidemiology. Lancet Neurology, 9(5), 520-532. 
	 407	
 
Koelmel, E.,Hughes, A. J., Alschuler, K. N., ,& Ehde, D. M. (2016). Resilience 
mediates the longitudinal relationships between social support and mental health 
outcomes in multiple sclerosis. Archives of Physical Medicine and 
Rehabilitation, 98(6), 1139-1148. doi:10.1016/j.apmr.2016.09.127 
 
Koopman, W., & Schweitzer, A. (1999). The journey to multiple sclerosis: A 
qualitative study. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 31(1), 17-26. doi:10.1097/01376517-
199902000-00003 
 
Köpke, S., Richter, T., Kasper, J., Mühlhauser, I., Flachenecker, P., & Heesen, C. 
(2012). Implementation of a patient education program on multiple sclerosis 
relapse management. Patient Education and Counselling, 86(1), 91-97. 
doi:10.1016/j.pec.2011.03.013 
 
Köpke, S., Solari, A., Khan, F., Heesen, C., & Giordano, A. (2014). Information 
provision for people with multiple sclerosis. The Cochrane Database of 
Systematic Reviews, (4), CD008757. 
 
Koudriavtseva, T., Onesti, E., Pestalozza, I. F., Sperduti, I., & Jandolo, B. (2012). 
The importance of physician–patient relationship for improvement of adherence 
to long-term therapy: Data of survey in a cohort of multiple sclerosis patients with 
mild and moderate disability. Neurological Sciences, 33(3), 575-584. 
doi:10.1007/s10072-011-0776-0 
 
Krahn, T. M. (2014). Care ethics for guiding the process of multiple sclerosis 
diagnosis. Journal of Medical Ethics, 40(12), 802-806. doi:10.1136/medethics-
2011-100063 
 
Kralik, D., Van Loon, A., & Visentin, K. (2006). Resilience in the chronic illness 
experience. Educational Action Research, 14(2), 187-201. 
 
	 408	
Krokavcova, M., van Dijk, J. P., Nagyova, I., Rosenberger, J., Gavelova, M., Middel, 
B., . . . Groothoff, J. W. (2008). Social support as a predictor of perceived health 
status in patients with multiple sclerosis. Patient Education and 
Counseling, 73(1), 159-165. doi:10.1016/j.pec.2008.03.019 
 
Krueger, R. A., & Casey, M. A. (2015). Focus groups: A practical guide for applied 
research (5th ed.). Thousand Oaks, California: Sage Publications. 
 
Kurtzke, J. F. (1955). A new scale for evaluating disability in multiple 
sclerosis. Neurology, 5(8), 580-580. 
 
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An 
expanded disability status scale (EDSS). Neurology, 33(11), 1444. 
 
Kvale, S., & Brinkmann, S. (2007). Introduction to interview research. Doing 
interviews, 2-11. 
 
Kylmä, J. (2005). Despair and hopelessness in the context of HIV-a meta-synthesis 
on qualitative research findings. Journal of Clinical Nursing, 14(7), 813-821. 
doi:10.1111/j.1365-2702.2005.01154.x 
 
Lange, M., Thom, B., & Kline, N. E. (2008). Assessing nurses' attitudes toward 
death and caring for dying patients in a comprehensive cancer center. Oncology 
nursing forum, 35(6). 
 
Larkin, M., Watts, S., & Clifton, E. (2006). Giving voice and making sense in 
interpretative phenomenological analysis. Qualitative Research in 
Psychology, 3(2), 102-120. doi:10.1191/1478088706qp062oa 
 
Larsen, P. (2016). Lubkin's chronic illness: Impact and intervention. Burlington, 
MA: Jones & Bartlett Learning. 
 
	 409	
Laslett, B., & Thorne, B. (Eds.). (1997). Feminist sociology: Life histories of a 
movement. Rutgers University Press. 
 
Lassmann, H., Van Horssen, J., & Mahad, D. (2012). Progressive multiple sclerosis: 
pathology and pathogenesis. Nature Reviews Neurology, 8(11), 647. 
 
Lee, Y., & Lin, J. L. (2010). Do patient autonomy preferences matter? linking 
patient-centered care to patient–physician relationships and health 
outcomes. Social Science & Medicine, 71(10), 1811-1818. 
doi:10.1016/j.socscimed.2010.08.008 
 
Leininger, M. M. (1985). Ethnography and ethnonursing: Models and modes of 
qualitative data analysis. Qualitative Research Methods in Nursing, 33-72. 
   
Lempp, H. K., Hatch, S. L., Carville, S. F., & Choy, E. H. (2009). Patients' 
experiences of living with and receiving treatment for fibromyalgia syndrome: A 
qualitative study. BMC Musculoskeletal Disorders, 10(1), 124-124. 
doi:10.1186/1471-2474-10-124 
 
Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense representation of 
illness danger. Contributions to Medical Psychology, 2, 7-30. 
 
Levine, E. G., Aviv, C., Yoo, G., Ewing, C., & Au, A. (2009). The benefits of prayer 
on mood and well-being of breast cancer survivors. Supportive Care in 
Cancer, 17(3), 295-306. doi:10.1007/s00520-008-0482-5 
 
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage 
Publications. 
 
Lincoln, Y. S., & Denzin, N. K. (1994). The fifth moment. Handbook of qualitative 
research. Thousand Oaks, CA: Sage Publications. 
 
	 410	
Liu, X.J., Ye, H.X., Li, W.P., Dai, R., Chen, D., & Jin, M. (2009.) Relationship 
between psychosocial factors and onset of multiple sclerosis. European Neurology, 
62 (3), 130–136. 
 
Liu, Y., Morgan, C., Hornung, L., Tyry, T., Salter, A. R., Agashivala, N., . . . Cutter, 
G. R. (2016). Relationship between symptom change, relapse activity and 
disability progression in multiple sclerosis. Journal of the Neurological 
Sciences, 362, 121-126. doi:10.1016/j.jns.2016.01.034 
 
Lode, K., Larsen, J. P., Bru, E., Klevan, G., Myhr, K. M., & Nyland, H. (2007). 
Patient information and coping styles in multiple sclerosis. Multiple 
Sclerosis, 13(6), 792-799. doi:10.1177/1352458506073482 
 
Lode, K., Bru, E., Klevan, G., Myhr, K., Nyland, H., & Larsen, J. (2009). Depressive 
symptoms and coping in newly diagnosed patients with multiple 
sclerosis. Multiple Sclerosis, 15(5), 638-643. doi:10.1177/1352458509102313 
 
Lohne, V. (2001). Hope in patients with spinal cord injury: A literature review 
related to nursing. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 33(6), 317-325. doi:10.1097/01376517-
200112000-00006 
 
Lohne, V., & Severinsson, E. (2006). The power of hope: Patients’ experiences of 
hope a year after acute spinal cord injury. Journal of Clinical Nursing, 15(3), 315-
323. doi:10.1111/j.1365-2702.2006.01301.x 
 
Lohne, V., Aasgaard, T., Caspari, S., Slettebø, Å., & Nåden, D. (2010). The lonely 
battle for dignity: Individuals struggling with multiple sclerosis. Nursing 
Ethics, 17(3), 301-311. doi:10.1177/0969733010361439 
 
Lorde, A. (2009). Poetry Makes Something Happen. I Am Your Sister: Collected and 
Unpublished Writings of Audre Lorde, 184-187. 
 
	 411	
Lorscheider, J., Buzzard, K., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, 
D.,... & Prat, A. (2016). Defining secondary progressive multiple 
sclerosis. Brain, 139(9), 2395-2405. 
 
Lublin, F. D., Baier, M., & Cutter, G. (2003). Effect of relapses on development of 
residual deficit in multiple sclerosis. Neurology, 61(11), 1528-1532. 
 
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., 
Thompson, A. J., . . . Polman, C. H. (2014). Defining the clinical course of 
multiple sclerosis: The 2013 revisions. Neurology, 83(3), 278. 
 
Lulu, S., Graves, J., & Waubant, E. (2016). Menarche increases relapse risk in 
pediatric multiple sclerosis. Multiple Sclerosis Journal, 22(2), 193-200. 
 
Lynch, S. G., Kroencke, D. C., & Denney, D. R. (2001). The relationship between 
disability and depression in multiple sclerosis: The role of uncertainty, coping, 
and hope. Multiple Sclerosis, 7(6), 411-416. doi:10.1177/135245850100700611 
 
Lynd, L. D., Traboulsee, A., Marra, C. A., Mittmann, N., Evans, C., Li, K. H., . . . 
Hategekimana, C. (2016). Quantitative analysis of multiple sclerosis patients’ 
preferences for drug treatment: A best–worst scaling study. Therapeutic Advances 
in Neurological Disorders, 9(4), 287-296. doi:10.1177/1756285616648060 
 
Lysandropoulos, A. P., Havrdova, E., & ParadigMS Group. (2015). ‘Hidden’ factors 
influencing quality of life in patients with multiple sclerosis. European Journal of 
Neurology, 22(S2), 28-33. doi:10.1111/ene.12801 
 
MacAllister, W. S., Christodoulou, C., Troxell, R., Milazzo, M., Block, P., Preston, 
T. E., . . . Krupp, L. B. (2009). Fatigue and quality of life in pediatric multiple 
sclerosis. Multiple Sclerosis, 15(12), 1502-1508. doi:10.1177/1352458509345902 
 
McCabe, M. P. (2004). Exacerbation of symptoms among people with multiple 
sclerosis: impact on sexuality and relationships over time. Archives of Sexual 
Behavior, 33(6), 593-601. 
	 412	
 
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. 
D., . . . Wolinsky, J. S. (2001). Recommended diagnostic criteria for multiple 
sclerosis: Guidelines from the international panel on the diagnosis of multiple 
sclerosis. Annals of Neurology, 50(1), 121-127. doi:10.1002/ana.1032 
 
McReynolds, C. J., Koch, L. C., & Rumrill, P. D. (1999). Psychosocial adjustment to 
multiple sclerosis: Implication for rehabilitation professionals. Journal of 
Vocational Rehabilitation, 12, 83-91. 
 
Madan, S., & Pakenham, K. I. (2014). The stress-buffering effects of hope on 
adjustment to multiple sclerosis. International Journal of Behavioral 
Medicine, 21(6), 877-890. doi:10.1007/s12529-013-9384-0 
 
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015). Pathological mechanisms in 
progressive multiple sclerosis. The Lancet Neurology, 14(2), 183-193. 
 
Makros, J., & McCabe, M. (2003). The relationship between religion, spirituality, 
psychological adjustment, and quality of life among people with multiple 
sclerosis. Journal of Religion and Health, 42(2), 143-159. 
doi:10.1023/A:1023681830716 
 
Malcomson, K. S., Lowe-Strong, A. S., & Dunwoody, L. (2008). What can we learn 
from the personal insights of individuals living and coping with multiple 
sclerosis?. Disability and Rehabilitation, 30(9), 662-674. 
 
Malterud, K., Siersma, V. D., & Guassora, A. D. (2016). Sample size in qualitative 
interview studies: Guided by information power. Qualitative Health 
Research, 26(13), 1753-1760. doi:10.1177/1049732315617444 
 
Manning, L. K. (2015). Resilience and aging: From conceptual understandings to 
opportunities for enhancement. The Gerontologist, 55(4), 703-704. 
doi:10.1093/geront/gnv086 
 
	 413	
Mantero, V., Abate, L., Balgera, R., La Mantia, L., & Salmaggi, A. (2018). Clinical 
application of 2017 McDonald diagnostic criteria for multiple sclerosis. Journal 
of Clinical Neurology, 14(3), 387-392. 
 
Marrie, R. A., Reingold, S., Cohen, J., Stüve, O., Trojano, M., Sorensen, P. S., ... & 
Reider, N. (2015). The incidence and prevalence of psychiatric disorders in multiple 
sclerosis: a systematic review. Multiple Sclerosis Journal, 21(3), 305-317. 
 
Masera, S., Cavalla, P., Prosperini, L., Mattioda, A., Mancinelli, C., Superti, G., . . . 
Pozzilli, C. (2015). Parity is associated with a longer time to reach irreversible 
disability milestones in women with multiple sclerosis. Multiple Sclerosis 
Journal, 21(10), 1291-1297. doi:10.1177/1352458514561907 
 
Matuska, K, & Erickson, B, (2011) Lifestyle balance: How it is described and 
experienced by women with Multiple Sclerosis. Journal of Occupational 
Science, 15:1, 20 -26, doi: 10.1080/14427591.2008.9686603	
 
Mays, N., & Pope, C. (2000). Qualitative research in health care: Assessing quality 
in qualitative research. British Medical Journal, 320(7226), 50-52. 
doi:10.1136/bmj.320.7226.50 
 
Mazanderani, F., Kelly, J., & Ducey, A. (2018). From embodied risk to embodying 
hope: Therapeutic experimentation and experiential information sharing in a 
contested intervention for Multiple Sclerosis. BioSocieties, 13(1), 232-254. 
 
Mead, N., & Bower, P. (2002). Patient-centred consultations and outcomes in 
primary care: A review of the literature. Patient Education and Counseling, 48(1), 
51-61. doi:10.1016/S0738-3991(02)00099-X 
 
Mealer, M., Jones, J., Newman, J., McFann, K. K., Rothbaum, B., & Moss, M. 
(2012). The presence of resilience is associated with a healthier psychological 
profile in intensive care unit (ICU) nurses: results of a national 
survey. International Journal of Nursing Studies, 49(3), 292-299. 
 
	 414	
Mendelson, C. (2006). Managing a medically and socially complex life: women 
living with lupus. Qualitative Health Research, 16(7), 982-997. 
 
Merrow, E. W. (2012). Project definition getting the front end right. (pp. 199-251). 
Hoboken, NJ, USA: John Wiley & Sons, Inc. doi:10.1002/9781119201045.ch10 
 
Merton, R. K. (1975). Thematic analysis in science: Notes on holton's 
concept. Science, 188(4186), 335-338. doi:10.1126/science.188.4186.335 
 
Messner, M. A. (1992). Power at play: Sports and the problem of masculinity. 
Beacon Press. 
 
Metcalfe, B. D. (2008). Women, management and globalization in the middle 
east. Journal of Business Ethics, 83(1), 85-100. doi:10.1007/s10551-007-9654-3 
 
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded 
sourcebook. (2nd ed.). Thousand Oaks CA: Sage Publications. 
 
Miller, A. E. (2016). Multiple sclerosis disease-modifying therapy and 
pregnancy. Multiple Sclerosis Journal, 22(6), 715-716. 
doi:10.1177/1352458516642316 
 
Miller, C. M. (1997). The lived experience of relapsing multiple sclerosis: A 
phenomenological study. The Journal of Neuroscience Nursing: Journal of the 
American Association of Neuroscience Nurses, 29(5), 294. 
 
Miller, C., & Jezewski, M. A. (2001). A phenomenologic assessment of relapsing 
MS patients' experiences during treatment with interferon beta-1a. Journal of 
Neuroscience Nursing: Journal of the American Association of Neuroscience 
Nurses, 33(5), 240. 
 
Miller, C. E., & Jezewski, M. A. (2006). Relapsing MS patients' experiences with 
glatiramer acetate treatment: a phenomenological study. Journal of Neuroscience 
Nursing: Journal of the American Association of Neuroscience Nurses, 38(1), 37. 
	 415	
 
Miller, G., & Dingwall, R. (Eds.). (1997). Context and method in qualitative 
research. London, UK: Sage Publications. 
 
Miller, J. F. (1985). Inspiring hope. The American Journal of Nursing, 85(1), 22-25. 
 
Miller, J. F. (1991). Developing and maintaining hope in families of the critically 
ill. AACN Advanced Critical Care, 2(2), 307-315. 
 
Mills, E. A., Mirza, A., & Mao-Draayer, Y. (2017). Emerging approaches for 
validating and managing multiple sclerosis relapse. Frontiers in Neurology, 8, 
116. 
 
Milo, R., & Miller, A. (2014). Revised diagnostic criteria of multiple 
sclerosis. Autoimmunity Reviews, 13(4-5), 518. 
 
Minden, S; Turner, A; Kalb, R; Burke, D. (2014). Clinical Bulletin: Information for 
Health Professional, National MS Society. National MS Society, USA. 
 
Minderhoud, J. M., van der Hoeven, J H, & Prange, A. J. (1988). Course and 
prognosis of chronic progressive multiple sclerosis. results of an epidemiological 
study. Acta Neurologica Scandinavica, 78(1), 10. 
 
Mishel, M. H. (1990). Reconceptualization of the uncertainty in illness 
theory. Journal of Nursing Scholarship, 22(4), 256-262. 
 
Mishel, M. H., & Braden, C. J. (1988). Finding meaning: Antecedents of uncertainty 
in illness. Nursing Research, 37(2), 98. 
 
Mishler, E. (1995). Models of Narrative Analysis: A Typology. Journal of Narrative 
and Life History, 5, 2, 87–123.  
 
	 416	
Mitolo, M., Venneri, A., Wilkinson, I. D., & Sharrack, B. (2015). Cognitive 
rehabilitation in multiple sclerosis: A systematic review. Journal of the 
Neurological Sciences, 354(1), 1-9. doi:10.1016/j.jns.2015.05.004 
 
Moberg, J. Y., Larsen, D., & Brødsgaard, A. (2016). Striving for balance between 
caring and restraint: Young adults' experiences with parental multiple 
sclerosis. Journal of Clinical Nursing, 26(9-10), 1363-1374. 
doi:10.1111/jocn.13587 
 
Moore, I. S. (2013). The beast within: Life with an invisible chronic 
illness. Qualitative Inquiry, 19(3), 201-208. doi:10.1177/1077800412466052 
 
Moore, S. L. (2005). Hope makes a difference. Journal of Psychiatric and Mental 
Health Nursing, 12(1), 100-105. doi:10.1111/j.1365-2850.2004.00802.x 
 
Morgante, L. (1996). Multiple Sclerosis: comprehensive care for a complex 
population. In: Flarey, D.L, Blancett, S.S (Eds.). Case studies in nursing case 
management. Gaithersburg, MD: Aspen Publishing Inc.  
 
Morgante, L. (2000). Hope in multiple sclerosis: a nursing perspective. International 
Journal of MS Care, 2(2), 9-15. 
 
Moriya, R., & Suzuki, S. (2011). A qualitative study relating to the experiences of 
people with MS: Differences by disease severity. British Journal of Neuroscience 
Nursing, 7(4), 593-600. doi:10.12968/bjnn.2011.7.4.593 
 
Morrow, S. A. (2018). Anxiety is more important than depression in MS – 
yes. Multiple Sclerosis Journal, 24(4), 440-441. doi:10.1177/1352458517751652 
 
Morse, J. M. (2001). Toward a praxis theory of suffering. ANS. Advances in Nursing 
Science, 24(1), 47-59. doi:10.1097/00012272-200109000-00007 
 
Morse, J. M. (2007). What is the domain of qualitative health research? Qualitative 
Health Research, 17(6), 715-717. doi:10.1177/1049732307303820 
	 417	
 
Morse, J. M. (2012). Qualitative health research: Creating a new discipline. Walnut 
Creek, CA: Left Coast Press. doi:10.4324/9781315421650 
 
Morse, J. M. (2015). Critical analysis of strategies for determining rigor in 
qualitative inquiry. Qualitative Health Research, 25(9), 1212-1222. 
doi:10.1177/1049732315588501 
 
Morse, J. M., Bottorff, J., Anderson, G., O'Brien, B., & Solberg, S. (1992). Beyond 
empathy: Expanding expressions of caring. Journal of Advanced Nursing, 17(7), 
809. 
 
Morse, J. M., & Carter, B. (1996). The essence of enduring and expressions of 
suffering: The reformulation of self. Scholarly Inquiry for Nursing 
Practice, 10(1), 43. 
 
Morse, J. M., & Coulehan, J. (2015). Maintaining confidentiality in qualitative 
publications. Qualitative Health Research, 25(2), 151-152. 
doi:10.1177/1049732314563489 
 
Morse, J. M., & Doberneck, B. (1995). Delineating the concept of hope. Journal of 
Nursing Scholarship, 27(4), 277. 
 
Morse, W. C., Lowery, D. R., & Steury, T. (2014). Exploring saturation of themes 
and spatial locations in qualitative public participation geographic information 
systems research. Society & Natural Resources, 27(5), 557-571. 
doi:10.1080/08941920.2014.888791 
 
Morse, J. M., & Penrod, J. (1999). Linking concepts of enduring, uncertainty, 
suffering, and hope. Journal of Nursing Scholarship, 31(2), 145. 
 
Mortensen G. L., & Rausmussen P.V. (2017). The impact of quality of life on 
treatment preferences in multiple sclerosis patients. Patient Preference and 
Adherence,11:1789-1796. 
	 418	
 
Moss, P., & Dyck, I. (2002).Women, body, illness: Space and identity in the 
everyday lives of women with chronic illness. US: Rowman & Littlefield 
Publishers. 
 
Moss‐Morris, R. (2013). Adjusting to chronic illness: Time for a unified 
theory. British Journal of Health Psychology, 18(4), 681-686. 
doi:10.1111/bjhp.12072 
 
Mozo-Dutton, L., Simpson, J., & Boot, J. (2012). MS and me: Exploring the impact 
of multiple sclerosis on perceptions of self. Disability and Rehabilitation, 34(14), 
1208-1217. doi:10.3109/09638288.2011.638032 
 
Multiple Sclerosis Australia (MSA). (2018). About MSA. Retrieved from 
https://www.msaustralia.org.au/about-msa.Viewed 18 May 2018. 
 
Multiple Sclerosis Nurses, Australasia (MSNA). Primary aims & objectives. (2018). 
Retrieved from: http://www.msnainc.com.au/index. Viewed 20 May 2018. 
 
Multiple Sclerosis Research Australia (MSRA). (2018).MS is on the rise but still 
flying under our radar. Retrieved from https://msra.org.au/news/ms-rise-australia-
still-flying-radar/ 16th June 2018.  
 
Multiple Sclerosis Research Australia (MSRA). (2018). About Us. Retrieved from: 
https://msra.org.au/about-ms-research-australia/. Viewed 18 May 2018. 
 
Munhall, P. L. (2012). Nursing research: A qualitative perspective (5th ed.). 
Sudbury, MA: Jones & Bartlett Learning. 
 
Mynors, G., Bowen, A., Doncaster, D., & MS Trust. (2016). MS Specialist Nursing 
in the UK 2016: report on progress towards equitable provision. Letchworth: MS 
Trust. 
 
	 419	
Nettleton, S. (2006). ‘I just want permission to be ill’: Towards a sociology of 
medically unexplained symptoms. Social Science & Medicine, 62(5), 1167-1178. 
doi:10.1016/j.socscimed.2005.07.030 
 
Neuendorf, K. A. (2002). The content analysis guidebook. Thousand Oaks, CA. Sage 
Publications. 
 
Newland, P. K., Thomas, F. P., Riley, M., Flick, L. H., & Fearing, A. (2012). The 
use of focus groups to characterize symptoms in persons with multiple 
sclerosis. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 44(6), 351. 
doi:10.1097/JNN.0b013e318268308b 
 
Newsome, S. D., Aliotta, P. J., Bainbridge, J., Bennett, S. E., Cutter, G., Fenton, K., 
... & Weigel, M. (2017). A framework of care in multiple sclerosis, part 2: 
symptomatic care and beyond. International Journal of MS Care, 19(1), 42-56. 
 
Newton, G., Griffiths, A., & Soundy, A. (2016). The experience of fatigue in 
neurological patients with multiple sclerosis: A thematic 
synthesis. Physiotherapy, doi:10.1016/j.physio.2016.11.004 
 
Ng, A., Kennedy, P., Hutchinson, B., Ingram, A., Vondrell, S., Goodman, T., & 
Miller, D. (2013). Self-efficacy and health status improve after a wellness 
program in persons with multiple sclerosis. Disability and Rehabilitation, 35(11), 
1039-1044. doi:10.3109/09638288.2012.717586 
 
NHMRC. (2007). National Statement on Ethical Conduct in Human Research (2007) 
updated 15 May 2015. Retrieved from: https://www.nhmrc.gov.au/guidelines-
publications/e72 
 
Nielsen, N. M., Pedersen, B. V., Stenager, E., Koch-Henriksen, N., & Frisch, M. 
(2014). Stressful life-events in childhood and risk of multiple sclerosis: A danish 
nationwide cohort study. Multiple Sclerosis Journal, 20(12), 1609-1615. 
doi:10.1177/1352458514528761 
	 420	
 
Nightingale, F., & Skretkowicz, V. (1992). Florence Nightingale's notes on nursing. 
England, UK:Scutari Press. 
 
O'Brien, M. R., Whitehead, B., Jack, B. A., & Mitchell, J. D. (2012). The need for 
support services for family carers of people with motor neurone disease (MND): 
Views of current and former family caregivers a qualitative study. Disability and 
Rehabilitation, 34(3), 247-256. doi:10.3109/09638288.2011.605511 
 
O'Connor, E. J., & McCabe, M. P. (2011). Predictors of quality of life in carers for 
people with a progressive neurological illness: A longitudinal study. Quality of 
Life Research, 20(5), 703-711. doi:10.1007/s11136-010-9804-4 
 
O'Loughlin, E. (2015). Thesis. The experience of transitioning from relapsing 
remitting to secondary progressive Multiple Sclerosis. Royal Holloway, 
University of London, United Kingdom. 
 
Olsson, M., Lexell, J., Söderberg, S.  (2008). The meaning of women's experiences 
of living with multiple sclerosis. Health Care for Women International, 29(4), 
416-430. doi:10.1080/07399330701876646 
 
Olsson, M., Skär, L., & Söderberg, S. (2010). Meanings of feeling well for women 
with multiple sclerosis. Qualitative Health Research, 20(9), 1254-1261. 
doi:10.1177/1049732310371103 
 
Onwuegbuzie, A. J., & Leech, N. L. (2005). The role of sampling in qualitative 
research. Academic Exchange Quarterly, 9(3), 280. 
 
Opler, M. E. (1945). Themes as dynamic forces in culture. American Journal of 
Sociology, 51(3), 198-206. 
 
Ormston, R., Spencer, L., Barnard, M., & Snape, D. (2014). The foundations of 
qualitative research. Qualitative research practice: A guide for social science 
students and researchers, 1-26. 
	 421	
 
Ostacoli, L., Carletto, S., Borghi, M., Cavallo, M., Rocci, E., Zuffranieri, M., . . . 
Picci, R. L. (2013). Prevalence and significant determinants of post-traumatic 
stress disorder in a large sample of patients with multiple sclerosis. Journal of 
Clinical Psychology in Medical Settings, 20(2), 240-246. doi:10.1007/s10880-
012-9323-2 
 
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England 
Journal of Medicine, 353(5), 487-497. doi:10.1056/NEJMra050100 
 
Owen, D. C. (1989). Nurses' perspectives on the meaning of hope in patients with 
cancer: a qualitative study. In Oncology Nursing Forum (Vol. 16, No. 1, pp. 75-
79). 
 
Owens, G. M. (2013). Managed care aspects of managing multiple sclerosis. The 
American Journal of Managed Care, 19(16 Suppl), s307. 
 
Pakenham, K. I. (1999). Adjustment to multiple sclerosis: Application of a stress and 
coping model. Health Psychology, 18(4), 383. 
 
Pakenham, K. I. (2005). Benefit finding in multiple sclerosis and associations with 
positive and negative outcomes. Health Psychology, 24(2), 123-132. 
doi:10.1037/0278-6133.24.2.123 
 
Pakenham, K. I. (2005). The positive impact of multiple sclerosis (MS) on carers: 
Associations between carer benefit finding and positive and negative adjustment 
domains. Disability & Rehabilitation, 27(17), 985-997. 
doi:10.1080/09638280500052583 
 
Pakenham, K. I., & Cox, S. (2009). The dimensional structure of benefit finding in 
multiple sclerosis and relations with positive and negative adjustment: A 
longitudinal study. Psychology & Health, 24(4), 373-393. 
doi:10.1080/08870440701832592 
 
	 422	
Pakenham, K. I., & Samios, C. (2013). Couples coping with multiple sclerosis: A 
dyadic perspective on the roles of mindfulness and acceptance. Journal of 
Behavioral Medicine, 36(4), 389-400. 
 
Pakenham, K. I., Tilling, J., & Cretchley, J. (2012). Parenting difficulties and 
resources: The perspectives of parents with multiple sclerosis and their 
partners. Rehabilitation Psychology, 57(1), 52-60. doi:10.1037/a0026995 
 
Papadopoulos, I., & Ali, S. (2016). Measuring compassion in nurses and other 
healthcare professionals: An integrative review. doi:10.1016/j.nepr.2015.08.001 
 
Parisé, H., Laliberté, F., Lefebvre, P., Duh, M. S., Kim, E., Agashivala, N., . . . 
Weinstock-Guttman, B. (2013). Direct and indirect cost burden associated with 
multiple sclerosis relapses: Excess costs of persons with MS and their spouse 
caregivers. Journal of the Neurological Sciences, 330(1), 71-77. 
doi:10.1016/j.jns.2013.04.007 
 
Parsa, B. G., Bidari, A., Maafi, A. A., & Ghalebaghi, B. (2015). Review article : The 
iceberg nature of fibromyalgia burden: The clinical and economic aspects. The 
Korean Journal of Pain, 28(3), 169. 
 
Patching, J., & Lawler, J. (2009). Understanding women's experiences of developing 
an eating disorder and recovering: A life-history approach. Nursing 
Inquiry, 16(1), 10-21. doi:10.1111/j.1440-1800.2009.00436.x 
 
Paterson, B. L. (2001). The shifting perspectives model of chronic illness. Journal of 
Nursing Scholarship, 33(1), 21-26. 
 
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003). 
Major depression in multiple sclerosis A population-based 
perspective. Neurology, 61(11), 1524-1527. 
 
	 423	
Payne, D., & McPherson, K. M. (2010). Becoming mothers. multiple sclerosis and 
motherhood: A qualitative study. Disability and Rehabilitation, 32(8), 629-638. 
doi:10.3109/09638280903204708 
 
Pearce, J. (2004). Labe Scheinberg, 78, Physician and Multiple Sclerosis Specialist. 
The New York Times. Retrieved from: 
https://www.nytimes.com/2004/03/01/nyregion/labe-scheinberg-78-physician-
and-multiple-sclerosis-specialist.html. Viewed 13th June 2018. 
 
Pennebaker, J. W. (2000). Telling stories: The health benefits of narrative. Literature 
and Medicine, 19(1), 3-18. 
 
Pérez, L. P., González, R. S., & Lázaro, E. B. (2015). Treatment of mood disorders 
in multiple sclerosis. Current Treatment Options in Neurology, 17(1), 323. 
 
Peters, K., & Halcomb, E. (2015). Interviews in qualitative research: A consideration 
of two very different issues in the use of interviews to collect research data. Nurse 
Researcher, 22(4), 6-7. doi:10.7748/nr.22.4.6.s2 
 
Pilnick, A., & Dingwall, R. (2011). On the remarkable persistence of asymmetry in 
doctor/patient interaction: A critical review. Social Science & Medicine, 72(8), 
1374-1382. doi:10.1016/j.socscimed.2011.02.033 
 
Plumb-Parlevliet, A. M. (2015). The lived experience of mothering for women with 
multiple sclerosis. (Honours dissertation). Edith Cowan Univeristy. Retrieved 
from http://ro.ecu.edu.au/ theses_hons/1465  
 
Plummer, K. (1983). Documents of life: An introduction to the problems and 
literature of a humanistic method. Allen & Unwin. 
 
Plummer, K. (2001). Documents of life 2: An invitation to a critical humanism. 
Thousand Oaks, CA: Sage Publications. 
 
	 424	
Polit, D. F., & Beck, C. T. (2010). Essentials of nursing research: Appraising 
evidence for nursing practice (7th ed.). Philadelphia: Wolters Kluwer 
Health/Lippincott Williams & Wilkins. 
 
Pollock, S. E., Christian, B. J., & Sands, D. (1990). Responses to chronic illness: 
Analysis of psychological and physiological adaptation. Nursing Research, 39(5), 
300. 
 
Pollock, S. E., & Sands, D. (1997). Adaptation to suffering: Meaning and 
implications for nursing. Clinical Nursing Research, 6(2), 171-185. 
 
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., . . . 
Neurology, L. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to 
the "McDonald criteria". Annals of Neurology, 58(6), 840. 
 
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., . . 
. Lublin, F.D. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to 
the McDonald criteria. Annals of Neurology, 69(2), 292-302. 
doi:10.1002/ana.22366 
 
Pompili, M (Ed.). (2012). Suicide: A global perspective. Sharjah UAE: Bentham 
Books. doi: 10.2174/97816080504991120101	
 
Ponsonby, A., Lucas, R. M., van der Mei, I A, Dear, K., Valery, P. C., Pender, M. P., 
. . . Dwyer, T. (2012). Offspring number, pregnancy, and risk of a first clinical 
demyelinating event: The AusImmune study. Neurology, 78(12), 867. 
 
Porten, L., & Carrucan-Wood, L. (2017). Caring for a patient with multiple 
sclerosis. Kai Tiaki: Nursing New Zealand, 23(6),16. 
 
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. 
C., ... & Tourtellotte, W. W. (1983). New diagnostic criteria for multiple sclerosis: 
guidelines for research protocols. Annals of neurology, 13(3), 227-231. 
 
	 425	
Powers, B. A., & Knapp, T. R. (2006). Dictionary of nursing theory and 
research (3rd ed.). New York, NY: Springer Publishing company. 
 
Pozzilli, C., Pugliatti, M., & ParadigMS Group. (2015). An overview of 
pregnancy‐related issues in patients with multiple sclerosis. European Journal of 
Neurology, 22(S2), 34-39. doi:10.1111/ene.12797 
 
Prunty, M., Sharpe, L., Butow, P., & Fulcher, G. (2008). The motherhood choice: 
Themes arising in the decision-making process for women with multiple 
sclerosis. Multiple Sclerosis, 14(5), 701-704. doi:10.1177/1352458507086103 
 
Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Vécsei, L., & Milanov, I. 
(2006). The epidemiology of multiple sclerosis in Europe. European journal of 
Neurology, 13(7), 700-722. 
 
Pyett, P. M. (2003). Validation of qualitative research in the "real world". Qualitative 
Health Research, 13(8), 1170. 
 
Quinn, D., Bowen, A., & Leary, A. (2014). The value of the multiple sclerosis 
specialist nurse with respect to prevention of unnecessary emergency 
admission. Multiple Sclerosis Journal, 20(12), 1669-1670. 
doi:10.1177/1352458514527865 
 
Ramagopalan, S. V., & Sadovnick, A. D. (2011). Epidemiology of multiple sclerosis. 
Neurologic Clinics, 29(2), 207. 
 
Reade, J. W., White, M. B., White, C. P., & Russell, C. S. (2012). What would you 
say? Expressing the difficulties of living with multiple sclerosis. Journal of 
Neuroscience Nursing: Journal of the American Association of Neuroscience 
Nurses, 44(1), 54-63. 
 
Redelman, M. J. (2009). Sexual difficulties for persons with multiple sclerosis in 
New South Wales, Australia. International Journal of Rehabilitation 
Research, 32(4), 337-347. doi:10.1097/MRR.0b013e3283298166 
	 426	
 
Reed, F. C. (2003). Suffering and illness: Insights for caregivers. Portland OR: 
Ringgold Inc. 
 
Reinert, K. G., & Koenig, H. G. (2013). Re-examining definitions of spirituality in 
nursing research. Journal of Advanced Nursing, 69(12), 2622-2634. 
 
Remington, G., Rodriguez, Y., Logan, D., Williamson, C., & Treadaway, K. (2013). 
Facilitating medication adherence in patients with multiple sclerosis. International 
Journal of MS Care, 15(1), 36. 
 
Reynolds, F., & Prior, S. (2003). "Sticking Jewels in your Life": Exploring women's 
strategies for negotiating an acceptable quality of life with multiple 
sclerosis. Qualitative Health Research, 13(9), 1225. 
 
Richards, L., & Morse, J. M. (2007). Readme first for a user's guide to qualitative 
methods (2nd ed.). Thousand Oaks CA: Sage Publications. 
 
Richardson, L., & Lockridge, E. (1998). Fiction and ethnography: A 
conversation. Qualitative Inquiry, 4(3), 328-336. 
 
Rieckmann, P., Boyko, A., Centonze, D., Elovaara, I., Giovannoni, G., Havrdová, E., 
. . . Vermersch, P. (2015). Achieving patient engagement in multiple sclerosis: A 
perspective from the multiple sclerosis in the 21st century steering 
group. Multiple Sclerosis and Related Disorders, 4(3), 202-218. 
doi:10.1016/j.msard.2015.02.005 
 
Riessman, C. K. (1990). Strategic uses of narrative in the presentation of self and 
illness: A research note. Social Science & Medicine (1982), 30(11),1195. 
 
Rintell, D., & Melito, R. (2013). "her illness is a project we can work on together": 
Developing a collaborative family-centered intervention model for newly 
diagnosed multiple sclerosis. International Journal of MS Care, 15(3), 130. 
	 427	
 
Río, J., Comabella, M., & Montalban, X. (2011). Multiple sclerosis: Current 
treatment algorithms. Current Opinion in Neurology, 24(3), 230. 
 
Robinson, C. A. (1993). Managing life with a chronic condition: The story of 
normalization. Qualitative Health Research, 3(1), 6-28. 
doi:10.1177/104973239300300102 
 
Robinson, I. (1990). Personal narratives, social careers and medical courses: 
Analysing life trajectories in autobiographies of people with multiple 
sclerosis. Social Science & Medicine (1982), 30(11), 1173. 
 
Roessler, R., Hennessey, M., Neath, J., Rumrill, P., & Nissen, S. (2011). The 
employment discrimination experiences of adults with multiple sclerosis. Journal 
of Rehabilitation, 77(1), 20. 
 
Roger, K., Wetzel, M., Hutchinson, S., Packer, T., & Versnel, J. (2014). “How can I 
still be me?”: Strategies to maintain a sense of self in the context of a neurological 
condition. International Journal of Qualitative Studies on Health and Well-
being, 9(1), 23534-10. doi:10.3402/qhw.v9.23534 
 
Rommer, P. S., Sühnel, A., König, N., & Zettl, U. (2016). Coping with multiple 
sclerosis—the role of social support. Acta Neurologica Scandinavica, 136(1), 11-
16. doi:10.1111/ane.12673 
 
Rommer, P. S., König, N., Sühnel, A., & Zettl, U. K. (2018). Coping behavior in 
multiple sclerosis—complementary and alternative medicine: A cross-sectional 
study. CNS neuroscience & therapeutics 24(9), 784-789.doi: 10.111/cns.12857  
 
Roper, J. M., & Shapira, J. (2000). Ethnography in nursing research: Methods in 
nursing research 1.Thousand Oaks, CA: Sage Publications. 
 
	 428	
Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1988). Social learning theory 
and the health belief model. Health Education Quarterly, 15(2), 175-183. 
 
Rosland, A., Heisler, M., Janevic, M. R., Connell, C. M., Langa, K. M., Kerr, E. A., 
& Piette, J. D. (2013). Current and potential support for chronic disease 
management in the United States: The perspective of family and friends of 
chronically ill adults. Families, Systems, & Health, 31(2), 119-131. 
doi:10.1037/a0031535 
 
Ross, A. P., Halper, J., & Harris, C. J. (2012). Assessing relapses and response to 
relapse treatment in patients with multiple sclerosis: A nursing 
perspective. International Journal of MS Care, 14(3), 148. 
 
Ross, A. P., & Thrower, B. W. (2010). Recent developments in the early diagnosis 
and management of multiple sclerosis. The Journal of Neuroscience Nursing: 
Journal of the American Association of Neuroscience Nurses, 42(6), 342-353. 
doi:10.1097/JNN.0b013e3181f8a5d0 
 
Roy-Bellina, S., Benes, G., Camu, W., Carlander, B., Thouvenot, E., Landragin, N., 
Geny, C. (2010). Psychopathology of multiple sclerosis: Influence of the 
perception of the disease on the disorders of mood and the emotions. Journal of 
Neurology, 257, S189.  
 
Rubin, H. J., & Rubin, I. S. (2011). Qualitative interviewing: The art of hearing 
data. Thousand Oaks, CA. Sage Publications. 
 
Russell, C. S., White, M. B., & White, C. P. (2006). Why me? why now? why 
multiple sclerosis?: Making meaning and perceived quality of life in a midwestern 
sample of patients with multiple sclerosis. Families, Systems, & Health, 24(1), 65-
81. doi:10.1037/1091-7527.24.1.65 
 
Ryan, G. W., & Bernard, H. R. (2003). Techniques to identify themes. Field 
Methods, 15(1), 85-109. 
 
	 429	
Ryen, A. (2016). Research ethics and qualitative research. In Silverman, D. (Ed.). 
Qualitative research, 31-46. Thousand Oaks, CA:Sage Publications. 
 
Saboteur. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/saboteur 
 
Saldaña, J. (2015). The coding manual for qualitative researchers. Thousand Oaks 
CA: Sage Publications. 
 
Saul, A., Ponsonby, A., Lucas, R. M., Taylor, B. V., Simpson, S., Valery, P., . . . van 
der Mei, Ingrid AF. (2017;2016;). Stressful life events and the risk of initial 
central nervous system demyelination. Multiple Sclerosis Journal, 23(7), 1000-
1007. doi:10.1177/1352458516667566 
 
Scheff, T. (2015). Toward defining basic emotions. Qualitative Inquiry, 21(2), 111-
121. doi:10.1177/1077800414550462 
 
Schulman-Green, D., Jaser, S., Martin, F., Alonzo, A., Grey, M., McCorkle, R., ... 
Whittemore, R. (2012). Processes of Self-Management in chronic illness. Journal 
of Nursing Scholarship, 44(2), 136-144. doi:10.1111/j.1547-5069.2012.01444.x 
 
Schwartz, C. E., Grover, S. A., Powell, V. E., Noguera, A., Mah, J. K., Mar, S., . . . 
Yeh, E. A. (2017). Risk factors for non-adherence to disease-modifying therapy in 
pediatric multiple sclerosis.  Multiple Sclerosis Journal, 24(2), 
135245851769546-185. doi:10.1177/1352458517695469 
 
Seale, C. (1999). Quality in qualitative research. Qualitative Inquiry, 5(4), 465-478. 
 
Sellner, J., Kraus, J., Awad, A., Milo, R., Hemmer, B., & Stüve, O. (2011). The 
increasing incidence and prevalence of female multiple sclerosis--a critical 
analysis of potential environmental factors. Autoimmunity Reviews, 10(8), 495. 
 
	 430	
Sencer, W. (1988). Suspicion of multiple sclerosis. to tell or not to tell? Archives of 
Neurology, 45(4), 441. 
 
Settle, J. R., Maloni, H. W., Bedra, M., Finkelstein, J., Zhan, M., & Wallin, M. T. 
(2016). Monitoring medication adherence in multiple sclerosis using a novel web-
based tool: A pilot study. Journal of Telemedicine and Telecare, 22(4), 225-233. 
doi:10.1177/1357633X15597115 
 
Shapiro, J. (2011). Perspective: does medical education promote professional 
alexithymia? A call for attending to the emotions of patients and self in medical 
training. Academic Medicine, 86(3), 326-332. 
 
Sharifi, S., Borhani, F., & Abbaszadeh, A. (2016). Factors affecting dignity of 
patients with multiple sclerosis. Scandinavian Journal of Caring Sciences, 30(4), 
731-740. doi:10.1111/scs.12299 
 
Sharpe, L., & Curran, L. (2006). Understanding the process of adjustment to 
illness. Social Science & Medicine, 62(5), 1153-1166. 
doi:10.1016/j.socscimed.2005.07.010 
 
Shirani, A., Okuda, D. T., & Stüve, O. (2016). Therapeutic advances and future 
prospects in progressive forms of multiple sclerosis. Neurotherapeutics, 13(1), 
58-69. doi:10.1007/s13311-015-0409-z 
 
Silverman, A. M., Molton, I. R., Alschuler, K. N., Ehde, D. M., P & Jensen, M. P. 
(2015). Resilience predicts functional outcomes in people aging with disability: A 
longitudinal investigation. Archives of Physical Medicine and 
Rehabilitation, 96(7), 1262-1268. doi:10.1016/j.apmr.2015.02.023 
 
Silverman, A. M., Verrall, A. M., Alschuler, K. N., Smith, A. E., & Ehde, D. M. 
(2017). Bouncing back again, and again: A qualitative study of resilience in 
people with multiple sclerosis. Disability and Rehabilitation, 39(1), 14-22. 
doi:10.3109/09638288.2016.1138556 
 
	 431	
Silverman, D. (2001). Interpreting qualitative data: Methods for analysing talk, text, 
and interaction (2nd ed.). Thousand Oaks, CA: Sage Publications. 
 
Silverman, D. (2010). Doing qualitative research. (3rd Ed.).London, UK: Sage 
Publications.  
 
Silverman, D. (2016). Qualitative research (4th. Ed.). London UK: Sage 
Publications. 
 
Siouta, N., Beek, K. V., Preston, N., Hasselaar, J., Hughes, S., Payne, S., . . . Menten, 
J. (2016). Towards integration of palliative care in patients with chronic heart 
failure and chronic obstructive pulmonary disease: A systematic literature review 
of European guidelines and pathways. BMC Palliative Care, 15(1). 
doi:10.1186/s12904-016-0089-4 
 
Skår, A. B. R., Folkestad, H., Smedal, T., & Grytten, N. (2014). “I refer to them as 
my colleagues”: The experience of mutual recognition of self, identity and 
empowerment in multiple sclerosis. Disability and Rehabilitation, 36(8), 672-677. 
doi:10.3109/09638288.2013.808273 
 
Slater, R. J., & Yearwood, A. C. (1980). MS facts, faith, and hope. The American 
Journal of Nursing, 80(2), 276. 
 
Smeltzer, S. C. (2002). Reproductive decision making in women with multiple 
sclerosis. The Journal of Neuroscience Nursing: Journal of the American 
Association of Neuroscience Nurses, 34(3), 145-157. doi:10.1097/01376517-
200206000-00007 
 
Smith, A. L., Cohen, J. A., & Hua, L. H. (2017). Therapeutic targets for multiple 
sclerosis: Current treatment goals and future directions. Neurotherapeutics, 14(4), 
952-960. doi:10.1007/s13311-017-0548-5 
 
 
 
	 432	
Smith, C. M., Hale, L. A., Olson, K., Baxter, G. D., & Schneiders, A. G. (2013). 
Healthcare provider beliefs about exercise and fatigue in people with multiple 
sclerosis. Journal of Rehabilitation Research and Development, 50(5), 733. 
doi:10.1682/JRRD.2012.01.0012 
 
Smith, J. A., Larkin, M., & Flowers, P. (2008). Interpretative phenomenological 
analysis: Theory, method and research. London UK: Sage Publications. 
 
Smith, J., & Noble, H. (2014). Bias in research. Evidence Based Nursing, 17(4), 100-
101. doi:10.1136/eb-2014-101946 
 
Snyder, C. R. (1989). Reality negotiation: From excuses to hope and 
beyond. Journal of Social and Clinical Psychology, 8(2), 130-157. 
 
Snyder, C. R. (1994). The psychology of hope: You can get there from here. New 
York NY: Free Press. 
 
Snyder, C. R. (2002). Hope theory: Rainbows in the mind. Psychological 
Inquiry, 13(4), 249-275. 
 
Snyder, J., Adams, K., Crooks, V. A., Whitehurst, D., & Vallee, J. (2014). “I knew 
what was going to happen if I did nothing and so I was going to do something”: 
Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek 
unproven interventions abroad. BMC Health Services Research, 14(1), 445. 
 
Snyder, C. R., Irving, L. M., & Anderson, J. R. (1991). Hope and health. Handbook 
of social and clinical psychology: The health perspective, 162, 285-305. 
 
Snyder, C. R., Lehman, K. A., Kluck, B., & Monsson, Y. (2006). Hope for 
rehabilitation and vice versa. Rehabilitation Psychology, 51(2), 89. 
 
Snyder, C. R., & Lopez, S. J. (2009). Oxford handbook of positive psychology. New 
York; NY: Oxford University Press. 
 
	 433	
Solari, A., Acquarone, N., Pucci, E., Martinelli, V., Marrosu, M. G., Trojano, M., . . . 
Messmer Uccelli, M. (2007). Communicating the diagnosis of multiple sclerosis - 
a qualitative study. Multiple Sclerosis, 13(6), 763-769. 
doi:10.1177/1352458506074689 
 
Solari, A., Grzeda, M., Giordano, A., Mattarozzi, K., D’Alessandro, R., Simone, A., . 
. . on behalf of the SIMS-Trial, SIMS-Practice and Agorà studies. (2014). Use of 
rasch analysis to refine a patient-reported questionnaire on satisfaction with 
communication of the multiple sclerosis diagnosis. Multiple Sclerosis 
Journal, 20(9), 1224-1233. doi:10.1177/1352458513518261 
 
Sorensen, P. S. (2014). New management algorithms in multiple sclerosis. Current 
Opinion in Neurology, 27(3), 246. 
 
Soundy, A., Benson, J., Dawes, H., Smith, B., Collett, J., & Meaney, A. (2012). 
Understanding hope in patients with multiple sclerosis. Physiotherapy, 98(4), 
344-350. doi:10.1016/j.physio.2011.05.003 
 
Soundy, A., Smith, B., Dawes, H., Pall, H., Gimbrere, K., & Ramsay, J. (2013). 
Patient's expression of hope and illness narratives in three neurological 
conditions: a meta-ethnography. Health Psychology Review, 7(2), 177-201. 
 
Soundy, A., Stubbs, B., & Roskell, C. (2014). The experience of Parkinson’s disease: 
a systematic review and meta-ethnography. The Scientific World Journal, 2014. 
 
Soundy, A., Roskell, C., Elder, T., Collett, J., & Dawes, H. (2016). The 
psychological processes of adaptation and hope in patients with multiple sclerosis: 
a thematic synthesis. Open Journal of Therapy and Rehabilitation, 4(01), 22. 
 
Spradley, J. P. (1979). The ethnographic interview. New York NY: Holt, Rinehart 
and Winston. 
 
	 434	
Sprangers, M. A., & Hanneke C. De Haes. (2000). The usefulness of crisis theory in 
explaining experienced levels of quality of life. Quality of Life Research, 9(3), 
251-251. 
 
Spencer, D. C., & Karceski, S. (2015). About Multiple Sclerosis. Neurology, 85(13), 
e103. DOI: 10.1212/WNL.0000000000002048 
 
Spiers, J. A., & Wood, A. (2010). Building a therapeutic alliance in brief therapy: 
The experience of community mental health nurses. Archives of Psychiatric 
Nursing, 24(6), 373-386. doi:10.1016/j.apnu.2010.03.001 
 
Spitzer, C., Bouchain, M., Winkler, L. Y., Wingenfeld, K., Gold, S. M., Grabe, H. J., 
. . . Heesen, C. (2012). Childhood trauma in multiple sclerosis: A case-control 
study. Psychosomatic Medicine, 74(3), 312. 
 
Srivastava, P., & Hopwood, N. (2009). A practical iterative framework for 
qualitative data analysis. International Journal of Qualitative Methods, 8(1), 76-
84. doi:10.1177/160940690900800107 
 
Stanton, A. L., Danoff‐burg, S., & Huggins, M. E. (2002). The first year after breast 
cancer diagnosis: Hope and coping strategies as predictors of 
adjustment. Psycho‐oncology, 11(2), 93-102. doi:10.1002/pon.574 
 
Stephenson, C. (1991). The concept of hope revisited for nursing. Journal of 
Advanced Nursing, 16(12), 1456-1461. 
 
Sterz C, Ellenberger D, Meißner H, Friede T, Flachenecker P. (2016). Employment-
associated factors in multiple sclerosis: Results of a cross-sectional study in 
Germany. Journal Disability Rehabilitation l, 2:24–33. 
 
Stewart, D. C., & Sullivan, T. J. (1982). Illness behavior and the sick role in chronic 
disease. the case of multiple sclerosis. Social Science & Medicine (1982), 16(15), 
1397. 
 
	 435	
Stewart, D. E., & Yuen, T. (2011). A systematic review of resilience in the 
physically ill. Psychosomatics, 52(3), 199-209. 
 
Strickland, K., Worth, A., & Kennedy, C. (2015). The experiences of support 
persons of people newly diagnosed with multiple sclerosis: An interpretative 
phenomenological study. Journal of Advanced Nursing, 71(12), 2811-2821. 
 
Strober, L. B., Christodoulou, C., Benedict, R. H., Westervelt, H. J., Melville, P., 
Scherl, W. F., . . . Krupp, L. B. (2012). Unemployment in multiple sclerosis: The 
contribution of personality and disease. Multiple Sclerosis Journal, 18(5), 647-
653. doi:10.1177/1352458511426735 
 
Strupp, J., Hartwig, A., Golla, H., Galushko, M., Pfaff, H., & Voltz, R. (2012). 
Feeling severely affected by multiple sclerosis: What does this mean? Palliative 
Medicine, 26(8), 1001-1010. doi:10.1177/0269216311425420 
 
Stueber, K. R. (2011). imagination, empathy, and moral deliberation: The case of 
imaginative resistance: Imagination, empathy, and moral deliberation. The 
Southern Journal of Philosophy, 49, 156-180. doi:10.1111/j.2041-
6962.2011.00065.x 
 
Stuke, K., Flachenecker, P., Zettl, U. K., Elias, W. G., Freidel, M., Haas, J., . . . 
Rieckmann, P. (2009). Symptomatology of MS: Results from the German MS 
registry. Journal of Neurology, 256(11), 1932-1935. doi:10.1007/s00415-009-
5257-5 
 
Stüve O., & Racke M.K. (2016). Will biomarkers determine what is next in Multiple 
Sclerosis? Biomarkers in Multiple Sclerosis. JAMA Neurol, 73(5):496–497. 
doi:10.1001/jamaneurol.2015.4841 
 
Synnot, A., Hill, S., Summers, M., & Taylor, M. (2014). Comparing face-to-face and 
online qualitative research with people with multiple sclerosis. Qualitative Health 
Research, 24(3), 431-438. doi:10.1177/1049732314523840 
 
	 436	
Tabuteau-Harrison, S. L., Haslam, C., & Mewse, A. J. (2016). Adjusting to living 
with multiple sclerosis: The role of social groups. Neuropsychological 
Rehabilitation, 26(1), 36-59. doi:10.1080/09602011.2014.993403 
 
Tams, R., Prangnell, S. J., & Daisley, A. (2016). Helping families thrive in the face 
of uncertainty: Strengths based approaches to working with families affected by 
progressive neurological illness. Neurorehabilitation, 38(3), 257. 
 
Tan-Kristanto, S., & Kiropoulos, L. A. (2015). Resilience, self-efficacy, coping 
styles and depressive and anxiety symptoms in those newly diagnosed with 
multiple sclerosis.Psychology, Health & Medicine, 20(6), 635-645. 
doi:10.1080/13548506.2014.999810 
 
Tanner, K. (2009). “I’m crying too... help, what do I do?”–Unexpected encounters 
experienced by a first time researcher. Current Narratives, 1(1), 69-79. 
 
Taylor, G. W., & Ussher, J. M. (2001). Making sense of S&M: A discourse analytic 
account. Sexualities, 4(3), 293-314. 
 
Taylor, S. E. (1983). Adjustment to threatening events: A theory of cognitive 
adaptation. American Psychologist, 38, 1161–1171. 
 
Taylor, S. E., & Armor, D. A. (1996). Positive illusions and coping with 
adversity. Journal of Personality, 64(4), 873-898. doi:10.1111/j.1467-
6494.1996.tb00947.x 
 
Taylor, S. E., & Aspinwall, L. G. (1996). Mediating and moderating processes in 
psychosocial stress: Appraisal, coping, resistance, and vulnerability. In H. B. Kaplan 
(Ed.), Psychosocial stress: Perspectives on structure, theory, life-course, and 
methods (pp. 71-110). San Diego, CA, US: Academic Press. 
 
	 437	
Terrill, A. L., Molton, I. R., Ehde, D. M., Amtmann, D., Bombardier, C. H., Smith, 
A. E., & Jensen, M. P. (2014). Resilience, age, and perceived symptoms in 
persons with long-term physical disabilities. Journal of Health Psychology, 21(5), 
640-649. doi:10.1177/1359105314532973 
 
Thach, A. V., Brown, C. M., Herrera, V., Sasane, R., Barner, J. C., Ford, K. C., & 
Lawson, K. A. (2016). Associations Between Treatment Satisfaction, Medication 
Beliefs, and Adherence to Disease-Modifying Therapies in Patients With Multiple 
Sclerosis. International Journal of MS Care, 20(6), 251-259. doi: 10.7224/1537-
2073.2017-031 
 
Thannhauser, J. E. (2009). Grief-Peer dynamics: Understanding experiences with 
pediatric multiple sclerosis. Qualitative Health Research, 19(6), 766-777. 
doi:10.1177/1049732309334859 
 
Théaudin, M., Romero, K., & Feinstein, A. (2016). In multiple sclerosis anxiety, not 
depression, is related to gender. Multiple Sclerosis Journal, 22(2), 239-244. 
 
Thomas, W. I., & Znaniecki, F. (1927). The Wider Community and the Role of the 
Press. The Polish Peasant in Europe and America, 2, 1367-397. 
 
Thompson, A., Banwell, B., & Barkof, F. (2018). Diagnosis of multiple sclerosis: 
2017 revisions of the McDonald Criteria. Lancet Neurology, 2018; 17(2): 162–
173.  
 
Thompson, H. (2011). Nursing management of the patient with multiple 
sclerosis. Journal of Neuroscience Nursing: Journal of the American Association 
of Neuroscience Nurses, 43(6), 354. doi:10.1097/JNN.0b013e318236176a 
 
Thormann, A., Sørensen, P. S., Koch‐Henriksen, N., Thygesen, L. C., Laursen, B., & 
Magyari, M. (2017). Chronic comorbidity in multiple sclerosis is associated with 
lower incomes and dissolved intimate relationships. European Journal of 
Neurology, 24(6), 825-834. doi:10.1111/ene.13297 
 
	 438	
Thorne, S. (2008). Making sense of data. Interpretative Description, Qualitative 
research for applied science. New York NY: Routledge. 
 
Thorne, S., McGuinness, L., McPherson, G., Con, A., Cunningham, M., & Harris, S. 
R. (2004). Health care communication issues in fibromyalgia: An interpretive 
description. Physiotherapy Canada, 56(1), 31. doi:10.2310/6640.2004.15288 
 
Thorne, S. E., Ternulf Nyhlin, K., & Paterson, B. L. (2000). Attitudes toward patient 
expertise in chronic illness. International Journal of Nursing Studies, 37(4), 303-
311. doi:10.1016/S0020-7489(00)00007-9 
 
Thornton, E. W., Tedman, S., Rigby, S., Bashforth, H., & Young, C. (2006). Worries 
and concerns of patients with multiple sclerosis: Development of an assessment 
scale. Multiple Sclerosis, 12(2), 196-203. doi:10.1191/135248506ms1273oa 
 
Tierney, W. G. (1994). On method and hope. Power and method: Political activism 
and educational research, 97-115. 
 
Tierney, W.G. (2000). Undaunted Courage. In Denzin, N. K., & Lincoln, Y. S. (Eds) 
Handbook of qualitative research (2nd ed.). Thousand Oaks, CA: Sage 
Publications. 
 
Tierney, W. G., & Lincoln, Y. S. (Eds.). (1997). Representation and the text: Re-
framing the narrative voice. Suny Press. 
 
Tintoré, M., Alexander, M., Costello, K., Duddy, M., Jones, D. E., Law, N., ... & 
Wray, S. (2017). The state of multiple sclerosis: current insight into the 
patient/health care provider relationship, treatment challenges, and 
satisfaction. Patient Preference and Adherence, 11, 33. 
 
Toombs, S. K. (1988). Illness and the paradigm of lived body. Theoretical 
Medicine, 9(2), 201-226. 
 
	 439	
Toombs, S. K. (1990). The temporality of illness: Four levels of 
experience. Theoretical Medicine, 11(3), 227-241. 
 
Toombs, S. K. (1992). The body in multiple sclerosis: A patient’s perspective. In The 
body in medical thought and practice 43: 127-137.  
 
Toombs, S. K. (1995). The lived experience of disability. Human Studies, 18(1), 9-
23. doi:10.1007/BF01322837 
 
Toombs, S. K. (2001). Reflections on bodily change: The lived experience of 
disability. In Handbook of phenomenology and medicine (pp. 247-261). 
Dordrecht: Springer. 
 
Torkildsen, Ø., Myhr, K. M., & Bø, L. (2016). Disease-modifying treatments for 
multiple sclerosis–a review of approved medications. European Journal of 
Neurology, 23(S1), 18-27. 
 
Travelbee, J. (1971). Interpersonal aspects of nursing. Nursing Management, 1(1), 
44. doi:10.1097/00006247-197112000-00009 
 
Tremlett, H., Zhao, Y., & Devonshire, V. (2008). Natural history of secondary-
progressive multiple sclerosis. Multiple Sclerosis Journal, 14(3), 314-324. 
 
Tremlett, H., Zhao, Y., Rieckmann, P., & Hutchinson, M. (2010). New perspectives 
in the natural history of multiple sclerosis. Neurology, 74(24), 2004. 
 
Tuckett, A. G. (2005). Part II. Rigour in qualitative research: complexities and 
solutions. Nurse Researcher, 13(1), 29. 
 
Turner, A. P., & Alschuler, K. N. (2018). Anxiety is more important than depression 
in MS–No. Multiple Sclerosis Journal, 24(4), 442-444. 
 
	 440	
Tutton, E., Seers, K., & Langstaff, D. (2009). An exploration of hope as a concept 
for nursing. Journal of Orthopaedic Nursing, 13(3), 119-127. 
doi:10.1016/j.joon.2009.07.006 
 
Twork, S., Wirtz, M., Schipper, S., Klewer, J., Bergmann, A., & Kugler, J. (2007). 
Chronic illness and maternity: life conditions, quality of life and coping in women 
with multiple sclerosis. Quality of Life Research, 16(10), 1587-1594. 
 
Uchino, B. N., Cacioppo, J. T., & Kiecolt-Glaser, J. K. (1996). The relationship 
between social support and physiological processes: A review with emphasis on 
underlying mechanisms and implications for health. Psychological 
Bulletin, 119(3), 488-531. doi:10.1037/0033-2909.119.3.488 
 
Umberson, D., & Montez, J. K. (2010). Social relationships and health: A flashpoint 
for health policy. Journal of Health and Social Behavior, 51(1_suppl), S54-S66. 
doi:10.1177/0022146510383501 
 
Utz, K. S., Hoog, J., Wentrup, A., Berg, S., Lämmer, A., Jainsch, B., ... & Schenk, T. 
(2014). Patient preferences for disease-modifying drugs in multiple sclerosis 
therapy: a choice-based conjoint analysis. Therapeutic Advances in Neurological 
Disorders, 7(6), 263-275. 
 
Vaismoradi, M., Turunen, H., & Bondas, T. (2013). Content analysis and thematic 
analysis: Implications for conducting a qualitative descriptive study. Nursing & 
Health Sciences, 15(3), 398-405. doi:10.1111/nhs.12048 
 
van Capelle, A. D. C., van der Meide, H., Vosman, F. J., & Visser, L. H. (2017). A 
qualitative study assessing patient perspectives in the process of decision-making 
on disease modifying therapies (DMT’s) in multiple sclerosis (MS). PloS 
one, 12(8), e0182806. 
 
 
 
	 441	
Van Dijk, P. A., Kirk-Brown, A. K., Taylor, B., & van der Mei, I. (2016). Closing 
the gap: Longitudinal changes in employment for Australians with multiple 
sclerosis. Multiple Sclerosis Journal, 23(10), 1415-1423. 
doi:10.1177/1352458516678934 
 
van Gorp, D. A. M, van der Klink, J. J. L, Abma, F. I., Jongen, P. J., van Lieshout, I., 
Arnoldus, E. P. J., . . . van der Hiele, K. (2017). The value of work-correlates of 
sustained employability in workers with multiple sclerosis (MS). Multiple 
Sclerosis Journal, 23(6), 913-914. 
 
Vasey, M. W., Crnic, K. A., & Carter, W. G. (1994). Worry in childhood: A 
developmental perspective. Cognitive Therapy and Research, 18(6), 529-549. 
doi:10.1007/BF02355667 
 
Vick, A. (2013). The embodied experience of episodic disability among women with 
multiple sclerosis. Disability & Society, 28(2), 176-189. 
doi:10.1080/09687599.2012.699279 
 
Vickers, M. H. (1997). Life at work with “invisible” chronic illness (ICI): The 
“unseen”, unspoken, unrecognized dilemma of disclosure. Journal of Workplace 
Learning, 9(7), 240-252. doi:10.1108/13665629710190040 
 
Vukusic, S., & Confavreux, C. (2003). Prognostic factors for progression of 
disability in the secondary progressive phase of multiple sclerosis. Journal of the 
Neurological Sciences, 206(2), 135-137. 
 
Waldman, A., Ness, J., Pohl, D., Simone, I. L., Anlar, B., Amato, M. P., & Ghezzi, 
A. (2016). Pediatric multiple sclerosis Clinical features and 
outcome. Neurology, 87(9 Supplement 2), S74-S81. 
 
Ward, J., Cody, J., Schaal, M., & Hojat, M. (2012). The empathy enigma: An 
empirical study of decline in empathy among undergraduate nursing 
students. Journal of Professional Nursing, 28(1), 34-40. 
doi:10.1016/j.profnurs.2011.10.007 
	 442	
Watson, L. C., & Watson-Franke, M. B. (1985). Interpreting life histories: An 
anthropological inquiry. New Brunswick NJ: Rutgers University Press. 
 
Waubant, E., Ponsonby, A. L., Pugliatti, M., Hanwell, H., Mowry, E. M., & Hintzen, 
R. Q. (2016). Environmental and genetic factors in pediatric inflammatory 
demyelinating diseases. Neurology, 87(9 Supplement 2), S20-S27. 
 
Weinshenker, B. G. (1994). Natural history of multiple sclerosis. Annals of 
Neurology, 36(S1). 
 
Wertz, F. (1983). From everyday to psychological description: Analysing the 
moments of a qualitative data analysis. Journal of Phenomenological Psychology, 
14, 197-241.  
 
White, B. (2012). The role of the multiple sclerosis specialist nurse in counselling 
patients at diagnosis. British Journal of Neuroscience Nursing, 8(4), 179-182. 
doi:10.12968/bjnn.2012.8.4.179 
 
White, C. P., White, M. B., & Russell, C. S. (2008). Invisible and visible symptoms 
of multiple sclerosis: Which are more predictive of health distress? The Journal of 
Neuroscience Nursing : Journal of the American Association of Neuroscience 
Nurses, 40(2), 85. 
 
Whitehead, B., O’Brien, M. R., Jack, B. A., & Mitchell, D. (2012). Experiences of 
dying, death and bereavement in motor neurone disease: a qualitative 
study. Palliative Medicine, 26(4), 368-378. 
 
Whitehead, L. (2017). The family experience of fatigue in heart failure. Journal of 
Family Nursing, 23(1), 138-156. doi:10.1177/1074840716684232 
 
Wicks, P., Brandes, D., Park, J., Liakhovitski, D., Koudinova, T., & Sasane, R. 
(2015). Preferred features of oral treatments and predictors of non-adherence: 
Two web-based choice experiments in multiple sclerosis patients. Interactive 
Journal of Medical Research, 4(1), e6. doi:10.2196/ijmr.3776 
	 443	
 
Willig, C., & Stainton Rogers, W. (2008). The Sage handbook of qualitative research 
in psychology. London UK: Sage Publications. 
 
Wilsdon, T., Barron, A., Mitchell-Heggs, A., & Ginoza, S. (2014). Access to 
medicines for multiple sclerosis: Challenges and opportunities. Report prepared 
for Biogen Idec. London. Charles River Associates.  
 
Wilson, L. S., Loucks, A., Gipson, G., Zhong, L., Bui, C., Miller, E., . . . McCulloch, 
C. E. (2015). Patient preferences for attributes of multiple sclerosis disease-
modifying therapies: Development and results of a ratings-based conjoint 
analysis. International Journal of MS Care, 17(2), 74. 
 
Willson, C.L; Tetley, J; Lloyd, C, Messmer Uccelli, M; & MacKian, S. (2017).The 
impact of multiple sclerosis on the identity of mothers in Italy. Disability and 
Rehabilitation, 40: 12, 1456-1467. doi: 10.1080/09638288.2017.1300339 
 
Wiman, E., Wikblad, K. (2004). Caring and uncaring encounters in nursing in an 
emergency department. Journal of Clinical Nursing, 13(4), 422-429. 
doi:10.1111/j.1365-2702.2004.00902.x 
 
Windle, P. (2011). Obstacles and drawbacks to avoid in qualitative nursing 
research. Journal of PeriAnesthesia Nursing, 26(3), 173-175. 
doi:10.1016/j.jopan.2011.03.007 
 
Wingerchuk, D. M., & Carter, J. L. (2014). Multiple sclerosis: Current and emerging 
disease-modifying therapies and treatment strategies. Mayo Clinic 
Proceedings, 89(2), 225. 
 
 
Wirth, A., & Büssing, A. (2016). Utilized resources of hope, orientation, and 
inspiration in life of persons with multiple sclerosis and their association with life 
satisfaction, adaptive coping strategies, and spirituality. Journal of Religion and 
Health, 55(4), 1359-1380. doi:10.1007/s10943-015-0089-3 
	 444	
 
Wiseman, J. (1974) The research web. Urban life and culture. 3(3), 317-328. 
 
Wolcott, H. F. (1994). Transforming qualitative data: Description, analysis, and 
interpretation. Thousand Oaks CA: Sage Publications. 
 
Wood B, van der Mei IAF, Ponsonby AL, Pittas F, Quinn S, Dwyer T, Taylor BV. 
Prevalence and concurrence of anxiety, depression and fatigue over time in 
multiple sclerosis. Multiple Sclerosis Journal. 2013;19(2):217–224. doi: 
10.1177/1352458512450351. 
 
World Health Organisation. (WHO). (2003). Adherence to long term therapies. 
Evidence for Action. Retrieved from: 
http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf 10th 
May 2018. 
 
Worry. (2017). In OxfordDictionaries.com. Retrieved from 
https://en.oxforddictionaries.com/definition/worry 
 
Yamasaki, R., Matsushita, T., Fukazawa, T., Yokoyama, K., Fujihara, K., Ogino, M., 
... & Tomioka, R. (2016). Efficacy of intravenous methylprednisolone pulse 
therapy in patients with multiple sclerosis and neuromyelitis optica. Multiple 
Sclerosis Journal, 22(10), 1337-1348. 
 
Yu, C., & Mathiowetz, V. (2014). Systematic review of occupational therapy-related 
interventions for people with multiple sclerosis: Part 1. Activity and 
participation. The American Journal of Occupational Therapy : Official 
Publication of the American Occupational Therapy Association, 68(1), 27. 
 
Zivadinov, R., & Weinstock-Guttman, B. (2018). Multiple sclerosis: Extracranial 
venous angioplasty is ineffective to treat MS. Nature Reviews Neurology, 14(3), 
129. 
 
	 445	
APPENDICES 
 
Appendix 1. HREC approval documents  
 
Appendix 2. Flyer: for recruiting study participants 
 
Appendix 3. Reflection questions prior to interviews 
 
Appendix 4. Safety checklist before interviews 
 
Appendix 5. Policy to notify of interview attendance/completion 
 
Appendix 6. Example of field notes 
 
Appendix 7. Example of the development of semantic and latent codes 
 
Appendix 8. Example of thematic map development 
 
Appendix 9. Patient information and consent forms (PICF) 
 
Appendix 10. Flyer: procedure to follow-up participants if needing psychological 
care 
 
Appendix 11. Questions to ask myself before/after interviews 
 
Appendix 12: Diary excerpt from reflexive diary on how I was feeling 
 
Appendix 13. Interlinking of the life journey reflecting the study themes and 
subthemes of participants, Margot (13a), Kate (13b), Rudi (13c), Joy (13d), Jane 
(13e), Paul (13f), Ruby (13g), Davina (13h), Evie (13i). 
 
 
	 446	
Appendix 1 HREC correspondence
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Therese Burke  
69 Grove St Lilyfield 2040 NSW 
         
 
22nd February 2016 
 
Dr Natalie Giles 
Research Ethics Officer 
Research Office 
The University of Notre Dame Australia 
Fremantle Campus 
 
Dear Natalie, 
Reference Number: 016002S 
Project Title: “What is the experience of living with RRMS?” 
 
The table below outlines the conditions/issues raised by the HREC and the researcher's 
response summary, including the location of the required amendment in the full application. 
 
Condition / Issue Raised Researcher Response 
Storage plans for data 
collected during the 
research 
A copy of the data collected will be stored in the School of 
Nursing, Darlinghurst Campus, to comply with university policy: 
Code of conduct for research. This is now amended in the 
original submission section 6.2b and 6.2c and a copy of the 
electronic form with this addition clearly marked is attached.  
Addition of UNDA logo to 
subject recruitment 
advertisement/flyer 
The UNDA logo has been added and the subject recruitment 
advertisement/flyer is now known as version 2, dated 22nd 
February 2016. The new advertisement  is attached. 
 
I hope this addresses the concerns raised by the HREC. I look forward to hearing from you. 
 
Yours sincerely, 
 
Therese Burke (Student) 					
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   Appendix 2: Recruitment flyer  
ARE	 YOU	 LIVING	 WITH	 RELAPSING	 REMITTING	 MULTIPLE	
SCLEROSIS?	
	
A	research	study	is	being	undertaken	to	explore	the	life	experiences	of	
people	living	with	Relapsing	Remitting	Multiple	Sclerosis	(RRMS).	To	be	
eligible	 for	 inclusion	 in	 this	 study,	 you	 need	 to	 meet	 the	 following	
criteria:	
	
! to	have	been	diagnosed	with	RRMS		
	
! aged	18	years	or	over	
	
! be	able	to	read	and	understand	English	
	
! be	able	to	walk	unassisted	
	
! To	be	available	for	an	individual	interview	with	the	researcher	at	
a	mutually	agreed	location	in	Sydney	 	 	
	
If	 you	 are	 interested	 in	 finding	 out	more	 information,	 please	
contact	 the	 Principal	 Researcher,	 Therese	 Burke,	 by	 mobile	
telephone	 on	 0412	 365	 667	 or	 by	 email	 on	
therese.burke2@my.nd.edu.au	
	
	
There	 is	 no	 obligation	 to	 participate	 in	 the	 research	 by	 making	 an	
enquiry.	
	
	
This	 research	study	has	been	approved	by	 the	Human	Research	Ethics	
Committee	of	the	University	of	Notre	Dame,	Australia.	
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Appendix 3: Reflection questions 
Reflection questions prior to interview 
 
These are some reflection questions you might like to think about before the 
interview, to help organise your thoughts and give you an opportunity to give 
consideration to important things or personal events of significance that may have 
happened in your life.  
 
What have been the major events in your life so far? 
 
What have been the major turning points in your life? 
 
In what ways has the diagnosis of relapsing remitting multiple sclerosis (RRMS) 
changed or altered your life plan/s? 
 
When were you first diagnosed with RRMS and what was happening in your life at 
that time? 
 
What symptoms did you have leading up to the diagnosis of RRMS? 
 
How did you feel waiting for the diagnosis? 
 
How did you feel when the diagnosis was confirmed? 
 
What effect have the relapses had on your life? 
 
Has RRMS affected your relationships, and if so, who with, and in what ways? 
 
Has RRMS affected your work life or employment, and if so, in what ways? 
 
How have the new medications to treat RRMS impacted on your life? 
 
What impact has RRMS had on your life generally? 
 
What other health issues have you experienced and what impact have they had on 
your life? 
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Appendix 4:Safety checklist 
Safety checklist prior to participant interviews 
HDR project TB/ “What is the experience of living with RRMS?” 
 
Where possible, perform the interview during the day. 
 
Information on name, address and contact number of the participant should be 
provided to the nominated Supervisor on the day of the interview (TM or JP 
depending on their lecturing schedule). 
 
Have Supervisor numbers pre-programmed into mobile phone, as well as emergency 
number (000) and ensure the phone is charged and in working order for every 
interview. 
 
Phone questions PRIOR to interview to assess safety risks: 
 
Are the premises a unit, house or place of business? 
 
Are the premises easily accessible from the street? 
 
Are there any stairs to gain entry? 
 
Are there fences around the premises? 
 
Is it likely that there will be anyone else home at the time of the interview? If so, 
who? 
 
Are their any pets on the premises? If yes, what sort and are they aggressive? 
 
Are there any other safety issues that I need to be aware of?  
 
On arrival: 
 
Contact nominated Supervisor (TM/JP) with time of entry and expected time of 
departure. 
 
Assess the premises for the presence of safety risks, weapons, the influence of drugs 
or alcohol. 
 
Leave the premises immediately if any safety risk is identified or observed. 
 
Keep mobile phone and keys with me at all times. 
 
After the interview: 
 
Contact nominated Supervisor (TM/JP) to advise of interview completion and 
leaving the premises. 
 
 
Version 1 dated 31st March 2016 
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Appendix 5: Interview policy 
	
SUBJECT	INTERVIEW	POLICY	
	
	
HDR	study:	“What	is	the	experience	of	living	with	RRMS?”	
	
Subject	 interviews	will	 take	 place	 at	 a	mutually	 agreed	 location	 between	 subject	
and	Interviewer	(Therese	Burke).	Ideal	locations	for	the	interview	include:	
	
• UNDA	interview	rooms	at	Broadway		
• UNDA	interview	rooms	at	Darlinghurst	
• Library	interview	rooms	(public	libraries	in	Sydney)	
• Subject	homes	if	preferred	by	subject		
• Interview	room	at	Westmead	Education	Centre	 (under	Westmead	Hospital	
research	and	education	network)	–	this	is	not	a	clinical	area	
	
	
Therese	will	contact	Tracey	Moroney	and	Joanna	Patching	(Supervisors)	to	let	them	
know	 she	 has	 an	 interview	 planned	 and	where	 and	when	 the	 interview	will	 take	
place.	
	
Therese	will	check	in	by	phone	and/or	email	on	arrival	to	the	interview	and	also	at	
interview	 completion	 so	 that	 all	 parties	 are	 aware	 of	 proceedings	 and	 safety	 is	
monitored.		
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Appendix 6: Field notes 
 
TB HDR STUDY: FIELDNOTES FOR EACH SUBJECT INTERVIEWED 
 
Interview name: 
 
Date of Interview: 
 
Time of interview: 
 
Time on and off: 
 
Breaks: 
 
__________________________________________________________________ 
 
General demeanour (mood/dress etc): 
 
 
Periods of Distress: 
 
 
Periods of Joy: 
 
 
Difficulties encountered during life : 
 
 
Things which went well during life: 
 
 
Themes/areas that came up during the interview: 
 
 
Overall feelings after interview: 
 
 
Things I could work on/do differently next time: 
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Appendix  7: Code development 
 
Examples of the development of semantic and latent codes from raw study data 
 
 
Study participant and line:  Rudi, line 276 
 
Quote: “It was degrading that time because I had to be wheeled to the toilet and so 
that sort of stuff was hard to cope with…and so I do tend to crash and burn 
emotionally as most people probably tend to do because things are just taken from 
you” 
 
Semantic data codes: feelings of degradation, hard to cope, crash and burn 
emotionally, RRMS takes from you 
 
Latent data codes: Losses from RRMS, despair, negotiating normalcy and disability, 
fear of progression/disability, seeds of resilience 
 
 
 
 
Study participant and line: Susan line 788 
 
Quote:” I remember how I was trying to be strong…that I think it didn’t help me 
because it delayed my grieving…it delayed me dealing with it because I was trying 
to be strong for Mum and Dad…just you know, accept it, embrace it, because it 
doesn’t mean the end…and I then looked at it, you know, it was a new beginning for 
me and how I had to look at it. 
 
 
Semantic data: trying to be strong for others, delayed grieving, accepting the 
diagnosis, new beginnings 
 
 
Latent data: how others see me, maintaining independence, impact of RRMS on 
parenting, accepting gains, worry about being a burden to family, purposeful 
positivity, optimism, searching for meaning  
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Appendix 8 : Thematic map 
 
Thematic map development  
 
Theme example 1: Searching for answers (original title when still a candidate theme, 
later became Piecing Together the Puzzle)  
 
What’s going on            ➜         Lead up symptoms what could it be?  
 
↕ 
    
I need an answer 
 
↕ 
 
Seeing doctors ➜  brushed off, go away, nothing’s wrong with you  
 
↕ 
 
More doctors ➜ brushed off 
 
↕ 
 
Tests   
 
↕ 
 
More tests  ➜ No answers  ➜ I need an answer 
 
      
                    ➜Answers 
 
↕ 
 
Whose fault? 
➷ 
 I have a diagnosis 
 
↕ 
 
What now? 
 
➷ 
 
Is MS causing what I feel? 
 
➷ 
 
Triggers, reasons 
 
Who do I tell? And how?  
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Theme example 2: Imposter to the throne  (original title when still a candidate theme, 
later became High Invisibility)  
 
 
 
 
Quest to be normal 
This is good 
No-one can see, no-one suspects 
I don’t want to look disabled to others 
 
       ↕ 
Benefits- what’s good about invisible symptoms? 
Disclosure, keep secrets 
Normal- I look normal 
I can fit in better 
I’m in charge 
 
↕ 
 
Imposter to the throne 
Invisible symptoms 
Things you can’t see 
 
↕ 
 
The push/pull of symptoms- the good and the bad  
 
↕ 
 
What’s bad about invisible symptoms? 
 
Frustration 
Lack of understanding 
Relationship tolls 
Family burdens 
Hard to explain 
Brush-offs 
Centre of attention 
“imposter” 
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	 	 Appendix 9:PICF	
PARTICIPANT	INFORMATION	SHEET	
	
What	is	the	Experience	of	Living	with	Relapsing	Remitting	Multiple	
Sclerosis?	
	
Dear		
	
You	are	invited	to	participate	in	the	research	project	described	below.	
	
What	is	the	project	about?	
This	 research	 project	 will	 explore	 your	 experiences	 of	 living	 with	 Relapsing	 Remitting	
Multiple	 Sclerosis	 (RRMS)	 in	 today’s	 world.	 There	 have	 been	 many	 recent	 advances	 in	
RRMS	treatment	and	science	over	the	 last	decade,	but	very	 little	 information	for	Multiple	
Sclerosis	(MS)	Nurses	and	other	health	care	professionals	(HCPs)	working	in	the	field	of	MS,	
about	what	the	experience	of	living	with	MS	is	like	for	the	patient.	This	research	study	aims	
to	 understand	 your	 experiences	 and	 the	 impact	 that	 RRMS	 has	 on	 your	 life,	 with	 the	
ultimate	 goal	 of	 providing	 more	 individualised,	 holistic,	 patient	 focused	 care	 to	 people	
diagnosed	with	RRMS.	
By	sharing	your	experiences	of	living	with	RRMS,	you	may	be	helping	people	working	in	MS	
care	to	have	a	richer	understanding	of	what	it	feels	like	to	be	living	with	this	condition.		
	
Who	is	undertaking	the	project?	
This	project	is	being	conducted	by	Therese	Burke	and	will	form	the	basis	for	a	higher	degree	
by	research	at	The	University	of	Notre	Dame	Australia,	under	the	supervision	of	Associate	
Professor	 Tracey	 Moroney	 and	 Associate	 Professor	 Joanna	 Patching	 in	 the	 School	 of	
Nursing,	Sydney,	NSW.	
	
What	will	I	be	asked	to	do?	
If	you	consent	to	take	part	 in	this	research	study,	 it	 is	 important	that	you	understand	the	
purpose	of	 the	study	and	the	tasks	you	will	be	asked	to	complete.	Please	make	sure	that	
you	ask	any	questions	you	may	have,	and	 that	all	your	questions	have	been	answered	 to	
your	satisfaction	before	you	agree	to	participate.	
You	will	be	asked	to	participate	in	a	one-on-one	interview	with	the	researcher,	and	possibly	
further	 follow-up	 interviews	 or	 telephone	 interviews,	 if	 they	 are	 needed	 and	 if	 you	 are	
happy	 to	 participate	 further.	 One	 interview	 may	 provide	 enough	 information.	 The	
interview/s	will	be	audio	taped	to	assist	the	researcher	with	capturing	all	of	the	important	
information	you	provide	and	will	not	be	used	for	any	other	purpose.		It	is	anticipated	that	
the	 interview/s	 will	 take	 approximately	 1-2	 hours	 and	 will	 take	 place	 at	 a	 mutually	
convenient	location.	
The	question	you	will	be	asked	to	respond	to	will	revolve	around	the	experiences	you	have	
had	in	your	life	in	relation	to	living	with	RRMS	–	“What	is	the	Experience	of	Living	with	
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Relapsing	Remitting	Multiple	Sclerosis?”	You	will	be	provided	with	some	reflection	
questions	prior	to	the	interview	to	think	about	and	you	may	or	may	not	choose	to	use	them	
to	help	you	get	your	thoughts	in	order	prior	to	the	interview.	
There	will	be	no	reimbursement	to	you	for	taking	part	in	the	research	study.		
	
Are	there	any	risks	associated	with	participating	in	this	project?	
It	is	possible	that	you	may	experience	some	level	of	anxiety	or	distress	during	the	session	as	
a	result	of	talking	about	your	experiences	of	living	with	RRMS.	You	will	be	monitored	closely	
during	the	interview	and	you	are	free	to	withdraw	at	any	time	during	the	session,	or	to	stop	
the	 session	 to	 have	 a	 break	 at	 any	 time	 you	 need	 to.	 If	 these	 feelings	 persist	 after	 the	
completion	of	 the	session,	arrangements	will	be	made	 for	you	 to	access	 support	 from	an	
experienced	counselor	at	no	expense	to	you.	
	
What	are	the	benefits	of	the	research	project?	
There	may	be	no	immediate	benefits	to	you	by	taking	part	in	this	research	project.	General	
benefits	 to	 the	 wider	 MS	 community	 are	 not	 yet	 known,	 but	 may	 possibly	 include	 an	
improved	understanding	of	the	experiences	of	people	living	with	RRMS	to	others	in	the		MS	
community.	
	
What	if	I	change	my	mind?	
Participation	in	this	study	is	completely	voluntary.	Even	if	you	agree	to	participate,	you	can	
withdraw	from	the	study	at	any	time	without	discrimination	or	prejudice.	If	you	withdraw,	
all	 information	 you	 have	 provided	 will	 be	 erased	 and	 removed	 from	 the	 study	 findings	
where	 possible.	 You	may	 stop	 or	 suspend	 the	 interview	 at	 any	 time	 and	 for	 any	 reason.	
Withdrawal	 from	 the	 study	will	 not	 affect	 your	ongoing	 treatment	with	 your	MS	medical	
team	or	any	potential	future	care	from	the	researchers.	
	
Will	anyone	else	know	the	results	of	the	project?	
Information	gathered	about	you	will	be	held	in	strict	confidence.	This	confidence	will	only	
be	broken	if	required	by	law.	Only	the	researchers	will	have	access	to	your	data,	which	will	
be	coded	after	the	interview	to	remove	your	real	name	in	order	to	protect	your	identity.	All	
data	related	to	you	will	be	known	by	a	pseudonym	(a	pretend	name)	and	special	features	
about	your	case	that	may	identify	you	(such	as	suburb,	specific	occupation	and	the	like)	will	
be	generalised	so	that	you	cannot	be	individually	identified.	The	audiotapes	and	the	written	
data	(transcripts)	will	be	stored	securely	and	electronic	data	will	be	stored	on	a	password-
protected	computer	with	all	identifying	information	removed	(“de-identified”).	
Once	 the	 study	 is	 completed,	 the	 data	 collected	 from	 you	 will	 remain	 de-identified	 and	
stored	 securely	with	 the	 researcher	 for	 at	 least	 a	 period	 of	 fifteen	 years,	 as	 directed	 by	
current	 NSW	 laws.	 The	 results	 of	 the	 study	 will	 be	 published	 as	 a	 thesis,	 and	 for	 the	
purposes	of	education,	may	be	presented	in	the	form	of	journal	articles	and	presentations	
at	medical	and	nursing	educational	meetings	in	Australia	and	overseas.	Your	privacy	will	be	
protected	 by	 continuing	 use	 of	 the	 pseudonym	 and	 protection	 of	 your	 case	 features	
throughout	these	various	publications	and	presentations.	
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Will	I	be	able	to	find	out	the	results	of	the	project?	
Once	we	have	analysed	the	information	from	this	study,	the	researcher,	Therese	Burke,	will	
contact	 you	 by	mail	 or	 email	 with	 a	 summary	 of	 the	 study	 findings.	 	 You	 can	 expect	 to	
receive	 this	 feedback	 in	about	1-2	years.	 If	 you	do	not	wish	 to	 receive	 information	about	
the	study	findings,	please	let	the	researcher	know.	
	
Who	do	I	contact	if	I	have	questions	about	the	project?	
If	 you	 have	 any	 questions	 about	 this	 project	 please	 feel	 free	 to	 contact	 either	 the	
researcher,	 Therese	 Burke	 on	 phone	 number	 0412	 365	 667	 or	 email:	
therese.burke2@my.nd.edu.au	 or	 the	 study	 Supervisors,	 Associate	 Professor	 Tracey	
Moroney,	on	email	tracey.moroney@nd.edu.au	or	Associate	Professor	Joanna	Patching	on	
email	 joanna.patching@nd.edu.au.	 The	 researcher	 and	 	 Supervisors	 are	 happy	 to	 discuss	
with	you	any	concerns	you	may	have	about	this	study.		
	
What	if	I	have	a	concern	or	complaint?	
The	study	has	been	approved	by	the	Human	Research	Ethics	Committee	at	The	University	
of	Notre	Dame	Australia	 (approval	number	016002S).	 If	 you	have	a	 concern	or	 complaint	
regarding	 the	 ethical	 conduct	 of	 this	 research	 project	 and	 would	 like	 to	 speak	 to	 an	
independent	person,	 please	 contact	Notre	Dame’s	 Ethics	Officer	 at	 (+61	8)	 9433	0943	or	
research@nd.edu.au.	 	 Any	 complaint	 or	 concern	 will	 be	 treated	 in	 confidence	 and	 fully	
investigated.	You	will	be	informed	of	the	outcome.	
	
How	do	I	sign	up	to	participate?	
If	you	are	happy	to	participate,	please	sign	both	copies	of	the	consent	form,	keep	one	for	
yourself	and	mail	the	other	to	the	researcher	in	the	envelope	provided.	The	researcher	will	
then	contact	you	to	organise	further	details.	
	
Thank	you	for	your	time.	This	sheet	is	for	you	to	keep.	
	
Yours	sincerely,	
	
	
	
Therese	Burke	RN	CNC	MSCN	
	
	
Associate	Professor	Tracey	Moroney	
	
	
Associate	Professor		Joanna	Patching	
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CONSENT	FORM	
What	is	the	Experience	of	Living	with	Relapsing	Remitting	Multiple	
Sclerosis?	
• I	agree	to	take	part	in	this	research	project.	
• I	have	read	the	Information	Sheet	provided	and	been	given	a	full	explanation	of	the	purpose	of	this	study,	the	procedures	involved	and	of	what	is	expected	of	me.		
• I	 understand	 that	 I	 will	 be	 asked	 to	 attend	 an	 interview/s	 with	 the	researcher,	 Therese	 Burke,	 and	 I	 will	 be	 asked	 questions	 about	 my	experience	living	with	RRMS.	The	interview	will	be	audio-taped	only	for	the	purpose	 of	 the	 researcher	 transcribing	 the	 interview	 to	 analyse	 my	responses	to	better	understand	my	experiences.	
• The	 researcher	 has	 answered	 all	my	 questions	 and	 has	 explained	 possible	problems	that	may	arise	as	a	result	of	my	participation	in	this	study.	
• I	 understand	 that	 I	may	withdraw	 from	 participating	 in	 the	 project	 at	 any	time	without	prejudice.	
• I	 understand	 that	 all	 information	provided	by	me	 is	 treated	 as	 confidential	and	will	not	be	released	by	the	researcher	to	a	third	party	unless	required	to	do	so	by	law.		
• I	 agree	 that	 any	 research	 data	 gathered	 for	 the	 study	 may	 be	 published	provided	my	name	or	other	identifying	information	is	not	disclosed.	
• I	understand	that	research	data	gathered	may	be	used	for	future	research	but	
my	name	and	other	identifying	information	will	be	removed.		
• I	confirm	that	I	have	provided	the	Information	Sheet	concerning	this	research	project	to	the	above	participant,	explained	what	participating	involves	and	have	answered	all	questions	asked	of	me.		Signature	of	Researcher		
		 	Date	 	
 
	Name	of	participant	
	
			Signature	of	participant	
	
		 	Date	 	
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Appendix 10:Post interview care 
	
POST	INTERVIEW	CARE	
	
If	you	feel	any	distress	after	we	finish	the	
interview	and	you	would	like	to	talk	to	someone	
else	about	it,	please	let	me	know	on	the	contact	
details	listed	below.	I	can	put	you	in	touch	with	a	
counsellor	who	is	experienced	in	MS	care	or	refer	
you	to	a	psychologist	for	further	management.	
Alternatively	you	can	see	your	GP	to	discuss	
further	and	they	can	assess	to	see	if	you	would	
benefit	from	a	mental	health	care	plan.	
	
	
Therese	Burke	
	
Mobile:	0412	365	667	
	
Email:	therese.burke@sydney.edu.au	
	
	
	
	
If	you	feel	suicidal	or	extreme	distress,	please	
present	to	your	closest	emergency	department	for	
access	to	a	mental	health	emergency	team.	
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Appendix 11:Personal questions 	
Questions	to	ask	myself	and	comments	to	remind	myself	of,	prior	 to	
each	interview	
	
Before	interviews:	
	
1. How	am	I	presenting	myself	physically	to	the	study	participants?	
	
2. I	need	to	be	aware	of	my	tendency	to	problem	solve,	and	instead,	
just	 listen	 and	 let	 the	 study	 participant	 direct	 the	 interview.	
Probe	 when	 necessary	 to	 obtain	 more	 information	 or	 to	 delve	
deeper	about	living	with	RRMS.	
	
3. I	am	not	the	clinical	MS	Nurse	in	this	situation.	I	am	a	researcher	
listening	to	a	PwRRMS	describe	their	experiences	and	then	asking	
questions	 to	 better	 understand	 the	 lived	 experience	 of	 RRMS.	
That’s	it.	No	clinical	care.	
	
4. These	participants	are	not	my	friends	and	not	my	children.	 I	am	
empathic,	but	I	don’t	have	to	take	their	struggles	on	as	my	own.	I	
need	 to	 “feel”	 the	 data	 but	 not	 have	 it	 overtake	 my	 analysis	
emotionally.	 I	 need	 to	 firmly	 ground	 in	 the	 data.	 	 I	 have	 an	
important	job	to	do	for	the	participant	here.	
	
5. Don’t	 assume	 anything,	 always	 ask	 for	 clarification	 and	 further	
explanation	(if	and	when	appropriate).	
	
After	interviews:	
	
1. How	did	the	interview	proceed?	Was	there	a	natural	flow?	Did	I	
overtake	the	conversation	too	much?	
	
2. Was	 I	 able	 to	 step	 away	 from	 my	 clinical	 role	 and	 fulfill	 the	
position	of	researcher/listener?	
	
3. What	can	I	do	better	in	next	time?	
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Appendix 12 : Diary excerpt 
 
Diary excerpt from reflexive journal: Participant interview/feelings related 
 
 
Date: 27th May 2016, home NSW 
 
Context: I had just completed the interview and writing the field notes for participant 
number 3, Kate. 
 
Quote from diary: I had lots of feelings after this interview, which I just discussed 
with JP (Supervisor). I felt changed forever. I am not sure if this was in recognition 
of Kate’s work as a scientist and my “fan-like” view of her achievements or as a 
fellow mother with her absolute dedication to her career whilst still having a strong 
bond with her child. I felt I learnt life lessons from her in resilience, reaching for 
your dreams and pushing on. 
 
I felt sorry that she was clearly pushed out of her job when she had significant things 
to contribute. Did they base this decision on her physical disabilities and assume her 
mind was following? Did she display some cognitive signs not apparent to her, but to 
others? (I am recalling the literature and how PwRRMS may not read facial cues etc) 
Were there other, unrelated reasons?  
 
 
Diary excerpt from reflexive journal: Methodology/method related  
 
Date: 23rd June 2017, Balmoral NSW 
 
Context: Pondering nursing core values 
 
Quote from diary: “What is the essence of nursing? What makes us nurses? What 
makes us a “good” nurse and is a “good” nurse defined differently by other nurses 
than a patient would define a “good nurse”? 
What makes patient insights and understandings more valuable? 
Why should people care what a nurse thinks? 
Do patients care what we, as nurses, think? 
 
I downloaded 8-10 articles to review, looking at nursing, core values, social justice 
and the like to help me come up with a statement that I could use in my Methodology 
chapter- under nurses and ethnography/qualitative research.  
 
“This study is inspired by patient focused, holistic care and is rooted in the nursing 
values/core beliefs of honesty, empathy and understanding”. 
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Appendix 13:Life journey and themes 
13a. Margot’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
Child of a migrant family fleeing revolution 
Multicultural issues 
University graduate 
Two children 
Onset of first symptoms prior to 
diagnosis- injury from sudden fall 
Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
Symptoms remain and reinvestigated 
by GP 
Piecing Together the Puzzle (what’s happening?, tests, tests, 
tests) 
 Battling the Demons (fear, worry & anxiety) 
 Taming the Beast (support from family, friends and 
community) 
  
 High (In)visibility (strive to be visible) 
  
 Taming the Beast (support from family, friends and 
community) 
Confirmed diagnosis of RRMS Piecing Together the Puzzle (the day my life changed forever, 
vivid recall, relief, disclosing, with-holding disclosure) 
 Holding Hands with Hope (purposeful positivity, optimism) 
 Taming the Beast (support from family, friends and 
community, resilience) 
 Battling the Demons (fear, worry & anxiety) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy, working out work, losses & gains, parenting with 
RRMS) 
Commenced Betaferon® The DMT Dance (hardyards: decisions based on hope) 
 Taming the Beast (support from family, friends and 
community) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
Stopped Betaferon® commenced 
Tysabri® 
The DMT Dance (hardyards: decisions based on hope) 
 Taming the Beast (support from family, friends and 
community) 
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 Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, searching for meaning) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, negotiating normalcy) 
 Battling the Demons (all fears, worry & anxiety, uncertainty) 
 Piecing Together the Puzzle (with-holding disclosure) 
 Battling the Demons (fear of the wheelchair) 
Travelling around the world Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
 Re(defining) Me now that I have RRMS (normalcy) 
 Battling the Demons (fear of the wheelchair) 
Keeping RRMS secret from parents  Piecing Together the Puzzle (with-holding disclosure) 
 Battling the Demons (fear of the wheelchair) 
 Holding Hands with Hope (defiant hope, functional hope, 
search for meaning) 
 High (In)visibility (welcome cloak) 
Disclosing to parents Piecing Together the Puzzle (disclosure) 
 Holding Hands with Hope (defiant hope, functional hope, 
search for meaning) 
 Re(defining) Me now that I have RRMS (normalcy) 
 Battling the Demons (fear, worry, saboteurs, uncertainty) 
Struggling with disability and loss of 
mobility, carpark stories 
Re(defining) Me now that I have RRMS (normalcy, dare to 
compare, losses & gains) 
 Battling the Demons (fear of the wheelchair, worry, saboteurs, 
uncertainty, I’m never free, social isolation) 
 High (In)visibility (strive to be visible, reverse stigma) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness) 
Retiring from work  Re(defining) Me now that I have RRMS (normalcy, working 
out work, losses & gains) 
 Holding Hands with Hope (purposeful positivity, functional 
hope, search for meaning, sense of humour) 
Life gets busy living with RRMS  Re(defining) Me now that I have RRMS (normalcy, losses & 
gains, parenting with RRMS) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, sense of humour) 
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Surrendering to wheelchair when 
travelling or fatigued 
Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, losses & gains) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness, resileince) 
 Holding Hands with Hope (purposeful positivity, functional 
hope, search for meaning, sense of humour) 
Moving forward with RRMS  Taming the Beast (support from family, friends and 
community, maintaining health & wellness, resilience) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy) 
 Holding Hands with Hope (, purposeful positivity, optimism, 
sense of humour, giving back and getting involved) 
 
13b. Kate’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
Child of a migrant family 
Studying forensic work 
Working with sick children 
Married with a baby, working full time and studying 
Onset of first symptoms – sudden 
blindness 
Piecing Together the Puzzle (what’s happening? Tests tests 
tests) 
 High (In)visibility (strive to be visible) 
Told it could be a brain tumour Battling the Demons (fear, worry & anxiety, uncertainty) 
 Taming the Beast (support from family, friends and 
community) 
Not a brain tumour, but no other 
diagnosis - symptoms worsen- 
repeated episodes of blindness come 
and go over several years 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Piecing Together the Puzzle (what’s happening?)-repeated 
 Surplus Suffering (brushed off)- repeated 
 Piecing Together the Puzzle (tests, tests, tests)- repeated 
 High (In)visibility (strive to be visible) 
Consults a neurologist- it may be MS Piecing Together the Puzzle (the day my life changed forever) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Taming the Beast (support from family, friends and 
community) 
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 Surplus Suffering inflicted by clinical care and by brush-off 
Prescribed antidepressants “to get 
over it” 
Battling the Demons (worry & anxiety, depression & despair, 
fear of disability and the wheelchair) 
 Surplus Suffering inflicted by clinical care and by brush-off 
New specialist- works out possible 
connection between scar infection 
and symptoms- stop antidepressants, 
start treatment, still no confirmed 
diagnosis 
Piecing Together the Puzzle (what’s happening? Tests tests 
tests) 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Taming the Beast (getting a handle, choosing my A-Team, 
resilience) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, faith from mother) 
Infection scar extracted, thereafter a 
long period of remission 
Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
 Holding Hands with Hope (defiant hope, functional hope, 
search for meaning) 
Continuing to study, work, parent Battling the Demons (all fears, worry, uncertainty) 
 Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
Symptoms return, start methotrexate 
(unconventional treatment to 
suppress immune system) and many 
courses of steroids 
The DMT Dance (hardyards: decisions based on hope) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism) 
 Battling the Demons (all fears, worry & anxiety, uncertainty) 
  
First MRI to show active lesions, 
now confirmed diagnosis of RRMS, 
nondisclosure to son 
Piecing Together the Puzzle (the day my life changed forever, 
with-holding disclosure) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
negotiating normalcy, parenting with RRMS) 
 Battling the Demons (fear of burden, worry & anxiety, fear of 
the wheelchair) 
 Holding Hands with Hope (restorative hope, purposeful 
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positivity- searching for meaning) 
 The DMT Dance (hardyards: decisions based on hope) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, negotiating normalcy) 
 Battling the Demons (all fears, worry & anxiety, despair, 
uncertainty) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on hope) 
 Battling the Demons (fear of the wheelchair) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, getting a handle, resilience) 
Chance opportunity to meet initial 
neurologist and cause of Surplus 
Suffering 
High (In)visibility (strive to be visible) 
 Holding Hands with Hope (defiant hope, search for meaning) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
 Taming the Beast (finding my North Star) 
 Battling the Demons (fear, despair, saboteurs) 
Commence new DMT Betaferon® 
when it comes onto the Australian 
market 
The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
 Holding Hands with Hope (purposeful positivity, restorative 
hope, functional hope, defiant hope, search for meaning) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, choosing my A-
Team) 
Struggling with side effects 
Betaferon®  
Piecing Together the Puzzle (what’s happening?) 
 Holding Hands with Hope (defiant hope, functional hope, 
search for meaning) 
 High (In)visibility (strive to be visible) 
Decision to stop all DMT Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, choosing my A-
Team) 
 Battling the Demons (despair, uncertainty, social isolation, 
I’m never free) 
 Holding Hands with Hope (defiant hope, search for meaning) 
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Referral to new neurologist, 
commence Copaxone® 
The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Holding Hands with Hope (purposeful positivity, restorative 
hope, functional hope, defiant hope, search for meaning) 
 Battling the Demons (uncertainty, I’m never free) 
Still relapsing regularly on treatment  Battling the Demons (all fears, worry & anxiety, despair, I’m 
never free, uncertainty) 
 Taming the Beast (getting a handle on RRMS, maintaining 
health & wellness) 
Change to Rebif® when it comes 
onto the Australian market 
The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Holding Hands with Hope (purposeful positivity, restorative 
hope, functional hope, defiant hope, search for meaning) 
Rebif® side effects unbearable but 
continues treatment and tries to hide 
symptoms 
Battling the Demons (uncertainty, I’m never free) 
 High (In)visibility (welcome cloak) 
 Holding Hands with Hope (purposeful positivity, optimism) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, parenting with RRMS) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness) 
Decision to stop Rebif®  Battling the Demons (all fears, worry & anxiety, saboteurs) 
 Re(defining) Me now that I have RRMS (normalcy, parenting 
with RRMS, losses & gains) 
Tysabri® opportunity  Holding Hands with Hope (purposeful positivity, optimism, 
restorative hope, functional hope) 
 Re(defining) Me now that I have RRMS (normalcy, parenting 
with RRMS, losses & gains) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
Anaphylaxis to Tysabri®  Battling the Demons (all fears, worry & anxiety, despair, I’m 
never free) 
 Re(defining) Me now that I have RRMS (normalcy, losses & 
gains) 
Volunteers for research trial- back to Holding Hands with Hope (purposeful positivity, defiant 
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interferon treatment Betaferon® hope, search for meaning, giving back & getting involved) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, choosing my A-Team) 
Remission from relapses for four 
years 
Holding Hands with Hope (purposeful positivity, defiant 
hope) 
 Re(defining) Me now that I have RRMS (normalcy, parenting 
with RRMS, losses & gains) 
Fall and injury: mobility affected Battling the Demons (all fears, worry & anxiety, despair, I’m 
never free) 
 Re(defining) Me now that I have RRMS (normalcy, losses & 
gains) 
 Taming the Beast (support from family, friends and 
community, finding my North Star) 
Faces losing career &  employment: 
symptoms from fall and MS make 
work difficult and then employer 
makes the decision and stops 
funding 
Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness) 
 Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, losses & gains) 
 Battling the Demons (all fears, worry, despair, I’m never free, 
uncertainty, social isolation) 
Living in forced retirement and 
coping with RRMS, now on 
Gilenya® as DMT  
Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, sense of humour) 
 Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, parenting with RRMS, losses & gains) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, choosing my A-Team) 
Advocates for others with MS  Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, sense of humour, giving back & 
getting involved) 
 Taming the Beast (finding my North Star) 
 Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, losses & gains) 
 
13c. Rudi’s life journey reflecting the study themes and subthemes 
	 471	
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• Tumultuous childhood 
• Mother lives with bipolar disorder 
• Rebellious teens 
• Small rural community upbringing 
• Stillbirth of her third son at full-term 
Onset of first symptoms Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
Symptoms worsen Piecing Together the Puzzle (what’s happening?) 
 Surplus Suffering (brushed off, misdiagnosis) 
 Piecing Together the Puzzle (tests, tests, tests) 
 Battling the Demons (fear, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity) 
Hospitalised into intensive care Battling the Demons (all fears, worry & anxiety, despair, 
uncertainty) 
 Piecing Together the Puzzle (what’s happening? tests, tests, 
tests) 
Confirmed diagnosis of RRMS after 
waiting for several weeks 
Piecing Together the Puzzle (the day my life changed forever) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
 Battling the Demons (fear of burden, worry & anxiety) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare, normalcy) 
 Battling the Demons (all fears, worry & anxiety, despair) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on hope) 
 Battling the Demons (fear of the wheelchair) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, search for meaning) 
 Taming the Beast (support from family, friends and 
community, resilience, choosing my A-Team, finding my 
North Star) 
Severe relapse Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (fear, worry & anxiety, saboteurs: social 
isolation, uncertainty) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on fear and 
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hope) 
Recovery from relapse Taming the Beast (support from family, friends and 
community, resilience) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare) 
Relapse Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (all fears, worry & anxiety, uncertainty, 
parenting with RRMS) 
 The DMT Dance (decisions based on fear and hope) 
 Re(defining) Me now that I have RRMS (working out work) 
Anxiety in children, especially 
daughter 
Battling the Demons (all fears, worry & anxiety, uncertainty, 
parenting with RRMS) 
 Taming the Beast (support from family, friends and 
community, resilience, choosing my A-Team) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, search for meaning) 
MS condition worsens and advised 
to stop working to recover 
Re(defining) Me now that I have RRMS  (working out work, 
normalcy, balancing losses & gains)  
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, finding my A-Team) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, restorative hope) 
 Battling the Demons (fear of being a burden, fear of the 
wheelchair) 
 The DMT Dance (hardyards: decisions based on fear and 
hope) 
Start Gilenya® The DMT Dance: switching to a better life) 
 Taming the Beast (resilience) 
Stop Gilenya® due to skin cancers 
developing  
The DMT Dance (hardyards: decisions based on fear) 
 Holding Hands with Hope (purposeful positivity) 
 The DMT Dance (decisions based on fear) 
 Taming the Beast (resilience, maintaining health & wellness) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains) 
 Battling the Demons (fear, worry, I’m never free) 
Starts travelling, trips away, playing 
sport 
Taming the Beast (resilience, maintaining health & wellness, 
finding my North Star) 
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 Holding Hands with Hope (purposeful positivity, optimism) 
Life parenting with RRMS Taming the Beast (support from family, friends and 
community) 
 Holding Hands with Hope (purposeful positivity, optimism, 
harnessing sense of humour) 
 Battling the Demons (fear of being a burden, worry) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, parenting with RRMS, working out work) 
Change of DMT to Tecfidera® The DMT Dance (hardyards: decisions based on fear & hope) 
 Holding Hands with Hope (purposeful positivity, optimism) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
Further severe relapse Piecing Together the Puzzle (what’s happening? tests, tests, 
tests) 
 Battling the Demons (fear of being a burden, worry, I’m never 
free, uncertainty) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness) 
 The DMT Dance (hardyards: decisions based on fear & hope) 
Trying to regain a sense of self Holding Hands with Hope (purposeful positivity, optimism, 
giving back & getting involved, functional hope, restorative 
hope, defiant hope) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness, resilience) 
 
13d. Joy’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• Neglect as a child 
• Constant illness and pain as a child and teen 
• Married and baby at 18 years of age 
• Divorced twice, two children 
• Multiple life challenges 
• Raised in a small rural town 
Onset of first neurological symptoms 
– dyslexia at age 16 
Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
Ignored, brushed off by family and 
school 
Battling the Demons (fear, worry, despair uncertainty) 
 Piecing Together the Puzzle (what’s happening?)-repeated 
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 Surplus Suffering (brushed off)- repeated 
 High (In)visibility (strive to be visible) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, faith) 
Drop out from school, pregnant the 
next year, married at age 18 
Surplus Suffering (brushed off) 
 Battling the Demons (fear, worry, despair uncertainty) 
 High Invisibility (strive to be visible) 
Sudden episode of intermittent 
blindness 
Battling the Demons (fear, worry, despair uncertainty) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
 Piecing Together the Puzzle (what’s happening?)-repeated 
Difficult birth, further symptoms not 
investigated 
Surplus Suffering (brushed off) 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Taming the Beast (resilience) 
(Non related to RRMS) post partum 
complications 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
  
Sudden onset deafness Surplus Suffering (brushed off) 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Piecing Together the Puzzle (what’s happening?)-repeated 
Sudden onset leg weakness Surplus Suffering (brushed off) 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
Marriage breakdown  Battling the Demons (worry, despair, uncertainty, social 
isolation) 
New relationship begins, intermittent 
neurological symptoms persist 
Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, faith from mother) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
 Taming the Beast (support from family, friends and 
community, resilience) 
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Second child arrives, breakdown of 
relationship ensues 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, faith) 
Remission from neurological 
symptoms, only fatigue remained 
Taming the Beast (getting a handle, resilience) 
 Holding Hands with Hope (purposeful positivity, optimism, 
faith) 
 Battling the Demons (uncertainty) 
Symptoms, nerve pain returns with a 
vengeance  
Piecing Together the Puzzle (what’s happening?)-repeated 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
Begins relationship with and marries 
a HCP who organises referral to a 
neurologist 
Piecing Together the Puzzle (what’s happening; tests, tests, 
tests) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
Diagnosed formally with RRMS  Piecing Together the Puzzle (the day my life changes forever; 
relief at the diagnosis, vivid recall) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy, parenting with RRMS, losses & gains, working out 
work) 
Begins treatment for nerve pain and 
also DMT glatiramer acetate  
Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, faith) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, getting a handle, resilience) 
 High (In)visibility (strive to be visible) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty, I’m never free) 
 The DMT Dance (hardyards: decisions based on hope) 
Husband becomes abusive, won’t 
allow sick-leave with relapse, forces 
medication overdosage and toxicity  
Battling the Demons (fear, worry, despair, uncertainty, I’m 
never free, social isolation) 
 Surplus Suffering (inflicted by family) 
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 Re(defining) Me now that I have RRMS (normalcy, losses & 
gains, working out work) 
Husband dies, collapsing on top of 
her and trapping Joy, she 
survives…Joy decides to take 
control 
Holding Hands with Hope (restorative hope, functional hope, 
defiant hope, purposeful positivity, optimism, faith, search for 
meaning) 
 Battling the Demons (all fears, worry & anxiety, uncertainty) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, negotiating normalcy) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, getting a handle, resilience) 
Sees a new neurologist  Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism) 
 Re(defining) Me now that I have RRMS (dare to compare) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness, choosing my A-
Team) 
Diagnosed with co-morbidity 
complex partial epilepsy, neurologist 
unsure of cross-over between the 
two neurological diseases, begins 
treatment but remains off DMT since 
Copaxone by choice 
Piecing Together the Puzzle (the day my life changes forever; 
relief at the diagnosis, vivid recall) 
 Battling the Demons (fear of burden, worry & anxiety, fear of 
the wheelchair) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, negotiating normalcy) 
 Holding Hands with Hope (restorative hope, functional hope, 
defiant hope, purposeful positivity, optimism, search for 
meaning) 
Offered Tysabri® DMT by 
neurologist but politely refuses 
The DMT Dance (hardyards: decisions based on hope; 
switching to a better life) 
 Battling the Demons (fear of burden, worry) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, searching for meaning, faith) 
Begins to improve, remission from 
relapses, travels overseas for the first 
time 
Re(defining) Me now that I have RRMS (dare to compare, 
normalcy) 
 Taming the Beast (support from family, friends and 
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community, finding my North Star, maintaining health & 
wellness, getting a handle, resilience) 
 Battling the Demons (uncertainty) 
Gains employment in a 
community/counselling 
environment, and thrives 
Taming the Beast (support from family, friends and 
community, finding my North Star, resilience, choosing my 
A-Team) 
 Holding Hands with Hope (defiant hope, search for meaning) 
 Re(defining) Me now that I have RRMS (normalcy, working 
out work, losses & gains) 
 High (In)visibility (welcome cloak) 
Neurologist retires, new young 
neurologist takes an interest in the 
case and revisiting investigations  
Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, losses & gains) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, choosing my A-Team) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, sense of humour, giving back & 
getting involved) 
Advocates for others with MS, 
thriving being a grandmother, 
working and living well with RRMS 
Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, sense of humour, giving back & 
getting involved) 
 Taming the Beast (finding my North Star) 
 Re(defining) Me now that I have RRMS ( normalcy, losses & 
gains) 
 
13e. Jane’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• University degree 
• Very active and fit 
• Unmarried 
• World traveller, remote locations, adventurer 
• Works in education 
• No prior medical conditions 
Onset of first symptoms  – visual 
disturbance and headache 
Piecing Together the Puzzle (what’s happening? Tests, tests, 
tests) 
 Battling the Demons (fear) 
Told possible brain tumour Piecing Together the Puzzle (what’s happening? Tests, tests, 
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tests) 
 Surplus Suffering (misdiagnosis) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Taming the Beast (maintaining health & wellness) 
No diagnosis, continues on with 
intermittent symptoms 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
New symptoms- referral to 
neurologist   
Piecing together the Puzzle (what’s happening? Tests, tests, 
tests) 
 Taming the Beast (support from family, friends and 
community, choosing my A-Team) 
 High (In)visibility (strive to make visible) 
Diagnosis of RRMS  Piecing Together the Puzzle (the day my life changed forever, 
relief at diagnosis, disclosure, with-hold disclosure) 
 Battling the Demons (fear of wheelchair, fear of disability, 
worry & anxiety) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
working out work, normalcy) 
Decision not to have DMT at first  Re(defining) Me now that I have RRMS (getting acquainted, 
working out work, dare to compare, normalcy, ) 
 Battling the Demons (all fears, worry & anxiety) 
 High (In)visibility (welcome cloak, hide) 
Living well with RRMS, raising 
money for MS research 
Battling the Demons (uncertainty) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
working out work, normalcy) 
 High (In)visibility (welcome cloak, hide) 
 Holding Hands with Hope (defiant hope, giving back & 
getting involved) 
Inconsideration by MS event 
organisers 
Surplus Suffering (inflicted by community) 
 High (In)visibility (strive to make visible) 
 Piecing together the Puzzle (what’s happening?) 
Going to MSL groups to meet others 
living with MS 
Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare, normalcy) 
 Holding Hands with Hope (defiant hope, giving back & 
getting involved) 
 Taming the Beast (finding my North Star, choosing my A-
Team) 
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 Battling the Demons (fear of disability, of the wheelchair, 
worry, despair, uncertainty) 
 High (In)visibility (strive to make visible) 
Further relapses, decision to start 
Rebif® 
The DMT Dance (hardyards: decisions based on hope) 
 Holding Hands with Hope (restorative hope, restorative hope) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, choosing my A-Team) 
 High (In)visibility (welcome cloak, hide) 
Continuing to work, not disclosing 
diagnosis 
Piecing Together the Puzzle (with-hold disclosure) 
 Battling the Demons (worry, uncertainty) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness) 
 High (In)visibility (welcome cloak, hide) 
Issues taking DMT Rebif® Re(defining) Me now that I have RRMS (working out work, 
losses & gains) 
 Battling the Demons (worry & anxiety, despair, uncertainty, 
social isolation) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
Change to Gilenya® Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, optimism) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 High (In)visibility (welcome cloak, hide) 
 Re(defining) Me now that I have RRMS, losses & gains, 
normalcy) 
Masters degree at university Holding Hands with Hope (purposeful positivity, defiant 
hope, optimism) 
 Re(defining) Me now that I have RRMS, losses & gains, 
normalcy) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, resilience) 
Fear of losing contract at work is 
RRMS disclosed  
Battling the Demons  (worry & anxiety, I’m never free, 
uncertainty) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, dare to compare, normalcy) 
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Belief in future living with RRMS  Holding Hands with Hope (purposeful positivity, curative 
hope, searching for meaning) 
 High (In)visibility (welcome cloak, hide) 
 Re(defining) Me now that I have RRMS ( normalcy, working 
out work, losses and gains) 
 Taming the Beast (resilience, getting a handle, finding my 
North Star, choosing my A-Team, support from family, 
friends and community, health & wellness) 
 
13f. Paul’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• University degree 
• Very active and fit 
• Unmarried 
• World traveller, remote locations, adventurer 
• Works in education 
Onset of first symptoms five years 
before diagnosis – optic neuritis 
Piecing Together the Puzzle (what’s happening? Tests, tests, 
tests) 
 Battling the Demons (fear) 
 High (In)visibility (welcome cloak, hide) 
 Surplus Suffering (misdiagnosis, brushed off) 
Living well, no symptoms  Taming the Beast (maintaining health & wellness) 
Two years later neck senstaions– in 
hindsight, L’hermittes  
Piecing Together the Puzzle (what’s happening? Tests, tests, 
tests) 
 High (In)visibility (strive to make visible, welcome cloak, 
hide) 
 Surplus Suffering (misdiagnosis, brushed off) 
Onset cognitive “cloud” High (In)visibility (strive to make visible) 
 Battling the Demons (all fears, worry & anxiety) 
 Taming the Beast (support from family, friends and 
community, choosing my A-Team) 
GP refers to a neurologist Piecing Together the Puzzle (what’s happening?, 
Tests,tests,tests) 
 Battling the Demons (all fears, worry & anxiety) 
 High (In)visibility (strive to make visible) 
Diagnosis of RRMS and referred to 
another neurologist with more MS 
experience, awaiting appointment 
Piecing Together the Puzzle (the day my life changed forever, 
with-hold disclosure) 
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 High Invisibility (welcome cloak, hide) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
working out work, dare to compare, normalcy, parenting with 
RRMS) 
 Battling the Demons (fear of burden, worry & anxiety, 
despair, saboteurs, uncertainty) 
Panic attack shortly after diagnosis, 
new symptoms  
Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (worry & anxiety, despair, uncertainty) 
 Re(defining) Me now that I have RRMS (knowledge, dare to 
compare) 
Coincidental meeting with third 
neurologist- unsure of role- enters 
clinical trial without explanation, 
starts fingolimod  
Surplus Suffering (inflicted by research care, brushed off) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
 Piecing Together the Puzzle (what’s happening?) 
Learning to live with RRMS Battling the Demons (all fears, worry & anxiety, depression & 
despair, uncertainty) 
 High (In)visibility (welcome cloak, hide) 
 The DMT Dance (hardyards: decisions based on hope) 
 Holding Hands with Hope (defiant hope, giving back & 
getting involved) 
 Taming the Beast (finding my North Star, choosing my A-
Team) 
 Piecing Together the Puzzle (with-hold disclosure) 
Meets new neurologist, life turns, 
confidence rises 
Holding Hands with Hope (defiant hope, restorative hope) 
 The DMT Dance (hardyards: decisions based on hope) 
 Taming the Beast (Finding my North Star, my A-Team) 
 High (In)visibility (welcome cloak, hide) 
Well and relapse free on fingolimod Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, choosing my A-Team) 
 Piecing Together the Puzzle (with-hold disclosure) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, curative hope searching for meaning) 
 Re(defining) Me now that I have RRMS (working out work, 
parenting with RRMS balancing losses & gains) 
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MSA meetings and meeting others 
with MS- confronting, chooses never 
to do this again 
Battling the Demons (fear of disability, of the wheelchair, 
worry & anxiety, despair, uncertainty, social isolation) 
 Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star) 
 High (In)visibility (welcome cloak, hide) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, curative hope) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, dare to compare, normalcy) 
Constant research and reading – I 
want a more efficacious treatment  
Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, curative hope, optimism, searching for 
meaning) 
 Re(defining) Me now that I have RRMS, losses & gains, dare 
to compare, normalcy, parenting with RRMS) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Battling the Demons (fear, worry & anxiety) 
 Taming the Beast (resilience, choosing my A-Team) 
New MRI lesion- radiological 
relapse  
Battling the Demons (fear of the wheelchair & disability, 
worry & anxiety, I’m never free, uncertainty) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, dare to compare, normalcy) 
 Piecing Together the Puzzle (what’s happening?) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 High (In)visibility (welcome cloak, hide) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, searching for meaning) 
Fighting on, awaiting appointment 
with a new neurologist to hopefully 
escalate treatment (his current 
neurologist prefers not to)  
The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Re(defining) Me now that I have RRMS (negotiating 
normalcy, disability and independence, working out work, 
balancing losses and gains, parenting with RRMS) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, curative hope, optimism, searching for 
meaning) 
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 Taming the Beast (resilience, getting a handle, finding my 
North Star, choosing my A-Team) 
 
13g. Ruby’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• Child of a migrant family 
• University degree 
• Long distance relationship 
• Working in education 
• Married with two children, working full time 
Onset of first symptoms  Piecing Together the Puzzle (what’s happening? Tests tests 
tests) 
 Surplus Suffering (brushed off) 
 Battling the Demons (fear, worry & anxiety, uncertainty) 
Consults a neurologist- it may be MS 
but not conclusive, told not to worry 
and to go away and have a family 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Piecing Together the Puzzle (what’s happening?) 
 Surplus Suffering (brushed off) 
Has two children, continues to work Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism, defiant hope) 
 Re(defining) Me now that I have (may have) RRMS (dare to 
compare, parenting with RRMS, normalcy) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
Severe relapse – reported to 
neurologist by phone and posted a 
prescription for steroids, no 
consultation  
Surplus Suffering (brushed off) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
I can’t pick up my baby Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, normalcy) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
Referral to new neurologist and MS 
Clinic  
Piecing Together the Puzzle (tests, tests, tests, the day my life 
changed forever) 
 Battling the Demons (fear, worry & anxiety, despair, 
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uncertainty I’m never free) 
 Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, normalcy, working out work, getting 
acquainted) 
 The DMT Dance (hardyards: decisions based on hope) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism) 
Commenced Tysabri® The DMT Dance (hardyards: decisions based on hope) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty) 
 Holding Hands with Hope (restorative hope, purposeful 
positivity, optimism) 
 Taming the Beast (getting a handle, choosing my A-Team, 
resilience) 
 Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, getting acquainted) 
Continues to worsen on Tysabri® 
and now losing ambulatory function 
Battling the Demons (fear, worry & anxiety, despair, 
uncertainty, social isolation, I’m never free) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, normalcy, working out work, getting 
acquainted) 
 Piecing Together the Puzzle (what’s happening?) 
Continuing to work, parent Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
 The DMT Dance (hardyards: decisions based on hope) 
 Battling the Demons (fears, worry, uncertainty) 
Decision to stop Tysabri® and 
change to Lemtrada® - guilt from 
not starting Lemtrada® earlier 
The DMT Dance (hardyards: decisions based on fear, 
switching to a better life) 
 Battling the Demons (fear, worry & anxiety, despair, 
uncertainty, I’m never free) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, normalcy, getting acquainted) 
 Taming the Beast (finding my North Star, getting a handle, 
resilience) 
 Holding Hands with Hope (restorative hope, functional hope, 
purposeful positivity, optimism) 
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 Piecing Together the Puzzle (what’s happening?) 
Fall at work in front of others Re(defining) Me now that I have RRMS (dare to compare, 
working out work, normalcy) 
 Piecing Together the Puzzle (what’s happening?) 
 Battling the Demons (fear, uncertainty, I’m never free) 
Life in limbo awaiting to see if 
Lemtrada® has been effective 
Piecing Together the Puzzle (what’s happening?) 
 Re(defining) Me now that I have RRMS (dare to compare, 
parenting with RRMS, normalcy, working out work) 
 Battling the Demons (all fears, worry & anxiety, despair, 
uncertainty, I’m never free) 
 Holding Hands with Hope (defiant hope, restorative hope, 
functional hope, defiant hope, search for meaning) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, getting a handle, choosing my A-Team, resilience) 
 The DMT Dance (hardyards: decisions based on hope) 
Decision to work part-time next year 
and concentrate of regaining strength 
and adoring her children  
Holding Hands with Hope (defiant hope, restorative hope, 
functional hope, defiant hope, search for meaning) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, getting a handle, resilience) 
 
13h. Davina’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• Felt vulnerable with father growing up (bullied), felt 
isolated 
• Unwell often as a child 
• Physically and emotionally demanding employment 
• Working in healthcare 
• Marries early at 20 years of age 
Onset of first symptoms – visual 
disturbances – brushed off by GP 
Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
 Battling the Demons (fear, worry & anxiety) 
Symptoms worsen – sees a different Piecing Together the Puzzle (what’s happening?, tests, tests, 
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GP tests) 
 Surplus Suffering (brushed off) 
 Holding Hands with Hope (purposeful positivity) 
 Battling the Demons (all fears (uncle with MS), worry & 
anxiety) 
Further relapse- sudden and severe - 
hospitalised, it could be MS 
Surplus Suffering (inflicted by clinical care) 
 Battling the Demons (all fears, worry & anxiety, depression & 
despair, uncertainty, social isolation) 
 Holding Hands with Hope (purposeful positivity) 
Confirmed diagnosis of RRMS – 
traumatic diagnosis delivery 
Piecing Together the Puzzle (the day my life changed forever) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy, working our work, dare to compare) 
 Battling the Demons (fear of burden, wheelchair, disability) 
 Surplus Suffering (inflicted by clinical care) 
Learning to live with RRMS Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare, parenting with RRMS) 
 Battling the Demons (all fears, worry & anxiety, despair) 
 High (In)visibility (strive to be visible) 
Changes neurologist Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, finding my A-Team) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
dare to compare, normalcy) 
Regaining control, starting family Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, search for meaning) 
 Re(defining) Me now that I have RRMS (working out work) 
 Taming the Beast (support from family (mother only) friends 
and community) 
 Battling the Demons (all fears, worry & anxiety) 
 High (In)visibility (strive to be visible) 
Further relapses and temporary loss 
of function managing a young 
family of four children including 
newborn twins  
Taming the Beast (support from family (mother only) friends 
and community, resilience, finding my North Star, choosing 
my A-Team) 
 Battling the Demons (all fears, worry & anxiety, uncertainty, 
I’m never free, social isolation) 
 Piecing Together the Puzzle (what’s happening?) 
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 High (In)visibility (strive to be visible) 
Starts interferon Avonex® when 
released onto Australian market, 
continues many years 
The DMT Dance (hardyards: decisions based on hope) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, parenting with RRMS) 
 Battling the Demons (all fears, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, restorative hope, optimism) 
Continues on managing family and 
worklife through several relapses 
Taming the Beast (support from family, friends and 
community, getting a handle on RRMS, finding my North 
Star, maintaining health & wellness, finding my A-Team) 
 Holding Hands with Hope (purposeful positivity, defiant 
hope, functional hope, restorative hope, optimism) 
 Battling the Demons (all fears, worry & anxiety) 
 High (In)visibility (strive to be visible) 
Death of much loved and supportive 
mother 
Battling the Demons (all fears, worry, depression & despair, 
uncertainty) 
 Re(defining) Me now that I have RRMS (balancing losses & 
gains, normalcy, parenting with RRMS) 
 Holding Hands with Hope (purposeful positivity) 
 Taming the Beast (resilience) 
Seeks help from a psychologist, 
diagnosed with depression, refuses 
medication but accepts counselling 
Battling the Demons (all fears, worry, depression & despair, 
uncertainty, I’m never free) 
 Holding Hands with Hope (purposeful positivity, optimism) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, choosing my A-Team) 
Leaves marriage Battling the Demons (all fears, worry, depression & despair, 
uncertainty) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, choosing my A-Team) 
 Holding Hands with Hope (purposeful positivity, optimism, 
faith, sense of humour) 
Meets new life partner, feels loved, 
supported 
Children grown up and moved on 
Taming the Beast (support from family, friends and 
community, finding my North Star, maintaining health & 
wellness, choosing my A-Team) 
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 Holding Hands with Hope (purposeful positivity, optimism, 
defiant hope) 
 Battling the Demons (fear of being a burden) 
Lack of support from family with 
new life 
Re(defining) Me now that I have RRMS (balancing losses & 
gains, parenting with RRMS) 
 Battling the Demons (all fears, worry, depression & despair, 
uncertainty) 
 Holding Hands with Hope (purposeful positivity, optimism, 
defiant hope) 
Change of DMT to Gilenya® The DMT Dance (decisions based on fear & hope) 
 Holding Hands with Hope (purposeful positivity, optimism, 
restorative hope) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
 Battling the Demons (all fears, worry & anxiety) 
 Holding Hands with Hope (purposeful positivity, optimism, 
defiant hope) 
 Taming the Beast (support from family, friends and 
community, resilience) 
Life settles with RRMS- current 
status quo 
Holding Hands with Hope (optimism, giving back and getting 
involved, faith) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness, finding my North 
Star) 
 
13i. Evie’s life journey reflecting the study themes and subthemes 
 
Life events Links to study findings: themes and subthemes 
Earlier life story: major life events 
and clues to resilience 
• Significant childhood illness 
• Felt bullied at primary school, ”left out” 
• Alcoholic, abusive father, loving and supportive 
mother 
• Later parental divorce 
• Estranged from only sibling 
• Same sex relationships 
• (Secretive) government career 
Onset of first symptoms at 18 years 
of age 
Piecing Together the Puzzle (what’s happening?) 
 High (In)visibility (strive to be visible) 
 Surplus Suffering (brushed off) 
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Symptoms worsen – still no 
diagnosis 
Piecing Together the Puzzle (what’s happening?, tests, tests, 
tests) 
 Battling the Demons (fear, worry) 
 High (In)visibility (strive to be visible) 
 Taming the Beast (resilience) 
Finally after two years, MRI 
confirms RRMS 
Piecing Together the Puzzle (the day my life changed forever) 
 Holding Hands with Hope (purposeful positivity, optimism) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
negotiating normalcy) 
 Taming the Beast (choosing my A-Team) 
Accepted diagnosis, moving on, but 
those around fall apart  
Piecing Together the Puzzle (what’s happening?) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
negotiating normalcy) 
 Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
I don’t jump in, I choose to be 
positive  
Holding Hands with Hope (purposeful positivity, optimism, 
defiant hope, sense of humour, spirituality, searching for 
meaning) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
negotiating normalcy, working out work, losses & gains) 
 High (In)visibility (welcome cloak) 
Commences interferon Rebif® The DMT Dance (hardyards: decisions based on hope) 
 Battling the Demons (fear, worry) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
losses & gains) 
 Holding Hands with Hope (restorative hope, functional hope, 
purposeful positivity, optimism) 
Intolerable side effects from Rebif®, 
missed doses and then cease 
medication altogether 
Battling the Demons (worry, uncertainty) 
 Re(defining) Me now that I have RRMS (normalcy) 
 High (In)visibility (strive to be visible) 
Relapses increase The DMT Dance (hardyards: decisions based on hope) 
 Re(defining) Me now that I have RRMS (dare to compare, 
normalcy, getting acquainted) 
 Battling the Demons (all fears, worry, I’m never free, 
uncertainty) 
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Constant life stressors persist Battling the Demons (all fears, worry, despair, uncertainty) 
 High (In)visibility (strive to be visible) 
 Taming the Beast (finding my North Star, maintaining health 
& wellness, getting a handle, resilience) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy) 
 Holding Hands with Hope (defiant hope, search for meaning, 
spirituality) 
Commences Betaferon® Battling the Demons (all fears, worry, uncertainty) 
 Holding Hands with Hope (defiant hope, functional hope) 
 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
Enjoying career but previous 
disclosure at work induces collision 
between work and personal space 
Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy, working put work, dare to compare, losses & gains) 
 High (In)visibility (welcome cloak) 
Further relapses, change of treatment 
to Tysabri®, remains relapse free 
and well for several years 
The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Holding Hands with Hope (defiant hope, functional hope, 
restorative hope) 
 Taming the Beast (support from family, friends and 
community, finding my North Star, choosing my A-Team) 
 Re(defining) Me now that I have RRMS (getting acquainted) 
JCV blood tests positive high titre- 
ceases Tysabri® immediately 
The DMT Dance (hardyards: decisions based on fear)  
 Battling the Demons (fear, worry, I’m never free, uncertainty) 
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness) 
Commences Tecfidera® The DMT Dance (hardyards: decisions based on hope, 
switching to a better (safer) life))  
 Re(defining) Me now that I have RRMS (normalcy) 
 Battling the Demons (all fears, worry & anxiety, uncertainty) 
Side effects from Tecfidera® – cease  The DMT Dance (hardyards: decisions based on hope, 
switching to a better (safer) life))  
 Taming the Beast (getting a handle on RRMS, finding my 
North Star, maintaining health & wellness) 
Decision to commence Lemtrada® Holding Hands with Hope (purposeful positivity, defiant 
hope, search for meaning, spirituality) 
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 The DMT Dance (hardyards: decisions based on hope, 
switching to a better life) 
 Taming the Beast (support from family, friends and 
community, maintaining health & wellness, resilience) 
 Re(defining) Me now that I have RRMS (losses & gains) 
 Battling the Demons (all fears, worry, uncertainty) 
Relationship breakdown with partner 
– RRMS blamed by partner 
Battling the Demons (all fears, uncertainty) 
 Piecing Together the Puzzle (what’s happening?) 
 Re(defining) Me now that I have RRMS (losses & gains, 
normalcy) 
 High (In)visibility (strive to be visible) 
 The DMT Dance (hardyards: decisions based on hope) 
 Taming the Beast (support from family, friends & community, 
resilience) 
  
 Holding Hands with Hope (purposeful positivity, functional 
hope, restorative hope) 
Moving forward with RRMS and 
advocacy work  
Taming the Beast (support from family, friends and 
community, maintaining health & wellness, resilience, finding 
my North Star, choosing my A-Team) 
 Holding Hands with Hope (purposeful positivity, optimism, 
giving back and getting involved, spirituality) 
 Re(defining) Me now that I have RRMS (getting acquainted, 
normalcy, losses & gains, working out work) 
 
 	
 
